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R1897 Lack of compatible hospital room at a reference
infectious disease unit in Northern Italy
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Objective and methods: A 4-year retrospective survey was carried
out at our infectious disease (ID) ward, to point out discrepancies
between immediately hospitalised patients (p), and those referred
to us for admission but needing transferral elsewhere due to lack
of suitable hospital rooms.
Results: Since the year 2000, 493 p of 2073 needing hospitalisa-
tion (23.8%), could not ﬁnd an appropriate place at our ward.
Paralleling the increased room number at our division since
June 2002 (16–35 beds), the described phenomenon had a sharp
drop in frequency, but a subsequent stabilisation followed, with
around 14% of ID p sent elsewhere for hospitalisation, until
October 2003. Starting from the year 2000, the percentage of
denied hospitalisations decreased from 34.3% in the year 2000,
to 26.9% of 2001, to 12.9% of 2002, until 13.1% registered dur-
ing the ﬁrst 10 months of 2003 (P < 0.0001). HIV disease repre-
sented the most frequent diagnosis (44% of cases), followed by
acute-chronic-complicated infectious hepatitis, central nervous
system infection, undetermined hyperpyrexia, respiratory tract
infection, infectious exanthems, paediatric infectious diseases
and gastroenteritis. Suspected-conﬁrmed tuberculosis represented
the only illness who showed a signiﬁcant increase of hospitali-
zation requests, from year 2000 to October 2003 (P < 0.02), with
large contribution given by p recently immigrated to Italy
(>80% of overall episodes). P with severe, transmissible diseases
are of particular concern, when the accepting ID unit is located
40–120 km far from our city. This occurrence involved telephone
contacts and search of an ID ward, and ambulance transfer
(with medical assistance when warranted) and happened in
around 25% of p denied by our ID and Hospital, since the year
2000.
Conclusion: The role of ID wards represent a ‘moving target’
which needs of a continuous ﬁtting to economic, technical,
human, and professional health care resources, on the ground of
ever-changing predominant disorders and/or problems. A strict
monitoring of needs of hospital admission in the ID setting is
strongly needed, to improve patient’s managed care in our metro-
politan area in the next future.
R1898 Sepsis in a department of infectious diseases in a
general hospital, Celje, 2000–2003
G. Lesnicar, J. Blatnik, B. Sibanc
Celje, SI
Objectives: The aim of our study was to establish the incidence
of sepsis, and to identify the causes and source of infection in
patients treated at the Department of Infectious Diseases and
Febrile Conditions of General Hospital Celje in the years 2000–
2002.
Methods and results: In our retrograde study, sepsis was estab-
lished in 496 (9.3%) of 5316 admitted patients. Our deﬁnition of
patients with sepsis was based on additional and stricter criteria
than those reported in the literature. Thus, the source of sepsis
was known in all patients, while the causative agent was proved
in 277 (55.8%) of them, of these only in 41 (8.3%) patients it was
isolated from haemoculture, while in 236 (47.6%) patients the
causative agent was isolated from other infectious cultures.
Among the patients with known cause of infection, those with
isolated Gram-positive bacteria are prevailing (201 patients, i.e.
62.2%).
Conclusions: As in Slovenia we still have not reached an agree-
ment on the deﬁnition of sepsis, there is a great discrepancy
between the number of patients diagnosed with sepsis and the
number of patients registered by the Epidemiological Service.
According to our relatively strict deﬁnition, at least one tenth
of all the admissions to our Department are attributable to sep-
sis, while in the period 2000–2002, only 57 cases were reported
to the Epidemiological Service from Celje health region with a
population of 220 000, which represents only slightly over 10%
of all patients treated for sepsis at our Department. The data
reported call for an urgent consensus on deﬁnition, reporting
and registration of sepsis in our country.
R1899 An investigation on frequency of mental disorders
amongst TB victims in the city of Zahedan
M. Rakhshaninejad, M. Shakiba, A. Kebriaei, M. Saravani,
M. Abili, B. Fadaei, A-H. Mohagheghi
Zahedan, IR
Objectives: Tuberculosis has been known for many years. It
mainly affects human beings and usually involves the lungs
although in one third of the cases other organs are also affected.
Hence, the main target group in this project was pulmonary TB
victims, who comprise 1.7 billion throughout the world and
more than 90% of the victims are observed in underdeveloped
and developing countries. As a result the main consequences of
chronic TB are anxiety, stress and fatigue. Nonetheless, the dan-
gers of psychological effects of the patient along with mental,
cardiovascular disorders, long-term disabilities and social prob-
lems all together threaten the victim at home. The highest inci-
dence of TB in Iran exists in Sistan and Baluchistan province
(14 times more than state average), this might be due to proxim-
ity of the province with Afghanistan and Pakistan, the incidence
is uncontrollable. Hence, this research study was designed to
investigate the frequency of mental disorders amongst TB suffer-
ers in Zahedan.
Methods: This cross-sectional study comprised of 200 victims
who were suffering from TB for at least 11 years referring to
Zahedan Bou-Ali hospital and other centres combating TB for
diagnosis and continuation of treatment. All the patients were
evaluated by standard questionnaire of scl-90-R regardless of
their gender. The obtained data were analysed by bio-statistical
procedures.
Results: The results showed signiﬁcant differences (with the help
of T-test) between male and female TB sufferers i.e. mental disor-
ders amongst women were more than men (55.5%). Furthermore,
it was revealed that somatic disorders as well as stress were more
within females than males (47.7, 39.3%, respectively). The least
occurrence of violent behaviours was observed among victims
between 15 and 19 years of age and the highest was attributed to
individuals >50 years (the ﬁgure was even more for men than
women).
Conclusions: According to the ﬁndings of this study the fre-
quency of mental disorder within TB affected women was
higher that correlates with the other researches. The latter might
be due to gender discrimination, socioeconomic conditions,
more stressful life, limited sociability within women of this par-
ticular area and their cultural attitudes are all encountered as
reasons. It is concluded that, as high incidence of mental disor-
ders within women is evident, in parallel with treatment of TB
certain centres for counselling are required to reduce their
ordeals.
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R1900 Behavioural attitudes on the topic of prevention
and treatment approach of hospital-based physicians in Greece
G. Tsiros, E. Jelastopulu, P. Voila, K. Chrisanthopoulos
Rio Patras, GR
Objectives: The aim of this investigation was to evaluate prevent-
ive practices, attitudes and behaviours of hospital-based physi-
cians of different specialties with regard to their own health and
to identify areas that can be targeted for improvements.
Methods: A total of 208 physicians of four specialties groups (gen-
eral practitioners, internal, surgical and laboratory specialties) in
two tertiary care hospitals in Athens and one University hospital
in Patras answered in the presence of the interviewer a single-
page written questionnaire with eight items. Analyses were made
by using the statistical programme SPSS.
Results: The overall response rate was 100%. Of the 208 physi-
cians, 36.5% were internal specialists, 28.4% surgical specialists,
26% laboratory specialists and 9.1% general practitioners. A total
of 108 (51.9%) were males and 100 (48.1%) females with a median
age of 32 and 31 years, respectively. 62.5% of the total documen-
ted had an adequate immunisation for their age group, whereas
10.6% reported not to have been vaccinated and 26.9% declared
ignorance. Females and laboratory specialists were signiﬁcantly
more likely than males and the other specialists to be vaccinated.
On average, 67.8% reported to always take proper protective
measures and 28.4% declared to often take such measures. Factor
associated with greater use of preventive strategies was the speci-
alty (laboratory assistants 79.6, surgeons 74.6, internists 60.5 and
general practitioners 42.1%). About 50% (37% males, 62%
females) of the respondents reported that they face early critical
health situations. More than 90% are always (38.5%) or most
times (53.4%) in compliance with the guidelines and advices of
their specialists colleagues when facing health problems. A high
medication compliance is reported for all specialties. 66.8% repor-
ted avoiding polypharmacy, whereas 31.3% declared to take more
drugs when indicated. Only 2.4% reported having no conﬁdence
in other physicians, whereas the great majority trusts their col-
leagues, based on different criteria.
Conclusion: This study shows that hospital-based physicians have
in general a relatively high level of preventive and personal
health care at work. Although more than 60% reported a sufﬁ-
cient immunisation, there is still a need for improvement of the
effectiveness by ensuring that vaccination schedules are comple-
ted and by targeting physicians, especially those who declared
having no vaccination or ignorance.
R1901 Intramuscular antibiotics for outpatient treatment in
Italy: is it time for change?
F. Marchetti, G. Bettoncelli
Verona, Brescia, I
Objectives: Among the profound variation of use of different clas-
ses of antibiotics in the European Countries, consistent prescrip-
tion of intramuscular third generation cephalosporins (3GC) is
registered in Italy since many years. Such a difference is unlikely
to be caused by frequency and severity of bacterial infections, but
it is probably linked to physician’s and patient’s attitudes, histor-
ical background, cultural and social factors.
Methods: Literature analysis and market data review allows evalu-
ating the major prescription pattern of antibiotics in Italy and
costs for the National Healthcare System.
Results: Nearly half of the prescriptions of 3GC are related to
lower respiratory tract infections, but upper respiratory tract and
urinary-tract infections are also included. The major driver for the
3GC use seems to be the severity of infection and the clinical con-
ditions of the patients and a perceived higher clinical efﬁcacy and
speed of action by either General Pratictioners (GP) or Specialists
(mainly pneumologists, ENT and urologists). Patient’s request as
a reason for 3GC treatment is often reported. A trend of increas-
ing use of 3GC is observed from the North to the South of Italy.
The 3GC costs expressed as per DDD are consistently high.
Conclusion: Recent pharmacokinetic/dynamic concepts have deﬁn-
itively provided evidences that the probability of clinical success
is linked to speciﬁc drug/MIC ratios that oral antibacterials with
high (>80%) bio-equivalence and proper in vitro activity can
safely reach. Educational programs for both GPs and selected spe-
cialists are awaited to reduce inappropriate prescriptions of anti-
bacterials.
R1902 Surveillance of antimicrobial resistance at a tertiary
hospital in Tanzania
B. Blomberg, S. Harthug, N. Langeland on behalf of the joint
study group on antimicrobial resistance at Muhimbili National
Hospital, Dar es Salaam, Tanzania and the University of Bergen,
Norway
Objectives: Antimicrobial resistance is particularly harmful to
infectious disease management in low-income countries since
expensive second-line drugs are not readily available. The objec-
tive of this study was to implement and evaluate a computerised
system for surveillance of antimicrobial resistance at a tertiary
hospital in Tanzania.
Methods: A computerised surveillance system for antimicrobial
resistance (WHONET) was implemented at the national referral
hospital in Tanzania in 1998. The antimicrobial susceptibilities of
all clinical bacterial isolates received during an 18 month period
were recorded and analysed.
Results: The surveillance system was successfully implemented at
the hospital. This activity increased the focus on antimicrobial
resistance issues and on laboratory quality assurance issues. The
study identiﬁed speciﬁc nosocomial problems in the hospital and
led to the initiation of other prospective studies on prevalence
and antimicrobial resistance of bacterial infections. Furthermore,
the study provided useful data on antimicrobial patterns in bac-
terial isolates from the hospital. Gram-negative bacilli displayed
high rates of resistance to common inexpensive antibiotics such as
ampicillin, tetracycline, trimethoprim-sulphamethoxazole and sul-
phonamides, leaving ﬂuoroquinolones as the only reliable oral
drugs against common Gram-negative bacilli. Gentamicin and
third generation cephalosporins remain useful for parenteral ther-
apy.
Conclusion: The surveillance system is a low-cost tool to generate
valuable information on antimicrobial resistance, which can be
used to prepare locally applicable recommendations on antimicro-
bial use. The system pinpoints relevant nosocomial problems and
can be used to efﬁciently plan further research. The surveillance
system also functions as a quality assurance tool, bringing atten-
tion to methodological issues in identiﬁcation and susceptibility
testing.
R1903 Bacteraemia in a Portuguese hospital: a 9-year
analysis
M. Pessanha, C. Marcelo, A. Azevedo, E. Gonc¸alves, T. Cruz,
H. Silva, I. Alves, P. Bruno, N. Rosa, J. Santos, F. Martins,
J. Esperanc¸a-Pina
Lisbon, P
Objectives: The aim of this study was to analyse the bacteriaemia
rate and evolution of the most frequent microbiological agents iso-
lated at the laboratory of a central hospital in Lisbon, between
1994 and 2002.
Methods: We studied 40 039 blood cultures and we analysed the
most frequent agents responsible for bacteriaemia. Until 1996,
blood cultures were processed with Oxoid blood bottles, manu-
ally. Since 1997, BactAlert was introduced and microbiologic iden-
tiﬁcation and susceptibility tests were performed by Vitek system.
Results: From the 40 039 blood cultures we have obtained a posi-
tivity rate of 9.7% (3871 bottles) and a contamination rate of 6Æ3%
(2508 bottles). Coagulase-negative staphylococci were the most
frequent isolated agent (mean: 16.3% with a slightly decrease in
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the last years. It was followed by methicillin susceptible Staphy-
lococcus aureus (MSSA) (15.6%), which has a tendency to
decreased, and E. coli (12.7%) that seems to be increasing. Spe-
cially in the last years, it is important to notice the emergence of
methicillin-resistant Staphylococcus aureus (MRSA) (8.2%), Entero-
coccus faecalis (7.3%) and Candida spp (4.8%). Other organisms
had a low incidence and their emergence was intermittent (Strep-
tococcus pneumoniae, Klebsiella pneumoniae).
Conclusions: The elevated contamination rate alert us for the
importance of a correct sample collection as goal of results qual-
ity. Although Staphylococcus epidermidis is the most commonly
isolated agent, as expected, we notice a pattern change in which
E. coli is more often isolated and reached the top at 2000 and
2002. It is also concerning the increasing incidence of MRSA and
Enterococcus faecalis. Since 2001, yeasts started to assume an
important role as an etiologic agent as a result of the more and
more agressive antimicrobial therapies that are prescribed to the
patients.
R1904 Cost-effectiveness analysis of miniVITAL
automated system vs. routine blood culturing procedure
A. Bedenkov, D. Galkin, O. Kretchikova, A. Nikulin,
L. Stratchounski
Smolensk, RUS
Objectives: To evaluate the rate of positive blood cultures, incuba-
tion time to detect positive results from inpatients using an auto-
mated miniVital system (bioMerieux) (AS) vs. routine blood
culture procedure (RBCP) and to determine if AS is a more cost-
effective then RBCP.
Methods: Consecutive blood cultures were obtained from polyva-
lent ICU patients with sepsis (ACCP Consensus Conference, 1992)
in three Smolensk city hospitals from June 2002 through Decem-
ber 2002 and included in prospective comparative observational
study. Incidence rate of positive results for AS and RBCP was
evaluated. Time to detection of positive results for both methods
was determined and compared. Direct costs of comparable alter-
natives were calculated (the hospital perspective was studied) and
cost-effectiveness ratios were collated.
Results: A total of 221 blood samples (55 – AS, 166 – RBCP) were
obtained from 180 patients. Positive results with AS were
obtained in 12 (21.8%) patients and RBCP – 15 (9.0%) patients
(P ¼ 0.017). Mean time for positive results for AM was
5.3 + 2.1 days, for RBCP – 6.9 + 1.6 days (P ¼ 0.0001). Two vials
were used in 52.7% (29) in AM and 12.7% (21) in RBCP. Direct
costs of culture procedure for AS and PBCP were 8.7 USD and 4.8
USD, respectively. Cost-effectiveness ratio for AS amounted to 0.4
USD and for RBCP to 0.5 USD.
Conclusions: As method has proved to be a more sensitive proce-
dure for evaluating blood cultures in comparison with RBCP. Pro-
cessing of blood cultures with AS reduces time to positive results
thereby guiding rational antibiotic therapy. AS is a more cost-
effective then RBCP for blood culturing.
Acknowledgement: The study was performed under the APUA
Small Grants Programme
R1905 Microbial investigation of the possible association
between pre-term birth and early periodontitis
E. Urban, E. Nagy, M. Radnai, I. Gorzo´, T. Nova´k, A. Pa´l
Szeged, HUN
Objectives: According to many studies, generalised periodontitis
caused by complex anaerobic bacterial ﬂora can be a risk factor
for preterm birth (PB). A microbiological study was carried out to
examine if early localised periodontitis could be a risk factor for
adverse pregnancy outcome.
Methods: Postpartum women without any systemic disease were
included into the study. Similar numbers of patients belonged to
the case (85) and to the control (80) groups. A PB case was
deﬁned if a patient had a threatening premature labour during
pregnancy, preterm premature rupture of membranes, or sponta-
neous preterm labour, and/or the weight of the newborn was
<2499 g. Control women had delivery after the 37th gestational
week and the newborn’s weight was >2500 g. For the microbial
investigation the periodontal areas are being sampled directly
with sterile paper points that were placed in the gingival crevice.
Samples were transported in reduced transport medium to the
microbiology laboratory immediately after collection. After gentle
dispersion the suspensions were diluted (10-1-10-6) in reduced
broth and the suspensions were plated on selective and nonselec-
tive media to enumerate the total cultivable bacterial ﬂora. For the
isolation of anaerobic organisms, cultures were performed in an
anaerobic chamber for 6 days at 37C. After incubation, total aero-
bic and anaerobic colony counts were determined. Isolated bac-
teria were identiﬁed by using commercial methods and/or ATB
identiﬁcation procedures.
Results: A signiﬁcant association was found between PB and early
localised periodontitis of the patient with the criteria having
bleeding at 50% of the examined sites and having at least at one
site 4-mm probing depth. The average weight of the newborns in
the periodontitis group was less than in the control group, the dif-
ference being signiﬁcant (P ¼ 0.047). There was considerable vari-
ation in terms of the total bacterial counts, it was generally higher
of the patients belonged to the case group. The total anaerobic
count varies from 1  106 to 1  109/mL and Prevotella interme-
dia/nigrescens, Porphyromonas gingivalis, Actinomyces sp. and Pepto-
streptococcus sp. were found in greater proportion in the patients
suffered from early localised periodontitis.
Conclusion: The results indicate that early localised periodontitis
caused by signiﬁcant number of anaerobic bacteria of the patient
during pregnancy can be regarded as an important risk factor for
PB.
R1906 Economical consequences of an outbreak of bullous
impetigo in Viborg County, DK, 1999–2003
J. Prag, C. Borg
Viborg, DK
In August 1999 Department of Clinical. Microbiology. suddenly
recorded a manyfold increase in the number of swabs taken
from patients with bullous impetigo in general practice. The
causative microorganism was a toxine producing Staphylococcus
aureus. Most of the patients were preschool children, evenly dis-
tributed from both sexes. The epidemic never ceased and in
2001–2003 there was each year a marked peak in August/Sep-
tember. The incidences were up to 1200 yearly in a population
of 235 000. Intra-institutional and inter-family clusters were often
noted. Few relapses occurred despite otherwise effective treat-
ment with oral dicloxacillin. All strains were penicillin resistant,
but none of the strains were methicillin resistant. In the start of
the epidemic only 10% of the strains were resistant to fucidic
acid raising to 60% in autumn 2002. Despite that more strin-
gent hand hygiene was recommended to the institutions by the
health authorities the epidemic now continues unchanged on the
ﬁfth year. Concurrent with the epidemic of bullous impetigo in
the community more than 10 babies with staphylococcal scalded
skin syndrome (SSSS) were admitted each year to the local pae-
diatric department. Average admission 8 days. SSSS was not
diagnosed every year before 1999. Rough calculations of the
expenses to visit practitioners, microbiological analyses, prescrip-
tions, drugs and parents lost income as they had to stay home
to care for the children amounts to >2 million Euro in the 4-year
period. Extrapolated to whole Denmark the epidemic has so far
cost >40 million Euro.
Conclusions: It has so far not been possible to stop the country
wide, expensive epidemic of bullous impetigo by recommending
general hygienic precautions for children alone. To elucidate the
true transmission risks some carefully conducted studies should
be carried out.
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R1907 A targeted approach to ﬂuoroquinolone use
improves appropriateness and reduces cost of therapy
S. Davis, P. McKinnon
Detroit, USA
Background: Increasing ﬂuoroquinolone (FQ) use has been des-
cribed nationally and was observed locally at an urban trauma
center, coinciding with increasing FQ resistance rates among
P. aeruginosa. An antimicrobial management team assessed FQ
use daily, reporting results quarterly, and noted an increase in
inappropriate levoﬂoxacin (L) prescribing. Excessive use of
quinolones can contribute to development of resistance and
increased antimicrobial costs. We implemented a formulary con-
version from L to moxiﬂoxacin (M) and ciproﬂoxacin(C). M use
was targeted to CAP only, with C reserved predominantly for
P. aeruginosa.
Objectives: The objective was to assess the impact of the conver-
sion on appropriateness of FQ use, cost of FQ use, cost of all anti-
biotics, and resistance.
Methods: We conducted an interventional study comparing the 12
months prior to and after the formulary conversion. Appropriate-
ness of FQ use was deﬁned based on criteria deﬁned by the anti-
microbial subcommittee. Endpoints assessed were FQ use, FQ
appropriateness, FQ costs, total antibacterial use, and total anti-
bacterial costs.
Results: After conversion, total ﬂuoroquinolone use decreased
from 49 DDDs/1000 pt days to 33; respiratory FQ use from 25
to 10, and ciproﬂoxacin use remained stable, 22 to 24. Adher-
ence to criteria improved for all FQs (65% increased to 76%,
P < 0.001), respiratory FQs (67 up to 88%, P < 0.001), and for
ciproﬂoxacin (54 up to 62%). Formulary conversion also cor-
responded with a decrease in FQ expenditures: pre-
intervention ¼ $607, Post ¼ $327 (USD per 1000 pt days). A
modest increase was seen in costs of cephalosporins ($2085 up
to $2542) and macrolides ($1109 up to $1277). These data corre-
spond to an estimated annual savings of $20 000 our hospital,
or $132 500 when extrapolated to our entire 2000-bed medical
center. Total antibacterial expenditures for the hospital
decreased from $646 000 to $594 000 for the two study periods.
Resistance analysis will be performed and reported once 2003
data is complete.
Conclusion: A targeted approach to formulary FQ management
improved appropriateness of FQ use and decreased cost.
R1908 A food-borne outbreak of Salmonella enteritidis in
Ankara, Turkey
A. Gozalan, B. Levent, A.P Ozkan, H. Simsek, F. Durlu Ozkaya,
N. Sahiner, L. Akin, B. Esen
Ankara, TR
Objective: To investigate a foodborne outbreak with clinical and
laboratory features which was detected in a restaurant of a work-
place.
Methods: A cluster of cases with same symptoms associated with
gastroenterititis had been identiﬁed among the employees of the
same organisation who had eaten lunch and dinner produced in
the same central kitchen by a food company, was investigated.
Salmonella enteritidis was isolated from stool samples of six
patients out of nineteen by conventional culture methods with
serotyping and antimicrobial susectibility tests were done by disc-
diffusion method. Interviewes with the related people including
the managers, responsible people from kitchen and the food han-
dlers were done. A questionnaire was applied to the people who
had eaten suspected meal in order to obtain information for des-
criptive epidemiology and the food histories.
Results: All foods was prepared at the same kitchen and were
delivered ﬁve restaurants for lunch and two restaurants for dinner
on the day of outbreak. The precooked materials which were all
fresh have been stored in healthy conditions and the expire dates
were suitable. The lunch consisted of soup with meatball, dolma,
yogurt, macaroni with sausages and tomato paste sauce and
desert. Except the soup and macaroni recooked, the dinner menu
was the same with lunch. Dolma, yogurt and sauce were stored in
refrigerator until the dinner. The questionnaire were conducted to
90 people who had eaten from the same kitchen. 20/31 (64.5%),
15/15 (100.0%) and 36/44 (81.8%) of people got ill who had eaten
only lunch, only dinner and lunch and dinner respectively. The
incubation period ranged from 3 to 32.5 h with a mean incubation
period of 17.4 h. The age ranged between 17 and 60 years and the
median of age was 32 years. The highest ratio of the infection was
observed as 84.3% (70/83) among the people who had eaten maca-
roni with sausages and tomato paste sauce. The antimicrobial su-
sectibility tests of the six Salmonella enteritidis strains revealed that
all were uniformly intermediately resistant to tetracycline, and
were uniformly sensitive to ampicillin, chloramphenicol, trimetho-
prim, trimethoprim/sulpfamethoxazole, ciproﬂoxacin, streptomy-
cin, kanamycin, gentamycin, amikacin, nalidixic acid.
Conclusion: According to those descriptive epidemiological results
several hypothesis have been developed and in order to test them
an analytical epidemiological study is still on going.
R1909 Antimicrobial prescribing for outpatient adults with
acute otitis media
S. Kozlov, S. Ratchina, A. Tarasov, L. Stratchounski, O. Egorova,
T. Dobrovolskaja, V. Kuzin, S. Paljutin, A. Karamisheva,
S. Chemesov
Smolensk, Rjazan, N.Novgorod, Yaroslavl, Volgograd, Ekaterinburg,
RUS
Objectives: Acute otitis media (AOM) is a common infection requi-
ring physician visits and prescription of systemic antimicrobials
(AM) in outpatient departments all over the world. The objective of
the study was to evaluate the frequency and patterns of AM prescri-
bing for outpatient adults with AOM in European part of Russia in
comparison with previously published recommendations.
Methods: The study was carried out in randomly chosen public
outpatient departments in six regions of Russia. In each depart-
ment consecutive cases of AOM, registered in 2001, were selected
for clinical chart evaluation. The appropriateness of AM choice
was assessed in accordance with the available guidelines.
Results: The study included 1115 patients with AOM (501 males,
614 females) aged from 17 to 83 years, average age 39.9  13.8
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years. AM were prescribed to 78% of patients with AOM. The
recommended ﬁrst-or second-line AM were used in 14.8% of
cases (6.7, 7.0, 7.8, 15.5, 22.4 and 43.8% in Volgograd, Rjazan,
Smolensk, Ekaterinburg, Yaroslavl and N. Novgorod, respect-
ively). Among 33 different AM frequently prescribed as initial
therapy were doxycycline, amoxicillin, ampicillin, ciproﬂoxacin,
co-trimoxazole and lincomycin (19.5, 19.3, 16.7, 11.5, 7.2 and 6.7%
of cases, respectively). Smolensk and Ekaterinburg were character-
ised by predominant use of ampicillin (41.7 and 30.3%, respect-
ively), Yaroslavl–doxycycline (31.9%), Rjazan–ciproﬂoxacin
(24.7%), Volgograd–co-trimoxazole (21.3%). The average course of
AM treatment was 7.2  3.4 days and varied from 5.7  3.2 days
in Rjazan to 9.0  6.1 days in Volgograd.
Conclusions: AM therapy is still the mainstay of AOM management
in outpatient adults despite the lack of substantial evidence of their
beneﬁts. The AM choice differs signiﬁcantly from current recom-
mendations. The appropriate educational efforts should be underta-
ken to improve AM treatment of AOM in outpatient adults.
R1910 Aetiology and risk factors of infective endocarditis
A. Slavcovici, D. Carstina, M. Lupse, D. Bedeleanu, N. Sasca
Cluj-Napoca, RO
Objective: The purpose of our study is to investigate the aetiology
and risk factors of infective endocarditis (IE) in our geographic
area.
Methods: In a retrospective chart review all 125 patients who ful-
ﬁlled the Duke criteria for IE between January 1998 and December
2003 were included in the study. For reasons of accuracy for the
aetiological diagnosis we have used the automatic method for
bacterial detection (BacT/Alert system). The strains were identi-
ﬁed by API system.
Results: The persistent bacteraemia was demonstrated in 63.2%
cases. The majority of endocarditis were caused by gram-posit-
ive cocci (78.5%): Streptococcus viridans (25.3%), Streptococcus bo-
vis (5%), Enterococcus spp. (6.3%), Staphylococcus aureus 34%
(MSSA24%, MRSA 10%). Gram-negative bacilli were detected
in 19% cases. Viridans streptococcal endocarditis were associ-
ated with dental procedures (P ¼ 0.000) and staphylococcal
endocarditis were associated with prosthetic valve or intravas-
cular devices. Frequency of Gram-negative endocarditis was
correlated with urinary and gastrointestinal diseases or proce-
dures.
Conclusions: A large variety of microorganisms was implicated in
IE, but staphylococci and streptococci remained the most common
etiologic agents. The streptococcus aetiology is associated with
stomatological invasive procedures or periodontal infections. The
prosthetic valve represents an important risk of staphylococcus
endocarditis. The endocarditis prophylaxis is not adequate at such
time, especially in situations of stomatological or genitourinary
invasive procedures.
New drugs
R1911 Novispirins – a new class of antimicrobial peptides
with potent in vivo activity
S. Zhijun, D. Raventos, P. Mygind, C. Sonksen, O. Taboureau,
N. Høiby, H. Kristensen
Copenhagen, Bagsvaerd, DK
Objectives: The novispirins are a new class of antimicrobial pep-
tides originally developed by Robert Lehrer and coworkers. They
resemble a sheep cathelicidin, SMAP-29, and are linear, amphi-
pathic, a-helical peptides. In vitro, the novispirins have broad and
potent activity against Gram-positive and Gram-negative bacteria,
certain yeasts and fungi while exhibiting limited haemolytic and
cytotoxic activities. The objective of this study was to determine
the in vivo therapeutic potential of the novipirins in reducing the
bacterial burden and lung pathologies associated with pulmonary
infections.
Methods: A rat pneumonia model has been employed. In brief, the
rats were anaesthetized and via intra-tracheal delivery inoculated
with 10E9 colony forming units of a stable mucoid clinical isolate
of P. aeruginosa. Immediately after infection and 3 h postinfection,
the rats were administered 200 lL of a 0.1 mg/mL solution of no-
vispirin G10 or 200 lL PBS intratracheally to the left lung. The
rats were divided in eight groups and analysed for lung pathol-
ogy, pulmonary bacteria, and histopatholgy at days 3, 5, 7 and 10.
Results: The pathology results showed a large and signiﬁcant
decrease in several macroscopic lung indexes (e.g. lung index of
macroscopic pathology -LIMP) on days 3, 5, 7 and 10. In addi-
tion, the number of bacteria recovered from the lung was signiﬁ-
cantly reduced during the initial course of the experiment (day 3
and 5). However, the infections were almost resolved in both trea-
ted and untreated animals by day 7 and 10.
Discussion: The results presented here shows that the novispirins
holds great promise as therapeutics to combat or limit pulmonary
infections, such as P. aeruginose in patients diagnosed with cystic
ﬁbrosis. Interestingly, several AMPs have been shown to boost
various functions of the immune-system. It has still to be deter-
mined whether the observed effects are a direct effect of reducing
the bacterial burden in the lungs or if it is an indirect effect medi-
ated through stimulation of the immune-system.
R1912 Safety and tolerability of outpatient caspofungin
therapy
N. Kartsonis, M. DiNubile, A. Meibohm, C. Sable
West Point, USA
Objectives: Outpatient (OP) parenteral therapy may offer a safe,
convenient, and cost-effective approach for some fungal infec-
tions. We reviewed our experience with OP administration of ca-
spofungin (CAS) for esophageal candidiasis (EC).
Methods: We evaluated the use of CAS as OP therapy in four
phase II/III studies of the primary treatment of EC. The doses of
CAS included 35, 50 and 70 mg given intravenously once daily.
The recommended duration of CAS was 7–21 days. Adverse
events (AE) judged by the investigator as deﬁnitely, probably, or
possibly related to study drug were considered drug-related (DR).
OP therapy was used at the discretion of the investigator. For the
purposes of analysis, inpatients (IP) were deﬁned as receiving
their entire treatment in the hospital; all other patients were coun-
ted as OP.
Results: A total of 141/272 (52%) EC patients were OP, of whom
125 (89%) were treated entirely as OP; the remaining 16 received
part of their CAS therapy as OP (nine received 50% of doses as
OP). The 131 IP and 141 OP with EC were comparable in age,
gender, and baseline endoscopic grade. The large majority of both
IP and OP had advanced HIV infection. Frequencies of DRAE in
IP and OP are shown in the table. The most common DRAE in
OP were fever (10%), infusion site complications (11%), phlebitis
(6%), headache (6%), nausea (6%), elevated aspartate transami-
nase levels (12%), and elevated alkaline phosphatase levels (7%),
and were similar to DRAE seen in IP. Four OP (3%) were admit-
ted to the hospital during CAS therapy, but no admission resulted
from a DRAE or treatment failure.
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Conclusions: CAS was generally well tolerated as OP therapy for
EC. There were no serious DRAE and DRAE leading to discon-
tinuation were infrequent in OP. Under appropriate conditions,
CAS can be safely administered in an OP setting.
R1913 Novispirins – novel antibiotics with potent activity
in wounds
L. Steinstraesser, D. Raventos, P. Mygind, C. Sonksen,
O. Taboureau, H.-H. Kristensen
Bochum, D; Bagsvaerd, DK
Objectives: The novispirins are a potent class of antibiotics with
broad antimicrobial activities against bacteria, yeasts and fungi.
Despite their broad activity, they show limited in vitro toxicity. The
objective of this study has been to investigate the potential of the
novispirins in reducing the bacterial burden in a pig wound model.
Methods: A number of small wound chambers were installed on
the dorsal sides of Go¨ttinger mini-pigs. The wound chambers
were kept sterile and monitored for 8 days before inoculation
with test bacteria. At day 8, each wound chamber was infected
with 5  108 colony forming unit, and the infection was allowed
to establish for 4 days. Clinical isolates of either Staphylococcus au-
reus or Pseudomonas aeruginosa were employed in two separate
experiments. At day 2 after bacterial inoculation, all wound cham-
bers were infected. At day 4 after initial inoculation, the wound
chambers were washed, freshly inoculated with 108 bacteria and
treated with different doses of novispirin. The number of viable
bacteria in the wound chambers were monitored at T ¼ 0, 1, 2, 3
and 4 h posttreatment. The wound-chamber CFU was determined
by plating of serial dilutions of the samples.
Results: The data revealed a fast and dramatic decline in the num-
ber of bacteria in the wound chambers. As reﬂected in vitro, the
fastest and most potent response was seen with P. aeruginosa,
where 99.99% of the bacteria were eliminated within minutes.
The same degree of reduction was seen with S. aureus, albeit with
a little slower kill kinetic.
Discussion: The data shows that the novispirins are a potent alter-
native to current antibiotic therapies directed against wounds and
other topical infections. The potency, antimicrobial spectrum, lack
of spontaneous resistance and the speed of bacterial elimination
makes this class of antibiotics an ideal candidate for further clin-
ical development.
R1914 The in vitro activity of a new oxazolidinone
(linezolid) against ﬂuoroquinolone-resistant enterococci isolated
in Romania from January 1999 to June 2003
M. Pana, M. Ghita, D. Blana, R. Papagheorghe, N. Popescu,
G. Bancescu, M. Andrei, O. Dorobat, V. Ungureanu, I. Nistor,
S. Iacob, D. Andries
Bucharest, RO
Objective: To study the antibiotic resistance in Enterococcus spp.
isolated in Romania.
Methods: A total of 553 enterococci isolated between January 1999
and June 2003 were collected from: urine, surgical wounds, blood,
drain and others: bile, synovial and peritoneal ﬂuid. The strains
were characterised by using standard protocols (NCCLS). The en-
terococci were studied for susceptibility to seven antibiotics:
amoxicillin (Amx), ciproﬂoxacin (Cip), gentamicin (Gn), strepto-
mycin(Str), vancomycin(Va), norﬂoxacin(Nor), linezolid(Lzd) by
three methods: disc-diffusion, screening agar plates and agar dilu-
tion according to NCCLS recommendations.
Results: The data were analysed according to NCCLS 2002 and
showed the following aspects: 77% E. faecalis, 22% E. faecium, 1%
E. durans. Amx resistance was seen only in E. faecium: 83% in
urine, 100% drain, 100% surgical wounds and 98% in blood. No
b-lactamase producers were detected. Concerning E. faecium high
level resistance (HLR) to Gn was 100% in drain, 89% in surgical
wounds and 77.8% in blood and HLR to Str was 38% in drain,
57.5% in surgical wounds and 14.3% in blood. For E. faecalis HLR
to Gn was 7.9% in surgical wounds and 26.3% in blood and HLR
to Str was 31.6% in drain, 24% in surgical wounds and 12.9% in
blood. Only one strain (E. faecium) resistant to Va was found. Con-
cerning Lzd intermediate resistance among ﬂuoroquinolone
(FQL)-resistant E. faecium (72.9%) only one strain was found. FQL
resistant E. faecalis (25.7%) showed the same aspect (only one
strain Lzd intermediate resistant.)
Conclusion: The Lzd susceptibility pattern showed an excellent and >
nearly complete in vitro activity against the Romanian enterococci.
Pharmacokinetics, pharmacodynamics, drug interactions, tolerability
R1915 In vitro activity of iclaprim (formerly AR-100)
against lower gastrointestinal tract isolates
G.G. Zhanel, T.L. Hisanaga, M.R. DeCorby, N.M. Laing,
K.A. Nichol, L.P. Palatnick, A.M. Noreddin, S. Hawser, K. Islam,
D.J. Hoban
Winnipeg, CAN; Munchenstein, CH
Objectives: Antibiotic use in respiratory tract infections is fre-
quently associated with bowel ﬂora alterations and selection of
antibiotic resistant ﬂora. Iclaprim is a novel diaminopyrimidine in
development that reportedly possesses activity against antibiotic-
resistant pathogens. This study examined the activity of Iclaprim
to over 2000 isolates recovered from the lower GI tract (bowel) of
60 volunteers receiving antimicrobials.
Methods: During 2002/3, 60 healthy volunteers in groups of 15
received four different antimicrobial regimens. Quantitative stool
cultures performed over 12 weeks yielded multiple Gram-negat-
ive/positive isolates. The activity of Iclaprim was determined util-
izing NCCLS speciﬁed microbroth dilution MIC testing.
Results: The MIC50;90 (lg/mL) and range of Iclaprim vs. bowel
ﬂora isolates is shown below:
IP [n ¼ 131] OP [n ¼ 141]
Duration of CAS
therapy, median [range] in days
10 [1–18] 10 [1–20]
Clinical AE
DRAE 76 (58%) 58 (41%)
Serious DRAE 0 (0%) 0 (0%)
D/C due to DRAE 2 (2%) 1 (1%)
Laboratory AE
DRAE 66 (50%) 44 (31%)
Serious DRAE 0 (0%) 0 (0%)
D/C due to DRAE 2 (2%) 1 (1%)
Organism (n) MIC50;90 Range Organism (n) MIC50;90 Range
Enterobacteriaceae
(790)
1/8 0.12–64 Enterococcus
sp. (330)
0.06/0.5 0.06–64
E. coli (444) 1/8 0.12–64 E. faecalis (162) 0.06/0.5 0.06–64
K. pneumoniae
(103)
1/8 0.5–64 E. faecium (104) 0.06/0.5 0.06–64
E. cloacae (59) 1/4 1–64 S. aureus (23) 0.06/0.12 0.06–32
C. freundi (42) 1/2 0.5–16 S. agalactiae (32) 0.12/0.25 0.06–32
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Conclusions: Iclaprim demonstrates good activity against lower GI
Gram-negative bacilli and enhanced activity against lower GI
gram positive cocci.
R1916 In vitro elution of moxiﬂoxacin by two types of
cement: norian versus acrylic bone cement
K. Athanassiou, I. Skiadas, T. Tsaganos,
E.J. Giamarellos-Bourboulis, K. Kanellakopoulou, H. Giamarellou
Athens, GR
Objectives: Local antibiotic delivery systems for chronic osteomy-
elitis have evolved in an attempt to reduce the extended use of
oral therapy. Moxiﬂoxacin is a novel quinolone active on Gram-
positive pathogens of chronic osteomyelitis. Its in vitro release of
moxiﬂoxacin from Norian and acrylic bone cement was evaluated.
Methods: NORIAN skeletal repair system (Norian) is a novel bio-
compatible type of bone cement proposed for structural augmen-
tation of cancellous bone after traumatic injury or fractures.
Norian and acrylic bone cement were admixed at a 100:3 ratio to
moxiﬂoxacin at room temperature in sterile vials. Five samples
were prepared per type of material. Mueller–Hinton broth (1 mL)
was added over the free surface of the mixture and replaced
every 24 h for 28 days; samples were incubated at 37 C Concen-
trations of moxiﬂoxacin were determined in daily specimens by
an HPLC assay with a Nucleosil-5 150 lM  2.4 lM column with
a 50:50 buffer:acetonitrile mobile phase. A pH: 3 phosphate buffer
was applied with a 1 mL/min ﬂow rate.
Results: They are given as means of ﬁve samples each day.
Conclusions: Elution of moxiﬂoxacin is higher by Norian after the
ﬁrst days compared with acrylic bone cement so as to be promis-
ing for the management of bone infections.
R1917 Penetration kinetics of moxiﬂoxacin in human
pancreas
R. Wacke, S. Fo¨rster, S. Park, R.G. Mundkowski, U. Adam,
W. Schareck, E. Klar, B. Drewelow
Rostock, Freiburg, D
Objectives: Acute necrotizing pancreatitis is still related to an
extremely high mortality rate, based on local infectious complica-
tions, particularly in necrotising areas. Limited penetration of anti-
microbial drugs in these areas is considered to be a major cause
of failure of therapy of severe infections. However, ﬂuoroquinolo-
nes have been shown to penetrate sufﬁciently into pancreatic
tissue. On that score, the value of new quinolones such as moxiﬂ-
oxacin (MXF) has not been investigated yet. Using a rat model of
acute necrotizing pancreatitis MXF has been demonstrated to pen-
etrate rapidly and efﬁciently into pancreatic tissue, even into the
inﬂamed and necrotic pancreas.
Methods: Addressing the penetration capability of MXF with
respect to the human pancreas, a prospective clinical trial was
designed using a single oral dose of 400 mg MXF for antimicro-
bial prophylaxis in 40 patients (diagnose: chronic pancreatitis or
pancreas carcinoma) undergoing pancreas surgery. Samples were
taken from blood at 1.7, 3.7 and 5.3 h after application and from
resection area of pancreatic tissue at 3.7 and 5.3 h. Concentrations
of MXF were determined by HPLC/UV using oﬂoxacin as inter-
nal standard.
Results: Mean plasma concentrations of MXF at 1.7 h after applica-
tion were 1.4  0.8 lg/mL, at 3.7 h 1.2  0.6 lg/mL and at 5.3 h
1.0  0.5 lg/mL. Corresponding mean concentrations in pancre-
atic tissue were two to three times higher (at 3.7 h 2.7  1.3 lg/g
and at 5.3 h 3.1  1.8 lg/g). The MIC90 of the relevant pathogens
encompassed by MXF (e.g. E. coli, Klebsiella spp. and Staph. aureus)
were exceeded for at least 5 h in pancreatic tissue. However, the
MXF concentration achieved did not reach the MIC of Pseudomon-
as spp. and Enterococcus spp.
Conclusion: MXF has been demonstrated to penetrate rapidly and
efﬁciently into human pancreatic tissue. From the pharmacokinetic
point of view MXF may have a potential clinical beneﬁt in patient
with infectious complications of acute necrotising pancreatitis.
R1918 Bactericidal activity of moxiﬂoxacin against
Haemophilus species
J. Herrington, J. Remy, C. Tow-Keogh, M. Patzuk, J. Federici
West Haven, USA
Objectives: Haemophilus inﬂuenzae is frequently isolated in respir-
atory infections. Pharmacokinetics suggest that macrolides are
not as effective against H. inﬂuenzae as ﬂuoroquinolones. Time-
kill kinetics were used to compare the bactericidal rate of mox-
iﬂoxacin (MXF) to levoﬂoxacin (LEV), azithromycin (AZ),
clarithromycin (CLA) and telithromycin (TEL) against strains of
H. inﬂuenzae and H. parainﬂuenzae with elevated macrolide
MICs.
Method: Two strains of H. inﬂuenzae and H. parainﬂuenzae were
tested in Haemophilus test medium (HTM). Antibiotics were tested
at concentrations of 4, 2, and MIC. The tubes were incubated
in ambient air. Readings were at 10, 20, and 30 min, 1, 1.5, 2, 2.5,
3, 3.5, 4, 4.5 and 6 h. Plate counts were done in HTM and incuba-
ted for 48 h at 35C in 5% CO2. Activity was measured by
log 10 U (CFU/mL) reductions over time.
Results: For both strains of H. inﬂuenzae at 4  MIC MXF there
was a 1 log 10 decrease within the ﬁrst 10 min, and a 3 log 10
decrease (99.9% killing) by 1 h. MXF had the fasted killing rate. A
3 log 10 decrease for both strains was seen at 1.5–2 h for 4  MIC
LEV, and at 4.5 h for one strain at 4  MIC AZ. TEL and CLA
were static. By 2.5 h 2  MIC MXF achieved 99.9% killing for
both strains; it took LEV 3.5 h. AZ, CLA and TEL had no activity
until after 2 h. At MIC, MXF was again the most active. For H.
parainﬂuenzae a 3 log 10 decrease was achieved by 4 and 2
MIC MXF for both strains, but for only one strain for LEV. MXF
had activity within the ﬁrst 10 min; AZ, the most active macro-
lide, did not show any activity for the ﬁrst hour. CLA and TEL
were the least active.
Conclusion: The time-kill kinetics of MXF were superior to AZ,
CLA and TEL against H. inﬂuenzae. MXF had a faster killing rate
than LEV at all concentrations tested. The bactericidal activity of
MXF was better than AZ, CLA and TEL against H. parainﬂuenzae.
The killing kinetics of TEL mimicked the macrolide CLA. MXF
demonstrated excellent time-kill kinetics against these respiratory
pathogens.
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R1919 Stability and compatibility of temocillin for
administration by continuous infusion in intensive care patients
V. Basma, F. Van Bambeke, M.P. Mingeot-Leclercq, P. Tulkens
Brussels, B
Objective: b-lactams are time-dependent antibiotics and adminis-
tration by continuous infusion (CI) appears, therefore, a meaning-
ful approach on a pharmacodynamic basis while affording
pharmacoeconomic advantages compared with conventional, mul-
tiple-daily dosing. Previous studies, however, showed that the sta-
bility of individual b-lactams, and their compatibility with other
drugs, must be carefully checked under the practical conditions of
their projected clinical use. The present study aims at deﬁning the
conditions of safe use of temocillin (TMO), a narrow spectrum
b-lactam, in this context.
Methods: We mimicked the conditions foreseen for the use of TMO
by CI in intensive care patients, namely a daily dose of 4 g dis-
solved in 48 mL (8.3%) and (i) maintained at appropriate tempera-
tures for up to 24 h (stability studies) or (ii) mixed with drugs
commonly used in intensive care patients at mass ratios corres-
ponding to those observed if TMO and the companion drug are
administered through the same infusion line (compatibility stud-
ies). TMO concentration was determined by HPLC and deﬁned as
the sum of its R and S isomers. Criteria for acceptance were (i)
chemical stability (90% for each isomer and for the sum of both)
and (ii) no evidence of physical incompatibility (inspection against
a black and white background using an Industry-standard viewer).
Results: TMO was stable for 24 h at temperatures from 20C
through 37C, and compatible with amikacin (borderline), gen-
tamicin, tobramycin, clindamycin, ﬂucloxacillin, erythromycin,
moxiﬂoxacin, ceftazidime, and ﬂuconazole, and with adrenaline,
dopamine, dobutamine, isosorbide dinitrate, furosemide, uradipil,
theophyllin, omeprazole, insulin, methylprednisolone, ketamine,
morphine, sufentanyl, phenytoin, tramadol, penthotal, paracet-
amol, valproic acid, N-acetyl-cysteine, and aminoacid solutions. In
contrast, clarithromycin, ciproﬂoxacin, meropenem, imipenem,
piperacillin/ tazobactam, vancomycin were all found incompat-
ible, and propofol, piritramide and midazolam.
Conclusion: Temocillin can safely be used under the conditions
foreseen for the use by CI in intensive care patients and is com-
patible with many of the drugs commonly used in intensive care
patients. Clinical studies of temocillin given by CI are warranted.
R1920 Stability and compatibility of vancomycin for
administration by continuous infusion in intensive care patients
V. Basma, F. Van Bambeke, M.P. Mingeot-Leclercq, P. Tulkens
Brussels, B
Objectives: Continuous infusion is a potentially useful mode of
administration for time-dependent antibiotics in severely ill
patients both on pharmacodynamic and pharmacoeconomical
bases. In this context, many investigators have advocated the
administration of vancomycin (VAN) by continuous infusion (CI).
No detailed study, however, is available concerning VAN stability
and compatibility with other drugs when used under the practical
conditions required for intensive care patients. The present study
aims at deﬁning the conditions of safe use of VAN in this context.
Methods: All experiments were made with VAN available on the
Belgian market as VANCOCIN. We mimicked the conditions
foreseen for its use by CI in intensive care patients, namely a max-
imal daily dose of 4 g in 48 mL (8.3%) (i) maintained at appropri-
ate temperatures for up to 72 h (stability) and (ii) mixed with a
series of drugs at mass ratios with VAN similar to those that would
be observed if VAN and the companion drug would be infused
through the same line (compatibility). Criteria were a chemical sta-
bility 90% (as determined by HPLC) and no visible evidence of
physical incompatibility (visualisation-inspection against a black
and white background using an industry-standard viewer).
Results: VAN was stable at temperatures ranging from 4C
through 37C for up to 72 h [signiﬁcant degradation (>10%) was
seen at 50C]. VAN was compatible with cefepime (up to 12.5%),
ceftazidime (up to a concentration 0.1%), amikacin, gentamicin,
tobramycin, erythromycin, clarithromycin, ciproﬂoxacin, ﬂuconaz-
ole, and insulin, isosorbide dinitrate, nicardipin, uradipil, dopam-
ine, dobutamine, adrenaline, sufentanyl, midazolam, ketamine,
morphine, piritramide, N-acetyl-cysteine, and aminoacid solu-
tions. In contrast VAN was incompatible with temocillin, merope-
nem, imipenem, piperacillin/tazobactam, ﬂucloxacillin,
moxiﬂoxacin, and concentrated solutions of with cefepime
(>12.5%) and ceftazidime (>0.1%), and propofol, valproic acid,
phenytoin, theophyllin, furosemide and methylprednisolone.
Conclusion: VAN is stable in 8.3% solutions maintained up to 72 h
at up to 37C and is compatible with some but not all drugs com-
monly used in intensive care patients. Special care is required if
VAN is co-administered with many b-lactams currently used
against Gram() organisms.
R1921 Cerebrospinal ﬂuid penetration and
pharmacokinetic/pharmacodynamic parameters of cefepime in
serum and cerebrospinal ﬂuid
M.E. Jime´nez-Mejı´as, J. Jime´nez-Palacios, J.M. Flores-Cordero,
M.E. Pacho´n-Iban˜ez, M. Callejo´n-Mocho´n, M.E. Bellido-Sa´nchez,
C. Pichardo, J.C. Jime´nez-Sa´nchez
Seville, E
Objectives: To assess the cerebrospinal ﬂuid (CSF) penetration and
the pharmacokinetic/pharmacodynamic parameters in serum and
CSF of intravenous cefepime in adults with external ventricular
drains (EVD).
Patients and methods: Five patients with EVD and normal renal
function. Two patients (cases 1 and 2) with Pseudomonas aeruginosa
meningitis (MIC of cefepime 1.5 and 1 mg/L, respectively)
received cefepime 2 g i.v./8 h. Three patients with nosocomial
pneumonia without central nervous system infection, were treated
with cefepime 1 g i.v./8 h (cases three and four) or 2 g i.v./8 h
(case ﬁve). Serial CSF and serum samples were obtained on day 3
of treatment, following administration of i.v. cefepime (0, 30, 60,
120, 180, 240, 360, 480 min). Serum and CSF cefepime concentra-
tions were determined by HPLC assay. Proportion of CSF/serum
of cefepime in the CSF Tmax and time of cefepime concentration
above MIC (T/CMI) were calculated.
Results: Tables 1, 2 and 3.
Table 1 Patients with meningitis. Cefepime Concentrations (mg/l)
00 300 600 1200 1800 2400 3600 4800
Case 1 (serum) 7.3 107 73.5 47.6 30.5 25 14.7 11.9
Case 1 (CSF) 12.5 11.9 14.3 15.8 15.5 15 13.6 13
Case 2 (serum) 6.9 71 44.7 28.1 28.5 10.6 4.9 2.3
Case 2 (CSF) 1.9 5 7.4 6.4 5.9 5.5 3.5 2.1
Table 2 Patients with nosocomial pneumonia. Cefepime Concen-
trations (mg/L)
00 300 600 1200 1800 2400 3600 4800
Case 3 (serum) 4.5 55.8 33.8 21.4 16.2 12.8 7.7 6.5
Case 4 (serum) 1.7 32.8 22.6 15.3 9.3 7.1 4.3 2.9
Case 5 (serum) 2.4 76 42.2 20.8 12.9 9.5 5.4 3.3
Case 3, 4, 5 (CSF) 0 0 0 0 0 0 0 0
Table 3 Patients 1 and 2. Pharmacodynamic parameters
D T/MIC (serum) D T/MIC (CSF) Proportion CSF/CSF
Case 1 100% 100% 33.1
Case 2 100% 100% 16.6
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Conclusions: In patients with meningitis intravenously adminis-
tered cefepime 2 g/8 h, penetrated CSF at levels sustaining above
de MIC during the total time between dosing. In patients without
meningeal inﬂammation cefepime did not penetrate in CSF.
R1922 Concentrations of cefotaxim and its metabolite
desacetylcefotaxim in infants and children during continuous
infusion
M. Klaassens, B.A. Semmekrot, G.J. Gerrits, E.M. te Poele,
J.W. Mouton
Nijmegen, NL
Purpose: Despite its widespread use surprisingly few data exist on
pharmacokinetics of cefotaxim and its metabolite in children. PK/
PD relationships indicate that continuous infusion of b-lactam
antibiotics may be advantageous. We determined concentrations
of cefotaxim and its metabolite during continuous infusion in a
routine hospital setting.
Materials and methods: Cefotaxim is routinely given as a continu-
ous infusion in all hospitalised children requiring antimicrobial
chemotherapy in our hospital. As part of a therapeutic drug mon-
itoring program, serum samples were taken on day 1, and day 3
and 5 if applicable, as a routine workup. The ﬁrst blood sample
was taken at least 18 h after start of infusion, 100 mg/kg/day
after a loading dose of 33 mg/kg. Samples were stored at 70C
until assayed. Concentrations of cefotaxim and its principal meta-
bolite were performed by HPLC in one run using an assay devel-
oped to that purpose.
Results: Evaluable serum samples were obtained from 77 children.
Of those with samples at both day 1 and 3 (n ¼ 53) mean (SD) cefo-
taxim concentrations were 23.4 (15.1) and 16.8 (8.7) mg/L, respect-
ively (P < 0.01). Desacetylcefotaxim concentrations amounted to
33.5 (26.0) and 22.6 (19.9) mg/L (P < 0.01). The variation between
patients was high. 10 children had cefotaxim concentrations
<10 mg/L. Correlation between sample 1 and 2 was 0.6 (pearson r).
Concentrations on day 5 (n ¼ 22) were in the same range 19.9 (11.3)
and 19.9 (13.8), respectively.
Conclusions: Although the mean concentrations of cefotaxim and
its metabolite were within expectations based on data from adults,
there were large variations between individual children. In nearly
20% of children concentrations could be regarded as suboptimal,
probably due to a high elimination rate. More detailed pharmaco-
kinetic studies in children are much needed.
In vitro activity to antimicrobial agents
R1923 Nearly unchanged susceptibility against
piperacillin/tazobactam, 10 years after its introduction
H. Grimm, H.-J. Stodt
Weingarten, Munster, D
Objectives: To determine the antimicrobial susceptbility rates
for piperacillin/tazobactam and selective bacterial pathogens
in the ﬁrst decade of piperacillin/tazobactam use in clinical
therapy.
Methods: The in vitro activity of piperacillin/tazobactam was
checked by means of a metanalysis of published MIC distribu-
tions in the period 1993–2003. Papers concerning unselected
Escherichia coli, Citrobacter freundii, Klebsiella pneumoniae, Klebsiella
oxytoca, Enterobacter cloacae, Proteus mirabilis, Morganella morganii,
Pseudomonas aeruginosa and Bacteroides fragilis were enrolled, only.
The interpretation of the MIC data occurred on the basis of
NCCLS-recommended MIC breakpoints.
Results: The percentage of susceptibility against piperacillin/tazo-
bactam is undulatory over the time. The ﬁgures reported in the
ﬁrst and last two papers published up to now were as follows:
The only species showing moderate decrease in susceptibility to
piperacillin/tazobactam is C. freundii. Minimal decreases in suscep-
tibility were found for E. coli, K. pneumoniae, E. cloacae, P. mirabilis
and M. morganii. However, minimal increases in susceptibility
were found for K. oxytoca, P. aeruginosa and B. fragilis.
Conclusion: Piperacillin/tazobactam remains the antibiotic of ﬁrst
choice in empirical clinical chemotherapy because of its broad
spectrum of activity and its extremely low potential to develop
increasing resistance.
R1924 Comparative in vitro activity of cefepime with
third-generation cephalosporins against Gram-negative bacilli
isolated from different clinical specimens in a clinical centre,
Serbia
S. Jovanovic, M. Prica, Z. Stojanovic-Varagic, B. Jovanovic,
V. Mioljevic, N. Mazic, J. Obrenovic
Belgrade, CS
Objectives: This study was performed to compare in vitro activity
of cefepime (FEP), with that of the third-generation cephalospo-
rins–cefotaxime (CTX), ceftriaxone (CRO) and ceftazidime (CAZ)
against extended spectrum b-lactamase (ESBL) nonproducing
Gram-negative bacilli isolated over 6 months.
Methods: During the study period, 1898 isolates of Pseudomonas
spp.(465), Escherichia coli (456), Stenotrophomonas maltophilia (254),
Klebsiella spp.(234), Acinetobacter spp. (202), Proteus mirabilis (137),
Serratia marcescens (76), Proteus vulgaris (24), Providencia stuarti
(20), Citrobacter freundii (18), Enterobacter spp.(nine) and Morganella
morganii (three) were examined. The strains were isolated from
various specimens from May 2003 to November 2003. Antibiotic
susceptibility test was done by standard Kirby–Bauer disc-diffu-
sion method. ESBL production was determined by double-disc
synergy test with CTX, amoxicillin-clavulanate (AMC) and CAZ.
Results: None of the investigated strains manifested ESBL activity.
Cefepime inhibited Serratia marcescens, Pseudomonas spp., Escheri-
chia coli and Klebsiella spp. isolates in 91.6, 85.5, 82.1 and 70.7%,
respectively. The highest resistance was noted in Acinetobacter
spp. 23.8% and Stenotrophomonas maltophilia 17.1%. These species
were also intermediate susceptible to FEP 28.6 and 36.6%, respect-
ively. Twenty-six per cent of strains were susceptible to FEP and
resistant to third-generation cephalosporins. Escherichia coli, Klebsi-
ella spp., Pseudomonas spp., Acinetobacter spp. and Stenotrophomonas
maltophilia were resistant to CAZ in 21.4, 75.6, 44.7, 90.6 and
Year n % Susceptibility Year n % Susceptibility
E. coli 1993 2933 98.81 2003 1349 96.89
C. freundi 1996/1997 54 92.59 2003 148 77.70
K. pneumoniae 1996 615 97.24 2003 467 92.72
K. oxytoca 1996 327 89.91 2003 298 91.61
E. cloacae 1996/1997 161 83.23 2003 496 77.62
P. mirabilis 1993 593 99.83 2003 419 98.57
M. morganii 1996/1997 60 100 2003 156 97.44
P. aeruginosa 1993/1994 3895 83.52 2003 1296 87.73
B. fraqilis 1993/1994 938 98.08 2003 504 99.80
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87.8%, respectively, to CRO in 42.8, 85.4, 61.8, 95.2 and 97.5%,
respectively, and to CTX in 46.4, 92.7, 93.4, 100 and 100%, respect-
ively. Gram-negative strains, which appeared to be complete
resistant to all tested cephalosporins (12.1%), were susceptible to
carbapenems.
Conclusion: These data showed the high level of sensitivity of the
most detected isolates of bacteria to FEP, thus it seems to be a
promising antimicrobial agent for the therapy of infections due to
ESBL nonproducing Gram-negative bacilli resistant to third-gen-
eration cephalosporins. The overall susceptibitiy rates to third-
generation cephalosporins in our study indicate the increasing
problem of resistance to these antibiotics in our centre.
R1925 Antimicrobial resistance among Streptococcus
pneumoniae isolates causing invasive disease in Crete, Greece
S. Maraki, E. Nioti, I. Kyriakakis, A. Georgiladakis, Y. Tselentis
Heraklion, GR
Streptococcus pneumoniae remains an important pathogen causing
severe infections in both children and adults, annually resulting
in signiﬁcant morbidity and mortality.
Objective: To determine the antimicrobial resistance of Streptococ-
cus pneumoniae isolated from clinically signiﬁcant specimens in the
University Hospital of Crete, Greece.
Material and methods: Eighty-two S. pneumoniae isolates were stud-
ied. The origin of these was blood (n ¼ 33), cerebrospinal ﬂuid
(n ¼ 8), middle ear aspirates (n ¼ 22) and other sites (n ¼ 19). Sus-
ceptibility testing was performed using the Etest method according
to NCCLS guidelines. The following antibiotics were tested: peni-
cillin G, cefuroxime, cefotaxime, ceftriaxone, cefepime, imipenem,
meropenem, erythromycin, clarithromycin, azithromycin, roxithro-
mycin, clindamycin, ciproﬂoxacin, levoﬂoxacin, sparﬂoxacin,
moxiﬂoxacin, chloramphenicol, tetracycline, trimethoprim/sulpha-
methoxazole, and vancomycin.
Results: Among the 82 isolates, 54 (65.9%) were susceptible to
penicillin, 15 (18.3%) were intermediate and 13 (15.8%) had high-
level resistance to penicillin. Resistance rates observed to other
antibiotics were as follow: erythromycin 24.4%, clarithromycin
24.4%, roxithromycin 24.4%, azithromycin 26.8%, clindamycin
7.3%, chloramphenicol 6.1%, tetracycline 15.8%, and trimetho-
prim/sulphamethoxazole 17%. Resistance to multiple (at least
three) antimicrobial agents was observed among 13 strains. All
isolates tested were sensitive to vancomycin, ciproﬂoxacin, levoﬂ-
oxacin, and moxiﬂoxacin.
Conclusion: These ﬁndings highlight the need for continuous sur-
veillance and susceptibility testing of all pneumococcal isolates
recovered from patients with invasive disease.
R1926 Transferable resistance to b-lactam and
aminoglycoside antibiotics in ESBL-producing clinical isolates
of Klebsiella pneumoniae
M. Vrabelova, D. Michalkova-Papajova, E. Sodomova, D. Rovna,
M. Kettner
Bratislava, SK
Objectives: We studied transferability of resistance to b-lactam and
aminoglycoside antibiotics in two sets of ESBL-producing Klebsiel-
la pneumoniae clinical isolates obtained from University Hospital
Ruzinov, Bratislava (Slovakia) in 2002 and 2003, respectively.
Methods: The level of resistance to selected b-lactam and aminogly-
coside antibiotics was determined using the standard agar dilution
method according to the NCCLS guidelines. The antibiotics inclu-
ded in the study were penicillins (ampicillin–AMPI), second-gen-
eration (cefoxitin–CFOX), third-generation (cefotaxime–CTAX,
ceftazidime–CTAZ, ceftriaxone–CIAX) and fourth-generation
(cefepime–CEPI) cephalosporins, monobactams (azthreonam–
AZTR), carbapenems (meropenem–MERP) and aminoglycosides
(gentamicin–GEN, tobramycin–TOB, netilmicin–NET, amikacin–
AMI, isepamicin–ISE). Transferability of b-lactam and aminoglyco-
side resistance determinants was studied by bacterial conjugation
with Escherichia coli K-12 3110 as a recipient strain. Transconjugants
were selected as resistant to ampicillin.
Results: All clinical isolates tested were resistant to AMPI and none
of them was resistant to MERP, NET, AMI and ISE. In the ﬁrst set
of 25 clinical isolates obtained in 2002, 36% of clinical isolates were
resistant to CFOX, 72% to CTAX, 96% to CTAZ, 80% to CIAX, 4%
to CEPI, 80% to AZTR, 40% to GEN and 64% to TOB. In the sec-
ond set of 21 clinical isolates obtained in 2003, 71% of clinical iso-
lates were resistant to CFOX, 95% to CTAX, 95% to CTAZ, 90% to
CIAX, 86% to CEPI, 90% to AZTR, 29% to GEN and 95% to TOB.
Determinants of resistance to AMPI, CTAX, CTAZ, CIAX, CEPI,
AZTR, GEN and TOB were transferable by bacterial conjugation to
the recipient Escherichia coli K-12 3110. The frequency of tranfer
ranged from 7.3  106 to 1.7  103.
Conclusions: The antibiotics MERP, NET, AMI and ISE had high
efﬁciency in ESBL-producing Klebsiella pneumoniae clinical isolates.
All b-lactam and aminoglycoside resistance determinants present in
clinical isolates (donors), with exception of CFOX, were transferable
by bacterial conjugation to the recipient Escherichia coli K-12 3110.
Our results point to the fact, that b-lactam and aminoglycoside
resistance in tested clinical isolates is plasmid-determined and this
contributes to the spread of resistance in the mentioned hospital.
R1927 Studies on in vitro antimicrobial activity of silicon
oil against major causative agents of endophthalmitis
E. Kosior-Jarecka, A. Szczepanik, M. Wojtowicz, J. Mackiewicz,
M. Koziol-Montewka
Lublin, PL
Purpose: Silicon oil (PDMS 5000) has been widely used as an inter-
nal tamponading agent in vitreous surgery, yet after internal eye
surgery bacterial or fungal endophthalmitis, blindness causing
complication, may develop. The aim of the study was to evaluate
antimicrobial properties of silicon oil in vitro against Staphylococcus
aureus, Pseudomonas aeruginosa, Candida albicans, which are consid-
ered the major causative agents of postoperative endophthalmitis.
Materials and methods: The clinical isolates of representative micro-
organisms (S. aureus, P. aeruginosa, C. albicans) were selected. The
bacteria and the fungus were separately inoculated in PDMS 5000
(produced by AcriMed, Germany). Control inoculations in physio-
logical saline and sugar bouillon were performed. The samples of
0.01 mL from each medium were diluted according to serial dilu-
tion procedure and plated in Petri dishes with 5% sheep blood
agar for bacteria and Sabouraud broth for Candida albicans. After
24 h incubations for bacteria and 48 h incubations for fungus
CFUs were counted.
Results: All the microorganisms revealed an apparent decrease in
CFUs in PDMS 5000. The total elimination was observed for S. aure-
us after 5 days. For P. aeruginosa solitary colonies (<25 CFUs) were
observed up to 7 days, after 7 days of incubation no growth of P.
aeruginosa was observed. High C. albicans CFU values were counted
up to 3 days of the incubation. After 5 days single fungal colonies
were observed. CFUs of the examined microorganisms declined
slightly in physiological saline. A growth pattern similar to the
growth curve of microorganisms was observed in sugar boullion.
Conclusion: Our study indicates that silicon oil could have an anti-
microbial activity against Staphylococcus aureus, Pseudomonas aeru-
ginosa, Candida albicans, which are considered the major causative
agents of postoperative endophthalmitis.
R1928 Isolation rate and sensitivity to antibiotics of
Moraxella (Branhamella) catarrhalis isolated from adult’s
expectorated sputum samples. A 5-year experience in a tertiary
Greek hospital, 1998–2002
M. Kanellopoulou, N. Skarmoutsou, M. Martsoukou,
A. Charalambopoulou, A. Vergaki, M. Katopodi, E. Papafrangas
Athens, GR
Objective: To investigate the isolation rate of M. catarrhalis from
adult’s expectorated sputum samples (ESS) and to determine the
sensitivities of the strains to common used antibiotics.
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Material and methods: A total number of 7056 ESS were examined
during 1998–2002. The identiﬁcation of M. catarrhalis was per-
formed by Gram stain, observation of typical colonies growth on
5% human blood agar after 48 h of aerobic incubation at 37C
and positive oxidase and DNAase production. Sensitivities were
obtained in Muller–Hinton agar according to proposed biblio-
graphy. b-lactamase was examined by nitroceﬁn sticks (Oxoid).
Results: The overall isolation rate of M. catarrhalis from adult’s
ESS was 2% (1998, >1.3%; 1999, >1.5%; 2000, >3.1%; 2001, >2.5%;
2002, >2%). The sensitivities to antibiotics were as follows: ampi-
cillin 2%, amoxicillin/clavulanic 100%, erythromycin 96%, telith-
romycin 100%, cefaclor 97%, cefuroxime 100%, trimethoprim/
sulphamethoxazole 97%, chloramphenicol 100%. Almost all
strains (98%) produced b-lactamase.
Conclusions: In contrast to old reports from other countries the
isolation rate of M. catarrhalis to our study was low (2%). All
ampicillin-resistant strains produced b-lactamase. Resistance to
erythromycin, which constitutes the drug of choice for M. catarrh-
alis respiratory infections, was remarkable (4%).
R1929 Trends in resistance of P. aeruginosa isolates from
lower respiratory tract in adults over a 5-year period (1998–2002)
in a tertiary hospital
N. Skarmoutsou, M. Kanellopoulou, M. Martsoukou, H. Fakiri,
E. Margeti, G. Mitropoulou, E. Papafrangas
Athens, GR
Objective: To monitor trends in the antimicrobial behaviour of
P. aeruginosa isolates from bronchial secretions and sputa of
patients hospitalised in ICU and pneumological departments (PD)
of a tertiary Greek hospital over a period of 5 years.
Material and methods: A total number of 3497 strains (ICU 1715,
PD 1782) were examined during 1998–2002. Isolation and identiﬁ-
cation were performed according to conventional microbiological
methods. Sensitivities were obtained by microdilution method
(Wider I, Fransisco Soria Melguizo SA) guidelined by NCCLS.
Results: The annual resistance (%) (1998–2002) for PD/ICU were
respectively: Ceftazidime 25/78, 28/70, 28/70, 24/65, 25/69, Pip-
eracillin/tazobactam 18/67, 22/59, 26/62, 30/52, 15/40, Aztreo-
nam 35/86, 42/78, 41/87, 46/70, 34/68, Amikacin 24/79, 31/58,
34/77, 24/46, 12/42, Ciproﬂoxacin 31/84, 40/68, 40/78, 40/70,
38/69, Imipenem 15/20, 8/55, 2/55, 28/61, 19/67, Cefepime 38/
65, 40/68, 43/73, 42/71, 34/74.
Conclusions: (i) The resistance in both departments to Ceftazidime
and Cefepime showed a stable route. (ii) An increasing resistance
rate to Imipenem was observed over time in ICU while. (iii) The
resistance to Piper/tazobactam, Amikacin and Aztreonam (ICU)
showed a decreasing trend during the last 2 years of the study.
R1930 Susceptibility of H. inﬂuenzae isolated from adult
lower respiratory tract infections. A 5-year experience in a
tertiary Greek hospital, 1999–2003
M. Kanellopoulou, N. Skarmoutsou, M. Martsoukou,
I. Fotopoulou, I. Naum, G. Kaderakis, E. Papafrangas
Athens, GR
Objective: To survey the antimicrobial susceptibility of H. inﬂuen-
zae strains over a period of 5 years, isolated from patients who
were suffered from community acquired lower respiratory tract
infections and had admitted in the outpatient’s ward of our hospi-
tal.
Material and methods: A total number of 742 (1999, 136; 2000, 158;
2001, 173; 2002, 139; 2003, 136) H. inﬂuenzae strains were isolated
on chocolate agar and incubated in CO2 7% at 37
C. The identiﬁ-
cation was performed by Gram stain, catalase and oxidase tests
and by X and V requirements. The susceptibilities were obtained
in Haemophilus test medium (HTM) agar, according to NCCLS
guidelines. Nitroceﬁn sticks (Oxoid) were used for b-lactamase
determination.
Results: The overall resistance (%) to ampicillin was 8.3 (6.6, 7.6,
6.9, 10.1, 10.2), to Cefaclor 2.9 (2.2, 2.0, 3.5, 4.0, 3.0), to cefuroxime
0.8 (0, 0, 1, 2, 1), to trimethoprim/sulphamethxazole (T/S) 20.5 (
24.2, 26.7, 28.5, 14.3, 8.8) and 0% for imipenem, cefotaxime, ci-
proﬂoxacin, moxiﬂoxacin, amoxicillin/clavulanic acid. All resist-
ant to ampicillin strains produced b-lactamase.
Conclusions: An increasing resistance of H. inﬂuenzae strains to
ampicillin was observed during the last 2 years of our study
(P > 0.10). The decreasing resistance to T/S was remarkable but
not statistically signiﬁcant (P > 0.10). All H. inﬂuenzae strains
appeared to have stable sensitivities to quinolones and imipenem.
R1931 In vitro interaction of b-lactams and ciproﬂoxacin
on multiresistant Pseudomonas aeruginosa
P. Saraﬁs, Z. Chryssouli, D. Plachouras, A. Antonopoulou,
H. Giamarellou, E.J. Giamarellos-Bourboulis
Athens, GR
Objectives: Increased prevalence of multidrug-resistant (MDR)
P. aeruginosa in the nosocomial setting raised the need for the
study of any probable susceptibility to the interaction of b-lactams
and ciproﬂoxacin.
Methods: A 6 log 10 inoculum of 21 isolates resistant to ceftazidime
(CZ), imipenem (IM), meropenem (MM), aztreonam, ciproﬂoxacin
(CIP), amikacin and colistin were in vitro exposed over-time to CZ,
IM, MM, CIP and to their interaction in tubes with Mueller–Hinton
broth. All b-lactams were applied at a concentration of 16 mg/L
and CIP at 2 mg/L; these concentrations are equal to the mean
serum levels of the applied antimicrobials. Tubes were incubated
at 37C. Bacterial growth was estimated at regular time intervals
and any equal or more than a 2 log 10 decrease compared with the
most active single agent was considered indicative of synergy.
Results: Synergy between CZ and CIP was documented in one
(4.76%), three (14.3%) and four (19%) isolates at 4, 6 and 24 h of
growth respectively. Respective results for synergy between IM
and CIP involved eight (38.1%), seven (33.3%) and seven (33.3%)
isolates and between MM and CIP involved two (9.5%), two
(9.5%) and three (14.3%) isolates.
Conclusions: Results of in vitro synergism between b-lactams and
ciproﬂoxacin suggest the application of imipenem and ciproﬂoxa-
cin for the management of infections by MDR P. aeruginosa.
R1932 Antibiotic susceptibility of the Acinetobacter
species isolated from clinical specimens
U. Arslan, I. Tuncer, O. Ural, D. Findik
Konya, TR
Introduction: Members of the genus Acinetobacter are implicated in
a wide spectrum of infections, including nosocomial bacteraemia,
pneumonia, secondary meningitis, skin and soft tissue infections
and urinary-tract infections.
Methods: The susceptibilities of Acinetobacter strains to twelve anti-
biotics isolated during the period of January 2001–December 2003
were determined by the disc-diffusion method as recommended
by NCCLS.
Results: A total of 259 Acinetobacter spp. were collected and 77 of
them were isolated from blood samples, 62 from wound infec-
tions, 58 from the respiratory tract, 40 from urine, 12 from cathat-
ers, eight from the peritonium and two from cerebrospinal ﬂuid.
The resistance of Acinetobacter species to the 12 antibiotics tested
were respectively: Chloramphenicol 82%, ceftazidime 77%, cefo-
taxime 76%, gentamicin 70%, trimethoprim/sulphamethoxazole
66%, amikacin 61%, ciproﬂoxacin 75%, piperacillin 56%, cefoper-
azone 54%, tobramycin 53%, cefepime 40%, netilmicin 29%, imi-
penem 22%.
Conclusion: Acinetobacter strains represent a real problem especi-
ally in nosocomial infections as they are routinely more resistant.
Surveillance programmes and infection-control protocols are
essential to control this problem.
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R1933 In vitro activity of cefepime and cefpirome in
comparison with third-generation cephalosporins against
Enterobacteriaceae
E. Ikonomopoulou, C. Frangides, K. Papadopoulos, S. Andreatou,
P. Grammenou, A. Regli
Patras, GR
Objectives: To determine the in vitro antimicrobial activity of
fourth-generation cephalosporins (cefepime and cefpirome) in
comparison to third-generation cephalosporins against Enterobac-
teriaceae.
Methods: During a 2-year period (November 2001–October 2003) a
total of 696 Enterobacteriaceae strains (371 E. coli, 75 Klebsiella
spp., 69 Proteus spp., 67 Enterobacter spp., 62 Serratia spp., 25 Cit-
robacter spp., 17 Salmonella spp., eight Morganella morgannii and
three Providencia spp.) were isolated in our laboratory. The identi-
ﬁcation and the in vitro activity to cephalosporins were carried
out by the Vitek system (Biomerieux).
Results: The susceptibility for all isolates of Enterobacteriaceae to
fourth-generation cephalosporins was: cefpirome 95% (662/696)
and cefepime 94% (652/696). The susceptibility for all isolates of
Enterobacteriaceae to third-generation cephalosporins was: Ceftaz-
idime 90.4% (629/696), Ceftriaxone 87% (606/696), Cefotaxime
86% (598/696) and Ceﬁxime 80% (555/696).
Conclusions: Both of the fourth-generation cephalosporins had
signiﬁcantly better in vitro activity than all the third-generation
cephalosporins against Enterobacteriaceae. Cefpirome was found
to be more active in vitro than Cefepime against Enterobacteria-
ceae.
R1934 In vitro activity of ﬁve third-generation
cephalosporins against Enterobacteriaceae
E. Ikonomopoulou, K. Papadopoulos, C. Frangides, S. Andreatou,
P. Grammenou, A. Regli
Patras, GR
Objectives: To compare the in vitro activity of ﬁve third-generation
cephalosporins against Enterobacteriaceae since these drugs are
commonly used to treat these infections.
Methods: During a 2-year period (November 2001–October 2003) a
total of 696 strains belonging to Enterobacteriaceae (371 E. coli, 75
Klebsiella spp., 69 Proteus spp., 67 Enterobacter spp., 62 Serratia
spp., 25 Citrobacter spp., 17 Salmonella spp., eight Morganella mor-
gannii and three Providencia spp.) were isolated from clinical speci-
mens in our laboratory. The identiﬁcation and the in vitro
susceptibility to third-generation cephalosporins were performed
by the Vitek system (Biomerieux). Tested cephalosporins were: ce-
fotaxime, ceftriaxone, ceftazidime, ceﬁxime and cefpodoxime.
Results: The susceptibility for all isolates of Enterobacteriaceae to
third-generation cephalosporins was: ceftazidime 90.4% (629/
696), ceftriaxone 87% (606/696), cefotaxime 86% (598/696), cefpo-
doxime 82% (570/696) and ceﬁxime 80% (555/696). E. coli, Citrob-
acter spp and Providencia spp strains had the same susceptibility
to Ceftazidime, Ceftriaxone and Cefotaxime (97.3, 96.0 and 100%,
respectively). Klebsiella spp strains had the same susceptibility to
ceftriaxone, cefotaxime and ceﬁxime (96%). Enterobacter spp.
strains had the same susceptibility to cefotaxime and ceftazidime
(60%). Serratia spp. strains had the same susceptibility to ceﬁxime
and cefpodoxime. Salmonella spp strains and Morganella morgannii
strains had the same susceptibility to all third-generation cephalo-
sporins (100 and 80%, respectively).
Conclusions: All third-generation cephalosporins had an excellent
in vitro activity to the majority of Enterobacteriaceae (80% to
90%). Ceftazidime proved to be the most active of the tested ce-
phalosporins. Ceﬁxime and Cefpodoxime were the less-active of
third-generation cephalosporins against Enterobacteriaceae.
R1935 Impact of the incubation atmosphere on the
susceptibility of Streptococcus pyogenes isolates to erythromycin
and azithromycin determined by disc-diffusion test
M. Ostojic, I. Curic, B. Vidovic
Mostar, Sarajevo, BIH
Objectives: Streptococcus pyogenes is an important cause of upper
respiratory-tract infections.
Methods: During the 8 months period (since September 2001 till
May 2002.) a total of 579 strains of S. pyogenes were isolated and
tested against penicillin, erythromycin and azithromycin. The
strains were isolated from throat swabs (513), nose swabs (55),
wound swabs (seven), vagina swabs (two) and ear swabs (two).
Disc-diffusion tests were used for susceptibility testing. Cultures
of all 579 isolates were incubated at 37C in an atmosphere con-
taining 5% CO2 and at the same time were also incubated in air.
Results: In an atmosphere containing 5% CO2 all strains of S. pyo-
genes were susceptible to penicillin, 14.3% (83) were resistant to
erythromycin and 14.9% (86) were resistant to azithromycin. We
had also intermediate strains to erythromycin 0.9% (ﬁve) and to
azithromycin 0.9% (ﬁve). In air all strains were susceptible to
penicillin too, 8.1% (47) were resistant to erythromycin and 6.6%
(38) were resistant to azithromycin. Here we had also intermedi-
ate strains, 11.6% (67) to erythromycin and 9.5% (55) to azythro-
mycin.
Conclusion: All strains were susceptible to penicillin. The activity
of macrolides, in case that susceptibility testing was performed in
air, was signiﬁcantly greater than activity of the same drugs in an
atmosphere containing CO2.
R1936 Antifungal effects of griseofulvin and terbinaﬁne
against some dermatophytes species
M. Shams, N. Amirrajab, A. Ghajari, M. Razzaghi Abyaneh
Tehran, IR
Objectives: In recently years, antifungal drug resistance has dra-
matically been increased with resulted in the unsuccessful intreat-
ment of dermatophytic patients. Thus, the emergency of ﬁnding
new antifungal drugs with low side-effect has recently been noted
by several researchers. Fungal infection of the skin and its
appendages specially dermatophytosis to be considered as the
most prevalent skin disorders. Dermatophytosis is a fungal infec-
tion which involve the stratum corneum of skin, hair and nail.
This contagious animal infection caused by a special group of
fungi called dermatophytes.
Methods: In this study the effect of different concentrations of two
known antifungal drugs, griseofulvin (8.25–2000 lg/mL) and ter-
binaﬁne (0.005–4lg/mL) on Microsporum canis, Epidermophyton ﬂo-
ccosum, Microsporum gypseum, Trichophyton mentagrophytes and
Trichophyton rubrum investigated. The fungal isolates were sepa-
rately added to different concentrations of above-mentioned drugs
(1000 cells/mL) and then mixed with semisolid SDA medium in
plates. Then the plates were incubated at 28C for 7–12 days. The
drug free sample was mentioned as control for MIC (minimum
inhibitory concentration) and MFC (minimum fungicidal concen-
tration).
Results: The results show that the MIC, 50–100% for both antifun-
gal drugs. This growth for inhibitory effects of griseofulvin was
obtained at 1–31.25, 1–31.25, 2–125, 0.06–0.25 and 0.03–0.25 lg/mL
for Microsporum canis, Epidermophyton ﬂoccosum, Microsporum gyp-
seum, Trichophyton mentagrophytes and Trichophyton rubrum,
respectively. These values for terbinaﬁne were measured as 0.007–
0.5, 0.007–0.125, 0.005–0.5, 0.06–0.25 and 0.03–0.25 lg/mL for
M. canis, E. ﬂoccosum, M. gypseum, T. mentagrophytes and T. rubrum
accordingly.
Conclusions: In spite of difference observed in antifungal suscepti-
bility, the examined fungi our results indicated that both drugs
can effectively inhibit the growth of some important native der-
matophytes and thus, have potential values for treatment of clin-
ical dermatophytosis in human and animals.
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R1937 In vitro susceptibility of Candida species isolated
from clinical specimens against some antifungal agents
N. Balaban, S. Aksaray, B. Ozcelik, S. Cesur, A. Cayirli
Ankara, TR
Objectives: The aim of this study was to determine the resistance
of Candida species isolated from hospitalised patients to ketocon-
azole (KET), ﬂuconazole (FLU), itraconazole (ITRA), amphotericin
B (Amp), ﬂucytosine (FCU) and voriconazole (VOR).
Methods: A total of 118 clinical isolates of Candida were obtained
from a variety sources (urine, blood e.g). Identiﬁcation was done
by germ-tube test and ID 32 C identiﬁcation system (BioMerieux,
France). The most common species of identiﬁed Candida was C.
albicans (69), followed by C. parapsilosis (16), C. glabrata (12) C.
tropicalis (nine), C. kefyr (eight) and one of C. lusitania, C. spherica,
C. sake, C. lambica, respectively. An adapted NCCLS M 27 – a
method was used to evaluate the activity of KET, FLU, ITRA,
AmpB, FCU and VOR. The MICs of the strains were evaluated by
RPMI 1640 medium with microdilution method.
Results: There were no isolates of tested Candida spp. resistant to
KET, FLU, ITRA, FCU, AmpB and VOR. Intermediate resistant
appeared in 21 isolates to KET and FLU, 10 isolates to ITRA. It is
known that the investigational voriconazole have not been
assigned interpretive breakpoints.
Conclusion: Among 120 Candida isolates were found highly suscept-
ible to KET (MIC; KET 8 lg/mL) followed by FLU (MIC;
FLU  8 lg/mL), ITRA (MIC; ITRA  0.125 lg/mL) FCU (MIC;
FCU  4lg/mL) AmpB (MIC; AmpB < 1 lg/mL) and VOR (MIC;
VOR  0.0312 lg/mL), so voriconazole and AmpB were each more
active than ketoconazole, ﬂukonazole, itraconazole and ﬂucytosine.
R1938 Inhibition of staphylococcal bioﬁlm formation and
eradication of established bioﬁlms by oregano oil
A. Nostro, A.R. Blanco, M.A. Cannatelli, V. Enea, F. Procopio,
A. Sudano Roccaro, V. Alonzo
Messina, Catania, I
Objectives: To evaluate the effect of oregano essential oil on bio-
ﬁlm formation and eradication of established bioﬁlms of staphylo-
cocci strains.
Methods: The strains (20) were characterised by polymerases chain
reaction (PCR) for icaA and icaD detection and adherence to poly-
styrene microtitre plates for bioﬁlm production. The inﬂuence of
subinhibitory concentrations (sub-MICs) of oregano oil was evalu-
ated on bioﬁlm producers deﬁned as strong or medium using
absorbance values. The bioﬁlm inhibitory (BIC) and bioﬁlm-eradi-
cating concentrations (BEC) of oregano oil were also determined
for bacteria grown attached to polystyrene microtitre plates for
56 h and compared with the values obtained for the planktonic
cells (MIC and MBC).
Results: Oregano oil inﬂuenced bioﬁlm formation, greater inhibi-
tion was obtained with levels of 1/2 MIC (65%) than 1/4 MIC
(33%) and this effect did not correlate with the initial degree of
adherence. For the most strains tested the BIC (0.125–0.250% v/v)
and BEC (0.25–0.5% v/v) values were coincident or twofold
greater than the concentration required to inhibit growth in sus-
pension (MIC and MBC, respectively).
Conclusions: Oregano essential oil showed a good in vitro activity
in inhibiting and eradicating bioﬁlm produced by staphylococci
strains commonly involved in medical-devices related infection.
R1939 Reproducibility of Sensititre M. tuberculosis broth
microdilution susceptibility procedure
M. Brimecombe, T. Tiradani, R. Grist, N. Sullivan
East Grinstead, UK; Sun Prairie, USA
Objective: To measure reproducibility of three QC strains,
M. tuberculosis ATCC 25177 (H37Ra), ATCC 27294 (H37Rv) and
T32948 (clinical strain resistant to rifampicin, isoniazid and etham-
butol) in a commercial broth microdilution panel containing ﬁrst
and second line tuberculosis drugs after 7, 14 and 21 days incuba-
tion compared with a frozen panel.
Method: Freezer stocks were thawed and inoculated on 7H11 agar
slants. Cultures were incubated for 7–14 days until good growth.
Cultures were suspended in tubes containing saline, 0.2% Tween
and glass beads. Vortexed for 5 min and allowed to settle for
30 min before removing the top 1–3 mL. Transferred aliquot to a
fresh tube and turbidity adjusted in a nephalometer to be equival-
ent to a 0.5 McFarland. 75 lL transferred to 10 mL 7HSF broth.
100 lL dispensed into each well of a panel containing dried anti-
microbics. Plates were sealed and incubated at 35C and exam-
ined for growth after 7, 14 and 21 days. Five replicates per strain
were put up each day for 10 days. Frozen plates contained 50 lL
of broth and drug per well. Plates were thawed and dosed with
50 lL of broth containing a 2 concentration of organism. Five
replicates were put up each day for 2 days.
Results: Viable counting a 0.5 McFarland adjusted suspensions for
eight replicates of four strains gave a mean count of 9  107 CFU/
mL (range 2  107–3  108 CFU/mL). All plates could be read
after 7 days although growth was heavier after 14 days and
21 days MICs fell within one dilution of the mode for amikacin,
clofazimine, kanamycin, capreomycin, oﬂoxacin, rifampicin, eth-
ambutol, ansamycin and streptomycin. There was no shift in the
modal MIC over time. MICs for ethionamide shifted two to three-
fold during incubation. There was two well shift between MICs of
dried and frozen panels for Isoniazid for the two sensitive strains.
This shift was not seen with the resistant strain.
Conclusion: Broth microdilution susceptibility of the three M. tuber-
culosis strains was easy to read, highly reproducible and with the
exception of ethionamide not affected by length of incubation.
The difference in MICs with isoniazid for sensitive strains
between dried and frozen panels will be investigated.
R1940 Comparative evaluation of the resistance of
piperacillin/sulbactam and piperacillin/tazobactam to
nosocomial pathogens isolated from patients with complicated
urinary-tract infections
M.T. Yavuz, I. Karabiyik, H. Ika
Duzce, Bolu, TR
Objectives: This study was designed to assess and compare the in
vitro activity of piperacillin/b-lactamase inhibitor combinations
vs. piperacillin against common nosocomial pathogens isolated
from patients with complicated urinary-tract infections. We evalu-
ated the in vitro activity of piperacillin/sulbactam and piperacil-
lin/tazobactam versus alone piperacillin against 314 clinical
isolates (253 Gram-negative and 61 Gram-positive) collected from
Izzet Baysal Bolu State Hospital located in Bolu, Turkey in 2001–
2003 years.
Methods: A total of 314 strains, isolated at Bolu State Hospital dur-
ing the period of January, 2001 to September, 2003, made up of
Pseudomonas spp. (114), Acinetobacter spp. (19), Enterobacteriaceae
(135), Staphylococcus (41) and Enterococcus (ﬁve) were tested using
the disc-diffusion method. Only one sample per patient was inclu-
ded in the study. All consecutive isolates where collected from
urine and urinary catheter of patients with complicated urinary-
tract infections that considered to occur 3 days later after hospital-
isation were tested for their susceptibility to piperacillin/sulbac-
tam, piperacillin/tazobactam and piperacillin, The zone inhibition
was interpreted according to NCCLS recommendations.
Results: Generally, piperacillin/b-lactamase inhibitor combinations
exhibited greater activity according to piperacillin against all
strains. For Gram (+) bacteria, antimicrobial susceptibilities to the
three drugs were almost identical. Pseudomonas aeruginosa showed
extremely high resistance to the three drugs. Piperacillin/tazobac-
tam was most effective compound for Gram (-) bacteria except
Acinetobacter. Piperacillin/tazobactam retained activity against
89% of Enterobacteriaceae, 79% of Acinetobacter and 71% of Pseu-
domonas, while piperacillin/sulbactam was effective against 89%
of Acinetobacter.
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Conclusion: Our results might prove important for the appropriate
choice of antibiotic therapy with Piperacillin-b-lactamase inhibitor
combinations and sulbactam could be a good therapeutic alternat-
ive for the treatment of Acinetobacter infections.
R1941 Mutant prevention concentration: a comparison of
different quinolones for macrolide-susceptible or resistant
Streptococcus pyogenes and macrolide-susceptible or resistant
Streptococcus pneumoniae
S. Esposito, S. Noviello, F. Ianniello
Naples, I
Objectives: Mutant prevention concentration (MPC) represents the
lowest antibiotic concentration able to prevent growth of resistant
bacterial mutants when a large inoculum (>1010 CFU/mL) is
exposed to drugs. The aim of the present study was to compare
MPCs of different quinolones such as moxiﬂoxacin (MXF), garen-
oxacin (GNX), ciproﬂoxacin (CIP), levoﬂoxacin (LVX) and grepaﬂ-
oxacin (GRX) against Streptococcus pyogenes and Streptococcus
pneumoniae, either susceptible (MS) or resistant (MR) to macro-
lides.
Methods: Overall, 30 clinical isolates of S. pyogenes (MS, n ¼ 15;
MR, n ¼ 15) and 30 S. pneumoniae strains (MS, n ¼ 15; MR,
n ¼ 15) were tested towards MXF, GNX, CIP, LVX and GRX.
MICs were determined with a microdilution method (NCCLS).
MPCs determination was performed by applying 109–1010 CFU/
mL of bacteria to serially diluted drug-containing plate which
were incubated at 37C for 24 + 48 h. MPC was the lowest con-
centration of drug with no growth at 48 h. All procedures were
performed in duplicate to ensure reproducibility.
Results: The MIC90–MPC90 (lg/mL) for S. pyogenes and S. pneu-
moniae were as follows: 0.12–0.5/0.25–1 (MXF); 0.06–0.25/0.06–0.25
(GNX); 2–4/4–16 (CIP); 0.5–2/1–4 (LVX); 0.5–2/0.5–2 (GRP). The
rank order of potency, based on MPC, capacity of restricting the
selection of resistant mutants, was, for both Streptococcus pyogenes
and Streptococcus pneumoniae: MXF ¼ GNX > LVX > CIP ¼ GRX.
Time above MPC was >24 h for MXF and GNX. Different suscep-
tibility to macrolides did not affect results.
Conclusions: This study suggests that MIC and MPC consistently
predict quinolones activity against macrolide-susceptible and
macrolide-resistant Streptococcus pyogenes and Streptococcus pneu-
moniae. MPCs determination represents an innovative strategy for
preventing selection of resistant mutants as therapeutic behav-
iours able to achieve and maintain MPC drug concentration could
result in restricting the selection of resistance.
R1942 In vitro susceptibility of anaerobic bacteria isolated
in 2000–2003
E. Chmelarova, V. Torsova, D. Chmelar
Ostrava, CZ
Introduction: The resistance among clinical isolates of anaerobic
bacteria increase to antimicrobial agents, frequently to clindamy-
cin. The role of anaerobic bacteria and intra-abdominal sepsis
has been extensively examined during the past 25 years. This
situation is accompanied by improved cultural techniques, chan-
ges in method for susceptibility testing in vitro and changes tax-
onomy.
Materials and methods: The susceptibility of recent clinical isolates
of anaerobic bacteria were tested by using broth micro-dilution
method by NCCLS recommendation and by E-test. The anaerobic
strains were obtained from clinical specimens in Faculty and
Town hospitals in Ostrava in years 2000–2003. MIC to penicillin,
ampicillin/sulbactam, piperacillin/tazobactam, meropenem, cefox-
itin, clindamycin, metronidazole and chloramphenicol were deter-
mined.
Results: The table shows MIC 90 (mg/L) for most common organ-
isms.
Conclusion: The results indicate very good activity against anaer-
obic bacteria for used antibiotics. The lowest MIC was determined
for meropenem. The susceptibility testing of anaerobes is needed
for adequate therapy of individual patient, for good choice of empi-
ric therapy and for monitoring susceptibility patterns of anaerobes.
R1943 In vitro activity of ertapenem against clinical strains
isolated from abdominal infections
G. Bonﬁglio, G. Russo, M. Caccamo, V. Nicolosi, G. Nicoletti
Catania, I
Objectives: Ertapenem has a broad spectrum of activity and is
effective against most clinically relevant microorganisms, inclu-
ding Gram-positive and Gram-negative aerobes and anaerobic
strains. It has potential for use as empirical treatment of a wide
range of infections including intrabdominal infections where the
bacteriology is often complex. The aim of our study was to com-
pare the in vitro activity of ertapenem with that of other antibiot-
ics with a broad-spectrum of antibacterial activity against aerobic
clinical strains isolated exclusively from community acquired in-
trabdominal infections.
Methods: All antibiotics were tested by E-test method. The antibi-
otics tested were: ertapenem, imipenem, ceftazidime, cefepime,
piperacillin/tazobactam,. ciproﬂoxacin and amikacin. NCCLS
breakpoints values were adopted.
Results: A total 136 microorganisms were isolated and their suscep-
tibility analysed. E. coli (37.5%) was the most isolated microorgan-
isms followed by S. epidermidis (11.8%) and S. aureus (10.5%). Age
range of patients was 3–85 years (mean 56.3). Peritonitis was the
most prevalent disease (48.5%), followed by visceral abscess
(30.2%) and colecystitis (21.3%). Ertapenem and imipenem exhib-
ited essentially the same spectrum of activity. All members of En-
terobacteriaceae were susceptible to ertapenem and imipenem,
with the former showing lower MIC values than the latter. On the
contrary, ertapenem was often less-potent notably against the few
strains of P. aeruginosa and enterococci. Conversely, the activity of
the ceftazidime and cefepime was unreliable against many genera
of Enterobacteriaceae and Gram-positive microorganisms. In many
cases, tazobactam failed to restore completely the activity of pipera-
cillin against many Enterobacteriaceae. Ciproﬂoxacin had modest
activity against Gram-positive, variable activity against Enterobac-
teriaceae and low activity against nonfermenting Gram-negative
rods. Methicillin-resistance was found in 22.2% of staphylococci,
whereas ESBL was detected in 25.9% of Enterobacteriaceae.
Conclusion: Judged on the in vitro activity, this study suggests that
in intrabdominal infections, ertapenem is an excellent alternative
for empirical antibacterial monotherapy of polymicrobic infec-
tions, especially when local epidemiology indicates the predomin-
ance of multiresistant Enterobacteriaceae.
R1944 In vitro susceptibility of fusidic acid in
staphylococcal strains during 3 years
E. Hakko, A. Murtezaoglu, B. Mete, R. Ozaras, A. Mert, R. Ozturk,
F. Tabak
Istanbul, TR
Objectives: In this study, we investigated the suspectibility of fusi-
dic acid (FD) of the methicillin susceptible (MS) and resistant
Test organism n
MIC90 (mg/L)
PEN AMP/SUL PIP/TAZ MER CXT CLI MET CMP
Cl. perfringens 222 0.25 0.25 0.5 0.125 1 0.5 1 4
B. fragilis 719 16 1 2 0.125 8 0.5 0.5 4
B. fragilis group
Prev. bivia 143 1 0.25 1 0.125 4 0.25 1 2
Prev. melaninogenica 381 0.125 0.125 0.5 0.25 2 0.125 0.25 1
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(MR) 1208 staphylococci isolated from different clinical specimens
of hospitalised patients in our hospital in years 2000, 2001, 2002.
Methods: Oxacillin and fusidic acid susceptibilities were deter-
mined by disc-diffusion method according to NCCLS standart
and Comite´ de l’Antibiogramme de la Socie´te´ Francaise de Micro-
biologie, respectively.
Results: The results are demonstrated in the table.
Conclusions: Fusidic acid is an antibiotic of choice, particularly for
the treatment of methicillin resistant staphylococci. However, in
our study the relatively high resistance rate (%48) of fusidic acid
was observed in methicillin-resistant coagulase-negative staphylo-
cocci.
R1945 Synergy of antimicrobial combinations against
pan-resistant Acinetobacter baumannii clinical isolates
E. Platsouka, A. Kallimani, E. Perivolioti, S. Constantoulaki,
O. Paniara
Athens, GR
Objective: To assess the activity of antimicrobial combinations:
amikacin plus cefepime. (AMI + CEF), amikacin plus ciproﬂoxa-
cin(AMI + CIPRO), amikacin plus imipenem (AMI + IMI), amika-
cin plus meropenem (AMI + MER) against 14 pandrug-resistant
Acinetobacter baumannii isolates by Etest.
Methods: The E-test strips (AB Biodisk, Sweden) were used to
evaluate the activity of AMI + CEF, AMI + CIPRO, AMI + IMI,
AMI + MER combinations using the fractional inhibitory concentra-
tion (FIC). E-test regarding antimicrobial combinations has com-
pared with the checkerboard method in previous evaluation with
90% agreement. One antibiotic strip (A) was placed on an agar
plate for 1 h and then removed and a second antibiotic strip (B) was
placed on top of the gradient of the ﬁrst agent. The MIC A + B was
interpreted after overnight incubation at 35C as the value at which
the inhibition zone intersected the scale on the E-strip. Synergism
was deﬁned as an FIC index <0.5. FIC index ¼ FIC of drug A + FIC
of drug B, where FIC A ¼ MIC A + B in combination/MIC A alone;
and FIC B ¼ MIC A + B in combination/MIC B alone.
Results: AMI + CEF was the most effective combination in seven of
14 (50%) of strains. The combinations of AMI + MER and AMI +
CIPRO were synergistic against ﬁve (36%) and three (21%) strains
of Acinetobacter baumannii, respectively. AMI + IMI combination
was associated with synergy only in one isolate tested.
Conclusion: Synergy was detected with all combinations tested.
The highest rate of synergy were observed with AMI + CEF com-
bination followed by AMI + MER and AMI + CIPRO. These
results suggest that these combinations may be useful in the treat-
ment of pandrug-resistant. Acinetobacter baumannii clinical isolates
in our hospital.
R1946 Antimicrobial activity of root canal sealers – in vitro
evaluation
T. Zareˆba, W. Bojar
Warsaw, PL
Objectives: According to some researchers, antimicrobial activity is
a desirable feature of an endodontic sealer. Bacteriostatic effect
can be helpful in preventing a growth of any remaining microbes
after chemo-mechanical treatment of root canal. The aim of the
study was evaluate antimicrobial activity of sealers such as: zinc
oxide–eugenol-based – Canason and Endomethason N, zinc
oxide-bismutum-based – Diaket, glass ionomer cement – Endion,
urethane methacrylate resin-based – Endorez, zinc oxide–calcium
hydroxide-based – Proxiapex, silicon-based -RSA, and Gutta-
Percha. Quality of all materials were conformable to Directive 93/
42/EEC.
Methods: Freshly mixed sealers were formed to disks and
allowed to set for 7 days in 100% humidity at 37C. The disks
were placed on agar plates. After incubation 20 h at 37C discs
were removed and plates were inoculated with standardised sus-
pension of microbial strains: Streptococcus sanguis, Streptococcus
mitis, Streptococcus mutans, Peptostreptococcus anaerobius, Enterococ-
cus faecalis, Staphylococcus aureus, Escherichia coli, Candida albicans
and Aspergillus niger. The plates were incubated up to 48 h at
37C. The growth of microorganisms were monitored and zones
of growth inhibition were measured. Nitrocellulose membranes
were applied onto inhibition zone then transferred to sterile agar
plate and incubated. The growth of microorganisms were com-
pared with those in previous step and antibacterial activity were
estimated.
Results: All the sealers showed different activity depending on the
tested strains. Biocompatible sealers such as Endion, RSA and
Gutta-Percha did not inhibit growth of bacterial and fungal
strains. Endorez were active to Peptostreptococcus anaerobius only.
Diaket, Canason, Endomethason N and Proxiapex proved to be
effective against tested microorganisms. They were bactericidal
for Gram-positive bacteria (Streptococcus sp. and Peptostreptococcus
anaerobius, however bacteriostatic effect was observed in cases of
Escherichia coli, Staphylococcus aureus and Candida albicans. Pepto-
streptococcus anaerobius was the most susceptible to all specimens
wherease Enterococcus faecalis was resistant.
R1947 Surveillance of erythromycin resistance of
Streptococcus pneumoniae in Nis, Serbia in the last 5 years
S. Antic, B. Kocic, M. Mraovic, M. Dinic, G. Randjelovic,
B. Tiodorovic, S. Ivic, L. Ristic
Nis, CS
Objectives: The surveillance of erythromycin susceptibility of
Streptococcus pneumoniae in Nis country.
Materials and methods: A total of 1825 strains of invasive and non-
invasive S. pneumoniae isolated from patients during the years of
1999–2002 were evaluated. Susceptibility testing was performed
by disk-diffusion for all isolates, and MICs were determined by E-
test and agar dilution (the breakpoints applied were NCCLS
2002), for 330 isolates.
Results: The origin of the 1825 isolates tested was: blood 0.38%,
CSF 0.49%, tracheal aspirate 10.19%, sputum 6.68%, nasal swab
77.89%, eye 3.56%, ear 0.65% and tracheostoma 0.16%. Clinical
isolates were 27%. 60.05% patients were male and 39.94% were
female. Under 1 year were 2.3%, 1 year old 12.6%, 2 years,
16.98%, 3 years, 12.98%, 4 years 10.57%, 5 years 10.46%,
6–15 years 21.97%, 16–60 years 11.12% and over 60 years were
0.98%. Of the total number of tested, there were 87.86% of chil-
dren and 12.14% adults. Resistant isolates to erythromycin in chil-
dren were 28.78, 19.83, 14.37, 17.19 and 31.6% from 1999 to 2003,
respectively. In adults, this percentages for resistant strains were
30, 16.12, 17.08, 11.11, 31.6% from 1999 to 2003, respectively. The
total number of resistant isolates was 27.7, 19.13, 14.91, 16.09 and
34.88% per age. The most of strains were isolated from October to
April, 75% of all isolates. A total of 330 strains were tested by
using disc-diffusion and Etest.
Conclusions: During the study period we have been observing a
signiﬁcant increase in the incidence of S. pneumoniae resistant to
erythromycin, especially in children, and generally high per cent
of resistant strains. This problem in our region underlines the
need for continuous surveillance of antimicrobial resistance pro-
ﬁles of S. pneumoniae.
FD susceptible FD resistant Total
MS coagulase (+) 303 19 322
MR coagulase (+) 419 55 474
MS coagulase () 92 14 106
MR coagulase () 176 130 306
Total 990 218 1208
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R1948 In vitro activities of imipenem, meropenem and
piperacillin-tazobactam against Pseudomonas aeruginosa and
Acinetobacter spp. caused infections in an ICU, 2001–2003
A. Yuce, M. Erdenizmenli, N. Yapar, S. Senger
Izmir, TR
Objectives: To determine in vitro activities of carbapenems and
piperacillin-tazobactam against nonfermentative Gram-negative
bacilli such as Pseudomonas aeruginosa and Acinetobacter spp. isola-
ted from the patients hospitalised in the ICU of a university hos-
pital in years 2001 through 2003.
Methods: A total of 109 P. aeruginosa and 97 Acinetobacter spp.
strains isolated from patients having infections in the ICU were
studied. The distribution of microorganisms among the isolates is
given the Table 1.
The antibiotic susceptibilities were determined by E-test (AB
BIODISK) using Mueller–Hinton agar OXOID) according to
NCCLS recommendations.
Results: The resistance ratios of studied P. aeruginosa and Acinetob-
acter spp. strains are presented in the Table 2.
Conclusions: High levels of carbapenem and piperacillin-tazobac-
tam resistance are observed among the P. aeruginosa and Acinetob-
acter spp strains isolated from the ICU patients of our hospital.
R1949 The activity of some chemical disinfectants on
Aspergillus niger
M. Staniszewska, B. Tadeusiak, B. Jakimiak, E. Rho¨m-Rodowald,
A. Gliniewicz
Warsaw, PL
The aim of study was to evaluate of fungicidal activity of com-
mercial chemical disinfectants, which are used for surface disin-
fectant in order to prevent hospital infection. The products used
were representatives for different groups of active substances: al-
cohols (I), aldehydes and QAC (II), compounds releasers chlorine
(III). The disinfectants were examined in the speciﬁed concentra-
tions and exposure times recommended by The National Institute
of Hygiene in Poland (PZH) and German Society for Hygiene and
Microbiology (DGHM) for clean surfaces. The ingredients and
parameters recommended by PZH and DGHM as fungicidal are
described bellow: I (400% ethanol (96%), 10.0% n-propanol,
0.05% benzalkonium chloride, 0.0018% glutaraldehyde): undi-
luted solution–2 min (PZH); 5 min (DGHM); II (9.5% glutaralde-
hyde, 7.5% glyoxal, 9.6% didecylodimethylammonium chloride):
1%–15 min, 0.75%–60 min (PZH); 1%–15 min; 0.5%–60 min
(DGHM); III (99% sodium dichloroisocyanurate: 1.5 g active
chlorine in tablet): 1000 ppm of active chlorine—15 min (PZH),
DGHM–lack of recommendation. The test was performed
according to the method described in European Standard EN
13697, but instead of stainless steel discs the frosted glass carriers
were used. The test strain was A. niger ATCC 14606. The product
according to this method shall demonstrate at least 3 log reduc-
tion in viable fungal counts. In our test the alkohol disinfectant
(I) reduces fungi strains at rate 99.9% in 5 min. The disinfectant
based on aldehydes and QAC (III) were ineffectiveness in recom-
mended parameters: 1% in contact time 15 and 60 min and when
was tested at concentration 2% in 15 min. The disinfectant with
sodium dichloroisocyanurate, when diluted at concentration
1000 ppm active chlorine was lack of fungicidal activity in
15 min, but at concentration 2000 ppm active chlorine was effect-
iveness. The A. niger is more resistant than other fungi (C. albi-
cans ATCC 10231 and T. mentagrophytes ATCC 9533) tested in
method propagated by PZH or DGHM. The alcohol disinfectant
posses fungicidal properties according to strain A. niger. The alde-
hyde disinfectants known as fungicidal products are ineffective
on mould spores. The disinfectant with sodium dichloroisocyanu-
rate was effective to tested strain A. niger in higher concentration
than recommended for disinfection clean surfaces.
Mechanisms of action and of resistance of antimicrobial drugs
R1950 Class 1 and class 3 integrons among Klebsiella
oxytoca in a paediatric hospital
T. Conceicao, A. Brizio, R. Barros, A. Duarte
Lisbon, P
The Klebsiella genus is responsible for the most frequent human
nosocomial infections in the respiratory and urinary tract. The
control of emergent klebsiellae in hospital environment is import-
ant as they easily acquire antibiotic resistance genes. The main
objective of this work was the characterisation of integrons associ-
ated to antibiotic resistance among Klebsiella oxytoca iso-
lates. Twenty-one Klebsiella oxytoca strains, isolated from
different biological products in a paediatric hospital, revealed
intermediate susceptibility to broad-spectrum cephalosporins and
aztreonam, resistance to aminopenicillins and inhibitors, amino-
glycosides and ﬂuroquinolones. By isoelectrofocusing it was
observed different isoelectric points (pIs) of 5.4, 5.6, 7.0, 7.4, 7.5
and 7.6 indicating the production of different types of beta-lacta-
mases, that was conﬁrmed by PCR reaction, with speciﬁc primers
for blaTEM, blaOXY e blaOXA genes. These strains showed three
class 1 integrons with approximately 1650, 2000 and 3500 bp in
size, detected with speciﬁc primers 50CS and 30CS. Class 3 integ-
rons were detected by ampliﬁcation of class 3 integrase with spe-
ciﬁc primers intI3F and intI3R. All isolates generated the same
M13 ﬁngerprinting proﬁle, suggesting that they were clonally
Table 1. The distribution of studied strains among the samples
Pathogens
(n ¼ 206)
Samples
Blood Urine BAL ETAS Catheter Wound CSF
P. aeruginosa
(n ¼ 109)
26 11 7 52 3 7 3
Acinetobacter
spp. (n ¼ 97)
41 3 0 35 6 10 2
BAL: Bronchoalveolar lavage, ETAS: Endotracheal aspiration spe-
cimen, CSF: cerebrospinal ﬂuid.
Table 2. The antimicrobial resistance ratios of P. aeruginosa ve Aci-
netobacter spp. strains
Pathogens (n ¼ 206)
Antibiotics
Piperacillin-
tazobactam (%)
Imipenem
(%)
Meropenem
(%)
P. aeruginosa
(n ¼ 109)
90 90 74
Acinetobacter
spp (n ¼ 97)
100 96 84
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related, although they produced different beta-lactamases. The
presence of mobile genetic elements, such as plasmids and integ-
rons, which facilitate the gene mobility between strains, increase
the necessity of control the dissemination of these strains, K. oxyt-
oca, in hospitals.
R1951 Presence of TEM-1 and ROB-1 beta-lactamases in
clinical isolates of Haemophilus inﬂuenzae and
H. parainﬂuenzae. Correlation with betalam resistance
C. Rodrı´guez-Avial, I. Rodrı´guez-Avial, M.E. Fernandez,
E. Culebras, J.J. Picazo
Madrid, E
Objectives: Two betalactamases, TEM-1 and ROB-1, have been
identiﬁed in H. inﬂuenzae and H. parainﬂuenzae. Given the lack of
information on the incidence and the resistance to betalactams
conferred by the production of the ROB-1 in our area, we decided
to undertake a study to determine if and how often it appears in
our isolates.
Methods: We collected 171 consecutive clinical isolates of the
genus Haemophilus, and we determined their susceptibility to
ampicillin, amoxicillin–clavulanate (AC), cefaclor, cefuroxime and
cefotaxime by the agar dilution method. Of them, 28 strains were
betalactamase positive by the nitroceﬁn test (16.4%): 22 H. inﬂuen-
zae and six H. parainﬂuenzae. We analysed the presence of the
genes bla-TEM-1 and bla-ROB-1 in the 28 betalactamase-positive
strains by PCR.
Results: In H. inﬂuenzae the presence of the bla-TEM-1 gene was
detected in 20 strains (91%) and the bla-ROB-1 in two (9%).
Whereas in H. parainﬂuenzae the bla-ROB-1 gene was detected in
three strains (50%) and in one of them together with the bla-
TEM-1 gene. All isolates were resistant to ampicillin and suscept-
ible to cefotaxime regardless of the betalactamase present. Two
betalactamase positive AC-resistant (BLPACR) isolates were TEM-
1 producers. The MIC90 (mg/mL) of cefaclor was 64 for the TEM-
1 positive and ROB-1 positive strains. The MIC90 (mg/mL) of ce-
furoxime was eight for the TEM-1 producers and 1 for the ROB-1
producers.
Conclusions: The presence of the ROB-1 betalactamase among our
H. parainﬂuenzae isolates is higher than among the H. inﬂuenzae.
The prevalence of ROB-1 betalactamase in the H. inﬂuenzae iso-
lates is very similar to previously published reports. Although
rare we have found one isolate with both betalactamases. The
strains with ROB-1 betalactamase did not have higher MIC than
the TEM-1 isolates for the betalactams studied.
R1952 Patterns of macrolide resistance determinants
among Streptoccus pneumoniae isolates
M. Oskoui, F. Shoorag, J. Raisi
Tehran, IR
It is well established that the prevalence of resistance to antibiotics
depends, in part, on their use, as countries with low rates or high
rates of penicillin resistance have low or high rates of b-lactam
prescription. Similarly, there is an apparent association between
prescription and resistance to macrolides. When the data are
examined in more detail a more complex situation is revealed.
Mocrolide resistance in Streptococcus pneumoniae is typically due to
acquisition of the erm (B) gene, which mediates ribosomal modiﬁ-
cation, or the mef gene, which encodes an efﬂux pump. In this
study, we assessed the relationship between various factors and
resistance and undertook systematic analysis of multidrug resist-
ance. Betalactam and macrolide resistance was characterised at a
molecular level.
Materials: Susceptibilities to macrolides were evaluated in 150
Streptococcus pneumoniae isolates of which 100 were from patients
with invasive diseases and 50 were from healthy carriers. Suscep-
tibility of pneumococci to erythromycin, was tested by the agar
diffusion technique.
Conclusions: The MIC of penicillin and cefotaxime for these iso-
lates had been assayed previously and showed a high rate of
penicillin resistance (68%). Compared with erythromycin as an
indicator of macrolide activity, 15 (10%) isolates had MIC > 1 lg/
mL and thus were classiﬁed as resistance. Among these strains,
only one (0.3%) had erythromycin MIC > 32 lg/mL. Twenty of
these strains, selected were examined by polymerase chain reac-
tion (PCR) for the presence of erm B gene. All strains, which were
resistant to erythromycin contained erm B-related genes
R1953 Study of amikacin resistance in A. baumannii
clinical isolates
L. Pe´rez, T. Alarco´n, M. Serrano, A. Perkins, D. Domingo,
M. Lo´pez-Brea
Madrid, E
The aim of this study was to determine the presence of the
aph(30)-VIa gene by PCR, which encodes an inactivating enzyme
amikacin in A. baumannii clinical isolates.
Methods: A total of 36 clinical isolates of A. baumannii (17 amika-
cin resistant and 19 amikacin susceptible), recovered from patients
admitted in Hospital La Princesa from 1999 to 2001 were inclu-
ded. Isolates were identiﬁed by MicroScan (Dade-Behring) and
amikacin susceptibility performed by agar dilution, according to
NCCLS guidelines. All the strains were studied for the presence
of the aph(30)-VIa gene by PCR. A. baumannii ATCC 19606 was
used as control. The ampliﬁed DNA products were resolved by
electrophoresis in 1.5% agarose gels.
Results: All resistant clinical isolates had positive PCRs for the
aph(30)-VIa gene (234 bp fragment) and 18 susceptible strains had
negative PCRs whereas one susceptible strain had a positive reac-
tion for the ampliﬁcation of aph(30)-VIa gene.
Conclusions: This study showed that all resistant isolates had the
aminoglycoside-30-phosphotransferaseVI [APH(3’)-VI], a type of
30-O-phosphotransferase which inactivates amikacin.
R1954 Accumulation of at least 17 different acquired-
resistance genes in a clinical Escherichia coli isolate
K.J. Sherwood, B. Wiedemann
Bonn, D
Objectives: Recently the rate of acquired antibiotic resistance in E.
coli has risen. Resistance causes bacteria to grow more slowly due
to the additional genetic material they have to replicate and
express. Yet the multiresistant strains isolated from hospitals
show no such deﬁcits. If bacteria are viable despite so many
resistance genes then an evolution of the genes or of their
arrangement must have taken place. In order to analyse this evo-
lution the molecular background of such multiresistant strains has
to be known. Strain 56 is a clinical E. coli isolate resistant to most
beta-lactams, quinolones, aminoglycosides, tetracyclines, chloram-
phenicol and co-trimoxazol. In this work we want to analyse the
responsible resistance genes and how they are arranged in the
cell.
Methods: Minimum inhibitory concentrations (MICs) of 50 antibi-
otics were determined. Resistance genes and accompanying
mobile structures were detected by PCR and sequencing, MAR-
phenotype was conﬁrmed by organic solvent tolerance assay.
Conjugation experiments were performed and the resultant trans-
conjugants were analysed to reveal which resistance genes were
transferable. The plasmids of donor and transconjugants were also
prepared and analysed.
Results: Strain 56 encodes at least 17 different acquired resistance
genes on the chromosome and on three different plasmids P1, P2
and P3. On the chromosome are two mutations in gyrA, one in
parC, and at least one leading to MAR-phenotype. The nontrans-
ferable plasmid P1 encodes the resistance genes catI, tet(B), and
aac(60). Aph(30)-Ia and TEM-1b are located on the transferable
plasmid P2.
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Plasmid P3 is capable of transferring the following resistance gen-
es: CMY-2, dfr12, ant(30)-I, qacED1, sul1, merA, ﬂo, tet(A), and sul2,
whereby dfr12, ant(30)-I, qacED1, and sul1 are arranged in a class1
integron in a Tn21-like structure.
Conclusions: The strain carries at least 17 resistance genes, mostly
located on transferable plasmids, conferring resistance to 43 of 50
tested antibiotics. It is remarkable that bacteria with so many
resistance genes have viability similar to their susceptible parent
cells. What is even more surprising is that despite the presence of
integrons and transposons that allow the bacteria to rearrange
these genes and give them the potential to reduce redundancy
and optimise gene expression we still see such a large redund-
ancy of resistance [tet(B) and tet(A), ﬂo and catI, sul1 and sul2,
CMY-2 and TEM-1b].
R1955 Abililty of Escherichia coli 0157:H7 EDL933 mutants
to develop resistance to ciproﬂoxacin and other antimicrobial
agents
A. Hamouda, L. Vali, S.G.B. Amyes – The Wellcome Trust
IPRAVE Consortium
Objective: Shigatoxin-producing Escherichia coli 0157:H7 is an
important food-borne human pathogen. The use of ciproﬂoxacin
in treating Escherichia coli 0157:H7 is contraversial. In vivo experi-
ments in mice demonstrated that ciproﬂoxacin increases free fae-
cal Shigatoxins, and causes death. However, in humans the
administration of ﬂuoroquinolones at early stages of infection
caused by Escherichia coli 0157 may slow the progression of the
disease to haemorrhagic uraemic sydrome (HUS). The objective of
our study was to examine ciproﬂoxacin resistance in Escherichia
coli 0157:H7 EDL933 and to develop resistant mutants to ciproﬂ-
oxacin and examine their cross-resistance to other antibiotics.
Method: Escherichia coli O157:H7 EDL933 is sensitive to ciproﬂoxa-
cin with the minimum inhibitory concentration (MIC) of 0.03 mg/L.
Mutants were selected at 1 and 2 times the MIC. The process was
repeated until high-level ciproﬂoxacin resistance (MIC >16 mg/L)
was detected. After each mutation step, MICs of mutants to
ciproﬂoxacin, nalidixic acid, tetracycline, and chloramphenicol
were measured by a standard agar dilution method. The stability
of mutants was investigated by serial sub-culturing of the mutants
on ciproﬂoxacin-free MacConkey agar plates for 10 generations,
and subsequently retesting their susceptibilities. Mutation fre-
quencies were determined by comparing the number of colonies
that grew on plates containing antibiotic with the number of col-
onies obtained in the absence of the compound.
Results: Four-step mutants were selected. Mutant frequencies were
determined to evaluate the rate at which mutations occur, and
were found to be in the range of 10e-8 and 10e-7 for each step of
the selection process. Mutations led to an increase in the MICs of
ciproﬂoxacin (00.6–32 mg/L), and a 16-fold increase in the MIC of
nalidixic acid (MIC > 128 mg/L) followed by a fourfold increase
in the MIC of chloramphenicol (MIC 32 mg/L). The MIC of tetra-
cycline was also increased by twofold (MIC 4 mg/L). These results
suggest the presence of a multiple resistance (Mar) phenotype.
Conclusion: These ﬁndings suggest the ability of Escherichia coli
0157:H7 EDL933 to easily develop resistance to ciproﬂoxacin and
other quinolones. This appears to be accompanied by an increase
in resistance to nonﬂuoroquinolone compounds. Patients infected
by Escherichia coli 0157:H7 when treated and exposed to ciproﬂ-
oxacin may acquire resistant bacteria in their gastrointestinal tract.
R1956 Extended-spectrum beta-lactamase producing
Enterobacteriaceae in a multidisciplinary Indian intensive care
unit
U. Sekar, P. Sireesha, T. Vinodh, P. Kumar, V. Kamat
Chennai, IND
Objectives: Extended spectrum beta-lactamase (ESBL) producing
organisms pose challenges to clinical microbiologists, clinicians
and infection control professionals especially in the setting of the
Intensive Care Unit (ICU). Due to concerns about the rise in anti-
biotic resistance in the ICU pathogens this study was under taken
to determine the prevalence of ESBL production in Enterobacteria-
ceae, which are common nosocomial pathogens in the ICU. The
study was performed in a multidisciplinary ICU in south India
during the period March–May 2003.
Methods: One-hundered consecutive clinically signiﬁcant isolates
from patients in the ICU which exhibited resistance to the ceftazi-
dime (<22 mm) or cefataxime (<27 mm) by disc diffusion test
were further subjected to phenotypic conﬁrmatory tests namely,
double disc synergy and inhibitor potentiated disc diffusion tests.
Minimal inhibitory concentrations (MIC) of oxyiminocephalospor-
ins and imipenem were determined by agar dilution method.
Detection of beta-lactamase genes speciﬁc for TEM and SHV types
was performed by PCR.
Results: Sixty-ﬁve per cent of all Enterobacteriaceae isolates from
ICU were ESBL producers and Escherichia coli was the most com-
mon organism. Seventy per cent of the isolates exhibited zone
enhancement with double disc synergy test. Ninety ﬁve per cent
of the strains exhibited potentiation with Ceftazidime and clavul-
anic acid combination and 91% with cefataxime and clavulanic
acid. Co-resistance was observed to gentamycin (87%), amikacin
(51%), tobramycin (54%) and ciproﬂoxacin (73%). All the strains
had high minimal inhibitory combination values for cephalospo-
rins and were uniformly susceptible to imipenem. A fourfold
reduction in the MIC was produced with inhibitor combinations.
TEM genes were detectable in 62 strains and SHV in 72 strains by
PCR. RFLP and DNA sequencing of the representative strains is
underway to study their clonal origin.
Conclusion: There is a high prevalence of ESBL producing Entero-
bacteriaceae in our ICU and this needs to be addressed by con-
tinuous monitoring programmes, antibiotic and infection control
policies. High degree of co-resistance to multiple antibiotics limits
the treatment options in the critically ill patients. TEM and SHV
genotypes are the most common types seen in our strains.
R1957 Characterisation of variant Salmonella genomic
island 1 harbours 3 integrons from serovar Typhimurium DT104
S. Kim, S.H. Kim, O.Y. Lim, S.G. Chun, Y.H. Kang, B.K. Lee
Seoul, KOR
Objective: Salmonella enterica serovar Typhimurium DT104 (DT104)
has become a major virulent pathogen emerged as a world health
problem. The organism commonly has resistant to ampicillin, chl-
oramphenicol, streptomycin, sulphonamides, and tetracycline, so
called pentadrug resistant pattern (ACSSuT). Its ﬁve antibiotic
genes are located between two integrons and clustered in about
13 kb size of chromosomal region. An antibiotic resistance genes
cluster in Salmonella genomic island 1 (SGI1) has been previously
elucidated in multidrug-resistant Salmonella enterica serovar Ty-
phimurium DT104 and its partially deleted or replaced gene clus-
ters were found in serovars Agona, Paratyphi B, and Albany. We
tried to ﬁnd another variant antibiotic genes clusters in Salmonella
enterica serovar Typhimurium DT104 isolates from Korean
patients.
Methods: Minimum inhibitory concentration (MIC) tests against
ampicillin and chloramphenicol, polymerase chain reaction with
speciﬁc primers for antibiotic resistance genes cluster in SGI1 and
southern analysis with aadA2, blaPSE-1 and ﬂoR probes were per-
formed to pentadrug resistant 14 DT104 isolates from Korean
patients. The novel 3.9 kb DNA fragment produced by XbaI and
XhoI digestion of a DT104 genomic DNA was cloned and se-
quenced.
Results: We identiﬁed a S. enterica serovar Typhimurium DT104
isolate from a diarrhoea patient which has two times of MIC val-
ues against ampicillin and chloramphenicol comparing with those
of other DT104 isolates. This isolate had a novel integron-associ-
ated gene cassette as well as a known antibiotic resistance gene
cluster in its SGI1. The novel integron-associated gene cluster har-
boured blaPSE-1 and sul1 carried by a class I integron and ﬂoR,
and partial tetR in that order.
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Conclusion: This ﬁnding is the ﬁrst report that shows multiplicated
antibiotic genes associated with integron in SGI1, suggesting the
recombinational events that lead to the resistance genes shufﬂing
as well as intragenomic transfer of this integron.
R1958 The prevalence of pmrA, the ﬂuoroquinolone efﬂux
pump gene, in clinical isolates of Streptococcus pneumoniae
I. Morrissey, S. Bakker, S. Buckridge, D.J. Farrell
London, UK
Objectives: The role of efﬂux in ﬂuoroquinolone (FQ) resistance in
Streptococcus pneumoniae (SP) is unclear. It has been suggested that
almost 50% of ciproﬂoxacin (CFX)-resistant SP actively efﬂux CFX
(Antimicrob Agents Chemother 42, 2032). However, 80% of SP efﬂux
CFX irrespective of CFX susceptibility (J Antimicrob Chemother 44
(Suppl. A): abst. P381). Both studies relied on reserpine to inhibit
efﬂux, which might not be an ideal screening method. As the FQ
efﬂux gene, pmrA, has been identiﬁed (Antimicrob Agents Chemo-
ther 43, 187) we screened a panel of SP clinical isolates for the
presence of pmrA.
Methods: 1871 SP isolated between 1999 and 2001 from 11 countries
was evaluated for levoﬂoxacin (LFX) MIC by NCCLS microbroth
dilution. Total DNA was then extracted from these isolates and a
533-bp region of pmrA ampliﬁed by PCR (16S rRNA internal prim-
ers were also included as a control). PCR products were then sub-
jected to agarose gel electrophoresis to determine the presence of a
533-bp product from pmrA and/or a 200-bp product for the 16S con-
trol. The whole pmrA gene was also ampliﬁed using primers 177 bp
upstream and 74 bp downstream and sequenced as required.
Results: In summary, LFX produced MIC 50% and MIC 90% val-
ues of 0.5 and 1 mg/L, respectively. The percentage susceptible,
intermediate and resistant were 98.5, 0.4 and 1.1, respectively. As
would be expected from other surveillance data, LFX resistance
was rare in SP. Nevertheless, all isolates (including SP R6 control)
possessed pmrA. Furthermore, 50 of 1871 SP produced a smaller
pmrA band than usual. Complete pmrA was sequenced from a
sample of these isolates and all were found to contain a 28 amino
acid deletion (AA 159–186) compared with SP R6. Forty-nine of
these isolates were susceptible to LFX but one was intermediate.
Twenty-four of 50 were from Germany, which may suggest that
the isolate is a short-pmrA clone.
Conclusions: It would appear that pmrA is a constituent of the ‘nor-
mal’ SP genome and presence of the gene is not associated with
LFX MIC. A shorter derivative of pmrAwas also found in a minority
of isolates but this again was not associated with LFX resistance. If
efﬂux has a role to play in LFX resistance it may involve differential
expression of the gene, although a recent study has found that pmrA
expression and FQ-efﬂux inhibition by reserpine do not correlate
(Antimicrob Agents Chemother 46, 808).
R1959 Effect of phenylalanine arginine beta-
naphthylamide (PAN) on the activity of quinolones against
Klebsiella pneumoniae (Kp) strains expressing or not increased
active efﬂux of norﬂoxacin (IAE-NOR)
M.-C. Conejo, I. Garcı´a, L. Martı´nez-Martı´nez
Seville, E
Objectives: To evaluate the effect of the efﬂux pump inhibitor
PAN on the activities of the hydrophilic quinolone norﬂoxacin
(NOR) and two hydrophobic compounds, nalidixic acid (NAL)
and peﬂoxacin (PEF), against 25 clinical isolates of Kp, and to
relate this effect with the presence of active efﬂux of norﬂoxacin.
Methods: MICs of NOR, NAL, and PEF were determined by micro-
dilution (NCCLS guidelines) in the presence or in absence of PAN
(20 mg/L). IAE-NOR was determined previously in our laborat-
ory by a spectroﬂuorometric assay [Antimicrob Agents Chemother
(2002) 46, 3926–3932) and deﬁned as a 50% increase in the accu-
mulation of this quinolone in the presence of carbonyl cyanide
m-chlorophenylhydrazone (CCCP) in comparison with the corres-
ponding basal value in the absence of CCCP. Among the 25 strains
evaluated, 13 expressed IAE-NOR, and 12 lacked IAE-NOR.
Results: PAN reduced at least four times the MICs of NOR for 67
and 25% of strains expressing or lacking IAE-NOR, respectively.
However, PAN caused a reduction of at least four times in the
MICs of PEF for all strains evaluated, with independence of IAE-
NOR expression. Similarly, in the presence of PAN, the MICs of
NAL decreased at least four times for all strains expressing IAE-
NOR and for 92% of strains lacking IAE-NOR. PAN caused
reductions 8 and 16 times in the MICs of PEF against 85 and
69% of IAE-NOR(+) strains and against 67 and 50% of strains
lacking IAE-NOR. PAN caused reductions 8 and 16 times in
the MICs of NAL against 85 and 77% of IAE-NOR(+) Kp, and
against 92 and 66% of IAE-NOR() Kp.
Conclusions: PAN is able to reduce 4 times the MICs of NOR
against many Kp isolates expressing IAE-NOR, but also against a
minority of isolates lacking IAE-NOR. When considering more
hydrophobic quinolones, PAN reduces the MICs of PEF and of
NAL against 100% and 92–100% of the tested isolates, respectively,
with independence of IAE-NOR expression. The synergistic effect of
PANwith quinolones is independent of the expression of IAE-NOR.
R1960 First description of TEM-24 beta-lactamase
produced by nosocomial strains in Portugal
N. Mendonc¸a, M. Ferreira, E. Ferreira, D. Louro, G. Ribeiro,
M. Salgado, M. Canic¸a
Lisbon, P
Objective: Characterisation of the ﬁrst extended spectrum beta-lac-
tamase (ESBL) TEM-24 described in Portugal, produced by two
nosocomial strains: Klebsiella pneumoniae and Escherichia coli.
Methods: Two uropathogenic isolates (K. pneumoniae – Kp2638 and
E. coli – Ec1248) were collected from two patients in two hospitals
in different geographic areas, on March and April 1999. MICs of
14 different beta-lactams (alone or in combination with beta-lacta-
mase inhibitors) were evaluated by an agar dilution method,
according to SFM guidelines. To conﬁrm the ESBL production, the
isolates were re-tested with the E-test ESBL strips. The beta-lacta-
mases were identiﬁed by isoelectrofocusing, a multiplex-PCR
method and sequencing.
Results: Kp2638 strain showed only reduced susceptibility to ceftaz-
idime (MIC ¼ 32 mg/L) and the Ec1248 strain presented resistance
to aztreoname (MIC > 256 mg/L), ceftazidime (MIC > 256 mg/L)
and reduced susceptibility to cefepime (MIC ¼ 32 mg/L). Both
strains were ESBL positive: MIC synergy between the third-genera-
tion cephalosporins and aztreoname alone and in combination with
clavulanate was detected; this synergy was conﬁrmed by E-test.
Multiplex-PCR method showed that Kp2638 strain presented a bla-
TEM gene plus a blaSHV gene and Ec1248 strain showed a blaTEM
gene plus the ubiquitariy ampC gene. Sequencing blaTEM genes
from both strains allowed to the identiﬁcation of blaTEM-24, with
the following nucleotide mutations (and corresponding amino acid
substitutions): C317!A (Gln39!Lys), G512!A (Glu104!Lys),
C692!A (Arg164!Ser), G911!A (Ala237!Thr) and G917!A
(Glu240!Lys). These enzymes are also under the control of the
strong PaPb blaTEM-2 gene promoter.
Conclusion: TEM-24 beta-lactamase was ﬁrstly reported in Portu-
gal in this study. Antimicrobial-resistant bacteria ESBL-producing
in Portuguese hospitals should be carefully monitored for its
impact on the nosocomial infections.
R1961 Interaction of ceftazidime and tobramycin with
vancomycin against Pseudomonas aeruginosa
F. Cavallini, S. Roveta, A. Marchese, E.A. Debbia
Genoa, I
Objectives: Pseudomonas aeruginosa is responsible of severe and
often lethal infections that can hit immunocompromised hosts.
The evolution of resistance in this pathogen to currently available
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agents poses major therapeutic threats globally. Vancomycin is a
powerful active antibiotic on the Gram-positive bacteria, and they
very rarely develop resistance. In Gram-negative the entry of the
glycopeptides is prevented by the lipopolisaccaride (LPS). It is
assumed that some antibiotics might disorganise the structure of
lipopolisaccaride and allow the passage of vancomycin into the
bacterial cell. In order to estimate this hypothesis and new thera-
peutic alternatives, the ceftazidime (CAZ) and tobramycin (TOB)
have been tested in association with vancomycin.
Methods: A bacterial suspension of about 109 CFU/mL was see-
ded on plates containing a ﬁxed concentration of VAN (500 mg/
L) and increased doses (2x, 4x, 8x, 16x) of CAZ and TOB. Survi-
vors were counted after 48 h at 37C. Result were interpreted as
synergism (99%), additive (90%) and indifference (no signiﬁcant
change) of the CFU/mL reduction found in the drug combination
in comparison to the drug alone.
Results: CAZ in combination with VAN reacted synergistically in
16 of 41 cases, additive was found in 17 of 41 interactions and
indifference was noted in eight of 41 tests. When TOB was added
to VAN synergism was registered in eight of 41 cases, additive
was detected in 15 of 41 cases and the remaining tests (18 of 41)
resulted in an indifferent reaction. Further tests were also carried
out employing teicoplanin (400 mg/L). Preliminary results (11
tests performed) indicated that this glycopeptide favourably reac-
ted with both CAZ and TOB showing similar incidence as repor-
ted for vancomycin.
Conclusions: Glycopeptides favourably interacted with the other
drugs against P. aeruginosa. This might be an interesting new
option in treating the above pathogens especially in situation were
the drugs could be administered topically. The possibility of using
glycopeptides under less restrictive conditions is under study,
because these drugs are characterised by a mode of action that
imply a very rare selection of resistant strains.
R1962 Detection of CMY-2 beta-lactamases in clinical
P. stuartii isolates from Egypt
N. Khalaf, I. Wiegand, B. Wiedemann
Cairo, EGY; Bonn, D
Objectives: The nosocomial pathogen P. stuartii is naturally sus-
ceptible to third generation cephalosporins and aminoglycosides.
Resistance to these antibiotics can be due to overexpression of
chromosomally encoded AmpC and AAC(2’)-Ia enzymes, respect-
ively. Overexpression arises from mutations in the regulatory
mechanisms for expression of the respective genes. The aim of
this work is to characterise the molecular mechanism of antibiotic
resistance in clinical isolates of P. stuartii.
Methods: In this study, three P. stuartii isolates from patients with
burn infections in a university hospital in Egypt were used. MICs
were determined using a microdilution method according to
NCCLS guidelines. SDS-PAGE analysis of crude beta lactamase
extracts was performed. Plasmid proﬁles were determined and
conjugation experiments were carried out using E. coli as recipi-
ent. PCR experiments were performed to detect blaTEM, blaCMY
and intI1 genes, amplicons of blaTEM and blaCMY genes were
sequenced. PCR was also used to detect the aminoglycoside resist-
ance genes aac(60)-Ib, ant(200)-Ia, aph(3)-I and aac(3)-IIc.
Results: All isolates were resistant to different aminoglycosides
and furthermore to third generation cephalosporins and cefoxitin,
but sensitive to cefepime and carbapenems. No clavulanic acid
effect was observed. For all strains resistance to beta lactams and
aminoglycosides was transferable. Two beta lactamase bands
(40 kDa, 28 kDa) were seen on the SDS-PAGE with all strains,
including the transconjugants. blaTEM and blaCMY genes were
detected by PCR. Sequencing of the amplicons revealed 100%
identity with the deduced amino acid sequences of TEM-1 and
CMY-2, respectively. Transferable aph(3)-I and aac(3)-IIc genes
were detected in two strains. Also, a class I integron with aac(60)-
Ib gencassette was detected in two isolates, the third isolate car-
ried an ant(200)-Ia gencassette within the integron.
Conclusion: In P. stuartii a combined beta lactam and aminoglyco-
side resistance is possible via independent mutations leading to
overexpression of chromosomally encoded resistance genes. This
was not observed in the examined clinical isolates. Resistance to
beta lactams was due to a CMY-2 enzyme located on a plasmid
carrying aminoglycoside resistance genes also. Even for a natural
AmpC producer acquisition of a plasmid encoded ampC gene can
be beneﬁcial in the respect that multiple resistance can easily
arise.
R1963 Isolation and antibiotic resistance of Salmonella
from Itsoseng and Mmabatho areas in the North West Province,
South Africa
K.M. Kwenamore, P.T. Mmolawa
Mmabatho, ZA
Background: In most countries (South Africa), antimicrobial drugs
are used in food-producing animals for treatment of infectious
disease and for growth-promoting effects and leads to the appear-
ance and persistence of resistant strains (Radotitis et al., 1995).
Aim: The aim and objective was to detect the prevalence of
Salmonella in sewage water and the antibiotic resistance of isolates.
Method: Sixteen sewage water samples from Mmabatho and Itso-
seng in the North West Province was collected from winter (June–
July) and spring (August–November). Sterile plastic bottles were
used to collect a litre of water, and were labelled with name, time
and place of collection. Water was well mixed and 10 mL was
poured into sterile tubes, and was centrifuged at speed of
300 rpm for 10 min. The supernatant was discarded and a pellet
was mixed with selenite broth and incubated overnight at 37C.
Selenite broth was sub-cultured onto SS agar plates and incubated
for 18–24 h at 37C. Following incubation, colonies from SS agar
were puriﬁed on another SS agar. Plates were then incubated for
18–24 h at 37C. API 20E test was used (according to the manu-
facturer’s instructions) to further characterise colonies suspected
to be Salmonella. Antibiotic resistance of isolates was performed
on MH agar plate (Bauer 1966). The following antibiotic discs
were used: streptomycin, chloramphenicol, amoxicillin, oxytetra-
cycline, sulphamethoxazole, erythromycin, trimetroprim, polym-
yxin B and cephalexin. A zone of inhibition (clear area) around
the disk indicated that bacteria were susceptible to the antibiotics
used. Serological Test Nonlactose fermenters (pale colony),
sometimes with black centres due to hydrogen sulphide (H2S)
production, were picked from Salmonella shigella agar to perform
serologygical typing.
Results: From 16 samples at Itsoseng, nine Salmonella isolates were
identiﬁed as group B and seven were identiﬁed as group E. At
Mmabatho, from 16 samples 10 Salmonella isolates were identiﬁed
as group B and six were identiﬁed as group E. Antibiotic resist-
ance was also performed. From both places, in winter and spring
100% of Salmonella isolates were found resistant to most antibiot-
ics, namely, erythromycin, amoxicillin, sulphamethoxazole, trime-
throprim, erythromycin and cephalexin.
Conclusion: Multiple antibiotic resistance was observed for all the
Salmonella isolates which might be greatly due to the miss use of
these drugs by individuals in the area.
R1964 Effect of amount of beta-lactamase on the post-beta-
lactamase inhibitor effect of clavulanic acid against isogenic
Escherichia coli strains producing SHV extended-spectrum beta-
lactamases
B. Bedenic
Zagreb, HR
Objectives: Post-beta-lactamase inhibitor effect (PLIE) is a phenom-
enon which enables beta-lactam/inhibitor combinations to remain
active in vivo throughout the interval between two consecutive
doses, even when inhibitor serum concentrations decrease to val-
ues below those active in vitro. The aim of this investigation was
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to determine the effect of increased amount of SHV-extended-
spectrum beta-lactamases (ESBLs) on the duration of the postanti-
biotic effect (PAE) and post-beta-lactamase-inhibitor effect (PLIE).
Methods: The experiments were performed on isogenic Escherichia
coli strains with strong and weak promoters which produce SHV-
2, SHV-3 and SHV-5 beta-lactamases. The strains with weak pro-
moter produced low amount of beta-lactamase (mpb strains)
while strains with strong promoter hyperproduce the enzyme
(mpa strains). The minimum inhibitory concentrations (MICs) of
beta-lactams alone and combined with clavulanic acid were deter-
mined by broth microdilution method. PAE and PLIE were
induced by exposing the cultures to cefotaxime (8 mg/L) and cla-
vulanic acid (4 mg/L) for 2 h. For PLIE determination clavulanic
acid was removed by dilution and the cultures were re-exposed
only to cefotaxime. The determination of PAE and PLIE was
performed by viable counting method. PAE was calculated as
PAE ¼ T – C, where T is the time necessary for viable bacteria in
the test culture to grow by 1 log10 and C is time necessary for
viable bacteria in the control culture to grow by 1 log10. PLIE was
calculated as PLIE ¼ total delay – (DG + PAE), where DG is delay
of growth due to experimental conditions.
Results: The PLIE lasted 1.4 h for the SHV-2 mpb strain, 2.2 h
with SHV-3 -mpb strain and 0.9 h for SHV-5 mpb strain. The
strains with strong promoter had shorter duration of PLIE. It ran-
ged from 0.3 h for SHV-3 mpa strain to 0.8 h for SHV-2 mpa
strain. No PLIE was detected for SHV-5-mpa strain. The PAE was
also of shorter duration in the strains which hyperproduce beta-
lactamase. It was not observed with SHV-3-mpa and SHV-5-mpa
strains. Mpb strains with lower amount of beta-lactamase had
duration of PAE, which ranged from 0.62 to 1.4 h.
Conclusions: The hyperproduction of SHV-ESBLs shortened the
duration of PAE and PLIE in isogenic E. coli strains. This phenom-
enon could be responsible for the resistance of some SHV-ESBL-
producing Enterobacteriaceae with high-level enzyme production
to beta-lactam/inhibitor combinations and for in vivo therapeutic
failures of such combinations.
R1965 Effect of linezolid on nitric oxide production by
lipopolysaccharide stimulation
O. Korzh, T. Bondarenko
Kharkov, UKR
Objectives: Low-dose and long-term administration of linezolid
into patients with airway inﬂammatory diseases could favourably
modify their clinical conditions. However, the therapeutic mode
of action of linezolid is not well understood. Free oxygen radicals,
including nitric oxide (NO), are well recognised as the important
ﬁnal effector molecules in the development and the maintenance
of inﬂammatory diseases. The aim of this study was to investigate
the inﬂuence of linezolide on NO generation in vivo.
Methods: Male ICR mice, 5 weeks of age, were orally administered
with linezolid once a day for 2–4 weeks. The mice were then
injected intraperitoneally with 5.0 mg/kg lipopolysaccharide
(LPS) and the plasma NO level was examined 6 h later.
Results: Although pretreatment of mice with linezolid for 2 weeks
scarcely affected NO generation by LPS injection, the administra-
tion of linezolid for 4 weeks signiﬁcantly inhibited LPS-induced
NO generation. The data in the present study also showed that
pretreatment of mice with linezolid for 4 weeks signiﬁcantly sup-
presses not only production of pro-inﬂammatory cytokines inter-
leukin-1beta, interleukin-6, and tumour necrosis factor-alpha, but
also inducible nitric oxide synthase mRNA expressions, which are
enhanced by LPS injection.
Conclusion: These results strongly suggest that suppressive activity
of linezolid on NO generation in response to LPS stimulation
in vivo may, in part, account for the clinical efﬁcacy of linezolid
on chronic inﬂammatory diseases.
Epidemiology of resistance, antibiotic usage
R1966 In vitro susceptibility to antibiotics of Escherichia
coli isolates in community-acquired urinary-tract infections in
1998–2003
S. Kurutepe, S. Surucuoglu, C. Segin, H. Gazi, M. Gu¨lay,
B. Ozbakkaloglu
Manisa, TR
Objective: To determine the change in antimicrobial susceptibility
of E. coli isolates during 1998–2003 in community-acquired urin-
ary-tract infections (CA-UTIs) and to suggest currently empirical
antibiotic therapy in these patients.
Methods: During January 1998–October 2003, a total of 880 E. coli
isolates causing CA-UTIs were included this study. Isolation and
identiﬁcation were performed by standard method and suscepti-
bility testing was performed by disc-diffusion method. Suscepti-
bility was tested ampicillin (AMP), amoxicillin–clavulanate
(AMC), trimethoprim–sulphamethoxazole (SXT), ciproﬂoxacin
(CIP), gentamicin (CN), cefuroxime (CXM) and nitrofurantoin (F).
Results: The prevalence of resistance among E. coli was >50.0%
for ampicillin and 40% trimethoprim–sulphamethoxazole for in
each year studied. The susceptibility pattern of E. coli to nitrofu-
rantoin (5.4, 6.3, 7.2, 5.3, 8.4 and 8.8%), cefuroxime (5.9, 6.9, 7.2,
6.2, 11.3 and 7.5%) and amoxicillin–clavulanate (18.4, 21.5, 25.0,
29.2, 23.9, 11.2%) did not present signiﬁcant differences in all six
years periods. There was a signiﬁcant increase in E. coli suscepti-
bility to ciproﬂoxacin (14.7, 11.3, 18.5, 25.6, 26.7 and 24.8%) and
gentamicin (7.0, 13.9, 15.3, 25.6, 23.2 and 13.8%).
Conclusion: The best in vitro susceptibility was shown for cefuroxi-
me and nitrofurantoin, followed by gentamicin, ciproﬂoxacin and
amoxicillin-clavulanate. Strains of E. coli show high resistance rate
to ampicillin and trimethoprim–sulphamethoxazole. Empirical
initial treatment with ampicillin and trimethoprim-sulfamethoxaz-
ole is inadequate in approximately one-third of UTI cases in our
region. A large number of pathogens can safely be treated with
nitroforantoin, cefuroxime and gentamicin and may be empirically
treated with amoxicillin–clavulanate and ciproﬂoxacin.
R1967 Vancomycin intermediate staphylococci in
neutropenic patients
O. Unaldi, O. Guzel, D. Engin, M. Yalinay Cirak, E. Senol,
S. Turet
Ankara, TR
Objectives: Since its discovery, reduced glycopeptide susceptibil-
ity of Staphylococcus species is a growing problem. The aim of
this study was to determine the prevalance of vancomycin inter-
mediate S. aureus and coagulase-negative (CNS) Staphylococcus
species isolated from neutropenic patients in Gazi University
Hospital.
Methods: A total of 64 CNS and 37 S. aureus isolates were agar
screened with plates containing 4 lg/mL of vancomycin. If no
growth was detected in the end of 48 h of incubation, the strain
was considered susceptible. Conﬂuent growers were designated
as possible vancomycin intermediate strains. Population analysis
was performed for the stains with a countable number (1–30) of
colonies in screening plates, to conﬁrm heterogenous vancomycin
intermediate susceptibility. In population analysis, criss-cross
serial dilutions of vancomycin and bacterial suspensions were tes-
ted to determine the frequency of vancomycin intermediate cells
in the culture.
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Results: Five of 64 CNS strains were found possible hetero-vanco-
mycin intermediate in screening plates. All ﬁve strains was con-
ﬁrmed to harbour more than 1/106 vancomycin intermediate
cells, thus identiﬁed as hetero-vancomycin intermediate. All of the
S. aureus strains were found susceptible to vancomycin. No con-
ﬂuent growers were detected in screening plates.
Conclusion: This preliminary report indicates that the rise of
vancomycin intermediate CNS is an imminent danger.
R1968 Quantity and quality of antibiotic usage in
hospitals and in the community in two areas in Indonesia
U. Hadi, I. Gyssens, E. Sri Lestari, O. Duerink, B. Riyianto,
E. Rahardjo, E. Kolopaking, W. Gardjito, P. van den Broek on
behalf of the AMRIN Study Group, Indonesia and
the Netherlands
Objectives: To gather data on antimicrobial use on different levels
of health care in order to develop a reliable method to measure
antibiotic use in a developing country.
Methods: Prospective audit in two cities. The quantity and qual-
ity-of-use was studied in patients admitted to hospital (group I),
patients discharged from hospital after >5 days (group II),
patients consulting a health centre (puskesmas) (group III), and
household contacts of the patients admitted to hospital (group
IV). Patients were included during 4 months in 2001 in Surabaya
(SBY) and 2002 in Semarang (SMG). The quantity of antibiotic
usage in the community (groups I–III and IV) was assessed by an
inquiry made at inclusion, for hospitalised patients (group II) it
was recorded from medical records on discharge. This method
was validated in a sample by the parallel prospective recording
of antibiotic use completed with interviews of nurses and
patients. Quality-of-use was analysed in a random selection of
hospitalised patients by an audit (Gyssens et al, J. Antimicrob.
Chemother. 1992; 30, 724–727). Groups of three reviewers assessed
indication, choice, dosage, route of administration and duration
of treatment.
Results: A total of 3996 individuals, equally distributed over the
groups, were enrolled. In SBY, 20% of the patients on admission
had used an antibiotic in the last month, 20% of the patients in
the puskesmas and 6% of the family members. In SMG this
amounted to 23, 14 and 6%, respectively. Total consumption of
antibiotic use of adult outpatients was 17.1 and 18.2 DDD/1000
person-days. Both in the community and in hospitals, penicillins
were most frequently used. Of all hospitalised patients, 83% were
prescribed at least one antibiotic. In SBY, 90.4% of patients in sur-
gery were prescribed antibiotics. At least 48% of these patients
were prescribed prophylaxis, and possibly more, since 16% were
prescribed for an unknown indication. Total antibiotic use in
adult hospitalised patients was 57.8 and 31.8 DDD/100 patient
days in SBY and SMG respectively. Results of the validation in
SBY showed that actual consumption was about 30% higher.
Although the reviewers had a widely different opinion on the
quality of individual prescriptions, they judged antibiotics not
indicated in 10–80% in SBY and 19–76% in SMG.
Conclusions: In hospitalised patients, high consumption and inap-
propriate use of antibiotics were prevalent. The study is continued
with interventions.
R1969 Adherence to surgical antibiotic prophylaxis
guidelines in Italy
A. Pan, S. Lorenzotti, P. Mondello, G. Gattuso, M. Valota,
L. Signorini, B. Cadeo, F. Cristini, P. Colombini, R. Stellini,
G. Carnevale, G. Gregis, P. Grossi, D. Santoro, E. Scalzini,
A. Orani, G. Carosi – on behalf of GLIO
Objective: Aim of the study was to evaluate the adherence to
guidelines of antibiotic prophylaxis (AP) in surgery. The study
was carried out contemporarily at the publication of the national
guidelines on antibiotic surgical prophylaxis (NGAP).
Materials and methods: We carried out a retrospective analysis of
AP in consecutive patients discharged from surgical units in ﬁve
hospitals in Lombardy, Italy. The following data were obtained
from the clinical chart: age, sex, duration of preintervention hospi-
talisation, type of intervention, level of surgical wound contamin-
ation, urgent surgery, type and duration of antibiotic prophylaxis,
and adherence to local guidelines.
Results: We analysed 526 surgical procedures, performed in 21 U.
18 U (86%) had written local guidelines. 275 patients were males
(52%), and had a mean age of 56 + 22 years. Sixty-four proce-
dures were urgent (12%) and in 77 cases (15%) prosthetic mater-
ial was implanted. Most interventions, 422 (80.2%), were clean, 49
were clean-contaminated (9.6%) and 55 were contaminated/infec-
ted. The AP was not performed in 93 cases. First generation ce-
phalosporins were used in 174 patients, second generation in 42,
and third generation in 45. Protected penicillins were utilised in
67 cases, and a combination two to three of antibiotics in 64 inter-
ventions, while glycopeptide were used as single agents in four
cases, and other antibiotics in 27. The mean duration of AP was
4 + 5 doses, or 2 + 3 days, while the median duration was two
doses, or 1 day. The AP was correct in 254 cases (48%). In 79 sur-
gical procedures (15%) the AP was started the day before the
intervention. Signiﬁcant differences in adherence were identiﬁed
among the wards, varying from 3 to 91%. The duration of the
prophylaxis was shorter in the wards with written guidelines as
compared with those without: 3 + 4 doses (2 + 3 days) and 10 + 8
doses (4 + 3 days) respectively (P < 0.001). Wide variations were
noted among different wards in the same hospital.
Conclusions: This study, implemented to evaluate the state-of-the-
art in antibiotic prophylaxis in some Italian hospitals when the
national guidelines (NG) were published, shows wide variations,
with adherence rate extremely low in some wards. This indicates
a possibility of improvement both on duration and on the choice
of the drug. This work may be useful to evaluate which will be
the impact of the NGAP.
R1970 Acinetobacter spp. bloodstream infections over a
9-year period at an inner city hospital in the USA
R. Jain, S. Gunderson, K. Ristow, P. Schreckenberger, L. Danziger
Chicago, USA
Objectives: The emergence of multi-drug resistant Acinetobacter has
become a major therapeutic dilemma for many institutions world-
wide. We sought to evaluate the trends of Acinetobacter infections,
including the susceptibility patterns to different antimicrobial
agents over a 9-year period at our institution.
Methods: Nonduplicate bacterial isolates from the University of
Illinois Medical Center from May 1994 to December 2002 were
entered into a relational database [Microsoft Access(R)]. Further
data collected included: culture species, date, susceptibility, and
patient location.
Results: A total of 89 unique Acinetobacter spp. bloodstream infec-
tions (ABSI) were identiﬁed from approximately 8500 blood iso-
lates. Since the year 2000, we have seen an increase ABSI at our
institution. Overall, 83% (74 of 89) were A. baumannii and 17%
(15 of 89) were A. lwofﬁi. The incidence of ABSIs was slightly
higher in the intensive care units (ICU) (55%) than the medicine
wards (44%). Most of ABSI were found in the medical ICU
Table 1 Per cent of Acinetobacter spp. susceptible to various anti-
microbials.
Year 1999 2000 2001 2002
Ceftazidime 100% 40% 29% 31%
Pipercillin 100% 20% 29% 31%
Imipenem 100% 100% 57% 80%
Gentamicin 67% 33% 24% 25%
Levoﬂoxacin 67% 33% 18% 41%
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(29%). 18% of ABSI were found in paediatric patients. Between
1999 and 2002, there was a decreasing trend of susceptibilities to
gentamicin, levoﬂoxacin, imipenem, pipercillin and ceftazidime.
Conclusions: Overall, there is an increased number of ABSI at
our institutions and these were not limited to ICU patients. In
the past 3 years, the Acinetobacter spp. have had decreasing sus-
ceptibilities to most antimicrobials at our institution which is
concerning.
R1971 Antimicrobial resistance in Streptococcus pyogenes
isolates in Moscow, Russia from 2002 to 2003
S.A. Grudinina, O.Y. Filimonova, N.M. Furletova, S.V. Sidorenko
Moscow, RUS
Objectives: Streptococcus pyogenes (SPY) is responsible for various
acute supportive conditions, including the tonsillitis/pharyngitis
in children and skin and soft tissue infections. In the last years
the resistance rates of SPY have been rising steadily. The aim of
this study was the evaluation of the current prevalence of antimi-
crobial resistance in Moscow.
Methods: Local microbiology laboratories in Moscow collected SPY
isolate from January 2002 to October 2003. The isolates were
recovered from throat swabs and pus samples. Identiﬁcation was
performed by routine laboratory techniques including latex agglu-
tination test. MICs were determined by the standard microdilu-
tion procedure and interpreted according to NCCLS criteria. The
following antimicrobial drugs were tested: penicillin G (PEN),
erythromycin (ERY), clindamycin (CLI), tetracycline (TET) and
levoﬂoxacin (LEV).
Results: A total of 192 SPY isolates were obtained in 2002 and 151
in 2003. Each of the 343 isolates was susceptible to penicillin. ERY
resistance rates in 2002 and 2003 were 7 and 3%, respectively
(MICs range 1–16 mg/L). Among 19 ERY-resistant isolates only
one demonstrated CLI MIC ¼ 1 mg/L. ERY-susceptible isolates
were susceptible to CLI. Tetracycline resistance rates in 2002 and
2003 were 44 and 47%, respectively. TET resistance was detected
in 18 of 19 ERY-resistant isolates. Decreased levoﬂoxacin suscepti-
bility was found in one isolate (MIC ¼4 mg/L).
Conclusions: The M-phenotype is predominant among macrolide-
resistant SPY isolates in Moscow. Considering the steady rise of
resistance to macrolides and other antibiotics, continuous sur-
veillance of this development as the basis for the formulation
of optimal treatment regimens for SPY infections, is clearly war-
ranted.
R1972 Antimicrobial resistance trends among Escherichia
coli and Klebsiella spp. from ICU patients: report from MYSTIC
Programme (1997–2003) in a Russian centre
S.P. Rezvan, S.A. Grudinina, S.V. Sidorenko
Moscow, RUS
Objective: Escherichia coli (EC) and Klebsiella spp. (KL) are the main
producers of ESBL and the highest ESBL rates were found in ICU
patients in Eastern Europe. Here we present the data on resistance
patterns of EC and KL, including possible ESBL-producers, from
Russian centre participating in MYSTIC Programme.
Methods: From 26 to 43 consecutive, nonrepetitive, clinically signi-
ﬁcant isolates of EC and KL from ICU patients with hospital-
acquired infections were collected prospectively each year from
1997 to 2003. Identiﬁcation of isolates was performed by routine
laboratory techniques; MICs of meropenem, imipenem, ceftazi-
dime, cefepime piperacillin/tazobactam, ciproﬂoxacin and gen-
tamicin were determined by the standard microdilution
procedure and interpreted according to NCCLS criteria. Ceftazi-
dime/clavulanate combination was used for phenotypic conﬁrma-
tion of possible ESBL production according to NCCLS
recommendations.
Results: During the study period the prevalence of ESBL produc-
ers increased among EC isolates from 20 to 40%. Among KL iso-
lates ESBL production varied from 40 to 70% in different years.
ESBL production was strongly associated with gentamicin and ci-
proﬂoxacin resistance. No carbapenem resistance was detected
among available isolates. Cefepime demonstrated signiﬁcantly
lower MICs against ESBL producers in comparison with ceftazi-
dime. High-level piperacillin/tazobactam resistance varied
between 10 and 20%, but intermediate resistance exceeded 40%.
Conclusions: Carbapenems are valuable options in the treatment of
EC and KL hospital-acquired infections in ICUs with high preval-
ence of ESBL production.
R1973 Changes in antibiotic resistance of the most
frequent Gram-negative bacteria isolated in intensive care units
A. Bisiklis, E. Tsiakiri, M. Chatzidimitriou, A. Halvatzis,
K. Doutsou, K. Makedou, S. Alexiou-Daniel
Thessalonica, GR
Objectives: The aim of our study was to observe the changes in
antibiotic resistance of the most frequent Gram() bacteria isola-
ted in the intensive care units (ICU) of AHEPA hospital, Thessalo-
niki, Greece.
Methods: The material of our study were Gram() bacteria iso-
lated from the culture of every pathological specimen which
was sent to our laboratory during the years 2000 and 2002.
The identiﬁcation of bacterial isolates and their antibiotic sus-
ceptibilities were performed by VITEK 60 analyzer of Bio-
Merieux. The most frequent bacteria isolated were: (i)
Pseudomonas aeruginosa 132 strains during 2000 and 106 during
2002 (ii) Acinetobacter calcoaceticus 98 strains during 2000 and
109 during 2002 (iii) Klebsiella pneumoniae 53 strains during
2000 and 83 during 2002.
Results : The phenotypical antibiotic resistance of the strains isola-
ted was as follows: Pseudomonas aeruginosa to Amikacin (A´I´) was
15 and 60% during 2000 and 2002 respectively, to Cefepime
(CFP) 45 and 65%, to Ceftazidime (CFZ) 35 and 35%, to Ciproﬂ-
oxacin (CIP) 40 and 65%, to Imipenem (IMP) 50 and 65%, to To-
bramycin (TO) 30 and 60%, to Ticarcillin/CA (T/CA) 50 and
70%, to Piperacillin/Tazobactam (P/T) 10 and 30%. Acinetobacter
calcoaceticus to AN was 93 and 95% respectively, to CFP 90 and
92%, to CFZ 97 and 99%, to CIP 91 and 95%, to IMP 15 and
67%, to TO 88 and 98%, to T/CA 68 and 70%, to P/T 41 and
72%. Klebsiella pneumoniae was to AN 10 and 50%, to CFP 20 and
20%, to CFZ 80 and 90%, to CIP 45 and 50%, to IMP 0 and 0%,
to TO 80 and 90%, to T/CA 75 and 95%, to P/T 65 and 90%,
respectively.
Conclusion: (i) Acinetobacters have the highest resistance percent-
age; (ii) a signiﬁcant increase in resistance was observed in Imipe-
nem and Piperacillin/ Tazobactam of Acinetobacter (52 and 31%,
respectively). No other changes in resistance of Acinetobacter was
noticed to the rest antibiotics. (iii) Pseudomonas aeruginosa presents
a signiﬁcant increase in resistance to all antibiotics, except ceftazi-
dime. (iv) Klebsiella pneumoniae has no resistance to Imipenem but
a great increase of its resistance is observed to Amikacin, ceftazi-
dime, tobramycin and b-lactamase inhibitors.
R1974 Analysis of bacteriological results of protected
telescopic catheter in ICU patients with ventilator-associated
pneumonia
E. Martziou, V. Koulourida, K. Arvaniti, D. Lathyris,
M. Drouggos, A. Fleva, M. Moskoﬁdis
Thessalonica, GR
Objective: The aim of the study was to evaluate the results (identi-
ﬁcation and antibiotic susceptibility patterns) of the protected
telescopic catheter (PTCs) performed in ICU patients with the
clinical suspicion of VAP.
Methods: During the years 2000–2003, we evaluated 132 positives
of a total of 233 samples performed in 233 ICU patients with the
clinical suspicion of VAP. Cultures were considered as positives
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when bacteria were discovered in at least 1000 CFU/mL. Identiﬁ-
cation and antibiogram were performed by the Wider Automatic
System according to NCCLS guidelines. Duplicates were excluded
from the analysis.
Results: The most frequent isolated microorganisms were: A. bau-
mannii in 24.2% of the specimens, P. aeruginosa in 22%, K. pneumo-
niae in 11.4%, E. coli in 6.8%, MRSA in 6.8% patients. In 23
samples, two types of bacteria were isolated, while four others
were recorded as contaminates (more than two types of bacteria).
Resistance to Imipenem was found in 3.1% of the A. baumannii
strains and in 27.6% of P. aeruginosa strains. Resistance to Me-
ropenem was recorded in 21.9% of A. baumannii, 27.6% of P. aeru-
ginosa and in 6.7% of K. pneumoniae stains. Resistance to
Ciproﬂoxacin was almost exclusively discovered in A. baumannii
isolates (85%) and less frequently in P. aeruginosa and K. pneumo-
niae strains (20.7 and 6.7%, respectively). Additionally, resistance
to third generation cephalosporins was recorded in 87.5% of the
A. baumannii strains, in 55.2% of P. aeruginosa, in 46.7% of
K. pneumoniae and in 22.2% of E. coli. Piperacillin/Tazobactam
resistance was found in 46.9% of the A. baumannii strains, in
17.2% of P. aeruginosa and in 20% of K. pneumoniae. All MRSA
isolates were sensible to Vancomycin and Teicoplanin.
Conclusion: Multiresistant Gram-negative bacteria was the most
frequent aetiologic agent in ICU respiratory infections. However,
MRSA infections were much less frequent, probably because of
the application of a multidisciplinary programme concerning the
early detection of MRSA in the ICU patients (upon admission)
and hygiene measures against MRSA cross-infections. A prospect-
ive study aimed to identify epidemic strains of A. baumannii and
P. aeruginosa is ongoing in our hospital.
R1975 Characterisation of Haemophilus inﬂuenzae strains
isolated from noninvasive and invasive infections in children
K. Semczuk, M. Modrzewska, K. Dzierzanowska-Fangrat,
H. Dmezska, D. Dzierzanowska
Warsaw, PL
Aims: The aims of the study were to determine the susceptibility,
biotype and capsular serotype of H. inﬂuenzae isolates obtained
from children with invasive and noninvasive infections, treated
in Children’s Memorial Health Institute, Warsaw, Poland in
2003.
Materials and methods: Altogether 371 H. inﬂuenzae strains were
collected from respiratory tract infections, meningitis and intra-
abdominal infections between January and December 2003.
Susceptibility testing was performed by Etests (AB Biodisk). b-
lactamase production was identiﬁed by use of nitroceﬁn disk
(BBL DrySlide Nitroceﬁn; Becton Dickinson). Biotype was deter-
mined by use of Api NH (Biomerieux), and serotype – by
agglutination tests (Haemophilus inﬂuenzae Agglutinating sera,
Abbott).
Results: Eighty-eight per cent of isolates were b-lactamase-negat-
ive and sensitive to ampicillin. One b-lactamase-negative ampi-
cillin-resistant (BLNAR) strain (Hib) was isolated from ovarian
ﬂuid. The strain was also resistant to amoxicillin/clavulanate
(MIC > 256 mg/L), cefuroxime (MIC > 256 mg/L), cefotaxime
(MIC > 256 mg/L), and imipenem (MIC > 32 mg/L); however it
was susceptible to azithromycin (MIC ¼ 1 mg/L), co-trimoxaz-
ole (MIC ¼ 0.064 mg/L), ciproﬂoxacin (MIC ¼ 0.008 mg/L) and
chloramphenicol (MIC ¼ 0.5 mg/L). All the remaining isolates
were susceptible to amoxicillin/clavulanate and cefuroxime.
Overall susceptibility to cefaclor, tetracycline, co-trimoxazole
and chloramphenicol was 98, 97, 60 and 100%, respectively.
Over 99% of isolates were sensitive to azithromycin and 97%
– to clarithromycin. All invasive infections were caused by
strains of type b, biotype I.
Conclusions: The study shows relatively high prevalence of b-lac-
tamase production in H. inﬂuenzae strains obtained from our
children. Most b-lactamase-positive, antibiotic-resistant strains
were isolated from children with chronic diseases such as cystic
ﬁbrosis, bronchiectasis and asthma, frequently exposed to antibi-
otics.
R1976 Microbiological assessment of bacterial septic
patients receiving monotherapy with cefoperazone/sulbactam
L. Stratchounski, D. Galkin, R. Kozlov – IRIS Study Group
Objective: To evaluate source of infection, main pathogens and
microbiological activity towards prevalent species in septic
patients receiving monotherapy with cefoperazone/sulbactam.
Methods: Samples from septic patients were collected from 18
study sites in 10 Russian cities. Sepsis was diagnosed according to
ACCP Consensus Conference, 1992. Collection was done in
patients who were assigned monotherapy with cefoperazone/sul-
bactam (1:1) 4–8 g every 8 h. Antimicrobial susceptibility testing
of the Enterobacteriaceae, Pseudomonas aeruginosa and Gram-negat-
ive nonfermenters was performed in a reference laboratory by
broth microdilution with data interpretation according to NCCLS
standards (2003). NCCLS recommendations for cefoperazone were
applied through absence of susceptibility testing criteria for cefop-
erazone/sulbactam.
Results: Aetiology was conﬁrmed in 73 patients of 127 enrolled in
the study and 119 strains were evaluated. Clinical specimens
included: wound discharge – 65 (54.6%), abdominal cavity pus –
25 (21.0%), blood – 13 (10.9%), tracheal aspirate – 5 (4.2%), urine
4 (3.4%), sputum – 4 (3.4%) and pleural cavity drainage – 3
(2.5%). Predominant bacteria were Enterobacteriaceae – 44
(37.0%), P. aeruginosa – 22 (18.5%) and Enterococcus spp. – 22
(18.5%). Less prevalent were Staphylococcus aureus – 19 (16.0%)
and Gram-negative nonfermentative bacteria – 12 (10.0%). Cefop-
erazone/sulbactam showed superior activity against Enterobacte-
riaceae in comparison to cefoperazone (P < 0.004), ceftazidime
(P < 0.017), cefepime (P < 0.002) and similar activity as piperacil-
lin/tazobactam (P ¼ 0.546), imipenem (P ¼ 0.514), and ciproﬂoxa-
cin (P ¼ 0.792). To cefoperazone 50.0% strains of P. aeruginosa
and 75.0% of Gram-negative nonfermentative species were resist-
ant. Cefoperazone/sulbactam showed no advantages in activity in
vitro against latter two groups of pathogens in comparison with
cefoperazone alone.
Conclusions: The main pathogens causing sepsis in the studied
cohort were Enterobacteriaceae, followed by P. aeruginosa and En-
terococcus spp. Cefoperazone/sulbactam showed favorable in vitro
activity against majority of pathogens and may be considered as a
potential drug of choice for empiric therapy of sepsis. However,
further multicentre studies are needed in order to conﬁrm its util-
ity for this indication.
R1977 Antimicrobial resistance in E. coli isolates in a large
German community-based hospital 1998–2003 – trends
correlated with antimicrobial use
C. Schro¨der, M. Lindner, C. Bethke, B.R. Ruf, T. Gruenewald
Leipzig, D
Objectives: Escherichia coli is the most commonly found Gram-neg-
ative pathogen in humans. It causes a broad range of infectious
diseases as sepsis, urinary tract infections, enterogenic and cholo-
genic infections and pneumonia and sometimes meningitis. Espe-
cially in the case of life-threatening infections, empirical therapy
is mandatory. For adequate treatment monitoring of antimicrobial
resistance is necessary.
Methods: The resistance against ﬂuoroquinolones, aminopenicil-
lines, third-generation cephalosporins and cotrimoxazole in a
large community-based German hospital from 1998 to 2003 was
evaluated with respect to antimicrobial use. The data for the
whole hospital (HOSP) were compared with those an internal
medicine department (DIM) caring for a huge number of geriatric
patients.
Results: From 1998 to November 2003 10056 E. coli strains
(n ¼ 3408, DIM) were isolated which comprised 23% of all
pathogens (DIM: 25%) and tested against levoﬂoxacin (MIC
breakpoint 1 mg/L), ampicillin (4 mg/L), cefotaxime (4 mg/L),
and cotrimoxazole (32 mg/L) using the Vitek 2 automated bac-
teriology system. During the observation period antimicrobial
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resistance increased against ﬂuoroquinolones (HOSP: 8–16%,
DIM: 9–20%), aminopenicillines (HOSP: 39–56%, DIM: 40–61%)
and cotrimoxazole (HOSP: 19–27%, DIM: 20–31%) signiﬁcantly,
while nearly all strains were fully susceptible against third-gen-
eration cephalosporins (HOSP: 0–1%, DIM: 0–1%). Trends for
ﬂuoroquinolones correlated well with the use of group 3 and
four which had doubled in the last two observation years where
the main increase in resistant strains (9–16% HOSP, 9–20%
DIM) occurred. In all other substances tested resistance
increased continuously over the period. Invasive (blood culture)
isolates had a signiﬁcantly higher ﬂuoroquinolone resistance
(HOSP: 23% in 2003, DIM: 38% in 2003) than other isolates.
Strains isolated in 2003 had a signiﬁcant higher resistance rate
compared those strains from published German and European
data.
Conclusions: Extent of antimicrobial resistance depends often more
on local conditions and speciﬁc treatment behaviours than on the
nation-wide situation. Therefore, treatment has to rely on local
data.
R1978 Monitoring of extended spectrum b-lactamase
producing Escherichia coli and Klebsiella sp. at secondary and
tertiary care hospitals in central Switzerland
M. Risch, A. Haner, T. Rutz, S. Thiermann, B. Steinmann,
G.E. Pfyffer
Luzern, CH
Objectives: In conferring resistance to all cephalosporins (except
cefamycins), penicillins, and monobactams extended spectrum
b-lactamase (ESBL) producers represent a serious threat to hospi-
talised patients.
Methods: During two 4-months periods (September to December
2002; August to November 2003) 1096 strains of E. coli and 292
strains of Klebsiella sp. have been isolated from clinical speci-
mens (E. coli: n ¼ 522 in 2002, n ¼ 574 in 2003; Klebsiella sp.:
n ¼ 131 in 2002/ n ¼ 161 in 2003). Patients were hospitalised at
a tertiary care center (Kantonsspital Luzern) and at three secon-
dary care hospitals (Schwyz, Sursee, Wolhusen). In 2002, con-
secutive screening for ESBLs has been performed by the Kirby-
Bauer disc-diffusion method on a separate plate, testing ceftazi-
dime (30 lg), cefpodoxime (10 lg), and ceftriaxone (30 lg)
according to the National Committee for Clinical Laboratory
Standards (NCCLS; M2-A8 and M100-S13). In 2003, screening for
ESBLs has been performed by the same method, but placing the
disks containing ceftazidime (30 lg) and ceftriaxone (30 lg) adja-
cent to one containing amoxicillin-clavulanic acid (20/10 lg) at a
distance of 23 mm. The plates were checked for inhibition zones
and phantom zones. Suspected presence of ESBLs have eventu-
ally been conﬁrmed by applying Etest (R); strips containing ceft-
azidime and cefotaxime, respectively, with and without
clavulanic acid.
Results: In the ﬁrst period, six ESBL producers have been detected
in ﬁve clinically unrelated specimens, while in the second, there
were six ESBL producers in four clinically unrelated specimens.
In 2002, one specimen and in 2003, two specimens contained both
K. pneumoniae and E. coli. All isolates originated from the tertiary
care hospital (n ¼ 1020). Prevalence of ESBLs ranged from 0.92%
in 2002 to 0.81% in 2003 [(P ¼ 0.94; E. coli 0.96% in 2002, 0.35%
in 2003 (P ¼ 0.38); Klebsiella sp. 0.77% in 2002 and 2.40% in 2003
(P ¼ 0.52)].
Conclusions: (i) Compared with our in-house data from 2001 the
isolation rate of ESBL producers at the four institutions has
increased over the past 2 years, due to improved screening
procedures. (ii) Prevalence of ESBL producing organisms in our
area is similar to that observed in other areas of Switzerland.
(iii) Based on detection algorithms other than the phenotypic
screening method recommended by the NCCLS (automated
systems such as VITEK2), the number of ESBL producers may
be underestimated, in particular, in areas with a low preval-
ence.
R1979 Antimicrobial resistance in high complexity
hospitals in Bogota´, Colombia, 2001–2002
J. Cortes, A. Leal, C. Alvarez
Bogota, CO
Background: Resistance to antimicrobials has increased during the
last decade around the world. Few data on resistance trends in
Colombia has been published.
Objective: To establish a surveillance programme of antimicrobial
resistance in high-complexity hospitals in Bogota´ (Colombia,
South America), evaluating the trend in 2001–2002.
Methods: A cross-sectional study was performed of microbial iso-
lates obtained in microbiology laboratories from 13 high-complex-
ity hospitals in Bogota´. Isolate identiﬁcation and antimicrobial
susceptibility testing were performed using standard manual and
automated systems and NCCLS criteria. Microbiological data from
2001 and 2002 was transferred into WHONET (ver. 5.2, World
Health Organisation).
Results: Between 2001 and 2002, 65 520 microorganisms were iso-
lated. E. coli was the most frequent isolate (13 162). According to
NCCLS criteria, 15% of E. coli isolates in intensive care units
(ICU) were suspected of extended spectrum b-lactamase (ESBL)
production, and 12% of those found in non-ICU wards. 43% of K.
pneumoniae isolates in ICU and 32% of those in non-ICU wards
were suspected of ESBL production. 13% of K. pneumoniae isolates
were resistant to ciproﬂoxacin. Methicillin-resistant S. aureus
(MRSA) was more frequently found in the UCI (71%) than in
other wards (47%). Isolates of P. aeruginosa resistant to imipenem
and ciproﬂoxacin were 43 and 69% of isolates in ICU, and 27 and
46% of those in no-ICU wards, respectively.
Conclusions: In hospitals of high complexity in Bogota´, there is
growing number of resistant isolates. MRSA, ESBL-producing
K. pneumoniae and multiresistant P. aeruginosa are the most
important and serious microorganims related to this problem.
The data presented here is the base for the formulation of poli-
cies in infection control for high complexity institutions in the
country.
R1980 Antimicrobial susceptibility patterns of
Gram-negative bacteria in Swedish intensive care units
involved in the MYSTIC study (2001–2003)
L.E. Nilsson, P. Larsson, M. Rylander, M. Walder
Linko¨ping, Gothenburg, Stockholm, Malmo¨, S
Objective: To investigate the antibiotic susceptibility amongst
Gram-negative isolates in Swedish intensive care units (ICUs).
Methods: Four Swedish hospitals participating in the Meropenem
Yearly Susceptibility Test Information Collection (MYSTIC) Pro-
gramme collected 1178 initial isolates of Gram-negative bacteria
during 2001–2003. Minimal inhibitory concentration (MIC) of ceft-
azidime (CTZ), ciproﬂoxacin (CIP), tobramycin (TOB), imipenem
(IPM), meropenem (MEM) and piperacillin/tazobactam (PTZ)
were determined. The breakpoints of the Swedish Reference
Group for Antibiotics (SRGA) were used.
Results: The most commonly isolated bacteria were Escherichia coli
(24%), Pseudomonas aeruginosa (17%), Enterobacter aerogenes (10%),
Klebsiella pneumoniae (10%) and Proteus mirabilis (6%). The number
of antibiotics to which >90% of isolates were susceptible was
one for P. aeruginosa (TOB), two for P. mirabilis (CTZ, PTZ) and
E. aerogenes (TOB, MEM/IMP) and four for E. coli/K. pneumoniae/
K. oxytoca (TOB, MEM/IPM, CTZ, PTZ). MEM was more active
than IMP against P. mirabilis and P. aeruginosa. A low frequency
of ESBLs amongst E. coli (1.1%) and K. pneumoniae (1.7%) was
seen. No such isolates of P. mirabilis were found.
Conclusions: CIP showed lowest activity of the agents tested for
the most frequently isolated species highlighting the escalating
problem with quinolone resistance. The overall susceptibility
based on SRGA breakpoints for the different antibiotics were CTZ
(93%), MEM (92%), TOB (92%), IMP (90%), PTZ (90%) and CIP
(82%).
569Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
R1981 Streptococcus pneumoniae infections in a general
hospital: characteristics and resistance proﬁles
J. Aguilar, A. Del Arco, J.L. Prada, J. De La Torre, I. Lopez,
N. Montiel, M. Marcos
Marbella, E
Objectives: To know the characteristics of the patient with
S. pneumoniae infection and the antibiotic susceptibility.
Methods: We have studied the retrospective cases of S. pneumoniae
infections with isolated in sputum, blood, pleural effusion and
cerebrospinal ﬂuid in our hospital from April 2002 to December
2003. Sputum were considered valid only with less than ﬁve cells
and more than 25 leucocytes
Results: We found 57 patients, 39 males (68%) and 12 females
(21%). Mean-age was 63 years. 15 were suffering from chronic
bronchitis or airway obstruction. In this group 73% had other
chronic illness. Seven had HIV infection and in this group 57%
had other chronic illness. Other 14 patients (24%) had a chronic
illness. Eleven had not pathological conditions. Isolated were 56%
from sputum, 33% blood cultures, 7% cerebrospinal ﬂuid and 4%
pleural effusion. Diagnosis were 23 pneumonia, two empyema, 18
respiratory infection without pneumonia, seven with sepsis cri-
teria (respiratory origin), four meningitis and one peritonitis. The
susceptibility (S) was deﬁned by IMC < 1, intermediate suscept-
ibility (I) IMC: 1–2, resistance (R) IMC > 2. The patters of suscept-
ibility were: penicillin 67% S and 3% R, clavulanic-amoxicilin
96% S, cefotaxime 100% S, eritromicin 75% S and 25% R, clinda-
micin 77% S and 23% R, cloramfenicol 98% S and vancomicin
100% S
Conclusions: In our centre the neumococal infection proﬁle is a
patient with a chronic health problem suffering from a respiratory
tract infections (pneumonia or infection without pneumonia) ori-
ginated by a S. pneumoniae susceptible to be treated with high
doses of penicillin, clavulanic–amoxicilin, cefotaxime, cloramfeni-
col and vancomicin.
R1982 In vitro activity of telithromycin against 1891
S. pneumoniae isolated in Europe, Africa, Middle East and Asia
(e-BASKETT 2002–2003)
H.B. Drugeon, M.E. Juvin for the e-Baskett 2 Study Group
Objective: E-BASKETT is an international prospective survey (23
countries) initiated in 2001 to identify trends in the development
of antibacterial resistance to Streptococcus pneumoniae isolated from
community-acquired respiratory tract infections and to determine
the activity of a new ketolide, telithromycin (TEL). From the ﬁrst
year, marked geographical differences were observed in the pre-
valence of penicillin (PEN) and macrolide resistance. Overall, TEL
was highly active in the different geographical areas studied. We
present here the results from the second year.
Methods: From September 2002 to June 2003, 1891 clinical isolates
of S. pneumoniae, collected from 23 countries, were tested at a cen-
tral laboratory. PEN, erythromycin (ERY) and TEL MICs were
determined by broth dilution method following NCCLS guide-
lines.
Results: The prevalence of PEN (PEN-I, MICs: 0.125–1 mg/L,
PEN-R, MICs  2 mg/L), ERY (MICs  1 mg/L), and TEL
(MICs  4 mg/L) resistance was shown in the table.
Overall, 99.8% of all isolates of S. pneumoniae were inhibited by
TEL MIC  1 mg/L.
Conclusion: (i) E-BASKETT 2 conﬁrmed large differences in rates
of PEN and ERY resistance among S. pneumoniae isolates in differ-
ent countries. An extremely high incidence of PEN and ERY
resistance was observed in some parts of Asia with no discernible
trend up or down compared with resistance rates reported in E-
BASKETT 1. (ii) TEL was highly active against S. pneumoniae clin-
ical isolates including PEN- and ERY-resistant strains. No resist-
ance to TEL was reported.
R1983 Increasing antimicrobial resistance of Pseudomonas
aeruginosa in an intensive care unit in Italy
B. Allegranzi, A. Azzini, L. Antozzi, A. Luzzani, E. Concia
Verona, I
Objective: To evaluate the patterns of antimicrobial resistance
(AMR) of Pseudomonas aeruginosa strains isolated in patients
admitted in an intensive care unit (ICU) during 2 years of
study.
Methods: During two different periods (period A: August 1999–
July 2000; period B: April 2001–March 2002) we conducted a
prospective survey on AMR of principal microorganisms isola-
ted in patients admitted for more than 48 h to ICU. We present
data about AMR in P. aeruginosa isolates. Susceptibility tests
were performed by Kirby–Bauer method (Becton Dickinson).
Data refer only to strains with different antibiotype in case of
repeated isolations in the same patient. We classiﬁed isolates as
multidrug-resistant (MDR) when resistance to piperacillin, imi-
penem, ceftazidime and gentamicin was detected and as PAN
resistant (PAN-R) when the isolate was resistant to all tested
antibiotics.
Results: In period A and B respectively, 397 and 400 patients
were evaluated. During period A, among 138 isolates of P. aeru-
ginosa, 18 (13.0%) were MDR, of which, two PAN-R. During per-
iod B (183 isolates), among 27 (14.7%) MDR, PAN-R strains
increased to 14 (P ¼ 0.02). The proportion of ICU-acquired infec-
Antibiotic
Period A
(138 isolates)
R%
Period B
(183 isolates)
R% P
Gentamicin 58.0 51.9 NS
Imipenem 33.3 57.4 <0.01
Piperacillin/Tazobactam 47.1 43.2 NS
Amikacin 15.2 33.3 <0.01
Ceftazidime 38.4 39.3 NS
Cefepime 23.8 37.2 .040
Azthreonam 48.5 53.0 NS
Ciproﬂoaxin 49.3 56.3 NS
Countries (n) PEN-I PEN-R ERY-R TEL-R
Greece (107) 12 48 47 0
Netherlands (64) 2 0 5 0
Spain (153) 21 15 34 0
Switzerland (70) 9 3 7 0
Hungary (103) 36 24 43 0
Poland (96) 6 8 8 0
Russis (85) 5 1 6 0
Slovaquia (49) 24 26 33 0
Slovenia (97) 9 7 4 0
Turkey (260) 23 11 17 0
Egypt (14) 36 21 21 0
Emirates (56) 31 14 25 13
Saudi arabia (119) 41 22 30 0
Tunisia (5) 20 40 40 0
Ivory Coast (50) 24 0 0 0
Senegal (5) 0 0 0 0
Hong-Kong (89) 20 35 52 0
Korea (50) 18 64 92 0
Malaysia (10) 20 10 10 0
Pakistan (50) 24 0 24 0
Singapore (20) 20 20 45 0
Taiwan (308) 20 50 90 0
Thailand (31) 23 29 45 0
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tions caused by P. aeruginosa increased from 18.3 (24/131 epi-
sodes) to 30.3% (30/99) (P ¼ 0.04). Resistance patterns of P. aeru-
ginosa isolates against the principal antibiotics are represented in
Table.
Conclusions: Compared with period A, ICU-acquired infections
caused by P. aeruginosa and isolation of PAN-R strains signiﬁ-
cantly increased during period B. AMR against the principal
available antibiotic reached very high levels, signiﬁcantly increas-
ing for imipenem, amikacin and cefepime. Since new anti-pseudo-
monas drugs are not expected to be soon available, current
possible solutions are the targeted choice of the best antibiotic
associations based on synergy assays and the implementation of
antibiotic rotation after periodically evaluating the local AMR pat-
terns.
R1984 Antibiotic susceptibility of urinary tract isolates of
Escherichia coli from outpatient women in Kosovo: multicentre
study
L. Raka, G. Mulliqi-Osmani, L. Berisha, L. Begolli, B. Gruda,
F. Ismajli, S. Mehmeti, F. Pllana, A. Jaka, A. Kurti
Pristina, CS
Objective: Urinary-tract infections are amongst most common
infections caused by pathogens with increasing resistance to anti-
microbials. The vast majority of these infections arise in female
outpatients with E. coli as primary aetiologic agent. The objective
of this study was to assess antimicrobial susceptibility pattern of
Escherichia coli among urinary isolates in oupatient women in Kos-
ova.
Methods: Retrospective study was carried out of urine samples
presented growth of Escherichia coli from outpatient women from
January 2, 2002 to December 1, 2003. Only one positive isolate of
E. coli per patient was included in the study. Bacterial susceptibil-
ity testing was performed by disc-diffusion method. The study
was conducted in ﬁve regional centres of Public Health of Kosova:
Prishtina, Gjilan, Mitrovica, Peja and Ferizaj.
Results: Results were available for 3720 urinary isolates of E. coli.
Of these isolates 65.1% were resistant to ampicillin, and 46.3%
were resistant to trimethoprim–sulphamethoxasole. Nitrofuranto-
in, ceftriaxone and ciproﬂoxacin expressed the highest susceptibil-
ity among these isolates. Their sensitivity pattern was 96.9, 96.8,
and 95.5%, respectively. Of all isolates, 8.7% (324) were resistant
to three or more agents and considered multi-drug resistant.
Conclusions: Resistance rates indicates the need for re-evaluation
of empiric treatment of urinary-tract infections caused by E. coli
and for continuous surveillance and monitoring studies.
R1985 Antimicrobial susceptibility and serotype
distribution of clinical isolated Salmonella spp. strains during
2000-2002 in a general hospital
M. Kalcani, S. Fokas, M. Tsironi, P. Andriopoulos, E. Kalcani,
M. Dionyssopoulou
Sparta, GR
Objectives: The aim of this study was to determine the trend in
the prevalence of Salmonella serotypes, to analyse their distribu-
tion and their antibiotic resistance patterns.
Methods: We studied the serotypes and we investigated the in vi-
tro antibiotic susceptibility patterns of Salmonella spp. isolated
from clinical specimens. The isolates were identiﬁed by conven-
tional microbiological methods. Serotyping was carried out by the
National School of Public Health of the University of Athens. Sus-
ceptibility tests to ampicillin (AMP), ciproﬂoxacine (CIP), trimeth-
oprim/sulphamethoxazole (SXT) and ceftriaxone (CRO) were
performed using the disc-diffusion method according to the
NCCLS recommendations.
Results: During the 3-year study period (2000–2002) a total of 52
Salmonella spp. Strains were isolated: 47 from 465 stool specimens
(10.1% positive for Salmonella) four from blood specimens and
one from urine specimen. 14 different Salmonella serotypes were
isolated. S. enterica serotype Enteritidis was the predominant iso-
late (21 strains, 40.4%), followed by S. enterica serotype Typhimu-
rium (13.4%), S. kottbus (7.7%), S. agona (5.7%), S. oranienburg
(3.8%) and other less-common serotypes (29%). The majority of
the Salmonella strains (65%, 34 strains) were isolated from children
(<14 years old) and the seasonal distribution revealed an
increased number of isolates in the summer months. Thirty-nine
(75%) of the Salmonella strains were susceptible to all antibiotics
tested. eight strains (15.4%) were resistant to AMP and ﬁve
strains (9.6%) to SXT.
Conclusion: Salmonella enteritidis continues to be the most common
clinical isolate, with a decreasing frequency compared with our
previous data. In our geographical area (South Greece) the resist-
ance of Salmonella spp. to AMP and SXT remains at relatively low
levels in a decreasing rate. Susceptibility to ﬂuoroquinolones is
still preserved. Though we did not observe any resistance to CIP
and CRO, the universal resistance pattern is alerting for rational
antibiotic use in salmonellosis and continuous surveillance for
resistance changes.
R1986 Detection of genetic diversity of pneumococcal
surface protein A in Streptococcus pneumoniae strains by
PCR-RFLP
M. Oskoui, J. Habiby
Tehran, IR
Objective: Streptococcus pneumoniae is a formidable human patho-
gen responsible for a major cause of over 3 million deaths world
wide. The high morbidity and mortality associated with Pneumo-
coccal disease is also being exacerbated by the rate at which this
microorganism is acquiring resistance to multiple antibiotics.
Pneumococcal surface protein A (PSPA) is an important virulence
factor of the pneumococcus that inﬂuences bacterium-host intero-
tions through interference with the ﬁxation of complement C3.
Pneumococcal surface protein A (PSPA) is a serologically variable
protein of Streptococcus pneumoniae.
Materials: We determined the degree of PSPA gene diversity
among 50 isolates by PCR, restriction proﬁling.
Conclusions: Ampliﬁcation of PSPA by polymerase chain reaction
and restriction endonuclease digestion showed that there is high
variation among these strains. However, isolates with identical
resistance pattern and same serotype which has suggested a clo-
nal origin in S. pneumoniae, now it reveals that this protein is gen-
etically variant among these pneumococcal isolates. Variability at
all PSPA can be exploited for purposes of strain identiﬁcation in
epidemiologic investigations.
R1987 In vitro activity of telithromycin against
Streptococcus pneumoniae resistant to b-lactams and macrolides
isolated from respiratory tract infections in France in 2002
H. Drugeon, N. Moniot-Ville, A. Bensalah
Nantes, Paris, Levallois Perret, F
Objectives: The objective of this surveillance study was to monitor
the in vitro activity of telithromycin (TEL) and other antibiotics
against Streptococcus pneumoniae (SP) isolated from respiratory
tract infections (RTI) in adult patients in France.
Methods: Strains were collected in 42 metropolitan French hospi-
tals during 2002. MICs of penicillin (PEN), erythromycin (ERY),
amoxicillin (AMX), cefuroxime (CFM), clarithromycin (CLA) and
TEL were determined by broth microdilution. Susceptibility rates
were calculated according to the Comite´ de l’Antibiogramme de
la Socie´te´ Franc¸aise de Microbiologie (CA SFM) recommendations.
CA SFM TEL breakpoints are: susceptible (S) MIC  0.5 mg/L,
intermediate (I) MIC 1–2 mg/L, resistant (R) MIC > 2 mg/
L. ErmB and mefA genes were detected by PCR. Quality control
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was performed with three SP strains (Susceptible- ATCC 49619,
ermB- Drug 3031, mefA- Drug 4428).
Results: In total, 432 (44.8%) SP strains concomitantly nonsuscep-
tible to ERY and PEN (ERY-IR/PEN-IR) were isolated among a
total of 965 SP strains. ERY-IR/PEN-IR strains were isolated
from patients aged 61.1  18 years and 65.9% of them were
male. The diagnoses associated with these isolated ERY-IR/
PEN-IR strains were: pneumonia 62.7%, acute exacerbation of
chronic bronchitis 16.9%, sinusitis 2.9%, others 17.6%. In total,
117 ERY-IR/PEN-IR strains (27.1%) were isolated from at least
one blood culture. The MIC50/90 (mg/L) and% of S/I/R
against ERY-IR/PEN-IR SP was the following: AMX: 1/2 –
28.2/66/5.8 CFM: 4/8 – 9.5/17.6/72.9 CLA: 32/32 – 4.2/8.7/
87 TEL: 0.03/0.25 – 97/3/0 In total, 420 (97.2%) ERY-R
strains contained the ermB gene, six (1.4%) the mefA gene and
two (0.46%) contained both genes. The four (0.93%) remaining
ERY-R strains were PCR-negative. No ERY-R strain was resist-
ant to TEL.
Conclusion: This study demonstrated that TEL has high activity
against SP resistant to b-lactams and macrolides, which represent
approximately half of the strains currently isolated from RTI in
adult patients in France.
R1988 The comparative in vitro activity of ciproﬂoxacin
against urinary-tract pathogens isolated from Europe during
2003 from Libra Targeted Surveillance
I. Morrissey, T. Veltman, A. Colclough, L. Viljoen, K. Dowling,
M. McKeon, M.J. Robbins
London, UK
Objectives: To assess the prevalence of bacterial pathogens causing
urinary tract infection (UTI) and their antimicrobial agent suscep-
tibility within Europe.
Methods: A total of 15 centres in four countries (France, Germany,
Italy and Spain) submitted a total of 529 consecutive isolates.
Bacteria were reidentiﬁed and their susceptibility to the orally
available agents ciproﬂoxacin (CIP), ampicillin (AMP), amoxicil-
lin–clavulanate (AMC), nitrofurantoin (NIT), trimethoprim–
sulphamethoxazole (SXT) and the parenteral agents gentamicin
(GEN), ceftazidime (CTZ), piperacillin (PIP) and PIP-tazobactam
(PTZ) was determined using the NCCLS broth microdilution
method in a central laboratory.
Results: E. coli was the most prevalent pathogen (391 isolates,
60.3%), followed by E. faecalis (52, 9.8%), K. pneumoniae and P.
mirabilis (31, 5.9% each). Overall per cent susceptibility for all
pathogens and all E. coli collected, plus comparisons for all path-
ogens from each of the four countries surveyed are shown
below:
Conclusion: PTZ and CTZ were the most active agents overall,
but these are not available orally. CIP was the most active oral
agent overall, but NIT was the most active against E. coli. How-
ever, inactivity against P. aeruginosa and Proteus spp. reduced
overall NIT activity and clinical utility. Irrespective of country
examined, CIP remains the most widely active broad-spectrum
oral antimicrobial agent against bacteria causing UTI in Europe.
CIP has the additional advantage of also being available in a
parenteral form.
R1989 Helicobacter pylori and its related risk factors
Z. Vakili, H. Shariﬁ, R. Moniri, V. Mehrzad, G.H. Mousavi,
H. Ehteram, H. Ahmadi
Kashan, IR
Object and aims: Role of Helicabacter pylori (HP) in many gastroin-
testinal disorders such as peptic ulcer, gastritis, intestinal metapla-
sia and stomach cancer is established. In order to determine risk
factors of its infection this study was done.
Material and methods: A total of 232 patients with gastrointestinal
signs were studied. Endocopy was done by internist and from
two to three biopsies from antrum was taken. Specimens were
processed by Shandon tissue Processor (Citadel). Prepared slides
were stained by Haematoxycillin and eosin and also giemsa. Two
pathologists and one microbiologist studied the slides. Patients,
blood groups were determined. Patients, data including age, sex,
smoking, residential status, clinical signs, pathologic diagnosis,
blood group were recorded and then analysed.
Results: Of 232 patients 130 (56%) were females and 102 (44%)
were males. 222 patients (124 women and 96 men) showed HP
infection . Frequency of infection in females was 95.4% and in
males 94%. A total of 88 patients (38%) were in age group 30
and 144 (62%) in age group 31–80 years. HP was detected in 84
(95.4%) in ﬁrst group and 136 (94.4%) in second group. 95.7%
rural and 41.8% urban showed HP infection. The most frequent
blood group was B (78%). All smoked patients and patients with
history of smoking showed infection. HP infection in active gastri-
tis was 98.3% and inactive gastritis with intestinal metaplasia was
64.2%. The most common symptom was epigastric pain and the
least common was hiccup and vomiting.
Conclusion: Frequency of HP infection is high (95.7%). No rela-
tion is between age, sex, clinical signs and HP infection. Persons
with blood group B are more predipose to HP and smokers are
high risk for HP infection. No difference is between urban and
rural.
R1990 Prevalence of erythromycin resistance among
Streptococcus pyogenes isolated in Kingdom of Bahrain
A. Jamsheer, K. Ravishekhar, G. Botta
Manama, BH
Objective: Numerous published studies have documented the rise
in erythromycin resistance among Streptococcus pyogenes. The aim
of our study is to determine the resistance to erythromycin among
our isolates.
Methods: A total of 55 clinical strains of S. pyogenes were isolated
from patients during the period from February to November 2003,
the strains were isolated from throat swab (65.5%) wound swabs
(9.1%) blood (3.6%) pus swabs (9.1%) sputum (3.6%) vaginal
swabs (3.6%), ear swabs (1.9%) and skin (3.6%). Identiﬁcation
was performed by routine laboratory techniques including latex
agglutination. Antimicrobial susceptibility testing was performed
by Kirby–Bauer disc-diffusion test. The minimal inhibitory con-
centration (MIC) of resistant isolate was determined by E-test
methodology according to the recommendation of the manufac-
turer.
Results: All S. pyogenes strains were fully susceptible to erythro-
mycin except one strain (1.9%) which was highly resistant,
MIC > 256 mg/mL.
Conclusion: Erythromycin resistant among S. pyogenes isolated at
Salmaniya Medical Complex in Kingdom of Bahrain is low (1.9%)
compared with other similar studies elsewhere; Italy 24.5%, Por-
tugal 23.8%, Spain 21.2%, France 12.9%, Turkey 2.9%.
%
susceptible
CIP AMP AMC NIT SXT GEN CTZ PIP PIZ
All
pathogens
81.9% 46.1% 73.0% 79.0% 64.8% 78.4% 84.9% 62.2% 90.9%
E. coli 84.6% 50.5% 76.5% 93.1% 75.5% 91.2% 98.7% 55.2% 92.8%
France 88.9% 52.0% 77.8% 87.7% 74.3% 83.6% 86.5% 64.3% 91.2%
Germany 78.8% 39.8% 69.9% 82.3% 57.5% 79.6% 85.8% 61.9% 88.5%
Italy 73.9% 52.2% 63.0% 73.9% 54.3% 58.7% 76.1% 67.4% 88.0%
Spain 81.0% 40.5% 75.8% 69.9% 66.0% 83.7% 87.6% 56.9% 94.1%
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R1991 Empiric treatment in urinary tract infections based
on resistance patterns
J.R. Mun˜oz, M. Jimenez Alvaro, J. Alonso, D. Alonso, A. Roldan
Plasencia, E
Background: Antibiotic resistance varies due to its irrational use.
Urinary tract infections (UTI) are very common infectious disease
and the clinicians need to know the epidemiology, and above all
the frecuency of agents and its resistance patterns in order to
manage UTI properly.
Objective: Stabilising an empiric treatment in our area depending
on the uropathogens isolated and its susceptibility to the antimi-
crobial agents used in UTI.
Materials and methods: Uropathogens agents isolated, from urine
cultures in our Microbiology laboratory, in 2002 were retrospec-
tively studied. Specimens came from outpatients mainly. We con-
sider 715 Gram-negative bacilli (E. coli, K. pneumoniae, P. mirabilis,
E. cloacae, M. morganii) and E. faecalis. Susceptibility strains was
performed against 15 drugs determining MIC with microdilution
NCCLS tests.
Results: We took into account the main microorganisms, above
2%; and focus on eight antimicrobial agents. The ﬁnal drug effect-
iveness, considering the frequency and susceptibility of each
microorganism, was ampicillin (40.96%), cotrimaxole (68.97), gen-
tamicin (93.66), fosfomycin (90.43), ciproﬂoxacin (83.88), cefuroxi-
me (87.58), amox-calvuanic acid (72.86), nalidixic acid (74.85). The
most important pathogen was E. coli (80.4%) and then K. pneumo-
niae (6.6%).
Conclusions: The best choice in UTI without complications is fosfo-
mycin, well tolerated and with few side-effects and no resistance
involvement. Amoxicillin-clavulanic acid was the ﬁrst choice drug
in our area 5 years ago, and the overuse might increase its resist-
ance rates. Cefuroxime or ﬂuorquinolones, may be a good alter-
native and the other agents need a susceptibility test prior to
treatment.
R1992 Penicillin-resistant pneumococci in a hospital in
Saudi Arabia
J.A. Al-Tawﬁq
Dhahran, SA
Objective: To study the pattern of antibiotic resistance among S.
pneumoniae in Saudi Aramco Medical Services Organization.
Methods: This is a retrospective study of pneumococcal isolates.
The isolates were tested with oxacillin diffusion disk and subse-
quently E-test was performed.
Results: A total of 162 isolates of S. pneumoniae were identiﬁed in
the study period from January 1999 to December 2002. Thirty-ﬁve
per cent of the isolates were obtained from the blood, 42.6% were
respiratory isolates, 2.5% were obtained from the CSF and 19%
were obtained from other sites. Of the total 162 isolates, 83 (51%)
were penicillin susceptible and the remaining 79 (48.8%) were
penicillin nonsusceptible. The prevalence of high level resistance
was 19.8% and that of intermediately resistant was 29%. A total
of 58 (35.8%) isolates were obtained from the blood. Of these iso-
lates, 31 (53%) were penicillin susceptible, 22 (38%) were interme-
diately susceptible to penicillin and ﬁve (1.7%) were highly
penicillin resistant. Of the total 69 respiratory isolates, 35 (51%)
were penicillin susceptible, 15 (22%) were intermediately suscept-
ible to penicillin and the remaining 19 (27%) were highly resistant
to penicillin. Of the 134 isolates tested for ceftriaxone, the majority
(95%) of the isolates were susceptible. Erythromycin resistance
was present in 30 of 119 (25%) tested isolates. Twenty-nine per
cent of the isolates were resistant to tetracycline and 42% were
resistant to trimethoprim-sulphamethoxazole (TMP–SMX). How-
ever, none of the isolates was resistant to vancomycin. Penicillin-
resistant isolates were more likely to be resistant to erythromycin
(50% of high-penicillin resistant isolates, and 24 and 17% of inter-
mediately resistant and susceptible S. pneumoniae, respectively
(P < 0.05). Resistance to tetracycline was present in 18% of peni-
cillin susceptible S. pneumoniae, and 65% of high penicillin resist-
ant organisms, respectively (P < 0.05). TMP-SMX resistance also
increased from 23% among penicillin susceptible S. pneumoniae to
78% among high penicillin resistant S. pneumoniae (P < 0.05)
(Fig. 2). Resistance to >3 or more class of antibiotics is deﬁned as
multi-drug resistant (MDR) S. pneumoniae. The prevalence of MDR
S. pneumoniae was between 9 and 12%.
Conclusion: High resistance of S. pneumoniae to antibiotics calls for
more efforts to promote the use of antimicrobials more judi-
ciously.
R1993 Prevalence and antimicrobial resistance of urinary
bacterial isolates from pregnant women in rural Tanzania
B. Blomberg, B.E. Olsen, S.G. Hinderaker, N. Langeland,
P. Gasheka on behalf of the joint study group on antimicrobial
resistance at Haydom Lutheran Hospital, Tanzania and the
University of Bergen, Norway
Objectives: Correct management of urinary-tract infections in preg-
nancy can reduce morbidity in mother and child, but antimicro-
bial resistance can impede effective chemotherapy. The objective
of the study was to describe the prevalence and antimicrobial
resistance of bacterial isolates causing urinary-tract infections in
pregnant women in a rural area in Tanzania.
Methods: Urine specimens obtained from April 1995 to March
1996 from 5163 pregnant women in a rural area in Northern Tan-
zania were examined. Among a total of 543 women who had pos-
itive dip-slide tests, 102 randomly chosen dip-slides were
investigated further with bacterial identiﬁcation and susceptibility
testing by the disc-diffusion method. The results were compared
with data from studies from urban areas of Tanzania and else-
where.
Results: A total of 116 bacterial isolates, 72 Gram-negative and 44
Gram-positve, were recovered from 102 positive dip slides. The
most frequently recovered Gram-negative and Gram-positive iso-
lates were E. coli (n ¼ 27) and enterococci (n ¼ 18), respectively.
Isolates of E. coli showed low rates of resistance to ampicillin
(17%), mecillinam (0%), cefalexin (0%), nitrofurantoin (4%), trim-
ethoprim (0%) and sulphamethoxazole (0%). Isolates of Enterob-
acter (n ¼ 9) and Klebsiella spp. (n ¼ 4) displayed higher rates of
resistance to these drugs, ampicillin (44 and 75%, respectively),
mecillinam (33 and 25%, respectively), cefalexin (22 and 0%,
respectively), nitrofurantoin (56 and 25%, respectively) trimetho-
prim (40 and 44%, respectively) and sulphamethoxazole (25 and
11%, respectively). All enterococcal isolates were sensitive to
ampicillin and trimethoprim, and only two isolates were resistant
to nitrofurantoin. The resistance rates in this study were low com-
pared with data from urban areas of Tanzania.
Conclusion: Although still lower than in urban areas, antimicrobial
resistance is emerging in these rural areas of Northern Tanzania.
Irrational use and over-the-counter sale of antimicrobials and use
of expired or poor quality drugs may have contributed to this
development.
R1994 Prevalence of oral candidiasis and antifungal
susceptibility of Mexican oral yeasts isolated from HIV-infected
and noninfected patients
L. Sa´nchez-Vargas, N. Ortiz, M. Moragues, J. Aguirre,
M. Cashat-Cruz, L. Gaita´n-Cepeda, G. Quindo´s
Mexico City, MEX; Bilbao, E
Objective: To establish the prevalence of oral candidiasis and the
in vitro antifungal susceptibility of Mexican oral yeast isolates
from HIV-infected and noninfected patients.
Patients and methods: A prevalence study over a 3-year period was
conducted on a consecutive series of HIV-infected and noninfect-
ed patients attending the General Hospital of Mexico, the ‘Fede-
rico Gomez’ Child Hospital and the Odontology Clinics at the
Facultad de Odontologia (Universidad Nacional Autonoma de
573Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
Mexico, Mexico DF). Oral swabs from 161 adults (52 HIV-infec-
ted) and from 163 children (60 HIV-infected) were plated onto
Sabouraud dextrose agar plates and 187 yeast isolates were recov-
ered. Yeast isolates were identiﬁed by mycological methods, inclu-
ding germ tube and chlamydospore production, and carbohydrate
assimilation proﬁles by using API ID 32C (Biomerieux, France).
Antifungal susceptibility to 5-ﬂuorocytosine, amphotericin B, mic-
onazole, ketoconazole, ﬂuconazole and itraconazole was assessed
with Fungitest (Bio-Rad, USA).
Results: Yeasts were isolated from 179 of 324 patients (55.2%);
of them 51 patients (45 HIV-infected) presented oral candidiasis.
Candida albicans was the most frequent species (117 of 187 iso-
lates, 62%, of them 94 were serotype A. Non- Candida albicans
species were isolated from 52 patients: Candida glabrata from 35
patients (31 from nonHIV-infected patients), Candida tropicalis
from 12, Saccharomyces cerevisiae from three and Candida parapsi-
losis from two. Candida dubliniensis was not isolated in the oral
specimens studied. There were six episodes of infection or colo-
nisation by at least two different yeast species. Overall 18.7%
of the yeasts were resistant at least to one or more azole anti-
fungal agents, being ketoconazole and itraconazole the less act-
ive. Most resistant isolates were Candida glabrata from patients
without HIV infection or Candida albicans from HIV infected
patients.
Conclusions: This is one of the ﬁrst studies providing baseline data
on oral Candida colonisation and infection in Mexican patients.
Azole resistance was present in <20% of oral isolates. Many resis-
tant isolates, mostly Candida glabrata, were from patients without
candidiasis. This work was ﬁnanced in part by grants 1/UPV
00093.327-E-14645/2002 from the Universidad del Pais Vasco and
PAPIIT 214300 DGAPA-UNAM.
R1995 A 2-year survey of K. pneumoniae isolates at a new
teaching hospital in Turkey
F. Begendik, C. Kulah, Z. Doyuk
Zonguldak, TR
Objective: To determine the antibiotic susceptibilities and the pre-
valence of ESBL production in K. pneumoniae isolates 2 year.
Methods: A total of 207 isolates (107 urine, 36 wound, 21 genital,
eight blood, 14 sputum, 11 drain and 10 others) were investigated.
Isolates were identiﬁed with conventional methods. Antibiotic
susceptibility was determined by Kirby–Bauer disc-diffusion
method according to NCCLS. ESBL production was determined
by double disc synergy test (DDS) and conﬁrmed by E-test (AB
BIODISK, Sweden).
Results: Ratio of ESBL producing strains was 23/207 (21.7%).
Among ESBL producing strains 75.5% of the isolates were recov-
ered from inpatients. Susceptibility to cephalosporins were 0–37%
in ESBL-producing strains and 82–94% in non-ESBL producing
strains. ESBL-producing strains were 20% more resistant to ci-
proﬂoxacin. Isepamicine was the most effective (100%) aminogly-
coside antibiotic against ESBL-producing strains. Karbapenem
resistance was not observed.
Conclusion: Depending on the high prevalence of ESBL-produ-
cing strains of K. pneumoniae in nosocomial infections, clinical
microbiology laboratories must effectively detect and report the
presence of ESBL routinely. DDS is reliable, cheap and not
much time consuming test for detecting ESBL production in
routine use.
R1996 Acinetobacter baumanii: epidemiology and
phenotypes of resistance to antibiotics in a Tunisian hospital
A. Soussen, M. Afef, Z. Meryem, Z. Amel, F. Chedlia
Tunis, TN
A. baumanii is recognised by his nosocomial character. Our study
was justiﬁed by several aspects : the increase in the isolation of
the strains these three last years, their multiresistance to antibiot-
ics which becomes usual, the exposed patients who are immuno-
compromised and ﬁnally, epidemic character of the
infections. This study related to 499 strains of A. baumanii isola-
ted from 65 852 pathological specimens in 3 years (2001–2003).
The identiﬁcation was made using the morphology (Gram) and
biochemical characters: negative oxidase and rapid identiﬁcation
(Api GN - biorad). The antibiogram was carried out according to
CA-SFM standards and the interpretation was done by the soft-
ware ‘SIR-i2a’. The strains supposed at the origin of epidemics
were analysed by AP-PCR after extraction of their DNA by the
kit ‘QIAmp DNA minikit-Quiagen’. A. baumanii was isolated
with a prevalence from 0.75% primarily from blood, punctures
and katheters, especially in the medical intensive care and sur-
gery units. Concerning b-lactams, 70% of the strains had a peni-
cillinase and a cephalosporinase, concerning in particular,
ceftazidim, cefsulodin, cefepim and tazobactam. A low sensitivity
or a resistance to imipenem was noted in 40% of cases, to ﬂuoro-
quinolones in 80% and to cotrimoxazole in 51%, to phosphomy-
cin in 60% of cases. Concerning aminosides, we noted the
phenotype KGA in 38% of cases, KGTA in 20%. A sensitivity to
colistin was noted in 100% of cases. Two epidemics were noted
with the medical intensive care unit (in September 2002 and from
September to November 2003). All these data show that A. bau-
manii gives a problem with surgery and intensive care units in
our hospital, with possibilities of antibiotic treatment often lim-
ited to imipenem and tobramycin. The epidemic strains were
often most resistant to antibiotics.
R1997 Resistance patterns of Streptococcus pneumoniae
strains isolated from infected individuals in 2001–2003 from
Western Pomeranian region of Poland
M. Nowosiad, S. Giedrys-Kalemba
Szczecin, PL
Introduction: The spread of pneumococcal infections caused by
multidrug-resistant strains is recently observed in the community.
Objectives: We analysed the antibiotic resistance patterns of
S. pneumoniae strains isolated from respiratory-tract infections in
years 2001–2003 in region.
Methods: The collection of 84 multidrug-resistant strains isolated
from nasopharyngeal swabs (78), BAL (two), eye (one) was estab-
lished using disk diffusion method according to NCCLS for the
following antibiotics: erythromycin (E), clindamycin (L), tetracyc-
line (T), cotrimoxazole (S) and oxacillin (P). Sensitivity of multi-
drug (ﬁve and four) resistance strains (33%) was veriﬁed with
Etests.
Results: Initially determined resistance degree of S. pneumoniae
was 60% for P, 40% E, 38% L, 50% T and 79% S. MIC results
conﬁrmed resistance of S. pneumoniae for E (>256 lg/mL), L
(>256 lg/mL) and T (8 to >32 lg/mL). E-test veriﬁcation for P
revealed that among examined strains with zone diameter
<20 mm for oxacillin, only 4% could be classiﬁed as PRSP
(MIC 2 lg/mL), 32% as PISP (MIC 0.125–0.75 lg/mL), 64%
was sensitive (MIC 0.023–0.064 lg/mL). For S 30% initially
resistant strain showed intermediate susceptibility (MIC 1.5–
32 lg/mL). These results found that real resistance degree to P
is 29% and to S 69%. In the years 2001–2003 the resistance for
E increased from 22 to 50% and for L from 22 to 45%, and
reduced for T from 67 to 43% and S from 74 to 64%. We also
noticed increase of percentage four-drug (7–12%) and three
drug resistant strains (30–36%) and reduce two-drug (33–29%)
and one-drug resistant strains (30–24%). Finally we observed
the following resistance patterns: ELTS 8%, PELT 2%, ELT
18%, ELS 7%, PTS 5%, PEL 1%, PES 1%, PS 18%, TS 10%,
PE 1%, EL 1%, S 20%, T 7%.
Conclusions: (i) We observed the increase of resistance for E and
L, and the decrease for T and S and the growth of multidrug (four
and three-drug)-resistant strains during last 3 years. (ii). E-test
veriﬁcation is necessary for determination of S. pneumoniae sensi-
tivity to P and S.
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R1998 Typing of S. aureus and S. epidermidis ocular
isolates by different methods
A. Sudano Roccaro, A. Marino, C.G. Spoto, A.R. Blanco, V. Enea
Catania, Messina, I
Objectives: The aim of this study, was to determine the number of
different strains among 52 staphylococci ocular isolates (33 S. epi-
dermidis and 19 S. aureus) using four typing methods as alternative
to the pulsed-ﬁeld gel electrophoresis (PFGE).
Methods: The typing methods used were: (i) analysis of plasmid
proﬁle, (ii) RAPD (random ampliﬁed polymorphic DNA analysis),
(iii) PCR-ribotyping and (iv) PCR analysis of the Inter-IS256
spacer length polymorphysims.
Results: As for the 19 S. aureus isolates we used the ﬁrst three
methods the results of which show a certain accordance resulting
in the typing of six, and seven different strains respectively. As
regards the 33 S. epidermidis isolates we used (i), (ii) and (iv) of
the typing methods listed above. The PCR analysis of the Inter-
IS256 Spacer Length Polymorphysms and plasmid proﬁle seem to
be the most efﬁcient method, both discriminating 23 different
strains; however RAPD analysis carried out with primers 1 and 6
also has a good discriminatory power, identifying 12 and 10
strains, respectively.
Conclusion: Genotyping techniques are valuable tools for the epi-
demiologic study of bacterial infections. Pulsed-ﬁeld gel electro-
phoresis (PFGE) is the current method of choice for typing of
staphylococci but it requires expensive equipment. The use of
these alternative methods proved to be able to monitor, with a
certain degree of signiﬁcance, changes within the bacterial ge-
nomes.
R1999 Childhood Haemophilus inﬂuenzae type B
meningitis in Ural
S.V. Penzhenina, N.V. Murunova, A.I. Gruzdev
Yekaterinburg, Kamensk-Uralsky, Asbest, RUS
Bacterial meningitis in children are one of the life-threatening
infections. However, the vaccination against the main causes of
bacterial infections such as S. pneumoniae and H. inﬂuenzae is not
part of the childhood immunisation programme in the Ural.
Objectives: The aim of this research was to investigate aetiology of
bacterial meningitis in children of the Ural region during period
from 1995 to 2003. Study was carried out in such towns as Ekater-
inburg, Asbest, Kamensk-Uralskiy, Kachkanar. From 150 to 200
children with bacterial meningitis were included in the study
annually.
Methods: The diagnosis was conﬁrmed by the identiﬁcation of the
responsible pathogen from CSF culture and/or detection of sol-
uble antigens in CSF (Slidex Meningitis Kit, Directigen Meningitis
combo Test). For investigation of aetiology were used ‘Haemo-
line’. Identiﬁcation was carried out by routine methods API NH,
JD srtep, JD g- or API NG. Biotyping of H. inﬂuenzae was followed
out according Kilian.
Results: Quantity of the bacterial meningitis increases during act-
ual period from 0.21 per mile in 1995 to 0.36 per mile in 2002.
Contribution of H. inﬂuenzae type b as casual agent to the general
quantity of bacterial meningitis varied from 3.5 to 10.1% in differ-
ent years. Hib-induced meningitis were the most frequently
(10.1%) in 1997 and in 2002. Other serotypes of H. inﬂuenzae was
not found. The H. inﬂuenzae biotype 1 was in the major case-
s. The study group was from 1 till 5. One patient with Hib-men-
ingitis was 3 months old (1996). Unlike meningococcus-induced
meningitis in children there was no any season ﬂuctuations of epi-
demiology of Hib-meningitis. We tested a total of 64 cultures for
antibiotic resistance by ATB NH or ATB Haemo using automatic
tester ATB-Expression. 95.2% of cultures were sensitive to: amoxi-
cillin, cefaclor, cefataxim, spektimycin, tetracycline, peﬂoksacin,
rifampicin, trimetaprim clotrimaxazom but they was resistant to
gentamycin and had intermediate susceptibility to erythromycin.
Intermediate susceptibility to kanamycin was found in two cul-
tures and to amoxicillin – in one culture. All cultures were sensi-
tive to chloramphenicol.
Conclusion: Hib-induced meningitis in children of our region are
relatively constant (from 3 to 10%) and take second or third place
after meningitis induced by N. meningitidis or S. pneumoniae.
R2000 Phenotypic and molecular identiﬁcation of
b-lactamase genes in Gram-negative bacteria isolated from a
university children’s hospital
L. Bagrade, N. Pugacova, L. Drukalska, M. Murovska,
E. Miklasevics
Riga, LV
Objectives: To examine the presence and distribution of b-lacta-
mase (bla) genes in clinical isolates at Children’s Hospital of Uni-
versity (CHU), Riga, Latvia.
Methods: A total of 215 isolates collected from inpatients of CHU
in the period May–November 2003 were investigated. Bacterial
isolates were identiﬁed by BBL Crystal. Antimicrobial susceptibil-
ity were determined by disc diffusion method; extended spectrum
b-lactamase production (ESBL) in E. coli and Klebsiella spp. – by
disc opposition and double disc methods. Typing of bla alleles
was performed by PCR ampliﬁcation using primers speciﬁc for
blaSHV, blaTEM, blaCTX-M, blaOXA and blaIMP.
Results: The biggest number of isolates belonged to E. coli,
K. pneumoniae and K. oxytoca – 52, 34 and 11, respectively. More
than 30% of these isolates were ESBL producers. From all tested
isolates >40% (93 isolates) contained at least one bla allele while
majority of bla positive strains harboured two or three alleles. Pre-
valent were blaTEM (in 72% of bla positive strains) and blaSHV
(55%) types but none of the tested isolates carried blaIMP allele.
R2001 Bacteriocin production and inmunity diversity
among enterococci from different origins
R. Del Campo, P. Ruiz-Garbajosa, C. Tenorio, R. Jimenez-Diaz,
A. Navas, C. Torres, F. Baquero
Madrid, Logron˜o, Seville, E
Material and methods: The diversity of bacteriocins in Enterococcus
was investigated in a collection of 100 broad-range bacteriocin
producers isolated from faecal samples [healthy volunteers (33),
food-handlers (19), animals (24)], clinical samples (20) and sewage
(four) selected from a total of 720 isolates. Clonal relationships
among strains were studied by PFGE- SmaI, using the Phoretrix
5.0 software. A chessboard strategy was used to classify groups of
production/susceptibility, using all strains either as producers or
indicators. Factorial correspondence analysis combining qualitat-
ive and quantitative variables was used to establish the cluster
analysis, and Dice’s coefﬁcient was calculated for both production
and immunity.
Results: Considering all the isolates, members of the species E. fae-
calis (57%) were more frequently bacteriocin producers than
members of E. faecium (50%) or Enterococcus spp. (8%). Neverthe-
less these frequencies may be altered when a particular origin is
considered. Among isolates with different production patterns,
similar immunity patterns tend to occur in isolates from each par-
ticular origin suggesting the interchange of immunity genes as
mechanism of resistance. Percentage of total inertia (32.76%) in
the factorial analysis of correspondence can be explained by three
ﬁrst axes and suggests a single phenotypic evolutionary structure
both in production and in immunity. Several pulsotypes, bacterio-
cin and immunity types were indeed shared by strains from dif-
ferent groups.
Conclusions: Bacteriocin production in enterococci is common
between different origins, and although differences can be
observed, this phenomenon could be part of a single structure
with ecosystem specialisation’s, but no foreign elements have
been acquired. Separated transference of immunity or production
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genes could be taken in account, especially between strains from
the same origin.
R2002 Antibiotic susceptibility pattern and population
structure of Streptococcus pneumoniae isolated from cystic
ﬁbrosis patients
R. Del Campo, M.I. Morosini, E. Garcia La Pedrosa de,
F. Almaraz, A. Fenoll, F. Baquero, R. Canto´n – Spanish Pneumo-
coccal Study Network (G03/103)
Background: Pseudomonas aeruginosa is the most common cause of
chronic colonisation in cystic ﬁbrosis (CF), but other bacteria as S.
pneumoniae may play a signiﬁcant role.
Material and methods: A total of 47 S. pneumoniae isolates were
obtained from deep-sputum samples of 26 CF patients, collected
along 1995–2003. Susceptibility testing to 19 antibiotics was per-
formed by the microdilution method (Wider system, Fco. Soria
Melguizo, Madrid, Spain). PFGE- SmaI was applied to analyse
genetic relatedness. Mutation frequencies were assessed using 5%
sheep blood agar plates containing 2 lg/mL of rifampin.
Results: The most representative serotypes were: 23F (16 isolates)
and 19F (eight isolates). High percentages of resistance (intermedi-
ate plus resistant) were observed for penicillin (75%), cefotaxime
(33%), erythromycin (42%), tetracycline (58%), SxT (67%) and
chloramphenicol (48%). All isolates remained susceptible to ci-
proﬂoxacin, levoﬂoxacin, and vancomycin. Co-resistance to four
or more antibiotics was found in 56% of the isolates. Thirty-one
different pulsotypes were identiﬁed among the 47 strains (from A
to AD). Twenty-nine pulsotypes were represented by a single iso-
late each; two isolates of serotype 37 belonged to the clone AB,
whereas clone A involved 16 isolates (all corresponding to the 23F
serotype) with ﬁve sub-pulsotypes (A1–A5). This clone (A) was
present in nine of 26 patients, being isolated along the 7-year-per-
iod of the study. Signiﬁcantly, the same clone A was recovered in
two patients after several years without S. pneumoniae detection.
This clone displayed penicillin MIC of 2 lg/mL and cefotaxime
MIC of 1 lg/mL and was resistant to macrolides, tetracycline,
SxT, and chloramphenicol. The most representative patterns of
colonisation were as follows: S. pneumoniae as sole isolate (18%),
and S. pneumoniae with Haemophilus inﬂuenzae (18%). Considering
all isolates, mutation frequencies to rifampin ranged from
7  1010 to 1  107, 32% being considered as mutator (mutation
frequency range 1–5  107).
Conclusions: CF- S. pneumoniae isolates displayed a higher percent-
age of mutators and antibiotic resistance if compared with non-CF
patients of the same age, being co-resistance a frequent feature.
This fact may be related with antibiotic selection in these patients,
persistence, and cross-colonisation of multi-resistant clones.
R2003 Fluoroquinolones in Gram-negative bacilli
meningitis
D. Leca, E. Miftode, A. Latis, C. Luca, V. Luca
Iasi, RO
Objective: To study the effectiveness and tolerance of ﬂuoroquino-
lones in the treatment of Gram-negative bacilli meningitis
Material and methods: During 1997–2003 we conducted a retrospec-
tive study, about 19 patients (15 males and four females, aged
from 9 month to 73 years) with Gram-negative bacilli meningitis,
treated with ﬂuoroquinolones.
Results: The meningitis was postneurosurgery in nine cases, post-
traumatic in three cases and othogenic in two cases. The germs
(Escherichia coli, ﬁve cases; Proteus mirabilis, two cases; Klebsiella
pneumoniae, six cases; Acinetobacter baumanii, three cases; Salmon-
ella, one case) were multiresistants to antibiotics, but susceptible
to ﬂuoroquinolones. The ﬂuoroquinolones (peﬂoxacine, 13 cases,
ciproﬂoxacine, six cases) was administered by ﬁrst intention in 16
cases, with synergic antibiotics association, for 13–30 days period.
The clinical parameters were normalized after 7–10 days and
laboratory parameters after 2 weeks of antibiotic therapy. The
evolution was favourable in 13 cases, with complications in six
cases (cerebral abcess, one case; subdural empiema, one case;
hydrocephalus, three cases, deft, one case and two deceased. We
registered four side-effects (increase TGP, one case; digestive, two
cases; rash, one case).
Conclusions: Fluoroquinolones are effectiveness and well tolerated
in the treatment of Gram-negative bacilli meningitis in associa-
tions with synergic antibiotics.
R2004 Resistance to imipenem in Pseudomonas
Z. Daoud, N. Hakime´
Beirut, LBN
Introduction: Pseudomonas aeruginosa is a common nosocomial
pathogen particularly isolated among immuno-compromised
patients. In the year 2000, 14% of the Saint George Hospital iso-
lates of Pseudomonas species were resistant to imipenem. Resist-
ance of Pseudomonas to carbapenems is increasing and noted
worldwide. The potency of b-lactams is limited by a rather imper-
meable outer membrane, which works in synergy with Inducible
b-lactamase (plasmidic or nucleoidic). The aim of this study was
to determine the susceptibility of the isolates of Pseudomonas spp
(including P. aeruginosa) and to analyse their resistance to Imipe-
nem.
Material and methods: This is a descriptive prospective study
extending from 1 Januuary 2000 to 1 August 2002. All the isolates
of Pseudomonas aeruginosa and other Pseudomonas species were col-
lected and antibacterial susceptibility testing (AST) was per-
formed. The results were compiled and statistically analysed.
Bacterial identiﬁcation and antibacterial susceptibility testing were
done according to the National Committee for Clinical Laboratory
Standards (NCCLS).
Results: Table 1 shows some characteristics of Pseudomonas isolates
where 68.4% of the patients were hospitalised and 95.3% consis-
ted of the species P. aeruginosa. Table 2 illustrates the different
susceptibility patterns of the Pseudomonas isolates including those
that are resistant to imipenem (IRP). Table 2-IRP: Imipenem-
resistant Pseudomonas (aeruginosa and other species). IP- Imipenem,
PIP- Piperacillin, TAZ- Tazob/pip, CFZ- Ceftazidim, CFP- Cefe-
pim, AZT- Aztreonam, GN- Gentamycin, TB- Tobramycin, AK-
Amikacin, OF- Oﬂoxacin, CP- Ciproﬂoxacin.
Discussion: P. aeruginosa was more isolated than Pseudomonas spp
regardless of the susceptibility patterns. The percentage of resist-
ance to Imipenem was higher among the hospital isolates in com-
parison with isolates coming from outpatients. The Imipenem-
resistant strains show higher level of resistance than those who
Table 1.
All Pseudomonas
Frequency (%)
IRP-Frequency
(%)
In 491.0 (68.4) 126.0 (83.5)
Out 226.0 (31.6) 25.0 (16.5)
P. aeruginosa 683.0 (95.3) 146.0 (96.7)
Pseudo. species 34.0 (04.7) 05.0 (03.3)
Total 717.0 (100.0) 151.0 (100.0)
Table 2.
IP PIP TAZ CFZ CFP AZT GN TB AK OF CP
IRP
Frequency
(%)
– 66
(43.7)
70
(46.4)
86
(57.0)
61
(40.4)
53
(35.1)
34
(22.5)
46
(30.5)
57
(37.8)
31
(20.5)
43
(28.5)
All
Pseudomonas
Frequency
(%)
541
(75.4)
533
(74.3)
548
(78.5)
580
(81.0)
523
(73.0)
483
(67.5)
415
(58.0)
475
(66.4)
499
(69.7)
393
(54.9)
452
(63.5)
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are susceptible to Imipenem (average of 32.9% of decrease in sus-
ceptibility). The average of susceptibility of IRP to antibiotics
other than Imipenem is estimated to 36.2 compared with 69.1 for
the susceptible strains. The highest percentage of susceptibility
was observed with Ceftazidim in both cases and the lowest per-
centage was observed with Oﬂoxacin.
R2005 Consumption of antibiotics and antifungals for
dermatological disorders
B. Matica, A. Mlinaric-Dzepina, N. Jarza-Davila, I. Vukusic,
J. Culig
Zagreb, HR
Objective: To deﬁne and analyse the use of drugs for skin disor-
ders in Zagreb based on ATC (anatomical- therapeutic-chemical)
drug clasiﬁcation system recommended by WHO.
Methods: The data obtained from 31 pharmacies units of Zagreb
Pharmacies Group were collected. The number and size of pack-
ages together with ﬁnancial indicators for each individual drug
and for each ATC classiﬁcation level were extrapolated on the
total number of pharmacies in Zagreb in 2001.
Results: The main anatomical group D for dermatological disor-
ders ranks eighth, or 4, 10% of all prescribtion drugs used in
Zagreb in 2001. The corticosteroids (D07) are on the top of the
rank, accounting 37.85% of group D drug use. They are followed
by antimycotics (D01), which makes 26.99% of the use. Antibiotics
and chemotherapeutics (D06) agents occupy the third position in
the rank and they account 21.77% of group D drug use. The three
major therapeutic group s of the drugs i.e. the D01, D06, D07
account for 86.61% of the overall use of drugs pertaining to the
ATC group D.
Conclusion: Comparing our data with those obtained for Finland,
it may be concluded that the structure of drug consumption is
similar in Zagreb and Finland for the main therapeutic group
comprising antimycotics. The use of antibiotics is twice smaller in
Finland than in Zagreb, whereas the use of preparations for anti
acne preparations is three times in Zagreb than in Finland.
R2006 Resistance of Mycobacterium tuberculosis to the
primer antituberculous agents in Greek, foreigner, and
repatriated Greek patients during the 10-year period 1993–2002
S. Nikolaou, S. Kanavaki, S. Karambela, A. Skroubellou,
P. Papageorgiou, V. Sgoutzos, E. Varonou, F. Kontos,
V. Tamvakis
Athens, GR
Objective: We investigated the resistance to Isoniazid (INH) and Rif-
ampicin (RIF) and the multidrug resistance (INH and RIF), of 4108
M. tuberculosis strains recovered at the National Mycobacterium Ref-
erence Centre of Athens, during the 10-year period, 1993–2002.
Methods: M. tuberculosis strains were recovered from 3368 Greek
patients and from 730 immigrant patients. Among the immigrants,
189 were repatriated Greeks from Eastern European countries and
551 were foreigners from other countries. All specimens were
stained by the Ziehl-Neelsen method and cultured on Lo¨wen-
stein–Jensen medium or on the Bactec MGIT 960 or 460TB sys-
tems. The susceptibility testing of strains was performed by the
method of proportion on Lo¨wenstein–Jensen medium, or by using
the MGIT 960 or the radiometric Bactec 460TB system.
Results: During the study period, the rates of newly diagnosed
tuberculosis have shown a decreasing trend in Greek and repatri-
ated Greek patients, whereas, in the foreigners they were increas-
ing. The rates of resistance to INH and RIF as well as the
multidrug resistance were respectively 6.6, 2.9 and 2.5 for Greeks;
29, 10.6 and 10% for repatriated Greeks and 11.4, 6 and 5.4% for
foreigners. A twofold and a fourfold increase in the INH-resist-
ance rates was detected in the Greeks and repatriated Greeks,
respectively, whereas in the foreigners there was not any signiﬁ-
cantly difference detected. Concerning RIF-resistance, there was a
sevenfold, a threefold and a 12-fold increase in Greeks, foreigners
and repatriated Greek patients, respectively, while concerning
multidrug-resistance there was an eightfold, twofold and 12-fold
increase in Greeks, foreigners and repatriated Greek patients
respectively.
Conclusions: The rates of the newly diagnosed tuberculosis show a
decreasing trend, both in Greeks and repatriated Greek patients,
probably due to an improvement of the standards of living and of
health care services. Our results, although may not represent the
mycobacterial resistance of the entire country, they give a good
information about the problem. The increasing rates to the major
of the primer antituberculous drugs in all three groups of the
patients studied, suggest the need of a continuous monitoring M.
tuberculosis drug resistance.
R2007 Sepsis in an infectology centre, Latvia:
epidemiological and microbiological aspects
A. Broduza, G. Ulme, B. Rozentale
Riga, LV
Objectives: (i) To carry out the epidemiological investigation of
patients with sepsis treated at the Infectology Centre of Latvia
and (ii) to estimate the main pathogens and their antimicrobial
susceptibility.
Methods: During the years 1993–2002 the case reports of 591
patients discharged from the Infectology Center of Latvia with
diagnosis of sepsis were evaluated with regard to patients sex,
age, duration of treatment, antimicrobial susceptibility. The
American College of Chest Physicians/Society of Critical Care
Medicine consensus conference (1992) deﬁnitions of sepsis were
applied.
Results: A total of 591 patients with sepsis make 1.42% of all
patients admitted to hospital during 10-year study period. Mortal-
ity rate was variable during this period, ranging from 0.92 to 20%
of all sepsis patients. 357 patients (60.4%) had positive blood cul-
tures and 234 – negative (39.6%). Predominant pathogens were
Gram-positive bacteria, ranging from 55 to 80%. Staphylococcus au-
reus, coagulase-negative staphylococci, a- and b-haemolytic strep-
tococci were mostly detected Gram-positive pathogens. The most
frequent Gram-negative pathogens were E. coli and Klebsiella spp.
In terms of antimicrobial resistance the methicillin-resistant S. au-
reus (MRSA) was documented overall in 18.7% of cases. During
the study period 28.5–66.6% of coagulase-negative staphylococci
were identiﬁed as methicillin-resistant. Only in 4.49% of cases
Gram-negative bacteria were nonsusceptible to ciproﬂoxacin and
more frequently (6.74%) resistance to ceftriaxon was registered.
Conclusions: Patients predisposed to sepsis were the elderly and
patients with comorbid conditions. As sepsis is a signiﬁcant
health care burden and is associated with the use of extensive
healthcare resources our ﬁndings may prove useful for the mak-
ing of infection control policy and correct treatment decisions in
the Infectology Centre of Latvia – tertiary care hospital in Latvia.
R2008 Carriage and acquisition of extended-spectrum
b-lactamases in Lebanese hospitals
C. Moubarek, Z. Daoud, N. Hakime, J. Mokhbat,
F. Doucet-Populaire, M. Hamze´, R. Rohban, H. Matta
Beirut, LBN; Paris, F; Tripoli, LBN
Introduction: Outbreaks of nosocomial infections due to extended-
spectrum b-lactamase (ESBL)-producing strains are being increas-
ingly reported in Lebanese health care facilities. The reservoir for
these strains appears to be the gastrointestinal tract of patients,
ESBL production being found mainly in Klebsiella pneumoniae and
Escherichia coli and also in other Enterobacteriaceae including, Pro-
teus mirabilis, Salmonella, Enterobacter, Citrobacter and Serratia.
Material and methods: A prospective multicentric point-prevalence
study extending over a 12-months period was performed in the
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intensive care units of the ﬁve Lebanese hospitals located in dif-
ferent areas of Lebanon (Saint George Hospital, Rizk Hospital,
Saint Joseph Hospital, Nini Hospital, and Arz Hospital) in order
to evaluate the epidemiology of ESBL-producing strains in the
country. The target population included the patients and the hos-
pital staff of these hospitals. A total number of 1500 faecal sam-
ples were collected overall the ﬁve hospitals. Patients were
checked for ESBL-producing strains upon admission, 72 h later
and then at weekly intervals over a 3–month period. Health work-
ers were checked for ESBL-producing strains once at the begin-
ning of the study and then monthly.
Results: Results are shown in the tables.
Conclusion: The identiﬁcation of the strains in patients and health
workers by means of surveillance cultures was helpful to assess
the prevalence of colonisation with this type of organisms, analyse
the endemic situation, identify predisposing conditions, and
evaluate -lactamase characteristics.
R2009 Resistance pattern in strains of Staphylococcus
aureus, isolated in a Spanish military hospital
M. Mateo, P. Puente, V. Buezas, F. Gutie´rrez, J.-R. Maestre,
F. Herva´s
Madrid, E
Objective: The knowledge of our epidemiological status, related to
S. aureus at our hospital (Hospital Central de la Defensa, Military
Hospital of 600 beds, in Madrid, Spain), specially referred to it’s
oxacillin resistance (MRSA, meticillin resistant Staphylococcus aure-
us) and the resistance pattern associated to it.
Methods: Staphylococcus aureus from clinical samples received in
our laboratory during the last year were isolated and identiﬁed
by latex agglutination (Pastorex Staph-Plus, BIORAD) to detect
the clumping-factor of the A-protein and the polysaccharides of
the capsule, conﬁrming with the automatic system VITEK2 (Bio-
Me´rieux), which also permits antibiotyping, with a later conﬁrm-
ing using a modiﬁed Kirby-Bauer (adding a supplement of NaCl-
2%, as NCCLS recommends).
Results: A total of 209 samples from 194 patients were selected,
32.5% MRSA. Resistance patterns more observed were OEC
(36.51%), OECCL (22.22%), OC (12.69%), OECCLG (11.11%) and
OECG (6.65%), being O ¼ oxacillin resistance, E ¼ erythromicin
resistance, C ¼ ciproﬂoxacin, CL ¼ clindamicin and G ¼ gentami-
tamicin. Individual resistance was outlined, qualiﬁed by oxacillin
susceptibility, as follows: for MRSA (E ¼ 83.6%, C ¼ 93.5%,
CL ¼ 36.5%, G ¼ 28.3%, V ¼ 0%) and for MSSA (methicillin-sus-
ceptible Staphylococcus aureus, E ¼ 15.7%, C ¼ 9.2%, CL ¼ 3%,
G ¼ 6.1%, V ¼ 0%, P ¼ 85.3%), being V ¼ vancomicin and P
¼ penicillin G.
Conclusions: The surveillance of MRSA (32.5%) in our hospital is
very similar to that observed in other Spanish hospitals, consid-
ered by Oteo as 33.6 in big hospitals (500–1000 beds) of our coun-
try. Resistance pattern for Spain is more frequently OECG
(40.32%), while ours is only 6.35%, although our ﬁrst pattern is
OEC (36.51%), so it means that resistance to gentamicin is not so
usual in our population. But our hospital patterns seems to be
similar to the French ones. The total strains isolated were suscept-
ible to vancomicin. It might be due to the change of our soldiers
proﬁle: many of our new professionals are proceeding from nor-
thern countries of African Centre or South America. In France, the
immigration from these countries is also important. The patterns,
obviously are linked to them too.
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R2010 In vitro antibiotic resistance of E. coli in urinary
tract infections during the last 2 years
E. Ikonomopoulou, T. Podimatas, S. Andreatou, K. Papadopoulos,
I. Katsarou, A. Kolotouros, A. Regli
Patras, Zante, GR
Objectives: To estimate the resistance of E. coli strains that isolated
from urinary-tract infections in our laboratory during the last
2 years (October 2001–September 2003).
Methods: During the last 2 years we isolated 1819 (57.6%) E. coli
strains from 3157 positive urine cultures. The identiﬁcation and
the susceptibility testing were carried out either by the breakpoint
system mini API or the Vitek system (Biomerieux).
Results: Sixty-three per cent (1144/1819) of E. coli strains were
isolated from outpatients’ urine cultures and 37% (675/1819) E.
coli strains were isolated from inpatients’ urine cultures. 79%
(904/1144) from outpatients and 69% (466/675) from inpatients
were women. The resistance of E. coli strains to antibiotics for
outpatients/inpatients respectively was: ampicillin 32.8/35.8%,
piperacillin 10/9.6%, amoxicillin/clavulanic acid 5/6%, Cefalo-
thine 11.6/12.2%, cefotaxime 1/1.5%, Imipenem 0/0.7%, Tobra-
mycin 1.7/2.2%, Amikacin 0.9/1.5%, Netilmicin 1/1.2%,
Gentamicin 2.1/2.5%, Trimethoprim/Sulphamethoxazole 15.8/
19.3%, Nitrofurantoin 2.4/3.6%, Nalidixic acid 8.6/9.2%, Ciproﬂ-
oxacin 7/7.4%.
Conclusions: Women were the majority of the patients especially
in outpatients. The outpatients’ E. coli strains had lower in vitro
resistance than inpatients’. The differences in resistance in the
majority of antibiotics were at the most 1.2% except ampicillin
and trimethoprim/sulphamethoxazole where the differences were
3 and 3.5%, respectively. Ampicillin and trimethoprim/sulpha-
methoxazole found to have the less in vitro activity against E. coli
strains.
R2011 Antimicrobial resistance of Salmonella enterica
isolates from diarrhoeal patients in Crete, Greece
S. Maraki, E. Nioti, A. Kapsoritaki, G. Samonis, Y. Tselentis
Heraklion, GR
Objective: To determine the antimicrobial drug resistance and the
prevalence of Salmonella enterica serotypes in isolates from diar-
rhoeal patients in Crete, Greece.
Methods: A total of 176 Salmonella enterica strains isolated from
faecal samples were studied. Identiﬁcation was made according
to standard microbiological procedures and serotyping was
performed with commercial antisera by the slide agglutination
method. Antimicrobial susceptibility testing was checked by the
disc-diffusion method following the recommendations of the
NCCLS. The following antibiotics were tested: ampicillin,
cefotaxime, ceftriaxone, gentamicin, chloramphenicol, tetracyc-
line, trimethoprim/sulphamethoxazole, nalidixic acid and
ciproﬂoxacin.
Results: A total of 176 Salmonella enterica strains were isolated,
corresponding to 13 serotypes. These strains were more fre-
quently isolated from children (70%). Salmonella enterica serotype
enteritidis was the predominant serotype (135 strains), account-
ing for 81.6% of all salmonellae isolated. Salmonella enterica sero-
type Typhimurium (21 strains) constituted 11.9%, while the
remaining 11 serotypes were rare, constituting 11.5% of the
strains. Resistance to ampicillin, tetracycline and nalidixic acid
was observed in 4, 3.4, and 13% of all the isolates, respectively.
Only one isolate was resistant to gentamicin, one to chloram-
phenicol and one to trimethoprim/sulphamethoxazole. All iso-
lates were susceptible to third-generation cephalosporins tested
and ciproﬂoxacin.
Conclusions: (i) Salmonella enterica serotype enteritidis predomin-
ates among other serotypes. (ii) resistance to commonly prescribed
antibiotics in Salmonella enterica is rare in our region.
R2012 Low nasopharyngeal carriage and high ampicillin
resistance of Haemophilus inﬂuenzae type B among children in
Taiwan
C.C. Wang, W.T. Lo, M.L. Chu
Taipei, TW
Objectives: In clinically, Haemophilus inﬂuenzae cause meningitis,
sepsis, pneumonia, epiglotitis, cellulitis and arthritis in neonate
and young children. The annual incidence of invasive H. inﬂuen-
zae type b (Hib) disease in Taiwan was estimated to be 1.5–2
cases/100 000 children >5 years of age/year, that was relatively
low compared with western countries. Because of there is no any
report of the Hib nasopharyngeal carriage rate in Taiwan. This
study is aimed to deﬁne the overall carriage rate of Hib among
healthy children in the community. In addition, antibiotic suscep-
tibility, serotype and the clonal relationship of these isolates will
be done.
Methods: (i) Survey of nasopharyngeal carriage of H. inﬂuenzae.
From January to December 2003, nasopharyngeal specimens was
obtained from healthy children, then identify isolated strains as
H. inﬂuenzae. (ii) antibiotic susceptibility test. The MICs of antibi-
otics were determined using Etest. (iii) serotype of isolates. Using
Bacto H. inﬂuenzae antisera seperate typable from nontypable iso-
lates. Typable isolates were further serotyped by the slide agglu-
tination test and (iv) molecular typing of isolates. Using PFGE
method.
Results: Thirty-two H. inﬂuenzae strains isolated from nasopharyn-
geal of 642 healthy children. Among these strains, four isolates
belong to type b; others are nontypable, the carriage rate of Hib is
0.6%. Antibiotic susceptibility test revealed ampicillin resistant
rate is 62.5%, cotrimoxazole resistant rate is 46.9% and resistance
to azithromycin, chloramphenicol, tetracycline are 6.3, 28.1, 28.1%
respectively, All isolates sensitive to the second and the third ce-
phalosporins. The PFGE of isolates showed diversity of genotype.
Conclusion: According to the results of this study, the nasophar-
ynx carriage rate of Hib is very low in Taiwan, and association of
high ampicillin resistance that may be due to antibiotic overuse,
these two factors may contributed the low incidence of invasive
Hib diseases in Taiwan.
R2013 Antimicrobial susceptibility of Escherichia coli
isolated from humans and retail meat
U. Frank, C. Lunke, D. Mlangeni, M. Dettenkofer, F. Daschner
Freiburg, D
Background: Multi-drug resistant food-borne pathogens have
increased markedly in recent years. The need for an integrated
surveillance system between human and veterinary microbiology
laboratories has been emphasized by the World Health Organisa-
tion.
Methods: Escherichia coli strains were isolated from human samples
(n ¼ 653) in South Germany, and from retail poultry, pork and
beef (n ¼ 113) grown in the same area. Identical isolation and
identiﬁcation methods were used for both human and food sam-
ples. Antimicrobial susceptibility testing was performed for all
isolates using the VITEK system (biome´rieux).
Results: All the human and animal strains were 100% susceptible
to imipenem. Most isolates were susceptible to cefuroxime (94
and 98%, respectively) and gentamicin (97 and 95%, respectively).
Susceptibility to oﬂoxacin was 90 and 93%, respectively; to pip-
eracillin 66 vs. 79%, to ampicillin 60 vs. 65% and to cotrimoxazole
73 vs. 70%. Resistance among clinical isolates to tetracyclines was
34%, but was very high (60%) among food-borne isolates, which
may reﬂect the frequent use of this substance group in animals
husbandry.
Conclusions: Escherichia coli isolates from meat tend to be similarly
resistant to commonly used antibiotics as isolates from humans.
Further investigation is necessary to establish whether the source
of the resistance in food isolates is directly related to antibiotic
use in animal farming.
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R2014 A. baumanii isolated from blood cultures during a
3-year period
M. Pouyiouka, M. Toutouza, V. Karabassi, X. Trelogianni,
A. Koumarela, C. Kontou-Castellanou
Athens, GR
Objectives: The purpose of this study was to determine the antimi-
crobial susceptibility of A. baumanii isolated from blood cultures
during a 3-year period.
Methods and material: Blood cultures were performed by the Bactec
system (Becton Dickinson), the identiﬁcation of A. baumanii was
carried out by the Vitek system and the susceptibility testing by
disc diffusion.
Results: During a 3-year period, 52 strains of A. baumanii were iso-
lated from blood cultures in our hospital. All isolated strains were
resistant to cefoxitin, cefotaxime, ceftazidime, ceftriaxone, oﬂoxa-
cin, peﬂoxacin, ciproﬂoxacin. Frequency of resistance to gentami-
cin, tobramycin and netilmicin was 57, 36 and 36%, respectively.
All strains were sensitive to colistin.
Conclusion: Our study showed a high rate of multidrug-resistant
A. baumanii isolated from blood cultures in our hospital. We
should re-examine our policy on restrictions on the use of antibi-
otics and warn clinicians of the emerging problem.
R2015 Compliance and impact of an ID physician’s
advisory consult on restricted antibiotic usage
B.-N. Kim, I.-G. Bae
Daegu, Jinju, KOR
Objectives: This study was to evaluate compliance and short-term
impact of targeted antibiotic advisory consult implemented since
October 2002 in Dongsan Medical Center.
Methods: A total of 339 prescriptions in 187 patients were retro-
spectively reviewed and antimicrobial utilisation density was
compared quarterly from January 2002 through June 2003.
Results: Overall 85.6% of prescriptions were inappropriate, with
73.7% inappropriate for therapeutic regimens and for 100% of
prophylactic regimens. Overall compliance antibiotic advisory con-
sult was 46.5%. The compliance was higher in the medical services
than in the surgical services (64.2% vs. 43.1%, P ¼ 0.005) and for
therapeutic use and prophylactic use (54.7% vs. 36.5%, P ¼ 0.001).
From 1Q 2002 to 2Q 2003, use of aminoglycosides was reduced
from 269.1 DDD/1000 patient days to 171.8 DDD/1000 patient
days, and that of antipseudomonal cephalosporins from 112.1
DDD/1000 patient days to 64.5 DDD/1000 patient days. Overall
inpatient use of parenteral antibiotics was decreased from 770.8
DDD/1000 patient days to 626.8 DDD/1000 patient days.
Conclusion: Targeted antibiotic advisory consult resulted in sub-
stantial reduction in antibiotic use despite relatively poor compli-
ance. This type of antibiotic control programme can be an
alternative for hospitals with limited human resources trying to
implement an antibiotic policy.
R2016 Epidemiological analysis of carbapenem-sensitive
and resistant Pseudomonas aeruginosa within a single hospital
in Scotland
F. Walsh, S. Bracher, P. Turner, S. Amyes
Edinburgh, Cheshire, UK
Objectives: One ICU within the Royal Inﬁrmary of Edinburgh in
2002 showed that a few patients were consistently colonised by
P. aeruginosa strains with reduced carbapenem susceptibility. This
study set out to identify whether these bacteria were genotypically
or phenotypically related to similar strains elsewhere in the hospital.
Methods: The genotype of seven P. aeruginosa strains with decreased
meropenem susceptibility isolated from the original unit in 2002
was compared with 104 P. aeruginosa strains collected in a prospect-
ive study from throughout Edinburgh in early 2003. These isolates
were analysed by pulsed-ﬁeld gel electrophoresis (PFGE) using
Bionumerics computer software to determine the level of homogen-
eity and heterogeneity within these two groups. The susceptibilities
of both groups of isolates were investigated to imipenem, merope-
nem, ceftazidime, piperacillin/tazobactam and ciproﬂoxacin.
Results: Five of the seven 2002 ICU isolates were identical when
measured by PFGE, one isolate was 98% similar and the other was
85% similar. However, the 104 isolates were far more heterogene-
ous and, except for one strain, showed <82% similarity to the
2002 ICU isolates. In addition there was no clear clonality amongst
the P. aeruginosa strains in this prospective study, as clusters of
strains showing >90% similarity always comprised greater than of
equal to four strains. There was just one isolate from the prospective
2003 study that showed 90% similarity with the 2002 ICU strains.
Interestingly, amongst the 2003 isolates, strains that had identical
resistance patterns often were unrelated genotypically and strains
from patients in close proximity were usually unrelated.
Conclusion: In 2002, there was a small outbreak of closely related
meropenem-resistant strains in 1 ICU. This outbreak was con-
tained and did not spread into the hospital as a whole. Within the
prospective study the P. aeruginosa strains are very heterogenous
and almost always carbapenem sensitive.
Community-acquired infections
R2017 ASSURE rapid test for diagnosis of Helicobacter
pylori infection: a new proposal test?
N. Sen, O¨. Yilmaz, A.A. Ku¨pelioglu, I. Simsek
Izmir, TR
Objectives: Helicobacter pylori, plays an important role in the patho-
genesis of some several extra or intragastroduodenal diseases. The
aim of this study was to evaluate the seropositivity of adult dys-
peptic patients who were referred to upper gastrointestinal endo-
scopy following rapid urease test and histopathologic
examination. Serological status was determined by IgG ELISA
and ASSURE H. pylori Rapid Test with current infection marker
for diagnosis of acute H. pylori infection.
Methods: During upper gastrointestinal endoscopy, biopsies were
taken two from gastric antrum and two from corpus was performed
in 54 patients (mean age 47 years) with dyspeptic complaints. Heli-
cobacter pylori was assessed by rapid urease test and by histopatho-
logical examination in these biopsy specimens. Patients’ sera were
tested with two serological tests: Anti-H. pylori IgG ELISA
(EUROIMMUN Medizinische Labordiagnostika, Lu¨beck) and
ASSURE H. pylori Rapid Test (Genelabs Diagnostics, Singapore).
Results: A total of 54 patients were evaluated and H. pylori infec-
tion was diagnosed in 46 (85%) patients by rapid urease test
and/or histopathology. Of the 46 patients, 34 (74%) were positive
for both ELISA and ASSURE, seven (15.2%) were positive by
ELISA, three (6.5%) were positive by ASSURE, two (4.3%) were
both ELISA and ASSURE negative. Rapid urease test and histo-
pathology negative eight patients sera showed three positivity by
ELISA and ASSURE, two were positive by ELISA, one was posit-
ive by ASSSURE and remaining two patients were negative by
both these tests.
Conclusion: Nowadays, there is a common effort to ﬁnd a correct,
reliable and simple H. pylori test. Among these noninvasive tests
are more prominent in the available tests of the dyspeptic
patients. That is why serology is widely used, cheap and noninva-
sive method to detect H. pylori infection but it has some limita-
tions because of the not able to distinguish between active
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infection and a previous ‘contact’. It seems that ASSURE H. pylori
rapid test with current infection marker provides us rapid diagno-
sis of H. pylori infection than ELISA.
R2018 The correlation between emergence of the troponin
T in the blood from patients with tonsillitis with
immunological and haemodynamic changes in early and late
convalescence periods
L.N. Fachrutdinova
Kazan, RUS
Objective: Explore changes of the immunity and haemodynamics
in patients with tonsillitis (PT) depending on emergence of the
troponin T (TnT) in the blood.
Methods: Bacteriological analysis of the microﬂora of the tonsil
lacunas, immune marker analysis of the lymphocytes, trials of the
IgA, -M, -G and circulating immune complexes (CIC). Two-
dimensional Doppler echocardiography, trials of the TnT by the
electrochemiluminescent method on the analyzer ‘Elexis’. A total
of 138 PT (mean age 19.8  0.5 years) were surveyed during acute
period (AP) of the tonsillitis (2–4 days from the beginning of the
illness), the early (7–9 days) and late (20–25 days) convalescence
(EC and LC). 20 healthy humans were the control group.
Results: ‘Nonrheumatogene’ species of the Streptococcus (Streptococ-
cus viridans, etc.) were in 87% pts. Increasing level of the TnT
(TnT>0.01 ng/ml) was discovered in the 15.2% PT during EC and
LS periods – TnT (+) group of the pts. The other 84.8% pts – TnT
() group. Quantity of immune competent cells with cytotoxic
function (CD8, CD16) have increased during AP for pts from TnT
(+) group more than for pts from TnT () group (P < 0.005).
Quantity of CD16 was more in TnT (+) group then in TnT ()
group at EC and LC periods (P < 0.05). Quantity of IgA, -M, -G
and CIC in TnT (+) group remains high during LC, but at the
same time this quantity are normal in TnT () group.
CIC ¼ 0.07  0.04 units of optical density (UOD) in TnT (+)
group, 0.04  0 01 UOD in TnT () group (P < 0.01). Cardiac
index (CI) was less in TnT (+) group than in TnT () group at LC
period (2.58  0.25 L/min/m2 and 3.29  0.21 L/min/m2,
P < 0.05). Peak E/peak A was 2.07  0.04 in TnT (+) group, and
1.87  0.04 in TnT () group (P < 0.001) in LC period.
Conclusion: More ‘bad showings’ as cellular and humoral immuni-
ties, so central and intraheart haemodynamics were in PT increas-
ing TnT in the blood by comparison with the PT without
increasing TnT. Determination of the TnT at PT is signiﬁcant
because its increasing points to myocard’s damage.
R2019 Transferrable beta-lactamase with extended-
spectrum produced by multi-resistant Gram-negative bacilli
A R. Aboud
Baghdad, IQ
A transferable extended-spectrum produced by a multidrug-resist-
ant clinical isolate of Gram-negative bacilli isolates from patients
with diarrhoea was studied. The gene was carried by a large plas-
mid were transferable to recipient strains of Escherichia coli
MM294. The transfer of gene determinant from donor strains was
demonstrated by the analysis of resistance spectrum in transconju-
gat clones of recipient strain by the method of indirect selection.
The ability of production of extended-spectrum beta-lactamase
(ESBL) was demonstrated by the double disc diffusion test. It is
concluded that pencillinase and the resistance markers for pencil-
lin was encoded by 4.2 kb plasmid, while that cephalosporinase
and the resistance markers for cefotaxime and cephaloxin were
encoded by 3.2 kb plasmid transferred by conjugation into Escheri-
chia coli MM294.
R2020 Neisseria meningitidis bacteraemia: 95 episodes
C. Ezpeleta, I. Atutxa, C. Busto, E. Go´mez, V. Cabezas, J. Unzaga,
R. Cisterna
Bilbao, E
Objective: To assess the epidemiological and clinical features of
N meningitidis (Nm) bacteriaemia in our hospital. Nm serogroup B
was traditionally more frequent than serogroup C in our country.
In the last years the serogroup C became more prevalent. In 1997
children and teenagers aged between 18 months and 20 years
were vaccinated with the polysaccharide vaccine A + C (415 000
people 88.6% coverage). In 1999–2000 after a decrease in the inci-
dence of disease by Nm C a new cluster of cases was noticed.
Children fewer than 7 years were vaccinated against N. meningit-
idis C with the new conjugated vaccine. This vaccine is adminis-
tered now to children at 2–4 and 6 months.
Methods: Prospective study of all cases of positive blood cultures
with N. meningitidis. An infection control nurse visited every
patient and ﬁlled a previously deﬁned form including demogra-
phic data, underlying illnesses, clinical presentation, and analyt-
ical data: microbiology WBC, coagulation and outcome. Study
period: December 1993 to December 2002. Blood culture method:
Bactec 9240 (Becton-Dickinson). Identiﬁcation: Biochemical test
API NH (Biomerieux) and Serogroup (Difco). Serotyping was per-
formed at the Hospital Donostia.
Results: A total of 95 patients had N. meningitidis bacteraemia
during the study period. Sex: 51.58% men. Age: 2 months to
1 year: 16 cases, 2–10 years: 36 cases, 11–20 years: 14 cases, 21–
60 years: 11 cases and >60 years: 18 cases. 20% were admitted to
the ICU because of the severity of the disease. Serogroups: C 52
(54.7%), B 39 (41%), Y 1, and three nongroupable. Serotype (50
cases studied): 2a/subtype 5: 16; 2b-8 and serotype 4: 11 cases
were the most frequents. Concomitant meningitis: 26 cases, 33%
of cases of N. meningitidis C and in 20% of cases of serogroup
B. Crude mortality: 11.57%. Eight of 11 (72.72%) died the same -
day of admission. Two clusters of cases were identiﬁed during
1997 and 2002 with 16 cases diagnosed each year. Cumulated
epidemic index 2.4 and 6.9 cases/100 000 inhabitants were
reached in our community in the period January to June 2002.
During the last cluster there have been three young women with
symptoms mimicking pielonefritis and two aged patients without
symptoms of sepsis.
Conclusions: N. meningitidis is the aetiologic agent of 1.8% of
bacteraemia in our hospital. N. meningitidis serogroup C related
to clusters is now more frequent in our hospital than the ende-
mic serogroup B. The clinical diagnosis of some cases can be
difﬁcult. Mortality was higher in serogroup B (15.38%) than in
C (9.61%).
R2021 Application of SIR (susceptible infectious recovery)
epidemiological model in determination of measles epidemics
F. Amani
Ardebil, IR
Introduction: In the nineteenth century recurrent epidemics of
cholera and inﬂuenza and decreasing cases of diseases in the
later years caused that produce the question why communicable
disease would suddenly produce epidemics and disappears then.
Designing one model bases mathematical such as SIR (susceptible
infectious recovery) model have been perfomed for the question
response the aim of research survey model on the measles in Iran
and determination of outbreaks of measles at 1996 and determine
necessary least vaccine covering for prediction of measles epidem-
ics in the future.
Methods and materials: With collection of data from disease control
centre, the number of suffering to measles, age mean of measles
and life expanses calculated and the number of suffering to mea-
sles, age mean of measles and life expanses calculated and the
amount of R0 (Basic Reproduction Rate) resulted.
Results: Calculating R0 amount at range 5.5–7.49 have been resul-
ted that for the reason R0 amounts greater than one the measles
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epidemic has occurred in our country and least effective vaccine
covering has been 81.8–86.65%.
Discussion: Calculating R0 and necessary least vaccine covering
for prediction measles epidemics determine that for epidemic con-
trol least vaccine covering, must more than 82.65%. Decreasing
herd immunity and increasing measles age mean under condi-
tions due to another epidemic in the 2005.
R2022 Antibiotic resistance of Escherichia coli from
community-acquired urinary tract infections considering
demographic and clinical data
J.-I. Alo´s, M.-G. Serrano, J.-L. Go´mez-Garce´s, J. Perianes
Mo´stoles Madrid, E
Objetives: In a population-based study we assessed the antibiotic
resistance of E. coli from community-acquired ITU considering
demographic and clinical data.
Methods: This prospective study considered 164 isolates of E. coli
(one per patient) from urine samples of patients with community-
acquired UTI diagnosed in the Emergency Service of our hospital.
The antibiotic susceptibility was determined for ampicillin, gen-
tamicin, fosfomycin, nitrofurantoin, cefazolin, nalidixic acid, norﬂ-
oxacin, ciproﬂoxacin and cotrimoxazole. The clinical records of
the 164 patients were reviewed and a protocol was ﬁlled out for
each one.
Results: The 164 E. coli isolated from urine proceeded from 112
women and 52 males with a mean age of 54.12 years
(SD ¼ 21.15 years). After analysing the clinical records it was
noted that 82 (50%) proceeded from uncomplicated UTI and 82
(50%) from complicated UTI (52 males and 34 females). Glo-
bally, 57.3% of the strains were resistant to ampicillin, 25.0% to
cotrimoxazole, 20.1% to nalidixic acid, 14% to norﬂoxacin and
ciproﬂoxacin, and 0% to fosfomycin and nitrofurantoin. Of the
82 strains proceeding from complicated UTI, 16 (19.5%) were
resistant to norﬂoxacin and ciproﬂoxacin whereas only seven
(8.5%) from uncomplicated UTI were resistant (P ¼ 0.043). Sig-
Signiﬁcant differences for the quinolones were found when the
resistance of isolates from patients 50 years were compared
with those from patients <50 years: 28% (25/90) vs. 11% (8/74)
(P ¼ 0.007) for nalidixic acid, and 20% (18/90) vs. 6.7% (5/74)
(P ¼ 0.015) for the ﬂuoroquinolones tested. Comparison of the
resistance by sex showed statistically signiﬁcant differences in
cefazolin, 11.5% (6/52) in males compared with 1.7% (2/112) in
women (P ¼ 0.013); and in ﬂuoroquinolones where the resistance
was 25% (13/52) in males and 9% (10/112) in females
(P ¼ 0.006).
Conclusions: In acute uncomplicated UTI fosfomycin, nitrofurantoin,
and the ﬂuoroquinolones show adequate rates of susceptibility for
empirical use in our area. For optimal interpretation of suscepti-
bility in cumulative data from the Primary Health setting it is
necessary to take into account the type of UTI (uncomplicated vs.
complicated), the sex and age of each patient.
R2023 Salmonella and Campylobacter food-borne
infections in the Czech Republic in 1984–2002
M. Prı´kazska´, E. Benes, V. Prı´kazsk
Prague, CZ
Objectives: Acute enteric infections caused by Salmonella and Cam-
pylobacter are still important issues in recent era of mass industrial
production and processing of food. Our aim was to provide con-
cise overview of main epidemiological features of these food-
borne infections.
Methods: Salmonelloses and campylobacterioses are notiﬁable dis-
eases on obligatory basis. Morbidity data on salmonelloses are
notiﬁable and available since 1951. Campylobacter infections are
notiﬁed since 1984. Data on both entities were collected by com-
puterised ‘Information System of Communicable Diseases’ the
ISPO. Newer system of notiﬁcation, the EPIDAT, was implemen-
ted in 1993. The core data structure remained the same and it
allowed preserving the continuity of both notiﬁcation systems
Results: Incidence of salmonellosis was growing during the period
from 1981 and got the plateau in late 1980s. The brake was in
1989 when incidence reached three times higher levels than in
previous years. The highest incidence rates were notiﬁed in 1995.
Since 1998 the rates are steadily dropping down. Salmonelloses
are unevenly distributed in our country. The highest rates are
notiﬁed in agricultural districts in the east. Imperfect production
of milk for nursed children was the most important cause in chil-
dren under 1 year of age, the mostly hit age group until 1989.
After 1989, quality of food products for babies improved. Less
attention is paid to thermic processing of poultry and eggs and
they became predominant risk food. Salmonella enteritidis is the
prevalent serotype (95% of all cases) in recent years. Campylobacter
is routinely diagnosed only in recent years and we observe typical
seasonal variation in its incidence. The increasing trend in inci-
dence was partly due to spread of diagnostic in all country.
Campylobacterioses have importance comparable with salmonel-
loses. The highest increase in morbidity is recorded for the lowest
age groups that are indicative of worsening conditions in food
processing (particularly in households). Almost three-fourths of
cases were infected via poultry products. Incidence of salmonel-
loses was 271/100 000 and campylobacterioses 225/100 000 inhab-
itants.
Conclusions: Salmonella and Campylobacter infections are important
food borne diseases. In recent years they reached equal levels.
The preventive potential is in improvement of food processing
and storage.
R2024 Lyme borreliosis morbidity/incidence rate among
the inhabitants of Podlasie region, 1996–2002
S. Pancewicz, M. Kondrusik, J. Zajkowska, S. Grygorczuk,
R. Swierzbinska, T. Hermanowska-Szpakowicz, J. Siemienkowicz,
I. Sienkiewicz, S. Kuroczycki-Saniutycz
Bialystok, PL
Objectives: The purpose of the study was to evaluate Lyme borrel-
iosis morbidity/ incidence rate among inhabitants of Podlaskie
voivodship in the years 1996–2002.
Material and methods: The notiﬁability of Lyme borreliosis cases
from Podlasie region in 1996–2002 was analysed.
Results: In Poland, 9437 cases of borreliosis were registered
in years 1996–2002 including 2195 (23.26%) in Podlasie region.
The morbidity rate of Podlasie region was: in 1996 – 15.05%; in
1997 – 30.79%; in 1998 – 46.56%; in 1999 – 33.96%, in 2000 –
21.29%, 2001 – 18.57% and in 2002 – 17.66% of all cases regis-
tered in the country. The incidence rate per 100 000 inhabitants
in Podlasie region was higher than in Poland and equaled in
1996 to 9.09; in 1997 – 16.25; in 1998 – 29.37; in 1999 – 24.78; in
2000 – 32.2; in 2001 – 37.6 and 2002 – 29.4. In 2002 year, the inci-
dence rate of Podlasie region exceeded 5.59-fold the incidence
rate of the whole country. The highest morbidity rate was repor-
ted in the east and centre of the region (76.95%) abundant in
large forests. A signiﬁcantly lower rate was registered in the
area of Augustowskie and Suwalskie Lake Districts (14.62%) and
the lowest rate in the west of the region (6.7%). The incidence
of the disease was analysed according to age of patients show-
ing decrease in its incidence among patients over 60 years old.
The highest number of cases was observed among patients aged
30–49, so Lyme borreliosis affects mainly professionally active
people.
Conclusion: The results of our studies indicate that Lyme borrelio-
sis is a serious health problem among the inhabitants of Podlasie
region, the area abundant in big forests being an endemic area of
a main Lyme disease vector – Ixodes ricinus ticks infected with
Borrelia burgdorferi spirochete.
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R2025 Epidemiology of infective endocarditis in Hungary:
a pilot study
A. Heczey, G. Prinz, E´. Ba´n
Budapest, HUN
Objectives: In Hungary, the epidemiology of infective endocarditis
is unknown. For the establishment of Hungarian Infective Endo-
carditis Registry a prospective pilot study was conducted.
Methods: Between October 1, 2002 and September 30, 2003 data
of 37 consecutive cases of infective endocarditis (IE) were col-
lected. Patients were either hospitalised in our Institution or
were encountered through infectious disease consultations. The
diagnosis of IE was validated by using the modiﬁed Duke
Criteria.
Results: Pathogens: The following organisms were isolated: Sta-
phylococcus aureus in nine cases (24.32%), enterococci in nine
cases (24.32%), [E. faecalis eight (21.62%), E. faecium 1 (2.70%)],
Streptococcus (S.) bovis three (8.10%), viridans streptococci three
(8.10%) (S. mitis 1, S. oralis 1, S. salivarius 1)], other pathogens
seven (18.91%). Six cases were blood culture negative. Predispo-
sing factors were valvulare disease: 11 cases (29.79%), prosthetic
valve: 12 (32.43%), pacemaker ﬁve (13.51%). Affected valves
were mitral: 15 (40.54%), aortic: eight cases (21.62%), tricuspidal
two (5.40%), aortic and mitral: 10 (37.0%), aortic, mitral, tricus-
pidal: 1 (2.70%), pacemaker was affected in one case. No IV
drug abusers or HIV positive patient were identiﬁed. The mean
time to establish the diagnosis of IE from the ﬁrst symptoms
was 6.2 weeks (standard deviations: 5.23). Vascular phenomena
were observed in 15 cases (nine cerebral, seven Janeway lesions,
two splenic, two pulmonary, two arterial embolisation). Surgery
was needed in 17 cases (45.9%). In-hospital mortality was
29.73%.
Conclusion: The results of this pilot study suggest the increasing
role of enterococci in IE. Further investigations are needed to
establish real epidemiology of IE in Hungary.
R2026 Epidemiological features in 469 adult cases of
brucellosis in Babol, north of Iran
M.R. Hasanjani Roushan, M. Hajiahmadi, M.J. Soleimani Amiri
Babol, IR
Objectives: Brucellosis still remains an important public health
problem in Mediterranean countries including Iran. The purpose
of this study was to evaluate the epidemiological features in adult
cases of brucellosis in Iran.
Methods: This study was conducted on 469 adult cases of brucello-
sis who were attended to the department of infectious diseases,
Babol Medical University from January 1997 to January 2003. Epi-
demiological data in all cases were recorded.
Results: A total of 469 cases of brucellosis [267 (56.9%) males and
202 (43.1%) females with the mean age of 31.99  17.10 years,
ranged 16–90 years] were studied. A total of 184 cases (39.2%)
were from urban and 285 (60.8%) were from rural areas. With
regard to seasonal distribution, the disease was seen in 118
(25.2%) cases in spring, 188 (40.1%) in summer, 103 (22%) in
autumn and 60 (12.8%) in winter. Risk factors of the disease were
seen in 203 (43.3%) of the patients. Brucellosis was also seen in
family members of 45 (9.6%) cases. The disease was acute in 255
(54.4%), subacute in 179 (38.2%) and chronic in 35 (7.4%) cases.
The distribution of these ﬁndings between sexes was equal
(P < 0.05).
Conclusion: Lack of risk factors of brucellosis in more than 50% of
our patients and involvement of more than 65% of cases in spring
and summer, show that the usage of unsafe dairy products are
the main source of infection.
R2027 Comparison of community-acquired pneumonia
clinic in young patients from different social groups
H.V. Demchuk, Y.M. Mostovoy
Vinnitsya, UKR
Object: To compare the features of community-acquired pneu-
monia CAP clinic at young soldiers (YS), at young intravenous
drug users (IVDU) and young adults (YA) with common life.
Methods: By means of the specially developed form, in which
demographic, anamnesis, objective and laboratory-instrumental
data were analysed, were clinically inspected 100 YS, 99 YA and
30 IVDU without HIV-infection. Age of patients was 15–30 years.
Statistic analysis was conducted using chi-square statistics and
H-test Kruskal–Wallis.
Results: The severity CAP was observed at 80% of IVDU, at
9% of YS and at 14.1% of YA (P < 0.05). At the admit to hos-
pital 26.8% of IVDU had altered mental status from the dor-
mancy to the coma, 53.2% of patients of this group were
excited and aggressive. YS and YA didn’t have same violations.
Haemophtysis was observed at 1% of YS, at 2% of YA and at
33.3% of IVDU(P < 0.05). Chest pain disquieted 47.5% of YA,
72% of YS and 73.3% of IVDU(P < 0.05). The dyspnoea was at
21% of YA, at 30% of YS and at 70% of IVDU(P < 0.05). Rheu-
matic paint, myalgias and digestive dyspepsia were observed
at 5% of YA, at 3% of YS and at 30% of IVDU
(P < 0.05). Objectively, except for the CAP signs, there were
the cardiovascular changes: tachycardia was at 27.3% of YA, at
15% of YS and 86.7% of IVDU, hypotonia – at 34.3% of YA,
at 33% of YS and at 60% of IVDU (P < 0.05). The hepatolienal
syndrome was observed at 3% of YA, at 4% of YS and at 50%
of IVDU (P < 0.001). Radiographic pattern of CAP was presen-
ted small nodal or segmental inﬁltration at 81% of YS and at
85.9% of YA. Lobe pulmonary consolidation or nonintensive,
many focal, conﬂuent inﬁltrates were present at 70% of IVDU
(P < 0.001). The thin-walled multiple cavities without an air-
ﬂuid level and with poor inﬂammatory board were formed at
30%. The pathogen of CAP was established at 29% of YS
29%, at 18.2% of YA and at 53.3% of IVDU. There was
S. pneumoniae at 31.4% of YS and 56.7% of YA. S. aureus was a
main pathogen at IVDU(62.5%). The complicated disease was
observed at 9% of YS, at 30.3% of YA and at 86.7% of IVDU
(P < 0.001). At IVDU sepsis was developed at 50%, septic endo-
carditis with affect the right side of the heart was at 20%. The
13.3% of this group had infectious-toxic shock. The 13.3% of
patients died. Infectious-toxic shock dominated at YS (4%) and
pleural effusion dominated at YA (8.1%).
Conclusions: CAP at IVDU unlike YA and YS is characterised by
the severe, complicated clinic and unfavourable prognosis.
R2028 Orchiepididymitis: a manifestation of brucellosis
T. Podimatas, E. Ikonomopoulou, A. Kolotouros,
K. Papadopoulos, A. Regli
Patras, GR
Objectives: To estimate the characteristics of primary orchiepidi-
dymitis of Brucella melitensis in the region of the mountainous
region of Achaia.
Methods: This is a retrospective study and included 127 patients
with orchiepididymitis that admitted our hospital during 1995–
2003. The mean age of patients was 43.75  9.38 years and the
mean duration of hospitalisation was 7.11  4.18 days. The serore-
action Wright was performed by the Difco Brucella antigen and
the blood culture were processed and cultured by the Bactec 9120
(Becton Dickinson). The laboratory analysis also included blood
examination and ultrasound.
Results: 10 (7.9%) of the 127 patients with mean age 38.65  8.75
appeared with unilateral orchiepididymitis due to Brucella meliten-
sis. All the patients were farmer–breeders. All the patients had a
painful inﬂation of one of the testicles and fever >38C. nine
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(90%) patients had redness of the same order of semiscrotum and
ﬁve (50%) patients had gentle dysuria. All patients had positive
the seroreaction Wright and eight (80%) had positive blood cul-
ture for Brucella melitensis. All the patients had leukocytosis with a
slight lymphocytosis and their urine culture was negative. The
ultrasound showed inﬂation of testis and epididymis. All patients
were treated with Doxycycline 200 mg and Rifampicin 900 mg
daily p.os for 6 weeks. The patients were also treated with anti-
inﬂammatory drugs and their testicles were suspensioned by little
pillows. The majority of patients showed a signiﬁcant remission
in the sixth to eigth day of treatment. The patients were followed
up in 3, 6 and 12 months and found to have negative blood cul-
ture, a normal ultrasound, a normal spermodiagram and a low
title of seroreaction Wright.
Conclusions: Orchiepididymitis as the main manifestation of bru-
cellosis was not rare during the last years in the region of Achaia
where the disease is endemic. The mean duration of hospitalisa-
tion has no considerable difference than orchiepididymitis due to
other causes. The disease goes on to cure with the proper treat-
ment. In patients with orchiepididymitis that have come from
mountainous region of Achaia we have always to consider of
Brucella melitensis as a cause.
R2029 Induced sputum cell count at different infectional
aetiology of COPD exacerbation
S.V. Nesterovich, E.B. Bukreeva, G.N. Seitova, B.V. Shilov,
L.V. Gudkova
Tomsk, RUS
Objectives: To reveal mean cytological markers at different infec-
tional aetiology of COPD exacerbations.
Methods: Clinical inspection of patients, Gram bacterioscopy of
sputum smears, quantitative bacteriological sputum research with
deﬁnition of germ concentration in 1 mL of sputum, deﬁnition of
Chlamidia pneumoniae, Mycoplasma pneumoniae antigens in sputum
via PCR method, IgG, IgM levels to them by immuno-assay
method, induced sputum (IS) cytological research were made.
Kruskell–Wallis analysis of variation was used. The COPD exacer-
bations caused by Streptococcus pneumoniae, Haemophilus inﬂuenzae,
Chlamidia pneumoniae, Mycoplasma pneumoniae, Moraxella catarrhalis
were analysed.
Results: Common cell count in 1 ml of IS at COPD exacerbations
caused by Mycoplasma pneumoniae was reliable most low
(1.87  0.16  106/mL, P < 0.05), but at other aetiology of COPD
exacerbations it was comparing and was deﬁned from
2.46  0.12  106/mL to 2.74  0.32  106/mL. Percentage of
macrophages in Mycoplasma pneumoniae COPD exacerbation was
reliable most high (31.91  3.99%), but in Moraxella catarrhalis
and Haemophilus inﬂuenzae COPD exacerbations it was reliable
most low (16.92  1.57%, 17.58  3.97% accordingly, P < 0.05).
Their absolute count in the group was comparing. Percentage and
absolute count of neutrophiles in Haemophilus inﬂuenzae COPD
exacerbation were reliable most high (70.35  3.72%,
1.83  0.13  106/mL), and in Mycoplasma pneumoniae COPD
exacerbation it was reliable most low (48.70  5.42%, P < 0.05,
0.969  0.146  106/mL, P < 0.05 accordingly). Percentage and
absolute count of eosinophiles in Moraxella catarrhalis and Strepto-
coccus pneumoniae COPD exacerbations were reliable most high
(3.09  0.64%, 0.061  0.015  106/mL, 2.82  0.35%,
0.061  0.008  106/mL accordingly), but they were most reliable
low in Haemophilus inﬂuenzae COPD exacerbation (1.35  0.46%,
P < 0.05, 0.036  0.013  106/mL, P < 0.05 accordingly). Percen-
tage of lymphocytes in Mycoplasma pneumoniae COPD exacerba-
tion was reliable most high (17.70  4.37%), in Haemophilus
inﬂuenzae COPD exacerbation they was reliable most low
(9.13  1.47% P < 0.05). Their absolute count in the groups was
comparing.
Conclusion: Thus there are pathogenesis features of inﬂammation
at COPD exacerbation in dependence on aetiology of infectious
process that is reﬂected on induced sputum cell count.
R2030 Infectious diseases as a major cause for
hospitalisation in internal medicine wards
R. Raz, Y. Abu-Daud, N. Reichman, E. Flatau
Afula, IL
Introduction: Infectious diseases (I.Ds) remain one of the most
common causes for hospitalisation in general and in Internal
Medicine Wards (IMW) in particular.
Objectives: To evaluate the percentage of patients hospitalised in
I.M.W due to I.Ds and to compare demographic and clinical char-
acteristics with patients hospitalised due to cardiovascular dis-
eases.
Materials and methods: The study was conducted during the -
months February, May, August and October 2002 in the Internal
Medicine Ward B of Ha’Emek Medical Center, Afula, Israel. Dur-
ing this period, 792 persons were hospitalised; 181 (22.9%) due to
I.Ds, and 324 (40.9%) due to cardio-vascular diseases (C.V.Ds).
The patients with I.Ds were signiﬁcantly younger (62.6 vs.
66.3 years, P < 0.0001); length of hospitalisation was longer (5.78
vs. 4.6 days, P ¼ 0.001) and mortality rate was twice higher than
of the C.V.Ds patients (7.7% vs. 2.2%, P ¼ 0.006). As expected,
respiratory tract infection was the main reason for hospitalisation
(48.6%), while 28.2% were hospitalised due to pneumonia. Urin-
ary Tract Infections were the second leading reason, 18.8%.
Regarding underlying diseases, 6.2% of the I.Ds patients had
underlying diseases vs 13.8% of the C.V.Ds patients (P ¼ 0.001).
The frequency of diabetes was similar in both groups (27.1% vs.
36.1%). 138 of 181 patients received antibiotics (76.2%); beta-lac-
tams - penicillins 42% and cephalosporins 13.8% were the most
common antibiotics prescribed, followed by quinolones (12.7%).
Conclusions: I.Ds represent one of the most frequent reasons for
hospitalisation in Internal Medicine Wards, creating a heavy bur-
den regarding beds occupancy and ﬁnancial expenses. Therefore,
intensive programs of diagnosis and treatment of infectious dis-
eases in the community should be implemented, in order to
decrease hospitalisation rates and accompanied expenses.
R2031 Complications of Brucella infection among adults: a
16-year retrospective evaluation
M. Ertek, H. Yazgi, A. Kadanali, K. Ozden, M.A. Tasyaran
Erzurum, TR
Objective: Brucellosis is a systemic infection in which any organ or
system of the body can be involved. We evaluate here complica-
tions involvement of Brucella infection in Erzurum, Turkey.
Methods: We analysed retrospectively 216 adult (89 female and
127 male) cases of brucellosis, which were diagnosed and treated
in Infectious Disease Clinic in Ataturk University Research Hospi-
Table 1.
Complications N%
Skeletal 147 (68.1)
Spondylitis 63 (27.9)
Sacroileitis 118 (56.2)
Peripheral monoarthritis 19 (8.8)
Peripheral poliarthritis 46 (21.3)
Nervous system 9 (4.2)
Cutaneous 9 (4.2)
Endocarditis 5 (2.3)
Orchitis 7 (5.5)
Thrombophlebitis 2 (0.9)
Hematologic 6 (2.8)
Thrombocytopenia 4 (1.9)
Pancytopenia 2 (0.9)
Gastrointestinal system
Hepatitis 7 (3.2)
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tal from 1985 to 2002. The diagnosis was based on clinical ﬁnd-
ings and serologic results and/or blood culture conﬁrmations.
Results: Complications in 216 patients with brucellosis are shown
in Table 1.
Conclusion: The most common complication of brucellosis was
skeletal involvement, followed by orchitis, nervous, cutaneous
and other complications. Primary health care physicians should
be alerted regarding the clinical and laboratory ﬁndings of
Brucella complications.
R2032 A retrospective analysis of the clinical and
microbiological characteristics of acute bacterial meningitis in
Crete, Greece during a 9-year period
D. Kofteridis, I. Kazakou, D. Alegakis, E. Galanakis, M. Mavridis,
G. Samonis
Heraklion, GR
Objectives: Acute bacterial meningitis is a life-threatening infec-
tion. The aim of this study was to evaluate the clinical and labor-
atory characteristics of the disease in the area of Heraklion of the
island of Crete, Greece.
Methods: Over a period of 9 years (1994–2002) 48 patients with
clinical and laboratory diagnosis of bacterial meningitis cured for
in the Department of Medicine of the University Hospital of
Heraklion, Crete were retrospectively reviewed.
Results: Twenty ﬁve men (55%) and 23 (45%) women with acute
bacterial meningitis were studied. The median age of the
patients was 25 (1–77) years. Sepsis criteria of systemic inﬂam-
matory response syndrome (SIRS) were present in 41 (85%)
patients. The most frequent clinical manifestations were fever in
40 (83%), headache in 36 (75%) and vomiting in 29 (60%). Skin
rash was present in 12 (16%) patients. Clinical signs of menin-
geal inﬂammation such as nuchal rigidity, and Brudzinsky’s and
Kerning’s signs were present in 34 (71%), 10 (21%) and eight
(17%) patients respectively. Photophobia was observed in 30
(63%) patients while changes in mental status were noted in 10
(21%). Microorganisms were isolated in the cerebrospinal ﬂuid
(CSF) cultures of 23 (48%) patients. The most common micro-
organism isolated was Streptococcus pneumoniae in nine (39%) of
23. No strains of S. pneumoniae resistant to penicillin were detec-
ted. Other responsible microorganism identiﬁed were N. menin-
gitidis in seven (30%), Listeria monocytogenes in three (13%),
Haemophilus inﬂuenzae, Klebsiella pneumoniae, Streptococcus suis,
and Brucella spp. were isolated in one patient each (4%). Antibi-
otic treatment was given in all patients on empirical basis on
admission. The regimens were proven appropriate based on
results of the CSF cultures, in all patients with identiﬁed bacteria
(48%). Forty-six of the 48 patients (96%) had a favourable out-
come. The reason of failure was delay in the initiation of the
appropriate antibiotic in one patient. The other died despite
early initiation of appropriate treatment because meningitis was
fulminant.
Conclusions: Acute bacterial meningitis remains a serious infection.
However, early diagnosis and treatment may reduce fatal out-
come and improve the severity of the disease. In the present ser-
ies the causative organisms of community-acquired meningitis
were mainly S. pneumoniae and N. meningitidis. No strains of
S. pneumoniae resistant to penicillin were detected.
R2033 Vaginal exudates. Aetiology and epidemiology
in outpatients
M.A. Orellana, M.T. Sanchez, G. Galera, M. Aramendi, L. Fraile,
I. Castro, M.A. Ame´rigo
Madrid, E
Objectives: To study the incidence of pathogens resposible of vagi-
nal infection in outpatients of the Centre Area of Madrid (Spain).
Methods: 1530 patients were studied between November 2002
and April 2003. The patients were asked about: age, nationality
and symptoms. The samples were studied by microscope and
cultured in blood agar, Sabouraud agar and chocolate-agar when
clue cells were viewed. In pregnant women with more than
20 weeks, the samples were inoculated in Todd medium for iso-
lating S. agalactiae. The identiﬁcation and sensibility were per-
formed by the MicroScan System (DADE-Behring), according to
NCCLS criteria.
Results: The patients’ ages varied from 3 to 85 years old. The
symptoms were: pregnancy 637 (41.6%), itch 392 (25.6%), ﬂow
142(9.3%), post-treatment 108 (7.1%), IUD change 50(3.3%),
pain 45 (2.9%), inﬂammation 10 (0.7%), discomfort 46 (3.0%),
sting 40 (2.6%), aontrol 57 (3.7%) and bleeding three
(0.2%). Among 1530 patients,752 (49.2%) were from Spain and
770 (50.8%) from foreign countries:603 (39.4%) South America,
68 (4.4%) Europa, 56 (3.7%) Asia, 49 (3.2%) Africa and 2
(0.1%) North America.
The positives samples were: 491 (32.1%). The microorganisms
isolated were: Candida sp. 389 (79.22%), G. vaginalis 40 (8.14%),
S. agalactiae 33 (6.72%), E. coli 19(3.86%) T. vaginalis 12 (2.44%),
H. inﬂuenzae three (0.6%), S. pyogenes 2(0.4%), S. aureus 2 (0.4%)
and other three (0.6%). The samples with two or more pathogens
were 13 (2.6%). The positives samples were isolated 238 (48.5%)
in Spanish women and 253 (51.5%) in foreign women.
The number of pregnant women was: 637 (41.6%); 266 (41.8%)
Spanish and 371 (58.2%) foreigner.
The percentage with S. agalactiae in pregnant women was: 15
(2.4%).
Conclusions: The number of foreign patients was higher than
Spanish patients. Candida sp. was the pathogen more frequent.
G. vaginalis was more frequent in South American women. The
positive samples were more frequent in foreign women. The per-
centage of S. agalactiae isolations in pregnancy was lower than
other published works.
R2034 Typical and atypical pathogens in lower respiratory
tract infections: a 2-year serological survey in a general hospital,
Perugia
A. Sensini, G. Burnelli, C. Ferranti, R. Castronari, F. Bistoni
Perugia, I
Objectives: The ‘atypical’ pathogens are important agents of lower
respiratory tract infection, causing mild to life-threatening dis-
eases. The most common atypical pathogens are Mycoplasma pneu-
moniae and Chlamydia pneumoniae. Others include Legionella ssp.,
inﬂuenza, parainﬂuenza, respiratory syncytial virus and adeno-
virus. Infection rates for these agents are difﬁcult to determine
because many clinicians do not routinely test for them. The aim of
this study was to evaluate the serological results obtained during
a 2-year survey in patients affected by lower respiratory tract
infections.
Methods: Nine hundred and sixty-eight patients were examined
from October 2001 to September 2003. Patients were classiﬁed
according to age, clinical symptoms and suspected diagnosis. Two
serum samples were collected from each patient in the acute and
convalescent periods. The following serological tests were used:
automated complement ﬁxation (CF) for detection of total Ig to
adenovirus, A and B inﬂuenza virus, parainﬂuenza virus and res-
piratory syncytial virus; CF for detection of total Ig and enzyme
immunoassay for IgM against M. pneumoniae. Speciﬁc IgG and
IgM antibodies to C. pneumoniae were determined by a micro-
immunoﬂuorescence test (MIF). Total Ig to Legionella pneumophila
was detected by indirect immunoﬂuorescence assay (IFA). An
acute infection was deﬁned by seroconversion or IgM positivity.
Results: Forty-one per cent of patients were over 60 years old.
Pneumonia was the suspected clinical diagnosis in 47.2% of
patients. The others manifested fever (12.8%), acute exacerbation
of chronic bronchitis (7.6%) and cough (4.3%). In 28.1% cases the
clinical manifestations were not related to respiratory disease or
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not reported. Acute infection by C. pneumoniae, M. pneumoniae and
inﬂuenza B virus was ascertained in 7.9, 4.0 and 0.4% of patients
with pneumonia, respectively. Acute infection by C. pneumoniae
was also demonstrated in 11.0% of patients with acute exacerba-
tion of chronic bronchitis, in 3.2% of patients with fever and in
4.8% of patients with cough. Furthermore, acute infection by
inﬂuenza B virus was observed in 5.4% of patients with acute
exacerbation of chronic bronchitis.
Conclusion: The study conﬁrms the relevance of atypical patho-
gens as aetiological agents of pneumonia and acute exacerbation
of chronic bronchitis, and underlines the need to routinely test for
them in case of lower respiratory tract infections.
R2035 Mortality risk factors in community-acquired
pneumococcal disease
L. Barahona Rondo´n, F. Soriano, J.J. Granizo, F. Santos-O’Connor,
J.C. Lo´pez, R. Ferna´ndez-Roblas
Madrid, E
Objective: To describe the risk factors associated to mortality from
invasive pneumococcal disease in a university hospital during an
11-year period.
Material and methods: We performed a retrospective review of case
histories from invasive pneumococcal disease patients attending
the emergency department of the Fundacion Jime´nez Dı´az
between January 1993 and August 2003. We registered mortality,
medical- microbiological evolution and disease relapses.
Results: A total of 263 cases of S. pneumoniae bacteraemia and
invasive disease (pneumonia, meningitis, sepsis, bacteraemia
without focus and arthritis) were assessed. The mortality was
12.5 %. In the logistical regression analysis the variables associ-
ated with mortality from bacteraemia and invasive pneumococcal
disease were the absence of leucocytosis (P ¼ 0.04), acid blood pH
(P < 0.01), respiratory symptoms or signs (chest pain, wheezing
and high respiratory rate) (P ¼ 0.02) and neurological manifesta-
tions (confusion) (P < 0.01).
Conclusion: In our hospital, patients critically ill without leucocito-
sis, but with serious respiratory or neurological manifestations
and undergoing invasive procedures such as mechanical ventila-
tion or tracheotostomy were prone to death from invasive pneu-
mococcal disease.
R2036 Treatment of Chlamydia pneumoniae infection in
asthmatic patients
D. Dokic, Z. Goseva, E. Trajkovska-Dokic, B Veljanovska
Skopje, MK
Objective: Chronic Chlamydia pneumoniae infection has been sug-
gested, as a cause for adult onset of asthma. The purpose of this
study was to determine weather anti-chlamydial treatment with
azithromycin would reduce asthma symptoms and improve lung
function in asthmatic patients.
Methods: The patients with moderate to moderately severe asthma
were included in the study. Enrolled patients were treated with
1000 mg azithromycin once weekly for 6 weeks. Post-treatment
lung function and symptom score were compared with baseline
values.
Results: Thirty patients (mean age 35.5 years), with moderate to
moderately severe asthma, with proved Chlamydia infection, detec-
ted by speciﬁc IgA 1: 40 and speciﬁc IgG 1:256 against Chlamydia
pneumoniae, received 1000 mg azithromycin once weekly for
6 weeks. Six weeks after azithromycin treatment the signiﬁcant
reduction in symptom score (P < 0.01) and signiﬁcant improve-
ment in lung function FEV1 (P < 0.01) were observed.
Conclusions: Treatment with azithromycin signiﬁcantly improved
asthma symptoms and lung function indicating that Chlamydia
pneumoniae may play an important role in enhancing the inﬂam-
matory processes in lower airways.
R2037 Survey of Legionnaires’ disease agents in treatment
devices and drinking water reservoirs in Iran
M. Moosavian, N. Khosroshahi
Ahwaz, IR
Objectives: Legionella species are ubiquitous in both, natural and
man-made water systems, which spread by the inhalation, or
aspiration of aerosolised organisms rose from water. Survey of
Legionnaires’ disease agents in treatment devices and drinking
water reservoirs in Iran, was the objective of this study.
Methods: In a 9-month study, 210 samples collected from different
water sources, such as: neonatal incubators, dental units, water
baths, cooling towers, drinking water reservoirs, hot water taps or
showers and little pools in parks, were examined. Sediment of
water samples were inoculated onto selective and nonselective
media such as : BCYE, BMPA and MWY, before and after acidic
treatment with KCl–Hcl buffer. Isolated colonies, which were sus-
pected to be Legionella, were examined by tests such as : ﬂuores-
cence of colonies under UV lights, no growing on ordinary media
(as EMB, McConkey or blood agar) and standard biochemical
tests.
Results: This study reSsulted in detection of 14 isolates (6.6%) of
Legionella, which were distinguished to nine isolates(64.3%) of
Legionella pneumophila and ﬁve isolates 35.7%) of Legionella spp.
Most of the contaminated sources were dental units (with 19%)
and the lowest of them (with 2.9 %) belonged to hot water taps
and showers. Two isolates of Legionella were identiﬁed from each
of examined sources, such as dental units, water baths and cool-
ing towers.
Conclusion: The results of this study showed that treatment equip-
ments and different water sources, as drinking water reservoirs,
were contaminated by Legionella pneumophila and so, regulatory
disinfection of these sources is necessary for prevention of aero-
sols transmission which are contaminated to Legionnaires’ disease
agents.
R2038 Flavimonas oryzihabitans peritonitis in an adult
patient on continuous ambulatory peritoneal dialysis
K. Papaefstathiou, M. Sonikian, M. Zoumberi, D. Arvanitis, D.
Vlassopoulos, G. Kouppari
Athens, GR
Objectives: To report a case of peritonitis caused by F. oryzihabitans
in a patient on continuous ambulatory peritoneal dialysis (CAPD).
Methods: Peritoneal efﬂuent specimens were examined for cells
count and after centrifugation were cultured onto appropriate
media and inoculated in brain heart infusion broth. Ten millilitres
of the samples were also inoculated in blood culture bottles (Bac-
tec Plus, Becton Dickinson Sparks, Maryland, USA). The identiﬁ-
cation of the microorganism was performed by standard methods,
colonies morphology and API ID32 system (bioMerieux). Suscepti-
bility testing was performed by disc diffusion method according
to the NCCLS performance standard.
Case report: A male patient aged 87 years on CAPD with end
stage renal failure (nephroangiosclerosis), was admitted to the
hospital because of turbidity of peritoneal efﬂuent. He started
CAPD ﬁve months ago. He was hypertensive and suffering from
coronary artery disease. This was his 3-day peritonitis episode
(previous two 30 and 45 days ago, the ﬁrst due to Klebsiella pneu-
moniae and Pseudomonas aeruginosa and the second to Staphylococ-
cus aureus CNS. For their treatment tobramycin I.P. and cefazolin
I.P. were administered, respectively. On the day of admission,
WBCs count of peritoneal ﬂuid was 300/ml (82% neutrophils)
and was increased to 1000/l (88% neutrophils) the next day. From
three peritoneal efﬂuent cultures F. oryzihabitans was isolated. The
strain was resistant to ﬁrst and second generation of cephalospo-
rines, to trimethoprime/sulfamethoxazole, to aztreonam, to ampi-
cillin and susceptible to third generation of cephalosporines, to
aminoglycosides, to amoxicillin/clavulanic acid, to ciproﬂoxacin
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and to imipenem. The patient was treated with tobramycin
20 mg  4 I.P. per day for 3 weeks and he recovered completely.
Conclusions: F. oryzihabitans is an infrequent cause of opportunistic
infections, especially in patients with the presence of a foreign
material or catheters (peritoneal, central venus). This is the ﬁrst
case report of peritonitis with this agent in a CAPD patient in
Greece and the ninth worldwide. F. oryzihabitans should be inclu-
ded in the potential pathogens that cause peritonitis in patients
on CAPD.
R2039 Peritonitis in patients on continuous ambulatory
peritoneal dialysis
C. Papaefstathiou, A. Karaitianou, D. Arvanitis, M. Zoumberi,
D. Vlassopoulos, G. Kouppari
Athens, GR
Objectives: The study of peritonitis in patients on continuous
ambulatory peritoneal dialysis (CAPD) during a 2-year period
(2002–2003).
Methods: 250 peritoneal ﬂuid specimens from 25 adults patients
on CAPD, aged 31–86 years (median 65 years) were examined
during the study period for WBC count and detection of micro-
organisms by Gram stained smears. They were cultured on appro-
priate media for aerobic and anaerobic microorganism after
centrifugation and were also inoculated in Bactec culture vials
(Becton Dickinson). The identiﬁcation of microorganisms was per-
formed by standard methods and API systems (bioMerieux). The
susceptibility testing was carried out by disc diffusion method
and the susceptibility testing of yeasts by microdilution method
and by E-test (AB biodisk, Solna, Sweden). Also in special cases
the specimens were examinated of the presence Mycobacterium
spp.
Results: Peritonitis developed 11 patients (44%) in overall 27 epi-
sodes. Peritonitis rate was one episode per 18.3 patient-month.
From the patients 3/11 had one episode, 4/11 two, 2/11 three,
1/11 four and 1/11 six. In 29.6% of the peritonitis cases were
polymicrobial. No episodes with amicrobial peritonitis were
noticed. The most frequent isolated bacteria were CNS (37%),
Streptococcus spp. (11%) and Enterococcus faecalis (7.9%). Fungi
were isolated in three patients, one of them died from this
cause. It is interest the isolation of very rarely reported microbial
species, as Streptococcus vestibularis, Alcaligenes faecalis, Corynebac-
terium jejunem, Aeromonas hydrophila, and Flavomonas oryzihabitans.
Conclusions: Peritonitis was frequent in the CAPD population
studied. The most frequent causative agents were CNS and Strep-
tococcus spp. Unusual causative agents were also isolated. The
fungus peritonitis were treated with appropriate antifungal
administration, catheter removal and replacement after 6 weeks.
R2040 Lyme neuroborreliosis, viral co-infections and
collateral conditions – a case series in a teaching hospital of
infectious diseases
D. Tatulescu, A. Radulescu, C. Jianu, M. Horvat,
L. Perju-Dumbrava
Cluj-Napoca, RO
Objectives: To present diagnostic difﬁculties and treatment hints
in neuroborreliosis.
Methods: Chronic Lyme disease was diagnosed based upon the
known criteria (duration – more than 1 year, persistent neuro-
logical involvement, active infection with Borrrelia burgdorferi)
and meeting the surveillance CDC ranking for Lyme borreliosis
highly likely of more than seven points. Between 2000 and 2003
we studied ﬁve patients (age range 22–57 years) in the Cluj-
Napoca Teaching Hospital of Infectious Diseases presenting evi-
dence of immunity to Borrelia burgdorferi: immunoﬂurescence,
IgM antibodies (ELISA) and polymerase chain reaction and
chronic neurological manifestations with no other identiﬁable
cause. Neurological involvement was clinically evaluated and
pathological ﬁndings were completed through analysis of cere-
brospinal ﬂuid, electroencephalograms, electromyographies and
magnetic resonance tomographies. A great number of other
laboratory tests were performed including evaluation of endo-
crine abnormalities, viral co-infections and autoimmune disor-
ders.
Results: The neurological manifestations were represented by leu-
coencephalitis with epileptic manifestations, encephalomyelitis
with symmetric spastic tetraplegia and in the remaining three
cases polyneuropathies with cranial nerves involvement. All cases
experienced fatigue, headache, poor stamina, myalgia, low-grade
fever and mild psychiatric disorders. In two cases active cytomeg-
alovirus infection coincident with reactivation of neuroborreliosis
was found and in another case hepatitis C virus infection with
vasculitis was detected. Endocrine abnormalities were demonstra-
ted in two cases in the presence of clinical hypothyroidism. Elec-
trolytes disorders were refractary to therapy in one case.
Treatment and retreatment with intravenous ceftriaxone 2 g/day,
3–4 weeks was performed in all cases. In one case Jarish-Herxhei-
mer reaction was observed after 3 days of treatment involving
short time relapse in neurological manifestations. Combination
therapy with macrolides and ciproﬂoxacin was considered in one
case. Orally ganciclovir was administered if primary cytomegalo-
virus coinfection was present. Improvement occurred during the
ﬁrst treatment cycle, all cases were considered cured after 2–4
treatment cycles, other therapies and rehabilitation were also per-
formed.
Conclusion: Diagnosis and treatment of late Lyme neuroborrelio-
sis are difﬁcult, antibiotic treatment greatly improves the progno-
sis.
R2041 Evaluation of brain-stem auditory potential in
brucellosis patients with and without neurobrucellosis
O. Coskun, G. Tuncer Ertem, U. Ergun, G. Kutlu, N. Tu¨lek,
L.-E. Inan, S. Ozkan
Ankara, TR
Objectives: Brucellosis may present with a wide variety of mani-
festations but involvement of the nervous system is rarely seen.
Brain-stem auditory evoked potentials are generated by the audit-
ory nerve and the brain-stem in response to a click stimulus.
Involvement of the auditory pathway within the brain-stem in
patients with brucellosis has been reported in a few studies. In
this study, we investigated the changes in brain-stem auditory
evoked potentials in patients with brucellosis.
Methods: Twenty-nine patients older than 14 years diagnosed with
brucellosis in the Department of Infectious Disease and Clinical
Microbiology of Ankara Training and Resarch Hospital were
included. The diagnosis of brucellosis was based on the following
criteria: (1). Clinical picture compatible with brucellosis and (2).
detection of speciﬁc antibodies by standard tube agglutination
testing at 1/160 titres or a fourfold or greater rise in antibody titer
in serum specimens drawn 2–3 weeks apart or (3). positive blood
or bone marrow culture. Seven of 29 patients were neurobrucello-
sis. No patient had a symptom of hearing loss. Brain-stem audit-
ory evoked potentials were evaluated in all patients before
treatment.
Results: Demographic characteristics of brucellosis patients with
and without neurobrucellosis were compared and were not found
signiﬁcant difference. Patients who had neurologic involvement
didn’t show any abnormalities in their brainstem auditory evoked
potentials recording. Only one brucellosis patient without neuro-
brucellosis showed prolonged I–III interpeak latencies but this
ﬁnding was not statistically signiﬁcant.
Conclusions: In this study, we suggest that brucellosis patients
who were in acute phase of the illness with or without neurobru-
cellosis and had no hearing problem, may have normal brain-stem
auditory potentials. The recording of brain-stem auditory evoked
potentials may not be a sensitive method for involvement of the
nervous system in brucellosis.
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R2042 Coronary artery mycotic aneurysm due to
Salmonella enteritidis presenting eith pericardial effusion:
a case report
B. Mutlu, G. Kahraman, H. Akbas, B. Muezzinoglu, D. Ural,
A. Willke
Kocaeli, TR
A 55-year-old man was hospitalised because of dyspnea and large
pericardial effusion detected on echocardiography. Salmonella ent-
erica subspecies enterica serotype enteritidis was isolated from the
culture of haemorrhagic pericardial effusion. Computed tomogra-
phy and cardiac magnetic resonance imaging detected an aneur-
ysm in right coronary artery which was subsequently conﬁrmed by
coronary angiography. Despite appropriate antibiotic treatment
and emergency surgical intervention, the patient died due to rup-
ture of the aneurysm. Pathological examination revealed mycotic
coronary artery aneurysm and acute inﬂammatory involvement of
pericardium. In this case mycotic coronary artery aneurysm due to
Salmonella infection occured in the absence of infective endocarditis
and a deﬁnite reason for bacteraemia. However, this is the second
case of pericarditis caused by S. enteriditis in Turkey.
R2043 Eleven years of bacteraemia caused by Brucella spp.
in a Madrid hospital
S.M. Quevedo-Soriano, M. D. Martı´n, G. Sesen˜a,
R. Jime´nez, Y. Gil, M. Pa´ez, A.C. Velasco, I. Wilhelmi
Legane´s, E
Objectives: Description of the epidemiology and clinical character-
istics of Brucella spp. bacteraemia detected in a 450 bed commu-
nity-based Hospital during eleven years (1990–2001).
Methods: Retrospective study on the clinical records of patients
with Brucella spp. bacteraemia. For isolation of Brucella in blood
cultures Bactec 660 was used from year 1990 up to the end of
1994 and therefore was changed to Bactec 9240 allowing a reduc-
tion of the isolation time.
Results: During the 11-year period included in the study, 41
strains were isolated (0.9% of all relevant bacteraemias). At the
moment of obtaining blood cultures, 37% of patients with Brucella
bacteraemia were outpatients and 63% were admitted in hospital.
The median age of patients was 36 years (range 6–90) and 62%
were male. Nineteen patients (46%) consulted for fever and mal-
aise, 34% had fever and arthralgia without patent arthritis, 8%
had orchiepididymitis, 8% showed arthritis, and 5% had a previ-
ous diagnosis of brucellosis. An epidemiology background com-
patible with brucellosis (raw milk or cheese compsumtion, or
laboral exposure) was found in 81% of the cases. In 54% of the
cases, paired acute and convalescence sera were tested (Rose Ben-
gal and COOMBS tests); in 31% only one sample of the acute
stage could be tested: in 8% of the patients no serologic tests were
made. Concomitant clinical and serologic relapse was found in
8% of cases. A 15% of patients gave up the treatment prema-
turely. Sacroileitis was the most frequent complication (observed
in 19% of our patients).
Conclusion: Bacteraemia caused by Brucella spp. is still relativelly
frequent in our environment, and should be still suspected in young
adults with fever, malaise, arthralgia, and/or orchiepididymitis.
Serological tests are a useful tool for the follow up of patients.
R2044 3-Day azithromycin course with and without
ambroxol: clinical comparative trial of efﬁcacy and safety in the
treatment of community-acquired pneumonia in adults
O. Dzyublyk, S. Simonov
Kiev, UKR
Objective: To assess the clinical efﬁcacy and tolerability azithromy-
cin treatment with and without of mucolytic agent – ambroxol in
the adult patients with CAP.
Methods: The patients with uncomplicated CAP, hospitalised in
the Main military hospital of the ministry of defense, Kiev,
Ukraine, form January to April 2003, were included in open
randomised study. Diagnosis of CAP was established according
to clinical data (fever, cough, general symptoms) and chest radi-
ography demonstrating the presence of a new inﬁltrate. The
patients were randomly assigned to treatment with azithromycin
(SumamedR PLIVA. Croatia) administered orally 500 mg once
daily for 3 days (group I) or equal dosage of azithromycin in
combination with ambroxol (LasolvanR Boehringer Ingelheim.
Germany) 30 mg three times/day for 14 days (group II). Cure
was deﬁned as resolution of fever within 96 h after initiation of
treatment with disappearance of other signs and symptoms of
pneumonia, and inﬁltrate regression within 2 weeks. Treatment
efﬁcacy was also evaluated by duration of fever after treatment
initiation.
Results: Thirty-one male adult patients were enrolled in the
study. Among them 15 patients were randomly assigned to
treatment with azithromycin alone (group I) and 16 patients
(group II) in combination with amoroso. Two treatment groups
were demographically well matched. At the end of therapy
clinical success was achieved in 14/15 patients (93%) in the
group I and in 14/16 of patients (88%) in the group II. The
results showed almost equal efﬁcacy in both treatment groups
(P > 0.05). The resolution of the signs and symptoms of pneu-
monia was similar in both groups. Both treatment regimens
were well tolerated.
Conclusion: Azithromycin was effective and well tolerated in all
patients with CAP. No statistical difference was found in clinical
efﬁcacy of the azithromycin treatment if it used alone or with
mucolytic agent.
R2045 Speciﬁc antibodies IgG-IgM for cytomegalovirus
detection in women of reproductive age between the second
semester of 2000 and ﬁrst semester of 2003
E. Daskalaki, X. Papachatzaki, Z. Loulakis, M. Tsakiri,
M. Chatzinikolaou, V. Koumpanis, V. Statiropoulou, V. Liakou
Heraklion, GR
Objective: Measurement of speciﬁc antibodies IgG–IgM for the
detection of CMV virus is useful in the diagnosis of early CMV
infection. In this study we present our experience resulting from
testing, in IgM-positive individuals in early diagnosis.
Materials and methods: During the 2000–2003 period 2293 women
were tested. Prenatal screening was performed on those women
during their pregnancy. CMV detection was made using ELISA-
Cobas Core method (Roche Diagnostics). In addition, the con-
ﬁrmation of all positive samples was performed using ELISA
(Biomerieux) on Vidas and Avidity test (Biomerieux).
Results: The following data represent our ﬁndings:
IgG()–IgM(): 420 (18.31%) IgG(+)–IgM():1839 (80.2%) IgG(+)–
IgM(+):24(1.04%) IgG()–IgM(+):10 (0.44%).
Conclusions: The present results show that 80.2% of the female
population that was under study had been infected from the
CMV virus. Much lower was the percentage (1.48%) of those
cases that have recently been infected, while for the percentage
of those women that have not been infected at all, a retesting
is recommended throughout their pregnancy. Depending on the
case, and after CMV virus diagnosis, the patient will be
advised with special information in order to deal properly with
the disease. Therefore, the early diagnosis of the infection is of
great importance for the pregnant. Concerning the prenatal
screening, it seems that its signiﬁcance is based on the preven-
tion and avoidance of unwanted dangers just in case of preg-
nancy.
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R2046 Serological testing for rubella on women in
reproductive age between 2000 (2nd semester) – 2003 (1st
semester)
X. Papachatzaki, M. Tsakiri, Z. Loulakis, E. Daskalaki,
V. Statiropoulou, V. Koumpanis, M. Chatzinikolaou, V. Liakou
Heraklion, GR
Objective: Evaluation of immunity against rubella on women in
reproductive age in terms of prenatal screening and during preg-
nancy.
Materials and methods: Between 2000 and 2003, 2135 women were
tested in the hospital’s microbiology laboratory. The prenatal sero-
logical screening included the IgG and IgM antibody testing for
rubella. The diagnostic test was performed using ELISA method
on Cobas Core (Roche Diagnostics).The conﬁrmation of the posit-
ive samples was performed using ELISA method on Vidas and
also Avidity test (Biomerieux).
Results: From a total of 2135 women tested the outcome was:
IgG()IgM(): 305 (14.28%) IgG(+)IgM():1816 (85.06%) IgG(+)
IgM(+):14 (0.66%) IgG()IgM(+):0 (0%).
Conclusions: It is obvious from the above percentages that there is
a number of seronegative women which strongly suggests the
prenatal screening of all women in reproductive age in order to
avoid the unwanted consequences of a ﬁrst infection during preg-
nancy. It would be better for women to be tested for rubella anti-
bodies before pregnancy.
R2047 Moxiﬂoxacin therapy in high-risk patients with
community-acquired lower respiratory tract infections or
sinusitis
G.A. Popescu, C. Popescu, E. Benea
Bucharest, RO
Objectives: Oral therapy with moxiﬂoxacin is indicated for mild/
medium severe community-acquired pneumonia (CAP) and sinus-
itis. However, the biodisponibility is more than 90% and we eval-
uated the efﬁcacy of oral therapy in patients with risk for severe
respiratory/ENT infections.
Methods: Retrospective analysis of patients admitted in ‘Matei
Bals’ Institute how received moxiﬂoxacin between November 2002
– October 2003 for CAP, COPD exacerbation and sinusitis. We
divided the patient in two groups: healthy immunocompetent
adults (group A) and patients with comorbidities: COPD, conges-
tive heart failure, diabetes, HIV (group B).
Results: 30 patients were included in group A and 31 in group B.
Clinical success rate was similar in both groups: 93.33 and
93.54%; the failures were caused by misleading diagnosis of
tuberculosis (group A), respectively recurrence of infection (group
B). The type of infection and the regimen rank (ﬁrst regimen or
after failure) were similar in both groups; no differences were
noted regarding mean duration of fever in cases with favorable
response: 1.44 days (group A) and 1.72 days (group B), and for
mean duration of therapy in sinusitis. The only difference was in
mean duration of CAP therapy; it was longer in group B: 9.1 days
than in group A 6.6 days. The side effects were registered in
14.5% of patients, lesser in group B.
Conclusion: Moxiﬂoxacin administered in oral therapy is a valu-
able alternative for patients with respiratory tract/sinusitis, even
in high-risk groups; the fast induction of apyrexia remains an
important advantage of moxiﬂoxacin.
R2048 Bacterial brain abscess: risk factors for
unfavourable outcome
C. Popescu, G.A. Popescu, E. Benea
Bucharest, RO
Objectives: Despite the improvement of brain abscess manage-
ment, the mortality rate is still high: 5–20%. The descriptions of
involved factors are controversial.
Methods: ‘Matei Bals’ Infectious Diseases Institute database were
utilised to identify all patients who had diagnosis of brain abscess
during December 2001 to November 2003 period. We excluded
the cases with deﬁnite or possible parasitosis (toxoplasmosis,
cryptococcosis or cysticercosis). Subsequently, we evaluated the
parameters correlated with mortality.
Results: Ten patients (six females, four males) fulﬁlled the criteria.
The mean age was 19.3 years, with 8/10 patients less than
30 years old. In a half of cases the aetiology was identiﬁed, and in
6/10 patients an ENT infection was the primary source of germs.
The mean diagnosis delay was 10.5 days for ENT-related BA and
28.75 days for other cases (P ¼ 0.02). Nine of 10 patients associ-
ated a meningitis and six of 10 fulﬁlled the criteria for sepsis.
Three patients died: two in the ﬁrst week of hospitalisation, and
one after 25 days with no initial improvement. Neither age, clin-
ical manifestations, initial adecvate antimicrobial regimen nor
abscess dimensions were related to unfavorable outcome. All the
ENT-related BA patients survived and only one from other four
patients (P ¼ 0.03); all patients with only one abscess survieved
vs. 2/5 with multiple abscesses (P ¼ 0.09).
Conclusion: We identiﬁed two patterns in BA: the ENT-related are
faster diagnosticated and the survival seems to be better. Multiple
abscesses tend to be associated to a higher mortality.
R2049 Incidence of acute Q fever in patients with
community-acquired pneumonia
M. Vasileva Duganovska, I. Kondova, A Anastasovska,
S. Petrusevska
Skopje, MK
Objective: To determinate incidence of the acute Q fever in hospi-
talised adult patients with low respitratory tract infection.
Methods: A total of 72 hospitalised patients with CAP within
1 year period (2002/2003) were included in our study. The mean
age was 45 years (range: 18–74), distributed by gender: 47 (65%)
male and 25 (35%) female. Diagnosis of Q fever was established
in a group of 10 patients by serological conﬁrmation by detection
of IgM, IgG or total antibody against Coxiella burnetti phase II Ag.
with Pneumoslide M (Vircell) IF test and/or Coxiella burnetti IgM,
IgG (Vircell) ELISA test.
Results: Acute Q infection as a cause of CAP in 72 hospitalised
patient was in 10 (13.9%) patients. The patients with acute Q
infection were with mean age 45 and distributed by gender: males
six (60%), females four (40%). There was no signiﬁcant discrep-
ancy, from urban or rural distribution of these patients. In 1 of 10
patients with Q fever, coinfection with Streptoccocus pneumoniae
was detected. Dominant clinical manifestation was febrile syn-
drome with acute onset. Altered liver function was noted in eight
patients (80%), in two of them transferases were ﬁve times higher
than the upper limit. Chest radiographic abnormalities were
alveolar, lobar or segment inﬁltration in four (40%) cases, diffuse
interstitial inﬁltrate in three (30%) cases, alveointestitial in the
remaining ones.
Conclusions: Acute Q fever takes signiﬁcant place among low
respiratory infection. Evidence of high incidence of Q fever has
created a ground for prospective study comprising several years
period, which will help us to determine prevalence and epide-
miological model in this region. The possibility of chronicity,
points the necessity of adequate diagnosis and successful treat-
ment.
R2050 Q fever: retrospective analysis of 25 patients (1985–
2003)
A. Grilo, N. Ascencio, S. Peres, J. Machado, F. Maltez
Lisbon, P
Objectives: Epidemiological, clinical, laboratorial and therapeutics
characterisation of Q fever clinical cases admitted to our Infectious
Diseases’ Department from 1985 to 2003.
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Methods: Clinical ﬁles’ review of male subjects admitted to our
Department with the diagnosis of Q fever, with positive Coxiella
burnetti serologies (complemment ﬁxation).
Results: Twenty-ﬁve clinical cases were reviewed, all caucasian,
median-age of 37.6 years old (16–85 years). The main clinical fea-
tures detected were fever (100% of cases), headache (80%) and
myalgia (56%). Cough was present in 28% of cases and sputum
in 24%. Gastrointestinal symptoms were detected in 16% of clin-
ical cases. A diagnosis of atypical pneumonia was established in
28% of patients. In three cases (12%), a clinical evolution compat-
ible with Chronic Q fever was seen (two cases with chronic hepa-
titis and one with endocarditis). Epidemiological query disclosed
50% of cases with exposure to sheep and goats. The laboratory
study revealed leucocytosis in 16% of cases, leucopenia and
thrombocytopenia, both in 20% of cases; in 76% of patients, an
two- to threefold elevation of liver enzymes. No renal failure was
detected. Monotherapy with doxycycline was used in 32% of
patients, 12% was treated with an association of doxycycline and
rifampicin, cloranphenicol and cotrimoxazol were used, each, in
8% of the patients. A favourable clinical evolution was seen in
the majority of cases. The patients in whom Chronic Q fever
was diagnosed were managed with doxycicline, rifampicine and
ciproﬂoxacin.
Conclusion: A positive relationship of animal exposure and Q
fever was established. In most of our patients Q fever presented
as an auto-limited disease. Mild hepatitis was diagnosed in 76%
of patients and atypical pneumonia in 28%. Three patients had a
chronic evolution – 2 as a chronic hepatitis and 1 with endocardi-
tis. Doxycicline was the main treatment option chosen, according
to literature.
Nosocomial infections
R2051 Brucellosis complicating arthroplasty: two case
reports
B. Polop Borras, F. Rodrı´guez Alema´n, L. Ferna´ndez Rodrı´guez
Motril, E
Infection after arthroplasty is a serious complication associated
with a high incidence of morbidity. Infection of prosthesis with
Brucella is extremely rare.
Objectives: Presentation of two cases of brucellar infections com-
plicating arthroplasty.
Methods: Case 1 – Men of 45 years of age with total hip arthropl-
asty by Perthes’ illness in infancy, that presented a prosthetic
slackening. In the culture of intraoperative exudate of replacement
grew Brucella melitensis. Case 2 – Men of 69 years of age with
total knee arthroplasty by gonarthrosis. Five months later, the
patient developed a ﬁstule with chocolate exudate where we iso-
lated Brucella melitensis.
Results: After 2–3 days, nonhaemolytic colonies of oxidase-posit-
ive, Gram-negative coccobacilli and obligate aerobes were identi-
ﬁed as Brucella melitensis for agglutination with Brucella
antiserum. Both patient specimens were cultured in solid media
(Columbia blood agar and chocolate agar) and enrichment
broth. Their agglutination Brucella titres were 1/80 and 1/40 and
Coombs test were 1/10 240 and 1/20 480, respectively.
Conclusions: Countries where brucellosis is still endemic it is
recommended to evaluate all patients before arthroplasty. Screen-
ing for brucellosis should also be included if the patient has pain
in their replaced joints at the follow-up examination.
R2052 The methods of postsurgical wound infection
prophylaxis in patients with acute appendicitis
N. Sivets, A. Adarchenko
Minsk, BLR
Introduction: Surgical intervention for acute appendicitis takes one
of the leading positions in the structure of urgent pathology in
surgical department of common proﬁle. Septic and purulent
infections (SPI) developing after surgical interventions for acute
appendicitis complicate the main disease, prolong the term of
treatment and cause signiﬁcant economic loss.
Materials and methods: The retrospective analysis of 1425 acute
appendicitis cases (catharal – 309; destructive – 1126) surgically
treated in third Minsk clinic during 1992–2002 was performed.
Treatment of these patients included complex methods of wound
purulent-septic complications prophylaxis based on protection of
wound edges by antibacterial surgical serviettes (52 patients);
decontamination of wound by CO2 laser irradiation or by
mechanical stream washing with isotonic solution (89 patients).
Two components (rational empiric antibiotic therapy + stream
washing with isotonic solution, 351 patients) and three component
(rational empiric antibiotic therapy + protection of wound
edges + stream washing of wound, 64 patients) prophylactic
methods were also analysed. 869 conventionally treated patients
formed a control group. Groups analysed were comparable for
appendicitis form, surgical intervention, age and sexual structure.
Results and discussion: The research conducted allowed to decrease
the rate of septic-purulent complications and to improve the out-
come of treatment of patients with acute appendicitis. Application
of isolating serviettes decreased the rate of septic-purulent compli-
cations (3.84 + 2.65) compared with control group (10.13 + 1.02%),
P < 0.05. Stream washing of wound with isotonic solution
reduced complications insigniﬁcantly (6.74 + 2 65%), P > 0.05.
Two and three component complex methods decreased the com-
plications rate to 5.69 + 1.26% and 3.12 + 2.18, respectively
(P < 0.01). The microbiological monitoring of aetiological struc-
ture of postsurgical septic-purulent infection-causative agents and
determination of their resistance to 26 antibiotics and eight anti-
septics were also conducted. The main pathogens were enterobac-
teria, nonfermenting Gram-negative bacteria especially P.
aeruginosa and E. faecium and S. epidermidis.
Conclusion: The worked out complex of measures for wound sep-
tic-purulent infection prophylaxis in acute appendicitis ensures
the decrease of complication rate (to 3.12 + 2.18%) and severity
and reduces the term of treatment.
R2053 Prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) as nosocomial pathogen in a clinical centre,
Serbia
B. Jovanovic, N. Mazic, V. Mioljevic, J. Obrenovic, S. Jovanovic
Belgrade, CS
Objective: Methicillin-resistant Staphylococcus aureus (MRSA) is one
of the most important nosocomial agents. The spread of methicil-
lin-resistant staphylococci has become an alarming problem
throughout the world. The object of this study was to determine
the frequency of MRSA, as a nosocomial agent, in different hospi-
tals of the Clinical Center Serbia.
Methods: All clinical strains of S. aureus, isolated from June 1, 2001
to April 30, 2002, in patients hospitalised in ﬁve different hospi-
tals of the Clinical Center Serbia, were included in the study.
Antimicrobial susceptibility testing was performed by agar dilu-
tion method. The susceptibility testing and interpretation of the
results were carried out according to the Torlak (Institute for
Immunology and Virology) guidelines.
Results: A total of 389 SA strains in hospitalised patients, isolated
from skin and soft tissue, respiratory samples, body ﬂuids, urine
and blood, obtained from June 1, 2001 to April 30, 2002, was tested.
363 (93.3%) MRSA and 26 (6.7%) MSSA were found. The preval-
ence of MRSA did not vary signiﬁcantly between different hospi-
tals. The highest rates of resistance to methicillin were found in the
Urgent Surgery (98%), the institutes for urology (94.4%), abdom-
inal (93.6%), cardiovascular surgery (93.3%) and nephrology
(85.1%). Most of these methicillin-resistant isolates were susceptible
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only to vancogal. In the Urgent Surgery, almost all isolates were
found in patients who were treated in the intensive Care Unit.
Conclusion: Our study indicated that the rate of MRSA as a no-
socomial agent was high and that the rate of resistance to other
antibiotics was on the increase, which might be a serious problem
for the treatment of hospitalised patients. Good infection control
measures for reduction of the incidence of MRSA transmission is
indicated.
R2054 Recurrent necrotising fasciitis caused by
methicillin-resistant Staphylococcus aureus
C.-H. Wong, S.-H. Tan, A. Kurup
Singapore, SGP
Objective: Colonisation with methicillin-resistant Staphylococcus
aureus (MRSA) with subsequent recurrent soft-tissue infection is
well documented. Recurrent necrotising fasciitis due to MRSA
however has not been previously noted.
Methods: A 57-year-old female, with signiﬁcant co-morbidities of
diabetes and long-term steroid ingestion, was admitted for right
thigh necrotising fasciitis. She was successfully treated and was
discharged after an appropriate course of antibiotics. Tissue cul-
ture isolated MRSA. Nasal swabs taken were negative for MRSA
carriage. Three months later, she was readmitted for left hand
necrotising fasciitis. Tissue and blood cultures again isolated
MRSA. She was successfully treated with early aggressive opera-
tive de´bridement. Again nasal swabs were negative for MRSA
and abdominal CT and heart echocardiography were negative for
occult sites of infection.
Results: The recurrence of necrotising fasciitis caused by the same
bacteria has not been previously documented. The MRSA isolated
had identical antibiogram. However, genomic ﬁngerprinting was
not performed for the MRSA isolates as the specimen from the
ﬁrst admission were unavailable for analysis. The identical antibi-
otic susceptibility pattern and close temporal relationship between
the two episodes of necrotising fasciitis suggested that these infec-
tions were caused by the same MRSA bacterial strain. While the
nasal swabs were negative on both admissions, other potential
sites of colonisation and carriage such as axilla and the groin were
not routinely investigated.
Conclusion: Recurrent MRSA necrotising fasciitis should be act-
ively excluded in patients with previous episode of fasciitis.
Patients who developed MRSA necrotising fasciitis may imply an
underlying susceptibility and possibly colonisation with virulent
strains of MRSA. Recurrent soft-tissue infections in a patient with
previous MRSA necrotising fasciitis should be treated with a high
index of suspicion. We report a ﬁrst case of recurrent necrotising
fasciitis, possibly due to the same bacterial strain carried by the
patient and highlight the danger the recurrence in susceptible
patients.
R2055 Nosocomial infections in a medical faculty hospital:
results, 2002
M. Ertek, A. Kadanali, H. Yazgi, U¨. Altoparlak, M.A. Tasyaran
Erzurum, TR
Objective: The aim of the study was to determine the prevalence
of nosocomial infections among patients in our hospital; the most
frequently reported infections, causative agents and their anti-
microbial susceptibility.
Method: The study was performed prospectively on 34 404
patients, hospitalised at Atatu¨rk University Hospitals. An infec-
tion disease specialist and infection control nurse analysed the
patients by active surveillance method based on laboratory and
patient data. The diagnosis of nosocomial infections was estab-
lished according to the ‘Centers for Disease Control and Preven-
tion (CDC)’ criteria.
Results: The rate of nosocomial infections was detected to be 4%
in Atatu¨rk University Hospitals. Catheter infections were detected
as the most common infection with 38.9% ratio followed by urin-
ary tract infections with 24.6% ratio and surgical site infections
with 19.8%. The highest infection rates were detected in intensive
care unit (34.1%) and burn unit (29.3%). The most frequently iso-
lated micro-organisms were Staphylococcus aureus, Escherichia coli,
CNS and Pseudomonas aeruginosa.
Conclusion: The study of prevalence pointed out the importance of
epidemiological surveillance in hospital infections.
R2056 Surveillance of nosocomial infections and antibiotic
consumption in a Latvian university hospital
U. Dumpis E. Kockina, D. Malina, K. Geldnere, I. Geldners,
A. Balode, A.Martinsons
Riga, LV
Stradins University Hospital with 967 beds is the largest teach-
ing hospital in Latvia. Traditionally, infectious diseases special-
ists in Latvia are employed only in specialised infectious
diseases hospitals and wards. Because of the mounting problem
of antimicrobial resistance and nosocomial infection a qualiﬁed
infectious diseases specialist and infection control nurse (ﬁrst in
the country) were employed in 2000 and 2002 respectively to
improve treatment, surveillance and education activities. Three
prevalence surveys on antibiotic consumption and nosocomial
infection were performed in May 2001, 2002 and 2003. Stand-
ardised point prevalence methodology was used. Prevalence of
NI was found to be 4.3% in 2001, 3.7% in 2002 and 3.3% in
2003. Prevalence of antibiotic use was 29% in 2001, 24% in
2002 and 25.9% in 2003. Four most commonly used antibiotics
in 2001 were cefazolin 48%, gentamicin18%, ampicillin/amoxi-
cillin 13%,and metronidazole 11.2%. In 2002: cefazolin 28%,
ampicillin/amoxicillin 13%, metronidazole 12%, and gentamicin
8%. In 2003: cefazolin 26.4%, ciproﬂoxacin 17.2%, ampicillin/
amoxicillin 11.9%, and metronidazole 10.9%. A prospective
study was conducted in the multidisciplinary ICU during a 2-year
period (May 2001–May 2003) to determine the incidence and main
characteristics of ventilator-associated pneumonia (VAP). Inter-
nationally accepted diagnostic criteria were used. Among 512
mechanically ventilated patients 37 (7.2%) developed VAP. The
estimated incidence of VAP was 13.6 per 1000 ventilator days. Inci-
dence was notably higher in summer months. Seventy per cent of
patients were males. The crude mortality in patients with VAP
was 29.7%. In half of the patients BAL isolated more than one
pathogen. Pseudomonas aeruginosa was isolated from 19 (51%), Aci-
netobacter baumanii in 11 (30%) Klebsiella pneumoniae in 13 (23%)
and Staphylococcus aureus in four (11%) patients. Nosocomial
urinary tract infections in urology ward were surveyed in the year
2002 using CDC deﬁnitions. The incidence of NUI was 7.7/1000
catheter days. Prevalent micro-organisms were Pseudomonas aerugi-
nosa (47%) and Klebsiella pneumoniae (11%).
Conclusion: Introduction of infectious diseases specialist and infec-
tion control nurse in the multidisciplinary hospital was associated
with decrease in prevalence of nosocomial infections and changes
in antibiotic prescription. In addition, surveillance activities were
started.
R2057 Clinical and epidemiological characteristics of ﬁrst
cases of MRSA infection in a Latvian university hospital
E. Kockina, E. Miklasevics, A. Balode, U. Dumpis
Riga, LV
Methicillin-resistant S. aureus (MRSA) is internationally well-
known pathogen, which can cause severe nosocomial infections.
There is no countrywide surveillance system for this pathogen in
Latvia. Stradins University Hospital in the largest teaching hos-
pital in Latvia and referral centre for cardio-thoracic and neuro-
surgery, transplantation and other highly speciﬁc manipulations.
First conﬁrmed case of MRSA was registered at the ICU in March,
2003. Patient was transferred from other hospital to perform hae-
moﬁltration. Since the vigorous surveillance and prevention strat-
egies were introduced in the hospital. Molecular epidemiological
methods are being used to characterise the outbreaks. In a per-
iod from 01.03.03 to 15.12.03, 38 patients had isolated MRSA.
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Mean age of the patients was 52 years and 78% of patients were
male. Eight patients did not have signs of infection and were
identiﬁed as carriers during the screening activities. The largest
number of MRSA cases (19) was identiﬁed in ICU (including ﬁve
colonised) due to outbreaks in July, 2003 (eight patients) and
November, 2003 (nine patients). These outbreaks are conﬁrmed by
molecular epidemiological methods. Mortality in ICU infected
patients was 64% (nine of 14). None of the ﬁve colonised patients
died. Other MRSA cases were identiﬁed in abdominal surgery
(8), neurosurgery (4 + 1 carrier), cardiology (2), nephrology (1),
pulmonary diseases (1), cardio thoracic surgery (2) and gastroen-
terology (1). Ten (50%) patients have apparently acquired the
infection in other hospitals because their cultures on admission
were positive. Mortality in these patients was 20% (4/20).
Patients with MRSA infection had following risk factors: previous
antibiotic use 92% (36/39), surgical intervention 72% (28/39), cen-
tral venous catheter 62% (24/39), urine catheter 74% (29/39),
mechanical ventilation 56% (22/39), and known diabetes 15%
(6/39).
Conclusion: MRSA infection has become endemic in Latvia since
many patients were admitted from other hospitals. Two local ICU
outbreaks with secondary cases were registered and conﬁrmed by
molecular epidemiological methods. MRSA infection in ICU is
associated with high mortality. Previous antibiotic use was the
most common risk factor for MRSA infection or colonisation.
R2058 Levoﬂoxacin in the treatment of nosocomial
pulmonary complications after lung resection for cancer
C. Lequaglie, P.P. Brega Massone, G. Giudice
Basiglio, I
A 2-year multicentre study is reported on 38 complicated
patients with tested lung infection and resected pulmonary for
cancer after antibiotic prophylaxis with cephalosporin. Twenty-
seven cases had chronic bronchopulmonary disease and bron-
chial asthma in four. Thirty-two lobectomies and six pneumonec-
tomies were performed. The microbiological diagnosis of
infection was achieved in the majority of the cases by bronchoal-
veolar lavage. The isolated pathogens were Haemophilus inﬂuenzae
(15), Streptococcus pneumoniae (11), Moraxella catarrhalis (3), Myco-
plasma pneumoniae (7), Chlamydia pneumoniae (1) and Legionella
pneumophila (1). A quinolone, Levoﬂoxacin, was administered at
the dosage of 500 mg i.v. twice day for 10 days. Cough was the
most frequent observed symptom (35/38 cases) between the
third and the 10th day of therapy; thoracic pain was present in
32/38 cases between the third and the 10th day; dyspnoea was
in 29/38 cases between the second and the 10th day. At the
basal visit, fever values ranged between 39.5 and 37.8C, on day
4 between 39.1 to 37.5C, and at the end of treatment between
37.5 and 36.5C. The basal sputum was positive in eight cases,
and on fourth day of therapy; at the end of treatment, any pres-
ence of pathogens was detected in the sputum. In the other 30
patients, the isolation of pathogens was performed during the
basal visit by bronchoalveolar lavage. On day 4, the tests were
still positive, while at the end of treatment only in two cases a
pathogen was isolated, but with reduction of the bacterial count.
All the isolated pathogens were in vitro susceptible to levoﬂoxa-
cin. A clinical success was observed in 36/38 cases, with only
cough in two cases. The eradication of the pathogen was
obtained in 34 patients, and presumed in two ones. The other
two cases reported one partial eradication and one colonisa-
tion. Remarkable adverse effects did not occur after administra-
tion of levoﬂoxacin: ﬁve diarrhoea for 5 days, three reported
headache for 2 days (with nausea in one) and one asthenia for
6 days. In conclusion, on the microbiological ﬁndings, on the
good clinical efﬁcacy of the drug in the acute exacerbations of
the pulmonary infections, on the low resistance rate of causative
pathogens to new quinolones and on the high penetration into
respiratory tissues, levoﬂoxacin allowed not only to reach the
microbiological eradication, but also a clean resolution of the
symptoms with a reduction of the postoperative hospitalisation
period and a saving of the related costs.
R2059 Bacteraemia caused by Rahnella aquatilis
I. Tuncer, U. Arslan, O. Ural
Konya, TR
A 70-year old women was hospitalised for coronary angiography.
In her history there were coronary artery disease, cerebrovascular
attack and coronary by-pass surgery 5 years ago. On the fourth
day after hospitalisation her fever increased and after taking
blood cultures therapy started with 6 g/day ampicillin. Despite
antibiotic therapy the fever did not decrease and the patient was
transferred to the infectious diseases department. From separate
two blood cultures Rahnella aquatilis was isolated. According to
antibiotic sensitivity tests, levoﬂoxacin 500 mg/day was added to
the therapy. On the second day of the combination therapy the
fever decreased. Control blood cultures were negative and the
patient was discharged on the 14th day. In this article a bacterae-
mia case caused by Rahnella aquatilis is presented and the litera-
ture is reviewed.
R2060 Stenotrophomonas maltophilia infection in cancer
patients
E. Chinou, M. Georgouli, H. Skouteli, O. Apostolakopoulos,
N. Trombouki,P. Golemati
Athens, GR
Objectives: Frequent use of empiric broad-spectrum antibiotic ther-
apy in cancer patients might result in the selection of some resist-
ant organisms. The aim of this study was to compare two periods
of survey for frequency of infection and the antimicrobial suscep-
tibility of Stenotrophomonas maltophilia isolate from cancer patients.
Methods: A total of nine episodes of S. maltophilia infections in
immunocompromised-cancer patients were detected in 2001 and
six episodes in 1991. Strains from blood cultures were isolated
through the semi-automated system Bact-Alert and identiﬁed with
Api20 NE. Kirby–Bauer method was used for the examination of
the susceptibility pattern.
Results: From the surveillance data there was no increasing occur-
rence of S. maltophilia infections found. Five of the isolated strains
were derived from blood, ﬁve from urine, two from sputum, two
from pus and one from cerebrospinal ﬂuid. Regarding the antibi-
otic susceptibility 70% of the strains were susceptible to cotrimox-
azol, 85% were susceptible to ceftazidime, and 85% were
susceptible to ciproﬂoxacin while 60% were resistant to carbapen-
ems, imipenem and meropenem. Mortality rate due to infection
was signiﬁcantly high in the S. maltophilia bacteraemia.
Conclusions: The frequency of S. maltophilia infection in cancer
patients was not changed during the last decade. Antimicrobial
susceptibility was variable with no single antimicrobial agent
inhibiting more than 85% of isolates. Some isolates were multi-
drug resistant and might require high-dose combination therapy.
R2061 The incidence of nosocomial infections, a parameter
for the comparison of surgical departments?
B. Tiodorovic, M. Visnjic
Nis, CS
Objective: To determine the applicability of registered nosocomial
infections as parameter for comparison of surgical departments.
Method and population: Between July 1, 2001 and 2002 postopera-
tive complications occurring in patients admitted to the surgical
department of a district hospital were registered. The nosocomial
infections were determined according to the CDC standards. A
total of 142 patients were admitted 153 times to the surgical
wards.
Results: Postoperative course was complicated in 18 patients
(12.12% of admission). Airway and wound infections were the
most frequently registered complications (in 3.7 and 3.5% of
the admissions respectively), 42% of the wound infections were
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recorded after discharge. 88% fully recovered by conservative
means. Two patients with airway infections died (1.4%).
Conclusions: The contribution of wound infections to overall post-
operative morbidity and the severity of these infections are low
and vary with the reason of admission. The morbidity and the
severity of airway infections are more serious.
R2062 Bacterial contamination and drug resistance in
isolated bacteria from intensive care units (ICU and NICU) in
Hamadan hospitals, West Iran
R. Youseﬁ Mashouf, F. Zareei, H.S. Naeini
Hamadan, IR
Objectives: Many reports from all over the world indicate that
multi-drug resistance in nosocomial organisms are increasing.
Bacterial contamination in intensive care units, surgery and burn-
ing rooms is also one of the major problems in hospitals. The aims
of this study were determination of bacterial contamination and
antibacterial drug resistance in isolated bacteria from intensive
care units (ICU and NICU) in Hamadan hospitals (Mobasher
Kashani and Fatemie).
Methods: In this study, 682 samples were randomly collected from
different areas including devices and apparatus, physical surfaces
and staff uniforms. The samples were inoculated in EMB and
blood agar by wet swabs and transferred to medical laboratory
for identiﬁcation and antibiogram of strains. A total of 140 cases
were selected and cultured on Muller–Hinton agar for antibio-
gram tests (Kirby–Bauer method). The antibiotics disks consisted
of: erythromycin, vancomycin, ciproﬂoxacin, carbenicillin, penicil-
lin G, tetracycline, chloramphenicol, ampicillin, gentamycin and
ceftriaxone.
Results: The ICU of Mobasher Kashani hospital showed more bac-
terial contamination (57.4%) rather than the NICU of Fatemie hos-
pital (48.3%). The most bacteria isolated from two hospitals were
as follow: micrococci, Staphylococcus epidemidis, Staphylococcus aure-
us, Pseudomonas aeroginosa, E.coli, Klebsiella, Enterobacter, Proteus,
Acinetobacter and Streptococcus faecalis. The most contaminated part
(80.3%), were the sink and staff uniforms the ICU of Mobasher
Kashani hospital. In this study, more than 80% of strains which
isolated from the ICU of Mobasher Kashani hospital were resist-
ant to: erythromycin, vancomycin, carbenicillin, tetracycline, chlo-
ramphenicol and ampicillin, whereas, the strains of the NICU of
Fatemie hospital were resistant to penicillin, ampicillin, chloram-
phenicol and gentamycin.
Discussion: Our results showed that intensive cares of Hamadan
hospitals both the ICU of Mobasher Kashani and the NICU of
Fatemie were contaminated with routine nosocomial micro-organ-
isms. There were also the high drug resistance (in vitro) in strains
isolated from two hospitals.
Conclusions: It seems that sterilisation and disinfection methods in
hospitals were not performed correctly and related authorities
should control it regularly.
R2063 Colonisation of unusual strains of Klebsiella
pneumoniae in tracheal tubes of hospitalised patients in
intensive care units
M. Deldari, M. Rahbar, K. Bahar, R. Atifeh, M. Bahar
Tehran, IR
Objectives: To evaluate colonisation of unusual urease-negative
strains of K. pneumoniae in tracheal tubes of patients hospitalised
in Intensive Care Units (ICUs).
Methods: Tracheal tubes were cultured by culture of the lumen’s
catheter after 10 times dilution, and then organisms isolated were
identiﬁed by routine bacteriological method. Isolated urea-negat-
ive strains of K. pneumoniae rechecked by a sensitive method for
assay of a few amount of urease enzyme. We ruled out nonmotile
E. aerogenes strains from these isolated strains, with ornithine de-
carboxylase test (isolated strains were ornithine negative). Also
conﬁrmatory test performed on K. planticola. Then the antimicro-
bial susceptibility test was compared with urea-positive strains of
K. pneumoniae.
Results: During 2 years of study (2001–2003), in total 765 tracheal
tubes were cultured. A total of 158 species of Klebsiella isolated
in which 29 strains were urea-negative K. pneumoniae and eight
species were K. planticola. More strains are resistant to all com-
mon antibiotics except imipenem. Nitrogen control of urease
synthesis occurs in a number of bacterial species. In K. pneumoni-
ae urease is not synthesised when the cells are grown in the
presence of high-quality nitrogen sources such as ammonia. We
guessed. Alkalosis in this patients is caused by unusual strains
of colonisation. We are going to follow up these isolates, which
grow in minimal medium containing a poor nitrogen source for
urease enzyme activation.
Conclusion: It is concluded that, there are unusual urea-negative
and K. planticola species isolated as emergent multiresistant no-
socomial pathogens in our hospital. In spite of, urease activity
plays a central role in the pathogenesis but isolation these strains
in two cases as blood stream infection showed the role of patho-
gens.
R2064 Surveillance of the infection in coronary artery
bypass graft surgery: an evaluation over 4 years
M. De Frutos Serna, T. Delgado Melia´n, Z. Cubas, I. Montesinos,
M.Cuervo Abarquero, A. Sierra Lopez
La Laguna, E
Objectives: Surgical site infections (SSIs) in coronary artery bypass
graft (CABG) surgery result in signiﬁcant patient morbidity and
mortality, as well as consumption of signiﬁcant healthcare
resources. The purpose of this study was to describe the surgical
site infections in CABG surgery.
Methods: Surgical site infections after CABG surgery have been
monitored at the Hospital Universitario de Canarias for 4 years
(2 months in 2000, three in 2001, six in 2002 and six in 2003). A
prospective study of 197 patients operated, all were followed up
for thirty days, and stratiﬁed according to intrinsic risk factors of
infection NNIS System (National Nosocomial Infection Surveil-
lance, CDC Atlanta). All infections are categorised using standard
Centers for Disease Control deﬁnitions.
Results: During this period, seven infections were documented,
two organ-space infections, two deep incisional infections and
three superﬁcial incisional infections. All incisional infections were
founded in the safenectomy. The wound infection rates (wound
infection*100/no. surgical patient) were 0 in 2000, 11.7 in 2001, 1.6
in 2002 and 2.5 in 2003. Table 1 shows rates of SSI by index cate-
gory. *National Nosocomial Infections Surveillance (NNIS) Sys-
tem Report, data summary from January 1992 to June 2002, issued
August 2002 [Am J Infect Control (2002) 30, 458–475].
The aetiology of the seven infections was: S. epidermidis and Ente-
robacter cloacae in organ-space infections, two Morganella morganii
Table 1. SSI rates by risk index category 2000–2003, and NNIS*
data (pooled mean rate).
NNIS 0 NNIS 1 NNIS 2 NNIS 3
N SSI RATE N SSI RATE N SSI RATE N SSI RATE
2000 0 0 0 15 0 0 5 0 0 2 0 0
2001 13 0 0 18 4 22,2 3 0 0 0 0 0
2002 27 1 4,5 38 0 0 1 0 0 0 0 0
2003 3 0 0 75 2 2,6 3 0 0 0 0 0
2000–03 43 1 2,3 146 6 5,1 12 0 0 2 0 0
NNIS* 1,28 3,51 5,62 5,62
N: operative procedures.
SSI: Surgical site infections.
RATE ¼ SSI*100/N.
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in two deep incisional infections and Proteus vulgaris, Enterobacter
cloacae and Morganella morganii in three superﬁcial incisional infec-
tions.
Conclusions: Comparing our data with those of the NNIS report,
our hospital rate in NNIS 0 and NNIS 1 is lower than the percent-
ile 90, and NNIS 2 y NNIS 3 is lower than the percentile 10. The
safenectomy is an area of the risk for surgical wound infection fol-
lowing CABG surgery.
R2065 Bacterial infection of lower respiratory tract
associated with positive blood culture in haematology patients
B. Kurcik, V. Kotevska, Z. Cekovska, I. Hadzi-Petruseva,
K. Popovska-Jovanovska, M. Petrovska
Skopje, MK
Objectives: The purpose of this study was to compare pathogens
isolated from lower respiratory specimens and blood cultures
from patients hospitalised at Clinic of Haematology, Clinical cen-
ter, Skopje, Macedonia, during two year period (September, 2000
– September, 2002).
Methods: 85 patients hospitalised at Clinic of Haematology were
chosen for having positive microbiological ﬁndings both in spu-
tum and in blood culture. Cultivation, isolation, identiﬁcation and
antimicrobial susceptibility testing were made using standard
microbiological laboratory methods.
Results: Sputum isolates were: Candida albicans 25, Streptococcus
pneumoniae 17, Pseudomonas aeruginosa 16, Candida spp. 11, Klebsiel-
la spp. 11, Staphylococcus aureus 8, E. coli 7, Acinetobacter spp. 4,
Haemophilus inﬂuenzae 4 and Streptococcus pyogenes 2. Blood iso-
lates were: Staphylococcus coagulase-negative 30, Staphylococcus
aureus 15, E. coli 10, Pseudomonas aeruginosa 9, Enterococcus 6,
Klebsiella spp. 6, Acinetobacter spp .4, Candida spp. 2 and Candida
albicans 1. Nineteen 19 patients had identical ﬁndings both in their
sputa and blood cultures: Pseudomonas aeruginosa 5, Staphylococcus
aureus 5, Klebsiella spp. 3, Acinetobacter spp. 2, E. coli 1 and Candida
albicans 1. Their bacterial antimicrobial susceptibility testing
showed similar resistance pattern.
Conclusion: Candida and Gram-negative bacilli were predominant
pathogens from lower respiratory tract samples. Gram-positive
cocci (Staphylococcus) were main pathogen in blood cultures. Iden-
tical ﬁndings together in sputa and blood cultures in 19 patients
showing similar resistance pattern have same origin.
R2066 Comparative results of a 7-year surveillance
programme for nosocomial Gram-negative pathogens prevalence
in Russian ICUs
L. Stratchounski, G. Reshedko, E. Ryabkova RosNet Study Group
Objectives: To evaluate the changes in prevalence of Gram-negat-
ive nosocomial pathogens in Russian ICUs in 1997–99 and 2002–
03.
Methods: Gram-negative pathogens isolated from patients with
documented nosocomial infections from ICUs in different Russian
cities were included in the study. Isolates were identiﬁed in local
laboratories using standard biochemical tests. Strains were trans-
ferred to central laboratory in Smolensk where re-identiﬁcation of
all pathogens was performed.
Results: Twenty-eight and 26 centres took part in the study dur-
ing 1997–99 and 2002–03, respectively. A total of 2664 isolates
were obtained in 1997–99 and 1813 in 2002–03. The comparison
of data obtained in 1997–99 and 2002–03 are presented in the
Table.
Conclusions: As in 1997–99 the most common nosocomial patho-
gens in 2002–03 were P. aeruginosa, E. coli, K. pneumoniae. There
was found to be a signiﬁcant increase in prevalence of Acinetobact-
er spp. and S. maltophilia in 2002–03 as compared with 1997–99
period. These data suggest the increasing role of nonfermenters as
nosocomial pathogens.
R2067 Acinetobacter baumannii bacteraemia in a medical
ICU: sensitivity pattern and outcome
M. Daganou, M. Kompoti, A. Paridou, P. Kithreotis,
A. Sakellaropoulos,S. Kanavaki, A. Rassidakis
Athens, GR
Objectives: To investigate the characteristics of Acinetobacter
baumannii bloodstream infection and its impact on outcome of
adult critically ill patients in a medical ICU.
Methods: Retrospective study of patients admitted to the ICU
between January 2001 and December 2003 with at least one blood
culture positive for A. baumannii. Antimicrobial treatment was
considered adequate if at least one drug used had in vitro activity
against the isolated strain.
Results: Among 429 admissions, 14 patients presented A. bauman-
nii bacteremia (3.3%). Eight patients were male. Mean age was
62.1  5 years and mean APACHE II score 14  4. Length of ICU
stay before the onset of bacteraemia ranged between 2 and
63 days. The majority of the bacteraemic events occurred during
two distinct periods of time: ﬁve episodes between July and
August 2002 and 4 between May and June 2003. The source of
infection was a contaminated central venous catheter in four cases
(29%), ventilator-associated pneumonia in two cases (14%) and
unknown in eight cases (57%). Six strains (43%) were resistant to
all antibiotics except polymyxin B (MDR). Three patients were
receiving adequate antimicrobial treatment at the time of diagno-
sis and in six adequate treatment was started after the culture
results. Attributable mortality was 14%. There was no difference
in mortality rate between MDR and non-MDR strains and
between patients who received adequate and inadequate antimi-
crobial treatment.
Conclusions: Bacteraemia due to Acinetobacter baumannii presented
mainly with an epidemic pattern in our medical ICU. Attributable
mortality was relatively low even for multi-drug resistant strains
and inadequately treated patients.
R2068 Epidemiological study and drug sensitivity against
clinical strains of S. maltophilia A 4-year review
A. Xanthaki, A. Tsiringa, M. Toutouza, V. Skandami,
C. Kontou-Kastellanou
Athens, GR
Objectives: S. maltophilia is an important nosocomial pathogen. The
number of S. maltophilia infections has dramatically increased in
recent years. Long-term hospitalisation, antimicrobial pressure
and presence of induelling catheters are serious predisposing fac-
tors for the disease. Also most of these strains are inherently and
highly resistant to antibiotics. We conducted a 4-year review of
episodes of colonisation or infection due to S. maltophilia in order
to study the epidemiology and resistance proﬁle of the microor-
ganism.
Methods: During a 4-year period (2000–2003) S. maltophilia was
isolated from 82 clinical specimens from 70 patients in our hos-
pital. All isolates were identiﬁed by API or VITEK-II system
Microorganisms 1997–99 (%) 2002–03 (%)
P. aeruginosa 30.0 33.4
E. coli 18.4 12.6
K. pneumoniae 14.6 14.7
Proteus spp. 10.0 5.4
Enterobacter spp. 7.6 4.9
Acinetobacter spp. 6.9 16.8
Serratia spp. 4.1 3.5
S. maltophilia 1.3 2.7
Citrobacter spp. 1.3 1.2
M. morganii 0.8 1.1
Others 5.0 3.7
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(Biomerieux, France). Susceptibility testing was performed by
disc-diffusion method according to NCCLS guidelines. Nineteen
antibiotics of all groups were tested. Also in some cases medical
records of patients were reviewed.
Results: Clinical samples were various and mostly of the respirat-
ory tract. In descending order other samples were blood, wounds,
catheters, urine, drainage ﬂuids. Thirty-eight of 82 (31.1%) speci-
mens, 32 patients, were from the ICU and concerned mostly
elderly and intubated patients. Most of these isolates were from
the respiratory tract and from a polymicrobial culture. The rest 44
of 82 (36%) specimens, 38 patients, were from different wards (36
of 38) and outpatients (two of 38). As to the susceptibility results
to antimicrobial agents, all isolates were resistant to several antibi-
otics, thus multiresistant. The most active antibiotics against
S. maltophilia were the newer ﬂuoroquinolones ciproﬂoxacin and
peﬂoxacin (71.5%). The combination of Ticarcillin–clavulanic acid
was the second most active antibiotic tested (62.3%) followed by
Trimethoprim–sulphomethoxazol (42.9%). Another important
ﬁnding was that susceptibility to ceftazidime showed to decrease
through the study period. In 2000 it was 34.6% and in 2003
decreased to 14.3%. All other isolates showed no or poor sensitiv-
ity. Also of importance was that one recently isolated clinical
strain from an ICU patient was found to be resistant to all 19 anti-
biotics tested.
Conclusions: We demonstrated that ﬂuoroquinolones are most act-
ive against clinical strains of S. maltophilia followed by Ticarcillin–
clavulanic acid that showed good sensitivity. Also the emergence
of a strain resistant to all antibiotics tested is a worrying event
and has to be taken under concern.
R2069 Incidence, aetiology and focus of postoperative
infections in cardiac surgery patients
A. Pallare´s, M. Gime´nez, L. Matas, C. Vilaplana, T. Tomasa,
J. Moreno, X. Ruyra, V. Ausina
Badalona, E
Objectives: To determine the incidence, pathogens, focus and out-
come of postoperative infections in patients undergoing cardiac
surgery. To assess their relationship with operative risk score and
type of surgery.
Methods: We reviewed 122 charts of adult patients who under-
went cardiac surgery with microbiological conﬁrmed infection out
of 814 operated during a 2-year period in a new Cardiac Surgery
Unit of an university hospital. Euroscore was used to evaluate
operation risk.
Results: The incidence of microbiological conﬁrmed infection was
16.2%. Sepsis was the most frequent infection (30.3% of infected
patients), followed by catheter (23.4%), sternal wound infection
(SWI) (16.6%), UTI (16.6%) and respiratory tract infection
(12.8%). Among sepsis, 35% were catheter related, followed by
primary focus (22.5%) and SWI (12.5%). Seven patients developed
early bloodstream infection (0.8%) predominantly related to
Gram-negative bacteria. Four patients suffered endocarditis. SWI
was superﬁcial in 14 patients and eight evolute to deep infection.
A decrease in the proportion of postoperative infections during
the second year was observed in parallel with the increase in the
number of operations performed (18.6% vs. 14,6%). Causative
agents were Gram-positive in 79%, being the most frequent in
SWI and catheter, and Gram-negative (47.8%) were mainly isola-
ted in sepsis, UTI and respiratory tract infection. MRSA was isola-
ted in ﬁve patients (4%) and multiresistant Acinetobacter baumanii
was found in one patient. Postoperative infections were more
common in patients with a higher Euroscore (64% of infected
patients) and after combined artery bypass grafting and valve-
related operations, followed by valve replacement and coronary
bypass grafting. Infection related mortality was 2% of all patients
who underwent cardiac surgery. Global mortality was 5.1% rela-
ted to a 5.27 value of Euroscore.
Conclusions: The incidence of postoperative infections remains
relevant after the second year of cardiac operations but with a
decrease parallel with the increasing number of operations. Cath-
eter-related sepsis is the main cause of infection, and S. aureus is
the most frequently isolated pathogen. Postoperative infections
are usually found in more complex surgery and in patients with a
superior preoperative euroscore.
R2070 Lung tuberculosis and different radiographic
appearance
J. Videnovic-Ivanov
Belgrade, CS
Postprimary lung tuberculosis in recent years manifested in other
than usual radiographic ﬁndings. In previously period we ﬁnd
out, lung tuberculosis shadows localised in others than usually
localisations, especially in lowers lobes. 35 (9.6%) patients, 21 M–
14 F, average years 51.3 years, were hospitalised during 1 year on
the Institute for lung disease. Dominant symptom was malaise in
29 (86.8%), who were previously hospitalised for 4—6 months.
Cough were the main symptom in 4 (12.9%) patients. Radio-
graphic manifestations in seven (20%) patients revealed micro-
nodular shadows and spot shadows pericardially to the right, and
in eight (20.2%) patients similar lesions were localised on the left
side. In 17 (45%) patients spirometry veriﬁed mixed types of
moderately severe ventilation disorders, in eight (20.2%) moder-
ately severe obstruction and in 10 (27.5%) patients restriction. 2
(5.7%) patients had associated diabetes and rheumathoid arthritis.
PPD test were positive in 12 (32.2%) patients. Sputum bacilli were
veriﬁed in one patient. Bronchoscopies were done in 34 patients
with speciﬁc ﬁndings and TBB were done in 27 (73%) patients.
Atypical lung radiographic appearance had recently become a
new differential diagnostic problem. Duration of treatment in
these group patients and duration of treatment in patients with
usual radiographic manifestations were very similar (no statistical
differences were found).
R2071 Nosocomial infection types and isolated micro-
organisms in Baskent University, Adana Education and
Research Medical Centre
T. Turunc, Z. Demiroglu, H. Uncu, F. Ergin, H. Arslan
Adana, TR
Purpose: In this study, we aimed to assess the surveillance study
results of our hospital infection control committee done between
January and November 2003 and to direct the nosocomial infec-
tion control strategies.
Method: Centres for Disease Control criteria was used to deﬁne
intensive care units infections. The identiﬁcation of the microor-
ganisms have been performed by using conventional methods
and Becton Dickinson, (BBL Crystal) system. The study has been
planned prospectively with patient and laboratory depending on
active surveillance.
Results: Nosocomial infection rate during the period was found
1.66%. Nosocomial infections were mostly encountered in the
burn unit (16.43%), followed by the intensive care unit (3.49%)
and the other inpatient wards (0.73%). The most frequent form of
infections were bacteraemia (39.14%), followed by urinary tract
infections (35.85%), surgical wound infections (9.21%), catheter
infections (6.25%), respiratory tract infections (4.96%), burn injury
tissue infections (4.66%), and soft tissue infections (0.98%).
Respectively a total of 341 pathogenic microorganisms were iden-
tiﬁed and 35.77% (n ¼ 122), of those were determinated as Gram-
positive bacteria, 52.78% (n ¼ 180) Gram-negative bacteria and
11.43% (n ¼ 39) Candida spp. The distribution of the bacteria was
as isolated follow; methicillin-resistant Staphylococcus aureus
(MRSA) (14.07%), Enterococcus spp. (7.91%), methicillin-resistant
coagulase-negative staphylococci (7.03%), methicillin-sensivite Sta-
phylococcus aureus (MSSA) (2.34%), a-haemolytic streptococcus
(0.87%), b-haemolytic streptococcus (0.29%) and the Gram-negat-
ive bacteria was Pseudomonas aeruginosa (15.27%), Acinetobacter
spp. (9.38%), Escherichia coli (14.36%), Klebsiella pneumonia
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(6.74%), Enterobacter spp. (3.22%), Klebsiella oxytoca (1.46%), Cit-
robacter spp. (1.46%), and Proteus mirabilis (0.87%).
Conclusion: Dissimilar to other studies, bacteraemia is considered
to be the most seen type of nosocomial infection in our hospital
that we believe its sourced from burn unit.
R2072 Emerging antimicrobial resistance in bacterial
strains isolated from intensive care unit patients with
bacteraemia
D. Gianneli, O. Zarkotou, D. Perimeni, K. Tryﬁnopoulou,
J. Tsimettas, E. Psevedourou, C. Nikolopoulou
Piraeus, Athens, GR
Objectives: To deﬁne the incidence of bacteraemia in intensive care
unit (ICU) patients, to study the isolation frequency of microbial
pathogens and evaluate their resistance patterns.
Methods: During a 3-year period (1 July 2000 to 1 July 2003) 1408
sets of blood cultures were obtained from 345 ICU-patients. The
cultures were incubated in BACTEC 9240 automated blood cul-
ture system (Becton and Dickinson). Gram stain and subcultures
to the proper media were performed from the vials reported pos-
itive by the instrument. The identiﬁcation of bacteria was based
on API system (BioMerieux) and BBL Crystal GP (Becton and
Dickinson). The antimicrobial susceptibility testing was carried
out by MIC values determination using broth microdilution
method (Sensititre, UK). The susceptibilities of enterococci were
studied by the E-test method as well (AB Biodisk, Sweden).
Results: Bacteraemic episodes were observed in 124/345 patients
(incidence ¼ 35.9%). Of the 124 patients with positive cultures
275 microbial strains were recovered. Gram-positive bacteria (GP)
prevailed: GP 51.5 % (142/275), Gram-negative (GN) 40% (109/
275) and fungi 8.5 % (24/275). Multimicrobial bacteraemia was
detected in 21 cultures (8.2%). The most prevalent bacteria were:
Staphylococcus epidermidis (21.9%), Staphylococcus haemolyticus
(12.2%), Enterobacter spp. (11.8%), Enterococcus spp (10.4%), Pseu-
domonas spp. (10%), Acinetobacter spp (7.2%), Klebsiella pneumoniae
(5%), Escherichia coli (3.6%) and Staphylococcus aureus (3.5%). The
antimicrobial resistance rates (%) for the most frequently isolated
GN bacteria are presented in the table below: Resistance to methi-
cillin was detected in all S. aureus strains and in 94.4% of coagu-
lase-negative staphylococci (CNS) strains. 41.5% of enterococci
were resistant to vancomycin.
Conclusion: The high prevalence of multiresistant, nosocomial
strains in ICU-patients with bacteraemia, limits our treatment
choices and subsequently leads to a high mortality rate.
R2073 The inﬂuence of diabetes mellitus on the spectrum
of uropathogens and their antibiotic resistance
S. Costarelli, G. Pichierri, P. Tanzilli, G. Morelli, S. Mori,
E. Tagliaferri, M. Bonadio
Pisa, I
Objectives: To evaluate the effect of diabetes mellitus on the spec-
trum of uropathogens and their susceptibility to the antimicrobials
in patients (pts) with urinary tract infection.
Methods: Urinary isolates and their patterns of susceptibility to
the antimicrobials were evaluated in 346 diabetic pts (229 females
and 117 males) and 975 nondiabetic pts (679 females and 296
males) with proven signiﬁcant bacteriuria (>105 CFU/mL urine).
Both diabetic and nondiabetic pts were more than 50 years old.
The mean age of the two groups was similar and the male/female
ratio was 0.33 and 0.30 respectively in diabetic and nondiabetic
pts.
Results: The most frequent causative organisms of bacteriuria in
diabetic and nondiabetic females were respectively: E. coli 54.1
and 58.2% (P ¼ NS), Enterococcus spp. 8.3 and 6.5% (P ¼ NS),
Pseudomonas spp. 3.9 and 4.7% (P ¼ NS). The most frequent
organisms in diabetic and nondiabetic males were respectively,
E. coli 32.5 and 31.4% (P ¼ NS), Enterococcus spp. 9.4 and 14.5%
(P ¼ NS), Pseudomonas spp 8.5 and 17.2% (P ¼ 0.02). The rates of
uropathogens in diabetic and nondiabetic pts with indwelling
bladder catheter were respectively E. coli 30.8 and 24.9%
(P ¼ NS), Enterococcus spp. 21.8 and 16.4% (P ¼ NS), Pseudomonas
spp 12.8 and 18.1% (P ¼ NS). No signiﬁcant differences in resist-
ance rates to ampicillin, nitrofurantoin, cotrimoxazole and cipro-
ﬂoxacin of E. coli and Enterococcus spp. were recognised between
diabetic and nondiabetic pts.
Conclusions: Diabetes mellitus doesn’t seem to have a relevant
effect on the spectrum of uropathogens and their susceptibilty
patterns to the antimicrobials in pts with urinary tract infection.
R2074 Epidemiological study of Acinetobacter spp. in ICU
and plastic surgery department over a 4-year period
A. Sledzinska, E. Czarniak, A. Samet, J. Kur
Gdansk, PL
Objective: The aim of this study was to analyse the epidemiology
of Acinetobacter spp. between 1996 and 1999 in two departments
in our hospital.
Methods: From May 1996 to January 1999 Acinetobacter spp. from
clinical and environmental specimens were studied. The isolates
were identiﬁed using the API 20NE and Vitek System (BioMerieux).
Susceptibility testing was performed by disc-diffusion method
according to the NCCLS standards. Molecular study was done
using recA/RFLP, PCR-ﬁngerprinting and ADSRRS-ﬁngerprinting.
Results: Sixty isolates were included in the study. Forty-seven of
them were from clinical specimens from patients hospitalised in
ICU and Department of Plastic Surgery and 13 from hospital envi-
ronment. Identiﬁcation in API 20 NE and Vitek System was con-
ﬁrmed by recA/RFLP. Fifty-nine isolates were identiﬁed as
genomic species 2 (A. baumannii) and one isolate as genomic spe-
cies TU 13. Seventeen isolates were grouped into PCR-ﬁngerprint-
ing type A, 23 to type C, 18- type D, one into type E and TU13
was type H. Using ADSRRS-ﬁngerprinting the following types
were obtained: A’ (n ¼ 46), B’ (n ¼ 1), C’ (n ¼ 12), D’ (n ¼ 1).
Using those two methods of ﬁngerprinting we obtained eight gen-
otypes: 2DA’– 17 isolates (28.3%), 2AA’ – 15 isolates (25%), 2CA’
– 14 isolates (23.3%), 2CC’– nine isolates (15%), 2AC’ – two iso-
lates and one isolate from genotypes 2DC’, 2EB’, 13HD’. We did
not conﬁrm correlation between antibiotic susceptibility proﬁle
and genotype.
Conclusions: (i) A. baumanii became an endemic organism in our
hospital. (ii) Three predominant genotypes prevailed during the
whole 4-year period in ICU and in 1 year (1998) in Department of
Plastic Surgery. (iii). Two methods gave comparable results with
regard to typing.
R2075 Genotypes of methicillin-resistant S. aureus blood
culture isolates in Slovenia
V. Krizan-Hergouth, M. Mueller-Premru, T. Zohar-Cretnik,
S. Lorencic-Robnik, I. Strumbelj, I. Grmek-Kosnik, T. Harlander,
J. Fiser, M. Kavcic, H. Ribic
Ljubljana, Celje, Maribor, Murska Sobota, Novo Mesto, Nova Gorica,
Koper, SI
Objectives: To determine the number of MRSA genotypes and
resistance proﬁles from blood culture isolates in Slovenia.
Bacteria Amicacin
Pip/
Tazo Cefotaxime Ceftazidime Ceﬁpime Cipro Imipenem
Enterobacter 15.6 87.5 96.8 96.8 51.5 96.8 15.6
Pseudomonas 67.8 46.5 100 75 60.8 82.2 75
Acinetobacter 90 90 85 85 45 95 60
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Methods: A total of 108 of 131 MRSA blood culture primoisolates
from 11 Slovene hospitals in the years 2000 and 2001 were typed
by pulsed-ﬁeld gel electrophoresis of chromosomal DNA and
compared with most prevalent European MRSA clones. Antimi-
crobial susceptibility testing was performed by the disc-diffusion
method.
Results: Seven different genotypes (A-G) were found among 108
MRSA isolates. 99 isolates belonged to genotype A (12 subtypes)
which was present in all hospitals and showed more than 80 %
similarity with South German clone. Three isolates belonged to
genotype E (1 subtype) and two to genotype F. Genotypes B, C, D
and G were found in one patients each. Genotypes A, F and G
were susceptible to rifampin, chloramphenicol, trimethoprim-sul-
phamethoxazole, tetracycline, vancomycin and teicoplanin, but
susceptibility of clones B, C, D and E was different.
Conclusions: Although seven genotypes were found among MRSA
blood culture isolates, a single genotype (A) was predominant,
but other genotypes (B-G) occurred only sporadically in Slovenia.
R2076 Susceptibility vancomycin-resistant Enterococcus
faecium to linezolid
M. Bronk, A. Samet, A. Sledzinska, M. Kochowska-Bronk
Gdansk, PL
Objectives: Enterococci are important nosocomial pathogens and
their growing resistance to antimicrobial agents is even more
important from therapeutical point of view. The aim was to deter-
mine the in vitro susceptibility of clinical isolates of vancomycin-
resistant Enterococcus faecium (VREM), phenotype VanA, to
linezolid. Linezolid, the ﬁrst in a new class of antibacterials, the
oxazolidinones, has activity against Gram-positive organisms,
both susceptible and resistant.
Methods: Susceptibility of 37 clinical isolates of VREM to linezolid,
vancomycin and teicoplanin we determined by the Kirby–Bauer
method according to NCCLS recommendations. MICs for vanco-
mycin and teicoplanin were determined by E-Test method. These
isolates were isolated from different clinical materials over one
year from patients of haematology unit.
Results: Among the 37 clinical isolates of VREM, phenotype VanA,
36 were susceptible to linezolid. One isolate was resistant.
Conclusion: The study revealed a very good activity of linezolid
against VREM VanA. The antimicrobial agent may be useful in
the treatment of serious infections caused by multiresistant E. fa-
cium. Linezolid resistant E. faecium was isolated for the ﬁrst time
in our hospital.
R2077 Postoperative meningitis following neurosurgery in
critically ill patients
R. Cooke
Liverpool, UK
Objectives: Meningitis is a serious complication following neuro-
surgery and is often caused by coagulase-negative staphylococci
(CNS). Staphylococcus aureus (SA) and Gram-negative bacilli may
also be of increasing importance. Data on such infections in the
critically ill is limited. The purpose of the study was to review the
microbiology of postoperative neurosurgical meningitis/ventricu-
litis (PONMV) and to compare antibiotic resistance rates with
empirical intravenous ceftriaxone and/or intraventricular vanco-
mycin given in the critical care unit (CCU) prior to the availability
of culture results.
Methods: A retrospective analysis of the microbiology of all cere-
brospinal ﬂuid (CSF) samples taken from patients with PONMV
managed in the CCU of a tertiary referral centre, 1996–2003.
Results: A total of 71 adult patients were identiﬁed from whom
208 CSF isolates were identiﬁed. 84 (40%) were ‘ﬁrst time’ iso-
lates: 66 were Gram-positive (43 CNS, eight Streptococcus sp, four
SA, four Corynebacteria sp, three Bacillus sp, two MRSA, one
Gemella sp.,), 16 Gram-negative (seven Pseudomonas sp., three
‘coliform’’, three Enterobacter sp., two Klebsiella sp., one Acinetob-
acter sp.) and two Candida sp. MRSA was only identiﬁed in the
year 2003. All Gram-positive isolates were vancomycin-sensitive.
39 ‘ﬁrst time’ isolates (46%) were ceftriaxone resistant (28 Gram-
positive, including 22 CNS isolates, and 11 Gram-negative). CSF
white cell counts varied from <1 to 87, 500/mm3.
Conclusions: Ceftriaxone may not be a suitable empirical agent for
PONMV, particularly if CNS infection due to external ventricular
drains is suspected. For Gram-negative infections, antibiotic treat-
ment with an anti-pseudomonal antibiotic should be considered.
The absence of a white cell count response in the CSF does not
always exclude infection.
R2078 Patterns of antibiotic prescribing in Italian
hospitals
G. Ippolito, G. Gesu, L. Giuliani, M. Larosa, G. Privitera – theINF-
NOS study group
Background: Inappropriate use of antibiotics is associated with the
emergence of resistant bacteria and increasing hospital expendi-
tures. Aim of the present study was to investigate patterns of anti-
biotic prescribing in Italian hospitals.
Methods: The ﬁrst of a serial one-day point prevalence survey for
the INF-NOS project 2002–2004 was performed in 31 Italian hospi-
tals during October–November 2002. Data on antimicrobial use,
type and site of nosocomial infections (NI) were collected trough
an electronic case report form. Descriptive statistical analysis was
conducted.
Results: A total of 3120 patients were surveyed, 45.0% of them
receiving at least one antibiotic on the day of the survey: 52.6% for
treating active infection (of community or nosocomial origin),
21.9% for surgical prophylaxis, 19.8% for prophylaxis for other
reasons and 5.7% for treatment of no more active infection. Among
760 infected patients treated with antibiotics, 58.3% received mo-
notherapy and among 286 patients with other reason for prophy-
laxis 52.8% were exposed to at least one invasive procedure,
mainly urinary catheter. Teicoplanin (9.9%), vancomicin (5.7%)
and piperacillin/tazobactam (5.7%) were the more common pre-
scriptions for therapy of NI, instead ceftriaxone (12.3%) was the
most preferred option for surgical prophylaxis. No active infection
was recorded for 2429 patients (75.7%), 28.0% of them receiving
antibiotic treatment, in 41.9% of cases for prophylaxis for other
reason and in 12.2% for therapy of no more active infection.
Conclusions: High rates of antibiotic usage were observed in Ital-
ian hospitals. Areas for improvement for the prescribing habits
were identiﬁed. The 1 day prevalence survey of antimicrobial use
may represent a tool of feedback to prescribers for more appropri-
ate drug selection and consumptions.
R2079 A natural antimicrobial agent able to inhibit
bacterial bioﬁlm formation on indwelling medical devices
G. Donelli, I. Francolini, E. Guaglianone, A. Piozzi, P. Norris,
P. Stoodley
Rome, I; Bozeman, USA
Objectives: Strategies to prevent medical device-associated infec-
tions include coating of polymeric surfaces with antimicrobials
that eluting from the device prevent microbial colonisation. Our
aim was to assess the antimicrobial activity of usnic acid, a secon-
dary lichen metabolite, against several planktonic bacteria known
to form bioﬁlm on implanted medical devices: Staphylococcus epi-
dermidis, S. aureus, Enterococcus faecalis, Pseudomonas aeruginosa.
Methods: To evaluate the possible inhibiting effect, the most
widely employed polymers in medical device production, poly-
urethanes, were loaded with usnic acid. Since usnic acid exhibit
acidic properties, the surface of polyether urethane acid was spe-
ciﬁcally modiﬁed by introducing amino groups able to establish
electrostatic interactions with the acidic groups displayed by usnic
acid. These functionalised polymers were then incorporated in a
597Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
ﬂowcell designed for growing bioﬁlms under a wide range of
hydrodynamic conditions, and subsequently analysed using con-
focal microscopy. The ability of usnic acid to control bioﬁlm for-
mation was assessed using the Gram-positive Staphylococcus
aureus and the Gram-negative Pseudomonas aeruginosa.
Results: Usnic acid-loaded polymers have been shown to be resist-
ant to bioﬁlm formation by S. aureus. In contrast, P. aeruginosa bio-
ﬁlm was formed on the surfaces of both the untreated and the
usnic acid-loaded polymers. However, usnic acid affected the
morphology of P. aeruginosa bioﬁlm, possibly indicating that this
drug may interfere with cell–cell communication by inﬂuencing
cell-signalling pathways.
Conclusion: The assessed activity of usnic acid on S. aureus and
presumably other Gram-positive bacterial species, opens new per-
spectives in the development of medical devices refractory to bac-
terial colonisation and bioﬁlm formation.
R2080 Microbiology of meningitis in hospitalised patients
of West Caracas, Venezuela: 10-year surveillance
C. Rodriguez, A. Rodriguez, A. Garcı´a, C. Duque, N. Molina,
P.Meijomil, J. Vargas, G. Gutierrez
Caracas, VE
Objectives: To study microbiology of meningitis in hospitalised
patients of West Caracas, Venezuela [West General Hospital
(WGH) of Caracas] in a 10-year period (1989–1999).
Methods: CSF of meningitis suspected patients hospitalised at
WGH were studied at Microbiology Laboratory. Complete cultures
and biochemical identiﬁcation as well API and automated media
were used to classify isolated organisms (bacteria and fungi).
Results: In this period, 4060 samples of CSF were submitted to
Microbiology Laboratory. From this total, only 140 (3.44%) had
bacterial growth. Most isolated organisms were: Haemophilus inﬂu-
enzae (25.71%), Streptococcus pneumoniae (14.29%), Staphylococcus
aureus (10.00%), Neisseria meningitidis (8.57%), Klebsiella pneumoniae
(7.14%), Pseudomonas aeruginosa (5.71%), Enterobacter cloacae
(5.71%), Escherichia coli (3.57%), Acinetobacter lwofﬁ (2.86%), Can-
dida albicans (2.86%), Klebsiella ozoaenae (2.14%), Acinetobacter bau-
mannii (2.14), among others.
Conclusions: H. inﬂuenzae isolation frequency is related to paediat-
ric services (more than half of CSF samples), meanwhile Gram-
negative bacilli isolation is due to a signiﬁcant proportion of no-
socomial infections, especially those acquired at services of inten-
sive care. Surveillance studies are needed especially in those
countries in the developing world.
R2081 Change in antimicrobial resistance pattern of
Pseudomonas aeruginosa species isolated from wounds and
abscesses over a 3-year period
B. Durmaz C¸etin, N. O¨zcan, M. Oktar, M. Gu¨l
Istanbul, TR
Objectives: Pseudomonas aeruginosa is one of the most commonly
isolated microorganisms from hospital infections and the wide
use of broad spectrum antibiotics causes increase in the ratio of
its antibiotic resistance. In this study the antibiotic resistance ratio
of Pseudomonas aeruginosa species isolated from wound and
abscess samples that were sent to our Microbiology Laboratory
between January-December 2002 were searched. It is aimed to
determine the change in the resistance ratio of Pseudomonas aerugi-
nosa species, isolated from the same group of samples that were
searched in 1999 in our hospital, compared with our ﬁndings.
Methods: A total of 100 Pseudomonas aeruginosa species, isolated
from wound and abscess samples that were sent from various
clinics to the Microbiology Laboratory in Sisli Etfal Research and
Training Hospital between January and December 2002, were
identiﬁed by conventional methods and API 20 NE (Biomerioux).
Their antibiotic sensitivities were searched by Kirby–Bauer disc
diffusion method according to NCCLS recommendations.
Results: The antibiotic resistance ratio of the isolated Pseudomonas
aeruginosa species were 45% for piperacillin, 50% for ceftazidime,
55% for cefepime, 40% for aztreonam, 45% for gentamicin, 35%
for amikacin, 39% for tobramycin, 30% for netilmycin, 36% for ci-
proﬂoxacin, 48% for imipenem and 49% for meropenem. In our
study the resistance to antibiotics in Pseudomonas aeruginosa spe-
cies were found to be high. The highest resistance was against ce-
fepim, ceftazidim and carbapenems while the lowest resistance
was against netilmycin, amikacin, tobramycin and ciproﬂoxacin.
Conclusions: In our study a marked increase in resistance was seen
when we compared the change of resistance ratio of the isolated
Pseudomonas aeruginosa species in 1999 and 2002 (P < 0.01).
R2082 Impact of nosocomial infections on medical
consumption in intensive care units of military hospital in
Tunis
F. Barguellil, Z. Ada, S. Kesraoui, A. Jebali, S. Blibech, I. Labbene,
M. Doagi, M. Ferjani
Tunis, TN
Objectives: Nosocomial Infections (NI) represents a major problem
of public health by their increasing frequency and their mortality
rate, but also by their considerable cost. In a context of control of
health expenses, the measure of the cost of the NI (direct and
indirect cost) became necessary.
Methods: In our survey, we are interested to determine the direct
costs generated by the NI: antibiotics and other medicines, com-
plementary investigations, medical devices and supplementary
days of hospitalisation. The survey took place in two departments
of ICU of the Main Military hospital of instruction of Tunis
(HMPIT), the adult ICU and the neonatology ICU.
Results: We recovered, on a period of 3 months spreading of the
12 March 2001 at 11 June 2001, a total cost of 28777 Euros for 31
NI recorded in adult ICU, and 15061 Euros for 14 NI in neonatol-
ogy. The cost of a NI in adult ICU was therefore 928 euros. The
one of a NI in neonatology was 1076 Euros. Components that
have the more weighed in the total cost of the NI were antibiotics
(62.5% of the total amount) follow-up by the biologic exams
(15.7%), in adult ICU. In neonatology, it is the supplementary
days of hospitalisation bound to the NI (47.2%) and the other
medicines than antibiotics (21.06%) that were determinants in the
total cost. In adult ICU, Acinetobacter was the more expensive
germ, with a middle cost by NI of 1446 Euros. If we exclude no-
socomial meningitis due to Acinetobacter, that cost 2867 Euros, the
middle cost by the most elevated infection has been assigned to
pneumonia (1882 Euros). In neonatology, Serratia marcescens
detains the more important part in the total cost of the NI
(73.01%), with a middle cost of 1571 Euros by infection. To the
exception of one nosocomial pneumonia, all infections observed
in neonatology were septicaemias of which one was complicated
by a brain abscess. The middle cost of a septicaemia was 1107
Euros or 891 Euros, if we exclude the complicated septicaemia.
Conclusion: Our survey reveals that in relative difﬁculty spite to
the calculation of the cost of the NI, notably with regard to the
supplementary days of hospitalisation, the ﬁnancial load is too
much important to be disregarded. It’s what can motivate the nur-
sing staff to ﬁght more again the NI and to incite administrators
and decision-makers to ﬁnance programmes of struggle against
these infections.
R2083 Bacterial proﬁle and antimicrobial susceptibility
pattern
H. Gazi, S. Surucuoglu, S. Kurutepe, A. Teker, B. Ozbakkaloglu
Manisa, TR
Objective: Aim of this study was to determine aetiology and the
antimicrobial resistance rates of bacteria causing catheter-related
infections in our hospital. After removal, semiquantitative culture
of the external surface and the internal lumen quantitative cath-
eter culture was performed.
598 Abstracts
Methods: Catheter colonisation was considered if >15 CFU in the
roll procedure or >1000 CFU in the quantitative.
Results: A total of 175 catheter samples were analysed, bacterial
growth was positive in 56 (32%) and negative in 119 (68%) sam-
ples. The most common isolate was Pseudomonas aeruginosa
(21.4%), followed by coagulase-negative staphylococcus (CNS)
(19.6%), Acinetobacter spp. (17.9%), Staphylococcus aureus (10.7%),
Stenotrophomonas maltophilia (10.7%), Klebsiella spp. (5.4%), Coryne-
bacterium spp. (3.6%), Candida spp. (3.6%), Enterococcus spp.
(1.8%), Escherichia coli (1.8%), Enterobacter spp. (1.8%) and Serratia
marcescens (1.8%). The prevalence of methicillin resistance was
common in CNS (81.8%), compared with S. aureus (16.7%) iso-
lates. Enterococcus spp. was not observed glycopeptide resistance.
Carbapenems and aminoglycosides were the most effective antibi-
otics in Gram-negative bacteria.
Conclusion: A knowledge of the resident microbial ﬂora and their
antimicrobial susceptibility pattern is necessary for formulating a
rational antibiotic policy in patients with catheter infection.
R2084 Risk factors for Clostridium difﬁcile infection
during an outbreak situation on a geriatric ward
G. Ackermann, S. Thomalla, F. Ackermann, A.C. Rodloff, B.R. Ruf
Leipzig, D
Objectives: Clostridium difﬁcile- associated diarrhoea (CDAD)
remains the leading cause of nosocomial-acquired diarrhoea. Pro-
longed hospital stay and diagnostic and therapeutic procedures
due to CDAD cause additional costs. Risk factors for the acquisi-
tion of C. difﬁcile in an outbreak situation were evaluated.
Methods: From June to April of 2003, 89 cases of diarrhoea were
reported from a geriatric ward of a clinic for Internal Medicine. C.
difﬁcile – toxin ELISA and culture were done on all stool samples.
Anamnestic data for 88 patients were evaluated. Statistical analy-
sis were done using chi-square test.
Results: Fourty-eight stools were positive for C. difﬁcile using cul-
ture and/or toxin ELISA. Vascular, heart, renal and pulmonal dis-
eases were associated with C. difﬁcile infection. Additionally,
treatment with more than ﬁve drugs was related to C. difﬁcile
infection. Comparing patients with diarrhoea but without diagno-
sis of C. difﬁcile and patients with CDAD, these factors were statis-
tically signiﬁcant correlated with the latter group. Interestingly, C.
difﬁcile infection was not associated with other gastrointestinal dis-
eases.
Conclusion: Risk factors for the acquisition of C. difﬁcile in out-
break situations seem to differ from risk factors in the normal hos-
pital setting.
Infection in the immunocompromised host (except HIV)
R2085 The afﬁgene(R) OPI Panel for Opportunistic
Infections – viral load monitoring of CMV, EBV and HHV-6
T. Eriksson, S. Palm, V. To¨rmnen, A. Hedrum
Bromma, S
Background: Cytomegalovirus (CMV), Epstein-Barr virus (EBV)
and Human Herpes virus 6 (HHV-6) infections are signiﬁcant
causes of disease and mortality among immunocompromised
patients e.g. AIDS patients, cancer patients and transplant recip-
ients. Anti-viral regimens are available and needs to be started
at an early timepoint in order to achieve the best effect. Con-
tinuous monitoring of these viruses in patients at risk of devel-
oping disease, using sensitive diagnostic tests, is therefore
important. Today, quantitative PCR is used in several laborator-
ies for the monitoring of viral loads. However, truly standard-
ised procedures are not available for all three viruses. The
afﬁgene(R) OPI (Opportunistic Infections) panel for Patient Dis-
ease Management (PDM) is comprised of three assays for efﬁ-
cient monitoring of CMV, EBV and HHV-6 viral load in
serum/plasma specimens.
Methods: The assays were performed according to method manu-
als and evaluated utilising QCMD reference panels, clinical speci-
mens and artiﬁcial specimens comprised of serum/plasma spiked
with each speciﬁc virus. The three assays share a common sample
preparation, which enables the user to analyse all three viruses
from one single specimen preparation.
Results: All three assays can reliably measure decrease and
increase in viral loads over time in clinical samples and good cor-
relation was determined compared with expected viral loads e.g.
reference panels, electron microscopy and in-house validated
assays. Limit of detection (LOD), deﬁned as more than or equal to
95% positivity rate, is 500, 500 and 1000 copies/mL for afﬁ-
gene(R) EBV VL, afﬁgene(R) HHV-6 VL and afﬁgene(R) CMV VL,
respectively.
Conclusions: The afﬁgene(R) OPI panel facilitates the monitoring
of active viral infection in patients at risk of opportunistic infec-
tions. The performance of the assays make them suitable for pre-
emptive monitoring.
R2086 Evaluation of predictive values of serum amyloid-A
(SAA) and C-reactive protein (CRP) for infection and mortality
in febrile neutropenic patients
A. Batirel, S. Gencer, S. O¨zer
Istanbul, TR
Introduction: Highly sensitive and speciﬁc indicators are being
searched as early predictors of infection to identify the cause of
fever and to determine the presence of infection in febrile neu-
tropenic patients with malignancy.
Objective: In one of our previous studies, we observed that CRP
values in the ﬁrst 48 h of the FEN (febrile neutropenia) episode
were statistically signiﬁcant to indicate infection (P ¼ 0.001), but
insigniﬁcant to predict mortality (P ¼ 0.595). Based upon this
work, this study is performed to identify the value of SAA and
CRP in early diagnosis of infection and prediction of mortality in
FEN patients.
Methods: We evaluated 65 FEN episodes of 52 patients covered by
FEN protocol in our Infectious Diseases Clinic. SAA and CRP lev-
els were measured daily by Latex Agglutination Nephelometric
Immunoassay during the course of antibiotherapy.
Results: Of total 26 infections, 23 were microbiologically and
three were clinically deﬁned, mortality was seen in only ﬁve
cases. When we examined the predictive values of initial SAA
and CRP levels regarding infection and mortality, it is not
assumed that a signiﬁcant difference exists (in case of infection,
P ¼ 0.244 for CRP, P ¼ 0.399 for SAA; in case of mortality,
P ¼ 0.949 for CRP and P ¼ 0.929 for SAA). SAA and CRP lev-
els on the last day of the follow-up were found to be signiﬁ-
cant regarding infection and mortality (in case of infection,
P ¼ 0.003 for CRP, P ¼ 0.026 for SAA; in case of mortality,
P < 0.001 for CRP and P ¼ 0.021 for SAA). Both initial and
daily-measured values of SAA and CRP were positively and
signiﬁcantly correlated with each other (P < 0.001). When the
changes of the two parameters in consecutive days were exam-
ined, increase in the levels of both parameters was greater on
the second and third days in comparison to the ﬁrst day but
statistically signiﬁcant gradual decline was observed after the
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third day (P < 0.001). The difference between daily serum levels
was more deﬁnite for SAA (for SAA 2 ¼ 186, for CRP
2 ¼ 153) therefore it is argued that SAA is a better parameter
to predict infection and degree of inﬂammation and is more
sensitive than CRP.
Conclusion: Despite low predictive values of these parameters in
decision of initial therapy, they would be helpful in decision of
modiﬁcation and evaluation of response to therapy.
R2087 Microbiologic monitoring (MM) of infectious
complications in patients undergoing radical mastectomy (RME)
N. Petukhova
Moscow, RUS
Objectives: To study pathogens and possible ways of developing
wound infections (WI) in breast cancer pts, who underwent RME.
Methods: MM included culturing of tumour (from cutting place),
taken intraoperatively, lymph – on the 2, 5 and 10 days after
operation, wound discharge – if WI was seen. Nasal swabs were
cultured twice before operation. If Staphylococcus aureus was isola-
ted, phagotyping of strains was made.
Results: Growth of aerobic pathogens from cutting place of
tumour was seen in 14.6%. All were coagulase-negative staphylo-
cocci (CNS). All these pts had no WI postoperatively, so it was
decided these strains to be contaminants. Lymph was cultured in
61 pts. Growth of microorganisms was seen in 12 (19.7%): S. aure-
us – in ﬁve cases, CNS – in ﬁve cases, Morganella morganii – in
one and Corynebacterium spp. – in one case. WI was seen in seven
pts and in ﬁve of them (71.4%) S. aureus was isolated. The two
other pathogens were: Morganella morganii and CNS, isolated
twice from wound discharge. Single isolation of CNS in ﬁve pts
and Corynebacterium spp. in one pt from lymph without WI was
considered contamination. A total of 49 pts were taken nasal
swabs and in 16 of 49 pts asympthomatic nasal carriage of S. aure-
us was seen. In two of 16 (12.5%) nasal carriers of S. aureus WI,
caused S. aureus were seen, but it means that two of ﬁve pts
(40%) with WI caused S. aureus were nasal carriers of S. aureus.
Phygotyping conﬁrmed identity of microorganisms isolated from
lymph and from basal swabs.
Conclusion: Staphylococcus aureus is the most common cause of WI
in pts undergoing RME. In pts who are nasal carriers of S. aureus
autoinfection may be the mechanism of development of WI. Clini-
cians must consider eradication of nasal carriage of S. aureus with
mupirocin before operation.
R2088 Investigation of bacterial peritonitis in
haemodialysed patients (30-month study)
A. Tsiringa, D. Petras, A. Xanthaki, M. Toutouza, A. Papadaki,
I. Kakavas, C. Kontou-Kastellanou
Athens, GR
Introduction: The microbial cause of peritoneal dialysis related
peritonitis is an important determinant of clinical outcome and
the basis of widely used treatment guidelines.
Objective: The aim of our study was to investigate the cause of
bacterial peritonitis in undergoing chronic haemodialysis
patients.
Materials and methods: A total of 27 patients on chronic HD were
studied for the period January 2000–June 2003. All the clinical
samples were examined in our laboratory. We did aerobic and
anaerobic culture with the BD BACTEC SYSTEM. All isolates
were identiﬁed by API or VITEK-II automated system, (Bio-
merieux, France). Susceptibility testing was performed by disc dif-
fusion method, according to the NCCLS guidelines.
Results: During the study period we found 51 cases of peritonitis
in 16 pts from 27 pts (59.2%). In three cases we had negative cul-
tures of peritoneal ﬂuid. We found Gram-positive peritonitis in 27
from 49 cases (55%). S. epidermidis was the most common cause of
peritonitis (30.6%) and the second common cause was E. coli
(20.4%). P. aeruginosa (12.7%), Streptococcus spp. (10.2%), Entero-
coccus spp. (10.2%), S. aureus (4%), and Klebsiella pneumoniae (4%)
were the other common causes. Methicillin-resistant staphylococci
were the 66.7% of Staphylococcus spp. We found in the Gram-neg-
ative strains multiresistant to antibiotics. About 20% of the strains
were resistant to ampicillin and cephalothin and 20% resistant to
ciproﬂoxacin.
Conclusions: Our study showed signiﬁcant trends of causative
pathogens of peritoneal dialysis-related peritonitis and increase in
antibiotic resistance.
R2089 A case of Salmonella enteritidis soft tissue and
joint infection in a patient with rheumatoid arthritis under anti
TNF-a treatment
I. Katsarolis, E. Giannitsioti, P. Panagopoulos, G. Poulakou,
A. Antoniadou, K. Kanellakopoulou, H. Giamarellou
Haidari Athens, GR
Background: Focal extraintestinal infections from nontyphoid sal-
monellae have increased in incidence during the past decade. Iso-
lated salmonella soft tissue infections are relatively rare,
occurring mostly in adults with chronic underlying conditions,
such as diabetes mellitus and cell-mediated immunity defects.
Patients treated with anti TNF-a antibodies exhibit increased sus-
ceptibility to infections caused by intracellular microbes, such as
Salmonella.
Purpose: To present a female patient with rheumatoid arthritis on
antiTNF-a treatment with a postoperative soft tissue and joint
infection due to Salmonella enteritidis.
Case presentation: A 52-year-old female patient with rheumatoid
arthritis, initially treated with corticosteroids and naproxen, was
operated for a right knee ruptured Baker’s cyst. Two weeks
postoperatively, arthritis symptoms rapidly deteriorated, and le-
ﬂunomide plus inﬂiximab were added. Despite prompt clinical
response, she developed a painful, inﬂammatory swelling of the
right popliteal area, which was automatically ruptured, draining
pus and serosanguinous material. Cultures revealed Salmonella
enteritidis, and markedly elevated ESR and CRP were noted.
Steroid-induced diabetes mellitus was also discovered. The
patient had no gastrointestinal symptoms and stool cultures
were negative for Salmonella spp. At that point, the patient was
referred to our clinic. MRI of the affected area showed a
marked inﬂammatory process of the surrounding soft tissue
with increased intra-articular ﬂuid collection and thickening of
the synovium. No radiological sign of osteomyelitis was evi-
dent. Immunomodulatory agents were stopped and ciproﬂoxa-
cin 750 mg q12 h and glibenclamide were administered.
Inﬂammatory markers soon dropped and optimal glucose con-
trol was achieved. Surgical debridement and reconstruction of
the knee joint was performed under antibiotic coverage
uneventfully. The patient completed a 12-week course of ciproﬂ-
oxacin without adverse events, and inﬂiximab is scheduled to
be restarted.
Conclusion: Salmonella spp. although rare, should always be con-
sidered as a potential pathogen in soft tissue and joint infections
in patients with certain comorbidities (e.g. diabetes) or under
immunosuppressive medications (such as antiTNF-a antibodies).
Opportunistic infections during antiTNF-a regimens do not neces-
sarily preclude its future use in the same patient, once infection is
treated, although secondary prophylaxis could be an issue.
R2090 Severe Clostridium difﬁcile infection in solid organ
transplant recipients
M. Claus, C. Knoop, M. Estenne, B. Byl, C. Nonhoff, M. Struelens,
F. Jacobs
Brussels, B
Objectives: Clostridium difﬁcile infection can lead to severe intesti-
nal disease in immunosuppressed patients (pts). However, the
importance of this infection is not well assessed in transplant
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recipients. Our objective was to review the clinical presentation
and treatment outcome of C. difﬁcile infection in our SOT popula-
tion.
Methods: We retrospectively reviewed the medical ﬁles of SOT
recipients with the C. difﬁcile infection (diagnosed by positive stool
culture and/or toxin detection) hospitalised in our academic hos-
pital over a 2-year period.
Results: Clostridium difﬁcile was detected by culture (21) and toxin
(10) in 21 pts (liver (seven), kidney (four), lung (four), heart-lung
(four), heart (one) and liver–kidney (one) transplantation). Six of
them (28%) had cystic ﬁbrosis. Fourteen pts developed C. difﬁcile
infection during hospitalisation (eight during the ﬁrst month
after TX) and seven were admitted for severe diarrhoea. Clinical
presentation consisted of uncomplicated diarrhea in 16 patients
(ﬁve of whom had diarrhoea severe enough to require admis-
sion). Toxin was detected in stools in six of them. Eight pts were
treated with metronidazole alone (six) or combined later with
oral vancomycine (two) because of failure. A kidney transplant
recipient presented four relapses in a few months and received
multiple courses of treatment. Severe clinical manifestations were
observed in four cystic ﬁbrosis patients, 3, 4, 8 and 9 years after
transplantation. They had major abdominal pain associated with
severe diarrhoea in one and constipation in three. They were
admitted in ICU for peritonitis and severe sepsis. Toxin was
detected in all four. Pancolitis was found on abdominal CT and
pseudomembranes or ulcerations were found on colonoscopy. A
laparotomy was performed in two pts for suspicion of perfor-
ation, which was found in one (colic perforation). Treatment con-
sisted in a combination of IV metronidazole with IV and
intracolic vancomycin (and IV Ig in one pt). Two pts died dur-
ing treatment.
Conclusion: In this study of C. difﬁcile infection in SOT, we identi-
ﬁed cystic ﬁbrosis patients with lung transplantation as a group at
risk for complicated disease (sepsis and perforation) and atypical
clinical presentation (constipation instead of diarrhoea).
R2091 Correlation of Helicobacter pylori infection with
gastric histopathologic and ultrastructural changes in chronic
end-stage renal failure patients
M. Demirbilek, G. Karabay, F. Can, H. Ozdemir, S. Aydemir,
H. Arslan, S.Boyacioglu, N. Ozdemir
Ankara, TR
Objectives: The aim of this study was to determine the histo-
pathologic and ultrastructural changes in Helicobacter pylori (Hp)
positive and negative patients with end stage renal disease
(ESRD).
Methods: We studied 36 ESRD patients with dyspeptic symptoms.
Hp was detected 12 of them with microscopic, cultural and rapid
urease techniques under endoscopic examination. For control
group 36 patients with normal renal function was selected. All
patients had dyspeptic symptoms. In control group out of 36, 12
patients were Hp positive and 24 patients were Hp negative.
Biopsies were obtained from antrum and corpus to determine
histopathologic and ultrastructural changes.
Results: There were no signiﬁcant histopathologic differences
between Hp positive and Hp-negative patients with ESRD. In
addition no signiﬁcant differences were found between patients
with ESRD and patients without ESRD in regards of the status of
Hp positivity. Chronic active gastritis was the main lesion in both
Hp-positive patients with ESRD and Hp positive control group. In
both Hp-negative groups beside chronic active gastritis, superﬁ-
cial gastritis, and chronic erosive gastritis were also the main
lesions. Ultrastructural changes in Hp-positive tissues were sim-
ilar in both groups but tight junction depletion was seemed more
distinct in patients with ESRD than control group.
Conclusions: Our study showed us histopathological and ultra-
structural changes not exactly differentiated ESRD group than the
control group. However, more studies should be preformed in lar-
ger groups.
Immunology, host defenses, immunotherapy
R2092 Cytokine induction in peripheral blood
mononuclear cells by various heat-stable serotypes of
Campylobacter jejuni
S. Chatzipanagiotou, M. Michalopoulou, I. Marinou, F. Bouﬁdou,
E. Papavasileiou, E. Trikka-Grafakos, E. Kabouri, C. Nicolaou,
N.-J. Legakis
Athens, GR
It is well known that some serotypes of Campylobacter jejuni, a
common enteropathogen, are associated with postinfectious auto-
immune-mediated disorders, like the neurologic demyelinating
Guillain-Barre´ syndrome (GBS), a result of the production of
cross-reactive antibodies to human peripheral nerve gangliosides.
However it has been reported that besides antibodies, other sol-
uble substances, like cytokines may contribute to this phenom-
enon of molecular mimicry. This prompted the hypothesis, that
GBS-triggering C. jejuni heat-stable (HS, Penner) serotypes could
induce in peripheral blood mononuclear cells (PBMC), cytokine
patterns promoting inﬂammatory processes. To test this, three
proinﬂammatory [IL-2 soluble receptor a (IL-2sRa), IL-6 and IFN-
c] and one anti-inﬂammatory (IL-10) cytokines were measured,
after induction in PBMC by seven GBS-associated C. jejuni sero-
types (HS:2, HS:5, HS:19, HS:37, the complexes HS:1,44, HS:4, 13,
16, 43, 50 and HS:23, 36, 53), ﬁve not yet reported as associated
with GBS (HS:8, HS:11, HS:15, HS:31, HS:52) and one serotype
known as not capable to cause GBS (HS:3). Interestingly no differ-
ences were found for IL-6, IFN-c and IL-10 among all serotypes
tested, whereas a decreased production of IL-2sRa characterised
serotype HS:3, the only nonsialylated serotype. Provided that IL-
2sRa is found in high concentrations in the serum of GBS patients,
our results could lead to the question suggesting, as to whether
the lack of sialylation as such, might be related to mechanisms
involving inﬂammatory factors like cytokines.
R2093 Expression of phagocyte Fc gamma receptors in
bacteraemia
S.P. Romero, J.A. Bernal, P. Ruiz, M. Rosety, M.A. Escobar,
M. Herran, C. Rivera, D. Garcia-Gil, F.A. Gomez
Cadiz, E
Background: Early markers of bacteriaemia are useful for prognosis
and, in decision making for i.v. antibiotic therapy.
Objectives: To assess the diagnostic power of the surface expres-
sion of Fc receptors for IgG (FcgRs) for the prediction of bacteriae-
mia in febrile patients.
Methods: We performed a prospective case-control study on 75
consecutive patients (pts) with an episode of bacteriaemia when
compared with 83 randomly selected concurrent febrile pts with
negative blood cultures (control). Demographic and clinical data
were collected by chart review and/or questioning their attending
physicians. Plasma levels of C-reactive protein (CRP), TNFg, IL-
1a, IL-6, IL-8 and IL-10 were determined. The surface expression
of Fc receptors for IgG (FcgRs): FcgRI, FcgRII and FcgRIII on per-
ipheral blood monocytes (M) and granulocytes (G) was assessed
by ﬂow cytometry. These studies were done concomitantly with
blood cultures.
Results: Both groups were not different for age, sex, previous
administration of immunosupressants or antibiotics, clinical sever-
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ity index or comorbid conditions. In univariate analysis, cases had
signiﬁcantly higher levels of CRP (P < 0.001), TNFg (P < 0.001),
IL-1a (P < 0.001) and IL-6 (P < 0.01) than controls. The expression
of FcgRIIA and FcgRIII by M and, that of FcgRI on G was signiﬁ-
cantly enhanced (P < 0.001) in bacteriaemic patients when com-
pared with culture-negative febrile pts; while the expression of
FcgRIIB by either M or G was signiﬁcantly decreased (P < 0.03).
Setting a cut-off value (25%) of the mean ﬂuorescence intensity
over controls for FcgRs surface expression and, assuming a preva-
lence of bacteriemia of 5-10% among hospitalized patients under-
going blood cultures, results in a sensitivity, speciﬁcity, positive
and negative predictive values of: 77%, 95%, 74%, and 98%,
respectively for M-FcgRIIA, 73%, 96%, 74% and 97%, respec-
tively for M-FcgRIII, 58%, 91%, 49% and 96%, respectively for G-
FcgRI and 71%, 81%, 57% and 73%, respectively for G-FcgRIIB.
Conclusions: Our results suggest that the surface expression of Fc
receptors for IgG on peripheral blood monocytes and granulo-
cytes may help clinicians to rule out bacteriaemia in febrile
patients.
R2094 Expression of phagocyte Fc gamma receptors in
active tuberculosis
S.P. Romero, J.A. Bernal, P. Ruiz, M. Rosety, C. Rivera,
D. Garcia-Gil, F.A. Gomez
Cadiz, E
Background: Surface receptors for IgG (FcgRs) on phagocytic cells
are important in host defence against infection.
Objectives: We have studied the expression of FcgRs by peripheral
blood monocytes (M), monocytes cultured for 72 h (M/Mø), and
granulocytes (G) in patients with active Tuberculosis (TB), during
anti-tuberculous therapy (anti-TB-Rx) and, after completition of
anti-TB-Rx.
Methods: The surface expression of the three type of FcgRs, FcgRI,
FcgRII and FcgRIII, on M, M/Mø and G were analysed by ﬂow
cytometry in 52 HIV-negative patients with TB (43 men and nine
women), at diagnosis of TB, and monthly thereafter until comple-
tion of anti-TB-Rx. FcgRs expression was assessed on resting M,
M/M and G, and on these cells after stimulation by culture in
the presence of IFNg.
Results: The expression of FcgRI and FcgRIII by M, M/M and G
was signiﬁcantly enhanced in patients with active TB by: 41  4%
and 23  2% for M, respectively (P < 0.001), 57  6% and
40  4% for M/M, respectively ( P < 0.001) and, 128  9% and
35  3% for G, respectively (P < 0.001). The expression of
FcgRIIA by M, M/Mø and G was signiﬁcantly decreased by
32  1% (P ¼ 0.02), -43  3% (P < 0.001), and 24  1%
(P ¼ 0.002), respectively. These alterations of phagocyte FcgRs
expression returned to normality after 8 weeks of effective anti-
TB-Rx and, remained normal until the end of TB treatment. The
expression of FcgRI, FcgRIIA and FcgRIII by M, M/M or G from
patients with TB was signiﬁcantly increased by culture in the
presence of IFNg (P < 0.001). Nevertheless, the expression of
FcgRIIB by M, M/Mø or G from patients after effective anti-TB-
Rx was not signiﬁcantly increased by culture in the presence of
IFNg.
Conclusions: Macrophages and granulocytes from HIV-negative
patients with active tuberculosis exhibit an increased expression
of FcgRI, FcgRIIA and FcgRIII and, an impaired expression of
FcgRIIB, that disappear after effective anti-TB therapy.
R2095 A durable response to relapsing Clostridium difﬁcile
colitis may require combined therapy with oral vancomycin and
intravenous gamma globulin
L. Cone, M. Taylor, H.l. Tarleton, R. Gade-Andavolu, V.D. Jodoin
Rancho Mirage, USA
Objectives: Since being ﬁrst described in the late 1970s relapsing
pseudomebranous colitis occurs in 10–20% of patients after
being treated with oral metronidazole, vancomycin or bacitracin.
Previous studies in children with relapsing C. difﬁcile colitis
have shown low or absent levels of toxin A antibodies. We
studied eight adult patients with relapsing C. difﬁcile colitis
who were hospitalised with profound diarrhoea and dehydra-
tion.
Methods: Eight adult patients were studied ranging in age from 55
to 78 years. All had at least 1 positive stool for C. difﬁcile Toxin A
or B by ELISA assay. Toxin A speciﬁc-immunoglobulin was also
assayed by ELISA using ﬂat-bottom microtitre plates and were
incubated overnight with toxin A in carbonate buffer. Horseradish
peroxidase conjugated afﬁnity-purifed goat anti-human IgG was
added. The OD was measured at 405 nm on a micro-ELISA plate
reader. Patients received oral vancomycin at a dose of 500 mg
thrice daily together with IVIG, 30 g twice within 48 h. Five
patients also received Saccharomyces boulardii orally twice daily.
Results: All eight patients failed to produce detectable C. difﬁcile
antibody. Treatment with oral vancomycin and IVIG resulted in
disappearance of diarrhoea and normalisation of leucocytosis
within 4 days of initiating treatment. C. difﬁcile toxin was no lon-
ger demonstrable in the stool by day 5 of treatment, although rec-
tal bleeding persisted in two patients with severe
pseudomembranous colitis. None of these eight patients had
recurrent disease after treatment.
Conclusion: A combination of oral vancomycin together with IVIG
appears to be successful treatment in patients with relapsing C.
difﬁcile colitis. All eight patients in this small study were defective
in their ability to produce speciﬁc antibody to toxin A. Further
studies evaluating the nature of the defect in speciﬁc antibody for-
mation that likely is responsible for this syndrome are currently
underway.
R2096 Alteration of phagocyte Fc gamma receptors
expression in HIV-infected patients with tuberculosis
P. Ruiz, J.M. Aparicio, M.B. Dominguez, A.A. Garcia-Egido,
F.J. Fernandez, M.E. la Hoz de, C. Rivera, F. A. Gomez
Cadiz, E
Background: Macrophage and granulocyte receptors for IgG
(FcgRs) are important in host defence against infection.
Objectives: We have studied the expression of FcgRs by peripheral
blood monocytes (M), monocytes cultured for 72 h (M/Mø), and
granulocytes (G) in HIV-infected patients with active tuberculosis
(TB), during anti-tuberculous therapy (anti-TB-Rx) and, after com-
pletion of anti-TB-Rx.
Methods: The surface expression of FcgRI, FcgRII and FcgRIII, on
M, M/Mø and G were analyzed by ﬂow cytometry in 36 HIV-
infected patients with active TB (33 men and three women), at
diagnosis of TB, and monthly thereafter until completition of anti-
TB-Rx. FcgRs expression was assessed on resting M, M/Mø and
G, and on these cells after stimulation by culture in the presence
of IFNg.
Results: The expression of FcgRI and FcgRIII by M, M/M and
G was signiﬁcantly enhanced in HIV-infected patients with act-
ive TB by: 32  3% and 16  2% for M, respectively
(P < 0.001), 41  4% and 27  2% for M/Mø, respectively
(P < 0.001) and, 52  5% and 18  1% for G, respectively
(P < 0.001). The expression of FcgRIIB by M, M/M and G
was signiﬁcantly decreased by 22  1% (P ¼ 0.02), 31  2%
and, 17  1% (P < 0.005), respectively. These alterations of
phagocyte FcgRs expression returned to normality after
12 weeks of effective anti-TB-Rx and, remained normal until the
end of TB treatment. The expression FcgRI, FcgRIIA and
FcgRIII by M, M/Mø and G from HIV-infected patients with
active TB was signiﬁcantly increased by culture in the presence
of IFNg (P < 0.005).
Conclusions: Macrophages and granulocytes from HIV-infected
patients with active tuberculosis exhibit an increased expression
of FcgRI and FcgRIII and an impaired expression of FcgRIIB.
These alterations of phagocyte FcgRs expression during active
tuberculosis in HIV-infected patients disappear after effective
anti-tuberculous therapy.
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R2097 High prevalence of phagocytic-resistant capsular
serotypes of Klebsiella pneumoniae in liver abscess
H. Li-Yueh
Taipei, TW
Objectives: To assess the role of K. pneumoniae CPS K1 or K2 in
liver abscess and development of endophthalmitis, we used an
experimental model of phagocytosis for K. pneumoniae with differ-
ent CPS isolated from patients with and without liver abscess and
compared the resistance of the isolates to neutrophil-mediated
phagocytosis.
Methods: Neutrophil phagocytosis of 70 CPS isolates included K1
(n ¼ 23)/K2 (n ¼ 10), non-K1/K2 (n ¼ 37) were evaluated by ﬂow
cytometry, ﬂuorescence imaging, and electron microscopy.
Results: K1/K2 isolates were signiﬁcantly more resistant to phago-
cytosis (P < 0.0001) than non-K1/K2 isolates, and displayed
increased resistance to intracellular killing. Although mucoid phe-
notype (M-type) K1/K2 isolates were signiﬁcantly resistant to
phagocytosis (P ¼ 0.0029) than M-type non-K1/K2, no signiﬁcant
difference in the phagocytosis rate was observed between K1/K2
isolates with M-type and non-M-type (P ¼ 0.0924). Mucoidy is an
associated factor that was predominant in K1/K2 isolates, but
which itself is not an independent inﬂuence to phagocytic resist-
ance. The K1/K2 CPS proved signiﬁcantly more resistant to pha-
gocytosis than non-K1/K2 CPS in liver abscess isolates
(P < 0.0001) and nonabscess isolates (P ¼ 0.0001), implicating K1/
K2 isolates were generally more virulent in both liver abscess and
in nonliver abscess conditions.
Conclusions: Resistance of CPS K1 or K2 K. pneumoniae to phagocy-
tosis and intracellular killing may thus contribute to their high
prevalence in liver abscess and uniquely in endophthalmitis.
R2098 Hierarchy of baby-linked immunogenetic risk
factors in vertical transmission of hepatitis C virus
G. Bossi, A. Maccabruni, I. Pacati, M. Degioanni, E. Minola,
M. Martinetti
Pavia, Seriate, Asti, Bergamo, I
Objective: Mother-to-infant transmission of hepatitis C virus
(HCV) represents the major cause of paediatric HCV infection
today but the rate of vertical transmission is low (5–6%). Data
about speciﬁc predictors of HCV transmission are conﬂicting.
Although the hypothesis regarding the role of host defences is
highly intriguing, immunogenetic inﬂuence has been poorly inves-
tigated. All existing studies on associations between HCV and
genetic markers have been done in adults and are mainly con-
ﬁned to HLA-class II serological polymorphisms.
Methods: Among 290 parities of HCV-RNA infected women, 21
babies (7%) resulted infected (HCV-RNA positive steadily posit-
ive over 20 months of age). All the 21 infected babies, 44 ran-
domly selected uninfected ones (steadily negative for HCV-RNA
during a follow-up of 2 years) and their mothers were investi-
gated for HLA-G, -C, -DRB1, -DQA1 and -DQB1 molecular poly-
morphisms. Several nonimmunogenetic parameters were also
considered and their contribution was weighted by multivariate
analysis.
Results: Among the different covariates, a hierarchy of suscepti-
bility has been settled using multiple logistic regression analy-
sis: HLA-Cw*07,-G*010401,-DRB1*0701,-DRB1*1401, maternal
viral genotype 1b, male sex, ﬁrst birth and breast feeding can
be considered as risk factors for HCV vertical transmission. On
the contrary, protection was conferred by the HLA-DQB1*06,-
G*0105N,-Cw*0602,-DRB1*1104,-DRB1*1302 alleles and by for-
mula feeding.
Conclusions: Our study demonstrates that the immunogenetic fac-
tors related to maternal and neonatal HLA proﬁle may affect
HCV vertical transmission and is independent from the other
nonimmunogenetic parameters. The ﬁnding of babies genetically
able to ﬁght the virus so precociously could be a tangible demon-
stration of the feasibility of a successful vaccine.
R2099 The role of interleukin-16 in juvenile idiopathic
arthritis: proinﬂammatory or antiinﬂammatory
B. Kocazeybek, S. Altun, O¨. Kasapcopur, M. Aslan, E. Kiray,
G. Ercan, S. Saribas, N. Arisoy
Istanbul, TR
Objectives: Juvenile idiopathic arthritis (JIA) is a systemic autoim-
mune disease of childhood characterised by chronic inﬂammatory
reaction in joints. Cytokine response in JIA patient is well deﬁned.
The proinﬂammatory and anti-inﬂammatory roles of different cy-
tokines are also determined. But the role of newly deﬁned inter-
leukin (IL)-16 (proinﬂammatory or anti-inﬂammatory) cannot be
clearly deﬁned in rheumatoid arthritis patients. The aim of this
study is to investigate the IL-16 levels in JIA patient as a novel
laboratory data and to determine the exact role (proinﬂammatory
or anti-inﬂammatory) of this cytokine.
Methods: Seventy-one JIA patients (47 female, 24 male) were stud-
ied in this study. Twenty-nine of JIA patients had active disease
during the evaluation. Control group consisted of 17 healthy chil-
dren. Serum samples of all subjects were studied. IL-1b, IL-6 and
TNF-a levels were determined to demonstrate the proinﬂammato-
ry response. Interleukin 1b, 6, 16 and TNF-a were measured by
ELISA methods. C-reacting protein (CRP) was studied turbidimet-
ric methods.
Results: IL-6, TNF-a, IL-16 and CRP levels of JIA patients were
signiﬁcantly higher than those of healthy children (P ¼ 0.014,
0.0001, 0.008 and 0.001, respectively). IL-6, TNF-a, IL-16 and CRP
levels of JIA patients with active disease were signiﬁcantly higher
than those of patients who were in inactive state of disease
(P < 0.05). Interleukin-16 levels of JIA patient showed signiﬁcant
correlation with IL-1b, IL-6, TNF-a, CRP levels, erythrocyte sedi-
mentation rate and platelet count. (P ¼ 0.16, 0.047, 0.001, 0.013,
0.026 and 0.034, respectively).
Conclusions: The results of this study that investigated the IL-16
levels of JIA patients for the ﬁrst time, demonstrated the correla-
tion between the levels of IL-16 and other well known proinﬂam-
matory cytokine. Thus, IL-16 can be deﬁned as a proinﬂammatory
cytokine.
R2100 Effect of thalidomide on serum pro-inﬂammatory
mediators in experimental sepsis by multiresistant Pseudomonas
aeruginosa
N. Bolanos, F. Baziaka, V. Papadakis, A. Pantopoulou,
H. Giamarellou, P.E. Karayannacos, E.J. Giamarellos-Bourboulis
Athens, GR
Objectives: Thalidomide has been proved to be a potent immuno-
modulator in experimental sepsis by susceptible Escherichia coli
(Giamarellos-Bourboulis et al. AAC 2003). Its effect was tested in
sepsis by multidrug-resistant (MDR) P. aeruginosa.
Methods: Sepsis was induced in 64 rats after intraperitoneal injec-
tion of an 8 log 10 inoculum of one isolate resistant to ceftazi-
dime, imipenem, ciproﬂoxacin and amikacin. Animals were
divided in three groups: A (n ¼ 15) controls; b (n ¼ 24) adminis-
tered seed oil; and C (n ¼ 25) administered 50 mg/kg of thalido-
mide. Thalidomide was diluted in seed oil and it was given by
an orogastric catheter 30 min before bacterial challenge. Five
hours after bacterial challenge animals were sacriﬁced and blood
was sampled by their inferior vena cava for determination of
endotoxins (LPS), tumour necrosis factor-alpha (TNF-a), inter-
feron-gamma (INF-c), nitric oxide (NO) and malondialdehyde
(MDA). LPS were estimated by the QCL-1000 LAL assay, TNF-a
and INF-c by EIA, NO by a colorimetric assay and MDA by the
thiobarbiturate assay.
Results: Median LPS of groups A, B and C were 13.1, 13.3 and
13.3 EU/mL, respectively. Respective values of serum TNF-a were
72.5, 62.5 (pNS compared with A) and <5 pg/mL (P ¼ 0.012 com-
pared with A); of serum INF-c 835.6, 125.0 and 385.0 pg/mL; of
serum NO 1150.0, 132.5 and 192.5 lM; and of serum MDA 5.5, 2.0
and 4.5 mM.
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Conclusions: In an experimental model of sepsis by MDR P. aerugi-
nosa with similar levels of enodoxaemia in all groups of treatment,
thalidomide decreases serum levels of TNF-a without affecting
the other pro-inﬂammatory mediators.
R2101 Assessment of the inﬂuence of IL-8 concentration in
the cerebrospinal ﬂuid on the course of bacterial meningitis
M. Bociaga-Jasik, A. Kalinowska-Nowak, A. Garlicki, T. Mach
Cracow, PL
Objectives: To determine the role of IL-8 in the pathogenesis of
bacterial meningitis (BM).
Methods: A total of 42 patients (13 female, 29 male, age range 20–
80 years, mean age 45.5 years) with BM were investigated. Con-
trol group consist of 25 patients (two female, 23 male, mean age
31 years) with viral meningitis (VM) and 23 patients (nine female,
14 male, mean age 30years) without meningitis. In all investigated
group concentration of IL-8 (cIL-8) in CSF was determine by
ELISA at the day of admission (CSF-I). In the group with BM cIL-
8 was checked in CSF taken 72 h later (CSF-II).
Results: cIL-8 in CSF-I in patients with BM was signiﬁcantly higher
(P < 0.001), mean 1696 pg/mL (min. 852 pg/mL, max. 2631 pg/
mL) than in VM (mean 405 pg/mL, min. 0 pg/mL, max. 2089 pg/
mL) and in the group without neuroinfection (mean 32.59 pg/mL,
min. 0 pg/mL, max. 324.9 pg/mL). In BM, cIL-8 in CSF-II was
lower (P < 0.001) than in CSF-I, mean 693.7 pg/mL (min. 58.4 pg/
mL, max. 2181 pg/mL). However during the analysis of selected
cases increase of cIL-8 in CSF-II was observed among patients
whose conditions had deteriorated. Correlation between cIL-8 and
pleocytosis (r ¼ 0.46647, P ¼ 0.002), protein (r ¼ 0.42710,
P ¼ 0.005) and glucose (r ¼ -0.4323, P ¼ 0.004) concentration in
CSF was observed. Inversely proportional dependence between
cIL-8 in CSF-I and number of points aggregated by patients in
GCS was found. There was no correlation between the course of
BM and cIL-8 in the CSF-I. Whereas, mean cIL-8 1369.8 pg/mL in
CSF-II was associated with increase risk of patient death, and was
higher (P < 0.001) than in group of patients who recovered with-
out sequels (mean cIL-8 29.84 pg/mL). Also in the group of
patients who developed neurological complications cIL-8 in CSF-II
was increase (mean cIL-8–940 pg/mL).
Conclusion: (i) Assessment of cIL-8 in CSF can be useful in differ-
ential diagnosis of meningitis. (ii) Correlation between cIL-8 and
severity of inﬂammation in subarachnoid space has been
observed. (iii) Persistence of high levels of IL-8 in CSF in spite of
therapy is associated with increase mortality rate and risk of neu-
rological sequels.
R2102 Moxiﬂoxacin modulates the immune responses of
human neutrophils
B. Ko¨nig, W. Ko¨nig
Magdeburg, D
Background: The new quinolones such as Moxiﬂoxacin are repor-
ted to accumulate in active form in phagocytic cells. Thus their
modulatory role on phagocyte functions is of great interest. Neu-
trophils control infection by a sequential multistep process leading
to oriented motility, the chemotaxis. The parallel changes in the
expression pattern of surface molecules can be regarded as a
reﬂection of neutrophil reaction (adhesion, oxidative burst etc.). In
addition human neutrophils recognise conserved pathogen-associ-
ated microbial products (PAMPs) through the mammalian toll-like
receptors (TLRs). Toll-like receptor 4 acts as the primary effector
of LPS recognition, TLR-2 mediates responses to Gram-positive
bacterial proteins and TLR9 is involved in recognition of bacterial
DNA. The objective of our study was to investigate the immuno-
modulatory properties of Moxiﬂoxacin, a 8-methoxyquinolone on
human neutrophils (PMN).
Methods: We used a two-compartment chamber system (Tran-
swell) to analyse the inﬂuence of Moxiﬂoxacin on the migration
of neutrophils towards the chemotactic factors interleukin-8 (IL-
8), leucotriene B4 (LTB4), and C5a. The surface expression of
function-associated surface molecules, such as CD11b, CD44,
CD69, CD66b, the fMLP receptor and the Toll-like receptors 2-
and 4 were studied on chemoattracted and on nonmigrated
PMN by FACS analysis and by quantitative PCR (TLR-2, TLR4).
Moxiﬂoxacin was used at total amounts between 0.008 and
80 lg.
Results: The presence of Moxiﬂoxacin resulted in an increased
migration of PMN towards IL-8 by up to 166 + 8%, but sup-
pressed the migration towards LTB4 down to 1.15 + 0.87% and
showed no effects with regard to C5a. With regard to the activa-
tion status of chemoattracted PMN Moxiﬂoxacin only modulated
C5a-induced CD66b expression; a downregulation by up to 26%
was observed. Moxiﬂoxacin modulated TLR2, TLR4 and TLR9
mRNA expression in chemoattracted neutrophils. All modulatory
effects of Moxiﬂoxacin were observed in a dose-dependent man-
ner (0.008–80 lg).
Conclusion: Our data emphasises that the antimicrobial agent
Moxiﬂoxacin has the potential to modulate the innate immune
response during host defence via deﬁned cellular signalling path-
ways. This immunomodulatory capacity of Moxiﬂoxacin may
thus contribute to the early host response against microbial infec-
tions.
R2103 Lipopolysaccharides of Proteus mirabilis O3 and
O18 induce cell-speciﬁc IL-8 response within the human urinary
tract
A. Brauner, M. Chromek, D. Stankowska, E. Dadfar, W. Kaca,
J. Lundahl
Stockholm, S; Lodz, PL
Objectives: Proteus mirabilis is commonly associated with complica-
ted urinary tract infections and may cause cystitis, eventually
acute pyelonephritis or even septicaemia. Patients with functional
urinary tract anomalies or with chronic instrumentation run the
greatest risk. The objectives of present study was to evaluate the
role of different cell types within the human urinary tract, uroepi-
telial cells, renal cells and monocytes, and different Proteus mirabil-
is strains O3 and O18 in relation to the local inﬂammatory
response. The immunodeterminant oligosaccharide characteristic
for P. mirabilis O3 (1959) is D-galacturonyl 1,4-D-galactosamine
disaccharide substituted by lysine, while Proteus O18 is character-
ised by a phosphocholine substitute.
Methods: Cells were stimulated with LPS from Proteus mirabilis O3
and O18. The production of interleukin-8 was measured on the
protein and mRNA levels using ELISA and real-time PCR,
respectively. Expression of CD-14 on the cell surface was studied
using ﬂow cytometry.
Results: Monocytes and uroepithelial cells reacted to LPS by
higher production of IL-8 when compared with renal epithelial
cells. The response to LPS of P. mirabilis O18 was higher when
compared with P. mirabilis O3 both in monocytes and renal epi-
thelial cells but without statistical signiﬁcance. Since P. mirabilis
O18 is characterised by its phosphocholine substitute, we stimula-
ted cells also with phosphocholine alone and in combination with
P. mirabilis O3 LPS. However, an IL-8 response was not induced
after stimulation with phosphocholine, nor was it augmented after
simultaneous stimulation together with LPS. Despite previous
controversies, uroepithelial cells expressed CD-14 and accordingly
reacted to LPS by higher production of IL-8, which was in con-
trast to renal epithelial cells.
Conclusion: Our ﬁndings suggest that phosphocholine-rich O18
lipopolysaccharide is not biologically more active in monocytes
and different cells of human urinary system. Likewise, IL-8
response was not induced or augmented by adding of free phos-
phocholine to the cells. Our data suggest that different cells
within the human urinary tract play distinctive roles during
urinary-tract infection and that the IL-8 response to lipopolysac-
charides does not differ between strains with different pathogen-
icity.
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R2104 Innate immunity as a site of production of
procalcitonin
D. Plachouras, A. Antonopoulou, M. Bristianou, T. Tsaganos,
H.Giamarellou, E.J. Giamarellos-Bourboulis
Athens, GR
Objectives: Although there are conﬂicting data in the literature, it
appears that procalcitonin (PCT), which is a reliable marker of
sepsis, is produced, at least in part, by cells of the monocyte/
macrophage lineage. Possible differences in production of PCT by
human monocytes after stimulation by susceptible and multidrug-
resistant (MDR) isolates of Gram-negative bacteria were studied.
Methods: Human monocytes were isolated from healthy volunteers
after centrifugation of heparinised blood over Ficoll Hypaque, incu-
bation of the mononuclear fraction in RPMI 1640 with 10% FCS and
2 mM glutamine, and removal of nonadherent cells. Monocytes
were subsequently harvested and resuspended at a ﬁnal concentra-
tion of 50 000 cells/well. Inocula of 4.6 log10 and 6.6 log10 of eight
susceptible and 12 MDR isolates of P. aeruginosa and 10 susceptible
and 10 MDR isolates E. coli were then added, one in each well and
supernatants were collected after 2 and 4 h of incubation. PCT was
measured by immunochemoluminometric assay.
Results: PCT (mean  SE ng/10 000 cells) after stimulation by a
4.6 log10 inoculum of Pseudomonas aeruginosa was 0.27  0.16 after
2 h. Respective values after stimulation with a 6.6 log10 inoculum
were 2.98  0.54 after 2 h and 2.08  1.04 after 4 h (P: NS). Values
of PCT after stimulation by a 4.6 log10 inoculum E. coli were
0.10  0.02 at 2 h and after stimulation by 6.6 log10 inoculum
were 0.05  0.05 and 0.13  0.05 at 2 and 4 h, respectively. Com-
pared with stimulation by P. aeruginosa, production of PCT after
stimulation by E. coli was signiﬁcantly decreased at both 2
(P < 0.001) and 4 h (P ¼ 0.04).
Conclusions: It appears that PCT production by human monocytes
depends on the challenge microorganism. It is possible that differ-
ent signal transduction pathways might be involved after stimula-
tion by various microorganisms. Correlation to clinical data
remains to be studied.
R2105 Clarithromycin: immunomodulatory therapy of
experimental sepsis and acute pyelonephritis by Escherichia coli
E.J. Giamarellos-Bourboulis, L. Sabracos, A. Antonopoulou,
F. Baziaka,P. Koutoukas, V. Koussoulas
Athens, GR
Objectives: Clarithromycin (CL) has been proved an effective im-
munomodulator when administered intravenously in parallel to
bacterial challenge in experimental sepsis by Pseudomonas aerugi-
nosa (Giamarellos-Bourboulis et al. AAC 2004). Its effect was
assessed in experimental sepsis by Escherichia coli when applied
on sepsis-associated pulmonary edema (SAPO).
Methods: Acute pyelonephritis was induced after ligation of the
right ureter and injection of one isolate susceptible to amikacin
(AM) into the renal pelvis of 70 rabbits assigned into seven
groups of treatment. A controls; B–D therapy initiation in parallel
to bacterial challenge as follows: B: CL; C: AM; D: both agents; E–
G: therapy initiation on SAPO as follows: E: CL; F; AM, G: both
agents. SAPO was presented six hours after bacterial challenge.
CL was infused at two iv doses with a 2-hour interval between
them, 80mg/kg the ﬁrst dose and 50mg/kg the second dose. AM
was given iv bolus at 15 mg/kg following the ﬁrst dose of CL.
Tumor necrosis factor-alpha (TNF) was estimated by a bioassay
on L929 ﬁbrosarcoma cell line and malondialdehyde (MDA) by
the thiobarbiturate assay. Blood monocytes were isolated after
centrifugation of whole blood over Ficoll Hypaque, incubation of
the mononuclears in RPMI with 10% FCS and removal of nonad-
herent cells. Monocytes were lysed and caspase-3 activity was
estimated in the cytosolic extract by a chromogenic assay.
Results: Mean  SE survival of animals of groupsA, B, C, D, E, F and
G were 2.51  0.61, 16.00  2.43, 13.45  2.55, 15.75  2.97,
7.60  2.79, 10.25  2.90 and 11.40  3.05 days, respectively. Med-
ian TNF at 48 h of groups A, B, C and D were 37.5, 5.75, 5.75 and
5.75 pg/mL respectively and of MDA 6.6, 2.7, 1.8 and 3.3 mM,
respectively. Median caspase-3 activity at 24 h of groups A, B, C and
Dwere 272.8, 18.1, 6.1 and 0 pmol/min/10 000 cells, respectively. On
SAPOmedian TNF of groups E, F and Gwere 8.62, 8.00 and 11.5 pg/
mL and at 48 h 11.5,11.5 and 5.75 pg/mL respectively. On SAPO
median MDA of groups E, F and G were 4.1, 5.1 and 5.2 mM and at
48 h 1.6, 2.3 and 4 mM, respectively. On SAPO median monocyte
caspase-3 activity of groups E, F and G were 4.9, 100 and 17 pmol/
min/10 000 cells and at 24 h 0,10 and 0 pg/mL, respectively.
Conclusions: Intravenous CL attenuates systemic inﬂammation and
apoptosis being a promising immunomodulator for sepsis since
its efﬁcacy was proven after administration on SAPO.
R2106 Absence of booster effect 6 months after
vaccination in individuals with initial long-term protection
against diphtheria
E. Danilova, A. Shiryaev, V. Skogen, E.K. Kristoffersen, H. Sjursen
Bergen, N; Arkhangelsk, RUS; Tromsø, N
Objectives: In the 1990s, the Newly independent States of the for-
mer Soviet Union experienced the largest diphtheria outbreak
since the 1960s. This resulted in a change in the Russian vaccine
programme, including extra booster doses. Increased herd immu-
nity was a result of this initiative but additional boosters also
caused vaccination of highly protected individuals especially
among children and young adults. The main objective of the
investigation was to study the booster response in individuals
with initially high antitoxin levels.
Methods: Sixty participants of the study got a single dose of diph-
theria-tetanus vaccine (5 Lf diphtheria toxoid). The mean age was
18.7 years and the mean time since the last vaccination was
4.3  3.6 (SD) years. Blood samples were taken before the booster
doses were given and 1 week and 1, 2, 3 and 6 months after. A
double antigen enzyme linked immunosorbent assay was used for
the assessment of the antibody levels. The study population was
divided into two groups based on antibody levels to investigate if
high initial antibody levels inﬂuenced on the antibody response.
The ‘low’ group included participants with initial antibody level
<1 IU/mL, the ‘high’ group with initial antibody level higher than
or equal to 1 IU/mL (long-term protection).
Results: The initial antibody level was high in all individuals; geo-
metrical mean titre (GMT) was 0.73 IU/mL. The highest antibody
levels in both groups were reached 1 month after the vaccination
(GMT 5.07 IU/mL); the difference between the groups was not sig-
niﬁcant. The ratio between initial and 1 month antibody concentra-
tions was >10 times higher and after 6 months still four times
higher in those with initial antibody levels <1 IU/mL. In indivi-
duals with initial antibody levels >1 IU/mL a twofolddecrease was
observed after 6 months compared with the initial levels.
Conclusions: Both groups responded to the booster by signiﬁcant
enhance of the GMT, but 6-month after the booster effect was
maintained only in the ‘low’ group. Thus, vaccination of individu-
als with initial long-term protection against diphtheria is unneces-
sary and should be avoided.
R2107 The inﬂuence of LPS on AMPs expression in
HaCaT keratinocytes
J. Tustanowski, K. Cholewa
Katowice, PL
Objectives: Antimicrobial peptides (AMPs) – very important com-
ponent of innate immunity acts either directly, destroying bacteria,
fungi and some viruses or indirectly, stimulating some elements of
inﬂammatory and immune reactions. They are present usually in
regions, where contact with environmental pathogens is more fre-
quent (on mucosal and epithelial surfaces). Constitutive (hBD-1) or
inducible (hBD – 2–4; hCAP18/LL-37) expression of AMPs has
been observed in keratinocytes. We expected that LPS – important
external stimulus, originated from G(-)bacteria cell wall and acting
via TLRs should increase expression of genes coding for b-defen-
sins and cathelicidines. The aim of this study was to evaluate
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correlation between LPS concentrations, time of acting and AMPs
expression in immortalised human keratinocyte line HaCaT.
Methods: Human immortalised keratinocytes HaCaT were cultured
in NUNCs 6-well culture plates in 37C and 5% CO2, using K-SFM
medium (Gibco BRL). Upon reaching 100% conﬂuency, keratino-
cytes were stimulated with LPS from E. coli K-235 (Sigma Chemical
Co.) in concentrations of 1 and 10 lg/mL, acting 1 and 24 h. Every
variant was repeated three times. mRNA was isolated from each
well with TRIZOL (Gibco BRL) according with Chomczyn-
ski. Primers for LL-37, hBD-1 and hBD-2 were manufactured in
Proligo LLC and used to determine mRNA levels in RT-QPCR
reaction performed in ABI Prism 7000 device. AMPs expression
was measured in numbers of copy/1 lg of total RNA.
Results: A low LPS concentration (1 lg/ml) in culturing medium
resulted in decreasing of expression of all examined AMPs after
1 h and 24 h of incubation. 10 lg/ml concentration was most
effective for hBD-2 stimulation, reaching over 2 times higher
expression after 1 h incubation and almost 5 times higher concen-
trations after 24 h incubation with LPS. Less effective was this
LPS concentration for hBD-1 expression, almost 2 times higher
expression has been observed only after 24 h incubation with this
stimulant. LPS concentrations used in the experiment were inef-
fective for kathelicidine stimulation.
Conclusion: There are different requirements for LPS concentra-
tions and time of action for different AMPs. LPS acts on expresion
of AMPs by time-and-dose-dependent manner.
Pathogenesis, animal models including experimental treatment
R2108 Moxiﬂoxacin pleural concentrations in a human
like treated experimental pneumococcal pneumonia rabbit
model
M. Etienne, D. Croisier, C. Lequeu, L. Piroth, H. Portier,
P. Chavanet
Dijon, F
Pleural effusion, most often purulent, occur in approximately 25%
of pneumococcal pneumonia cases and are associated with poor
prognosis and therapeutic failure. Little is known concerning the
pleural diffusion of drugs.
Objective: To investigate the pharmacokinetics (PK) of MXF 400
mg od in the pleural space.
Methods: A total of 140 rabbits were intrabronchially inoculated
with 10 log CFU/mL of penicillin-resistant pneumococci. Pleural
punctions were done once to thrice during the second day of the
experiment. MXF was infused through central venous catheter by
computer controlled pump in order to simulate the human PK of
MXF 400 mg o.d. for 48 h; then, MXF doses were modiﬁed in
order to simulate low (6%) to high doses (600%). Blood samples
(5–7 per rabbits) were obtained through the second central venous
catheter. A microbiologic assay was used. PK data were analysed
by using specialized software.
Results: The human MXF 400 mg regimen was correctly simulated
in rabbits ; the variations in doses were associated with propor-
tionnal variations of both seric concentrations and AUCs. Pleural
MXF concentrations varied with the dose and proportionnally
with the blood concentrations. For MXF 400 mg o.d., a ﬁnal model
was constructed with the following pleural concentrations [mg/L
(SD)] vs. time (hour : H):H1: 5.2 (2); H3: 3.8 (0.7); H4: 4.4 (0.3);
H5: 3.2 (0.5); H6: 2.4 (1.2); H7: 2.9 (0.6); H21: 1.8 (1.2); H24: 1.6
(1.2). Positive pleural cultures were associated with lower MXF
concentrations both in blood and pleural effusion.
Conclusion: MXF concentrations were similar in blood and pleural
space during parapneumonic pleuresia; however the interindivid-
ual variations were high.
R2109 The procalcitonin expression in stimulated human
peripheral blood mononuclear cells
H. Choi, Y. Lee, M. Cho
Seoul, KOR
Objectives: Procalcitonin (PCT) is well known as a marker of
severe systemic bacterial infection. PCT consists of fragments kat-
acalcin and calcitonin, which are precursors of calcitonin in thy-
roid. The potential role in the pathophysiology of PCT in
inﬂammatory process is still unclear. This study was aimed to
determine whether PBMC can induce PCT when they are stimula-
ted with endotoxin or other stimuli including pro-inﬂammatory
cytokine. PCT was investigated in terms of its biologic role and its
role as a surrogate marker in sepsis.
Methods: Mononuclear cells were prepared from heparinized
venous blood from donor by density gradient. PBMC were
cultured in RPMI with 10% FCS and penicillin/streptomycin. Sti-
mulated cells were incubated overnight in media containing each
LPS (1 mg/mL), PMA (5 ng/mL), TNF-a (10 ng/mL), and IL-18
(5 nM). Intracellular PCT content was estimated using anti-katacal-
cin Ab-FITC, and anti-calcitonin Ab-FITC each. Monocytes were
identiﬁed by phycoerythrin-conjugated CD14 Ab. Flow cytometric
analysis was performed in treated PBMC with brefeldin A and
permeabilising solution. Ten micrograms of soluble TNF receptor
(sTNFR) were pretreated in PBMC 1 h prior to adding stimuli.
Quantitation of PCT was performed in U937 cells and whole
blood by immunoluminometer.
Results: (i) LPS slightly increased the expression of intracellular
PCT from 9.0 to 13.2% in CD14-positive monocytes from healthy
donors (one representative, n ¼ 5). When PMA was used, the
expression of intracellular PCT in CD14-positive cells increased
from 2.9 to 7.6%. (ii) For PBMC from patients with sepsis, PMA
induced much higher expression of PCT than in cells from
healthy donors (from 5.8 to 36.9%, n ¼ 3). LPS slightly increased
PCT in the same cells (from 1.0 to 4.0%). In the same cells, sTNFR
mildly inhibited the PCT expression in PMA stimulated cells.
However, LPS-induced PCT expression rather decreased in the
presence of sTNFR. (iii) PCT was slightly increased by various
stimulants including LPS, PMA, TNF-a, IL-18 (control 0.51 ng/
mL, vs. 0.76, 0.87, 0.61, 0.62 ng/mL, respectively), but PCT in
whole blood was not signiﬁcantly increased by stimuli.
Conclusion: The PCT expression increased in monocytes of PBMC.
The induction of PCT in stimulated cells was higher when using
PMA compared with LPS. Also, the monocyte response to inﬂam-
matory stimuli was enhanced in septic patients. The PCT expres-
sion is partly mediated through TNF-a production.
R2110 Inﬂuence of 82MDa plasmids Yersinia
pseudotuberculois on morphological changes in mice
I. Shurigina, I. Malov, V. Klimov, M. Chesnokova
Irkutsk, RUS
Objectives: Two strains of ﬁrst serotype Y. pseudotuberculosis were
used in the study. One of them had a plasmid 47 MDa and the
second had plasmis 47 and 82 MDa.
Methods: The mice CBAj were inoculated per os by the agent in
isotonic solution. The doze contained 1000 millions microbial cells
on one animal. Ileums, livers and liens of the animals were inves-
tigated by light and electronic microscopy. The distribution rate
of agent in mice was investigated by indirect immunoﬂuorescence
during 1–10 days after inoculation.
Results: The morphological changes in ileum included of the
inﬂammatory of gut, desquamation of epithelium, enlargement of
Peyer’s platelets. Inﬂammatory process in case of Y. pseudotubercu-
losis (82:47 MDa) initiated in earlier periods and was more inten-
sively, then in case of Y. pseudotubtrculosis (47 MDa) infection. In
liver we observed the inﬁltration by granulocytes, macrophages
and granulomas later. Same as process in ileum we saw more
quickly and early changes if infectious agent had plasmids 47 and
82 Mda from second day vs. fourth if it had only 47 MDa plasmid.
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By lien investigation we observed interested immunomorphologi-
cal changes – reactive centres in white pulp developed from sec-
ond day in mice with only 47 MDa Y. pseudotuberculosis induced
infection vs. fourth day in case with 47 and 82 MDa. Mice which
were inoculated two-plasmid strain, had white pulp necrosis from
seventh day. Immunoﬂuorescence analysis of different tissues
developed more quick spread of Y. pseudotuberculosis (82:47 MDa)
vs. Y. pseudotuberculosis (47 MDa) in organisms of animals.
Conclusions: There are some morphological differences in investi-
gated organs at the animal infection by agent strains possessing
various plasmid spectrum. Mice infected by two-plasmid agent
strain (82:47 MDa) had the morphological changes in investigated
organs occurred in earlier periods that were more expressed in
comparision with a contamination by a one-plasmid strain
(47 MDa). In controversy of this immunomorphological process in
lien was more expressed in case with 47 MDa only strain. If infec-
tious agent has both 47 and 82 MDa plasmids we observed sup-
pression of immunological response.
R2111 Rabbit and murine models of Borrelia burgdorferi
infection for evaluating immune protection and the treatment of
Lyme disease
C. Pavia, S. Bittker, T. Daniels
Old Westbury, Valhalla, USA
Objectives: To further evaluate the usefulness of two experimental
animal models of Lyme borreliosis for providing key insights on
borrelial transmission and the development of immune mecha-
nisms associated with, and on therapeutic options for, Borrelia
burgdorferi (Bb) infection.
Methods: New Zealand white rabbits were exposed to Ixodes scapu-
laris ticks that had been collected from an area of Westchester
County, NY, that is highly endemic for Lyme disease. Ten to 15
adult deer ticks were placed onto the ears of each of 24 rabbits,
and the ability of ticks to transmit infection was based on the
recovery of live organisms from the draining nodes and by sero-
logic testing. At 2 and 6 weeks post-tick exposure, the rabbits
were humanly killed, bled out and cultures in BSK medium were
established in extracts derived from the cervical nodes. In related
experiments involving mice, high titre antiborrelial rabbit sera
were passively transferred to normal C3H mice who were subse-
quently challenged intradermally with low-passage, culture-
grown strain B31. The mice were then evaluated for protection
against borrelial infection, based on whether or not extract cul-
tures of their urinary bladders (a key target site) contained motile
spirochetes. Control mice were treated with either normal rabbit
serum or the antibiotic ceftriaxone.
Results: Spirochetes were culturable from the nodes of 75% of the
tick-exposed rabbits. Reactivity with a speciﬁc panel of monoclonal
antibodies identiﬁed all of the isolates as Bb. Borrelial antibodies
were detctable in 67% of the rabbits, based on an indirect haemag-
glutination antibody test. Most of the seropositive rabbits had high
titres (4096) and immunoblot analysis revealed a serologic
response reactive with multiple low to high molecular weight pro-
tein bands. It was also found that passively transferred high titre
rabbit sera fully protected the mice against borrelial challenge infec-
tion in a manner analogous to those receiving ceftriaxone alone.
Conclusions: These experiments show that these animal models
are extremely useful for understanding tick–Borrelia–host interac-
tions related to immune protection, that may have a bearing on
vaccine development, and to possible treatment for Lyme disease.
R2112 Inﬂuence of probiotic antibacterial and
antioxidative lactobacilli on gut mucosa in generalised
experimental Salmonella typhimurium infection
K. Truusalu, P. Naaber, T. Kullisaar, H. Tamm, R. Mikelsaar,
K. Zilmer, M. Zilmer, M. Mikelsaar
Tartu, EST
Objectives: The purpose of the present study was to test in a
mouse model the ability of the probiotic Lactobacillus sp. with high
antimicrobial and antioxidative potential to compete the invasive
Salmonella enterica serovar Typhimurium infection and protect the
gut mucosa against excessive oxidative stress during inﬂamma-
tory tissue damage.
Methods: Altogether 47 mice were divided into four groups. The
mice of control groups were treated either with PBS (group 1)
or with 0.5  108 CFU/mL of human intestinal lactobacilli L. fer-
mentum ME-3 (DSM 14241) and L. acidophilus 0.5  108 CFU/mL
(Gr 4) daily during 15 days. Group 2 and 3 mice were chal-
lenged with a clinical isolate of S. typhimurium (0.5  105 CFU/
mL). The Gr 3 mice were additionally orally inoculated with
lactobacilli for 5 days before and 10 days after the challenge
with S. typhimurium. The counts of salmonellas and lactobacilli
in blood, intestine, liver and spleen were found, the morphologi-
cal indices of inﬂammation in the same organs and oxidative
stress-indicative biochemical status (lipid peroxidation, total anti-
oxidative activity, redox ratio of glutathione and iron content) of
gut mucosa were assessed on the tenth day after oral inocula-
tion.
Results: The administration of probiotic lactobacilli of human
origin did not increase the total count of lactobacilli in terminal
ileum of mice, however mild hyperplasia of lymph nodes
was registered in Gr 4 mice compared with the Gr 1. In
S. typhimurium challenged mice the administration of in vitro
antagonistic lactobacilli did not decrease the count of salmonel-
las in the gut and prevent their invasion into tested organs.
The reduced level of iron, lipid peroxidation and increased total
antioxidative activity, glutathione redox value in gut mucosa
was found. In conclusion, the administration of probiotic lacto-
bacilli of human origin did not increase the colonisation resist-
ance against S. typhimurium in mice gut and prevent the
generalisation of the infection. The possibility to inﬂuence the
pro- and antioxidant balance of gut mucosa by speciﬁc probiot-
ic lactobacilli with antioxidative properties could have signiﬁ-
cant therapeutic implications in management of inﬂammatory
tissue damage.
R2113 Synergistic cytotoxic effects of verotoxin1 and
monophosphoryl lipidA on vero cells in culture media
H. Hosain Zade, M. Sattari, M. Zahir, A. Allame
Tehran, IR
Objectives: Verotoxigenic E. coli strains have a high rate of mor-
bidity and mortality such as chronic renal failure in effected
patients. We studied the interaction of monophosphoryl lipidA
(MPL) and verotoxin1 on cell death and proliferation in Vero cells
in culture system. Cytotoxicity of puriﬁed verotoxin1 was com-
pared with the MPL alone or in combination with verotoxin1 and
controls.
Methods: Cells were cultured on glass slides to conﬂuency (18 h).
After 12 h incubation with verotoxin1 and MPL or verotoxin1
plus MPL toxicity and cell deaths was determined by direct exam-
ination with invert microscope and trypan blue exclusion dye.
Cell proliferation determined by MTT assay.
Results: Cytotoxicity and cell death was time-dependent and
increased for 3 days after treatment. MPL-treated cells have
mainly undergone necrosis as studied by Hoechst 33258/propi-
dium iodide staining. Cell proliferation was signiﬁcantly
decreased in verotoxin1 and MPL plus verotoxin1 groups in com-
parison with MPL alone. The mechanism of cell death was stud-
ied by DNA fragmentation and nuclear condensation by Hoechst
33258 staining.
Conclusion: Results were analysed by univariate analysis of vari-
ance and concluded that MPL could profoundly increase the cyto-
toxicity of verotoxin1 in in vitro, and suggest that MPL beside
adjuvant properties could have synergistic effects with other bac-
terial metabolits such as verotoxin1.
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R2114 Concentration of IFN-g, Il-6, Il-12 and Il-15 in
cerebrospinal ﬂuid of patients with neuroborreliosis
S. Pancewicz, J. Zajkowska, T. Hermanowska-Szpakowicz,
M. Kondrusik, R. Swierzbinska
Bialystok, PL
Objectives: To evaluate concentration of IFN-g, Il-6, Il-12 and Il-15
in cerebrospinal ﬂuid (csf) of patients with neuroborreliosis pre-
senting as meningitis.
Material and methods: The study group consisted of 25 patients,
aged from 21 to 64 years. Neuroborreliosis was conﬁrmed by
detection of IgM and/or IgG antibodies in serum and/or csf by
ELISA (Biomedica, Austria). Before and after 4 weeks of treatment
with cefotaxime, csf concentration of IFN-g, Il-6, Il-12 and Il-15
was measured with ELISA kits (Quantikine, R&D Systems, USA
and Human Interleukin-12, Endogen, USA). The control group
consisted of csf ﬂuids of 10 patients with discopathy.
Results: In control csf, moderate concentrations of IFN-g
(x ¼ 0.93 pg/mL), Il-6 (x ¼ 0.79 pg/mL), Il-12 (x ¼ 1.11 pg/mL)
and Il-15 (x ¼ 0.27 pg/mL) were observed. Inﬂammatory chan-
ges (cytosis of 38–80 cells/mm3, protein concentration 32.0–
91.0 mg/dL) were initially observed in csf of all patients, but
resolved after treatment. Concentrations of all measured cytok-
ines were signiﬁcantly increased in csf of all neuroborreliosis
patients before treatment (IFN-g x ¼ 13.10 pg/mL, Il-6
x ¼ 9.8 pg/mL, IL-12 x ¼ 167.19 pg/mL, Il-15 x ¼ 7.71 pg/mL),
compared with controls. After 4 weeks of antibiotic treatment csf
cytokine concentrations decreased signiﬁcantly (IFN-g to
x ¼ 4.32 pg/mL, Il-6 x ¼ 4.56 pg/mL, IL-12 x ¼ 43.67 pg/mL,
IL-15 x ¼ 4.8 pg/mL), but still remained signiﬁcantly higher than
in control group.
Conclusions: Signiﬁcant and substantial increase of csf concentra-
tions of IFN-g, Il-6, Il-12 and Il-15 was observed in neuroborrelio-
sis patients when compared with control group. It persisted after
the end of 4-week antibiotic therapy, in spite of clinical recovery
and normal csf parameters.
R2115 Serum concentration of IFN-g, Il-6, Il-12 and Il-15 in
patients with neuroborreliosis
S. Pancewicz, J. Zajkowska, T. Hermanowska-Szpakowicz,
M. Kondrusik, R. Swierzbinska
Bialystok, PL
Objectives: To evaluate concentration of IFN-g, Il-6, Il-12 and Il-15
in serum of patients with neuroborreliosis presenting as menin-
gitis.
Material and methods: The study group consisted of 25 patients,
aged from 21 to 64 years. Neuroborreliosis was conﬁrmed by
detection of IgM and/or IgG antibodies in serum and/or cere-
brospinal ﬂuid by ELISA (Biomedica, Austria). Before and after
4 weeks of treatment with cefotaxime, serum concentration of
IFN-g, Il-6, Il-12 and Il-15 was measured with ELISA kits
(Quantikine, R&D Systems, USA and Human Interleukin-12,
Endogen, USA). The control group consisted of 10 healthy
volunteers.
Results: In control sera, moderate concentrations of IFN-g
(x ¼ 0.9 pg/mL), Il-6 (x ¼ 1.04 pg/mL), Il-12 (x ¼ 5, 19, 15 pg/
mL) and Il-15 (x ¼ 0.29 pg/mL) were observed. Inﬂammatory
changes (cytosis of 38–80 cells/mm3, protein concentration 32.0–
91.0 mg/dL) were initially observed in csf of all patients, but
resolved after treatment. All measured serum cytokine concentra-
tions in neuroborreliosis patients were signiﬁcantly, many times
higher than in control sera (IFN-g x ¼ 6.77 pg/mL, IL-6
x ¼ 5.67 pg/mL, IL-12 x ¼ 319.39 pg/mL, IL-15 x ¼ 0.96 pg/mL).
After 4 weeks of cefotaxime treatment cytokine concentrations
decreased signiﬁcantly to: IFN- x ¼ 1.82 pg/mL, IL-6
x ¼ 2.93 pg/mL, IL-12 x ¼ 217.4 pg/mL and IL-15 x ¼ 0.11 pg/
mL. However, they remained signiﬁcantly higher than in control
group, in spite of normal csf parameters and lack of clinical
symptoms of neuroborreliosis.
Conclusions: Signiﬁcant and substantial increase of serum concen-
trations of IFN-g, Il-6, Il-12 and Il-15 was observed in neuroborrel-
iosis patients when compared with control group and persisted
even after the end of 4-week antibiotic therapy.
R2116 Concentration of MCP-1 in serum and cerebrospinal
ﬂuid of patients with Lyme borreliosis
S. Grygorczuk, R. Swierzbinska, S. Pancewicz, M. Kondrusik,
J. Zajkowska, T. Hermanowska-Szpakowicz
Bialystok, PL
Objectives: Chemokines are family of chemotactic cytokines,
playing important role in pathogenesis of inﬂammatory
response. Chemokines of CC subfamily act mainly on different
populations of mononuclear cells. They are synthesised after sti-
mulation with Borrelia burgdorferi, but there are few data as for
their role in pathogenesis of Lyme borreliosis in vivo. In our
previous study concentration of CC chemokines: macrophage
inﬂammatory protein 1a and 1b (MIP-1a, MIP-1b) was only
moderately increased in borreliosis and was lower in csf than
in serum in neuroborreliosis, thus not creating chemotactic gra-
dient for cell migration into the csf. It suggests other chemok-
ines, probably also of the CC family, may be responsible for
mononuclear cells recruitment in Lyme disease. MCP-1 (mono-
cyte chemoatractant protein 1) is CC chemokine acting on T
cells and monocytes, which is synthesised by human cells after
incubation with small quantity of B. burgdorferi spirochetes. We
investigated its synthesis in patients with different clinical
forms of Lyme borreliosis.
Methods: A total of 29 patients were included: 13 with erythema
migrans (EM), 10 with Lyme arthritis (LA) and six with neurobor-
reliosis (NB). Controls (K) were eight healthy volunteers (control
blood samples) and eight patients in whom lumbar puncture
excluded the possibility of meningitis or neuroborreliosis (control
csf). Samples were obtained before (examination 1) and 2–4 weeks
after start of antibiotic treatment (examination 2). MCP-1 concen-
tration was measured by ELISA. Statistical signiﬁcance was con-
sidered at P < 0.05.
Results: MCP-1 concentration (mean  SD, ng/mL) in serum was:
in EM: 277.17  86.35 in ex.1 and 323.50  140.55 in ex.2; in LA
388.97  208.00 in ex.1 and 429.06  216.64 in ex.2; in NB
245.78  78.24 in ex.1 and 497.47  215.87 in ex.2; while in K –
253.71  55.25. MCP-1 concentration in csf in NB was
589.11  235.11 in ex.1 and 510.95  253.17 in ex.2, compared
with 356.01  36.94 in K. MCP-1 tended to increase in borreliosis
patients, but the increase was only signiﬁcant in serum in NB in
ex.2 and of borderline signiﬁcance in LA in ex.1 and in csf in NB
in ex.1. MCP-1 concentration in csf was signiﬁcantly higher than
in serum in ex.1. No correlation was observed between MCP-1
concentration and inﬂammatory changes in the csf.
Conclusions: MCP-1 synthesis seems to be increased in Lyme bor-
reliosis. MCP-1 may participate in stimulating mononuclear cells
ﬂux into the csf in neuroborreliosis.
R2117 Concentration of I-TAC in serum and
cerebrospinal ﬂuid of patients with Lyme borreliosis
S. Grygorczuk, R. Swierzbinska, S. Pancewicz, M. Kondrusik,
J. Zajkowska, T. Hermanowska-Szpakowicz
Bialystok, PL
Objectives: Chemokines are family of chemotactic cytokines, inclu-
ding CXC-chemokines which act either on neutrophils (interleukin
8, Il-8) or on active T cells (interferon-g-inducible T-cell chemoa-
tractant - I-TAC). Chemokines are synthesised after stimulation
with Borrelia burgdorferi, but data on their role in Lyme borreliosis
in vivo are scarce. In previous study we observed raised levels of
Il-8 in serum and cerebrospinal ﬂuid (csf) of patients with borreli-
osis, as well as chemotactic gradient created by Il-8 between csf
and serum in neuroborreliosis. However, concentration of chem-
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okines possibly acting on T-cells: macrophage inﬂammatory pro-
teins 1a and 1b was only moderately increased and was lower in
csf than in serum. It suggests other chemokines, possibly I-TAC,
being responsible for T-cells recruitment in Lyme disease. We
investigated I-TAC synthesis in patients with different clinical
forms of Lyme borreliosis.
Methods: A total of 29 patients were included: 13 with erythema
migrans (EM), 10 with Lyme arthritis (LA) and six with neurobor-
reliosis (NB). Controls (K) were eight healthy volunteers (control
blood samples) and eight patients in whom lumbar puncture
excluded the possibility of meningitis or neuroborreliosis (control
csf). Samples were obtained before (examination 1) and 2–4 weeks
after start of antibiotic treatment (examination 2). I-TAC concen-
tration was measured by ELISA. Statistical signiﬁcance was con-
sidered at P < 0.05.
Results: I-TAC concentration (mean  SD, ng/mL) in serum was:
in EM 73.00  54.18 in ex.1 and 88.66  12.16 in ex.2; in LA
78.87  132.51 in ex.1 and 90.26  191.43 in ex.2; in NB 87.25 
38.58 in ex.1 and 96.76  28.82 in ex.2 and in K 29.86  15.49.
I-TAC concentration in csf in NB was 36.69  13.12 in ex.1 and
44.84  11.70 in ex.2, compared with 23.23  3.38 in K. The differ-
ence between I-TAC concentration in study atients and in controls
was signiﬁcant only in serum and csf in NB and of borderline sig-
niﬁcance in EM in ex.1. I-TAC concentration was signiﬁcantly
higher in NB than in LA in ex.2. I-TAC concentration in csf was
lower than in serum and did not correlate with csf cell count.
Conclusion: Synthesis of I-TAC in Lyme borreliosis is increased
and depends on clinical form of the disease. I-TAC does not seem
responsible for lymphocyte ﬂux into csf in neuroborreliosis. The
role of other chemotactic factors in Lyme disease should be inves-
tigated.
R2118 The susceptibility of different mouse strains to
Legionella longbeachae infection
I. Gobin, M. Susa, M. Doric
Rijeka HR; Stuttgart, D
Objectives: Since the ﬁrst isolation of Legionella longbeachae in
1981 it was considered as an uncommon pathogen of Legion-
naires’ disease. Today we are aware that, besides some individ-
ual cases observed in Japan, USA, Spain, Germany and France,
L. longbeachae is responsible for up to half of the legionellosis in
Australia. In contrast to L. pneumophila, this bacteria has been
detected only occasionally in water. More commonly, it has been
isolated from soil and decomposing materials. In this study we
examined the pathogenesis of Legionella longbeachae (strain
D4968) lung infection in different mice strains, since previous
studies pointed to a genetically driven permisivity of mice to
L. pneumophila (BALB/c and C57Bl/6 mice are highly resistant
and A/J mice susceptible).
Methods: A/J, BALB/c, and C57Bl/6 mice were infected by intra-
tracheal inoculation of L. longbeachae using different doses from
102 to 105 CFU. In the infected animals we followed the bacterial
clearance from lung tissue, mortality assay and histopathological
changes in the lungs.
Results: Irrespective of mouse strains the intratracheal inoculation
of 105 L. longbeachae caused death in 90% of the animals within
six days.The LD50 dose of L. longbeachae for all mice strains was
determined at 104 CFU. The animals that received 102 or 103 bac-
teria survived 14 days post inoculation. During that period the
multiplication of bacteria in the lungs reached a peak at 72 h after
inoculation (106–108 CFU/lung) and thereafter decreased gradu-
ally to the detection level on day seven. Histological appearance
of the lungs taken from infected animals was constraint with
bronchoalveolar pneumonia.
Conclusion: Our results indicate that all three mice strains are sus-
ceptible to infection with L. longbeachae. The LD90 and particularly
LD50 dose was unusually low indicating a high infectivity poten-
tial of L. longbeachae. Histopathological changes in the lung tissue,
indicate on a bronchopneumonia rather than on interstitial pneu-
monia as seen in L. pneumophila infection.
R2119 Study of cell surface hydrophobicity and its
correlation with bacterial adherence capacity to catheter sections
V. Lazar, R. Cernat, C. Balotescu, F. Boulean, G. Andrei,
D. Stewart-Tull
Bucharest, RO; Glasgow, UK
Introduction: Generally, bacteria with hydrofobic surface are less
adherent to the cellular substratum, but they are intensively
adherent to hydrofobic materials causing medical devices associ-
ated infections, very difﬁcult to treat because their phenotypic
resistance to antibiotics.
Purpose: Determining cell hydrophobicity of 10 selected enterobac-
teria opportunistic strains with different isolation sources (previ-
ously tested for adhesion and invasion on cellular substratum)
and to investigate the adherence capacity to an hydrophobic sub-
stratum (poliuretan silicon coated catheter sections).
Material and methods: Bonner’s method (1997) is based on the
spectrophotometric assay of bacterial suspensions capacity to mix
with organic solvents and to pass from the aquatic phase to the
organic one, having as consequence the decrease of optic density
in the aquatic phase. The adherence capacity to an inert substra-
tum was tested in vitro on a model in 24 – multi-well plate, incu-
bating the catheter sections with bacterial suspensions. After
incubation, the catheter pieces were washed in sterile PBS, fresh
medium was added, further incubated for 24 h and the optic den-
sity of the bacterial cultures was assayed. An Enterobacter cloacae
strain, selected for its intense adherence capacity to a cellular sub-
stratum, also proved to be moderately hydrophobic and was
studied for its interaction with catheter surface by SEM. With this
aim, bacterial culture on nutrient broth was introduced in a cir-
cuit including a fragment of catheter and recirculated with a peri-
staltic pump. After 24 h, the catheter was removed and examined
by SEM.
Results: Our study demonstrated that cell surface hydrophobicity
promotes strong bacterial adherence capacity to the hydrophobic,
inert substratum represented by plastic catheter. SEM results dem-
onstrated that an opportunistic enterobacterial strain isolated from
food could become an aetiologic agent of prosthetic devices asso-
ciated infections due to its adherence capacity to the inert substra-
tum and to its capacity to form bioﬁlms.
Conclusion: The hydrophobic bacterial surface, even moderate,
could constitute a virulence feature of opportunistic enterobacte-
ria. In this sense, an Enterobacter cloacae (43) strain isolated from
food and previously proved to be able to generate A/E lesions on
a cellular substratum was also able to adhere and to form bioﬁlms
to the internal surface of a catheter fragment, as SEM results
clearly demonstrated.
R2120 Bioﬁlm formation of pathogenic Escherichia coli
isolates
A. Reisner, K. Krogfelt, E. Zechner, S. Molin Lyngby
Copenhagen, DK; Graz, A
Objective: Infectious diseases caused by E. coli are initiated by
adhesion to the surfaces of the human genitourinary, gastrointesti-
nal or respiratory tracts. Although the utilised adhesion mecha-
nisms have been extensively studied they are only part of the
story since additional postadhesion events are required for bacter-
ial cells to establish themselves and to initiate infection. In situ
studies indicate that as in most natural bacterial surface-associated
communities (bioﬁlms), many adhered bacterial cells at a given
infected site do not have a direct cell-surface contact but are
rather attached to other E. coli cells. We therefore aim to under-
stand the genetic repertoire that allows pathogenic E. coli to
adhere to each other withstanding the strong shear forces present
at many host sites. In a ﬁrst step towards that goal, we started to
characterise the potential of pathogenic E. coli isolates to form bio-
ﬁlms in vitro.
Methods: E. coli strains (each collection n > 80) isolated from faeces
of healthy children, from faeces of children with diarrhea, from
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blood of patients with bacteraemia, and from urine of male
patients suffering from complicated UTI were tested for bioﬁlm
formation on the surface of polystyrene microdishes. Bacteria
were cultured in standard media such as LB medium and min-
imal medium supplemented with glucose or casaminoacids but
also in physiologically more relevant environments such as urine
and mucus. In addition, the prevalence of factors known to pro-
mote bioﬁlm formation of E. coli K-12 strains in vitro (curli expres-
sion, AAF ﬁmbriae and conjugative IncF plasmids) was assessed
in the different strain collections. Finally, molecular approaches
were applied to dissect the genetic repertoire that allows patho-
genic E. coli strains to form bioﬁlms in vitro.
Results: In LB medium only about 5% of the strains were able to
form bioﬁlms to a similar extent as E. coli K-12 strains expressing
bioﬁlm-promoting factors. In minimal medium however, 10–20%
of the strains formed strong bioﬁlms. Our initial analysis shows
that strains able to form bioﬁlms in standard media are equally
distributed among the different strain collections.
Conclusion: Our data suggests that the ability to form strong bio-
ﬁlms in vitro is not clearly associated with pathogenicity. How-
ever, additional analysis also indicates the presence of previously
unrecognised genetic pathways that enable bioﬁlm formation of E.
coli.
R2121 Studies on bioﬁlm formation by opportunistic
species of Corynebacterium and coryneform
A. Chudnicka, J. Walory Lublin
Warsaw, PL
Ability of bioﬁlm production by some microorganisms after adhe-
sion to different surfaces is important feature inﬂuencing course
of the infection. Frequency, kinetics and amount of produced bio-
ﬁlm may be correlated with pathogenesis course, clinical symp-
toms and treatment. In the case of bioﬁlm producing species
chemiotherapeutics penetration to bacterial targets is hindered.
Moreover, solitary cells from primary colonisation site may be
released and create new colonisation sites associated with persist-
ent infections. In immunocompromised subjects it may be clinic-
ally important. The important feature pointing that opportunistic
corynebacteria may produce bioﬁlm is the course of their patho-
genesis. Some of them were observed to cause difﬁcult to treat
persistent infections.
Objectives: The aim of the study was to determine the bioﬁlm for-
mation in vitro by opportunistic species of Corynebacterium and
coryneform isolated from either different clinical materials or
model strains from Institute of Serum and Vaccines (Copenha-
gen).
Methods: Studied material constituted model strains of C. pseudo-
diphteriticum 3633, C. afermentans.subsp. afermetans AB2746, C. jeike-
ium 6717, C. striatum AB2545Ci, C. ulcerans, C. amycolatum, C.
macgineleyi, C.urealyticum, C.propinquum, Rhodococcus equi, Brevibac-
terium spp.). Culture (bacterial suspension 0.5 McFarland diluted
1:100) was assessed in BHI medium growth enriched with rabbit
serum and performed in 96 ﬂat-bottomed plastic tissue culture
plates (37C). Produced bioﬁlm was ﬁxed with Bouin’s Solution
and stained with 1% crystal violet. Optical density (OD) was
measured after 24, 48, 72, and 96 h by an enzyme immunosorbent
assay reader at 540 nm. The procedure was performed in tripli-
cate.
Results: The most abundant bioﬁlm formation was observed after
24 h for C. striatum (OD ¼ 0.128–0.134) and C.macgineleyi
(OD ¼ 0.202). After 72 h bioﬁlm formation of C. propinquum and
C. jeikeium reached OD ¼ 0.148 and OD ¼ 0.123, respectively
(blank OD ¼ 0.068).The most dynamic bioﬁlm production was
observed in C. macgineley (OD ¼ 0.202–0.438) and C. striatum
(OD ¼ 0.128–0.400). After 96 h of incubation the formation was
seen in R. equiculture, however, it was not persistent.
Conclusions: As we expected, corynebacteria showed various
intensity of bioﬁlm formation. C. macgineleyi (sputum, throat),
C. striatum (throat, pus), and C. striatum AB2545Ci were character-
ised with the most efﬁcient level of the production.
R2122 Investigation of translocated E. coli isolates from
general surgical patients
A.M. Snelling, A. McCleery, L.R. Macfarlane, P. Jain, S. Anderson,
J. MacFie
Bradford, Scarborough, UK
Objectives: Translocation, the passage of viable enteric bacteria
across the intact mucosa of the gastrointestinal tract into sterile
tissues, is a key cause of postoperative septic morbidity. Host
factors that predispose to it have been studied, but little is
known about whether or not bacterial pathogenicity factors are
involved in the phenomenon. E. coli is one of the most common
translocating species. This study aimed to determine if translo-
cated isolates have any unusual adherence or invasive properties
that might facilitate or explain their passage across the lamina
propria.
Methods: Thirty-four E. coli strains isolated between 1991 and 2003
from 30 general surgical patients at a District Hospital were stud-
ied. Patients were aged 23-85 (mean 71) yrs, none had intra-
abdominal sepsis at the time of isolation. A single mesenteric
lymph node was harvested during laparotomy, suspended in ster-
ile saline and sent for culture. E. coli isolates were identiﬁed by
standard techniques then stored at 70C. For adherence assays,
HEp-2 and T84 epithelial cells were grown on glass coverslips,
then co-incubated with aliquots of overnight cultures of E. coli for
3 h, in 5% CO2 at 37
C. After washing, ﬁxing and staining, cells
were examined for adherent bacteria. The gentamicin protection
assay was used to assess invasion into HEp-2 cells. PCR was used
to screen invasive isolates for the ipaH gene, characteristic of en-
teroinvasive E. coli (EIEC).
Results: Only two of the 34 (5.9%) isolates were adherent. Both of
these adhered to HEp-2 and T84 cells with a diffuse pattern, sim-
ilar to that seen with diffusely adherent E. coli (DAEC). Both of
these isolates were highly invasive in the gentamicin protection
assay compared with an EIEC control strain, but tested negative
for the ipaH gene.
Conclusions: The majority of the E. coli isolates were nonadherent
and may represent members of the normal commensal ﬂora that
have been translocated as a result of changes in the patient’s GI
tract. However, some cases of translocation were associated with
unusual adherent/invasive E. coli. Similar strains have previously
been reported from cases of Crohn’s disease. The origin and con-
tribution of such strains to postoperative septic complications
remains to be elucidated.
R2123 Effects of different antioxidants and amrinone on
vancomycin-induced nephrotoxicity
I. Celik, M. Cihangiroglu, N. Ilhan, N. Akpolat, A. Akbulut,
S. Felek, S.S. Kilic
Elazig, TR
Objectives: In the present study, we investigated the effects of
three antioxidant agents and amrinone, an inotropic agent, on
vancomycin-induced nephrotoxicity.
Methods: Thirty adult female Sprague Dawley rats (168–234 g)
were divided into six groups. Saline-treated group (group 1)
served as a control. The other ﬁve groups were treated with
vancomycin (VCM, 100 mg/kg, intraperitoneally) alone (group 2)
or with combination. Group 3 received VCM plus amrinon (Amr,
100 mg/kg i.p.). Group 4 received VCM plus melatonin (Mel,
10 mg/kg i.p.). Group 5 received VCM plus a-lipoic acid (ALA,
10 mg/kg i.p.). Group 6 received VCM and Ginkgo Biloba extract
(EGb 761) 100 mg/kg p.o. All the drugs and vancomycin were
administered for 7 days. All rats were sacriﬁced by decapitation,
kidney tissues were excised immediately at day 8, and blood and
kidney samples were collected. Blood urea, and creatinine levels,
and kidney tissue malondialdehyde (MDA), superoxide dismutase
(SOD), glutathione peroxidase (GPHx) levels were measured. Kid-
ney samples were examined histologically and were assigned
scores 0–4 as reported by Houghton et al.
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Results: The biochemical and pathological ﬁndings were shown at
table.
Conclusion: The present study indicates that the three antioxidants
and amrinone protect vancomycin-induced nephrotoxicity. Amri-
none was the most effective drug based on pathological score.
R2124 Effect of EPs7630 (Umckaloabo) on the adherence
of Streptococcus pyogenes to human epithelial cells
C. Lallemand, F. Carrapatoso, A. Dorfmu¨ller, I. Engels,
F. Daschner, U. Frank
Freiburg, D
Introduction: EPs7630 (Umckaloabo,ISO-Pharmaceuticals, Ger-
many) is an extract of the root of the South African geranium
Pelargonium sidoides. The phytotherapeutic remedy has been suc-
cessfully used for the treatment of upper-respiratory tract infec-
tions (Phytomedicine 2003; 10, 7–17).
Study objective: To investigate the biological effects of EPs7630 in
the pathogenesis of upper-respiratory tract infection.
Material and methods: Using a ﬂow cytometric technique, we
assessed the inﬂuence of EPs7630 on streptococcal adherence (i) to
the human HEp-2 cell line (90% viable) and (ii) to human buccal
epithelial cells (BEC; 90% dead), sloughed off from the oral
mucosa. Streptococcus pyogenes (DSM 2071) was stained with Calc-
ein-AM which is retained by viable bacteria. Adherence was
determined after incubating bacteria and epithelial cells for
120 min. EPs7630 was applied in ﬁve concentrations, 30, 10, 3.0,
1.0 and 0.3 lg/mL. Alternatively, either streptococci or epithelial
cells were preincubated with EPs7630 and washed before further
incubation. The readout was the percentage of epithelial cells with
adhering ﬂuorescent bacteria.
Results: Streptococcal adherence to HEp-2 cells decreased signiﬁ-
cantly with rising concentrations of EPs7630: for 30, 10 and
3.0 lg/mL adherence was reduced by factors 0.54, 0. 6 and 0.7,
respectively. In contrast, streptococcal adherence to BEC increased
signiﬁcantly under treatment with EPs7630: for 30 lg/mL by fac-
tor 7, for 3.0 lg/mL by factor 2.9, and for 1.0 lg/mL by factor
1.7. Preincubation of bacteria with EPs7630 showed similar
results, whereas preincubation of epithelial cells had no effect.
Conclusions: The decrease in bacterial adherence to viable HEp-2
cells and the increase in bacterial adherence to dead BEC under
the inﬂuence of EPs7630 could be an important mechanism in pre-
venting and mitigating upper respiratory tract infections.
R2125 Chlamydophila pneumoniae and atherosclerosis: the
eventual role of iron
F. Rodrigues, V. Bairos, A. Magalhes-Sant’Ana
Coimbra, P
Several studies (serological, pathological and in animal models)
suggested that the arterial chronic infection by C. pneumoniae
(more frequent in males, smokers an in the elderly) plays an
important role in the atherosclerosis pathogenesis. Some authors
postulated that stored iron interacts with C. pneumoniae in the
pathogenesis of atherosclerosis, stimulating the organism’s
growth. Reinforcing iron’s key role, infected cells present an
increased number of transferrin receptors.
Objectives: To evaluate the importance of iron’s intracellular con-
centration in the association between chronic infection by C. pneu-
moniae and atherosclerotic lesion.
Methods: Serum from 26 patients with coronary disease conﬁrmed
by angiography, was stored at 80C. Simultaneously, we also
studied a control goup (26 persons), sex and age matched. IgG
and IgA antibodies to C. pneumoniae were determined by microim-
munoﬂuorescence (MIF), using puriﬁed elementary bodies of the
organism (MRL Diagnostics). Serum ferritin (sFt), soluble transfer-
rin receptors (sTfR) and C-reactive protein levels were assessed
by kinetic nephelometry (Behring Nephelometer II). We have also
calculated the ratio of sTfR/sFt, apparently independent of
inﬂammation.
Results: IgG and IgA antibodies to C. pneumoniae were present in
55.5 and 18.5% of the coronary disease group, and in 62.9 and
7% of the control group, respectively. Mean levels of sFT (lg/L)
and sTfR (mg/L) were higher in the coronary disease group
(167.6 and 1.55) compared with the control group (153.2 and 1.23).
C-reactive protein mean levels were low in both groups (<8 mg/
dL).
Conclusions: The positive association between chronic infection by
C. pneumoniae and iron concentration in tissues seems to be sup-
ported by this study. Higher sTfR blood levels in the coronary
disease group may signify an increase of soluble transferrin recep-
tors within infected cells.
Molecular bacteriology
R2126 The comparison of two diagnostic tolls in Lyme
neuroborreliosis: the proof of intrathecally produced
antiborrelial antibodies and PCR
D. Pı´cha, L. Moravcova´, S. La´sikova´, E. Zda´rsk, H. Roha´cova´
Prague, CZ
Objective: Aim of the study was the comparison of the diagnostic
effectivity of antibody index CSF/serum (AIBb) and PCR in neu-
roborreliosis.
Methods: In 55 patients with neurological symptoms of Lyme bor-
reliosis was evaluated secretion of the CSF speciﬁc antibodies
(AIBb) comparing with PCR in CSF, plasma and urine. AIBb was
established according to Reiber et al. DNA of Borrelia burgdorferi
sensu lato was detected by three sets of primers encoding: plas-
mid gene for OspC protein and two chromosomal genes for
16SrDNA and ﬂagellin. The nested PCR was examined in the
CSF, plasma and urine in parallel at the beginning, testing of the
urine was repeated still after 3 and 6 months.
Results: Spirochetal DNA was found in 20 patients (46%) in
CSF and in 10 (18%) in plasma. In urine DNA was detected
one times in 36 (65%) patients at least. Five times was spiroch-
etal DNA found in CSF, plasma and urine when examinated in
parallel. The AIBb was positive in 50 patients, in the other ﬁve
patients antibodies remained negative and only DNA was
found.
Conclusion: The results show that the AIBb is much more sensitive
in neuroborrelios (96%) comparing with the detection of DNA in
CSF (46%), plasma (18%), and urine (50%), when we have exam-
ined before antibiotic treatment. PCR can not replace antibody
diagnostic in Lyme neuroborreliosis, but it can supplement it very
well.
Table. Effects of vancomycin and different antioxidants on differ-
ent parameters (meanSD)
Parameter Control VMC VMCþAMr VMCþMel VMCþALA VMCþEGb
BUN 25.603.28 54.004.95* 37.603.97 39.606.65 34.205.26 31.404.56
Creat 0.420.13 0.760.11* 1.520.08 0.480.08 0.380.08 0.440.11
MDA 2.260.25 3.840.21* 2.210.76 1.440.29 1.630.58 1.600.68
SOD 22.711.92 12.821.66* 19.772.93 21.492.66 21.973.42 22.203.31
GPHX 2.120.52 1.210.12* 2.040.38 2.070.45 2.270.44 2.170.40
Pathological
Score
0.000.00 3.800.45* 1.400.55 1.600.55 1.600.55 2.800.45
*p<0.05, the levels of all parameters at VMC group were statistically signiﬁcant different
from other groups.
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R2127 LAL activity of lipopolysaccharides extracted from
reference strains of the Bacteroides fragilis group
A. Rokosz, P. Gorska, J. Slusarczyk, M. Luczak
Warsaw, PL
Objectives: To determine a biological activity of lipopolysaccha-
rides from reference strains of the Bacteroides fragilis group (BFG)
using quantitative Bacterial Endotoxins Test (BET) with Limulus
amoebocyte lysate (LAL reagent).
Methods: Lipopolysaccharides were extracted from eight strains of
the Bacteroides fragilis group (BFG): B. thetaiotaomicron NCTC
10582, B. ovatus ATCC 8483, B. vulgatus ATCC 8482, B. distasonis
ATCC 8503 and B. fragilis NCTC 9343, IPL E 323, IPL E 2360,
ATCC 43858 (enterotoxigenic strain, ETBF 1). LPS preparations
were extracted by the hot phenol–water method and puriﬁed by
nuclease treatment and ultracentrifugation. Quantitative, photo-
metric BET method (formerly LAL assay) with LAL reagent and
chromogenic substrate S-2423 (ENDOCHROME kit, Charles River
Endosafe Ltd., USA) was applied to determine biological activities
of Bacteroides lipopolysaccharides.
Results: The highest LAL activity showed the LPS from B. fragilis
NCTC 9343 strain followed by the LPS of B. thetaiotaomicron
NCTC 10582 strain. Lipopolysaccharides from B. vulgatus and B.
distasonis strains demonstrated considerably lower activities. LPS
of ETBF one strain was much less active than LPSs from nonen-
terotoxigenic (NTBF) strains. Lipopolysaccharides of the Bactero-
ides genus were less active than the E. coli O55:B5 LPS (Sigma
chemical Co., USA) used as positive control.
Conclusions: Lipopolysaccharides from reference strains of the B.
fragilis group are active in reaction with LAL reagent. Lipopoly-
saccharides of BFG rods demonstrate some differences in endotox-
ic potential and lower LAL activity than the LPS of E. coli O55:B5
strain.
R2128 LAL activity of lipopolysaccharides extracted from
clinical Bacteroides fragilis and Bacteroides thetaiotaomicron
strains isolated in Central Europe
A. Rokosz, P. Gorska, J. Slusarczyk, M. Luczak
Warsaw, PL
Objectives: To examine a biological activity of lipopolysaccharides
derived from eleven clinical B. fragilis and B. thetaiotaomicron
strains isolated in Poland and Roumania using quantitative Bac-
terial Endotoxins Test (BET) with Limulus amoebocyte lysate
(LAL reagent).
Methods: Lipopolysaccharides were extracted out of one B. thetaio-
taomicron and nine B. fragilis strains isolated from different clinical
specimens from patients of a university hospital in Warsaw, and
one B. fragilis strain cultured from blood sample in Bucharest.
Puriﬁed LPS preparations were examined by the quantitative,
photometric BET mehod (previously LAL test) with Limulus
amoebocyte lysate and chromogenic substrate S-2423 (ENDO-
CHROME kit, Charles River Endosafe Ltd., USA).
Results: Lipopolysaccharides of strains cultured from pancreatic
ulcers and blood were much more active in BET than LPS prepa-
rations of strains isolated from other clinical specimens. Moderate
activities showed LPSs of strains cultured from wounds after
appendectomy. Considerably less active in reaction with LAL rea-
gent were LPSs extracted out of strains originating from following
samples: postoperative abdominal wound, traumatic wound of
perineum, wound after removal of colon tumour and perirectal
abscess. LPS of E. coli O55:B5 (Sigma Chemical Co., USA), used as
positive control, was the most active compound in reaction with
LAL reagent.
Conclusions: LAL activities of investigated Bacteroides lipopolysac-
charides were differentiated, but lower than the activity of E. coli
O55:B5 LPS. Some correlations between the origin of clinical
strains and activities of their lipopolysaccharides in reaction with
LAL reagent were observed.
R2129 Identiﬁcation of the novel a-like protein gene in
group B. streptococci
A. Dmitriev, L. Tkacikova, I. Mikula
Saint-Petersburg, RUS; Kosice, SK
Objectives: Streptococcus agalactiae (group B. streptococcus, GBS) is
important cause of severe infections of human and animals. Cer-
tain surface antigens, e.g. Rib protein and Bca (alpha) protein, are
potentially involved in GBS virulence. Both Rib and alpha pro-
teins belong to the family of surface proteins containing repetitive
elements, which produce variations in protein size and antigenici-
ty. Recently some a-like protein genes (alp2, alp3 and alp4) were
identiﬁed in GBS. In this study the novel a-like surface protein
gene alp5 discovered in bovine GBS strains is described.
Methods: A collection of 35 human and 44 bovine GBS strains was
analysed. The GBS chromosomal DNA was isolated by phenol/
chloroform extraction. The strains were tested for the presence of
bca, alp2, alp3, alp4 and rib genes. PCR was performed using the
primers for conserved regions of bca, alp2, alp3, alp4 and rib
genes including start codon and stop codon of the genes under
study. PCR products were sequenced using ABI Prism 377 Per-
kin-Elmer Sequencer.
Results: PCR analysis of bovine GBS for the presence of bca, alp2,
alp3, alp4 and rib genes was performed. In two strains, the PCR
products of unusual size (850 bp) were received. After sequencing
of one of these two PCR products, the complete open reading
frame (ORF) consisted of 852 bp was identiﬁed. The 5’-end and
3’-end of this ORF contained the sequences of 145 bp and 258 bp
highly homologous to the conserved regions of bca, alp2, alp3,
alp4 and rib genes. However, the internal region of this ORF was
not homologous to bca, alp2, alp3, alp4, rib genes or any other
bacterial sequences. The complete ORF identiﬁed in this study
was named as novel a-like surface protein gene alp5. The alp5
gene did not contain repetitive regions found in bca, alp2, alp3
and rib genes. The alp5 gene was revealed in two of 44 GBS
strains isolated from the dairy cows (4.5%) and was not found in
human GBS. The possible evolution relationship of bca, alp2, alp3,
alp4, alp5 and rib genes and the possible role of the novel Alp5
protein in GBS virulence are discussed.
Conclusions: In this study the gene encoding for the novel GBS
surface protein is described. Features of this gene organisation
allow considering it as a novel a-like protein gene alp5. This
gene was revealed only in 4.5% of bovine GBS and was not
found in human GBS. This work was supported by VEGA 1-
8021-01, Russian Grants MK-2782.2003.04, NSh-2206.2003.4, RFBR
03-04-49760.
R2130 Evaluation of the BD ProbeTec (TM) ET Legionella
pneumophila ampliﬁed DNA assay
S.A. Uldum, M. Segovia, G. Vera, G. Yague, B. Dohn
Copenhagen, DK; Murcia, E
Objectives: New assays for diagnosing atypical pneumonia caused
by Mycoplasma pneumoniae, Chlamydiaceae family and Legionella
pneumophila are currently under evaluation on the BD ProbeTecTM
ET System (BD Diagnostics) from throat swabs and lower respir-
atory specimens (LRS). These assays are based on strand displace-
ment ampliﬁcation (SDA) technology with real time detection. We
took part in the evaluation of the BD ProbeTec ET Legionella pneu-
mophila (LP) Assay with retrospective (frozen) lower respiratory
specimens.
Methods: Seventy-eight samples were included in this study. Sen-
sitivity and speciﬁcity of the assay were calculated against the
gold standard (culture positive) and against the expanded refer-
ence method [culture positive or Binax urinary antigen (UA) pos-
itive and PCR positive]. The in-house PCR assay for detection of
Legionella pneumophila and Legionella spp. was performed on the
BD ProbeTec ET processed samples (Qiagen DNA extraction) for
some samples, including those that yielded discrepant results and
from the original LRS on another subset of the samples.
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Results: Gold standard: of 19 samples with positive cultures for L.
pneumophila, 8 were LP Assay positive (sensitivity 94.7%). The
negative LP Assay sample was culture and PCR positive but from
a patient with a negative UA result. Of the 59 samples with negat-
ive cultures, 51 were LP Assay negative (speciﬁcity 86.4%) inclu-
ding one specimen from which L. micdadei was isolated.
Expanded reference method: 30 samples were culture positive or
from UA-positive patients and positive by PCR from the proc-
essed samples. Of the 30 samples, 24 were positive by the LP
Assay (sensitivity 80%). There were 27 specimens that were cul-
ture and PCR negative and that were from patients with negative
UA. Of the 27 specimens, eight samples were PCR negative from
the BD ProbeTec ET processed samples and 19 were PCR negative
from the original LRS. The speciﬁcity of the LP Assay was 100%
(27/27).
Conclusion: The BDProbeTecTM ET LP Assay is a sensitive and
speciﬁc assay for the rapid identiﬁcation of Legionella pneumophila
from lower respiratory specimens.
R2131 Development of a real-time PCR assay for the
detection and biovar discrimination of Ureaplasma urealyticum
J. Yi, E. Lee, B. Yoon, E. Kim
Seoul, KOR
Objectives: Intrauterine infection with Ureaplasma urealyticum has
been implicated in premature births. U. urealyticum is clustered
into two distinct biovars, parvo and T960, and it is suggested that
biovar difference might play a role in the association with prema-
turity. The aim of this study was to develop a diagnostic assay
which can simultaneously detect U. urealyticum and discriminate
between its two biovars.
Methods: Vaginal swab specimens were obtained and inoculated
into liquid culture media for screening U. urealyticum. DNA was
extracted from culture-positive liquid media as well as from each
standard U. urealyticum biovar strain, and used as a template for
conventional PCR of U. urealyticum urease gene with speciﬁc
primers. DNA sequences were determined for the amplicons of
this conventional PCR. Based on the obtained sequence data,
primers and probes for real-time PCR (TaqMan assay) were devel-
oped. In this real-time PCR assay, two common primers and two
biovar-speciﬁc probes each labelled with different reporter dye
were designed to detect U. urealyticum and to discriminate
between the biovars simultaneously in one reaction tube. The pre-
viously extracted DNA samples positive for the conventional PCR
were subjected to the real-time PCR.
Results: Forty-four specimens including standard biovar strains
were positive for the conventional PCR. On analysing these ampl-
icon sequences, the parvo biovars were present in 38, the T960 in
ﬁve, and the both in one. With the real-time PCR assay, we
obtained the same result with the conventional PCR and subse-
quent analysis of amplicon sequence except that one specimen
which was expected to be the parvo biovar did not yield any sig-
niﬁcant ﬂuorescent signal. Overall turnaround time of the real-
time PCR was within 6 h.
Conclusion: The real-time PCR assay we developed can simulta-
neously detect U. urealyticum and discriminate between its bio-
vars. This assay is also efﬁcient and rapid.
R2132 The genome macrorestriction analysis, serological
typing and antimicrobial susceptibility patterns of sequential
mucoid Pseudomonas aeruginosa strains from patients with
bronchiectasis without cystic ﬁbrosis
B.-M. Shin, E.-C. Kim
Seoul, KOR
Objective: The respiratory tracts of bronchiectasis patients without
cystic ﬁbrosis may be persistently colonised with Pseudomonas ae-
ruginosa, especially mucoid type, in spite of intensive chemother-
apy. It is questionable and beneﬁcial whether it is recurrence with
the same strain or reinfection with a new strain. This information
is useful and vital for epidemiologic study and patients manage-
ment.
Methods: We studied 25 bronchiectasis patients over a period of
1 year(1–3 year) with more than 3-months intervals. Of these
patients, 65 sequential mucoid P. aeruginosa were isolated. They
were characterised by a genotyping method, pulsed-ﬁeld gel elec-
trophoresis (PFGE), and serotyping method using 14 antisera
against O-group antigens of P. aeruginosa (Denka Seiken, Japan).
Antimicrobial susceptibility tests were determined by disc diffu-
sion method according to the NCCLS guidelines with six antibiot-
ics (ciproﬂoxacin, imipenem, gentamicin, cefotaxime, ceftazidime,
amikacin).
Results: The intrapatient macrorestriction similarity pattern of all
of the 25 patients were 96–100%. However, diversity was
observed in the P. aeruginosa isolates from all 25 patients, with
relatedness of only 50–70% in PFGE. Serotyping yielded seven
different patterns (type A, E and M were 12%, respectively,
and type B and G were 8% respectively and type K and I
were 4%, respectively) but 32% of isolates were nontypable.
No remarkable relationships were observed between serological
types and PFGE patterns. Antimicrobial susceptibility patterns
were all susceptible for all 65 isolated P. aeruginosa to all test
antibiotics.
Conclusion: The study showed the mucoid P. aeruginosa infection
in bronchiectasis without cystic ﬁbrosis are recurrence with the
same strain rather than reinfection and PFGE is the most useful
tool rather than serotyping. Although the antimicrobial suscepti-
bility patterns could not discriminate the strains, the recurrence of
infection might be uneradicated colonisation of mucoid P. aerugi-
nosa after chemotherapy, not by the antibiotic resistance.
R2133 Gene expression proﬁling of patients with chronic
fatigue syndrome
H. Ojaniemi, P. Nilsson, B. Evengrd
Stockholm, S
Objectives: To identify genes in peripheral blood mononuclear
cells (PBMCs), which may play an important role in pathogenesis
and diagnostics of chronic fatigue syndrome (CFS), using microar-
ray technology.
Population and methods: The study cohort consists of 23 patients
(six men and 17 women), from a clinic for infectious diseases, ful-
ﬁlling criteria for CFS and 19 healthy age- and sex-matched con-
trols. The average age of the patient group is 38 years (26–
60 years) and the median illness duration time is 3.5 years (1–
27 years). Twelve patients had an insidious onset of illness and 11
a sudden onset. Several onset triggers were identiﬁed among the
group, e.g. Ehrlichia, Herpes Encephalitis, Borrelia, sarcoidosis,
ﬂu, upper respiratory infection, tonsillitis and abortion. For gene
expression analysis PBMCs were isolated from freshly drawn
blood, from both patients and controls, using a lymphocyte separ-
ation media (LymphoprepTM, Medinor AB). Three micrograms of
extracted PBMC total RNA [TRIzol(R) Reagent, Invitrogen] was
used to synthesise biotin or ﬂuorescein-labelled cDNA. Matched
patient and control samples (biotin/ﬂuorescein) were hybridised
to human cDNA microarrays representing approximately 30000
genes. The HiLight dual-color kit (Qiagen) with anti-biotin and
anti-ﬂuorescein antibodies, conjugated with gold and silver parti-
cles, respectively, was used for resonance light scattering (RLS)
detection. Experiments were performed in duplicates or triplicates
using dye swap. Signal intensities were evaluated using Gene
Pix(R) Pro 5.0 and data preprocessing is performed using the R-
package.
Results: Good quality total RNA was achieved from 21 patients
and 18 controls (average of 8.5 lg from 10 million PBMCs). Pre-
liminary biological results from the initial data analysis will be
demonstrated together with data showing excellent technical qual-
ity and reproducibility for the hybridisations.
Conclusion: This study will contribute to increased understanding
of the so far unknown pathogenesis of CFS and could possibly be
used for the diagnostics.
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R2134 Advances in diagnostic testing of
Chlamydia trachomatis
S. Bonin, M. Eickhoff
Hamburg, D
Objectives: The diagnostic testing for genital chlamydia infection
has changed in the past few years. New highly sensitive tests
based on nucleic acid ampliﬁcation technology (NAATs) have
been developed to allow noninvasive specimen collection and to
create new opportunities for innovative screening programs. We
evaluated the performance of the RealArt C. trachomatis RG PCR
Kit (artus, Germany) on the Rotor-Gene 3000 instrument (Corbett
Research, Australia) with swab, urine and sperm specimens to
improve our ability to diagnose chlamydia infections in invasive
and noninvasive specimens.
Methods: The RealArt assay combines sequence-speciﬁc primers
and a dual labeled ﬂuorogenic probe. In addition, it contains a
second ampliﬁcation system (internal control) to identify possible
PCR inhibition and to control the isolation procedure. Swab speci-
mens were puriﬁed using the QIAamp DNA Mini Kit, urine and
sperm specimens by the QIAamp Viral RNA Mini Kit (QIAGEN,
Germany). The evaluation of the assay was performed with 298
retrospective swab specimens (233 eye, four Douglas, 31 urethral,
15 cervical, one penis and 10 vaginal swabs) as well as for 322
prospective specimens (187 urine, 100 cervical swabs and 35
sperm samples).
Results: On retrospective specimens the RealArt C. trachomatis RG
PCR Kit showed an inhibition rate of 0.3% appearing on one eye
swab. One of 11 previously positive tested swab samples could
not be detected due to this inhibition. The speciﬁcity for retro-
spective specimens was 100%. For prospective specimens the inhi-
bition rate was 0.3%, too. The inhibition occurred on one urine
sample. The results for the prospective samples showed a positive
rate of 1.6% for urine, 4% for cervical swabs and 2.9% for sperm
specimens. The positive result for the sperm sample was con-
ﬁrmed by retesting and parallel testing of a urine sample of the
same person.
Conclusions: Our results showed that the new real-time PCR
assay provides a sensitive and speciﬁc way to detect C. trachoma-
tis not only in invasive but also in noninvasive specimens. These
collection methods are more acceptable to patients and allow for
testing outside traditional clinic settings by eliminating the need
for painful urethral swabs in men and uncomfortable pelvic
exams in women. This increases the access to care for high-risk
groups.
R2135 Evaluation of a real-time PCR assay for the
detection of Chlamydia trachomatis in different specimen types
M. Eickhoff, S. Bonin, S. Thamm, G. Michel
Hamburg, D
Objectives: Bacteria of the species Chlamydia (C.) are of great epi-
demiological importance worldwide. Until recently, the gold
standard for identifying C. trachomatis has been the culture
method. Although speciﬁc, this procedure is time consuming,
laborious and is unﬁt for the routine screening of C. trachomatis in
clinical specimens. We evaluated the performance of the RealArt
C. trachomatis TM PCR Kit (artus, Germany) on the ABI PRISM
7000 SDS instrument (Applied Biosystems, USA) to improve
access to screening methods in routine clinical practices.
Methods: This new real-time PCR assay combines sequence-speci-
ﬁc primers and a dual labelled ﬂuorogenic probe. In addition, it
contains a second ampliﬁcation system (internal control) to iden-
tify possible PCR inhibition and to control the isolation procedure.
The results of the RealArt C. trachomatis TM PCR Kit for 150 retro-
spective swab specimens (50 urethral, 50 cervical and 50 vaginal
swabs) and for 100 retrospective urine specimens (50 male and 50
female) were compared with those of Abbott’s ligase chain reac-
tion (LCx CT/GC assay) and GEN-PROBE’s transcription medi-
ated ampliﬁcation (APTIMA Combo 2 assay).
Results: On retrospective specimens the RealArt C. trachomatis TM
PCR Kit showed a correlation to LCx CT/GC and APTIMA
Combo 2 of 98.8%, respectively. Two RealArt C. trachomatis posit-
ive, LCx and APTIMA-negative samples were further analysed by
sequencing which revealed a C. trachomatis speciﬁc sequence.
Conclusion: Our results showed that the new real-time PCR assay
is a sensitive and speciﬁc way to detect C. trachomatis in swab and
urine specimens, enabling fast screening of this important target
group.
R2136 Rapid detection of Salmonella sp. in clinical
veterinary samples
M. Oliveira, M. Vieira-Pinto, C. Martins, F. Bernardo
Lisbon, Vila Real, P
Salmonella sp. is the main cause of human gastroenteritis world-
wide. Salmonellosis, which symptoms may vary from mild diar-
rhoea to severe sepsis, affects 2–4 million individuals per year in
the USA, with a mortality rate of 1–10%. Pork and derivate prod-
ucts is an important vehicle of Salmonella transmission. Since their
consumption has increased in Portugal in the last decade, it is
urgent to develop rapid methods for the detection of Salmonella in
slaughterhouse samples. Using a speciﬁc probe described by Nor-
dentoft et al. (1997), a FISH protocol for Salmonella sp. detection
was developed. This protocol was applied to 129 samples from a
slaughterhouse, which included ileum, intestinal ganglia, amyg-
dales, mandible ganglia, carcass and liver. These samples were
also analysed through VIDAS. It was observed that 78 samples
(60%) revealed to be positive through FISH analysis, while VIDAS
originated 22 positive results (17%). These results show that the
FISH protocol developed allows the detection of Salmonella sp. in
clinical samples in 48 h, with high sensitivity and low cost. This
technique is currently applied to the microbiological analysis of
faeces, urine and blood samples.
R2137 Inactivation of pbp4b gene in Salmonella enterica
serovar Typhimurium SL1344, Escherichia coli BW 25113,
CS-801-4 and RP1 by using PCR products
D. Vega Mendoza, J. Ayala Serrano, D. Menguin Lecreulx
Madrid, E; Paris, F
Objectives: To understand what are the molecular mechanisms
(and the proteins implied in them) by which Salmonella carries out
the cellular division and peptidoglycan biosynthesis within the
cell eucariota, and contribute for the design of therapeutic strat-
egies that can limit the infection and prevent the antimicrobial
resistance. An important virulence factor in STM is its capacity to
replicate itself intracellularly in epithelial cells. Studies made in
mutants of STM, that normally invade nonphagocitics cells in cul-
ture, but that are not able to proliferate intracellularly, suggest the
existence of a genetic loci-speciﬁc and necessary to be able to mul-
tiply intracellularly and confer to STM the pathogenic character.
By this reason we have designed a mutant of STM for the pbp4b
gene implied in the process of cellular division and the peptidog-
lycan biosynthesis. This pbp4b-mutant, was obtained by a new
technique of PCR, using primers of 60 nucleotide of length, which
amplify the cassettes of Cloranfenicol and Kanamicina resistance
that are ﬂanked by regions FRT (FLP Recognition Target) and
regions homologous to adjacent genes to the pbp4b gene and then
transform bacterial strain containing the pKD46 vector of low
number of copy and termosensible that codiﬁes for the recombin-
as red of the Lambda phage that is under the control of an indu-
cible promoter by arabinosa, and the mutants generated were
selected by their resistance to antibiotic. These resistance genes
were eliminated using a vector thermosensible that codiﬁes for
FLP recombinase. This mutant pbp4b- have been put under stud-
ies of kinetic of intracellular proliferation using mice model and
in vitro tests using cellular lines Hela, Swiss 3T3 and NRK for the
obtaining of the respective rate of intracellular proliferation in
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nonphagocytics cells. The results obtained until the moment indi-
cate that STM displays a different infection behavior and intracel-
lular proliferation depending on the cellular type that it invades.
Despite it is important to make a mention and indicate that this
research is actually in developing process, and we are sure that
the results that will obtain allow an experimental but deep board-
ing in the identiﬁcation of new useful targets in STM in the
design of new drugs with therapeutic application.
R2138 Correlation between pigment production and
b-haemolysin of Streptococcus agalactiae
G. Bro¨ker, B. Gottschalk, J. Ozegowski, M. Kuhn, B. Spellerberg
Ulm, Jena, D
Objectives: Streptococcus agalactiae (group B streptococci) is the
leading cause of bacterial sepsis, pneumonia and meningitis in ne-
onates. The production of an orange-red pigment is frequently
used for diagnostic purposes. Pigment formation and production
of haemolysin is associated with the cyl genes, a locus that com-
prises a cluster of 12 different genes.
Methods and results: To investigate the linkage between pigment
and haemolysin formation, nonpigmented mutant strains har-
bouring a deletion in the cyl A, cyl G, cyl E or cyl K gene were
compared with pigment-forming wild-type strains. It was possible
to extract haemolytic activity from pigmented intact cells using
an extractor solution containing starch as stabilising agent. How-
ever, at room temperature this activity was rapidly lost. No hae-
molysis was found associated with the analysed nonpigmented
mutant strains or in wild-type strains grown under conditions not
leading to pigment production. Interestingly, the formation of
haemolysin and pigment is inhibited by an excess of glucose in
the growth medium. Streptococcus agalactiae pigment is produced
in the late exponential phase and is associated with the bacterial
cells. However, in presence of a suitable carrier molecule it could
also be found in the medium. Pigment from lysed wild-type-cells
was isolated under acidic and basic conditions, resulting in
orange-red solutions with different spectral properties. Further
analysis was performed on the extracts, a lyophilised extract, and
precipitated extract preparations. As a result the association of
the pigment with a high-molecular weight carrier molecule was
observed.
Conclusion: Our ﬁndings conﬁrm the proposed linkage between
the expression of hemolytic activity and pigment production of
Streptococcus agalactiae. The described isolation methods enable
further analysis of the pigment and will give new insights into
the nature of this molecule. The pigment isolation along with the
knowledge on stability and production of the haemolysin will
allow the elucidation of the correlation between haemolysis and
pigment production.
R2139 Detection of common agents of bacterial
meningitis with a low density DNA array
H. Grewal, H. Valvatne, K. Kalland, E. Ulvestad, J. Lazaar,
P. Telleman, C. Christenssen
Bergen, N; Lyngby, DK
Bacterial meningitis is a serious infection of the central nervous
system, whose aetiology may be missed in 10–15% of cases.
Rapid diagnosis is a prerequisite for the initiation of prompt and
effective treatment. Traditional laboratory diagnostic methods
with culture for the identiﬁcation of bacterial meningitis patho-
gens may take 36 h or more. Furthermore, following an increase
in the practice of starting antimicrobial therapy prior to clinical
sample collection, the ability to conﬁrm the pathogenic microor-
ganisms of bacterial meningitis may not always be possible.
Compared with conventional methods, assays based on nucleic
acid detection have the potential of greater speed and sensitivity.
In recent years, PCR techniques have increasingly been used to
amplify and detect microbial DNA in clinical samples. By using
a combination of PCR methods and array technology we des-
cribe a method for identifying common bacterial agents of pyo-
genic meningitis (S. pneumoniae, N. meningitidis, H. inﬂuenzae by
amplifying and detecting both universal and variable regions of
bacterial 16S ribosomal DNA and pathogen-speciﬁc virulence or
pathogenicity-associated genes on an oligonucleotide DNA array
platform.
R2140 Improving method of chromosomal DNA extraction
of Brucella melitensis for multiplying gene pieces by PCR
I. Pakzad, A.Z. Hossaini, M.J. Rassaee, B. Tabrai, A. Kazemnejad
Tehran, IR
Brucella melitensis is a Gram-negative bacterium, which has a cell
wall with a complex structure. Because of cell wall characteristics,
the common methods for chromosomal DNA extraction of Gram-
negative bacteria have some problems with this bacterium. In this
research, chromosomal DNA extraction of this bacterium was car-
ried out for multiplying gene pieces by PCR by CTAB and com-
mon method. Because of low efﬁciency of these two methods,
chromosomal extraction of this bacterium was performed by com-
bining these two methods. First, we treated bacteria by SDS and
TE, and then we destroyed peptidoglycan by lysozyme. After that,
we precipitated protein with phenol–chloroform and polysaccha-
ride by CTAB. In this research, appropriate time for chromosomal
extraction from liquid culture was 48 and 72 h, Then we obtained
appropriate amount of 10% SDS and lysozyme, 90 ml and 85 ll,
respectively (5 g/mL). Our results showed that the amount of
DNA extracted with this method is higher than the other two
methods and it reaches 500 g/mL. In addition, purity of extracted
DNA in this method is better than the other two methods. The
extracted chromosomal DNA was used for multiplying l7/l12 (a
bacterial ribosomal protein). Because of improved efﬁciency of
this method, it may be used as a method for chromosomal DNA
extraction in clinical samples of blood and milk for diagnosing
brucellosis.
R2141 Detection of Listeria monocytogenes in fresh FISH
using real-time PCR, PCR and ISO methods
C. Salamoura, C. Papadopoulou, G. Vrioni, G. Filioussis,
C. Dontorou, M. Malamas, D. Mpaseas, S. Leveidiotou
Ioannina, GR
The objectives of the present study were the assessment of Lis-
teria monocytogenes contamination of ﬁsheries and the evaluation
of standard ISO methods and modern molecular techniques. Sev-
enty samples of fresh and saltwater edible ﬁsh were examined
for L. monocytogenes contamination, using the standard ISO cul-
tural methods and two different polymerase chain reactions
(PCR). The samples were collected from local ﬁsh markets and
local aquacultures. Half-Fraser broth and Fraser broth were used
for pre-enrichment and enrichment reciprocally, while Oxford
and Palcam agar (ISO 10560) were used as selective agars. Two
PCR automated systems, the LightCycler (Roche) with detection
limit 103 CFU/mL, and the Bax (Qualicon), with detection limit
105 CFU/mL were used for the performance of PCR. Two
strains of L. monocytogenes were isolated with the ISO cultures
and also detected by both PCR systems. One isolate (L. monocyto-
genes serotype 4) was detected from a ﬁsh of local capture
(cephalus) and the other strain (L. monocytogenes serotype 1) was
isolated from imported fresh salmon ﬁlet. Both isolates were sus-
ceptible to routinely used antibiotics. The results indicate the
possible risk of L. monocytogenes infection transmitted from ﬁsh-
eries to humans through inadequately cooked seafood and/or
through contamination of culinary tools. The results also suggest
that molecular techniques minimise considerably the recovery
time of L. monocytogenes from food, enabling a more efﬁcient
safeguarding of public health with regard to food-borne infec-
tions.
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Diagnostic methods (other than molecular)
R2142 Development and application of a Dot blot assay
for detection of human immunodeﬁciency virus types 1 and 2
using recombinant p24, gp41 and gp36 proteins from Iranian
strains
M. Ravanshad, F. Mahboodi, F. Sabahi, M. Roostaee
Tehran, IR
Recombinant p24, the capsid protein region and recombinant
gp41, the transmembrane protein of human immunodeﬁciency
virus type 1 (HIV-1) and also recombinant gp36, the speciﬁc
human immunodeﬁciency virus type 2 (HIV-2) antigen had been
expressed in Escherichia coli BL21 (DE3). The antigenic reactivity
of all recombinant proteins was conﬁrmed by Dot blot with
human antisera to HIV-1 and HIV-2 separately. HIV-negative
human sera failed to recognise the recombinant proteins, thereby
showing the speciﬁcity of the HIV Dot blot. Sixty-ﬁve human-pos-
itive serum samples as well as human-negative serum samples
were tested for the presence of anti-HIV antibodies by the recom-
binant protein-based Dot blot and a reference assay. There was a
100% concordance when all recombinant proteins were used in
the Dot blot. However, the Dot blot using the recombinant pro-
teins as its test antigen identiﬁed two HIV-positive human sera,
which had tested negative in the reference assays. The results of
this study showed that the recombinant p24, gp41 and gp36 pro-
teins could be used as test antigens for detection and conﬁrmation
of HIV-infection in human.
R2143 Standardisation of an ELISA test for detection of
hydatid cyst antigen/s in human serum
M.J Mehrabanpour, M.H Hosseini, N. Dehghani
Shiraz, IR
Introduction and objectives: Serological methods to conﬁrm the
diagnosis of hydatidosis are mainly based on detection of antibod-
ies against cyst antigen/s in patients serum, but as antibody pro-
duction is time consuming (several days) as well as low or no
antibody responses to cyst antigens are recognised in some
human patients as well as animals such as sheep, so serology
based on antibody detection may not be fully dependable. There
for, serology based on antigen/s detection may be more valu-
able. In this study a capture ELISA for detection of hydatid cyst
antigen/s in human serum was designed and standardised.
Methods: Antibodies used for coating ELISA plate wells and for
conjugation with HRP were prepared in rabbits and guinea pigs.
ELISA test was standardised by coating one microgram antibody
/well of microtitre plate in carbonate-bicarbonate buffer at 4C
over night, blocking with 3% BSA, conjugated antibody 1/75 dilu-
tion, and use of H2O2 as substrate and OPD as chromogen.
Results: Results show that the standardised ELISA test is able to
detect as less as 312 ng of cyst antigens/mL of patients serum or
in PBS with cut off 0/13 i.e. mean of negatives plus two standard
deviations. The sensitivity of the standardised test for hydatid cyst
ﬂuid, protoscolex soluble antigens, and mixture of both was same.
Discussion and conclusion: The standardised test seems to be useful
for diagnosis as well as follow-up of treatment.
R2144 Selected markers in the monitoring of infections in
an abdominal surgery setting
R. Marciniak, M. Drews, P. Majewski, A. Oko, R. Kedziora-Bart-
kowska, J. Zurawski, P. Marciniak
Poznan, PL
The aim of the study was to construct our own model of the mon-
itoring of severe inﬂammation in patients after surgical operations
within the abdominal cavity.
Methods: For evaluation of the inﬂammation we have taken the
scale, which included clinical state, also, the results of microbiolo-
gical cultures and biochemical parameters. The level of PCT, TNF-
alpha, IL-1beta, IL-6 in the blood serum was designated. The
blood samples were taken in the 0-3-5 day after the operation
and, in case of need, later depending on the clinical state of the
patient. 103 determinations of the PCT level in 34 patients were
performed, 71 determinations in 29 patients to measure TNF- alfa
and IL-1 beta levels and in nine patients 21 determinations for
IL-6.
Results: The mean PCT level in the group of patients with local
infections was 0.39  0.52 ng/mL, in acute pancreatitis was
2.46  3.05 ng/mL, in diffuse peritonitis 4.98  6.46 ng/mL, and
in septic shock was 12.8  7.9 ng/mL. Signiﬁcant statistical differ-
ences between particular groups were noticed with P < 0.001. In
the group of patients who survived this value was: l.63  l.22 ng/
mL and in those who died 7.36  4.4 ng/mL/ P < 0.001. The
median plasma concentration of TNF-alpha was
13.55  10.15 pg/mL in the examined group and 12.44  3.62 pg/
mL in the control group; II-1beta respectively 5.46  3.43 pg/mL
and 2.14  2.15 pg/mL; IL-6: 828  573 and 254  78 pg/mL. Sig-
niﬁcant statistical differences were noticed only for IL-6/
P < 0.05/. In the group of patients who survived, TNF-alpha level
was 12.11  7.90 pg/mL and in those who died 14.53  16.37 pg/
mL; IL-1beta, respectively, 6.19  4.47 pg/mL and
4.24  1.05 pg/mL; IL-6: 763.5  120.4 and 1243  906.6 pg/mL/
n.s.
Conclusions: The dynamics of changes in the values of each
parameter in time were compared. PCT is the most sensitive and
precise prognostic factor in the group of patients with severe
infections of the abdominal cavity. This marker can facilitate the
diagnosis of sepsis and permits objectivisation of the dynamics of
the clinical picture. It’s difﬁcult to evaluate cytokines‘ usefulness
in monitoring of infections.
R2145 Performance of TechLab C. DIFFICILE ANTIGEN
CHEK for the detection of Clostridium difﬁcile in stool
specimens
H. Snell, M. Ramos, S. Longo, M. John, Z. Hussain
London, Ontario, CAN
Objectives: TechLab Inc. (Blacksburg, VA) has recently developed
an ELISA test for the detection of glutamate dehydrogenase, a C.
difﬁcile antigen. We evaluated the performance of this kit, TechLab
C. DIFF CHECK (TL-AG) and compared its results with those of
cultures and the component of Triage C. difﬁcile panels detecting
GDH (Tr-AG).
Methods: Stools submitted for the diagnosis of C. difﬁcile-associ-
ated diarrhoea (CDAD) were inoculated onto C. difﬁcile selective
media (Oxoid, Canada) and tested with TL-Ag and Tr-AG accord-
ing to the manufacturers’ instructions. After 48 h incubation
under anaerobic conditions, suspected colonies were identiﬁed as
C. difﬁcile by the MicroScreen C. difﬁcile slide agglutination test
(Microgen Bioproducts Ltd, Surrey, UK). C. difﬁcle isolates were
also tested for the presence of toxin A and B genes by PCR.
Results: The study included 497 specimens. Because of blacken-
ing, Triage panels could not be evaluated in 15 (3%) of cases. C.
difﬁcile was isolated from 93 specimens. Twenty (21.5%) were
nontoxogenic. TL-Ag correctly identiﬁed the presence of C. difﬁ-
cile in 87 specimens, and Tr-Ag detected C. difﬁcile in 79/93
cases. Compared with culture results sensitivity, speciﬁcity, pos-
itive- and negative-predictive values were 93.5, 98, 91.6 and 98,
respectively, for TL-Ag, and 84.9, 98.8, 94 and 96.6%, respect-
ively for Tr-Ag.
Conclusions: ELISA methods for the detection of C. difﬁcile were
more rapid than cultures. TL-Ag was more sensitive than Tr-AG.
Like cultures, the tests for GDH detect both toxogenic and nontox-
ogenic strains of C. difﬁcle therefore, these tests should only be
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used as screening tests. Should TL-Ag be used in the diagnosis of
CDAD, it should be used in combination with a toxin detection
test.
R2146 Mycoplasma hominis in the genital tract of women
M. Hrdinova, J. Mazurova
Pardubice, CZ
Mycoplasmas are the smallest free-living micro-organisms able to
replicate on cell-free media. They possess the smallest genome of
all prokaryotes. M. hominis belongs to the sensitive micro-organ-
isms and its determination is very difﬁcult. The role of M. ho-
minis in pathogenesis of genital infections has not been proved
yet. Mycoplasma hominis can be isolated with different frequency
from the women urogenital tract and it is thought to cause var-
ious syndromes such as pelvic inﬂammatory disease, infertility,
amniotic ﬂuid infection, aborts, lowborn weight, postpartum en-
dometritis and fever. The aim of this study was to determine the
incidence of M. hominis in the genital tract of women and its sus-
ceptibility to antimicrobial agents. Specimens were taken from
the cervix of randomly selected women and cultivated on PPLO
agar. Isolates were tested in PPLO-arginine broth and conﬁrmed
by PCR method. 252 cervical swabs were investigated. M. hominis
was isolated in 44 cases (17.5%) from this cervical specimens.
Susceptibility of clinical isolates of M. hominis was studied to
doxycyclin, ciproﬂoxacin and erythromycin. This research was
supported by MSM 253100002.
R2147 Prevalence of Staphylococcus aureus in the
university dairy herd
K.M. Mokgejane, P.T. Mmolawa, D. Beighle
Mmabatho, ZA
The prevalence of Staphylococcus aureus in the university dairy
herd during two seasons (winter and summer) was investigated.
A total of 12 Friesland cows (42 quarters because the other six
quarters were blocked) were used during the research. California
mastitis test (CMT) and bacteriological culturing were employed.
All tests were negative in all cows during winter. During summer,
10 quarters were negative in CMT and all bacteriological cultures.
The remaining 19 quarters were positive on both CMT and bac-
teriological culturing of S. aureus. S. epidermidis was isolated in the
remaining 13. These results suggest that the incidence of S. aureus
was high in summer as compared with winter (0% in winter vs.
45% in summer). Interestingly, S. aureus was also isolated from
other milking equipments in the dairy, probably because of poor
sanitary measures.
R2148 Distribution of systemic inﬂammatory response
syndrome (SIRS) according to the cause in emergency ward
admissions Esfahan, Iran, 2002–03
M. Rostami, A. Emami Naeini
Esfahan, IR
Objectives: The systemic inﬂammatory response syndrome may
have an infectious or noninfectious aetiology. SIRS is usually pre-
sented by signs and symptoms such as fever or hypothermia,
tachycardia, leucocytosis or leucopenia, and appearance of band
cells in peripheral blood. Any of the above can happen in severe
infections. This study is conducted to evaluate share of any clin-
ical entity inducing SIRS.
Material and methods: The study included every patient over
12 years with a minimum of two measures for SIRS during 1 year
(21 October 2002 to 21 October 2003). A criteria selection form
was ﬁlled by resident physician and rechecked by specialist.
Those who proved to be SIRS were evaluated for the cause and
ﬁnal diagnosis was registered in the form.
Results: Totally 904 cases were referred to the emergency room
because of different conditions. A total of 429 cases had criteria to
be SIRS. The most frequent causes of SIRS presentation were
trauma (34.7%), infection (26.3%), CVA (5.6%) GI bleeding (4.9%)
and other conditions including convulsion, vaginal delivery, CHF,
unstable angina, malignancy, acute myocardial infarction, pam-
phigus, thrombocytopenic purpura, thromboembolism, hypogly-
caemia, cardiomyopathy, atrialﬁbrilation, pancreatitis, Steven–
Johnson syndrome, DKA and pancytopenia.
Conclusions: Although SIRS may be the preliminary stage of sepsis
and septic shock but a wide range of diseases initially may pre-
sent with this syndrome. Physicians have to evaluate and observe
these critically ill patients course of the illness. Many noninfec-
tious causes may trigger SIRS which are not responsible to antibi-
otics and do not need this kind of drugs.
R2149 Evaluation of Helicobacter pylori stool antigen test
for diagnosis of infection and posteradication follow-up
M.H. Shirazi, S. Eshraghi, S.R. Fatemi
Tehran, IR
A total of 54 patients with epigastric discomfort referred to
lmmam Khomeini teaching hospital for upper gasterointetinal
endoscopy were enrolled in this study. Helicobacter infection was
conﬁrmed with rapid unease test; culture and histological meth-
ods. Cold standard tests were positive culture or positive RUT
plus histology with which HpsAT was compared; and gold stand-
ard for negative infection; was negative Rut; negative culture and
histology.
A total of 26 patients with positive infection with omeprazol,
tetracycline; metronidazol; bismuth subsalisylate; for 2 weeks.
Then l and 3 months later revaluated with gold standard tests
and HpsAT.
Results: Sensitivity and speciﬁcity and accuracy of Helicobacter py-
lori stool antigen test before eradication was 78.6, 92.3 and 85.2%
respectively. One month after eradication sensitivity and speciﬁci-
ty, and accuracy of test was 100 and 59.5%, and 61.5%, respect-
ively, and 3 months after treatment was 85.7, 89.5 and 88.5%,
respectively. These results implicate that HpsAT for primary diag-
nosis of Helicobacter pylori infection is an excellent method; but its
speciﬁcity and accuracy in early period fallow-up of eradication
are low. Also 3 months fallowing eradication and later than that,
HpsAT has very good and acceptable results.
R2150 CPS ID 3 – a new chromogenic media used in
detection of urinary infection agents
P. Ciragil, M. Gul, M. Aral
Kahramanmaras, TR
Objectives: In our university hospital, the chromogenic media
recently started to be integrated and used in parallel with Colum-
bia 5% sheep blood, Cled and Mac Conkey agar. We have evalu-
ated the fertility, identiﬁcation performance for the micro-
organisms isolated in our laboratory and the enumeration special-
ity of the new media called CPS ID 3 (bioMe´rieux S.A. France).
Methods: In total, 105 urine specimens were included in this
study, collected between September and November 2003 in the
university hospital of Kahramanmaras Sutcu Imam. The speci-
mens were inoculated in parallel on the CPS ID 3 medium,
Columbia 5% sheep blood, Cled and Mac Conkey agar. They
were incubated at 37 C during 18–24 h.
Results: Seventeen specimens were sterile (<1000 CFU/mL), they
were not included in the study. 65 of 79 specimens had a single
type colony, and 14 of 79 had mixed type colony (12 of 14 two
types, two of 14 three types). The distribution of the bacteria were
respectively: 44 Escherichia coli, 10 Enterobacter spp., 8 Proteus spp.,
8 Klebsiella spp., 3 Pseudomonas aeruginosa, 4 B group streptococci,
7 Enterococcus spp., 6 Staphylococcus spp, 2 Candida spp. and 2
Morganella spp. The sensitivity of CPS ID 3 for identiﬁcation of
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E. coli, Klebsiella, Enterobacter, enterococci were 93.2, 100, 100 and
100%, respectively. CPS ID 3 efﬁciently prevented the swarming
of Proteus.
Conclusion: CPS ID 3 is a useful chromogenic media to perform
urine specimen testing because of rate of identiﬁcation of the most
frequent bacteria, efﬁcient enumeration and fertility.
R2151 An evaluation of MRSA ID: a new chromogenic
medium for the isolation and identiﬁcation of methicillin-
resistant Staphylococcus aureus
A. Davies, J.D. Perry, L.A. Butterworth, A. Nicholson, F.K. Gould
Newcastle upon Tyne, UK
Objectives: MRSA ID is a new chromogenic medium, which relies
upon alpha-glucosidase detection for the visualisation of methicil-
lin-resistant Staphylococcus aureus (MRSA) as green colonies. The
medium is selective against Gram-negative bacteria, enterococci
and fungi and also inhibits methicillin-sensitive staphylococci due
to the inclusion of a beta-lactam antibiotic. The aim of this project
was to evaluate the effectiveness of MRSA ID for the isolation of
MRSA from nasal swabs. Its performance was compared with that
of two commercially available agars.
Method: A total of 192 nasal swabs from distinct hospital
patients were each emulsiﬁed in 750 lL of saline (0.85%). A
50 ll sample of the resulting suspension was inoculated onto
MRSA ID, CHROMagar MRSA and ORSAB medium. The ino-
culum was spread for single colonies and all media were incu-
bated at 37C. The culture plates were examined for the
presence of MRSA after 20–22 h incubation and were examined
again after a total of 48 h incubation. All suspect colonies of
MRSA on all media were conﬁrmed using standard methods
including the tube coagulase test and detection of the mecA
resistance determinant.
Results: A total of 28 strains (14.6%) were isolated on at least one
of the three media. After 20–22 h incubation 25 of these strains
(89%) were isolated as coloured colonies on MRSA ID compared
with 20 (71%) on CHROMagar MRSA and 21 (75%) on ORSAB
medium. After 48 h incubation, 26 strains (93%) were isolated as
coloured colonies on MRSA ID and ORSAB medium compared
with 25 (89%) on CHROMagar MRSA. The chromogenic reactions
of all three media were highly speciﬁc for MRSA after 20–22 h
incubation. The speciﬁcities of the media were 100, 100 and 95%
after 20–22 h for MRSA ID, CHROMagar MRSA and ORSAB,
respectively. After 48 h, some strains of coagulase-negative sta-
phylococci generated pale green colonies on MRSA ID, they were
clearly distinguishable from S. aureus colonies.
Conclusions: MRSA ID is a highly effective medium for the detec-
tion of MRSA from nasal swabs and has an excellent sensitivity
and speciﬁcity after 20–24 h incubation.
R2152 Disk diffusion (DD) synergy test with cefotetan/
cloxacillin (CTT/CLX) for discrimination between Klebsiella
pneumoniae (Kp) producing plasmid-mediated AmpC-type beta-
lactamase (pACBL+) from other cefoxitin-resistant (FOX-R)
strains
M.-C. Conejo, M. van der Hooft, F. Ferna´ndez-Cuenca, A. Pascual,
L. Martı´nez-Martı´nez
Seville, E
Background: It is important to differentiate between Kp pACBL+
from other FOX-R strains because of diagnostic, therapeutic, and
epidemiological reasons.
Methods: Sixty Kp clinical strains were studied, including 26
pACBL+, 12 strains producing extended-spectrum beta-lactamas-
es and deﬁcient in porins (ESBL+/POR) and 22 strains with
other mechanisms of resistance (10 ESBL/ACBL/POR+; 10
ESBL+/ACBL/POR+; 2 ESBL/ACBL/POR). Strains were
identiﬁed as pACBL+ when they transferred FOX-R by conjuga-
tion and contained a beta-lactamase inactivated CLX but not by
clavulanic acid, as determined by in situ analysis on isoelectric
focusing gels. ESBL were detected by microdilution (NCCLS
method). Porin loss was determined by SDS-PAGE of outer
membrane proteins. The activity of both FOX and CTT was
determined by DD (30 lg disks) and by microdilution (MD)
(NCCLS guidelines). Synergy between CLX and CTT was deter-
mined by MD and DD in medium containing CLX (0.25 mg/
mL) or by using CTT/CLX disks (CLX content: 0.25, 0.5 or
1 mg).
Results: All 26 pACBL+, all 12 ESBL+/POR strains, and 12/22 of
other strains were FOX-R. CTT-R was only noted among pACBL+
(21/26 strains). By MD, the MICs of CTT decreased 3 twofold
dilutions in the presence of CLX 0.25 mg/mL for 23/26 Kp pAC-
BL+, and in none of the remaining groups. By DD, zones around
CTT disks increased 4 mm for 19/26 Kp pACBL+ in medium
containing CLX (0.25 mg/mL). DD with CTT/CLX disks gave
zones of inhibition that were 4 mm in comparison with those of
CTT disks alone for 18/26, 19/26 and 24/26 Kp pACBL+ when
CLX content in disk was 0.25, 0.5 and 1 mg, respectively. In all
other organisms this increase was 3 mm.
Conclusion: A 4 mm increase in the diameter of inhibition zone
of a CTT/CLX disk (30 lg/1 mg) in comparison with the diam-
eter of a CTT disk (30 lg) alone allows an easy-to-perform dis-
crimination between clinical isolates of Kp pACBL+ from other
FOX-R Kp.
R2153 Diagnostic accuracy of anti-cyclic citrullinated
peptide antibodies in juvenile idiopathic arthritis
S. Altun, O¨. Kasapcopur, M. Aslan, S. Karaarslan, A. Kamburo-
glu-Goksel, S. Saribas, N. Arisoy, B. Kocazeybek
Istanbul, TR
Objective: The aim of the study is to evaluate the positivity of
anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients
with juvenile idiopathic arthritis (JIA) and its relationship with
disease subtype and erosive form of the disease.
Methods: The study population consisted of 122 patients (72 girls,
50 boys) with JIA. 16 of them were evaluated both during active
disease and remission period. 19 children with systemic lupus
erythemathosus (SLE), 27 patients with rheumatoid arthritis (RA)
and 15 healthy children were also included in the study. RF posi-
tivity was observed only in 12 children with JIA and 34 patients
had persistent erosive lesions in their joints. Anti-CCP antibody
levels were determined by via ELISA and values above 5 relative
units (RU) were regarded as positive.
Results: Only three girls with seropositive polyarticular JIA and
erosive joint disease had positive anti-CCP values. Children evalu-
ated both during active and remission period of the disease as
well as those with SLE and healthy children all had negative anti-
CCP antibody levels. However, 19 (70%) of adult patients with
RA showed positive anti-CCP antibody values.
Conclusions: In contrary to RA, in patients with JIA, which has a
heterogeneous nature, anti-CCP antibody positivity is only rarely
found. In patients with RF positivity and/or in patients with ero-
sive joint disease, anti-CCP antibodies can be detected. For that
reason, in patients with JIA, anti-CCP antibodies should not be
used as a screening method, but as early indices of joint damage,
especially in children with polyarticular JIA.
R2154 Procalcitonin level measurement in juvenile
idiopathic arthritis
B. Kocazeybek, S. Altun, O¨. Kasapcopur, M. Aslan, G. Ercan, Y.
Tastan, Y. Seyhun, S. Saribas, N. Arisoy
Istanbul, TR
Objectives: The aim of this study is to determine the role of pro-
calcitonin (PCT) in diagnosis and follow ups of JIA as acute phase
reactants.
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Methods: Eighty-one JIA patients (50 females, 31 males) were stud-
ied. Sixty of the patients had active disease during the evaluation.
Control group consisted of 15 healthy children and 21 children
diagnosed with bacterial meningitis. PCT was measured with
immunoluminometric method. ROC curve was obtained with
results and cut-off points were accepted as 0.856 ng/mL.
Results: Procalcitonin levels of JIA patients [1.04 (range 0.52–
7.42) ng/mL] were signiﬁcantly higher than those of healthy chil-
dren [0.71 (range 0.6–1.17) ng/mL] and was lower than those of
children diagnosed as bacterial meningitis [13.5 (range 0.8–
209) ng/mL]. The PCT levels of JIA patients with active disease
were signiﬁcantly higher than the JIA patients whose disease is in
remission. The PCT level showed signiﬁcant correlation with leu-
cocytes and CRP in JIA patients. There was no correlation
between PCT levels and erythrocyte sedimentation rate. Twenty-
one (25.9%) of JIA patients studied had positive PCT levels
according to range limit of 2 ng/mL. All of these children had
active disease and 13 (62%) of them also had bacterial upper res-
piratory infection ﬁndings.
Conclusions: PCT level shows only a slight elevation in inﬂamma-
tory disease although very signiﬁcant elevations are seen during
bacterial infection. The presence of active disease and infectious
ﬁndings in most of the patients may be useful to predict the anti-
bacterial treatment.
R2155 Protein C6 in serodiagnosis of Lyme borreliosis in
patients from Poland – a premilinary study
S. Grygorczuk, J.-M. Zajkowska, R. Swierzbinska, S. Pancewicz,
M. Kondrusik, I. Sienkiewicz, T. Hermanowska-Szpakowicz
Bialystok, PL
Objectives: The purpose of the study was to analyse the percent-
age of seropositive results in patients with Lyme borreliosis in
comparison with blood donors, using ELISA (C6-Immunetics and
Biomedica Recombinant kits).
Methods: The study included 136 patients treated in the outpatient
clinic or hospitalised in the Department of Infectious Diseases and
Neuroinfection of the Medical University of Bialystok. They were
divided into two groups: Group I n ¼ 36 patients with erythema
migrans, group II n ¼ 68 patients with Lyme arthritis. Group III n
consisted of 42 healthy blood donors. Serum samples were
obtained from patients before treatment. The diagnosis was based
on the criteria of CDC and EUCALAB. The tests of Immunetics
Quick ELISA C6 Borrelia Assay Kit (USA) and Biomedica Recom-
binant IgM, IgG (Austria) were used according to the producers’
recommendations.
Results: Only one individual of 42 blood donors had a positive
result in the test of Immunetics Quick ELISA C6 Borrelia Assay
Kit. It showed antibodies in IgG class (+++)59 BBU and in IgM
class (+)13 BBU. One individual with a doubtful result in the test
of Biomedica Recombinant had a negative result in the test of Im-
munetics Quick ELISA C6 Borrelia Assay Kit. Twenty-two
patients of 36 patients with erythema migrans had positive or
doubtful results and four patients – negative results in the test of
Immunetics Quick ELISA C6 Borrelia Assay Kit. In the test of Bio-
medica, 10 patients of 34 examined had positive results in IgM
class and four patients of 34 in IgG class. Antibodies in IgG class
were found in 68 patients with chronic borreliosis using the test
of Biomedica Recombinant and 20 of them had antibodies in IgM
class. In the test of Immunetics, positive or doubtful results were
proved in 57 patients and negative results were found in 11
patients.
Conclusions: ELISA test based on C6 protein is highly sensitive not
only at the early stage of borreliosis and erythema migrans but at
the later stage, as well.
– This test enables to detect antibodies in patients without clinical
symptoms.
– The results proved to be useful and necessary especially in
patients who had doubtful serum results in other tests.
– This test can be used as a screening and verifying test.
R2156 The isolation and characterisation of Actinomyces
strains in patients suffering canaliculitis in a teaching hospital,
Tehran
S. Eshraghi, M.H. Salari, Z. Bagheri
Tehran, IR
The main purpose of the study was to isolate and detect Actinom-
yces species and Propionibacterium propionica from lachrymal duct
infection. A total of 112 patients with advanced symptomatic
canaliculitis and dacryocystitis, who had been referred to Farabi
Teaching Hospital eye clinic in Tehran, were studied over a per-
iod of 18 months. From each sample three thin smears were pre-
pared for microscopic observations. The samples were cultured
anaerobically and micro-aerophilically in appropriate rich media.
Medical histories of patients were also recorded in the certain
questionnaire for further data analysis. The results demonstrated
that eight strains of bacteria (ﬁve strains of Actinomyces and three
strains of Propionibacterium propionica) from the canaliculitis
patients and 12 other micro-aerophilic bacteria from dacryocystitis
patients were isolated. The incidence of canaliculitis in women
(20%) was signiﬁcantly higher than the men (2.9%) (P < 0.05).
The rate of actinomycotic canaliculitis was 48.6% in household
women and 11.4% in students and 40% in other professions,
which indicates the role of occupation in the incidence of this
infection.
R2157 Isolation and characterisation of Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis with
aggressive peridontitis
M. Paknejad, S. Eshraghi, M. Jafari
Tehran, IR
Statement of problem: One of the best ways for treatment of
Aggressive Periodontitis (AP) is identiﬁcation and eliminations of
aetiological factors specially micro-organisms including Aa and
Pg in patients referring to Tehran University, Dental clinic. The
main purpose of the present study was to determine the preval-
ence of Aa and Pg in active sites of AP Patients. The correlation
between the incidence of Aa and Pg and such variables as age
and sex was also investigated. This investigation is a cross-sec-
tional and descriptive study. At ﬁrst marginal gingival dried and
Sampling Performed by number 30 paper point. The samples
obtained from 54 sites (Pocket depth Pd > 5 nm) in 15 patients.
From each sample thin smears were prepared for microscopic
observations. The samples were cultured in selective medium for
isolation of Aa and in TSBV and Brucella agar for isolation of Pg.
Stalistical tests were ﬁsher and X2. A total of 13 patients or 38
sites (%70.4) identiﬁed Aa positive and three patients or 10 sites
(% 18.4) Pg positive. There was not signiﬁcant difference between
incidence of Aa and sex (P ¼ 0.177) or age (P ¼ 0.086). Pg in men
found more than women (P < 0.0001) but about Pg it was not the
same. Aa with Pd had a signiﬁcant positive correlation.
(P ¼ 0.002). It means with increasing pd, the probability of Aa
existence would be high but about Pg it was not the same. Also
Aa had signiﬁcant negative correlation with family number that
means with increasing them, Aa+ sites decrease. Our results
revealed that the most of A.P Patients could consider Aa positive
but not Pg positive.
R2158 ELISA vs. routine tests in the diagnosis of patients
with brucellosis
A Esmaeilzadeh, H Baghchesaraei
Zanjan, IR
Objective: Brucellosis is one of the endemic disease in Zanjan
province and a zoonosis disease among animal and human
beings. Because of the importance of the brucellosis, there are
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many serological techniques for diagnosing the disease. Each of
them has advantages or disadvantages. Amongst serologic meth-
ods ELISA test is a choice method. The major aim of this study is
comparison of routine tests vs. ELISA in the diagnosis of brucello-
sis in Zanjan.
Methods: In this survey, 176 patients, showing clinical symptoms
of malta fever. The routine serological test for wright (rapid),
standard tube agglutination (STA), Coombs wright and IgM, IgG
ELISA were performed in serum samples. Sensitivity, speciﬁcity,
ppv and npv of them vs. total ELISA is compared.
Results: A total of 176 cases (92 males and 84 females) were affec-
ted by Brucella ranging from 15 to 65 years. Sensitivity, speciﬁci-
ty, ppv, npv wright(rapid) vs. ELISA sequencially is: 62.5, 100,
100 and 79.3%. STA vs. total ELISA sequencially is: 68.0, 100, 100
and 81.8% and coombs wright vs. total ELISA sequencially is:
80.0, 100, 100 and 88.1%.
Conclusion: ELISA is the most sensitive and more speciﬁc of the
Brucella serologic routine tests and is useful to monitor antibodies
in patients undergoing treatment, isotype determining and phase
of disease. Over all extrapolation of data from our study indicate
that the ranking of tests according to their reliability of diagnosing
human brucellosis is as follows: ELISA > coombs > STA > wright
(rapid).
R2159 Survey of Rose Bengal test vs. ELISA in the
diagnosis of acute and chronic brucellosis
H. Baghchesaraei, A. Esmaeilzadeh
Zanjan, IR
Objective: Brucellosis is one of the endemic diseases in Iran and
because of the importance of the brucellosis, there are many sero-
logic techniques for diagnosing the disease. Each of them has
advantages or disadvantages. Amongst serologic methods ELISA
test is a preferable (choice) method. The major aim of this study is
comparison of Rapid Rose Bengal test vs. ELISA in the diagnosis
of acute and chronic brucellosis (2002) in Zanjan.
Methods: In this survey, 176 patients, showing clinical symptoms
of malta fever. The serological test for Rose Bengal and IgG and
IgM ELISA were performed in all serum samples. Sensitivity, spe-
ciﬁcity, ppv and npv of Rose Bengal vs. ELISA are compared.
Results: Of 176 cases (92 male and 84 female) affected by Brucella
ranging from 15 to 65 years old. Sensitivity, speciﬁcity, ppv and
npv Rose Bengal vs. IgM ELISA is 100, 95.6, 70.8 and 100%
sequentially and for IgG ELISA is: 36.9, 100, 100 and 73.0%
sequentially.
Conclusion: ELISA is the most sensitive and more speciﬁc of the
Brucella serologic tests and is useful to monitor antibodies in
patients undergoing treatment. Isotype and phase of disease
determining Rose Bengal tests highly correlated with IgM ELISA
in acute phase of brucellosis but not correlated with IgG ELISA in
chronic diseases.
R2160 Laboratory diagnostic of suspect neuroborreliosis –
results from 1997 to 2003 in patients from West Slovakia
D. Huckova, J. Predny, L. Vozarova, M. Ondrkalova, P. Traubner,
A. Streharova
Bratislava, Trnava, SK
Background: Neuroborreliosis affects peripherial and central ner-
vous system.
Objectives: Point out on possibilities of laboratory diagnostics of
neuroborreliosis.
Subjects and methods: During the years 1997–2003 we tested 902
pair samples of CSF and serum from 894 patients with different
neurological diagnosis by ELISA, Western blot, PCR, completed
by biochemical and cytological investigations.
Results: Forty-ﬁve of 894 patients were anti-borrelia seropositive
(5%), 19 of them had speciﬁc IgG only (2.1%), 12 had only speciﬁc
IgM (1.3%) and 14 (1.6%) had both classes of speciﬁc antibodies in
serum. We conﬁrmed intrathecal speciﬁc IgG antibodies produc-
tion by AI in 22 cases (2.44%) of total 902 samples tested. From
those in 12 cases there were present also IgM antibodies in CSF.
We found borderline AI values in three cases (0.33%) and isolated
intrathecal production, antibodies present only in CSF, in two cases
(0.22%). There were normal AI values found in 29 cases (3.2%).
Speciﬁc antibody positivity in CSF without seroposivity was detec-
ted by WB method only in two cases. DNA positivity by PCR was
detected in one CSF from 112 samples during the last 4 years.
Conclusions: There should be used a complex of methods in algo-
rithm of microbiological testing for suspect neuroborreliosis. The
results have to be interpreted only in correlation with the biochemi-
cal and cytological tests and even with clinical symptoms and epi-
demiological data to lead to a correct overall clinical diagnosis.
R2161 Impact of CPS ID 3, a new chromogenic medium,
on identiﬁcation and susceptibility results
S. Mailler, S. Orenga, E. Pillon, D. Robichon, C. Roger-Dalbert
La Balme les Grottes, F
Objectives: CPS ID 3 is a new chromogenic medium for the diag-
nosis of urinary tract infections, enabling the enumeration of
micro-organisms, the identiﬁcation of Escherichia coli and Proteus
as well as the preliminary identiﬁcation of enterococci and the
Klebsiella–Enterobacter–Serratia–Citrobacter group (KESC). We have
veriﬁed that the use of this medium is compatible with the bio-
Merieux identiﬁcation and susceptibility testing products API, ID
32, ATB strips and the VITEK system. CPS ID 2, the previous for-
mula, was used for comparison as well as another medium when
it was recommended by the products information.
Methods: A set of 60 strains of micro-organisms representative of
those commonly encountered in urine and various mechanisms of
resistance were streaked on CPS ID 3, CP ID 2 and a reference
medium. A 24-h-old plate was used to inoculate API 20E, ID
32GN, Rapid ID 32E, ID 32 Staph, Rapidec Staph, Rapid ID 32
Strep, ID 32 C, VITEK GNI+, GPI, YBC and Rapid ATB UR, ATB
UR, ATB G(), ATB Staph, ATB Strep, VITEK cards GNS 513,
GNS 506, GNS 528. Identiﬁcations and MICs generated from the
different media were compared.
Results: When compared with CPS ID 2 or the recommended
medium, identiﬁcation testing on strips or on VITEK cards is not
affected by isolation on CPS ID 3. Agreement rates for each dispo-
sable were for API 20E: 80%, ID 32GN: 90%, Rapid ID 32E: 95%,
ID 32 Staph: 90%, Rapidec Staph: 100%, Rapid ID 32 Strep: 85%,
ID 32 C: 80%, VITEK GNI+: 90%, GPI: 70% and YBC:
100%. Concerning ATB strips and the VITEK cards GNS 513,
GNS 506, GNS 528, the MIC agreements were at least 97%. No
major discrepancy was encountered. There was no trend to induce
a higher susceptibility or resistance for speciﬁc species or drugs.
Conclusion: In conclusion, no interference due to the detection of
enzymatic activities is observed on identiﬁcation and susceptibil-
ity testing. Moreover the colours obtained and the improved
growth considerably reduces the risk of a mixed inoculum. There-
fore, the complete solution including CPS ID 3 medium and bio-
Merieux identiﬁcation and susceptibility products is perfectly
adapted to the isolation of most common uropathogens and even
most complex specimens, as it reduces misidentiﬁcation and con-
sequently time and cost.
R2162 Evaluation of MRSA Select, a new chromogenic
medium, for the detection of nasal carriage of methicillin-
resistant Staphylococcus aureus
S. Ben Nsira, A. Kammoun, C. Douilly, R. Leclercq
Caen, F; Stenvoorde, B
Objectives: MRSA Select is a new chromogenic medium for pre-
sumptive identiﬁcation of methicillin-resistant Staphylococcus aure-
us (MRSA) from clinical specimens as pink colonies after 24 h of
incubation. The performances of this new medium and of the oxa-
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cillin resistance screening agar base (ORSAB) for detection of
nasal carriage of MRSA were evaluated.
Methods: First, a well-deﬁned collection consisting 70 S. aureus
(29 susceptible to methicillin and 41 MRSA mecA + with various
levels of methicillin resistance) and 13 methicillin-susceptible
coagulase-negative staphylococci (CNS) was used. A standard ino-
culum (1 lL of a 0.5 McFarland suspension) was spread onto
MRSA Select, ORSAB and oxacillin-salt agar screening (Oxa-
Screen) plates. A low inoculum (a 103 dilution of a 0.5 McFar-
land suspension) was also tested. Then, 101 nasal swabs were
taken from 95 patients at high risk for MRSA carriage and dis-
charged in 1 mL of glycerol–BHI broth. A 50-lL of the suspension
was immediately inoculated onto MRSA Select, ORSAB and
Chapman salt agar plates. All media were incubated for 24 and
48 h at 37C. Pink colonies on MRSA Select, blue colonies on OR-
SAB and mannitol-fermenting colonies on Chapman salt agar
were identiﬁed by a coagulase test. Suspected MRSA colonies on
MRSA Select and ORSAB and ﬁve mannitol-fermenting colonies
on Chapman salt agar were checked for methicillin resistance by
using an Oxa-Screen medium.
Results: With the collection strains at the standard inoculum, sen-
sitivity for MRSA detection on MRSA Select, ORSAB and Oxa-
Screen after 24 h of incubation was 95.1, 87.8 and 95.1%, and spe-
ciﬁcity was 100, 93.3 and 100%, respectively. Using the low inocu-
lum, sensitivity for MRSA Select and ORSAB was 92.7 and 63.4%,
and speciﬁcity 100 and 97.7%, respectively. Of 101 nasal speci-
mens examined, 19 grew MRSA on at least one medium. As com-
pared with the Chapman-salt agar, after 24 h of incubation,
sensitivity for MRSA Select vs. ORSAB was 100% vs. 95.2%, and
speciﬁcity was 97.6% vs. 83.6%, respectively. Predictive positive
values for MRSA Select and ORSAB were 0.90 and 0.54, and pre-
dictive negative values were 1 and 0.97, respectively.
Conclusion: In this preliminary study, on the basis of ease of iden-
tiﬁcation of positive colonies, high sensitivity and speciﬁcity, and
unnecessary complementary coagulase testing, MRSA Select
appears to be a promising routine technique for presumptive
identiﬁcation of MRSA in nasal specimens.
R2163 Comparison of four laboratory tests for diagnosis of
Clostridium difﬁcile-associated diarrhoea
H. Malamou-Lada, H. Kafkoula-Alevizou, P. Karampoyia-Karaﬁll-
idis, K. Panteli, A. Strouza
Athens, GR
Objective: To evaluate four assays for the detection of C. difﬁcile-
associated diarrhoea (CDAD) in clinical practice.
Methods: Over a 20-month period (1/3/2002 to 31/10/2003) 642
liquid or semiliquid stool samples were tested for C. difﬁcile by
culture and for C. difﬁcile toxin A by three immunoassays. Con-
trol samples were examined from 50 patients without diarrhoea.
C. difﬁcile strains were isolated from cycloserine–cefoxitin–fructose
agar, supplemented with 5% egg yolk and identiﬁed by conven-
tional methods. Toxin A was detected in stool specimens by an
ELISA assay (Vidas, bioMerieux, France) and two chromato-
graphic assays [Color Pac (CP); Becton Dickinson, USA and Novi-
tec, Hiss Diagnostics, Germany]. C. difﬁcile isolated strains were
tested for toxigenicity (Toxigenic culture, TC). The overall efﬁ-
ciency of the tests was compared with results of TC assay.
Results: C. difﬁcile was isolated in 45/642 (7%) of stool samples.
Toxin A was detected in 43 strains using two assays, so TC was
positive in 43/642 (6,7%) of stool specimens. Toxin A was detec-
ted in 41 (6.3%), 33 (5.1%), and 25 (3.9%) stool samples using CP,
Vidas and Novitec assays, respectively. The sensitivities and spe-
ciﬁcities of CP, Vidas and Novitec were 77 and 99%, 70 and 99%,
and 44 and 99%, respectively. Positive and negative predictive
values were 80 and 98%, 91 and 98%, and 76 and 96%, respect-
ively. None of the 50 control specimens was positive by any of
the diagnostic tests.
Conclusions: All immunoassays appear useful rapid methods for
ruling out CDAD due to high negative predictive value. Of the
immunoassays, CP was the most sensitive, followed by Vidas and
Novitec but all had high speciﬁcity.
R2164 Prevalence of myocardial infarction caused by
C. pneumonia among residents of Yazd, Iran
M. Khalili, H. Sadeghian
Yazd, IR
Objectives: Miocardial infarction (MI) is one of the most important
death factors in the whole world. Today, it is well known that
some bacterial and virus species play a vital role in MI manifesta-
tion. C. pneumoniae is considered to be such a bacterium. The
general purpose of the cross-sectional study was to determine the
correlation between the MI and C. pneumoniae infection.
Methods: A total of 103 infracted patients along with 75 healthy
people as control with the similar demographic status were selec-
ted for this study. Following tittering IgG and IgM using ELISA
technique for detecting of antibodies against C. pneumoniae, all
patients‘ serum was furthering examined for determination of
sugar, CRP, cholesterol and triglyceride. Simultaneously, demo-
graphic status such as BMI, blood pressure, family history and
addiction to cigarettes were recorded.
Results: Results showed that 92 (89.3%) of serum samples from
patients and 58 (77.2%) of controls were positive for IgG; whereas
only two patient’s serum samples were positive for IgM. Preval-
ence of IgG positive in the patients regarding sex was in signiﬁ-
cant, although it was found to be signiﬁcant for age
(P ¼ 0.03). When the history of heart problem was searched, it
was found that the correlation of IgG+ patients with their mother
was signiﬁcant (P ¼ 0.04). In general, the relationship of patients
with IgG positive with BMI, smoking, chest pain and blood pres-
sure was not insigniﬁcant.
Conclusion: Although, the case numbers were limited, it may be
concluded that the chlamydial infection is prevalent among the
residents in Yazd and the silent infection could be the causative
factor in MI.
R2165 Electromigration techniques – rapid methods for the
detection and identiﬁcation of urinary tract pathogens
F. Ruzicka, V. Hola, M. Horka
Brno, CZ
Objectives: Rapid detection of micro-organisms is instrumental in
the timely beginning of the therapy. Sometimes, especially in
urinary infections, it is useful to quantify the micro-organisms
in the sample. The capillary electromigration separation tech-
niques, especially capillary zone electrophoresis and capillary
isoelectric focusing, seem to be suitable for this purpose. These
techniques, based on surface properties of microbes, were
recently used for on-line rapid separation, identiﬁcation and
quantiﬁcation of bacterial cultures. They can be used also for
the detection of some of factors of pathogenicity, e.g. the bio-
ﬁlm formation.
Methods: The micro-organisms often causing urinary tract infec-
tions, i.e. Escherichia coli, Candida albicans, Candida krusei, Candida
parapsilosis, Enterococcus faecalis, Pseudomonas aeruginosa, Stenotro-
phomonas maltophilia, Streptococcus agalactiae and Staphylococcus ep-
idermidis (including bioﬁlm-forming strains), were detected by
capillary zone electrophoresis and by capillary isoelectric focus-
ing and their isoelectric point has been assessed. The pyrenebut-
anoate and nonionogenic tenside based on pyrenebutanoate,
which were used as ﬂuorescent compounds, dynamically modi-
ﬁed microbial samples and strongly increased the sensitivity of
detection.
Results and conclusions: By means of the capillary isoelectric focus-
ing the isoelectric point of particular micro-organisms has been
assessed. This technique as well as the capillary zone electrophor-
esis was successful in the detection of micro-organisms causing
urinary tract infections. The identiﬁcation of respective micro-
organisms and their separation has been successful also from the
mixed culture and in the presence of human epithelia and pro-
teins as well. The sensitivity of the ﬂuorimetric detection was
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10E3–10E4 bacterial cells per ml, which is the limit of clinically
signiﬁcant ﬁndings. The study was supported by the grant of
Grant Agency of the Academy of Sciences of the Czech Republic
IAA4031302.
R2166 Use of time to positiveness to predict the presence
of Staphylococcus aureus in blood culture with clustered
Gram-positive cocci on direct smear examination
R. Ruimy, A. Andremont
Paris, F
Introduction: Rapid differentiation between Staphylococcus aureus
and coagulase-negative staphylococci (CNS) in positive blood cul-
ture can help clinician to decide to initiate antibiotic treatment.
Objective: To assess the value of time to positiveness of blood cul-
tures with clustered Gram-positive cocci on direct smear examina-
tion to predict presence of Staphylococcus aureus.
Methods: The time to positiveness of the ﬁrst positive blood cul-
ture was determined using a BACTEC 9240 system in 790 con-
secutive patients hospitalised in a 1200-bed university hospital
over a 2-year period with clustered Gram-positive cocci on direct
smear examination. Isolates were identiﬁed as S. aureus or CNS
on the results of the rabbit plasma coagulase test.
Results: One hundred and eighty-ﬁve episodes were identiﬁed as
S. aureus and 605 as CNS. Median time to positiveness was 14
(range: 2–115) and 26 h (2–123) for S. aureus and CNS, respect-
ively. Response Operating Characteristic (ROC) curve analysis
showed that the best cut-off value to differentiate between S. aure-
us and CNS was 18 h, resulting in 74% sensitivity and 86% spe-
ciﬁcity. Likelihood ratio for the presence of S. aureus were 16.4,
7.0, 2.7, 0.6 and 0.2 for time intervals of 2–9, 10–13, 14–17, 1–25
and >25 h, respectively. Given the prevalence of S. aureus bacter-
aemia in the sample studied, the positive predictive value for S.
aureus was 61.7% using the 18-h cut-off, and reached 83.3 and
74.4% using the 2–9 h, and the 10–13 h intervals, respectively.
Conclusion: Analysis of time to positiveness of blood culture with
clustered Gram-positive cocci on direct smear examination is an
efﬁcient mean to predict the presence of S. aureus and should be
included in medical decision criteria.
R2167 Investigation of interleukin 8 and 10 levels and
their relationship between prognosis in meningitis
G. Usluer, I. Ozgunes, Z. Gulbas, E. Doyuk Kartal, N. Erben,
K. Ozdamar
Eskisehir, TR
The most common form of central nervous system infections is
acute meningitis and rapidly aetiological diagnosis and treatment
are important for prognosis. Detection of cytokines such as TNF-
alpha, IL-6, IL-8 and IL-10 in CSF may have diagnostic and prog-
nostic value. Twenty-four patients diagnosed as meningitis
according to physical ﬁndings, biochemical and microbiological
evaluation of CSF were included to the study in a period
19 months. CSF of patients was examined on the ﬁrst and
10 days. The IL-8 and IL-10 levels in CSF were detected by
ELISA. Fourteen patients were diagnosed as bacterial meningitis
and 10 patients were diagnosed as viral meningitis. IL-8 levels
were found higher in bacterial meningitis than viral meningitis
samples obtained on the ﬁrst and 10th days. The difference
between pretreatment and post-treatment levels of IL-8 was signi-
ﬁcant in 24 patients (P < 0.05). Pretreatment and post-treatment
IL-8 levels in ABM group were found higher than viral meningitis
group (P < 0.05). There was no difference found between pre-
treatment and post-treatment IL-10 levels in 24 patients. Also
there was not a difference between ABM and viral meningitis
groups’ IL-10 levels. There was not a signiﬁcant relationship
between WBC, CSF cell count, CSF CRP, protein, glucose levels
and IL-8 or IL-10 levels (P > 0.05). The results of the present
study showed that detection of IL- 8 levels in CSF is useful for
diagnosis of bacterial and viral meningitis. Rapidly etiological
diagnosis of meningitis is critically important for treatment. Detec-
tion of cytokines in CSF is a part of diagnosis but its cost and
accuracy of results are limiting. Detection of serum IL-8 and IL-10
levels may be useful.
R2168 Evaluation of the performance of Candida ID2, a
new chromogenic agar medium for detection and differentiation
of clinically important yeasts
V. Chanteperdrix, B. Lebeau, J.M Roche, H. Pelloux, R. Grillot
Grenoble, Marcy l’Etoile, F
Objectives: Candida ID2 (CID2, BioMe´rieux, Marcy l’Etoile, France)
is a new chromogenic CE-labelled medium, recently developed
for the isolation of yeasts from clinical specimens. CID2 allows
the direct identiﬁcation of C. albicans, and presumptive identiﬁca-
tion of some other Candida species (C. kefyr, C. lusitaniae, C. tropi-
calis). The purpose of this prospective study was to evaluate the
performance of CID2 in comparison with the two other chromo-
genic media, Candida ID and Albicans ID2 (BioMe´rieux).
Methods: To assess selectivity, fertility and sensitivity of CID2, 294
biological specimens and 42 collection strains were isolated on the
three media. After dilution in 1 mL of sterile water, 100 lL of the
suspension were plated onto each medium. Media were incubated
at 37C, and red after 24 and 48 h. The inhibition of bacterial
growth, the number and the size of yeast colonies, the colouration
intensity of blue colonies (C. albicans) or pink colonies were appre-
ciated. A specimen was considered positive when yeast grew on
at least one of the three media. After 48 h, the pink and white col-
onies were identiﬁed by the standard methods.
Results: (i) CID2 appeared the most selective medium at 24 and
48 h (1.4% of samples showed a bacterial growth) comparatively
to Candida ID (5.1%) and Albicans ID2 (3.1%). (ii) 113 biological
samples (38.4%) were positive, and a total of 156 fungi were isola-
ted on at least one of the media: no signiﬁcant difference of fertil-
ity was seen between the three media. (iii) Regarding sensitivity,
CID2 was globally superior for intensity of the blue colour at
48 h, but it appears to be lightly inferior for pink coloration, espe-
cially at 24 h. Moreover, the blue colour is more homogeneous on
CID2 and Albicans ID2. Although evaluation of ﬁlamentous fungi
detection was excluded to the study, they can be reliably detected
on the tested media (seven samples positive with G. candidum,
and 10 with moulds mainly Aspergillus).
Conclusion: The new formulation of CID2 clearly improves the
selectivity of fungal isolation compared with the previous chrom-
ogenic media. This medium gives a great ability to detect mixed
cultures: indeed CID2 seems to be equivalent to other tested
media for fertility and time of blue colour apparition, but homo-
geneity of the coloration facilitates greatly the reading of cultures.
CID2 allows a direct and rapid identiﬁcation of C. albicans, but
other colonies must always be identiﬁed by the standard tech-
niques.
R2169 Evaluation of a new chromogenic culture medium
CPS ID 3 for urinary tract infections
R. Meley, S. Orenga, C. Roger-Dalbert
Saint Etienne, La Balme les Grottes, F
Over the past few years chromogenic media have become essen-
tial reagents in the bacteriology laboratory, notably for cytobacte-
riological examinations of urine to provide rapid and reliable
organism identiﬁcation to suggest the appropriate therapy to clini-
cians.
Objective: bioMe´rieux has reformulated the CPS ID 2 chromogenic
medium (speciﬁc to urine specimens) and now offers a new med-
ium, CPS ID 3, which enables increased colour intensity and
nutrient capacity for Escherichia coli, enterococci and particularly
Proteus species. Moreover, bacterial species previously exhibiting
little or no colouration on the original medium now demonstrate
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speciﬁc colouration, which can help identify Group B streptococci,
and Pseudomonas aeruginosa. In addition, the growth of Gram-pos-
itive bacteria and yeasts is improved.
Methods: The performance of the new medium was evaluated in
our laboratory during a 3-month period. In total, 104 urine sam-
ples (including 38 polymicrobial cultures) were tested in parallel
on the two media CPS ID 2 and CPS ID 3. Identiﬁcations of
micro-organisms recovered, were performed with both media,
according to current bacteriological criteria for identifying E. coli,
enterococci and Proteus mirabilis and with VITEK 2 cards for the
other bacteria. The performance results of both media in terms of
growth characteristics (number of different colonies isolated, enu-
meration, and size of colonies), as well as colony colour intensity,
were compared.
Results: In total 149 bacteria were identiﬁed as follows: 54.3%
Gram-negative bacilli, 38.3% Gram-positive cocci, 5.4% yeasts,
2.0% Gram-positive bacilli. The performance of CPS ID 3 was
found to be better than, or equivalent to, the performance of CPS
ID 2 in 97.1% of cases, for colony size, in 96.1% for enumeration
and 93.3% for the number of different colonies isolated. More-
over, the colour intensity of E. coli, Proteus and enterococci was
signiﬁcantly increased.
Conclusion: CPS ID 3 provides a practical improvement due to
increased colony size, and colour intensity for the main organisms
encountered in urinary tract infection, as well as better legibility
of the B-glucuronidase and deaminase metabolic activities. Fur-
thermore, the speciﬁc colouration observed, for Strept. agalactiae
and P. aeruginosa colonies enables better orientation of diagnosis.
Based on the results, this medium can be recommended for use in
the bacteriology laboratories for the direct examination of urine
specimens.
R2170 Use of sulesomab, a radio-labelled antibody
fragment, to detect spondylitis in patients with brucellosis by
leukoscintigraphy
A. Cascio, C. Iaria, A. Campennı´, A. Blandino, S. Baldari
Messina, I
Objective: To evaluate the role of a 99mTc-antigranulocyte Fab’
fragments (LeukoScan), the diagnosis of brucellar spondylitis. This
radiotracer, tank to its capacity to accumulate in the infectious
foci, has been used successfully in the diagnosis of orthopaedic
infections.
Patients and Methods: A total of 36 consecutive patients (mean age
52.3; SD 18) with brucellosis were enrolled; of these those with
suspected spondylitis underwent Leukoscan and MRI. Leukoscan
study was performed 4 and 24 h after the administration of
555 MBq of the radiotracer with dual headed gamma-camera
equipped with low energy high resolution collimator. Planar and
SPET images of the regional interest were acquired. Leukoscan
images were interpreted as positive when uptake in the region of
interest exceeds uptake in some reference point and also in pres-
ence of photopenia as demonstrated by Palestro. Sensitivity and
speciﬁcity of Leukoscan were computed taking MRI as ‘gold
standard’.
Results: A total of 22 with suspected spondylitis underwent MRI
and Leukoscan. MRI detected a skeleton involvement in 11/22
cases and showed still other alterations: nine paraspinal abscess,
four a psoas abscess and 10 epidural extension of disease. Leuco-
scintigraphy of the 11 patients positive to MRI demonstrated nor-
mal vertebral activity in seven cases, increased in two and
decreased in two. One of the two patients with antigranulocyte
increased uptake was not correspondence with the skeleton
involvement demonstrated by MRI. Leukoscintigraphy of the 11
patients negative MRI demonstrated increased activity in two
cases and in none a decreased one. Considering both hyperactiv-
ity and hypoactivity, Leukoscan sensitivity and speciﬁcity were
27.2 and 81.1%, respectively; negative predictive value and posit-
ive predictive value were 52 and 60%, respectively.
Conclusion: Contrary to what we had been longing, Leukoscan
was not useful, so we do not recommend its use in the managing
of patients with suspected brucellar spondylitis.
R2171 Comparative evaluation of antimicrobial
susceptibility testing methods in Indonesia and the Netherlands
J.A. Severin, E.S. Lestari, P.M.G. Filius, K. Kuntaman, H. Wahjono,
H.A. Verbrugh
Rotterdam, NL; Semarang, Surabaya, ID
Objectives: This study was designed to comparatively evaluate the
disk diffusion method with manual measurement of zones of inhi-
bition as performed in Indonesia and the Oxoid aura image sys-
tem, an automated image analyzer that measures zone diameters,
as performed in the Netherlands for the antibiotic susceptibility
testing of bacterial isolates.
Methods: Six hundred and eighty-three isolates, including 294 Sta-
phylococcus aureus, 195 Escherichia coli and 194 other Enterobacteri-
aceae, were studied. Bacteria were collected in Indonesia in order
to determine the prevalence of antimicrobial resistance in the
Indonesian population. For each isolate ﬁve or six clinically rele-
vant antibiotics were tested. The disk diffusion with manual zone
measurement was performed as recommended by NCCLS in three
laboratories in Surabaya, Indonesia and one laboratory in Sema-
rang (Indonesia). The aura image system was used in Rotterdam,
The Netherlands. The Vitek 2 system was used as the reference
method for the assignment of clinical categories (susceptible,
intermediate or resistant).
Results: In comparison with the reference method the disk diffu-
sion with manual zone measurement gave categorical agreements
of 1318/1470 (S. aureus), 892/975 (E. coli) and 859/970 (other En-
terobacteriaceae) with an overall agreement of 89.9%. The aura
image system gave categorical agreements of 1278/1470 (S. aure-
us), 838/975 (E. coli) and 851/970 (other Enterobacteriaceae) with
an overall agreement of 86.9%. Very major errors (VME; resistant
by reference method, susceptible by the investigated method) by
the aura system occurred with 30 of 3415 readings (0.9%), and
were mainly caused by oxacillin zone measurements with S. aure-
us. However, on further testing none of these strains harboured
the mecA gene. The percentage of VME made with manual meas-
urement was 3.2%. The majority of these were found with ampi-
cillin testing for Enterobacteriaceae. An overall correlation of
0.96 was observed for zone diameters measured manually and
measured using the aura image system.
Conclusions: The results of this study indicate that both the disk
diffusion method as performed manually in Indonesia and by the
aura image system in the Netherlands will yield acceptable sus-
ceptibility test results for medically relevant bacteria. The aura
image system, however, gave less VME.
R2172 External quality assessment of antimicrobial
susceptibility testing in the ofﬁce of general practitioners
J.K. Møller, M. Bøgild
Aarhus, DK
Objectives: To evaluate a system for quality assessment of suscep-
tibility testing performed on urine specimens in the ofﬁce of gen-
eral practitioners.
Methods: Simulated urine specimens with various common urin-
ary pathogens were stabilised with borax and distributed by mail
twice a year to general practitioners in Aarhus County. Strains
were designated as susceptible or resistant by the general practi-
tioner according to the instructions of the manufacturer of their
routine susceptibility assay. Results recorded on an enclosed
report form had to be mailed or faxed back to the laboratory
within a week.
Results: Twelve distributions were mailed between 1999 and 2002
for quality assessment of phase contrast microscopy, urine stix,
culture of urine, and susceptibility testing of urine specimens. In
average 50% of the about 170 participating general practitioners
reported results on susceptibility testing of the simulated urine
specimens. Reports included testing of susceptibility towards sul-
phonamides (SU), trimethoprim (TP), ampicillin (AP), mecillinam
(MC), and ciproﬂoxacin (CP). For quality control strains sensitive
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to SU, TP, AP, MC, and CP, correct results were obtained in 77,
95, 89, 78, and 99% of the assays, respectively. For strains resist-
ant to SU, TP, AP, MC and CP, correct results were obtained in
100, 97, 52, 13, and 48% of the assays, respectively. Repeated dis-
tribution of the same control strain showed that e.g. the percent-
age of correct reports on an E. coli strain sensitive to ampicillin
and sulphonamides increased from 77 to 94% and from 76 to
96%, respectively.
Conclusion: General practitioners have difﬁculties interpreting the
results of susceptibility testing on strains resistant to AP, MC, or
CP. False conclusions about the drug susceptibility may be caused
by reading zones without actual measurement of the zone-diam-
eter. Old and dried-out agar media may also cause misleading
results. Slight growth in inhibition-zones with disks containing
sulphonamides or mecillinam is often interpreted as resistance.
However, the reporting to the general practitioner of overall
results and comments on pitfalls of the various assays seems to
improve the performance on repeated distributions of a quality
control strain.
R2173 Utility of 293 cells in culture of enteroviruses
H.-S. Kim
Anyang, KOR
Objectives: Viral isolation in cell culture remains as a reference
method for diagnosis of enteroviral infection. Enteric adenoviruses
are cultivated in 293 cells. Enteroviral and enteroadenoviral trop-
isms for the gastrointestinal tract lead to the assumption that 293
cells would be useful in enteroviral culture. We evaluated useful-
ness of 293 cells in the diagnosis of enteroviral infection.
Methods: Human embryonic lung ﬁbroblasts (HEL), HeLa, RD
and 293 cells were used to evaluate viral isolation from clinical
specimens and susceptibilities of the cell lines to ATCC (American
Tissue Culture Collection) enteroviral strains. Type 9 echovirus
positive 31 stool specimens, type 30 echovirus positive 33 stool
and 59 cerebrospinal ﬂuid (CSF) specimens were inoculated onto
cell lines.
Results: Of 31 echovirus 9 isolates, 22 (71.0%), 21 (67.7%), 6
(19.4%) and 3 (9.7%) were detected in HEL, 293, RD and HeLa,
respectively. Of 33 echovirus 30 isolates from stool specimens, 32
(97.0%) were detected in 293, 17 (51.5%) were detected in RD. Of
58 echovirus 30 isolates from CSF specimens, 39 (67.2%) were
detected in 293, 50 (51.7%) were detected in RD. 293 cells were
sensitive for coxackievirus A9 ATCC strain and echovirus 7 ATCC
strain.
Conclusion: 293 cells are useful in the diagnosis of echoviral and
some enteroviral infection.
R2174 Calibration of imipenem and meropenem disk
diffusion susceptibility testing
C. Bore´n, G. Kahlmeter, G. Kronvall
Vxjo¨, Stockholm, S
Objectives: Using single strain regression analysis (SRA) to calcu-
late species related breakpoints and to select the appropriate disc
strengths for agar disk antimicrobial susceptibility testing of imi-
penem and meropenem.
Methods: A total of four reference strains and 20 clinical isolates
of Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae and
Pseudomonas aeruginosa were tested. MIC values were determined
with the help of the agar dilution technique. Disk diffusion tests
were performed according to the methodology of the Swedish
Reference Group for Antibiotics (SRGA), see www.srga.org. The
disk strengths 1, 5, 10, 50 and 100 lg imipenem and 1, 5, 10, 30,
100 and 300 lg meropenem were used for SRA.
Results: The single strain regression lines that were obtained
allowed us to correlate MIC-values and zone diameters for the
different disk contents. With the current SRGA breakpoints for
imipenem (1 and 8 mg/L Enterobacteriaceae, 4 and 8 mg/L Pseu-
domonas) and meropenem (0.12 and 8 mg/L Enterobacteriaceae,
2 and 8 mg/L Pseudomonas) all tested disc strengths could distin-
guish between susceptible (S) and intermediately susceptible (I)
strains. However, neither the 1-lg nor the 2-lg disks could distin-
guish between strains with MICs in the intermediate and the
resistant categories.
Conclusion: Our results indicated that the imipenem and merope-
nem 10 lg disks were unnecessarily strong and that the 5 lg disks
for both antibiotics best distinguished across the S-, I- and R-ran-
ges of MIC-values. A disk containing 5 lg imipenem clearly dis-
tinguished between strains with and without resistance
mechanisms. For meropenem, members of Enterobacteriaceae
showed sufﬁcient separation with a 5 lg disk whereas the separ-
ation for P. aeruginosa was less distinct.
R2175 URICHROM III, a new chromogenic medium for
urinary tract pathogens: a comparative study with UriSelect 4
A.M. Freydiere, A. Carricajo, C. Ploton, I. Verdier, N. Fonsale,
G. Aubert, F. Vandenesch
Lyon, St Etienne, F
Objectives: To comparatively assess the performance of URICH-
ROM III agar (INTERNATIONAL MICROBIO, Signes, France)
and UriSelect 4 agar (BioRad, Marnes la Coquette, France) for the
detection, enumeration and direct identiﬁcation of urinary tract
pathogens.
Method: A total of 207 clinical urine specimens, the majority of
which were identiﬁed by microscopic examination as containing
leucocytes and/or micro-organisms, were streaked prospectively,
in parallel and in two separate laboratories on the two agar
media. Further tests, as well as reading of the enzymatic reactions
were carried out according to the manufacturers’ instructions.
Results: Of the 207 urine specimens tested, eight were sterile and
199 yielded positive cultures: 119 were pure cultures and 80 were
mixed cultures. A total of 212 micro-organisms were considered
as clinically signiﬁcant including 115 E. coli, 29 Enterococcus spp.,
14 Enterobacteriaceae from the group Klebsiella–Enterobacter–Serra-
tia, and 14 from the group Proteus–Morganella–Providencia, 7 Pseu-
domonas spp., 3 Citrobacter spp., 2 Streptococcus spp., 1 Haemophilus
parainﬂuenzae, 16 Staphylococcus spp. and 11 Candida spp. For all
samples, enumeration of micro-organisms was comparable with
the two media. URICHROM III and UriSelect 4 gave detection
rates of 99.5 and 97.6%, respectively. For the direct identiﬁcation
of E. coli, the sensitivity was 90.4% for URICHROM III, which
detects beta-glucuronidase activity and 94.8% for UriSelect 4
which detects beta-galactosidase activity. On UriSelect 4, a strain
of Citrobacter freundii, as well as one of Enterobacter cloacae yielded
pink colonies similar to E. coli colonies, thereby conﬁrming the
necessity to perform the indole test on pink colonies. The total
identiﬁcation rates of E. coli, P. mirabilis and Enterococcus spp.
were superior to 67% for the two media. This resulted in a
marked reduction in workload, as well as signiﬁcant savings in
time. For the presumptive identiﬁcation of the Proteus–Morganella–
Providentia group and the Klebsiella–Enterobacter–Serratia group, the
two media performed equally well. On URICHROM III, the size
of staphylococci, yeast and lactobacilli colonies were slightly
superior to those obtained on UriSelect 4, enabling a better detec-
tion of the contaminants. An equal inhibition of swarming of Pro-
teus spp. and Pseudomonas spp. was observed for the two media.
Conclusion: URICHROM III, is an efﬁcient medium for the diag-
nosis of urinary tract infections.
R2176 The role of IgG avidity in the diagnosis of
toxoplasmosis; a comparative study of four commercially
available anti-Toxoplasma gondii IgG avidity assays
K.N. Horva´th, Z. Sze´na´si, J. Danka, I. Kucsera
Budapest, HUN
Objectives: The IgG anti-Toxoplasma avidity test is a conﬁrmatory
method that can differentiate between acute and chronic stage of
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toxoplasmosis in a single serum sample. It has proven useful in
management of pregnant women with anti-Toxoplasma IgM and/
or IgA antibodies. Our objective was to compare and analyse the
results of four commercially available assays to solve the previ-
ously experienced differences in the avidity obtained by the dif-
ferent kits.
Methods: Thirty-three samples positive for IgG and IgM and/or
IgA anti- Toxoplasma antibodies were used in order to examine
and compare the bioMe´rieux ‘VIDAS Toxo IgG Avidity’ ELFA
kit (France), the TEST-LINE ‘EIA Toxoplasma IgG’ ELISA (Czech
Republic), the ABOTT ‘Toxoplasma IgG Avidity EIA RADIM’
ELISA (Italy) and the FEROL ‘DIESSE Enzywell Toxoplasma IgG
Avidity’ ELISA (Italy) with each other. VIDAS and TEST-LINE
dilute the sera to 15 and 50 IU/mL, respectively, while
RADIM and DIESSE use a 1:300 and 1:100 dilution rates,
respectively.
Results: The discrepancies between the avidity results of the dif-
ferent kits varied between 5 and 35%, and the correlation
between the results of the different tests varied between
r ¼ 0.37 and r ¼ 0.88. The correlations between the avidity and
IgG level of sera were nonsigniﬁcant in the case of VIDAS
(r ¼ 0.07) and TEST-LINE (r ¼ 0.04), but there was good cor-
relation in the case of RADIM (r ¼ 0.56) and DIESSE (r ¼ 0.53).
Tests showed no correlation with the IgG level of the sera gave
a good correlation with the IgM and IgA level of sera (VIDAS:
0.60, 0.69 and TEST-LINE: 0.69, 0.61, respectively) while
the other tests showed a very weak correlation with the IgM
and IgA level of sera (RADIM: 0.20, 0.32 and DIESSE:
0.36, 0.34).
Conclusions: The kits with different diluting methods tend to give
different avidity. Two kits (RADIM and DIESSE) gave a good
correlation between the avidity and the IgG level of the sera,
while they showed a weak correlation between the avidity and
the IgM and IgA level of sera. The dilution of the sera seemed
to be very important in respect to the comparability of the
results.
R2177 Comparison of Bactec plus Aerobic/F medium and
BacT/Alert FA medium for detection of Gram-negative bacterial
strains
P. Cerma´k, M. Kola´r
Hradec Kra´love´, Olomouc, CZ
Objectives: The purpose of this study is to compare ability to culti-
vation of Gram-negative aerobic bacterial strains in the Bactec
Plus Aerobic/F and BacT/Alert FA systems.
Methods: All strains (Escherichia coli, Klebsiella pneumoniae, Enterob-
acter cloacae, Citrobacter freundii, Salmonella enteritidis, Morganella
morganii and Serratia marcescens) with aetiological relation were
isolated from blood of hospitalised patients in the University hos-
pital Hradec Kralove. Suspensions of bacterial strains in physiolo-
gical solutions in descending CFU/mL (colonies forming units)
concentrations were prepared. Each suspension was inoculated
onto the plates with Columbia agar broth (2 mL) and into the bot-
tles in both automated blood culture systems (5 mL per bottle).
The colonies (CFU) on agar plates were counted after 24 h of cul-
tivation. All results produced by automated systems were
reviewed by inoculating the bottle contents onto the agar plates.
The positive bottles were checked for the positivity time to detec-
tion (TTD).
Results: TTD depends in both systems on the number of inocula-
ted CFU. All tested specimens grew faster in the Bactec Plus Aer-
obic/F system. All inoculated Bactec bottles had shorter TTD than
BacT/Alert bottles inoculated with the same suspension of bacter-
ial strain. The highest difference was proved in the strain of Sal-
monella enteritidis. The difference of TTD was 3.0 h. Morganella
morganii, Serratia marcescens and Klebsiella pneumoniae had similar
results, and the difference between investigated systems was not
so high. The TTDs were from 2.5 to 2.9 h shorter in the Bactec
system. Escherichia coli had the shortest TTDs with difference 1.0 h
between both systems. Minimal differences of cultivation in both
systems had Enterobacter cloacae. (difference 0.3 h). The highest
TTD had Bact/alert bottle inoculated with only 10 CFU of Enterob-
acter cloacae.
Conclusion: The Bactec Plus Aerobic/F system is better deﬁned for
detection of aerobic Gram-negative bacterial strains than BacT/
Alert FA Aerobic system. Cultivation in this system is shorter and
difference of TTD is from 0.3 to 3 h. Both systems are able to cul-
tivate and to detect very low numbers of inoculated bacterial cells.
The TTDs of both systems are very short and both systems have a
high potential for successful culture and detection of Gram-negat-
ive blood stream infection.
R2178 The value of successive Infecton scans in the
management and follow-up of chronic bone and joint infection
J. Malamitsi, A. Papadopoulos, A. Vezyrgianni, E. Matselas, E.
Giannitsioti, H. Giamarellou
Athens, GR
Objectives: The aim of the study was to evaluate the usefulness of
successive Infecton scans in the diagnosis and treatment of
patients with chronic bone and joint infection.
Methods: We studied 33 patients with chronic osteomyelitis, septic
arthritis or both. All patients were submitted to successive Tech-
netium-99m radio labelled ciproﬂoxacin scans (INFECTON) with
vials supplied by St Bartholomew’s Hospital, London, at the
beginning and at the end of treatment. Infecton positivity was
graded in four grades. Clinical evaluation, erythrocyte sedimenta-
tion rate (ESR), C reactive protein (CRP) was also recorded. Infec-
ton and clinical outcome were classiﬁed as resolution (R),
improvement (I), stabilisation (S) and progression (P). Patients
(n ¼ 22) had a post-treatment follow-up for 4–48 (median 32)
months.
Results: Infecton was positive before treatment in 32 patients,
which was in concordance (88%) with clinical evaluation (p NS).
At the end of treatment resolution of grounds of the infecton was
noted to eight patients compared with 15 patients with clinical
resolution (P ¼ 0.05). ESR and CRP were less sensitive in evaluat-
ing therapy. Clinical relapse was noted in 81% of the patients
during post-treatment follow-up, when 79% of them had an R or
I infecton at the end of treatment.
Conclusions: (1) Evaluation on the basis of Infecton seems to be
compatible with initial clinical picture of chronic bone and joint
infection. (2) Infecton positivity at the end of treatment implies a
probable subclinical inﬂammatory process. (3) The role of Infecton
scintigraphy needs further elucidation.
R2179 POLMICRO 2003 – National External Quality
Control Assessment Scheme in Microbiology
B. Chmylak, E. Mlodzinska, K. Szczypa, J. Fiett, W. Hryniewicz
Warsaw, PL
Objectives: The objective of this study was to analyse the results of
2003. Polish National External Quality Assurance Scheme in
Microbiology (POLMICRO).
Methods: The following strains were distributed to participating
laboratories (n ¼ 435) Enterococcus gallinarum PM-39, and Klebsiella
oxytoca PM-38 (ESBL-positive). Each isolate was blind-coded and
laboratories were asked to identify the strains to species level and
to test for antimicrobial susceptibility. The susceptibility interpret-
ation results were assessed as correct, with minor error, major
error and very major error.
Results: Almost all laboratories were able to identify properly
K. oxytoca strain and 99% classiﬁed the strain as ESBL producer.
Ninety seven per cent of laboratories reported correct susceptibil-
ity – results for gentamicin for K. oxytoca. The most difﬁcult iso-
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late was E. gallinarum, which was properly identiﬁed by 68.3%
laboratories. The strain was classiﬁed as E. faecium by 8.7%, E. fae-
calis by 11.2%, and E. casseliﬂavus by 11.7% of laboratories. Most
of the laboratories were able to detect vancomycin resistance in
E. gallinarum PM-39. Ninety six per cent of laboratories reported
test results for teicoplanin as sensitive. Over 98% of laboratories
properly determined this strain as susceptible to each of amino-
glycosides–streptomycin and gentamicin.
Conclusions: The majority of the participating laboratories proved
to be reliable and keeping up with high standards of the micro-
biological diagnostics, which was conﬁrmed by their capabilities
to accurately identify species and determine susceptibility of clin-
ically relevant strains.
R2180 Evaluation of a microdilution sensitivity test which
uses 384 well plates
B. Wiedemann, A. Rodloff, I. Noll
Bonn, D
Objectives: Antibiotic susceptibility tests are the most frequently
used tests in clinical microbiology. Due to economic pressure
new test systems are developed in order to reduce personal
and reagents costs. Some of these systems are fully automatic
others partly automatic. In this study we want to compare the
MICRONAUT system using a 384-well microtitre plate with a
conventional microdilution method according to NCCLS guide-
lines.
Methods: The MICRONAUT system uses vacuum dried antibiot-
ics in a 384-well-plate. The inoculum is applied with an automa-
tic dispenser with a ﬁnal inoculum of 1  105 cells/lL in 50 lL
cation-adjusted Mu¨ller–Hinton medium with the addition of
0.025% phytagel. As the comparator we used the microdilution
method according to NCCLS guidelines. Evaluation was per-
formed by the comparison of the natural sensitivity of clinical
isolates of common pathogens – E. coli, P. aeruginosa, E. faecalis
and S. aureus – of the ﬁrst half of 2003. For each species–antibi-
otic combination meeting the conditions for comparison (at least
ﬁve-dilution series with a modal value at the third dilution of
the naturally sensitive population) two ﬁgures are calculated to
determine the degree of similarity of the MIC distributions: the
modal value and the percentage of strains within the range of
1 dilution step of the modal value. This way of evaluation
seems more reliable than the use of already evaluated results
with S, I and R categories describing errors, major errors and
very major errors.
Results: The results are shown in Table 1. In 10 of 15 cases the
results match very well with regard to the peak and the width of
the MIC-distributions. Only for imipenem and gentamicin and P.
aeruginosa as well as for vancomycin and E. faecalis the NCCLS
procedure tends to show lower MIC values than the MICRO-
NAUT system. In contrast moxiﬂoxacin and meropenem, and E.
faecalis show lower MIC values for the MICRONAUT system. Dif-
ferences of the modal value never exceed one dilution step. The
percentage of values within the range of 1 dilution step of the
modal value for the above-mentioned exceptions, however, is
nearly identical.
Conclusions: In general both methods show nearly identical
results. Differences in modal MICs are rare and never exceed one
dilution step.
R2181 Veriﬁcation of an automised blood culture system
via correlation between micro-organism concentration and
positive result
V. Tanju, M. Yu¨cel, E. Karakoc¸
Ankara, TR
Objective: To determine the correlation between genus, concentra-
tion and time required for the determination of micro-organisms
growth by BACTEC 9240 blood culture system and to provide the
result veriﬁcation of the blood culture system.
Methods: The study covered 239 strains including Enterobacteria-
ceae family members, Gram-positive cocci (S. aureus and spp., En-
terococcus spp., beta-haemolytic streptococci), Candida spp. and
nonfermentative bacteria. For each strain six dilutions changing
from 106 to 10 CFU/mL concentrations were prepared and see-
ded into BACTEC plus aerobic/F blood culture vials with 10 mL
human blood. These vials were followed in BACTEC 9240 instru-
ment. Acridin orange staining and subcultures were performed
from both positive and negative (after an incubation period of
7 days) blood culture vials.
Results: All the vials containing strains of Enterobacteriaceae and
Gram-positive cocci group were ﬂagged positive by the BACTEC
9240 system. For each group, the correlation between the time to
detection of growth (TTD) and the bacterial concentration also
for each dilution, the correlation between TTD and bacterial
genus was found to be statistically signiﬁcant
(P < 0.05). Twenty-six of 180 blood culture vials inoculated
with Candida spp. at different dilutions could not be ﬂagged pos-
itive by the system. These were conﬁrmed to be false-negative
results by Acridin orange staining and subcultures. In spite of
these results, the correlations between Candida concentration and
TTD; and correlation between bacterial genus and TTD at each
dilution were found to be statistically signiﬁcant
(P < 0.05). Forty-three of 180 blood culture vials inoculated
with nonfermentative bacteria could not be determined to be
positive which were also proved to be false-negative results. For
nonfermentative bacteria the correlation between bacterial con-
centration and TTD was not statistically signiﬁcant (P > 0.05),
whereas the correlation between bacterial genus and TTD at each
dilution was found to be signiﬁcant (P < 0.05).
Conclusion: The result veriﬁcation of BACTEC 9240 system for -
Enterobacteriaceae and Gram-positive cocci has been successfully
established. However, veriﬁcation of system for Candida species
and nonfermentative bacteria could not be established. Perform-
ing Acridin orange staining and subcultures from vials ﬂagged
to be negative by BACTEC 9240 blood culture system is recom-
mended.
Table 1. Comparison of naturally sensitive populations of selected
species: Modal value and percentage of strains within a range of
modal value +/1 dilution step derived from the microdilution
according to NCCLS standards and those derived from the
MICRONAUT system
Species/Antibiotic
NCCLS Micronaut
modal
value
percentage
(mvþ= 1)
modal
value
percentage
(mvþ= 1)
P. aeruginosa
Gatiﬂoxacin 0.5 77.7 0.5 77.6
Levoﬂoxacin 0.5 85.2 0.5 79.9
Piperacillin 4 77.7 4 82.8
Piperacilin/Taz 4 78.8 4 80.7
Ceftazidime 2 89.8 2 88.3
Imipenem 0.5 80.9 1 83.5
Gentamicin 1 85.2 2 87.4
E. coli
Cefuroxime 4 92.9 4 90.1
Tobramycin 1 87.2 1 92.3
E. faecalis
Moxiﬂoxacin 0.5 93.3 0.25 94.9
Imipenem 1 94.4 1 85.7
Merepenem 4 84.1 2 80.0
Vancomycin 1 92.7 2 97.2
Linezolid 1 99.0 1 98.1
S. aureus
Linezolid 1 99.0 1 98.1
626 Abstracts
R2182 An assessment of a rapid immunochromatographic
strip assay for the detection of antibodies to human visceral
leishmaniasis in serum samples
A. Kostoula, C. Bobojianni, E. Gitona, T. Priavali,
C. Papadopoulou, S. Leveidiotou
Ioannina, GR
The use of a simple immunochromatographic strip assay as a
screening test for the rapid detection of antibodies to human
visceral leishmaniasis (VL) in serum samples was assessed. A
total number of 282 serum samples collected from 52 conﬁrmed
leishmaniasis cases, 200 suspect patients and 30 healthy subjects
(control group) were screened using the LEISHMANIA Strip
quick test, commercially available by Cypress Diagnostics (LEIS-
MANIA Strip). This rapid assay is a qualitative membrane
based immunoassay used for the qualitative determination of
antibodies to VL in serum. The membrane is precoated on the
test line with a novel recombinant antigen (K39) speciﬁc for vis-
ceral leishmaniasis caused by parasite members of the L. dono-
vani complex and on the control line with chicken anti-protein
A. During testing the serum sample reacts with the protein A
colloidal gold conjugate, which has been precoated in the test
device. The mixture then migrates upward on the membrane
chromatographically by capillary action to react with the recom-
binant VL antigen on the membrane and generates either a red
line (positive result) or no line (negative result). During this
assessment study the 52 deﬁnitely conﬁrmed leishmaniasis cases
were tested with the LEISMANIA Strip test and were found
positive. The control group was also tested with the same strip
test and it was found negative. When the 200 suspect patients’
serum samples were tested with the LEISMANIA Strip test they
were all found negative; however, 10 of 200 were found posit-
ive when the immunoﬂuorescence test (IFA) was applied. Nev-
ertheless, the 10 samples reacted positively with IFA in very
low titres, thus deﬁnite diagnosis of leishmaniasis was excluded
based upon clinical manifestations and laboratory ﬁndings. The
results of the present assessment study indicate that the LEIS-
MANIA Strip test has the potential to be used as a preliminary
screening test and can be helpful especially for laboratories
lacking specialised lab equipment.
R2183 The BACTEC LX, a new continuous monitoring,
noninvasive and nonsensor technology for determining the
growth of micro-organisms in sealed culture reagents
P. Beaty, L. Crowther, M. Warns, L. Stewart, R. Pfeltz
Sparks, USA
Diode laser spectroscopy can be used to analyse the gas in a
sample volume. This technology has been integrated into a
microbial culture detection system. The instruments were con-
structed to incubate (35C), agitate and continuously monitored
the culture reagents for growth. The culture reagents contain
30–40 mL broth designed to accept clinical specimens (blood,
sterile body ﬂuids and processed specimens) for the detection
of viable organisms. Tests were performed with aerobic and
anaerobic as well media for the detection of mycobacteria. Some
tests included BACTECTM Resins for antimicrobial neutralisa-
tion. The test organisms included representative strains of en-
terobacteria, obligately oxidative nonfermentative bacteria,
staphylococci, streptococci, enterococci, obligate anaerobic bac-
teria (bacteroides and clostridia), mycobacteria, yeast and fungi.
Control systems included the BACTEC 9000 Blood Culture sys-
tem and plated media. The test conditions were designed for
typical laboratory usage of the product that includes varying
specimen volumes, culture delays and specimen types. The sys-
tem was capable of detecting the presence of metabolising
organisms at 104–105 cells/mL. Growth detection was generally
equivalent in a kinetic detection mode (monitoring analytic
changes during growth). Direct quantitative measurement of
carbon dioxide allows threshold detection (monitoring analytic
changes after growth) equivalent to kinetic detection. This tech-
nology can be applied to any microbial detection system (med-
ical, industrial, or research) in which reagents with an
unobstructed culture gas headspace path length can be monit-
ored for changes in gas metabolites.
R2184 Contribution of urinary pneumococcal antigen
detection combined with the research of Legionella antigen for
diagnosis of pneumonia in hospitalised adult patients
S. Honore´, M. Trillard, Z. Ould Hocine, L. Deforges, C.-J. Soussy,
P. Legrand
Cre´teil, F
Bacteriological conﬁrmation of pneumonia (PNM) in hospitalised
patients is often erratic or belated. Because of importance of prog-
nosis, early adaptation of treatment requires an empirical antimi-
crobial therapy (generally aminopenicillin and macrolide
combination). The starting therapeutic strategy should proﬁt by a
fast and reliable test asserting a pneumococcal aetiology . The Bin-
ax Now S. pneumoniae (BNP) test allows an urinary pneumococcal
antigen (UPA) detection using an immunochromatographic mem-
brane assay within 15 min.
We ﬁrst evaluated the BNP test for 28 patients [median age: 56
(30–98 years)] with pneumococcal PNM proved by culture, and
118 negative control patients [median age: 53 (15–92 years)]
without PNM. The sensitivity was 71.4% (85.7% for the 21 bac-
teraemic PNM), and the speciﬁcity was 98.3%; that is consistent
with previous published data. The BNP test was then evalu-
ated by testing urine from 158 hospitalised patients [median
age: 56 (19–98 years)] with a clinical picture of PNM (commu-
nity acquired: 90, nosocomial: 68) for whom a research of urin-
ary Legionella antigen (Binax Now) was prescribed and was
positive for only two cases. Fifty-seven patients (36.1%) were
hospitalised in ICU. UPA was detected in 17 cases of PNM
(10.8%): 15 among the community acquired (16.7%) and 2
(2.9%) among the nosocomial cases. The pneumococcal aetiology
was conﬁrmed by bacteriological samples in 7/17 patients (six
by blood cultures). The 10 others showed clinical and radiologi-
cal features in agreement with a pneumococcal PNM. Among
the 141 patients with negative AUP, S. pneumoniae was isolated
from six of them (two in blood cultures). The Binax Now
S. pneumoniae test allowed a fast and reliable aetiological diagno-
sis in 10,8% of hospitalised PNM (16.7% of the community-
acquired cases) having a research of urinary Legionella (conceiv-
ing with severity factors). So it could conduce to an improved
adjustment of the starting antimicrobial therapy of hospitalised
adult patients with PNM.
R2185 Invasive procedures and aetiological diagnosis in
severe pneumonia. A case study of 20 patients
S. Cordani
Sarzana, I
Objectives: The aim of this study was to improve the diagnostic
accuracy in patients with severe pneumonia using an invasive
procedure.
Methods: Over a 10-month period, 20 patients (ages 22–85 years)
were studied. These patients were admitted to the Pneumology
Department, the ICU or to pulmonary rehabilitation with clin-
ical ﬁndings of severe community or hospital acquired pneu-
monia (CAP) (HAP). In conjunction to serological and
microbiological diagnostic tests on the blood, urine, sputum (if
available) broncoalveolar lavage (BAL) and/or transthoracic ﬁne
needle agoaspiration (TTFNA) were performed to identify the
pathogens. Granulocytes >50% and a bacterial culture cut-off
>104 CFU/mL was accepted in BAL to deﬁne infectious pneu-
monia.
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Results: Aetiological diagnosis was possible in eleven of the
twenty cases; three polymicrobial pneumonia and eight monomi-
crobial pneumonia. In four other patients the ﬁnal diagnosis was
noninfectious disease. In the remaining ﬁve patients determined
as having infectious pneumonia the pathogens were unidenti-
ﬁed. The noninvasive procedures were only successful in diag-
nosing two cases; Legionella Pneumophila detected by means of
urinary antigen, and CMV disease by means of early viral anti-
gens. Twelve of the 16 BAL and one of the three TTFNA provided
diagnostic results.
Conclusions: Despite the low number of patients in the study, the
results showed that invasive procedures, in particular BAL was
very effective in conﬁrming infectious pneumonia and improving
diagnostic speciﬁcity.
R2186 Comparison of the BACTEC 9240 automated system
and Isolator 10 blood culture tube for the recovery of Brucella
species from blood cultures
H. Yazgi, M. Ertek, A. Ayyildiz, A. Kadanali, H. Malcok
Erzurum, TR
Objectives: Culture of blood for Brucella spp. has historically been
performed by broth-based methods and has required prolonged
incubation and the use of blind subcultures. Currently available
methods that have been advocated include both isolator blood
cultures and the use of automated, continuous monitoring blood
culture instrumentation. The sensitivity and time to detection of
Brucella spp. by the BACTEC 9240 (Becton Dickinson) and the Iso-
lator 10 blood culture system (Oxoid) were compared in a pros-
pective study.
Methods: The present study was prospectively carried out in the
Ataturk University Medical Faculty Hospital, Department of
Clinical Bacteriology and Infectious Diseases, between April 2001
and October 2003. Thirty-seven patients with suspected brucello-
sis, on the basis of clinical and epidemiological features or serol-
ogy, were included in this study. The blood specimen was
inoculated into a BACTEC 9240 (aerobic blood culture bottle and
one was inoculated into an Isolator 10 Microbial Tube. The bot-
tles and tubes were sent to the Clinical Microbiology Laborator-
ies. Bactec cultures were incubated for 7 days; those negative at
7 days were incubated for two additional weeks the blood lysate
was dispersed on the surface of trypticase soya agar medium
with 5% sheep blood and on chocolate agar plates. When a pos-
itive bottle or isolator blood lysate were detected, identiﬁcation
was carried out by conventional methods for Brucella spp.
Results: The BACTEC 9240 system detected 21 (56.8%) whereas in
the Isolator blood culture system detected only 18 (48.6%) posit-
ive cultures. Blood cultures were recovered within 2–4 days
(mean time 3.2) in BACTEC 9240 blood culture system, while
within 2–5 days (mean time 3.5) in isolator 10 culture system. The
two systems were not superior to each other in that of recovering
time (P > 0.05).
Conclusion: We concluded that BACTEC 9240 blood culture sys-
tem could isolate Brucella spp. little more rapid than The Isolator
10 blood culture tube.
R2187 Evolution of antibodies against LPS from B.
melitensis 16M and cytosolic proteins from B. melitensis B115 in
patients with acute brucellosis
M.A. Manteco´n, A. Ordun˜a, M.P. Gutie´rrez Rodrı´guez,
S. Garcinun˜o, M. Ortega, B. Sa´nchez Borge, I. Cruz,
J.M. Ferna´ndez Ferna´ndez, M. Moreno, M.A. Bratos,
A. Rodrı´guez Torres
Valladolid, E
Objetive: To study the serological evolution of speciﬁc inmuno-
globulins against LPS from B. melitensis 16M and cytosolic pro-
teins from B. melitensis B115 in patients with acute brucellosis.
Methods: It has been studied sera from 51 patients with brucello-
sis. The diagnosis of brucellosis was based on CDC criterions.
These subjects were followed clinically and serologically for up to
10 months. Sera were taken at the moment of ﬁrst clinical consult-
ant (baseline sera) and in the 2nd, 4th, 6th, 8th and 10th month
after have begun treatment (evolutive sera). All sera were tested
by two ELISAs developed by us. One of the ELISA detected speci-
ﬁc antibodies against LPS from smooth B. melitensis 16M and the
other one detected antibodies against cytosolic proteins from
rough B. melitensis B115.
Results: Each immunoglobulin against LPS showed a different
proﬁle (Fig. 1). From the beginning, IgG evolutive curve
increased progressively and reached values a 20% higher than
baseline sera during controlled period. Evolutive curve of IgM
maintained a descendent course along the ten months studied.
IgA levels decreased in the ﬁrst four months and then they
maintained them. The evolution of antibodies against cytosolic
proteins was similar between the three classes of immunoglobu-
lins (Fig. 2). Along the 10 months of follow-up they obtained val-
ues similar to the baseline sera. The curve of evolution of IgG
decreased its value until a 20% of baseline sera along 10 months
of follow-up.
Conclusions: IgM and IgA levels decreased progressively after
have begun treatment while the evolution of IgG against LPS
maintained high values during all period of study. This behaviour
shows that IgG antibodies are independent of clinical outcome.
Antibodies against cytosolic proteins showed little differences
between them. Behaviour of IgG against cytosolic proteins was
very different to observe against LPS because decreased slightly
along the 10 months of follow-up.
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Figure 2: Evolution of antibodies against cytosolic protein in
patients with acute Brucellosis.
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Figure 1: Evolution of antibodies against LPS in patients with
acute Brucellosis.
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R2188 The efﬁcacy of urine Gram stain microscopy in
predicting urine culture results
A. Yazici Karadenizli, C. Guven, F. Kolayli
Kocaeli, TR
Objectives: The purpose of this study was to compare the accuracy
of the microscopic examination of uncentrifuged urine in predict-
ing culture results in a group patient who had urinary tract infec-
tion symptoms.
Methods: A total of 200 urine cultures to diagnose or exclude urin-
ary tract infections were included in this study. Urine Gram-stain
microscopy was performed using one drop of well-mixed uncen-
trifuged urine applied to a slide. Gram-stained preparation was
examined for at least 20 oil immersion ﬁelds with the positive
smear having two or more organisms. Urine cultures were per-
formed by inoculating 10 lL of uncentrifuged and well-mixed
urine onto blood agar and EMB plates and incubating aerobically
at 37C overnight. Growth of 100 000 CFU/mL was considered
as positive.
Results: Of the 200 urine cultures, 128 were negative, 37 were con-
taminated, and 35 were positive. Presence of bacteria on Gram-
stain predicted 30 of 35 (85.7%) positive cultures. It was also
found 56 of 128 (43.7%) negative cultures. The predictive value of
a positive test of Gram-stain microscopy of uncentrifuged urine
was found 34.88%, the predictive value of a negative test was
93.5%, and the efﬁciency was 62.6%.
Conclusions: These results suggest that positive cultures cannot be
accurately predicted by only Gram-stain microscopy of uncentri-
fuged urine and that culturing should be performed.
R2189 Designing a new programme for calibration
bacteriological loop
M. Deldari
Tehran, IR
Introductions: Several methods for calibration of Microbiology
Loops are available, but colorimetric methods are the most com-
mon. The basis of the system consists in the absorbance of light
by the dye solution prepared by the loop from a previous dye
solution, which is used to delineate a calibration curve. Despite
the recommendation of Evans Blue dye for calibration, currently,
other dyes for instance methylene blue or crystal violet are being
used for this purpose. Therefore, we decided to design a compu-
ter program to avoid the time consuming process and the difﬁ-
culty of calculation and curve delineation; for this reason we
made a comparison among Evans blue, methylene blue and crys-
tal violet; the aim was to study the results of the experiments and
choose the most appropriate dye for this loop calibration method
by using a computer program.
Methods: The ﬁrst step was to prepare a stock solution of each
dye and the second step was to prepare different dilutions from
the stock solutions according to the references, and the following
step was to evaluate the light absorbance of each dilution in
proper wavelengths. Then, we used a disposable and a reusable
loop to prepare a ﬁnal solution from the diluted solutions. Finally,
we compared the light absorbance of the ﬁnal solutions with the
light absorbance of a solution made by two standard class A volu-
metric pipettes (0.01 and 0.001 mL). Evans blue (0.75% stock
solution – 600 nm wave length) Methylene blue (0.5% stock
solution – 700 nm wave length) Crystal violet (0.05% stock solu-
tion – 590 nm wave length)
Results: In comparison with experiments with methylene blue and
crystal violet, in the experiment using Evans blue, the light
absorbance of ﬁnal dilutions and standard dilutions showed
higher similarity. Furthermore, compared with crystal violet, the
results of metheylene blue were more acceptable.
Discussion: Concerning the importance and the frequency of the
use of calibrated loop by clinical microbiologists, implementing a
computer program will facilitate the calibration process including
calculation and curve delineation. Moreover, in comparison with
methylene blue and crystal violet, Evans blue is the most appro-
priate dye for the colorimetric method for calibration of microbio-
logy loop.
R2190 Comparison of stool test (HpSA) with rapid urease
test and histology in the diagnosis of Helicobacter pylori
infection
A. Gu¨ndu¨z, B.D. C¸etin, L. Erdem, M. So¨kmen
Istanbul, TR
Objectives: Helicobacter pylori is a curved Gram-negative bacillus
colonising gastric epithelial cells. Helicobacter pylori is often associ-
ated with chronic gastritis and peptic ulcers but besides this its
role in the aetiopathogenesis of gastric cancer and primary gastric
MALT (mucosa-associated lymphoid tissue) lymphoma makes it
more important. Invasive such as demonstration of the bacillus by
cytological, histological methods, culture growth, rapid urease test
and noninvasive tests such as urea breath test, serology are the
methods used for the detection of Helicobacter pylori infection.
Recently a new noninvasive test detecting Helicobacter pylori anti-
gens in the stool samples by EIA was developed. We aimed to
determine the sensitivity and speciﬁcity of stool test (HpSA) in
the diagnosis of Helicobacter pylori infection.
Methods: Between May 2001 and October 2003 in the Department
of Gastroenterology of Sisli Etfal Training and Research Hospital
gastroscopy was performed to previously untreated 102 patients
with dyspeptic complaints and the sensitivity and speciﬁcity of
HpSA (Premier Plarinum HpSATM, H. pylori Stool Antigen, Meri-
dian Diagnostic, USA) test was calculated by comparison with
rapid urease test and histology.
Results: In our study the sensitivity of HpSA was found 92.2%,
speciﬁcity 91.2%, positive predictive value 95.2%, negative pre-
dictive value 86.1%.
Conclusions: It seems that as the sensitivity and speciﬁcity of
HpSA was found to be high and it is accurate, simple, noninva-
sive it has the potential to become the preferred diagnostic tool
for Helicobacter pylori infections.
R2191 Helicobacter pylori infection: comparison of
methods of diagnosis
M. Chatzidimitriou, S. Stefanidis, T. Daskalou, A. Gagalis,
C. Agguridaki, E. Tsiakiri, S. Alexiou-Daniel, E. Giannoulis
Thessalonica, GR
Objectives: The purpose of our study was to correlate the histolog-
ical tests for Helicobacter pylori (HP) with (a) culture for HP, (b)
rapid urease test (CLO-test) and (c) values of anti-Cag A antibod-
ies as well as to correlate culture for HP with (a) CLO-test, (b)
treatment with proton-pump inhibitors (PPI) and (c) treatment
with nonsteroidal anti-inﬂammatory drugs (NSADS).
Methods: From June 2001 to June 2002 we studied 67 patients, 37
men and 30 women with median age 57 years old (range 20–84).
All our patients underwent upper gastrointestinal gastroscopy
and had up to three gastric biopsy specimens taken for culture,
histological examination for HP and CLO-test. Also blood samples
were taken for the estimation of anti-Cag A. Personal medical his-
tory was ﬁlled concerning cardiovascular disease, diabetes melli-
tus, peptic ulcer disease, alcohol consumption, smoking habit, PPI
and NSADS intake. All cultures were incubated at 37C under
microaerophilic conditions and high humidity for up to 4 days in
Skirrow agar base. Anti-CagA was estimated using ELISA (RA-
DIM, normal value <15 RU/mL). Statistical analysis was per-
formed by SPSS 10.0 program and methods used were: ANOVA
and Fischer exact test.
Results: Eighteen of 67 patients were positive for HP in the histo-
logical test and 49 were negative, 21 were smokers, 18 were trea-
ted with PPI, 24 were treated with NSADS, 24 cultures were
positive for HP and 42 were negative, 23 CLO-tests were positive
and 44 negative while the mean value of anti-CagA was 22.28
(range 0–260).The following statistically important correlations
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were found: (a) anti-CagA values with the histological result for
HP(P ¼ 0.007), (b) histological ﬁndings for HP with the culture
(P < 0.001), (c) histological ﬁndings for HP with CLO-test
(P < 0.001), (d) culture for HP with CLO-test (P < 0.001), and (e)
culture for HP with NSADS intake ( P ¼ 0.003). There was no sta-
tistically important correlation between the culture for HP and
PPI intake (P ¼ 0.169).
Conclusions: HP culture (a)is an economic and easy method for
the diagnosis of HP infection giving results in accordance with
histological examination, CLO-test and values of anti-CagA anti-
bodies, (b) is statistically important correlating with NSADS
intake, (c) can play a signiﬁcant and useful role in the treatment
of HP infection if it is followed by an antibiogram, as resistance
of HP seems to increase observing therapeutical failures.
R2192 Comparison of identiﬁcation of staphylococci in BD
PhoenixTM and Vitek
W. Williams, T. Dunk, V. White, E. Smith, K. Runyan, J. Salomon,
J. Reuben
Sparks, USA
Objectives: Staphylococci are well documented as opportunistic
human pathogens. The primary coagulase-positive species, S. aure-
us, has been implicated in numerous and widespread nosocomial
infections and has been a major cause of morbidity and mortality.
More recently, a growing number of species of the coagulase-neg-
ative staphyococci (CoNS) have also been associated with nosoco-
mial infection. These infections are due, in large part, to the
increased use of prosthetic and indwelling devices, as well as the
growing number of immunocompromised patients in hospitals.
Accurate and timely identiﬁcation of staphylococci is important for
a correct depiction of the clinical disease produced by these bac-
teria. This study examines two automated microbiology systems:
BD PhoenixTM Automated Microbiology System (BD Diagnostics),
and Vitek (BioMerieux) for their ability to identify staphylococci.
Methods: A total of 100 S. aureus and 195 non- S. aureus (mostly
CoNS) clinical isolates were tested in Phoenix and Vitek I. The
reference identiﬁcation was conventional testing according to the
methodology of Dr Kloos. Each system was set up and run
according to their respective manufacturer’s directions, including
off-line testing (catalase and coagulase) for the Vitek 1.
Results: Identiﬁcation accuracy for all 295 isolates was: Phoe-
nix ¼ 93.6% (276/295), and Vitek 1 ¼ 90.8% (268/295). Each sys-
tem correctly identiﬁed all 100 isolates of S. aureus with average
time to results (TTR) of: Phoenix ¼ 2.6 h, and Vitek 1 ¼ 5.3 h. The
non- S. aureus identiﬁcation accuracy was: Phoenix ¼ 90.3% (176/
195), and Vitek 1 ¼ 86.2% (168/195). Average time to results for
these isolates came out as Phoenix ¼ 7.0 h, and Vitek ¼ 12.7 h. In
this study supplemental testing (to get a single ﬁnal ID) was not
required for any of the S. aureus isolates for either system. For the
CoNS strains the Phoenix system did not require any supplemen-
tal testing, while the Vitek system required supplemental testing
for 116 isolates (59.5%).
Conclusion: Overall identiﬁcation of staphylococci was good in
both systems, while Phoenix provided an edge in the identiﬁca-
tion of non- S. aureus species. Time to results and need for supple-
mental testing were also favourable to Phoenix.
R2193 Detection of fosfomycin resistance in
Gram-negative and Gram-positive organisms using BD Phoenix
Automated Microbiology System
D. Turner, V. Kennedy, M. Votta, K. Fischbein, T. Wiles,
J. Reuben
Sparks, USA
Objectives: Fosfomycin (FF), a single-dose orally administrated
antibiotic, has been used in therapy for various systematic infec-
tions, as well as uncomplicated urinary tract infection. In vitro
antibiotic susceptibility testing (AST) of FF is limited to agar
dilution method with addition of glucose-6-phosphate (G6P) in
the agar medium. This study evaluated the BD Phoenix Automa-
ted Microbiology System for the detection of FF resistance among
Gram-Negative (GN) or Gram-positive (GP) organisms.
Methods: A total of 173 Gram-negative and 164 Gram-positive
clinical isolates were tested. Test battery included species that are
clinically commonly encountered. All testing was performed in
parallel using the Phoenix System and the NCCLS recommended
agar dilution method, Mueller–Hinton agar supplemented with
25 lg/mL of G6P (AD). AD plates were prepared in-house and
used within 5 days. Same inoculum of each test strain was used
for both Phoenix and AD testing. The results from Phoenix and
AD were analysed for Essential Accord (EA) and Categorical
Agreement (CA) based on the NCCLS recommended breakpoints
(M100-S13) or CA-SFM (Report 2003).
Results: EA and CA for the organism groups tested is listed in the
Table below:
There were two isolates (K. pneumoniae and P. aeruginosa), which
showed very major errors (VME) among GN isolates tested. No
VME was observed among GP isolates evaluated. Only 1 isolate
P. aeruginosa and E. faecalis demonstrated major errors.
Conclusions: This study indicates that the Phoenix System pro-
vides rapid, reliable AST results for FF against a broad selection
of GN or GP organisms.
R2194 Detection of resistance to cefepime in Gram-
negative bacterial isolates using the BD Phoenix Automated
Microbiology System
W. Brasso, T. Quivers, V. Fortune, T. Wiles, J. Reuben
Sparks, USA
Objectives: Increasing resistance to extended-spectrum cephalospo-
rins is a signiﬁcant threat to patient care because of limited thera-
peutic options. The ability to detect resistance in enteric gram-
negative bacilli (GNB) to Cefepime, a fourth-generation cepha-
losporin, using the BD PhoenixTM Automated Microbiology Sys-
tem (BD Diagnostics, Sparks, Maryland, USA), a rapid automated
ID/AST system, was evaluated in this study. Though the current
NCCLS recommendation is to force all invitro cephalosporin
results to resistant for ESBL-producing strains, the Phoenix MIC
results were evaluated for these isolates with and without the
BDXpertTM System modiﬁcation.
Methods: A total of 265 Gram-negative clinical isolates (227 in the
family Enterobacteriaceae and 38 glucose nonfermenters), inclu-
ding 123 cefepime-resistant strains, were included in the evalua-
tion. Among these, 50 were ESBL-producing strains based on the
NCCLS conﬁrmatory method. Each strain was tested simulta-
neously in the Phoenix System and the NCCLS-recommended
standard broth microdilution (SBM) reference method. Inocula
Table .
Gram-negative EA (%) CA (%)
Citrobacter freundii 100 100
Enterobacter aerogenes 88 88
Escherichia coli 93 97
Klebsiella species 85 96
Miscellaneous enteric 100 100
Proteus species 88 100
Pseudomonas aeruginosa 86 86
Serratia species 100 100
Overall 91 96
Gram-Positive EA% CA%
Enterococcus faecalis 94 94
Enteroccoccus faecium 88 88
Staphylococcus aureus 96 100
Staphylococcus epidermidis 74 100
Overall 91 96
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densities were adjusted to the equivalent of a 0.5 McFarland
standard, and then inoculated into both panel types. Phoenix pan-
els were placed into the BD Phoenix instrument for incubation
and automated reading to completion. SBM panels were incuba-
ted at 35C for 18–20 h in ambient air and read manually for MIC
endpoint determination. Cefepime breakpoints and QC strains
were based on those recommended in the current NCCLS stand-
ard (M100-S13).
Results: The essential agreement (EA) between Phoenix and the
SBM for cefepime was 92.1%, and categorical agreement (CA)
was 97.0%. The very major error (VME) and major (ME) rates
were 3.3% (4/123) and 2.6% (3/114), respectively. When ESBL-
producing E. coli and Klebsiella species were forced to be resistant
by the BDXpert System per the current NCCLS recommendation,
the CA increased to 98%. The EA also increased slightly to 94%,
and the VME rate was reduced to 1.6%.
Conclusions: The BD Phoenix System provides an acceptable level
of agreement for Cefepime results to the reference method, and is
effective for use in the detection of resistance to cefepime in
Gram-negative bacterial isolates.
Fungal infection
R2195 Iron acquisition from bacterial, fungal and human
siderophores by Candida albicans
H. Radwan
Cairo, EGY
Efﬁcient acquisition and sequestration of iron bound to bacterial
or human siderophores by Candida albicans could provide an
important mechanism of pathogenicity. A new developed blue
agar technique was used for cloning four nonpathogenic mutants
of clinically isolated C. albicans, which were tested by that tech-
nique for their ability to produce siderophore and/or acquisition
of iron from other types of siderophore. Only one mutant (M3) of
C. albicans lacks both the high-afﬁnity and low-afﬁnity transport
systems of iron. The nonpathogenic mutant (M3) of C. albicans can
acquire iron from bacterial, fungal as well as human siderophores.
The mechanism of iron uptake by various siderophores by non-
pathogenic mutant (M3) of C. albicans was investigated. Iron
acquisition from bacterial siderophores was glucose independent
but concentration contingent, this indicates that simple diffusion
is the underlying principle of bacterial siderophore (enterobacterin
and pyoverdin) transport. Whereas, the uptake of fungal sider-
ophores (ferricrocin, coprogen), as well as human siderophore
(transferrin, lactoferrin, and ferritin) was glucose-dependent indi-
cating they were transported via a high-afﬁnity energy-dependent
mechanism. Also the kinetic studies prove that, the afﬁnity of the
yeast cells to the bacterial siderophore is considerably lower than
that to fungal and human siderophore. However, the rate of
uptake of bacterial siderophore is much higher than the rate of
uptake of fungal or human siderophore. The evidence suggested
that the uptake of hydroxamates-type and ferrichrome-type sider-
ophores could involve speciﬁc permease(s).
R2196 The susceptibility of clinically signiﬁcant Candida
isolates to ﬂuconazole in the European part of Russia
A. Veselov, M. Sukhorukova, G. Kliasova, N. Dmitrieva,
N. Klimko, L. Stratchounski
Smolensk, Moscow, St. Petersburg, RUS
Objectives: To assess the susceptibility of clinically signiﬁcant
Candida isolates to ﬂuconazole (FLU).
Methods: These data are interim data of the global antifungal sur-
veillance program ARTEMIS Disk 2003, sponsored by Pﬁzer, Inc.
A total of eight centres participate in Russia with four of them
located in the European part of the country. Candida isolates were
tested using disk diffusion method (DDM) according M44-P
NCCLS guidelines. The results were assessed with automated
plate reading system (BIOMIC (R)).
Results: From July 2003 through October 2003, a total of 290
strains were tested in the four centres. The material was taking
from genitalia (32.4%), upper respiratory tract (19.3%), lower res-
piratory tract (17.9%), lower gastrointestinal tract (12.0%), urinary
tract (6.5%), blood (2.8%). The main locations were: medical/gen-
eral (35.8%), obstetrics/gynaecology (31.4%), those deﬁned as
‘other‘ (18.3%), medical ICU (6.5%), haematology/oncology
(5.5%). Among all isolates the predominant species were C. albi-
cans (73.8%), C. glabrata (8.6%), C. parapsilosis (4.1%), C. krusei
(3.8%), C. tropicalis (2.8%). Other species counted for <1–2%: C.
kefyr, C. lusitaniae, C. norvegensis, C. guilliermondii and Candida spp.
The susceptibility data are summarised in Table 1.
Conclusions: FLU remains active in vitro against all Candida spe-
cies except for C. glabrata and especially for C. krusei. The surveil-
lance programs such as ARTEMIS Disk 2003 are useful in
determining epidemiology and susceptibility of different types of
micro-organisms including fungi.
R2197 Assessment of species distribution and antifungal
susceptibility of yeasts and moulds isolated in a dept. of
microbiology and clinical microbiology deep mycoses
laboratory, Cerrahpasa: increase of non-albicans Candida
incidence over a 5-year period
A.S. Kantarcioglu, K. Altas
Istanbul, TR
Objectives: The aim of this study is to characterise the species dis-
tribution and antifungal susceptibility patterns of yeasts and
moulds isolated at a Turkish University Hospital deep mycoses
laboratory between 02 January and 18 December 03 and to detect
trends in species distribution by assessing the annual frequency in
comparison with the ﬁndings since 1999 to date.
Methods: Totally 272 specimens (8 CSF, 6 corneal, 3 ear, 2 nose, 59
sputum, 109 BAL, 6 pleural, 8 oral, 1 gastric juice, 1 eusophageal,
4 feces, 10 urea, 5 vaginal, 1 pericardium, 11 hemoculture, 12
blood, 6 pus, 20 tissue biopsy) submitted from different units
were studied. Yeast and moulds were identiﬁed by classical myc-
ological methods. Signiﬁcance of the isolates was assessed accord-
ing to EORTC criteria. Antifungal susceptibility tests were done
by NCCLS M27-A and M38-P methods.
Results: A total of 43 yeast and four moulds were isolated. C. albi-
cans strains were 30.2% (13/43), non- albicans Candida species
were 67.4% (29/43) and non- Candida yeast 2.3% (1/43). The
moulds isolated were Aspergillus niger 50% (2/4), Geotrichum capit-
atum 25% (1/4), hyalohyphomycete 25% (1/4). No growth was
observed in one antifungal receiving patient’s material despite of
microscopical positivity of fungal elements. Aspergillus latex aglu-
Table 1.
Organism
FLU
n% S % SDD % R
MIC50
(mg/ml)
MIC
(mg/ml)
C. albicans 98.6 – 1.4 0.57 1.63 214
C. glabrata 72 12 16 5.66 84.45 25
C. parapsibsis 100 – – 1.2 5.66 12
C. krusei – 45.5 54.5 36.76 128 11
C. tropicalis 100 – – 0.59 3.03 8
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tination (LA) test was found positive in four patients and Candida
LA in one patient. G. capitatum was isolated from a case of spond-
ylodischitis. MICs of ﬂuconazole (FLZ) were found mostly
(63.6%) in S-DD cathegory. In vitro resistance to itraconazole (ITZ)
(MIC higher than or equal to 1 lg/mL) as per NCCLS criteria
was observed in ﬁve C.tropicalis (11.9%), resistance to amphoteri-
cin B (AMB) (MIC higher than or equal to 1 lg/mL) in three C.
tropicalis (7.1%) isolates. Both A. niger srains showed high MIC
values to azoles. Invitro MICs of G. capitatum isolate was found as
0.25 for AMB, 32 for FLZ, 8 for ITZ, 4 for ketaconazole and 0.5 for
terbinaﬁne.
Conclusions: Non-albicans Candida spp. increased from 29.5% (in
1999–2002) to 86% (in 2002) and maintained to show high preval-
ence in 2003. Rare opportunistic moulds other than Aspergillus are
commonly encountered in deep mycoses suspected patients’ rout-
ine materials as previously shown in our lab. A casual link
between azole resistance and increase of non- albicans Candida spp
has been suggested. Our ﬁve years data could guide and serve as
a baseline for future choice of treatments and/or prophylaxis in
our hospital.
R2198 Candida Non-albicans oral isolates susceptibility
patterns to various antifungal agents
S. Alecu, D. Alecu, D. Ionescu, G. Bancescu, S. Dumitriu
Bucharest, Tulcea, RO
Purpose: To evaluate the incidence and susceptibility to antifun-
gals of other species of Candida than Candida albicans, recovered
from Romanian population.
Materials and methods: Fifty-three oropharyngeal samples were
included in the study. For identiﬁcation, the colony appearance
on Chromagar Candida medium, chlamidospores production and
substrate assimilation proﬁles with API 20 C aux system were
used. The ﬂuconazole (FL) susceptibility assessment was conduc-
ted using Etest method and ATB Fungus (bio Merieux, France),
was used to assess for susceptibility to six antifungals: nistatine
(NIS), miconazole (MIC), econazole (ECO), ketoconazole (KET),
amphotericine B (AMB) and 5-ﬂucitosyne (5FC).
Results: From 53 oral samples included in this study 65 Candida
spp. isolates were recovered: 41 (63%) C. albicans and 24 (37%)
other species. nine (13,8%) C. krusei, 4 (6.1%) C. kefyr, 3 C. glabrat-
a, 2 C. dubliniensis, 2 C. norvegensis, 1 C. inconspicua,1 C. lusitaniae,
1 C. magnoliae, 1 C. tropicalis. From all non-albicans Candida isolates
12(50%) were recovered in mixture with Candida albicans. The
antifungal susceptibility patterns for ﬂuconazole were 54.1% (13)
susceptible. 29.1% (7) S-DD, and 16.6% (4) resistent 9 all C. krusei
isolates). 91.6% from all non-albicans Candida isolates were sus-
ceptible to ketoconazole, 75% to miconazole, 66.6% to econazole,
62.5% to 5-ﬂucitosyne, 50% to nystatine and 45.8% to amphoteri-
cine B. The rest of isolates presented intermediate susceptibility to
these agents. No isolates were resistant.
Conclusions: The co-existence of C. albicans with other species of
Candida is quite important (12.3% from all samples), and some
problems in therapy could arise. Ketoconazole followed by ﬂuc-
onazole seem to be the most reliable antifungals from all drugs
tested against non- albicans Candida species recovered from Roma-
nian population.
R2199 Paecilomyces variotii fungaemia in a patient with
multiple myeloma, case report and literature review
Y. Douadi, V. Salle, T. Chouaki, F.X. Lescure, A. Smail,
T. De Revel, G. Nedellec, J.L. Schmit, J.P. Ducroix
Amiens, F
Background: Infectious complications are common in patients
with multiple myeloma. However Paecilomyces variotii, a common
saprophytic fungus, rarely causes human infection. We report
the ﬁrst case of P. variotii fungaemia in this illness with good
response with adapted antimycotic treatment. A 67-year-old
woman with stage IIIA IgAf myeloma was admitted at hospital
in March 2002 for fever, weight loss and anorexia. Myeloma
with high tumour burden (increased f2 microglobulinaemia level,
many and signiﬁcant lytic bone lesions) was diagnosed in Janu-
ary 2001. In March 2002, she presented fever for a long time
and chills. Cultures of blood samples from central catheter and
peripheral veins were positive for Paecilomyces variotii. No infec-
tion localisation was found. A treatment by liposomal amphoteri-
cin B was performed during six weeks with good response.
Unfortunately, in May 2002, his myeloma relapsed fulminantly
with many and progressive plasmacytomas with cutaneous,
facial and vertebral localisation but without increase in bone
marrow plasmacytosis. Despite chemotherapy by melphalan plus
dexamethasone and radiotherapy, her disease progressed and
she died 3 months later. Paecilomyces is a cosmopolitan ﬁla-
mentous fungus, which inhabits the soil, decaying plants, and
food products. Some species of Paecilomyces are isolated from
insects. Paecilomyces species can cause various infections in
humans. These infections are occasionally referred to as paecil-
omycosis. Corneal ulcer, keratitis, and endophthalmitis due to
Paecilomyces may develop following prolonged contact lens use
or ocular surgery. Paecilomyces is among the emerging causative
agents of opportunistic mycoses in immunocompromised hosts.
Direct cutaneous inoculation may lead to these infections. A
review of the literature suggests that infection with this fungus
can cause substantial morbidity and is probably best treated
with aggressive antifungal therapy and vigilant observation for
complications. However despite adapted antimycotic therapy, the
infection can be rapidly fatal
R2200 Catheter-associated funguria: identiﬁcation and
antifungal susceptibility
S. Saad El Din, L. Aboul Fadl, A. El Baz, M. El Damarawy,
M. Diab
Giza, EGY
Objectives: Recently, fungal urinary tract infection (UTI) repre-
sents a high-risk event. In the current study we aimed to deter-
mine the incidence of fungal infection associated with indwelling
urinary catheters and to assess yeasts proﬁles to antifungal
agents.
Material and methods: Urine specimens from 105 adult inpatients
with indwelling urinary catheters (group I: 45 intensive care unit
(ICU) patients, group II: 60 patients admitted to urology depart-
ment) were examined. Isolation of yeast strains was done by cul-
turing urine specimens on conventional media. Identiﬁcation of
isolates was performed by using CHROM agar Candida medium
and API20 C AUX Kit. Susceptibility of different yeast species to
different antifungal agents had been evaluated using candifast test
and E-test.
Results: The overall prevalence of fungal infections was 24% with
highest incidence among ICU patients (40%). Candida albicans
(C. albicans) (33.3%) was the most commonly isolated species
among ICU patients, while C. glabrata (28.5%) was mostly isolated
in urology department. Candida species represented a higher isola-
tion rate of 78.5% than other species of Trichosporon (14.3%) and
Cryptococcus (7.2%). Amphotericin B proved to be an effective
agent to most of yeast isolates with an overall sensitivity (93%)
by candifast test and with MIC less than or equal 2 lg/mL by
E-test. Seventy one per cent of isolated C. albicans strains were
resistant to ﬂuconazole with high value of MIC90.
Conclusion: In conclusion, Candida species, especially non-albican
species and other yeasts were prominent causes of funguria
associated with indwelling catheters. By virtue of recorded
resistance to ﬂuconazole, correction of iatrogenic risk factors,
such as removing of unnecessary antibacterials and changing or
removing indwelling catheters with alkalanisation of urine may
constitute an initial treatment of fungal UTIs. Periodic repeated
studies may establish identiﬁcation of emerging species and
their antifungal susceptibility to minimise the risk of antifungal
resistance and accordingly, achieve better control of fungal
infections.
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R2201 Investigation of fungi in bronchoscopically
acquired specimens of patients with pulmonary disorders
A.S. Kantarcioglu, S. Erturan, Y. Bagdatli, M. Yaman
Istanbul, TR
Objectives: The aim of our study was to determine the incidence
of fungi in bronchoscopic samples of patients with pulmonary
disorders
Methods: Between June 2001 and 30 April 2003 we obtained 162
bronchial lavage (BL) specimens from totally 157 patients. Fungi
were identiﬁed according to classical mycological methods and
assessed by EORTC criteria.
Results: Underlying disease and predisposing factors were lung
and organ cancers (99), past or active tuberculosis (20), pneu-
monia (19), interstitial lung disease (10), bronchiectasis (7), Hodg-
kin lymphoma (5), sarcoidosis (3), rheumatoid arthritis (2), KML
(1), Behcet’s disease (1), Pamphigus vulgaris (1), others (7), long-
term antibiotic usage (37), corticosteroids (13). Age range was 16–
85 years. Fungi isolated were 8 C. albicans and 16 non-albicans
Candida (5 C. tropicalis, 8 C. parapsilosis, 3 C. kefyr), 1 Trichosporon
sp, 1 Aspergillus niger, 1 A. versicolor. Of these patients one with
previous tuberculosis story was diagnosed as aspergilloma due to
A. niger with clinical and radiological ﬁndings and was proven by
culture of operation material. In one symptomatic patient three
yeast strains were isolated together as C. albicans, C. tropicalis and
Trichosporon sp. suggesting a mixed infection. Other Candida iso-
lates were assessed as oral ﬂora contamination or bronchial colo-
nisation mostly due to previous antibiotic usage, because of the
lack of evidence of pulmonary candidiasis.
Conclusions: Reported estimates of diagnostic utility of BL have
varied because of differences in patient populations, types of myc-
oses, diagnostic criteria and study methods. Aspergillus and Can-
dida were frequently identiﬁed in BL specimens but were
eventually proved to be pathogens in approximately 25 and 0%
of cases, respectively. In our study Candida were assessed as poss-
ible pathogen in 1.3% (2/157) of cases. Previous studies that
included neutropenic patients showed that Candida sp. isolation
from BL samples can represent an infection on some occasions.
The outstanding ﬁnding of our study was that Candida sp. isola-
tion from respiratory samples obtained through broncoscopy in
non-neutropenic patients is of no clinical relevance in most cases
however saprophytic fungi can be isolated as causative agents.
The combined evaluation of clinical information, radiographical
ﬁndings and mycological examination of BL samples offers a use-
ful approach to the diagnosis of respiratory mycoses due to
opportunistic fungi.
R2202 Antifungal susceptibilities and 25S intron
genotypes of Candida albicans pharyngeal isolates of oncology
patients
Z.C. Karahan, S. Cesur, F. Ic¸li, N. Akar
Ankara, TR
Objectives: Candida albicans is the leading aetiological fungal agent
in immune compromised hosts. C. albicans strains are divided into
three genotypes (A, B, and C) by 25S intron analysis on the basis
of the presence of a transposable group-I intron on the gene
coding for the 25S rRNA. Different genotypes are shown to have
different susceptibilities to antifungal agents, especially to ﬂucyto-
sine.
Methods: In this study, we determined the antifungal susceptibilit-
ies and 25S intron genotypes of 46 C. albicans strains isolated from
the pharyngeal specimens of oncology patients with solid
tumours. Antifungal susceptibilities were determined by microdi-
lution method and genotypes were determined by PCR using the
primers CA-INT-F (50-ATAAGGGAAGTCGGCAAAATAGATCC-
GTAA-30) and CA-INT-R (50-CCTTGGCTGTGGTTTCGCTAGA-
TAGTAGAT-30).
Results: A total of 21 (45.7%) of the 46 isolates were found to be
genotype A, 6 (13%) genotype B and 19 (41.3%) genotype
C. Results of antifungal susceptibilities are shown in table. No sig-
niﬁcant relationship was observed between the genotypes and
antifungal susceptibilities.
Conclusions: Genotype C was found at a higher frequency among
these isolates. Our previous studies showed that among colonis-
ing isolates genotype C was found at a higher frequency.
Although in previous studies genotype A was found to be more
resistant to ﬂucytosine, in our study group we found no signiﬁ-
cant difference.
R2203 The ﬁrst isolation and identiﬁcation of clinical
isolate Candida dubliniensis in routine microbiological
laboratory in Slovakia
P. Pavlik, S. Melkusova´, M. Lisalova, H. Bujda´kova´
Bratislava, SK
Objectives: This study presents the ﬁrst isolation and identiﬁcation
of Candida dubliniensis in Slovakia. This Candida was isolated from
24-year-old Slovak woman with inﬂammation of women pan
organs caused by mix-infection with Candida albicans and Candida
glabrata. The next inquiry after 3 months was positive for Strepto-
coccus agalactiae and C. albicans. In July 2003, this woman was pos-
itive for Escherichia coli, S. agalactiae and Candida sp. The dark and
light green colonies on CHROMagar Candida and the different
morphology of chlamydospores indicated the presence of two dif-
ferent Candida species.
Methods: Clinical Candida isolates were cultivated on CHROMagar
Candida (Becton Dickinson, UK). Identiﬁcation was performed
with commercial biochemical set API 20C AUX (bioMe´rieux,
France), germ-tube test in human serum, growth at 42 and 45C
on Sabouraud-dextrose agar, assimilation of sugars (D-xylose and
alpha-methyl-D-glucoside) performed by glass-tube test and the
production of chlamydospores. These tests were completed by
PCR assay using set primer pair (Cd-oligo2/F and Cd-oligo2/R)
speciﬁc only for C. dubliniensis. Standard C. albicans CCY 29-3-112
and C.dubliniensis CBS 7987 were used as control strains. Suscepti-
bility to antifungal drugs clotrimazole, ﬂuconazole, nystatin, mic-
onazole, pimaricin-natamycin and itraconazole was tested by disc
diffusion test.
Results: The combination of the mentioned tests conﬁrmed infec-
tion of this woman with both C. dubliniensis and C. albicans. The
patient was treated with the combination of miconazole/metroni-
dazole. After 4 months, when the ﬁrst isolation of C. dubliniensis
was examined, the inquiry for Candida presence was repeated.
The vaginal swab was positive for E. coli, Klebsiella oxytoca, Entero-
coccus faecalis, S. agalactiae and C. albicans, but it was negative for
C. dubliniensis. All clinical Candida isolates were susceptible to clo-
trimazole, ﬂuconazole, nystatin, miconazole, pimaricin-natamycin
and itraconazole.
Conclusion: We report the ﬁrst isolation of Candida dubliniensis
from patient in the Slovak Republic.
Antifugal Agent Genotype S I R
Ketakonazole A 21 – –
B 6 – –
C 19 – –
Flukanazole A 21 – –
B 6 – –
C 19 – –
Itrakonazole A 10 7 4
B 4 2 –
C 12 6 1
Amphotericine B A 20 1 –
B 6 – –
C 19 – –
Flucytosine A 18 3 –
B 6 – –
C 17 2 –
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R2204 Investigation of reidentiﬁed Trichoderma
longibrachiatum strains
Z. Antal, L. Kredics, A. Szekeres, I. Do´czi, L. Manczinger, E. Nagy
Szeged, HUN
Objectives: Trichoderma species are common soil-borne fungi.
Although they are mainly saprophytic organisms, they have
been reported to cause opportunistic infections in immunocom-
promised humans with increasing frequency. The most of these
clinical isolates are belonging to the T. longibrachiatum species.
To gain information about their biochemical properties and to
detect variability among them we collected data about the avail-
able T. longibrachiatum strains. This study was designed to sup-
plement these data with the examination of three further clinical
isolates, reidentiﬁed with molecular methods as T.longibrachiatum
species.
Methods: The inﬂuence of temperature and pH on growth was
studied on minimal agar medium. The utilisation of compounds
as carbon and nitrogen sources was investigated on microtitre
plates. Haemolytic abilities were detected in blood agar. The
extracellular protease activity proﬁles of the strains were obtained
by p-nitroanilide substrates after column chromatography. In vitro
antifungal susceptibilities were determined by E-test method.
Results: All the strains were able to grow on minimal media at
temperatures ranging from 10 to 40C, with an optimum at 30 or
35C. The pH ranging from 3.0 to 7.0 supported the growth, with
an optimum at pH 4.0. From the investigated compounds some
served both as nitrogen and carbon sources. The test in blood con-
taining agar revealed that all the strains secrete haemolysing
enzymes. Both trypsin- and chymotrypsin-like protease activity
proﬁles suggest the presence of several isoenzymes. The in vitro
antifungal susceptibilities of the isolates were as follows (in lg/
mL): 2.0–3.0 to amphotericin B, 64–256 to ﬂuconazole, 2–32 to
itraconazole and 0.25–2.0 to ketoconazole.
Conclusion: The aims of the investigation were to gain information
about the properties of clinical T. longibrachiatum strains. As it
was revealed, all the three reidentiﬁed T. longibrachiatum strains
have the ability to grow at elevated temperatures, to tolerate neut-
ral pH, to utilise compounds both as carbon and nitrogen sources
and to produce extracellular proteases and haemolytic enzymes.
All of these features can promote their growth as facultative
human pathogens; moreover their low susceptibility to some anti-
fungal drugs may cause difﬁculties in the medical treat-
ment. The work was supported by grant F037663 of the
Hungarian Scientiﬁc Research Fund.
R2205 Fluconazole susceptibility in yeasts and nosocomial
candidaemia: a south-west England tertiary hospital experience
R. Sharma
Bristol, UK
Background: Nosocomial candidaemia is a signiﬁcant cause of
morbidity and mortality in the hospitalised critically ill patients.
Reduced susceptibility of some Candida species to ﬂuconazole is
widely reported. A 3-year clinical audit was conducted across two
tertiary care hospitals (Bristol Royal Inﬁrmary and Bristol Chil-
dren’s Hospital) in southwest England to study the distribution of
Candida species and antifungal susceptibility proﬁles (AFST).
Methods: Blood culture yeast isolates and antifungal susceptibility
proﬁles over 3-years.
Results: A total of 39 yeast isolates in ﬁrst blood culture over
3-years. Candida albicans (51.28%), C. parapsilosis (28.2%),
C. glabrata (15.38%), C. guilliermondii and C. lusitaniae (2.56%
each). All isolates were sensitive (in vitro) to amphotericin B, ﬂuc-
onazole and ﬂucytosine. 16.6% of C. glabrata were susceptible to
itraconazole. 70% of yeast isolates were obtained in patients from
intensive care units.
Conclusion: Candida. albicans was the commonest cause of nosoco-
mial candidaemia. All isolates were uniformly susceptible to
amphotericin B, ﬂuconazole and ﬂucytosine (except reduced sus-
ceptibility of C.glabrata to itraconazole). No reduced susceptibility
to ﬂuconazole was evident. Amphotericin B and ﬂuconazole are
the current therapeutic options for newly diagnosed nosocomial
candidaemia.
R2206 Fungal contamination of soft contact lens and
conjunctivitis
A. Rodriguez, J. Vargas, G. Gutierrez, J. Blanco
Caracas, VE
Objectives: Fungal contamination of contact lenses is a common
occurrence, but Aspergillus fumigatus is not a frequent identiﬁed
aetiological agent in these cases. For this reason we report a case
of fungal contamination of soft contact lens and bilateral conjunc-
tivitis due to A. fumigatus in a immunocompetent patient.
Methods: Case report and review of literature. Patient was opht-
halmologically evaluated. Cultures were made from conjunctival
ﬂuid and from contact lens surface and liquid. Bacteriological and
mycological cultures were realised.
Results: A male patient, 20 years old, with long-time bilateral
myopia, using soft contact lens for 8 years, referred 3 weeks ago
inﬂammation and secretion in both eyes. Clinically impress as a
bacterial acute conjunctivitis. Samples were taken and initial treat-
ment with topic tobramycin and dexametasone was prompted.
Discontinuation on use of contact lens was advised for a couple
of weeks. Contact lens cultures on Saboraud were positive for
identiﬁcation of A. fumigatus (both lens). Due to clinical patient
improvement and negative results for cultures of conjunctival
ﬂuid no additional treatment was provided.
Conclusion: There are few articles in literature about contamin-
ation and infection related to contact lens use due to Aspergillus
fumigatus. This patient had no apparently additional risk factors
for this infection, he is immunocompetent and he is not working
in a risky environmental area. We concluded that probably con-
tact lens liquid was not appropriated in regard to its antimicrobial
activity. However, for an appropriate potential therapy we have
not commercially available any topic ocular antifungal drug. This
report also emphasise the importance of contact lens products
containing preservatives for lasting protection from micro-organ-
isms, especially those that could potentially produce even kerato-
conjunctivitis and other systemic complications.
R2207 Fungal infection of the bile from the patients
undergoing bile ductus surgery in a department of general and
liver surgery, Warsaw
E. Swoboda-Kopec, M. Wroblewska, D. Kawecki, B. Sulik Tyszka,
M. Luczak,A. Sawicka-Grzelak
Warsaw, PL
Objectives: The study comprised the patients undergoing surgery
in Department of general and liver Surgery, Medical University of
Warsaw during 3 years (2000–2002) due to the gall bladder and
bile ductus pathology.
Methods: Fungal strain were cultured from the following clinical
specimens: bile and swabs from the drains of the bile ductus,
taken before and after operation. Samples were inoculated into
Sabouraud’s medium with chloramphenicol and gentamicin. Cul-
tured isolates were identiﬁed using Candi Select (Biorad) media
and ID32C and API Candida tests (bioMerieux). Susceptibility to
antifungal agents was tested using an E-test system (AB Biodisk).
Result: In total 81 specimens were cultured (in 2000 – 11; in 2001 –
31; in 2002 – 39). Of them 87 strains of yeast-like fungi were isola-
ted. C. albicans was the most commonly isolated species: 42 strains
(48.4%), followed by C. glabrata – 13 strains (15%) and C. inconspi-
cua – 13 strains (15%), C. tropicalis – 7 (8.1%), C. krusei – 4 (4.7%),
C. parapsilosis - 1 (1.1%), C. guilliermondi – 1, C. valida – 1, C. holmii
– 1, Zygosaccharomyces spp. – 1, C. famata – 1, C. sake – 1, Saccharo-
myces cerevisiae – 1. C. albicans strains were sensitive to
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amphotericin B and ﬂuconazole. All strains of C. glabrata and C.
inconspicua were susceptible to amphotricin B and itraconazole.
Conclusion: C. albicans was the fungal species mast frequently iso-
lated from the bile of surgical patients. C. glabrata and C. inconspi-
cua were isolated with a high frequency (15%).
R2208 Candida spp. in urine specimens of a general
hospital’s patients
V. Skandami, C. Kotsi, P. Fostira, C. Kontou-Castellanou
Athens, GR
Purpose: To study the presence of Candida spp. in the urine sedi-
ment of patients treated in a general hospital.
Methods: During a 6-month period (May–October 2003), 3520
urine samples from patients equal in number, 1882 men and
1638 women, were examined in the microbiological laboratory
of our hospital. From them 80.7% were hospitalised patients
and 19.3% outpatients. Chemical analysis and microscopic
examination of fresh preparation of urine sediment was per-
formed in all specimens. Quantitative counting of white blood
cells (WBC) and blastoconidia as well as search of existence of
pseudohyphae characteristic of Candida spp. was done in the
urine sediment.
Results: Of the 3520 patients examined, presence of Candida spp.
was observed in the urine sediment of 213 patients (6.05%). The
percentage of men with Candida was 4.8% and women 7.5%.
The bigger percentage of patients with Candida spp. were treated
in the Intensive Care Unit (13.7% of patients in ICU had Candida
spp.) and followed cardiologic clinic (8.4%), pathological (8.0%),
surgical (6.2%), nephrologic (4.2%), urologic (4.0%) while the
1.9% of exterior patients had Candida spp. in the urine sediment.
From the 213 patients with Candida spp., the 42.7% had <5 WBC
per high power ﬁeld (hpf), while the 57.3% had >5 WBC per
hpf. In addition 33.8% had >15 WBC per hpf, while 17.4% had
>50 WBC per hpf. In the 25.8% of patients with Candida spp.,
casts were observed in the sediment of urine. From the 123
women with Candida spp., the 65.9% had in the examined sam-
ples seldom squamous epithelial cells while the 34.1% had a lot
of squamous epithelial cells, indicating vaginal contamination.
Conclusion: Urine sediment with pseudohyphae and blastoconidia
of Candida spp. is a frequent problem of hospitalised patients. A
majority of them present infection from Candida spp. as this
appears from the intense pyuria and presence of pseudohyphae.
To reduce this problem, restriction of abuse of antibiotics is
recommended and to receive concern for improvement of condi-
tions of individual hygiene of hospitalised patients.
R2209 Rhodotorula rubra fungaemia in an
immunocompetent patient successfully treated with ﬂuconazole
D. Kofteridis, S. Lazaridou, G. Roditakis, D. Alegakis,
V. Lathourakis, G. Samonis
Heraklion, GR
Introduction: Rhodotorula is an ubiquitous yeast of the family Cryp-
tococcaceae. The genus contains eight species, with Rhodotorula ru-
bra the most common cause of human disease. Rhodotorula
infection, although rare, can be serious and usually occur in im-
munocompromised hosts. The yeast is usually resistant to ﬂucon-
azole and is associated with considerable. A very limited number
of Rhodotorula rubra infections has been reported in immuno-
competent hosts.
Objectives: To describe a rare case of Rhodotorula rubra fungaemia
in an immunocompetent patient successfully treated with ﬂucon-
azole.
Case Report: A 64-year-old man was admitted to the hospital
because of altered consciousness and disorientation. The patient
suffered of hypertension and coronary heart disease and had a
history of COPD. His condition initially was evaluated as a case
of diuretic therapy induced electrolyte disturbances and dehydra-
tion. He was afebrile. Treatment with normal saline infusion with
potassium replacement was started. He regained consciousness on
day 3 of hospitalisation. On day six blood cultures yielded a
methicilin-resistant Staphylococcus aureus and the patient was trea-
ted with i.v. vancomycin 1 g b.i.d. for 4 weeks. On day 12 of hos-
pitalisation the patient’s temperature rose again to 38.5C. New
blood cultures yielded Acinetobacter baumani and imipenem was
added to regimen. He became afebrile on day 8 of imipenem
treatment. On day 25 of hospitalisation his temperature rose again
to 39C and new blood cultures yielded Rhodotorulla rubra sensi-
tive to ﬂuconazole. The patient was put on i.v. ﬂuconazole and
responded on day 2 of ﬂuconazole treatment he continued to
improve and became afebrile on day 5 of ﬂuconazole. Blood cul-
tures remained negative. The patient continued to receive oral
ﬂuconazole 200 mg bid at home for 1 month. He was seen in the
outpatient clinic 1 and 2 months later in excellent condition with-
out any evidence of infection.
Conclusions: Rhodotorulla rubra infection, although rare, can be
seen in immunocompetent patients. Prolonged treatment with
broad spectrum antibiotics can be the predisposing factor.
R2210 Epidemiology of Candida strains in a Greek
university infectious diseases (ID) centre
A. Antoniadou, K. Orlandou, M. Tzivra, D. Katsala,
H. Giamarellou
Athens, GR
Objectives: Candida sp. is emerging as an important pathogen or
coloniser in hospital settings. An alarming shift towards non-albi-
cans strains non susceptible to ﬂuconazole has been noted in sev-
eral studies complicating the selection of empirical antifungal
treatment. Aim of the study was to survey the epidemiology of
Candida strains isolated from various body sites in a Greek tertiary
University ID Centre.
Methods: Strains isolated and recultured on Sabouraud dextrose
2% agar underwent an identiﬁcation procedure including the
combination of: germ tube test, API TEST, inoculation on mycosel
agar and study of colony morphology cultured on corn-meal agar.
Strains were isolated either from hospitalised patients or from
patients referred to our ID outpatient clinic.
Results: Between 2001 and 2003, 145 Candida strains were isolated
from various body sites (27% vaginal, 23% oral, 23% urine, 9%
sputum, 3% bood, 5% pus specimens). Sixty-two per cent were C.
albicans. The most common non-albicans strain was C. glabrata
(20%). Isolation per specimen showed that C. albicans was isolated
from 61% of vaginal, 58% of sputum, 29% of pus, 88% of oral,
48% of urine, 75% of blood and 38% of other (mostly tissue)
specimens, respectively.
Conclusion: Non-albicans strains are emerging as common Candida
isolates, especially among isolates of nosocomial origin or from
recurrent vaginitis specimens. Identiﬁcation to the species level
must always be performed and concern should be raised about
the overuse of antifungal agents both in hospitals and the commu-
nity.
R2211 Melanin production in Cryptococcus neoformans
strains isolated from patients with AIDS
A. Trpkovic, A. Dzamic, L. Petkovic, D. Jeftovic, J. Ranin,
V. Arsic Arsenijevic
Belgrade, CS
Objectives: Cryptococcus neoformans is an encapsulated yeast which
causes infection predominantly in immunocompromised individu-
als. Cryptococcosis occurs in 6–8% of patients with AIDS. The
unique predilection of C. neoformans for the brain has been attrib-
uted to the presence of high concentrations of catechol precursors
that can serve as substrate for the fungus laccase enzyme. The lac-
case (CNLAC1) catalyses the synthesis of polymerised melanin
in vitro when the cells are grown in the presence of phenolic sub-
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strates. The ability of C. neoformans to synthesise melanin is associ-
ated with virulence. Melanin is deposited in the fungal cell wall,
where it could provide cell wall support and integrity. Melanised
C. neoformans cells are less susceptible to nitrogen- and oxygen-
derived oxidants, microbicidal peptides, and macrophage-medi-
ated phagocytosis than nonmelanised cells. It is now proved that
C. neoformans is melanised in human brain tissue by using the
melanin-binding monoclonal antibody 11B11. We investigated the
melanin production of 43 C. neoformans v. neoformans strains isola-
ted from cerebrospinal ﬂuid and blood of AIDS patients.
Methods: Melanin production was tested, after 6 days, at 37C on
niger seed agar and minimal deﬁned medium containing l-dopa.
Melanin production was scored as follows according to the colour
intensity of the medium: 3+ high activity, 2+ medium activity, 1+
low activity, and 0 no activity.
Results: The high pigment production was detected in 12/43
(27.9%) strains, medium activity was detected in 21/43 (48.8%)
and the low pigment production in 10/43 strains (23.2%). The
strains grown on the niger seed agar produced brown pigment
and intensely black colonies on the medium containing l-dopa
were observed.
Conclusion: The majority of tested strains had the medium pig-
ment production. There were no signiﬁcant difference in melanin
production on both media up to 7 days, but the activity produced
on medium containing l-dopa was more rapid.
R2212 The production of hydrolytic enzymes by
pathogenic Candida non-albicans species
S. Mitrovic, A. Trpkovic, I. Kranjcic Zec
Belgrade, CS
Objectives: Yeasts of genus Candida are human commensals and
they can cause superﬁcial and deep-seated candidosis. Some Can-
dida non-albicans species are able to cause damage to host cells
too, usually in immunocompromissed patients, but the hydrolytic
enzyme production of other Candida sp. is not well studied. We
have tested the in vitro production of acid proteinase, phospholi-
pase and acid phosphatase enzymes in different non-albicans spe-
cies.
Methods: A total of 97 strains of diferent Candida non-albicans spe-
cies (C. tropicalis 20, C. parapsilosis 17, C. kefyr 16, C. krusei 17, C.
guillermondii ﬁve, C. glabrata 18, C. lusitaniae one, C. incospicua one,
C. humicola one and C. famata one) were isolated from different
clinical specimens (blood, faeces, urine, sputum, vaginal swabs,
throat swabs) from neutropenic and other patients and healthy
persons. Isolated strains were identiﬁed by standard methods and
assimilation test API 20C AUX. Acid proteolytic activity was
assayed on a solid medium containing bovine haemoglobin as
substrate, the phospholipase activity was determined by plate
assay using phosphatidylcholine as substrate and acid phospha-
tase activity by liquid medium using phenophtaleine diphostate.
Results: It was noticed that enzyme activities were a strain charac-
teristic, but strains isolated from pathological material were more
productive than isolates recovered from carriers. No enzyme
activity could be demonstrated for examined strains of C. lusitani-
ae, C.incospicua, C. humicola and C. famata. The proteinase activity
was positive in 24.71% (23/97) of strains and phospholipase activ-
ity in 35.05% (34/97) non-albicans strains. Acid phosphatase
activity was detected in 51.55% (50/97) tested strains of Candida
sp.
Conclusions: In this study strains of several non-albicans species
isolated from pathogen samples were tested for hydrolityc
enzyme production. The difference in proteinase, phosfolipase
and phosphatase secretion between the isolates from the tested
groups (infection and colonisation) demonstrates the existence
of a correlation between hydrolytic enzyme production and
infection. The high proteolitic and phospholipase activity were
detected only in C. tropicalis and C. parapsilosis strains. These
results indicate that candidal extracelular hydrolytic enzymes,
like in C. albicans, seem to play a complex role in human candi-
dosis.
R2213 Virulence factors in dermatophytes: screening of
SUB genes encoding subtilisin-like proteases
A. Lemsaddek, L.M. Chambel, R. Tenreiro
Lisbon, P
Dermatophytes are a group of closely related ﬁlamentous fungi
capable to invade keratinised tissues (skin, hair and nails) of
humans and animals. Belonging to the genera Trichophyton,
Microsporum and Epidermophyton, these fungi are usually grouped
in three categories based on their host preference and natural
habitat. Members of the anthropophilic (human), zoophilic (ani-
mal) and geophilic (soil) ecological groups are potentially able to
cause human infections. The colonisation process is assisted by
the production of various hydrolytic enzymes, namely subtilisin-
like proteases, which are encoded by a family of three genes
(SUB1, SUB2 and SUB3). Since their expression is induced dur-
ing the infection process, they are considered potential virulence
factors. The presence of SUB genes was assayed by PCR with
speciﬁc primers in a collection of 209 human clinical dermato-
phytes, representing ten species previously identiﬁed phenotypi-
cally and genotypically, and 30 reference strains. The results
obtained showed that SUB genes are poorly represented among
the analysed dermatophytes. SUB1 was only detected for 22 of
29 (75%) M. canis and 22 of 23 (91%) M. audouinii isolates and 1
of 88 (1%) T. mentagrophytes isolates. SUB2 was found in 23 of
29 (79%) isolates of M. canis, 20 of 23 (87%) M. audouinii and 1
of 7 (14%) of M. gypseum isolates. Concerning SUB3 gene, posit-
ive results were obtained for two of three (67%) isolates of E.
ﬂoccosum, 19 of 29 (66%) M. canis, 20 of 23 (87%) M. audouinii,
one of seven (14%) M. gypseum, as well as for two of 88 (2%)
T. mentagrophytes and two of 46 (4%) T. rubrum isolates. The chi-
square analysis of contingency tables was used to test statistical
independence among occurrence of virulence traits and origin
and species allocation of isolates. Signiﬁcant associations
(P < 0.05) were found between the presence of SUB genes and
isolates of the species M. canis and M. audouinii, showing that
these virulence factors may have an important role in the infec-
tion process for theses two species and a reduced one for the
other species.
R2214 Epidemiological surveillance of Candida species
isolated from patients hospitalised in an intensive care unit
S. Marol, M. Yucesoy
Izmir, TR
Objectives: The aim of this study was to determine the epidemio-
logical surveillance of Candida infections in the anaesthesiology
intensive care unit (ICU) of Dokuz Eylul University hospital and
to evaluate the relation between colonisation and infection by
these species.
Methods: Weekly surveillance cultures of the oral and anal cavities
of the patients who admitted to ICU between 18/02/2002 and 31/
03/2003 were obtained. Thirty-nine Candida species isolated from
these cultures and 28 Candida strains isolated from various clinical
specimens of the same patients were included for the analysis.
The strains were identiﬁed by germ tube test, morphology on
CHROMagar Candida and corn meal Tween 80 agar and API 20C
AUX system. The susceptibility of the strains against amphotericin
B and ﬂuconazole were determined by microdilution method
according to NCCLS M27-A2 standards. Epidemiological surveil-
lance was carried out by resistotyping which included eleven
inhibitory substances and randomly ampliﬁed polymorphic DNA
(RAPD) PCR. Three primers were used for RAPD analysis of Can-
dida albicans and C. tropicalis and four primers for C. glabrata. Band
patterns were evaluated visually and coefﬁcient of Dice was cal-
culated.
Results: Thirty four of the isolates were determined to be C. albi-
cans, 21 and 12 were identiﬁed as C. glabrata and C. tropicalis,
respectively. There were 13 patients who was infected with C. alb-
icans. 9 and 3 of the patients were infected with C. glabrata and
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C. tropicalis strains, respectively. Most of the colonising and infect-
ing strains of the same patient had MIC values within twofold
dilutions. 22, 7 and 1 resistotypes were recognised for C. albicans,
C. glabrata and C. tropicalis isolates, respectively. 10–24 band pat-
terns were detected for C. albicans strains while 3–5 and 6–10 pat-
terns were observed for C. glabrata and C. tropicalis isolates. The
number of patients whose colonising and infecting pathogen
showed the same or related pattern by resistotyping changed
between 3 and 8 according to Candida species. This number was
found to be 7–9 for C. albicans, 6–9 for C. glabrata and 2–3 for C.
tropicalis infected patients with different primers.
Conclusion: A substantial risk of colonisation by Candida species
lead to infection in ICU. Candida infections in the ICU of our hos-
pital mostly originate endogenously.
R2215 Prevalence of fungal peritonitis in patients
undergoing peritoneal dialysis
S. Tasic, N. Miladinovic-Tasic, B. Petrovic, D. Zdravkovic,
Z. Bogojevic, A. Svetozarevic
Nis, CS
The patients undergoing peritoneal dialysis treatment are the
risk group of patients for appearance of fungal peritonitis. The
aim of the study was to establish prevalence of fungal perito-
nitis in patients undergoing peritoneal disease. According to the
results of the conducted sanitary control of the peritoneal dialy-
sis department a possible correlation between the appearance of
fungal infections and the presence of fungi in the smears of
work surfaces, and in the air in this department was estab-
lished.
Material and method: 968 peritoneal ﬂuids of patients undergoing
peritoneal dialysis were examined from 1.1.1997. to 1.7.2003.
The diagnosis of fungal peritonitis was established both on the
basis of clinical ﬁndings and on two consecutive positive myco-
logical examinations of peritoneal ﬂuids without ﬁnding any
pathogenic bacteria. Hygienic-epidemiological control of perito-
neal dialysis department in the above-mentioned period of time
included sanitary examinations of the air (23) and work surfa-
ces (615).
Results: In 54 (5.58%) patients the presence of fungi was estab-
lished, in 37 (3.82%) patients Aspergillus spp. were detected, in 12
patients Candida spp. were detected, and in only 5 patients
(0.52%) the ﬁnding of Penicillium spp. was detected. The import-
ant prevalence of fungal peritonitis was recorded in 1997 (14.59%)
whereas the percentage of positive samples was signiﬁcantly
reduced (0.62% – 1998, 1999, 2000; 0.52% – 2001; 0.41% – 2002;
0.00% – 2003) during the rest of the time. A signiﬁcant number of
air inspections (all the 23) in the peritoneal dialysis department
was done in the period of time from 1997–1999 when the preval-
ence of fungal peritonitis was the highest. Candida spp. was detec-
ted in only three of air samples by sanitary control in the
peritoneal dialysis department. Only one positive ﬁnding of Can-
dida spp. was established by sanitary control of work surfaces in
the peritoneal dialysis department. There is no correlation in
prevalence of fungal peritonitis in patients undergoing peritoneal
dialysis with the ﬁndings of fungi in the smears both of work sur-
faces from and from the smears of air in the rooms where dialysis
is performed.
R2216 Genomic diversity of Candida albicans and
Trichosporon spp. based on the analysis of the ribosomal DNA
M.L. Moretti, D. Blum-Menezes, F.H. Aoki, K. Fukushima,
K. Takizawa, K.Nishimura
Sao Paulo, BR; Chiba, JP
Candida species are the most common fungi causing hospital fun-
gal infection and Trichosporon species are emerging as opportunis-
tic agents that can cause a variety of diseases in hospitalised and
immunocompromised patients. Molecular typing characterisation
of C. albicans using subgrouping based in the analysis of the site
of transposable intron (intron site) of the 25S rDNA has been
applied and the analysis of the ribosomal DNA intergenic spacer
1 (IGS) region of Trichosporon species showed variation among T.
asahii clinical isolates.
Methods: Thirty clinical isolates of C. albicans were analysed
according to introns site region of the 25S rDNA using the pair of
primers: CA-INT-L: ATA AGG GAA GTC GGC AAA ATA CAT
CCG TAA and CA-INT-R: CA-INT-R: CCT TGG CTG TGG TTT
CGC TAG ATA CTA CAT. For the 7 isolates of T. asahii the
sequence analysis of IGS region was studied with the following
pair of primers: 26SF: ATC CTT TGC AGA CGA CTT GA and
5SR: AGC TTG ACT TCG CAG ATC GG.
Results: C. albicans isolates showed three groups: genotype A – 19
isolates, genotype B – nine isolates and genotype C – two isolates.
No correlation was observed among the three genotypes, source
of isolation and medical ward. For T. asahii, four types were iden-
tiﬁed. Types 1 and 4 were present only in urine specimen (4 spec-
imens) and types 3 and 5 in oropharyngeal secretion (3
specimens). All patients were hospitalised in different wards.
Interestingly, the urine and oropharyngeal specimens had speciﬁc
types of T. asahii and that the four genotypes were identiﬁed in
this collection.
Conclusions: Genotype A was the most prevalent in this collection
of C. albicans and these results are concordant with previous ones.
For T. asahii more data are necessary to conclude if there is a cor-
relation between types and specimen
R2217 The synergic antifungal effect of a monocloneal
antibody fragment with amphotricin B
A.A. Jafarri Nodoushan, M.H. Anvari Tafti, A. Fattahi Bafghi
Yazd, IR
Objectives: Systemic candidiasis prevalence is increasing as a
result of increasing in immnocompromised patients. Resistance to
current antifungal is another problem, but new molecular meth-
ods for production of recombinant antibodies made new hopes
for these patients.
Methods: The broth microdilution test was used in current study.
50 ll of a twofold dilution (40 to 0.02 lg/mL) of amphotricin B in
RPMI broth and 100 ll suspensions of the inoculum’s strains were
added to the sterile ﬂat-bottomed microtittre plate. 50 lL of the
antibody (50 and 5 lg/mL) were added to each wells. Final vol-
ume of 200 lL was made by RPMI. In the negative control 50 lL
of RPMI was used instead of antibody. The plates were incubated
at 37C overnight and the minimum inhibitory concentration was
deﬁned by the lower concentration inhibiting growth. The colony
count was conducted for each well, where there was seen a visual
reduction in the yeast growth. Results were represented as the
colony forming units in 1 mL of broth and analysed by SPSS soft-
ware.
Results: The amphotericin B MIC was reduced six folds against C.
tropicalis and C. parapsilosis (P ¼ 0.001) by this antibody. This
reduction is four fold for C. albicans outbreak (P ¼ 0.032), C. albi-
cans ﬂuconazol resistant (P ¼ 0.001) and C. krusei (P ¼ 0.008). The
lowest effect of antibody was seen against T. glabrata that showed
only twofold reduction for amphotericin B MIC. The greatest
effect of recombinant antibody was seen against C. tropicalis and
C. parapsilosis. C. albicans outbreak, C. albicans ﬂuconazole resist-
ance, and C. krusei were the next sensitive strains whereas C. glab-
rata showed the lowest sensitivity (only twofold reduction) to this
antibody. There wasn’t seen any growth in wells incubated with
55 lg/mL antibody but 9.4  10 CFU/mL was seen in wells with-
out antibody.
Conclusion: As there is seen an increasing change of systemic can-
didiasis from albicans to non-albicans Candida strains recently and
in respect to resistance of theses strains to commonly used anti-
fungal agents, combination of them with newly designed recom-
binant antibody can be increased their efﬁciency.
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R2218 Fungal infections in cases admitted to Yazd central
laboratory, from autumn 2000 to spring 2003
A.A. Jafarri Nodoushan, M.H. Hekmati, M.H. Anvari Tafti
Yazd, IR
Objectives: Cutaneous fungal infections are among the relatively
common mycoses, comprising a considerable percentage of admis-
sions to physicians, especially dermatologists. Knowing the fre-
quency, distribution, and geographic status of these diseases can
be helpful for planning for control and prevention of them by the
health system managers. The objective of this descriptive, retro-
spective study was to determine the relative frequencies of var-
ious fungal diseases in persons admitted to Yazd central
laboratory.
Methods: From autumn of 2000 to spring of 2003. Sampling had
been performed from the patients referred to this laboratory by
the physicians. After clearing the specimen in 10–20% KOH and
lactophenol, microscopic exam of direct smears, and if requested
by the physician, culture on Sabouraud’s dextrose agar and Myco-
sel agar (SC and SCC) had been done, and the results were writ-
ten in laboratory work lists. The demographic data and results of
tests on 3744 such cases were evaluated and analysed by SPSS
Win software.
Results: From total 3744 cases, 1508 cases (40%) were positive for
superﬁcial and cutaneous fungal agents, including 855 males and
653 females. There was a statistical signiﬁcant (P ¼ 0.000) differ-
ence between 2 sexes regarding the relative frequencies of infec-
tions. Dermatophytes (43.6%) and malassezia furfur (33.4%) were
the most common offenders, and erythrasma, candidiasis, other
yeasts, and saprophytes comprised other infections in decreasing
order of frequencies (P ¼ 0.001). The most commonly afﬂicted age
groups were 20–29 years (26.7%) and 10–19 years (26%). The least
commonly infected persons belonged to 60 years and more age
group. Upper extremities (17.8%) and axilla (1.6%) were the most
and least commonly infected areas, respectively. Only 169 cases
(17%) of 966 requested cultures were positive, and the zoophilic
fungus Trichophyton verrucosum (26.6%) was the most frequently
isolated organism. Trichophyton schoenleinii (1.2%) had the least
frequency.
Conclusion: It seems that tinea versicolor and the contagious der-
matophytosis with zoophilic agents have higher prevalence in this
area and more education and health care programmes are nee-
ded.
R2219 In vitro activity of MICAFUNGIN (FK-463) against
Candida spp.
M. Ramirez, C. Castro, E. Lopez, R. Claro, M. Serrano, A. Romero,
E. Martin-Mazuelos
Seville, E
Objectives: The increasing incidence of life-threatening fungal
infections has driven the search for new, broad-spectrum fungici-
dal agents that can be used for treatment and prophylaxis in in-
munocompromised patients. Micafungin (FK463) is a new
echinocandin with in vivo an in vitro antifungal activity against
Candida spp. The aim of this study was determinate the suscepti-
bility of Candida spp. to Micafunﬁn.
Methods: A total number of 98 Candida spp. (13 C. albicans ﬂucon-
azole resistant doses dependent, 45 C. albicans ﬂuconazole suscep-
tibles, 21 C. glabrata, 11 C. krusei, 6 C. tropicalis, and 2 C.
parapsilosis.) isolated from different clinical specimens were inclu-
ded in this study. We determined minimal inhibitory concentra-
tion (MIC) of Micafungin by following the NCCLS M27A-2 broth
microdilution method. Endpoints were deﬁned as the lowest con-
centration of drug resulting in prominent inhibition (MIC80) and
total inhibition (MIC100) of visual growth compared with the
growth in the control wells containing no antifungal. After MIC
was measured, 20 lL were subcultured from each well that
showed completed inhibition, from the last positive well, and
from the growth control, onto Sabouraud dextrose agar plates.
The plates were incubated at 35C until growth was seen in the
growth control subculture (24 h). The minimum fungicidal con-
centration (MFC) was the lowest drug concentration that showed
either no growth or fewer than three colonies to obtain approxi-
mately 99–99.5% killing activity.
Results: The MIC90–50 determined at 24 and 48 h were as follows:
C. tropicalis (6): MIC range: 0.5 to >4 mcg/mL. C. parapsilosis (2):
MIC range: 4. In these species MIC90 and MIC50 were not deter-
mined because no enough isolates. *SDD: Susceptible doses
dependent, R: Resistant and S: Susceptible.
Conclusion: These data suggest that Micafungin shows a good
in vitro activity against all Candida spp. except against C. glagrata
and C. parapsilosis. The value of these in vitro results as predictors
of therapeutic outcome is to be established in clinical trials
R2220 Protease activity in Candida spp. isolates from
patients with otitis externa
I. Matic, I. Radonjic, A. Trpkovic, L. Petkovic, A. Dzamic,
V. Arsic Arsenijevic
Belgrade, CS
Objectives: Candida spp. have emerged as important opportunistic
pathogens in immunocompromised patients. They have the ability
to produce a variety of hydrolytic enzymes, such as proteases,
phospholipases and phosphatases. There are some evidence for a
role of extracellular protease activity and their ability to cause
damage to host cells in vivo. The aim of this study was to deter-
mine in vitro protease activity of twelve strains of Candida spp.
isolated from external ear in patients with otomycoses.
Methods: The protease production was determined using the test
medium consisted of agar plates containing bovine serum albu-
min (BSA), 60 mL of a solution containing 0.04 g MgSO4.7H2O,
0.5 g K2HPO4, 1 g NaCl, 0.2 g dried yeast extract, 4 g glucose
and 0.5 g BSA. The solution was sterilised by ﬁltration, mixed
with 140 mL of melted agar and poured into Petri dishes. The i-
noculum of 106 CFU/mL was prepared in normal saline and
10 lL of suspension of each strain was inoculated in triplicate.
After the incubation at 370C for 7 days the diameter of the zones
around the colonies was considered as a measure of protease pro-
duction. The protease activity (Pz) was measured in terms of the
ratio of the diameter of the colony plus the precipitation zone.
Low Pz signiﬁed a high production of the enzyme, i.e. high viru-
lence, while a high Pz induced low production of the enzyme, i.e.
low virulence. The average Pz value was obtained with three sep-
arate samples of each strain.
Results: Eleven of 12 Candida spp. strains have shown a positive
protease activity and the Pz values ranged between 0.61 and 0.78
(Pz average 0.69). The protease activity of Candida spp. strains
was observed three days after inoculation.
Conclusions: The majority of tested Candida spp. had a protease
activity. Proteinase production is considered to enhance the
organisms’ ability to colonise and penetrate host tissues, which
could be important in establishing the infection of the external
ear. It is documented that protease enzymes are able to degrade a
number of proteins important in host defence such as immuno-
globulins, complement and cytokines.
Isolates
MIC24 h
(100/80%)
mcg/mL
MIC48 h
(100/80%)
mcg/mL MFC
C. albicans MC901=0:25 MC904=0:5 MFC90 > 4
SCD* and R* (13) MC600:5=0:25 MC601=0:25 MFC601
C. albicans S* MC900:25=0:12 MC900:5=0:25 MFC900:25
(45) MC600:25=0:06 MC600:12=0:06 MFC600:12
C. glabrata MC904=4 MC90 > 4= > 4 MFC90 > 4
(21) MC600:06=0:06 MC600:06=0:06 MFC600:06
C. krusei MC901=0:5 MC901=0:5 MFC901
(11) MC600:5=0:5 MC600.5/0.5 MFC600:5
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R2221 Voriconazole activity against clinical isolates of
Candida, focusing on ﬂuconazole-resistant strains
T. Pela´ez, J. Martı´nez-Alarco´n, J.V. Guinea, L. Alcala´,
M. Rodrı´guez-Cre´ixems, P. Mun˜oz, E. Bouza
Madrid, E
Background: Antifungal resistance among invasive isolates of Can-
dida is a source of concern. Candida kruesi and C. glabrata. are
known to express intrinsic (C. krusei) or acquired (C. glabrata)
resistance to ﬂuconazole and may also show decreased suscepti-
bility to amphotericin B. Data regarding the activity of voriconaz-
ole against Candida species expressing resistance to ﬂuconazole
are limited.
Objective: To determine the in vitro activity of voriconazole against
Candida spp. isolated in our hospital from blood, sterile, mucocu-
taneous and respiratory sites during the last 2 years.
Methods: The in vitro activities of ﬂuconazole (FZ), itraconazole
(IZ), ketoconazole (KZ), and voriconazole (VZ) were determined
by the microdilution method following NCCLS criteria. MICs
were visually determined after 24 h incubation at 35C. Interpret-
ative criteria have not yet been deﬁned for voriconazole; however,
for purposes of comparison, we have employed a susceptible
breakpoint of 1 mg/L.
Results: We tested 218 clinical isolates of Candida obtained from
164 patients. Overall, the frequency of FZ-resistance (64 mg/L)
and intermediate resistance (16–32 mg/L) was respectively: 7.8%
(17) and 16% (35). Of these, 98.6% (49) were inhibited by voricon-
azole at an MIC of 1 mg/L., and three strains (C. albicans, C.
parapsilosis, C. krusei) were resistant to voriconazole
(MICs  4 mg/L were observed). globally, the rate of voriconaz-
ole resistance was 1.4%.
Conclusion: Voriconazole was very active against all clinical iso-
lates of Candida (99% of MICs were 1 mg/mL) and showed a
excellent potency in vitro against ﬂuconazole-resistant Candida
strains.
R2222 Frequency of high-level ﬂuconazole resistance in
Candida isolates in a general hospital
J. Martı´nez-Alarco´n, T. Pela´ez, J.V. Guinea, L. Alcala´, E. Bouza
Madrid, E
Background: It is now known that there are isolates of Candida
exhibiting two types of azole resistance. The phenotype RR: high-
level resistance to both ﬂuconazole (MIC, 64 mg/L) and itracon-
azole (MIC, 1 mg/L) and the phenotype RS: high-level resist-
ance to ﬂuconazole (MIC, 64 mg/L) and susceptibility to
itraconazole (MIC,  0.125 mg/L). Reports on the frequency of
these phenotypes in a clinical setting are scarce.
Objective: To evaluate the frequency of the two different pheno-
types of azole resistance (RR and RS) in 712 Candida clinical iso-
lates from blood and other sterile, mucocutaneous and respiratory
sites during a 6-year period.
Methods: From 2001 to 2003, 712 isolates of Candida spp. from 516
patients were recovered. The species distribution identiﬁed by
ATB 32C was: 343 C. albicans, 127 C. glabrata, 121 C. parapsilosis, 50
C. tropicalis, 34 C. krusei and 37 others. The in vitro activities of
amphotericin B (AB), ﬂuconazole (FZ), itraconazole (IZ), ketocon-
azole (KZ) and ﬂucytosine (FC) were determined by the microdi-
lution method following NCCLS criteria.
Results: The percentages of resistance of Candida isolates were: AB
1.8%, FZ 8.7%, KZ 12%, IZ 16.6% and FC 2.1%. The frequency of
phenotype RR was 8.7% (62 isolates). The species distribution of
isolates RR was: 34 C. krusei, 18 C. glabrata, 5 C. albicans, 3 C. para-
psilosis, 1 Trichosporon and 1 Zygosaccharomyces. No isolates with
phenotype RS were observed.
Conclusion: Overall, resistance of Candida isolates in our institution
is 8.7% to FZ and 16.6% to IZ. In all isolates the high-resistance
phenotype (RR) was detected.
R2223 Dermayophytoses in Erzurum, Eastern Anatolia
H. Uslu, A. Ayyildiz, E. Aktas, A. Ozbek, H. Yazgi
Erzurum, TR
Objective: To determine the incidence of causative pathogens
responsible for the dermatophyte infections in Eastern Anatolia,
Erzurum.
Methods: In this study, hair, nail, and skin samples obtained from
503 patients, suspected with dermatophytoses, were studied. Dis-
tributions of patients were tinea pedis (n ¼ 141, 28.3%), tinea cor-
poris (n ¼ 121), tinea ungium (n ¼ 78), tinea ingiunalis (n ¼ 73)
Tinae manum (n ¼ 70), tinea capitis (n ¼ 20). First, native prepa-
rations were done for these clinical samples by using 20% KOH
and then stained with lactofenol cotton blue for direct microscopic
examination. In order to cultivate, isolate and identify, the der-
matophytoses, each sample was inoculated on saboraud dextrose
agar, mycobiotic dextrose agar and potato dextrose agar as dupli-
cate, and then incubated for up to 4 weeks at 37o C and room
temperature. At the end of the incubation period, cultures were
examined with macroscopic and microscopic.
Results: Diagnosis of the patients as dermathoytoses were per-
formed as to laboratory ﬁndings, and distributions of dermatho-
phytoses were tinea pedis (65 in 141 samples, 46.1%), tinea
corporis (n ¼ 12 in 121, 9.9%), tinea ungium (n ¼ 27 in 78,
34.6%), tinea ingiunalis (n ¼ 17 in 73, 23.3%), tinea manum
(n ¼ 7 in 70, 10.0%), tinea capitis (n ¼ 11 in 20, 55%). Disper-
sions of dermathophytes isolated from patients’ samples were
Trichophyton rubrum 72.5%, Trichophyton mentagrophytes 16.8%,
Trichophyton schoenleinii 3.6%, Trichophyton tonsurans 1.4%, Micro-
sporum canis 1.4% and Epidermophyton ﬂoccosum 0.7%. Trichophy-
ton rubrum was the most frequent one in all forms of
dermatophytoses except tinea capitis. Trichophyton schoenleinii was
the most frequent dermatophyte (45.4%) in tinea capitis.
Conclusion: As tinea pedis was the most frequent clinical form;
Trichophyton rubrum was the most frequently isolated one. When
we compare our results with the other studies performed in other
regions of Anatolia, on contrary to expectations due to geograph-
ical distinction, there were no differences.
R2224 Candidaemia at intensive care units in Saint-
Petersburg, Russia
L. Pestova, N. Klimko, T. Bogomolova, Z. Kolb, A. Saturnov,
I. Zuzgin, T. Schneider
Saint-Petersburg, RUS
Objective: To determine epidemiology, risk factors, clinical symp-
toms, treatment and outcomes of candidemia in ICU in Saint-
Petersburg.
Methods: We have analysed prospectively demographic, clinical
and microbiology data for 100 patients with candidemia at ICU in
19 hospitals in Saint-Petersburg, during the years of 1996–2003.
Results: Prospectively 985 patients at high risk for candidemia
have been observed. Candida spp. (110 strains) were isolated in
blood cultures from 100 patients (10%). Eighteen per cent of these
patients were children <15 years of age. The most common spe-
cies was C. albicans (28%), followed by C. parapsilosis (27%), C.
guilliermondii (13%), C. tropicalis (7%), C. krusei (4%), C. guillier-
mondii (4%), C. lipolytica (2%), C. zeylanoides (2%), C. rugosa (1%),
C. lusitaniae (1%), C. kefyr (1%), C. famata (1%) and Candida sp.
(9%). Two and more different Candida spp. were present in blood
of 10% of patients. Concomitant non- Candida fungaemia was pre-
sent in 3% of patients (Geotrichum candidum, Trichosporon spp.).
Concomitant bacteraemia (Ps. aeruginosa, Klebsiella spp. and other)
was present in 22% of patients. Associated risk factors for can-
didemia included broad spectrum antibiotics (95%), central lines
(92%), extensive surgery (32%) and underlying disease (cancer –
29%, trauma – 14%, burns – 12% and diabetes – 5%). At time of
diagnosis the majority of patients presented with non-speciﬁc
symptoms. Fever >38C was found in 88% of patients, whereas
hypotension occurred in 19% patients. Leucocytosis and leucope-
nia were observed in 21 and 16% of patients respectively. A focal
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site of infection was detected in 31% of cases, with lungs being
the most common target organ (28%). Other sites of infection
included kidneys, peritoneum, heart, liver, CNS, spleen, eyes, skin
and oesophagus. Seventy-four per cent of patients received an-
timycotic therapy: ﬂuconazole (55%), amphotericin B (31%), ca-
spofungin (7%), Ambisome (5%), itraconazole (1%), ketoconazole
(1%). In 63% of patients central lines were removed. Overall mor-
tality rate was 45% (28% in children and 49% in adults).
Conclusion: Candidemia is a nosocomial infection associated with
high mortality rate. Non-albicans Candida spp. predominated as
etiologic agents of candidemia. Effective antifungal treatment,
removal of contaminated central lines are important in the man-
agement of these infections.
R2225 Trichophyton tonsurans in Aragon (Spain)
A. Rezusta, J. Gil, M.C. Rubio, B. Moles, C. Aspiroz, M. Ferrero,
B. Zubiri, N. Porta, Y. Gilaberte, M. Navarro, I. Ramirez Ocariz
de, M.J. Revillo
Zaragoza, Huesca, E
Objective: The aim of this study is to examine the evolution of
T. tonsurans between 1987 and 2003 in Arago´n (Northeast of Spain).
Methods: Skin scrapings and hair samples were obtained after
cleaning the lesions with alcohol at 70%. The material collected
was microscopically examined in 40% KOH/Parker Quink ink
(v/v) stain for the presence of fungal hyphae and arthrospores,
and inoculated on Sabouraud’s dextrose agar with antibiotic, my-
cobiotic agar and dermatophyte test medium. Identiﬁcation of
fungal cultures was made on the basis of both macroscopic and
microscopic appearances. Slide cultures and other conﬁrmatory
tests such as Trichophyton agar slants, Christiansen’s urea agar
slant, potato dextrose agar, corn meal and in vitro hair perforation
test were performed when necessary (1).
Results: 74 patients had dermatophytosis caused by T. tonsurans
which was collected from the patients respectively in four Spanish
hospitals that were located in the same geographical area. Of
these 74 cases, only 25 were born in Spain of Spanish parents and
2 were born in Italy of Italian parents. But between 2000 and
2003, 53 cases (71.6%) were diagnosed and of these 53, 45
(84.9%), were immigrants or had immigrant parents.
Conclusion: Dermatophytoses caused by T. tonsurans it is increas-
ing in Arago´n (Spain). Most of the cases come from immigrant
families that originate in Africa. The rapid increase of immigration
in our country and the easy transmission of this antropophilic
dermatophyte are probably the main reasons for this increase of
T. tonsurans in our area.
Reference:
1. Rebell, G. & Taplin, D. Dermatophytes their recognition and identiﬁcation.
2nd Ed. 1974. University of Miami Press.
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Abstract withdrawn.
R2227 Study of Enterobius vermicularis infection among
kindergarten children in Ardabil, Iran
A. Daryani, B. Abyar, G. Ettehad
Ardabil, IR
Objectives: Enterobius vermicularis is a common helminthic infec-
tion, affecting almost 1 billion people worldwide from all socioe-
conomic classes. In Iran, its prevalence is 25–92%, with a high
prevalence among children. Aim of this study was to determine
the prevalence of this parasite in Ardabil kindergartens.
Methods: 400 children <7 years old from 10 kindergartens were
evaluated by Graham’s scotch adhesive tape technique in Ardabil,
Iran, 2003.
Results: The prevalence of enterobiasis in the studied children was
18.3%. The highest rate (21.9%) was observed in children
4–5 years old and the lowest rate (14.3%) was seen in children
1–2 years old. The infection rate of males and females was 16.4
and 21.2%, respectively (P > 0.05). Prevalence of enterobiasis in
children of illiterate mothers (54.5%) was higher than those of
literate mothers (12.2%) (P < 0.05).
Conclusion: Therefore for prevention of this infection, health edu-
cation, especially for illiterate or low literacy parents is necessary.
R2228 Seroepidemiology of toxoplasmosis in women
referred to Ardabil laboratory health centre for medical
examination before marriage, Iran, 2002
M Sagha, A Daryani
Ardabil, IR
Objectives: Infection with Toxoplasma gondii can cause sever illness
when the organism is transmitted to fetus or when it is reactiva-
ted in immune-suppressed persons. The aim of this study was to
determine the antibody prevalence of toxoplasmosis in women
referred to laboratory of health center for medical examines before
marriage.
Methods: This cross-sectional study was performed on 504 sera
collected from women in Arabia city, Iran, in 2002. The samples
were studied by indirect immunoﬂuorescent assay (IFA) for deter-
mination of IgG and IgM antibodies to toxoplasma.
Results: The seroprevalence of IgG antibody at a titre of 31:20 was
34.7%. There was the most of antibody titre frequency in 1:20 titre
(11.7%) and the least of them in 1:3200 (0.4%) and 1:6400 (0.4%)
titres. Only 20 persons (4%) showed IgM antibody against Toxop-
lama gondii. No statistically signiﬁcant differences in the levels of
antibodies were observed in relation to age.
Conclusion: As 65.3% of these women in Ardabil city were sero-
negative, health education to omit its risk factors, especially dur-
ing the pregnancy is necessary.
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R2229 Diseases imported from tropical regions in own
material
J. Niscigorska, I. Moranska, M. Marczewska, A. Leonciuk,
A. Boron˜-Kaczmarska
Szczecin, PL
Objectives: The development of tourism, business trips and migra-
tions have resulted in a real possibility of importing tropical dis-
eases to Poland. The aim of study was epidemiological analysis
of the diseases imported from tropics according to the regions of
the world in which they were acquired and methods of preven-
tion.
Methods: The study was based on own material accumulated in
the Department of Infectious Diseases of Pomeranian Medical
University in 1990–2000. The diagnosis of imported diseases was
based on clinical presentation, epidemiological history and acces-
sory investigations such as search for malaria plasmodium in per-
ipheral blood smears, examination of faeces for amoebic cysts or
eggs of trematodes and of urine sediments for schistosoma eggs.
Additionally, immunoserological tests were performed in case of
malaria, amoebic liver abscesses and schistosomiasis, typhoid
fever, as well as blood and faeces cultures, essential laboratory
tests and imaging-ultrasonography and computed tomography.
Results: Between 1990 and 2000.54 patients diagnosed with dis-
eases imported from tropics were hospitalised in the Departmen,
including 45 with malaria, 5 with amoebiasis, 2 with trematodiasis
and 1 female patient with typhoid fever. Tropical malaria due to
Pl. falciparum invasion was diagnosed in 31 cases, in 12 tertian
malaria (Pl. vivax), in 2 double infections (Pl. falciparum + Pl. vivax
and Pl. falciparum + Pl. ovale).Tropical malaria was imported from
equatorial Africa, tertian malaria from India and double infections
from West Africa. Amoebiasis due to Entamoeba histolytica was
diagnosed in 5 patients-in one case intestinal amoebiasis and in
four amoebic liver abscesses. The disease was associated with stay
in India, Syria or Sudan. Among two patients with trematodiasis
contracted in Africa, was one with schistosomiasis (Schistosoma
haematobium) and another-fascioliasis (Fasciola hepatica).The only
case of typhoid fever was diagnosed in a young woman who had
previously visited Nigeria. Less than half of patients used prophy-
lactic media against tropical diseases.
Conclusions: The knowledge of the principles of prevention of
tropical diseases is insufﬁcient among persons travelling to trop-
ical countries. Malaria was the most common cause of imported
diseases; the minority of travellers use pharmacological prophy-
laxis of the disease. Amoebic liver abscesses were found exclu-
sively in men. Trematoid invasions and typhoid fever were
relatively rare.
R2230 Parasitic infestation of the ceacum and acute
appendicitis. Case reports
A. Dervisoglou, P. Giannakakis, E. Karampali, A. Nikolaou,
S. Liveranou, S. Pinis
Pireus, GR
Objectives: Parasites such as Enterobius vermicularis may have a
causal role in appendicular pain and chronic inﬂammation. Nev-
ertheless it is rarely associated with histological changes of acute
appendicitis. The relationship between the parasite and acute
appendicitis is rare and much disputed. The incidence of acute
appendicitis and helminthic infestation in children is higher than
in adults. The highest incidence occurs in the range of 6 to 15-
year-old patients, while infestation is more frequent in female
than in male. Two interesting cases of patients older than 15 years
with acute appendicitis caused by Enterobius vermicularis, are pre-
sented in this study.
Methods: From December 2000 to December 2003 three patients
were admitted to our department with the clinical presentation of
acute appendicitis. Tow female patients, 15 and 19 years old,
respectively, and one male patient 16 years old were concerned.
Emergency appendectomy was performed.
Results: The histopathological study showed the presence of Ente-
robius vermicularis and acute inﬂammatory changes in the appen-
dix, in all of them. Laboratory examinations for Enterobius
vermicularis infestation of the bowel were followed.
Conclusion: The clinical presentation imitates an attack of acute
appendicitis, but the true nature of the disease is diagnosed only
through a histological examination. Appendectomy eliminates the
complication but not the cause of intestinal disease.
R2231 A decade of malaria in Yazd Province (near to
endemic areas of Iran)
M.H. Anvari Tafti, A. Fattahi Bafghi, A.A. Jafarri Nodoushan
Yazd, IR
Introduction and objectives: Despite vast efforts for eradicating and
controlling of malaria, this infection is known as one of infections
with high incidence and mortality especially in endemic parts of
the world. In few cities of Iran like Yazd, that hosted many
Afghan immigrants, who came from endemic areas caused
importing cases of malaria. The general purpose of this study was
to determine the demographic parameter of people, who infected
with malaria for handling and treatment of them.
Methods: A descriptive cross-sectional study was conducted on all
patients with malaria, who had been referred to Yazd health cen-
tres from 1990 to 2000. In this decade totally 3193 cases were been
diagnosed with positive blood smear. The demographic parameter
of patients was prepared using SPSS software.
Results: The maximum and minimum incidence of malaria was
seen in 1993 (847 cases) and 1997 (114 cases) respectively. The
most prevalent species’ was Plasmodium vivax (83%) but P. mala-
riae was detected only in 0.1% of cases. Majority of infected
patients were Afghan immigrants and fortunately no drug resist-
ant case was seen in this study.
Conclusion: According our results, we suggested that due to suit-
able climate conditions for various species of anopheline mosqui-
toes in Yazd province and also increasing the frequency of
Afghan immigrants entered to this province, there is a very high
risk of malaria transmission in this area and it is necessary to
have more attention for controlling of this infection.
R2232 Status of cutaneous leishmaniasis in Taft from 1997
to 2002
A. Fattahi Bafghi, M.R. Anvari Tafti, A.A. Jafarri Nodoushan
Yazd, IR
Introduction and objectives: Leishmaniasis is one of the most
important tropical and subtropical infections throughout of our
world. The visceral and cutaneous forms of this disease (both an-
thropophilic and zoonitic) are endemic in Iran. In recent years,
several Yazd cities have been highly infected with cutaneous
leishmaniasis. The general purpose of this study was to deter-
mine the disease proﬁles in the city of Taft.
Methods: This survey was a descriptive cross-sectional study,
which was conducted on coetaneous leishmaniasis patients, who
referred to Taft health centres from 1997 to 2002. Their infection
was diagnosed with laboratory tests and their demographic
parameters were collected by a designed questionnaire. Finally
data was collected and analysed using SPSS software.
Results: From 278 detected cases including 76% male and 24%
female, in 1997 a peak of infection incidence was seen as most of
cases were diagnosed (112 cases) in this year, whereas the mini-
mum rate of infection was seen in 2001 (only 12 cases). 67.3% of
cases were seen in 11–20 years age group and in different closed
rural areas Kahdouieh village was determined as the highest
infected area in Taft.
Conclusion: The incidence rate of cutaneous leishmaniasis in Taft
is lower than closed cities like Yazd. Since there are potential vec-
tors, sensitive humans and suitable environmental conditions in
this area, it is necessary to promote permanent controlling and
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surveillance programs to eliminate this infection, otherwise there
is the risk of spreading of this infection in Taft.
R2233 Malaria in university hospital patients in Oman,
1996–2001
E. Scrimgeour, A. Al Hashmi, H. El Khatim
Al Khod, OM
Objectives: Malaria used to be endemic in Oman, in 1990, there
were over 32 000 cases but with the introduction of malaria con-
trol in 1992, the incidence fell to 1091 cases in 1998. 70% of cases
were caused by PF usually chloroquine-resistant, and many
imported cases were in visitors to Zanzibar which used to be a
colony of Oman. By 2001, all but 2 of 635 cases diagnosed in
Oman were imported. To document the changing clinic-epidemi-
ology of malaria in hospital patients we started a prospective
study in 1996.
Methods: All patients with malaria admitted to the Unversity Hos-
pital from 1996 to 2001 were studied.
Results: 45 patients aged 2–58 years (mean 22 years), were inclu-
ded. Malaria was imported in 32 cases, 19 in returning visitors to
Zanzibar. Only eight patients had taken prophylaxis. Malaria was
caused by PF in 33 patients. Three patients had severe malaria,
but none died. Early diagnosis and treatment of PF cases with
quinine was invariable. The numbers of malaria cases declined to
only 5 in 2001.
Conclusions: Early diagnosis and appropriate treatment of malaria
in the University hospital has resulted in early recovery and no
deaths during the period. Most cases have been in visitors to Zan-
zibar. The declining numbers of cases may delay diagnosis and
appropriate treatment in the future.
R2234 Case report: broad ligament hydatic cyst
S. Ravani, M. Zangeneh
Azad Islamic University, Tehran, IR
Objective: To present an unusual presentation of an infectious dis-
ease such as hydatic cyst in the endemic area.
Case Report: Is a 49-year-old housewife woman complaining of left
lower quadrant pain, pelvic heavyness and irrigular vaginal
bleeding from 3 months before admission. In the genital exam
there was vaginal bleeding and a mass about 9  8  10 cm in
the left adenex.
Lab. exam: CBC¼WBC¼ 7800/Hb¼ 11/2mg. ESR 36. Sonography¼
endometrial diameter was 8 mm and a cystic mass without echo
about 98  86  90 mm in the left adenex. Diagnostic dilatation
and curretage were done. Its pathologic result showed prolifera-
tive endometrium with diagnosis of ovarian cyst cystectomy was
done. The pathologic result of the cyst showed broad ligament
hydatic cyst.
Conclusion: Hydatic cyst usually involve lung and liver but it can
infect other organs. Sometimes it has unusual presentation. There-
fore, in the endemic area every patient with a mass without speci-
ﬁc cause hydatic cyst must be considered.
R2235 Myopericarditis as a manifestation of primo-
infection by Toxoplasma gondii in an immunocompetent
patient: a case report
G. Sesen˜a-del Olmo, M.D. Martı´n, M.S. Quevedo, R. Jime´nez,
Y. Gil, A.C. Velasco, J.M. del A´lamo
Legane´s, E
Toxoplasma gondii is an intracellular parasite producing heart dis-
ease in immunodeﬁcient patients as well as in immunocompetent
individuals. We report the case of a previous healthy 23-year-
old male seen the Emergency Department of our hospital suffer-
ing from a 2-day thoracic pain. The patient presented a perma-
nent pleuritic retroesternal pain, irradiated to the right
hemithorax, worsening with respiratory movements. He did not
refer nausea, vomiting or sweating as well as previous trauma or
intense effort, or dyspnoea. The patient had not had any infec-
tious disease in the previous days. At the physical examination
the patient showed a blood pressure of 130/80 mmHg, 61 heart
beats/min, and a temperature of 36C. Blood oxygen saturation
was 98%. He was eupneic with normal cardiac and pulmonary
sounds. No relevant alterations were seen in the chest radiogra-
phy.
Blood chemistry ﬁndings were: RBC 4.98  106/mL, haemoglobin
16.2 g/dL, haematocrit 47.9%, leucocytes 10 180/mL (82.8% neu-
trophils, 7.5% lymphocytes, 6.9% monocytes) with some atypical
lymphocytes. The haemostatic values were normal. A CK of
1032 IU/L with a CK-MB of 108 IU/L was found. The ECG
showed an ST segment elevation in V1–V3, with decreasing T
wave in the lateral leads. The patient was admitted with the
clinical diagnosis of myopericarditis and treated with anti-in-
ﬂammatories (lysine aspirin). At day seven after admission the
patient was discharged asymptomatic with a normal ECG. Dur-
ing admission, serum test for inﬂuenza A and B virus, adenovi-
rus, respiratory syncytial virus, Chlamydia, Legionella, Mycoplasma,
Coxiella, Borrelia burgdorferi and HIV were all negative. ELISA test
for Toxoplasma was positive with an IgG of 9.24 IU (positive >3)
and IgM 4.9 EU (positive >1 EU). Although primary infection
with T. gondii is usually asymptomatic in inmunocompetent indi-
viduals, a small percentage can suffer myopericarditis, although
this manifestation is exceptional. Treatment is aimed to prevent
complications.
R2236 Evaluation of non-microscopic tests in malaria
diagnosis
M. Martinez Padial, M. Subirats, A. Morente, N. Camino,
R. De Julian, A. Amor, S. Puente, M. Lago, M. Baquero
Madrid, E
Objectives: The need of new rapid and easy to develop diagnostic
techniques such as dipsticks acquire a very important role in the
management and control of malaria. This disease is responsible
for more than 1 million of deaths each year, and the estimated
prevalence worldwide exceeds 300 million of cases. The severity
of this illness is closely related to the delayed laboratory results;
consequently inmunochromatographic tests (ICTs) can be consid-
ered a very useful tool in the diagnosis due to it’s easy perform-
ance that do not require highly trained personal, and short
duration to develop such tests. In this study dipsticks sensitivity
% infected RBC
Microscopic
examination (n) ICT (n) PCR (n)
P. falciparum
Positive
> 1% 12 12 12
0.1–1% 28 28 28
< 0:1% 21 20 21
Negative 15 2 0
P. vivex
Positive
> 1% 1 1 1
0.1–1% 3 3 1
< 0:1% 7 4 7
P. ovale
Positive
0.1–1% 2 1 2
< 0:1% 3 1 3
P. malariae
Positive
0.1–1 1 1 1
Negative 1 1 0
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and speciﬁcity were evaluated versus microscopic diagnosis and
results were compared with PCR.
Methods: ICTs were evaluated with EDTA venous blood samples
from symptomatic patients either with history of travel or living
in endemic malaria countries. Direct examination included both
thick and thin blood ﬁlms with Field’s stain. Finally all the sam-
ples were compared with PCR to assess differences between both
techniques. ICT studied was NOW Malaria (ICT-Amrad, Syd-
ney, Australia) that uses monoclonal P. falciparum antibodies
against HRP-2 and a panspeciﬁc Plasmodium spp. aldolase.
Results: ICT has a high sensitivity for P. falciparum including sam-
ples with low parasitaemia concentrations. There were 15 false-
negative microscopic examinations; all had positive PCR results
and ﬁnally ICT detected 13 cases. For other Plasmodium species
the sensitivity of the test was signiﬁcantly lower.
Conclusions: ICTs offers useful information in the rapid diagnosis
of P. falciparum infections with excellent speciﬁcity and sensitivity;
consequently these tests could be implemented in health centers
devoid of facilities for more complex laboratory tests. With the
rest of Plasmodium species the test lacks speciﬁcity due to the
monoclonal panspeciﬁc antibody used. Sensitivity decreases signi-
ﬁcantly when parasitaemia falls below 0.1% of infected red blood
cells.
Sexually transmitted diseases (except HIV)
R2237 PCR detection of Chlamydia trachomatis from
endocervical smears
L. Cisla´kova´, Z. Daxnerova´, R. Dankovzı´k, M. Hala´nova´, J.Adam
Kosice, SK
Objectives: Chlamydia trachomatis is one of the most common aetio-
logical agents of sexually transmitted diseases worldwide. Chlamy-
dia infection is largely asymptomatic, but if it is left untreated, it
can have particularly severe long term consequences for women.
These sequelae include pelvic inﬂammatory disease, ectopic preg-
nancy and infertility.
Methods: To evaluate the performances of the Amplicor CT PCR
assay (Roche Diagnostics) on endocervical smears for the detec-
tion of Chlamydia trachomatis. A population of 171 women
attending the gynaecology clinic of Kosice entered the study.
Endocervical smears specimens were processed according to the
manufacturer’s instructions. The majority of the patients presen-
ted with discharge and other symptoms of a genital infection. The
women were 17–45 years old.
Results: An overall prevalence of 18.7% (32/171) was observed for
Chlamydia trachomatis infection.
Conclusions: PCR is proved to represent a fast and precise method
of Chlamydia trachomatis evidence in smears from uterine cer-
vix. This work was supported by grant VEGA MS SR No. 1/
9279/02.
R2238 Markers of HBV, HCV and HIV infections among
persons with multiple sexual partners
V. Grunevska, L. Ivanovski, D. Dimitriev, C. Nastevska,
M. Gaseva, B.Tosevski
Skopje, MK
Objectives: To investigate the prevalence of HIV, HBV and HCV
markers among persons with multiple sexual partners.
Material and methods: This is a prospective study including per-
sons with more than 5 sexual partners for the period of 6 months
grouped by sex, age, education, nationality and sexual practice.
The investigation was made for HCV using ELISA kits: ORTHO
HCV 3.0 ELISA, ABBOTT HCV EIA 2nd GENERATION, Murex
anti HCV/Version III and UBI HCV 3.0 ELISA and conﬁrmed by
Immunoblot Assay Chiron RIBA HCV 3.0 Strip Immunoblot
Assay and HCV RNA, and genotypes were determined with RT/
PCR using Amplicor (Hoffman La Roche). HBV and HIV infec-
tions were checked using Behring ELISA kits and Enzygnost anti
HIV 1/2 Plus. Lia Tek HIV 1 + 2, Western blot Kits and Chiron
RIBA HIV1/HIV2 SIA.
Results: Tested were 200 persons with multiple sexual partners at
the age from 17 to 70 years. We veriﬁed present or past HCV and
HBV infections in 142 (71%) patients: 29 (14.5%) had veriﬁed
HBsAg, 41 (20.5%) anti HBs, 72 (36%) anti HCV and 21 (10.5%)
had been with HIV infections. 100 of them noted that they had
been drug users more than 1 year before this examination without
informing their partners. By monitoring the group of nondrug
users (100) we veriﬁed anti HCV in 13 (13%), HBsAg in 13 (13%),
anti-HBs in 22 (22%) and HIV infection in 21 (21%).
Conclusions: Sexual transmission of HBV, HCV and HIV among
persons with multiple sexual partners is intensive and among
them, drug users, present or past, may be one of the most import-
ant links of the transmission chain. Education and vaccination for
HBV is our duty in order to prevent these infections in our coun-
try.
R2239 PolA PCR in syphilis diagnostic
M. Heroldova´, V. Woznicova´
Brno, CZ
Objectives: Treponema pallidum, causative agent of syphilis, cannot
be cultivated in vitro. Although serology is a valid tool for syphilis
diagnosis in most cases, there are still some situations in which
the determination of the disease is very difﬁcult, e.g. at the begin-
ning of infection or in reinfection. Polymerase chain reaction
(PCR) as a direct detection method is very useful in such circum-
stances. However, serum samples taken for routine serological
diagnostic were found to be less suitable for PCR, since spirochet-
es are trapped in cloths.
Method: We put into practice polA PCR for DNA detection of
T. pallidum and examined 52 routine clinical specimens (49 serum
samples, 2 lesion swabs and 1 liquor) from persons in different
phases of syphilis.
Results: T. pallidum DNA was detected in three serum samples
(one syphilis primaria, two syphilis secundaria) and in one lesion
swab.
Conclusions: These data suggest that treponemal DNA is detect-
able not only in blood (as indicated by previous studies) but in
serum as well. Moreover, we report an interesting case of DNA
positivity in an adequately treated; patient 3 months after the
treatment in our study.
R2240 Amoxicillin-clavulanic acid in treatment of urethral
infections
J. Jordanoski
Prilep, MK
Objectives: Urethral infections are very frequent in young popula-
tion. We present our results with one drug treatment.
Materials and Methods: 62 male patients, aged among 16–24 years.
No fever, with disuric symptoms, Le<10  10/9/L, piuria, ure-
thral secretion. In neither of them, therapy was not given prior to
infection. Treatment was with amoxicillin–clavulanic acid oral,
1 g/bid, for 10 days. We performed urethral samples in all of
them three times: in the stage of disease, immediately after treat-
ment and 1 month after.
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Results: In ﬁrst group of 75% patients we isolated Streptococus fae-
calis and Escherichia coli. Second group of 15% was with Escheri-
chia coli, while third group of 10% was with Streptococus faecalis.
Amoxicillin–clavulanic acid was sensitive in all group of patients.
Follow up urethral samples showed complete healing in 69%
patients in ﬁrst group, while in second and third group success
was almost 95%.
Conclusion: Our results point toward very efﬁcient treatment with
amoxicillin–clavulanic acid in urethral infections. Recommended
dosage is 1 g/bid for 10 days.
R2241 Microscopic examination of vaginal discharge
specimens for Trichomonas vaginalis and other micro-organisms
in 18–45 age group women
R. Kesli, M. Ozdemir, O. Gunenc, E. Coskun, M. Baykan,
B. Baysal
Konya, TR
Objectives: Trichomonas vaginalis is a protozoon that causes tricho-
moniasis which characterised with a foamy yellowish odorous
discharge and superﬁcial defects and necrotic ulcers in vaginal
mucosa. Trichomoniasis is transmitted from human to human with
sexual contact and can be seen in almost every part of the world.
The aim of this study was to determine incidence of Trichomonas
vaginalis in 18–45 years age group women with vaginal discharge.
Seventy vaginal discharge specimens obtained from women who
applied to gynaecology Outpatient Clinic of Social Insurance Ins-
tution Hospital with vaginal discharge complaints in duration of
September 1 to December 15 2003.
Methods: Samples were taken from posterior forninx of vagen
with the help of a speculum and sterile cotton swabs. All the
samples examined by wet mount preparations, gram staining
and giemsa staining method under the light microscope. Wet
mount preparation were examined with 20 and 40 magniﬁca-
tion, the stained preparations were examined with 100 magniﬁ-
cation.
Results: Trichomonas vaginalis was seen in 6 (9%) of 70 speci-
mens; ﬁve of them were detected by three methods but one of
them detected by only wet mount preperation. Trichomonas vagi-
nalis most frequently observed between 25 and 35 years old
women. Of seventy samples 9 (13%) were positive for Gardne-
rella vaginalis, only one was positive with Mobiluncus spp. and
11 (16%) were positive for Candida spp. With Gram staining
method.
Conclusion: On the basis of our study, it is possible to say that in
spite of deﬁnite diagnosis of trichomoniasis made by cultivation
method, examining vaginal smear with direct microscope also has
an important role in the diagnosis of this infection. Fascilating
and shortening the time needed for the diagnosis of trichomonia-
sis with direct microscopic examination will help to decide and
begin the treatment of this infection.
R2242 Features of vaginal and intestinal microbiocenosis
of young women with menstrual function disturbances
T. Kolesova, N. Sarapulova, O. Odintsova, A. Galaktionov
Perm, RUS
Objectives: To study the vaginal and intestinal microbiocenosis
status in patients with menstrual function disturbances in child-
bearing age.
Methods: There were 57 women of childbearing age under super-
vision: 15 – with normal menstruations (I group), 22 patients –
with hypomenstrual syndrome (II) and 20 – with hypermenstrual
syndrome (III). Estimation of vagina and intestinal microbioceno-
sis status was carried out with the use of cytomorphological and
bacteriological methods.
Results: According to the results of cytomorphological analysis of
vaginal smears, in II and III groups of supervision, inﬂammation
changes with predominance of coccus ﬂora are registered in 50%
of cases. Indications of bacterial vaginosis in patients of these
groups are found in 3.5–4 times more often (P < 0.01), than in I
group. It is necessary to emphasise, that the mixed-infections are
most typical for the women with hypomenstrual syndrome: com-
bination of cytological features of bacterial vaginosis with mor-
phological features of chlamydiasis and DNA-virus infections
(HPV and herpes simplex). Thus contamination of women by Chl-
amydia and DNA-viruses was registered in 100% of cases. Dur-
ing the study of vaginal microbiocenosis in II and III groups of
patients, disbiothical disturbances which deal with the presence of
Enterobacteriaceae sp. and Candida sp. were most frequently
(P < 0.01) marked. It is typical that the concentration of Lactobacil-
lus sp. in III group of women was much lower (P < 0.01) than
those in I group. The degree of weight of intestinal microbioce-
nosis changes was less expressed. However, disbiothical changes
of intestinal biotope was met twice more often in II group of
patients in comparison with I. In this case disbiothical shifts are
caused by increase frequency presence of E. coli (lac) and
(haem+).
Conclusion: Hipomenstrual syndrome is characterised by disbioth-
ical disturbances in the structure of vaginal and intestinal biotops
in combination with Chlamydia sp. and DNA-virus genital infec-
tions. Disbiothical changes typical for the hypermenstrual syn-
drome abounded by the vaginal biotop.
R2243 Chlamydia trachomatis infections in a Northwestern
Greece population
S. Levidiotou, G. Vrioni, C. Gartzonika, N. Hita, D. Stefanou
Ioannina, GR
Objectives: Worldwide, Chlamydia trachomatis is one of the most
common sexually transmitted bacterial pathogens. The aim of the
present study was to determine the prevalence of C. trachomatis in
adult women and men in Northwestern Greece using a highly
sensitive PCR-based diagnostic assay.
Methods: 2672 symptomatic and asymptomatic women aged 18–
55 years and 214 symptomatic men aged 18–65 years not attend-
ing sexually transmitted disease (STD) clinic were enrolled in this
study from November 1998 to December 2003. Two types of spec-
imens were collected from each patient: cervical swab and ﬁrst-
void urine (FVU) from women, urethral swab and FVU from
men. All these specimens were examined with the automated
ampliﬁcation system: PCR Cobas Amplicor, CT-PCR test (Roche
Diagnostic Systems). Also, laboratory diagnosis for common
STDs, and collection of demographic information and behavioural
data were performed. According to our results, C. trachomatis
was detected in 46 women (1.72%) and 10 men (4.67%). As
regard female population, 65% of them were married, 64% did
not use condom, 12% were pregnant. Most commonly identiﬁed
sexually transmitted pathogens were Gardnerella vaginalis (45%),
and Candida (14%), while Trichomonas vaginalis infection was
found in 3%, and HPV in 0.5% of the women tested. As regard
male population, 51% of them were married, 73% did not use
condom, and one man had coinfection with N. gonorrhoeae.
Among patients with C. trachomatis infection, the majority of them
(88%) were young (under 30 years), 67% of them reported more
than one sexual partner within the last year, and 94% of the
women had urogenital symptoms. As regard the type of speci-
men, cervical swab specimens were slightly more sensitive than
FVU for the detection of C. trachomatis infection in women, and
FVU compared with urethral swab in men. In case of couples tes-
ted, screening males alone detected 80% of the infected couples.
After appropriate treatment, all C. trachomatis infected patients
had negative result in the follow-up visit. Repeated infections
with C. trachomatis were not detected. In conclusion, the preval-
ence of C. trachomatis infection in our geographic area is low. In
standard clinical practice, there is need to screen both males and
females, and test two types of specimens, urogenital swab and
urine.
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R2244 Occurrence of bacterial vaginosis, Mycoplasma
hominis and Ureaplasma urealyticum among women infected
with Chlamydia trachomatis
M. Romanik, D. Friedek, A. Ekiel, G. Martirosian
Katowice, PL
Objectives: We compared two groups of women infected and non-
infected with Chlamydia trachomatis to evaluate the frequency of
bacterial vaginosis (BV), Mycoplasma hominis and Mycoplasma urea-
lyticum.
Methods: Under investigation were 55 sexually active nonpregnant
women aged from 18 to 53 years old (the average age ¼ 29). Vagi-
nal swabs were collected for the diagnosis of BV, using Amsels’
criteria: – presence of ‘clue cells’ (vaginal epithelial cells so over-
laid with bacteria that cell border was obscured) – amine ‘ﬁshy’
odour upon mixing alkalinising vaginal ﬂuid with one drop of
10% KOH solution – pH greater than 4.5 – thin, homogenous,
milky vaginal discharge Endocervical swabs were collected for
C. trachomatis and urogenital mycoplasmas detection using Chla-
mydia Direct IF assay (bioMerieux, France) and Mycoplasma IS-2
assay (bioMerieux, France), respectively.
Results: Signiﬁcantly more cases of BV and urogenital mycoplas-
mas were found among women infected with C. trachomatis com-
pared with non-infected group.
Conclusion: Infection with C. trachomatis appears to be a risk factor
for occurrence of BV and urogenital mycoplasmas among women
in reproductive age. This suggests the necessity of using of appro-
priate diagnostic procedures. BV is associated with different com-
plications among pregnant and also non-pregnant women in
reproductive age. Amsels’ criteria are useful for rapid diagnosis
and appropriate treatment of BV.
R2245 Micro-organisms associated with bacterial vaginosis
and vaginal ﬂora changes in part of the population of
adolescent and adult women
L. Perdochova, P. Milosovic, P. Pavlik, A. Zakova, D. Huckova,
F. Ondriska, G. Vozarova
Bratislava, SK
Objectives: Evaluation of associated micro-organisms isolated from
the lower genital tract in part of the population of adolescent and
adult women in gynaecological ambulances.
Methods: Samples from vaginal and endocervical ﬂora of 383
women in the age from 17 to 58 years were diagnosed applying
direct detection method (Chlamydia trachomatis RNA detection),
nonspeciﬁc and speciﬁc culture isolation (Trichomonas vaginalis,
Neisseria gonorrhoeae, nonspeciﬁc aerobic and anaerobic ﬂora,
Lactobacillus sp., Gardnerella vaginalis, detection and identiﬁcation
of Candida sp., culture of Mycoplasma hominis and Ureaplasma urea-
lyticum.
Results: 37 adolescents (17–19 years) and 346 adult women (20–
58 years) were studied in the year 2003. Most frequently isolated
micro-organisms were U. urealyticum (22.3%), both M. hominis and
U. urealyticum (15.0%) followed by Candida sp. (12.7%). In 7.3%
were isolated both U. urealyticum and Candida sp. Mobiluncus sp.
was detected in direct smears in 3.0%. Anaerobes were isolated in
8.3%, Gardnerella vaginalis in 4.3%. C. trachomatis RNA was detected
only in 9 cases (2.3%). Typical sexually transmitted patogens (N.
gonorrhoeae and T. vaginalis) were isolated only in 1 case (0.03%).
Conclusions: A high prevalence of M. hominis and U. urealyticum is
remarkable, but their pathogenic role is not clear. In 52.3% sam-
ples with U. urealyticum was isolated Lactobacillus sp., which is
considered as a normal vaginal ﬂora. Vaginal candidosis is also
important, 6 species of Candida was detected, of which Candida
albicans is dominant (81.6%). Low prevalence of T. vaginalis,
N. gonorrhoeae, C. trachomatis and G. vaginalis is remarkable. Wide
analysis of all potentional pathogens is useful, all correlations can
be considered and interpretated succesfully.
Molecular virology (incl. diagnostics)
R2246 HBV genotypes in a selected group of patients
hospitalised in provincial hospitals in Lublin, Poland
B. Rajtar, M. Ziaja-Soltys, M. Polz-Dacewicz
Lublin, PL
Objective: The aim of present study was to determine the viral
genotypes in the chosen group of patients in different hepatitis B
stages.
Materials and methods: There were sera samples collected from 20
patients (3 women and 17 men) hospitalised in province hospitals
in Lublin. The patients’ age ranged from 10 to 75 years. Firstly,
HBV DNA level was examined in each sample by using commer-
cial molecular hybridisation kit (Digene Hybrid Capture System
HBV assay). Then the viral genotypes were detected according to
Inno-LiPA HBV DR Ampliﬁcation and Inno-LiPA HBV genotyp-
ing (Innogenetics) manufacturer’s instructions. QIAamp DNA
Mini Kit (Qiagen) was used for isolation viral DNA from the sera
samples.
Results: All studied sera were positive for HBV DNA. HBV geno-
type A was the most common in studied samples. It was deter-
mined in 16 (80%) patients. There was genotype D detected in 3
(15%) samples and both genotypes A and D were present in 1
(5%) serum.
Conclusions: Our results are similar to these presented by other
authors maintaining that the genotype A is the most common in
north – west of Europe.
R2247 Detection of enteroviruses, adenoviruses and
rotaviruses in sewage with nested RT- PCR
G. Komninou, A. Vantarakis, D. Venieri, E. Kouskouni,
M. Papapetropoulou
Patras, GR
Objectives: Enteroviruses, adenoviruses and rotaviruses are
incriminated for a lot of epidemics of gastroenteritis constituting a
signiﬁcant problem for the public health. The viruses resist in all
the common methods of sewage treatment that are applied in the
most biological treatment plants. Aim of present work is the
detection of these viruses in sewage of Attica and Achaia regions.
The sampling was performed in the period between July 2001 and
January 2003 from the entries of the biological treatment plants of
Psitallia and Patras.
Methods: For the detection of these viruses, molecular techniques
such as RT-PCR and nested PCR were used, that have signiﬁcant
sensitivity and speciﬁcity. Initially, the condensation of the sample
was performed with centrifugations and ultracentrifugation, in
order to isolate the viruses. Followed, isolation of RNA of entero-
viruses and DNA of adenoviruses with adsorption of nucleic
acids in aluminium particles. For the isolation of rotaviruses, a
speciﬁc RNA isolation kit was used (QIAGEN). For the detection
of viruses, RT-PCR and nested PCR was used with the use of suit-
able primers. The size of the 1st PCR products was 301 bp for
adenoviruses, 540 for enteroviruses, 1062 for rotaviruses, while in
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the nested PCR the sizes were 143 bp for adenoviruses, 123 bp for
enteroviruses and 189 bp for rotaviruses. For the evaluation of
reliability of the method positive markers were used supplied by
CEFAS, Weymouth, UK. For rotaviruses, positive samples were
from patients with gastroenteritis were used. In the end, PCR
products were visualised by electrophoresis in agarose gel 2%.
Results: 50 samples of untreated sewage were processed. All three
viruses were detected with the methodology used. Concretely, 19
samples were found positive for enteroviruses (38%), 42 samples
were found positive for adenoviruses (84%) and 19 samples were
found positive for rotaviruses (38%). The positive samples for a-
denoviruses were typed and found to be all adenoviruses 40 and
41.
Conclusion: Increased isolation of adenoviruses in the untreated
sewage strengthens the opinion for their utilisation as indicators
of virological pollution of environment. It was the ﬁrst time to
detect rotaviruses in sewage.
Viral diseases
R2248 Clinical complications of norovirus infections in
patients with severe underlying disease: a new syndrome of
norovirus infection?
F. Mattner, M. Koopmans, D. Sohr, P. Gastmeier
Hannover, D; Bilthoven, NL; Berlin, D
Introduction: The effects of Norovirusinfections have been des-
cribed as a short self-limiting disease. An investigation of a Noro-
virus outbreak in an universitiy hospital provided evidence for
severe complications in patients (pts) with severe underlying dis-
eases.
Methods: Attack rates were determined. Clinical outcomes were
deﬁned: >1 day diarrhoea, >1 day vomit, creatinine rises >10%,
potassium decrease >20%, CRP >56 mg/mL. Risk factor analyses
regarding underlying diseases and medication have been per-
formed using multivariate analyses. A norovirus infection syn-
drome was deﬁned using the sum of possible clinical outcomes as
a score for severity.
Results: Five wards experienced NV outbreaks in the period from
November 1, 2002 to January 31, 2003. These wards belonged to
the following departments: psychiatry, nephrology, gastroenterol-
ogy, cardiology and traumatology. In 5 outbreak wards 84
patients and 60 nurses had been infected and revealed an overall
attack rate of 32% (pts) and 76% (nurses), respectively
(P < 0.0001). 71 patients acquired nosocomial infections. 23 pts
showed clinical symptoms longer than 48 h, 14 pts developed
relapses, 3 pts needed haemodialysis, 1 pt needed cardioversion
for three times, creatinine increases >10% were seen in 22 pts,
potassium losses >20% in 7 pts, observed CRP levels were high
(median 58 mg/mL). Age >65 years (OR 12.6, CI95 2.0–243 for
prolonged course), immunosuppressive therapy (OR 22.7, CI95
3.7–449 for at least 4 possible positive outcomes), cardiovascular
disease (OR 17, CI95 2.2–401 for potassium decrease >20%), renal
transplant (OR 13.8, CI951.7–298 for potassium decrease >20%)
had been determined as risk factors for above deﬁned outcomes.
Conclusion: The high attack rates of Norovirus infections demon-
strates a high contagiosity of this virus-variant. In contrast to
healthy people Norovirus infections in hospitalised patients may
lead to severe consequences forming a certain new syndrome.
Therefore strict infection control measures should be applied.
R2249 Q-fever in Bulgaria in contemporary conditions
S. Martinov
Soﬁa, BG
Q-fever is most important rickettsiosis in Bulgaria. Observed are a
large number of sporadic cases and many epidemics covering
from several tenths to hundreds of sick persons. The rickettsiosis
is established on the territory of the whole country. A great num-
ber of epizootics among the domestic animals were described. In
humans Q – fever is observed in two essential forms: acute –
mainly atypical pneumoniae and chronic – Q-rickettsial endocar-
dites. During 1993–2000 years 14 353 sera from patients were tas-
ted for antibodies against C. burnetii II phase. The positive
reactions were 14.97%. In most of the sick persons no risk ele-
ment was found. A process of decrease of cases of Q-rickettsial
pneumoniae is observed. During the same period are discovered
and traced 22 patients with Q-rickettsial endocardites (1.02% of
the acute forms). During the last years is obvious a tendency to
decrease the number of the seropositive against C. burnetii domes-
tic animals. In 1989–2002, 226 085 sera from cattle, sheep and
goats were investigated and the seropositive were 5.17%. Highest
is the percentage of positive goats – 7.19%. For comparison – dur-
ing 1950–1976 years the seropositive animals were 17.56% (23 259
samples tested) and in 1977–1988 the positive were 14.79%
(38 470 tested). Those are periods of reforms in the Bulgarian agri-
culture.
R2250 Measles virus genotypes in Belarus
A.V. Atrasheuskaya, E. Blatun, A. Antonikovskaya, A. Neverov,
N. Maksimov, S. Kameneva, I. Karpov, G.M. Ignatyev
Novosibirsk Region, RUS; Minsk, BLR
Objectives: The European Regional Ofﬁce of WHO has targeted
measles for elimination from the region in 2007. In view of the
goal of measles elimination, it is of great importance to assess the
circulation of wild-type measles viruses (MV). However, there is
no available information on measles virus genotypes circulating in
Republic of Belarus. Measles cases admitted to the Hospital of
Infectious Diseases of Minsk (Belarus) within 2002–2003 have been
prospectively analysed. Clinical, routine laboratory, as well as se-
rological and virological examination of 13 patients hospitalised
with the diagnosis of measles infection has been carried out.
Patients, 16–25 years of age, had different history of vaccination
against measles. The work has been done in the framework of a
grant BTEP ID#16, 2002.
Methods: Patients’ clinical and routine laboratory data were collec-
ted prospectively. Paired serum specimens obtained from these
patients were examined at the SRC VB ‘Vector’ (Russia). Serum
specimens were assayed for the presence of MV-speciﬁc antibod-
ies using commercial test kits. Differential analysis with rubella
was carried out. Measles virus infection was conﬁrmed by RT-
PCR. Two primers speciﬁed for the hyper variable part of the N
gene were used for RT-PCR. The nucleotide sequence analysis
(Beckman Coulter XL-2000 DNA Analysis System) was carried
out.
Results: All 13 measles cases described here were laboratory con-
ﬁrmed. Sequence analysis revealed that genotype A was mostly
present in 2002. Isolates belonged to MV genotype D6 and D7
were identiﬁed through 2003. Retrospective analysis of clinical
manifestations showed measles infection caused by D6 and D7
virus genotypes had a more severe and prolonged course of the
disease in comparison with measles infection caused by A virus
genotype. Serological investigation revealed only D6 and D7 geno-
types caused MV-speciﬁc IgM appearance and four-fold MV-spe-
ciﬁc IgG growth in paired serum samples. The clinical cases of A
genotype MV infection revealed no IgM appearance within the
initial course of the disease, and IgG growth no more than 2–3-
fold.
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Conclusion: D6 and D7 MV genotypes have been registered in
Minsk (Belarus). These MV genotypes caused more severe disease
with the manifested antibody response, while A genotype caused
a milder disease with a weaker antibody response.
R2251 Heterologous expression of the HPV16.E6 increases
the resistance to stress
A. Pinto Oliveira de, T. Gonc¸alves
Coimbra, P
The malignant phenotype of high-risk types human papillomavi-
rus depends mainly on the expression of two viral genes, E6 and
E7. If control of E6 is lost, this protein can trigger immortalisation
of cells and cancer. The aim of this study is to determine if E6
protein changes the response of yeast to stress, as a model of euk-
aryotic cell immortalisation. In the present work we expressed
HPV16 E6 (pYES2.E6) in S. cerevisae in order to study the response
to thermal stress, to pheromone recovery, and to caffeine treat-
ment. The heterologous expression of E6 in yeast results in a
higher resistance towards caffeine, but there are no changes when
the cells are incubated in high temperatures. In what regards
pheromone treatment, E6 expressing cells are able to overcome
the cell cycle arrest, albeit exhibiting the morphogenetic altera-
tions due to the presence of pheromone. Since the protein kinase
C is a central protein in the general response to stress a deleted
mutant in PKC1 was transformed with pYES2.E6, in order to
study the suppression of the increased resistance to stress. The
subcellular localisation of the protein E6, under stress conditions,
is studied by co-localisation of the fusion protein E6-GFP, using
an inducible (pYES2) and a constitutive (pUG35) system. The
results obtained points to the conclusion that the heterologous
expression of E6 in the yeast S. cerevisiae leads to an increased
resistance to stress, showing that E6 interacts with speciﬁc compo-
nents of the biochemical machinery of yeast cells.
R2252 Evaluation of thyroid functions during interferon-
alpha treatment of patients with chronic viral hepatitis
M. Sunbul, E. Sahbat, M. Akkus, S. Esen, H. Kahraman,
H. Leblebicioglu
Samsun, TR
Objectives: Recombinant interferon-alpha (IFN-alpha) is used in
the treatment of chronic viral hepatitis. During IFN-alpha treat-
ment thyroiditis, Graves’ disease, permanent hypothyroidism can
develop. This retrospective study is designed to determine the fre-
quency of thyroid disease that is seen during IFN- alpha treat-
ment of patients with chronic hepatitis.
Material and Methods: We investigated the frequency of thyroid
functions in 182 patients with chronic viral hepatitis treated with
IFN-alpha in Department of Clinical Microbiology and Infectious
Diseases. 90 (49.6%) patients had chronic hepatitis B (CHB) and
92 (50.9%) of them had chronic hepatitis C (CHC). Thyroid hor-
mones levels were determined before, during (3 and 6 months)
and after (6 months) treatment.
Results: 62 (68.9%) of CHB patients were male and 28 (31.1%)
were female. The median age was 34  11 years (range 17–62). 37
(40%) of CHC patients were male, 55 (60%) were female and the
median age was 49  11 years (range 19–65). Thyroid dysfunction
was found in 10% of all patients. The incidence of thyroid dys-
function was 6.7% in CHB whereas 15.2% in patients with CHC
(P ¼ 0.1). Among these cases, 16 of 20 were females (80%) and 4
were males (20%) (P < 0.02. OR ¼ 5.6). In 12 patients hyperthyr-
oidism was detected and the others had hypothyroidism. In two
patients, hyperthyroidism antithyroid treatment was required
after the cessation of IFN-alpha treatment. Among the patients
with hypothyroidism, only one case necessitated hormonal repla-
cement. Spontaneous remission was observed in other patients.
Conclusions: Thyroid dysfunction is commonly seen among
patients with chronic viral hepatitis who receive IFN-alpha; there-
fore, close follow-up of these patients should be recommended.
R2253 Determination between recent and past
cytomegalovirus infection
D. Cvetkovik, T. Grdanoska, M. Petrovska, N. Panovski,
K. Cvetkovik
Skopje, MK
Introduction: The detection of virus-speciﬁc IgG and IgM antibod-
ies is of great value in the diagnosis of acute/primary CMV infec-
tion in women during their reproductive period. If both anti CMV
IgG and IgM are detected in ﬁrst monitoring, it is not possible to
clearly deﬁne whether or not infection event is going in the
patient as IgM may last for months from primary infection. Anti-
bodies with low avidity are detectable at a very early stage of
infection whereas high avidity antibodies indicate past infection.
Material and methods: A total of 51 sera from patients with diagno-
sis ‘spontaneus abortion’ were examined with ImmunoLISA CMV
IgG, IgM, and CMV IgG Avidity (Orgenics, Israel). This tests is
assigned for simultaneus detection of speciﬁc, IgG and IgM anti-
bodies for CMV. Anti CMV antibodies are treated with a denatu-
rating agent, able to dissociate low afﬁnity bound IgG antibodies
from the coated antigen.
Results: Speciﬁc anti CMV antibodies were detected in a total of
51 examined sera. Positve for speciﬁc IgM antibodies were only 2
sera(4%). As for the avidity of detected IgG antibodies in 49
(96%) sera the value was high, while in only 2(4%) the value was
low, indicating possible resent infection. Simultaneous presence of
both classes of antibodies could indicate anamnestic information
of previous infection, where IgM antibodies are residual or on-
going acute/primary infection.
Conclusion: The analysis of gained data, showed that positivity to
speciﬁc CMV IgG antibodies is frequent. Due to the rare detection
of low avidity index of these IgG positive determinated sera, we
agree with the recommendations for implication of this avidity
test mostly in the individuals belonging to the groups: pregnant
women and transplantated patients.
AIDS and HIV infection
R2254 Gynaecomastia in a vertically-infected adolescent
treated since birth
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Objective: gynaecomastia is an emerging untoward event of HIV
infection treated with antiretrovirals. Although ﬁrst related to pro-
tease inhibitors (PI) and eventual associated dysmetabolism, it has
been recently reported also in patients (p) who abandoned PI-
based HAART or never received PI.
Case report: At the age of 13.5 years, a p with congenital HIV
infection developed a true, sonography-conﬁrmed bilateral gynae-
comastia associated with local paresthesia. Developmental mile-
stones and pubertal stage were within normal limits. Chronic
kidney-liver disease and administration of drugs potentially rela-
ted to gynaecomastia were carefully excluded. An endocrinologi-
cal workout did not detect any gonadal, hypophyseal and thyroid
abnormality and prolactin proved normal. Notwithstanding the
absence of HIV-related disorders, at the age of 5 our p started
anti-HIV therapy due to increasing viremia. During the 8.5-year
follow-up, 5 different lines were administered including HAART
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regimens based on ritonavir, nelﬁnavir and lopinavir/r. Stavudine
(61 months) was the nucleoside analogue (NA) administered for
the longest time. At the time of onset of gynaecomastia (8 months
ago), a negligible viremia was retrieved (280 HIV-RNA copies/
mL) while CD4+ count was favourable (848 cells/lL). Clinical
alterations included in the deﬁnition of the lipodistrophy syn-
drome and abnormalities of lipid-glucose metabolism were never
detected. gynaecomastia did not show signiﬁcant modiﬁcations
during the 8-month monitoring.
Discussion: Our case report is exceptional, since among 	80 litera-
ture cases of gynaecomastia described in HIV-infected p, none
emerged in paediatric–adolescental age. Both pathogenesis and
evolution of gynaecomastia are increasingly investigated and spe-
cial attention is deserved to relations with dysmetabolism and the
fat redistribution syndrome (all absent in our report), as well as
antiretroviral agents. In the reported p, NA were administered
during 8.5 years, and PI during 7 years while non-NA reverse
trascriptase inhibitors were never used. While all PI were
involved in the described cases of gynaecomastia, among NA
stavudine seems to be the most frequent drug although biases
due to the common resort to this last compound in HAART com-
binations, cannot be excluded. Our p represents the ﬁrst case of
true gynaecomastia reported in pediatric HIV disease. The
absence of dysmetabolic and lipodistrophy alterations makes the
pathogenesis uncertain
R2255 HIV-Infected patients: detection of HIV-1 drug
resistance-associated mutations
A. Suarez, B.A. Sanchez, J.J. Picazo
Madrid, E
Objectives: Drug resistance mutations in the human immunodeﬁ-
ciency virus type 1 (HIV-1) Reverse transcriptase and protease
genes lead to lower sensitivity to antiretroviral agents and are
an important cause of drug failure. The aim of this study was
evaluating the presence of mutations in antiretroviral treated
patients.
Methods: The plasma of 314 HIV-1 infected patients were ana-
lysed. Plasma of patients were collected for genotyping analysis
to identify resistance mutations in reverse transcriptase and Prote-
ase regions using ABI ViroSeq HIV-1 genotyping system. Changes
in susceptibility were assessed by a computer program that inter-
prets drug resistance: Standford database (http//:/hivdb.stand-
ford.edu/hiv/).
Results: On the HIV-1 Reverse Transcriptase region 1097 muta-
tions were detected, 717 (65.36%) of them were primary muta-
tions correlated with high level of drug resistance. On the
Protease gene 1091 mutations were found, 749 (68.65%) of them
were secondary mutations. Wild codons were determined in
9.23% (29/314) on the Reverse Transcriptase region and 7.32%
(23/314) on the Protease gene. Genotyping was not available
because not enough cDNA were obtained in 22 (7%) sam-
ples. Presence of mutations related with high-level of resistance
were detected: 141 to Zidovudine, 128 to Lamivudine, 183 to No-
nucleoside RT inhibitors and 223 to Protease inhibitors.
Conclusion: The detection of key mutations associated with HIV-1
antiretroviral resistance is very useful because it enhances clinical
management, but further studies and more data are needed to
ﬁnd more relevant clinical procedures.
R2256 Evolution of HIV-1 resistance mutations in patients
on antiretroviral therapy
A. Suarez, B.A. Sanchez, J.J. Picazo
Madrid, E
Objectives: Antiviral drug resistance testing is being incorporated
increasingly into daily clinical management of HIV-1 infected
patients since the emergence of drug resistance is an important
limitation of antiretroviral therapy.
Methods: We examined the evolution of drug resistance mutations
in 11 therapy-experienced patients who had three resistance test
separated by a mean of 12 months (range 4–15). Plasma of
patients was collected for gentyping analysis to identify resistance
mutations in Reverse Transcriptase and Protease regions using the
ABI ViroSeq HIV-1 genotyping System with interpretation of anti-
retroviral susceptibility by the Standford database.
Results: The median viral load (copies/mL) and mean number
of mutation/patient for the ﬁrst, second and third time-points
were 204 000, 5.5; 122 000, 6.1 and 211 000, 8.1, respect-
ively. On the HIV-1 Reverse Transcriptase region 202 muta-
tions were detected, 84 of them were primary mutations
correlated with high level of resistance. Most common muta-
tions observed were on codons 67 and 215 (22) and 181 and
190 (14). On the Protease region 222 mutations were found, 166
of them were secondary mutations. Prevalent mutations
involved substitutions at codons 10 (21), 63 (31), 71, 26 and 90
(23). High prevalence of nucleoside inhibitors resistance-associ-
ated mutations was determined in eight of the 11 patients con-
tinuosly. Multinonucleoside-resistance was present in every
patient during all the study. Eight of the studied patients had
mutations associated with Protease inhibitors resistance from
the beginning.
Conclusion: The use of resistance test may signiﬁcantly improve
the selection of optimal treatment regimens for patients after fail-
ure of previous therapies.
R2257 Nodular regenerative hyperplasia, new
HIV-associated disease?
Y. Douadi, F.X. Lescure, V. Daneluzzi, I. Dadamessi, F. Brazier,
A. Smail, J.L. Schmit
Amiens, F
Many liver diseases have been described in HIV patients, some
of them are due to HIV treatment. We report one case of liver
disease not recognised as drug side effect. A 59-year-old
woman, known to be infected with HIV infection presents a
chlostatic hepatitis compatible with the diagnosis of nodular
regenerative hyperplasia. Nodular regenerative hyperplasia
(NRH) of the liver is well described and characterised grossly
by diffusely nodular liver resembling micronodular cirrhosis.
Nevirapine-induced hepatitis occurrs shortly after drug initiation
in patients with and without pre-existing liver disease. Signiﬁ-
cant elevations in liver enzyme levels occurr but resolve
promptly in most cases with discontinuation of the nevirap-
ine. NRH has never been reported previously in HIV infection
and at the moment there are no NRH associated with nevirap-
ine side effect.
R2258 Immune reconstitution without antiretroviral
therapy in patient with AIDS and tuberculosis
C. Jianu, C. Itu, D. Tatulescu, R. Iubu
Cluj-Napoca, RO
Objectives: Tuberculosis has a negative inﬂuence on HIV infection,
enhancing the viral replication and accelerate the progression of
HIV disease. We report a case of immune reconstitution under
antituberculous therapy in a patient with AIDS and lymph nodes
tuberculosis, without HAART.
Methods and results: A 29 years old male, heterosexual, non-drugs
user was admitted in our hospital for fever, lymphadenopathy
and loss of weight. He presented: fever, dry skin, submaxillary
and laterocervical lymphadenopathy (6/4 cm), left axillary lymph
nodes, tachycardia (120/min), TA ¼ 120/80 mmHg. Also he had
inﬂammatory syndrome (ESR ¼ 120–130mm/h, leukocyto-
sis ¼ 10100/mm3, CRP ¼ 3.65 mg/dL), blood cultures were neg-
ative for usual strains (BacT/Alert). Positive ELISA for HIV was
conﬁrmed by Western Blot and CD4 count was 102/mm3. Cervi-
cal ultrasonography examination showed many right cervical
648 Abstracts
lymph nodes disposed in cluster with medium enhanced echoge-
nity. The abdominal ultrasonography examination showed lymph-
adenopathy in the liver’s hila above 1.6 cm and retropancreatic.
Lymphoma was excluded by haematological examination. Lymph
nodes histopathology showed small granuloma containing macr-
ophage cells with epithelioid character and 1–2 giant multinucle-
ated Langerhans cells, suggestive for lymph node tuberculosis.
Tuberculosis has conﬁrmed by histopathology. We couldn’t do
blood cultures for mycobacterium and the cultures from lympha-
denopathy biopsy remained negative. The patient was under
antituberculous therapy in association (isoniazid + rifampin + eth-
ambutol + pyrazinamide); he didn’t receive any antiretroviral
therapy. After 2 months of antituberculous therapy, lymphaden-
opathy and ESR decreased, leukocyte was 6800/mm3
(PMN ¼ 71%, lymphocytes ¼ 27%, monocytes ¼ 2%) and CD4
count increased 263/mm3. After 7 months of antituberculous ther-
apy, re-evaluation showed: lymphadenopathy disappeared,
ESR ¼ 30–50 mm/h, leucocytes ¼ 4500/mm3 (PMN¼50%,
lymphocytes ¼ 40%, monocytes ¼ 5%, eosinophiles ¼ 5%) and
CD4 count was 241/mm3. Ultrasonographic, lymph nodes with
vascularisation, necrosis and calciﬁcation were described.
Conclusions: Despite the severe immunosupresion, probably the
lack of other coinfections produces a satisfying immune
response after 7 months of antituberculous therapy. Therapy of
tuberculosis as associated infection in AIDS patients can pro-
duce immune reconstitution even in the absence of antiretrovi-
ral therapy
R2259 HIV-related pulmonary hypertension. A case report
and literature review
P. Panagopoulos, G. Koratzanis, G. Poulakou, S. Kopanakis,
I. Katsarolis, A. Antoniadou
Athens, GR
Background: Isolated pulmonary hypertension is a rare manifesta-
tion of HIV infection, with a reported frequency of 0.5% among
HIV infected patients. To date more than 200 symptomatic cases
have been reported. Diagnosis is not related to CD4 count or
HIV-RNA levels, prognosis is unfavourable and the mean survival
is 6 months. Standard therapy includes oxygen administration
and vasodilating agents. Sildenaﬁl has also been used since 1998.
The effect of HAART is unknown.
Purpose: To report a new case of HIV-related pulmonary hyper-
tension in an asymptomatic patient presenting with low oxygen
saturation.
Case presentation: 36-year-old male, heavy smoker (60 pack/
years), diagnosed as HIV-positive 5 years ago (CDC stage C3),
with poor compliance to antiretroviral treatment. He presented
in the outpatient HIV clinic totally asymptomatic. His vital
signs were normal except for low O2 saturation (85–88%). Clin-
ical ﬁndings were unremarkable, and his laboratory tests and
electrocardiogram normal. His CD4 count was 24/mm3 and
HIV-RNA 1 500 000 copies/mL. The high-resolution chest CT
showed emphysematic lungs and spirometry revealed ﬁnal
bronchiolar disease without obstructive pulmonary disease. The
transthoracic cardiac ultrasound documented severe pulmonary
hypertension (systolic pulmonary arterial pressure 	63 mmHg).
He refused to undergo pulmonary catheterisation. All risk fac-
tors for secondary pulmonary hypertension were excluded in
this patient (addiction to iv drugs, interstitial pulmonary dis-
ease, chronic obstructive disease or acute infection) and the
diagnosis of HIV-related pulmonary hypertension was estab-
lished. Diltiazem and HAART regimen were administered, but,
once discharged from the unit, he did not adhere to the treat-
ment. Eight months later, he is hospitalised due to worsening
dyspnoea.
Conclusion: HIV-Pulmonary Hypertension should be included in
the differential diagnosis in patients with pulmonary hyperten-
sion and respiratory failure, despite the absence of typical symp-
toms.
R2260 Invasive infections in Romanian HIV patients
S.M. Erscoiu, O. Dorobat, D. Duiculescu, L. Raduta, P. Calistru,
E. Ceausu
Bucharest, RO
Objectives: To monitor the frequency of bacteraemia and fungae-
mia as well as spectrum of pathogens isolated in blood cultures of
HIV infected patients admitted in our clinic.
Methods: We evaluated the results of blood cultures using
BACT/ALERT automated systems and the resistance of patho-
gens isolated from HIV infected teenagers and adults, during
06/2002–12/2003. Antimicrobial susceptibility tests were per-
formed by the disk diffusion methods according to the NCCLS
standards.
Results: Of the total of 457 blood cultures, 30 were positive
(6.56%), isolated from 29 patients Three pathogens were isolated
only in one patient ( Enterococcus faecalis, Pseudomonas aeruginosa
and Staphyloccocus aureus). The mean age of teenagers was
15 years and of adults were 34 years, 23 men and 10 females.
gram-negative micro-organisms consisted 50% of pathogens and
the most of them were Salmonella spp. (23.33%), the second being
Haemophilus Inﬂuenzae (13.33%). Bacteroides fragilis was isolated
only from one patient. The others were E. coli, Shigella spp., Klebsi-
ella pneumoniae, each of them 3.33%. Cryptococcus neoformans
(26.67%) has been isolated in patients suffering from meningitis
or only fungaemia (3.33%). gram-positive micro-organisms (30%),
in particular Staphylococcus spp. (26.67%) were the other patho-
gens. All the patients suffered from severe immunodeﬁciency
(value of CD4 lymphocites count was <200/mmc). No patients
received antiretroviral therapy. Carbapenems, vancomycin, teico-
planin, linesolid were the most sensitive drugs. Trimethoprim/
sulphamethoxazole, a prophylactic drug was resistant for most of
micro-organismes. The fungal isolates were sensitive to all anti-
fungal drugs, except ﬂucytosine. Sepsis and fungal meningitis
were the most frequent cause of death, 69% of patients being still
alive.
Conclusions: Gram-negative bacteria (especially Salmonella spp.
and H. Inﬂuenzae) and Cryptococcus neoformans are isolated from
HIV infected pacients in most of cases. The high resistance rates
were found in Pseudomonas aeruginosa and some Staphylococcus
spp. All Cryptococcus neoformans were resistant to ﬂucytosine, two
of them becoming resistant to ﬂuconazole during the treat-
ment. HAART therapy and Hib vaccinations can improve the
prognosis of severe immunocompromised HIV patients.
R2261 Efﬁcacy and safety of the combination of tenofovir
and didanosine as a backbone regimen
P. Panagopoulos, A. Antoniadou, G. Poulakou, I. Katsarolis,
A. Papadopoulos, H. Giamarellou
Athens, GR
Background: Tenofovir, as a Nucleotide analog Reverse Transcrip-
tase Inhibitor, is one of the new antiretrovirals used in HAART.
Since Tenofovir (TFV) combinations have only recently been in
use, there is a lack of clinical data regarding to the co-administra-
tion of didanosine (ddI) and TFV.
Objective: To record the results of an antiretroviral regimen con-
taining ddI+ TFV as backbone in terms of HIV-RNA levels and
CD4 cell count and safety
Methods: Eleven (11) HIV (+) patients (10 males), with a mean age
of 43.9 years (range 30–72) were studied retrospectively. A combi-
nation of TV (245 mg) and ddI (250 mg) was administered with
either a PI (most commonly lopinavir/ritonavir) or efavirenz.
Results: Among the 11 patients, only 1 was nave, 8 were classiﬁed
as CDC stage A, 1 stage B and 2 stage C. The mean baseline val-
ues for CD4 and viral load were 283 c/mm3 and 375 172 c/mL
(4.34 logs), respectively. After a mean time of 18.5 weeks (range
8–36) under the new regimen the patients had mean CD cell count
373 c/mm3 and HIV-RNA mean value of 14326 c/mL (2.36 logs).
Fasting administration of ddI was always followed. One patient
discontinued medication due to gastrointestinal adverse events
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and a second one performed poor compliance. Only one patient
presented mild hypophosphotemia.
Conclusions: Co-administration of TFV and ddI (250 mg) seems to
be effective in experienced HIV(+) individuals. The use of didano-
sine at reduced dose was not associated with adverse events or
signiﬁcant toxicity.
R2262 C-reactive protein: which role today in infectious
diseases?
M. Bassetti, M. Vassallo, M.J. Majabo, F. Vitale, V. Del Bono,
D. Bassetti
Genoa, I
Objectives: C-reactive protein (CRP) is a marker of acute or chro-
nic inﬂammation, routinely used in the clinical practice; it repre-
sents a more speciﬁc and precocious value of diseases activity if
related to erythrocytes sedimentation rate. PCR is signiﬁcantly
higher in certain diseases as sepsis, pneumonia, osteomielytis and
prosthetic joint infections and is also related to the severity of ill-
ness but results lower in immunocompromised patients (pts).
Methods: We prospectively analysed a group of patients admitted
to our department in the period January 2002–October 2003; we
included the following conditions: pneumonia, sepsis, meningitis,
soft tissue infections, orthopaedic infections and HIV+ pts with
concomitant infections. We considered the following parameters:
gender, age, cause of admission, CRP at the admission and sero-
logical status for HIV. For our study we used a multi-way analy-
sis of variance.
Results: We considered 125 pts (50 females), mean age 48 years
(range 16–85), sorted in six different diseases: 32 pneumonia (13
HIV+), seven sepsis (1 HIV+), 18 meningitis (all HIV), nine soft
tissues infections (all HIV), 15 orthopaedic infections (one HIV+)
and 44 pts HIV+ with diseases others than the previous. CRP
mean value at admission for each pathology was: 75.5 mg/L in
pneumonia (99.3 in HIV and 44.2 in HIV+), 195.7 mg/L in sep-
sis (158.7 HIV and 418 HIV+), 66.5 mg/L in meningitis,
130.4 mg/L in soft tissues infections, 80.8 mg/L in orthopaedic
infections (86.3 in HIV and 4.2 in HIV+) and 37.7 mg/L for
HIV+ with other pathologies. The mean CRP value for HIV pts
was 102.0 mg/L signiﬁcantly higher then the mean CRP value
(38.6 mg/L) observed in HIV+ pts (P < 0.05). We found a signiﬁ-
cant correlation between CRP and diseases analysed; there were
higher values in sepsis, soft tissues infections and pneumonia.
Conclusions: Our study conﬁrms the importance of CRP in monit-
oring infectious diseases, especially in sepsis, soft-tissue infections
and pneumonia, where the CRP is signiﬁcantly higher than in
others infections. Besides we found relevantly lower the CRP
value in HIV infections: this conﬁrms the literature’s data about
the role of immunodepression and hepatic comorbidities in lower-
ing CRP. However, if we compare the causes of access in hospital
in HIV+ and HIV pts, we have to consider that in the ﬁrst group
there are more cases which could be cured as outpatients, and
that could partially explain this great difference in PCR value.
R2263 Role of Chlamydia pneumoniae in atherosclerotic
plaques seen in HIV-positive patients treated with different
antiretroviral regimens
P. Maggi, R. Monno, G. Epifani, F. Perilli, A. Lillo, G. Losacco,
G. Pastore
Bari, I
Vascular complications have been described in HIV-positive
patients treated with highly active antiretroviral regimens (HA-
ART). Protease inhibitors (PI) have been associated with the onset
of metabolic disturbances, including lipodystrophy and it has
been suggested that may play a role in determining an athero-
sclerotic damage of the vascular wall. Recent appreciation of
atherosclerosis as a chronic, inﬂammatory disease has rekindled
efforts to examine the role that infectious agents may play in
atherogenesis. Several infectious agents have been implicated as
likely culprits of atherosclerosis, being Chlamydia pneumoniae the
most suspected. To evaluate the possible role of C. pneumoniae in
the pathogenesis of atherosclerotic plaques in HIV-1 positive indi-
viduals, we have detected the presence of antibodies to C. pneumo-
niae in 59 HIV-infected patients: 30 (group A) with carotid
plaques and 29 (group B) without carotid lesion. Sixty-two
healthy individuals were the control group. Regarding the antiret-
roviral treatment, six patients of group A were naives to antiretro-
viral therapy, three were treated with NNRTI based regimens, 21
with PI based regimens. Among group B, 10 patients were naives,
two were treated with two NRTI, two with three NRTI, nine were
treated with NNRTI-based regimens, ﬁve with PI-based regimens.
All patients in groups A and B treated with antiretrovirals were
in stable therapy from at least 12 months. The patients were eval-
uated also for the presence of independent risk factors, such as
cigarette smoking, alcohol consumption, cholesterolaemia and tri-
glyceridaemia. No signiﬁcant correlation in the C. pneumoniae
seroprevalence and titer (IgG and IgA) was observed between
group A and group B and between these two groups of patients
and the control group. Patients using PI seem to be more prone to
have atheroma in comparison with the HIV-positive patients trea-
ted with NNRTI (P < 0.0001). In conclusion, in HIV-positive
patients, the serological status for C. pneumoniae is not associated
to development of atherosclerosis. Analysing the role of therapy
with PI and other well known risk factors for the development of
cardiovascular disease, it seem that the antiretroviral therapy may
play a pivotal role in the development of cardiovascular diseases
involving, in our study, the epiaortic vessels conﬁrming similar
evidences reported in the literature.
R2264 Response of HIV-positive patients to the long-term
salvage therapy by LPV/r
J. Prejdova´, L. Machala, M. Linka, M. Bruckova´, J. Vandasova´,
M. Stankova´, J. Konvalinka
Prague, CZ
Objectives: The cohort of 19 protease inhibitor (PI) experienced
patients was followed for the period of up to 37.5 months, during
the years 2000–2003. Changes of HIV-1 RNA plasma level and
CD4+ count were monitored and evaluated with regard to the
baseline characteristics.
Methods: The HIV-1 RNA plasma level was determined by a
quantitative RT-PCR; the CD4+ cell count was determined by
FACS. Analysis of the protease-coding region was performed by
direct sequencing of the PCR product (derived from the patient’s
peripheral blood mononuclear cells or plasma).
Results: First virologic and immunologic values were determined
after 3 months of therapy. Nine patients achieved complete sup-
pression of viral load, ﬁve patients showed only partial supres-
sion (at least by 1 order of magnitude) and ﬁve patiens did not
respond at all. The increase of CD4+ count closely corresponded
to decrease of viral load. Median increase by 100 cells/mL was
detected for patients with undetectable viral loads, 40 cells/mL
for patients with partial suppression and median decrease by
40 cells/mL in cases of virologic failure. Further analysis of
patients’ response lead to redistribution of patients to two groups:
‘responders’ – nine patients who exhibited complete suppression
of viral replication for the period of up to 37.5 months and ‘non-
responders’ – 10 patients who experienced virologic failure on
LPV/r treatment. The high incidence of negative predictive factors
such as lopinavir mutation score higher than ﬁve, prior use of
more than 3 PIs and occurrence of I54V mutation correlated with
long-term virologic failure. The distribution of these factors was
not signiﬁcant from the short-term point of view. On the contrary,
the correlation of positive factors (low lopinavir mutation score,
association with efavirenz and occurence of V77I mutation) with
decrease of viral load was more signifﬁcant in the short-term ana-
lysis.
Conclusion: The results of LPV/r salvage therapy showed to be
encouraging. 47% of patients from our study achieved stable sup-
pression of viral replication accompanied by signiﬁcant improve-
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ment of CD4+ count for 31 months on average. Furthermore, the
LPV/r proved to be potent inhibitor despite unfavourable progno-
sis, even though the effect lasted only few months.
R2265 The occurrence of CCR5 del32 and CCR2B alleles in
HIV-1 positive persons in the Czech Republic
D. Sedlacek, I. Subrt, M. Hejnalova, M. Stankova´, S. Snopkova,
J. Kolcakova, V. Chmelik
Pilsen, Prague, Brno, Ostrava, C. Budejovice, CZ
Objectives: Chemokine receptors CCR5 and CCR2 are important
surface coreceptor structures, which are reported to inﬂuence the
course of HIV-1 infection. It is known that people homozygous
for mutated CCR5 gene are HIV-1 resistant due to nonexpression
of CCR5, and the course of infection is delayed in heterozygotes.
However, 64I mutation of CCR2 gene (CCR2B) was found to
delay disease progression but not to reduce infection risk. Our
study was aimed to detect the frequency of both CCR5 del32 and
CCR2B alleles in the HIV-1 positive persons in the Czech Repub-
lic.
Methods: Genomic DNA samples from peripheral blood of 158
HIV-positive patients from ﬁve AIDS centres were analysed by
PCR and PCR-RFLP method, as we previously reported, for the
presence of CCR5 del32 and CCR2B alleles.
Results: CCR5 32-bp heterozygous deletion was present in 17.7%
samples, homozygous genotype was not found. Of 26 samples tes-
ted for the presence of CCR2B allele two samples were found to
be heterozygous and one homozygous. The analyses of additional
samples are continuing.
Conclusion: Our data on CCR5 del32 are similar to data from other
Western Europe HIV-1 positive populations. Our preliminary
ﬁndings on CCR2B suggest lower frequency than previously pub-
lished. We suggest examination of all HIV-positive patients for
the presence of CCR5 del32 and CCR2B alleles before the start of
the treatment with C–C antagonists in the future. Our work was
supported by grants of Ministry of Health 96/55 and by Charles
University VZ 111 4 0000 5.
R2266 Infections (non-AIDS) in a HIV-positive population
A. Marin, D. Blanco, M. Fernandez-Delgado, E. Molina, D. Olivo,
A. Maeso, J. Piqueras
Cartagena, E
Apart from the opportunistic infections that deﬁne AIDS, group
HIV shows a greater incidence of certain concomitant infections
than the general population, in relation to the route of infection.
We studied the existence of syphilis, hepatitis C virus (HCV),
cytomegalovirus (CMV) and herpes simplex virus type 2 (HSV-2)
in a group of 764 carriers of our sanitary area (311.720 people,
prevalence of 2451/100 000 inhabitants). The analytical tech-
niques of FTA-ABS, EIA, W-B, LIPA, etc., have been the habituals
ones of laboratory. Among HIV positive group, 93 cases (12.2%)
of syphilis have been diagnosed (six with positive serology also in
CSF), predominating in men (77.4%) with average age of
38.7 years old (24–64 rank), on women (average age 34.0 years,
rank: 21–43 years). In the infection by HCV, the co-infection is of
151 cases (19.8%), fundamentally genotype 1 (54.3%), 3 (23.8%)
and 4 (19.2%), corresponding the 82.8% to men with average age
of 37.9 years old, without difference of age withing the female
gender. In 17 cases (2.2%) there were coinfection by both virus,
mainly in men (76.5%). It was detected CMV in 416 carriers
(54.5%), mainly in men (75.5%), with an average age of 37.1 years
old, against 31.4 years old in women. The infection by HSV-2 was
present in 35.4% of the infected ones, being men 65.7% with an
average age higher than the women (40.8 and 33.3%, respect-
ively). Our conclusion is that there are a high rate of prevalence
in the infection by HIV among ower population, and coinfection,
fundamentally with CMV, HSV-2 and HCV, emphasising the last
one because of it aggravates the prognosis of the infection by
HIV, interfering in the treatment and increasing its mortality
remarkably.
R2267 Experience with lopinavir: solution vs. pills
J.L. Prada, J. De La Torre, A. Del Arco, J. Aguilar, F. Moreno,
J.M. Arango
Marbella, E
Objective: Lopinavir (LPV) is a protease inhibitor (PI) which is
available both in solution (SOL) and pills (PL): 5 mL bid vs. three
pills bid, so the solution seems to have a kinder adherence. We
want to study the LPV treatments and compare the SOL and the
PL treatments, considering indications, tolerability and efﬁcacy.
Method: Retrospective study of all the LPV treatments from
December 2001 to February 2003 in the HIV unit of the Costa del
Sol Hospital, a general hospital in Andalucia (South of Spain)
attending to 400 HIV-infected patients.
Results: A total of 59 patients have received LPV. Mean age:
42.9 years (30–59), 19 female (34%) and 40 male (71%). Mean
time from HIV diagnosis: 11 years. Risk: 44 (74.7 %) drug-abus-
ers, 11 (18.6%) heterosexuals and four (6.7%) homosexuals.
Three patients consumed toxic actively. CDC stage: C3: 40, A3:
8, A2: 5, B2: 2, B3: 2 and C2: 2; so 50 (89%) <200 CD4/mm3.
Adherence: 18 (30.5%) <80%, 8 (13.5%) 80–90%, 16 (27%) 90–
95% and 17 (28.8%) >95%. LPV indication: in >75% de patients
it was up a second line of treatment (32% after simpliﬁcation
procedure) and only seven (12.5%) were naives. 34 weeks tend
to treat analysis: 20 (33.9%) remain with viral load <50 copies/
mL, nine (15%) virological failure, three (5%) have died, six lost
of outcome, 2 (3.4%) needed therapy intensiﬁcation, six (10%)
repudiated the treatment, in 11 the outcome is not complete. We
have indicated 39 LPV-SOL (66.1%) and 20 LPV-PL (33.8%).
From 39 LPV-SOL, 16 (41% total SOL) must be stopped, switch-
ing to PL, mainly by gastrointestinal intolerance, and four of
them left deﬁnitely. From 20 LPV-PL, two left the treatment and
two were switched to SOL in order to improve the adherence,
with good tolerance in both.
Conclusions: In our group LPV is used as treatment after a simpli-
ﬁed regimen (32%) and in very hard conditions by adherence,
immunological stage and previous treatment. Although it is few
cases, we have found no differences in efﬁcacy between SOL and
PL. The SOL is in general worse tolerated than PL, but for many
patients it used is more gratify (only 5-mL bid vs. three pills bid),
so we think that it must be probe as initial way in-patients with
adherence problems.
R2268 Long-term survival and intermittent interruption of
antiretroviral therapy in a HIV-positive individual with
HIV-related pulmonary hypertension
A. Zinkernagel, J. Overbeck von, M. Opravil, R. Jenni, R. Speich,
N. Mu¨ller
Zurich, CH
Introduction: Pulmonary arterial hypertension related to HIV (PA-
HRH) is a rare complication of HIV infection. Treatment is difﬁ-
cult with a median survival of 6 months. Prospective studies have
shown a beneﬁt of antiretroviral therapy (ART). We report a
patient with PAHRH with long-term survival, in whom lipodys-
trophy necessitated interruption of ART.
Case report: A 34-year-old HIV-positive male was diagnosed with
PAHRH 10 years ago. Echocardiography revealed a right ventric-
ular systolic pressure 59 mmHg over right atrial pressure (RV/
RA-pressure). Therapy consisted of sorbidilat, digoxin and couma-
rin. At the same time, ART was started with AZT, then changed
to 3TC, d4T and indinavir. He remained stable until 5 years later
when he complained of worsening dyspnoea. Echocardiography
revealed increased enlargement of the right ventricle (RV/RA-
pressure 75 mmHg). An ACE inhibitor was added and ilumedin
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with clinical improvement, but ilumedin was stopped after
6 months due to severe headaches. Clinically, he regained the
level before deterioration; and the echocardiographic ﬁndings
returned to the previous values. ART was successful with a CD4
cell count >1000 cells under a persistently nondetectable viral
load. A signiﬁcant worsening of the lipodystrophy was noted and
therefore indinavir was switched to nevirapine. The lipodystrophy
progressed further to the point where the patient was severely
handicapped, not being able to hold his head upright due to a buf-
falo hump. Given the excellent CD4 values and the progressing
lipodystrophy, ART was stopped. One month after discontinu-
ation, the viral load had risen to >2  106 copies/mL. The CD4
count had fallen from 1882 to 1215 cells. Dyspnoea remained sta-
ble, as did the 6 min walking test and the echocardiographic exam-
ination (RV/RA-pressure 24 mmHg). After 7 months, the patient
wished to resume ART. Tenofovir, nevirapine and ddI were star-
ted, subsequent evaluation of PAHRH showed stable disease.
Conclusions: In this patient with long-term survival after diagnosis
of PAHRH, interruption of ART did not result in worsening of
PAHRH. Despite a rise in viral load and fall of CD4 cells, clinical
and echocardiographic parameters remained stable for a follow-up
of 7 months. If treatment interruption is considered a close follow-
up is warranted to detect early signs of deterioration of PAHRH.
Interruption should be reserved if no alternatives are available.
R2269 Mutational pattern in failing patients to
antiretroviral regimen including tenofovir
S. Garcı´a-Bujalance, C. Ladro´n de Guevara, J.R Arribas,
J. Gonzalez, A. Gutie´rrez
Madrid, E
Objective: To evaluate the resistance mutational pattern in antiret-
roviral-experienced patients including tenofovir in their therapy
regimens.
Material and methods: Twenty plasma samples from 20 HIV-1
infected patients were analysed for drug resistance. All the
patients were followed at the La Paz University Hospital, Madrid,
Spain. All the patients failed treatment with a mean viral load of
17 793 cop/mL (range 385–83 100). The CD4+ cell count ranged
from 15 to 977/mL, with a mean of 422/mL. The disease stages
CDC were as follows: 31.6% (C3), 21.1% (B3), 15.8% (C2) and
10.5% (A2, A3, B2). The 90% (n ¼ 18) of the patients received a
previous therapy regimens with zidovudine or stavudine. 16
patients received more than three therapy regimens. Only in two
cases did not receive any nucleoside analogues reverse transcrip-
tase inhibitor (NRTI). Sequencing of the protease gene and RT
gene was performed by the TruGene HIV-1 assay (Visible Genet-
ics, Toronto, Canada), following the manufacturer’s recomenda-
tions. Sequences were compared with the HIV-1 LAV1 reference
sequence. We analysed the selection of K65R mutation (selected
by tenofovir in vitro) and the accumulations of nucleoside ana-
logues mutations (NAMs).
Results: The frequency of the mutations were as follows: K65R in
45%, M41L in 40%, D67N in 30%, K70R in 15%, L210W in 30%,
T215Y/F in 55% and K219Q/E in 25% of the patients. The data
analysis are showed in Table 1.
Conclusions: Clearly, there are two mutational patterns in failing
patients to antiretroviral regimen including tenofovir: one with
K65 R alone mutation and the other with NAMs without K65R.
It’s conﬁrmed that K65R is negatively associated with the NAMs.
Hepatitis
R2270 Vertical transmission of hepatitis C virus in the
Czech Republic
J. Hobstova, L. Roznovsky, I. Capovova, J. Taborska, E. Vecerova
Prague, Ostrava, Brno, Pilsen, Havirov, CZ
Objectives: By the method of multicentre study to determine the
incidence of vertical transmission of the hepatitis C virus in chil-
dren who were born to mothers who suffer from hepatitis C.
Methods: From the year 2001 to 2003, we analysed a group of 73
children who were born to mothers who suffer from hepatitis C.
Of the 73 children who made up the analysis group, a determin-
ation as to whether or not vertical transmission occurred could be
made in 51 cases. Of the remaining 22 children, either they had
not reached the age of 18 months when a determination as to ver-
tical transmission could be made, or we were no longer able to
continue follow-up testing as the mothers stopped attending our
clinic. We collected blood samples from umbilical cord, and at the
age of 3, 6, 12, 18, 24 months, and in the affected children at 3
and 4 years of age. All the children were tested for the presence
of hepatitis C antibodies using the ELISA method, and when
possible we tested the children for RNA HCV using the RT-PCR
method. We evaluated vertical transmission positive if at least
two blood samples were tested positive for RNA HCV or if anti-
HCV antibodies persisted longer than 2 years of age.
Results: In our analysis we determined vertical transmission to
have occurred in seven of 51 cases analysed. Four of these seven
children were PCR-positive at the age of 2 years. The remaining
two of these seven children continued to test positive for hepatitis
C antibodies. One of the affected children lost viraemia and the
antibodies at the age of 1 year.
Conclusions: Vertical transmission occurred in seven of 51 cases
analysed (13.7%). We can state that the presence of RNA HCV in
umbilical cord blood or in the blood of 3-month old children does
not necessarily mean that vertical transmission has occurred. Fur-
thermore we can state that testing positive for viraemia at the age
of 6 months more than likely indicates the presence of vertical
transmission as well as the presence of antibodies at the age of
18 months.
R2271 Genotype analysis of chronic hepatitis C patients in
correlation with ways of contagion and patients’ origins
C. Drakoulis, S. Nikolaou, E. Nikitidis, L. Karassavidou,
S. Georgoulas, B. Koroneos, M. Minadaki
Piraeus, GR
Our objective is the study of chronic hepatitis C genotype expres-
sion and its correlation to ways of contagion and the patients’ ori-
gins. Our material consists of 64 patients of chronic hepatitis C
(42 men, 22 women, average age 39 years old). An analysis of
hepatitis C genotype was held and the correlation to the ways of
contagion and the patients’ origins was studied.
Results: See Tables
Conclusions: The main ways of contagion appears to be the intra-
venous administration of drugs and a considerable number of
patients refers to sporadic cases. In the category of drug addicts,
genotype 3 is prevailing, while in the category of the sporadic
cases there is a greater extent of heterogeneity – thing which
emphasises the heterogeneity of the group in itself. In the groups
NAM without K65R 11 patients (55%)
T215Y/FþK65R alone 0
K65R alone 9 patients (45%)
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of contagion through sexual intercourse and blood transfusion,
there seems to be an equal allotment of genotypes. Finally, the
group of the other ways of contagion appears to be inﬂuenced by
the other groups and is allotted between genotypes 2 and 3, prob-
ably because the carrier transmitting the virus belongs to these
groups. As regards the origins of the patients, and though the
cases are not equally allotted, it appears that there is a differenti-
ation between the Greeks and the immigrants. So the vast major-
ity of the Greeks is allotted between genotypes 2 and 3, while the
immigrants are allotted among genotypes 1, 2 and 3 (genotypes 1
and 3 showing a slightly higher percentage).
R2272 Relationship between the level of basal
antigenaemia of HCV and hepatic affectation in HIV patients
I. Guilabert, S. Garcinun˜o, M.A. del Pozo, J. Arias, T. Alvarez
Gago, B. Sanchez Borge, M.A. Manteco´n, M.A. Bratos, A. Ordun˜a,
A. Rodrı´guez Torres
Valladolid, E
Objective: The aim of this work is to study the relationship
between the antigenaemia (core Ag) of HCV and the rate of hep-
atic ﬁbrosis in patients HCV–HIV coinfected prior the treatment.
Materials and methods: We have studied the levels of HCV antigen
(HCV-Ag) in 22 sera from 22 patients with chronic hepatitis C by
ELISA (Ortho trak C assay, Ortho Clinical diagnosis, Raritan, NJ,
USA). The degree of hepatic ﬁbrosis was studied by the histologi-
cal activity rate (HAR-Metavir) in hepatic biopsy.
Results: Nine (40.9%) of 22 patients have antigenaemia levels
<100 pg/mL. Seven (77.8%) of these patients have a severe hepa-
tic affectation: ﬁve (55.6%) have a severe HAR-Metavir (degree 3)
and two have a cirrhosis HAR-Metavir (degree 4); and the rest
two patients have a moderate HAR-Metavir (degree 2). Six
(27.1%) patients have antigenaemia levels from 101 to 175 pg/
mL: three (50%) have a slight HAR-Metavir (1) and the three
other a moderate HAR-Metavir (2). Seven (40.9%) patients have
antigenemia levels higher than 175 pg/mL: one (14.3%) patient
has a slight HAR-Metavir (1), and six patients have a moderate
HAR-Metavir (2)
Conclusion: There is a decrease of antigenaemia with the increase
of hepatic affectation (HAR-Metavir) in HCV–HIV coinfected
patients.
R2273 Persistence of HBV-DNA in children who cleared
HBsAg after IFN treatment
K. Dzierzanowska-Fangrat, H. Gregorek, M. Woynarowski,
P. Jozwiak, D. Dzierzanowska
Warsaw, PL
Objectives: The aim of this study was to assess the long-term clin-
ical and virological response in children with chronic hepatitis B
who cleared HBs antigen during IFN-a treatment.
Material and methods: Twenty-seven children who cleared HBsAg
during IFN treatment were available for repeated clinical and
virological evaluation on the average 8 years (range 7–10 years)
after completion of therapy. Serological markers of HBV infection
were assessed by use of commercial tests AxSYM (Abbott). HBV-
DNA was detected in serum and immune complexes using HBV-
Sharp Signal System (Digene).
Results: All children were in good clinical condition without any
clinical or biochemical symptoms of liver disease. Two patients
(7%) had detectable HBsAg in serum, and one of them was also
positive for anti-HBs. The remaining 25 patients were HBsAg-neg-
ative, anti-HBs-positive. HBeAg was negative in all subjects,
whereas anti-HBe antibodies were present in 16 children. HBV-
DNA was detected in 11 (40%) children, mainly in a form of
immune complexes.
Conclusions: Our data suggests that HBV replication may persist
for years after antiviral therapy-induced clearance of HBsAg.
R2274 Seroprevalence of HBV markers in medical
students
B. Tosevski, L. Ivanovski, D. Dimitriev, M. Gaseva, V. Grunevska,
C. Evtimovska, M. Dimzova, K. Grozdanovski
(Skopje, MK)
Republic of Macedonia is a region with intermediary seropreva-
lence of HBV (2–4%) and interfamilial and sexual transmission as
a dominant routine. Universal vaccination of newborns is the only
cost-beneﬁt measure for prevention. In Macedonia vaccination is
not routinely undertaken due to economic reasons, although from
1990 we vaccinated a high risk groups such as health care work-
ers and medical students. For them HBV infection is professional
disease.
Objective: To present seroprevalence of HBV markers in medical
students and determining additional risk factors.
Material: This study was performed in two phases: phase I inclu-
ded 110 medical students (80 female, 30 male) age range 22–27
(median 24.5), testing ALT and HBV markers (HBsAg, anti HBc
total and antiHBs by ELISA, Behring Processor II.). If they had
normal ALT levels and negative HBV markers entered phase II
and 77 students were vaccinated on voluntary basis. Demographic
and personal characteristics including anonymous survey for sex-
ual contacts, were analysed for this group.
Results: From 110 medical students, eight (7.3%) had conﬁrmed
previous contact with HBV, three (2.7%) of them are HBsAg carri-
ers. 37/77 (48.1%) have previous nurse training school and all of
them performed bloody medical interventions while studying.
12/77 (15.5%) during clinical training as students also practiced
medical interventions. 58/77 (75.3%) have regular sexual partner:
29/58 (50%) with safe sex practicing, 19/58 (32.8%) using inter-
mittent and 10 (17.2%) do not use any kind of protection. 17/77
(22.1%) had irregular partners: 11/17 (64.7%) with constant, ﬁve
of 17 (29.4%) occasional and one of 17 (5.9%) with no protection
at all. Two of 77 (2.6%) without sexual contact. No drug users
among analysed students, and only one with piercing and tattoo.
Conclusion: Starting 2004, routine vaccination for all newborns will
take place in Macedonia and issue of additional group for vaccin-
Table 2. Allotment according to genotype and origins
Genotypes 1 2 3 4
Greeks 13 (28.3%) 9 (19.0%) 22 (47.8%) 2 (4.35%)
Immigrants 6 (33.3%) 4 (22.2%) 7 (38.8%) 1 (5.6%)
Table. Distribution of patients by HCV antigenaemia level and
degree of hepatic affectation (HAR-Metavir)
HAR-Metavir
Ag
(pg/mL)
Slight
(1) No.
Moderate
(2) No.
Severe
(3) No.
Cirrhosis
(4) No.
0–100 0 2 5 2
101–175 3 3 0 0
> 100 1 6 0 0
Spearman’s Rho: )0.703.
Table 1.
Genotype
1
Genotype
2
Genotype
3
Genotype
4
Intravenous Drug
Administration
5 0 23 0
Sexual intercourse 1 1 0
Blood transfusion 4 2 2 2
Nor determined
contag on way
7 4 6 1
High risk groups 0 2 1 0
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ation and its timing is actualised. Higher prevalence among med-
ical students suggests that vaccination should be initiated at the
beginning of nurse high school (inexperience and frequent practic-
ing of medical interventions) and before sexual activity, due to
high per cent of unsafe sex practicing, attacking same age group.
R2275 Serum HBV-DNA levels, serum aminotransferases
levels and serological markers in evaluation of chronic HBV
infection
C. Psillaki, P. Mamasi, A. Ifantidou, H. Chaidouli, T. Varnis,
A. Kansouzidou
Thessalonica, GR
The course and outcome of chronic HBV infection are variable.
Chronic HBV infection is also associated with an increased risk of
developing hepatic cirrhosis and hepatocellular carcinoma. The
recognition and diagnosis of this disease are supported by the
detection of HBV antigens and speciﬁc HBV antibodies. Quantita-
tive determination of viraemia levels in sera contributes to the
management of patients chronically infected with the HBV. The
aim of this study was to investigate the clinical signiﬁcance and
the disease progression in chronic HBV infection by the quantita-
tive determination of HBV-DNA, detection of serological markers
and determination of aminotransferases levels.
Material and methods: Serum samples (320 samples in total) of 235
patients, 4–73 years old, (225 adults, 10 children) with different
stages of chronic HBV infection were examined over a 2-year per-
iod, 2002–2003. Serum HBV-DNA was measured by a quantitative
PCR (Amplicor HBV Monitor Test, Roche Diagnostic Systems).
Also, in all samples detection of serological markers (HBsAg, anti-
HBs, HBeAg, anti-HBe) and measurement of ALT/AST were per-
formed. Serological markers were determined by an enzyme-
linked immunoassay MEIA (AxSym3) and aminotransferases by
kinetic method.
Results: According to the results of this study, 55 patients (50
adults, ﬁve children) were evaluated as chronic active hepatitis B
cases, rate 23.4% (HBsAg+, HBV-DNA>105 copies/mL, persistent
or intermittent elevation of ALT/AST levels). In 47 of them
HBeAg and anti-HBe+ were found, while eight patients had
HBeAg+ and anti-HBe. Another group of 151 patients (146
adults, ﬁve children) were evaluated as inactive HBsAg carriers,
rate 64.3% (HBsAg+, HBeAg, anti-HBe+, HBV-DNA<105 cop-
ies/ml and persistently normal ALT/AST levels). The remaining
29 adults patients were evaluated as resolved hepatitis B cases,
rate 12.3% (HBsAg, anti-HBs+, HBV-DNA<400 copies/mL and
normal aminotransferases levels).
Conclusions: The combination of quantitative determination of
HBV-DNA by polymerase chain reaction, detection of serological
markers and aminotransferases levels contribute signiﬁcantly to
the management of chronic infection and evaluation of the efﬁc-
acy of antiviral therapy. The majority of the patients with chronic
active HBV infection (85.4%) were found to have HBeAg(). This
data coincides with other studies in Greece and Mediterranean
area where viral mutations occur and might inﬂuence the expres-
sion of HBeAg.
R2276 Evolution of haematimetric parameters during the
treatment of chronic virus C infection with interferon and
ribavirine in HIV-coinfected patients
A. Arizcorreta, C. Ramos, F. Brun Romero, E. Perez-Guzman,
R. Garcı´a-Juarez, C. Fernandez-Gutierrez, M. Montes de Oca
Arjona, M. Martı´n-Zamorano, J. Giro´n-Gonza´lez
Cadiz, E
Objective: Analysis of the evolution of the haematological series
during the treatment of chronic hepatitis HCV with interferon
alpha plus ribavirin in HIV-coinfected patients.
Methods: Twenty-one HCV and HIV-coinfected patients were trea-
ted with PEG-Interferon a-2a (11 patients) or standard interferon-a
(10 patients), plus ribavirin. Patients with abnormal count of each
of the haematological series were excluded. Hemoglobin concen-
tration and leucocytes and platelets counts were analysed at 2, 4,
6, 8, 12, 18, 24 and 48 weeks after the beginning of the therapy,
and 24 weeks after the end. The results are showed as median
and interquartile range.
Results: At baseline, median haemoglobin concentration and
lymphocytes, polymorphonuclear neutrophyles and platelets
counts were 14.3 g/dL (13.50–15.50), 2280/mm3 (interquartile
range, 2080–2780), 2790/mm3 (2260–3200), and 179660/mm3
(126000–217000), respectively. A progressive decrease of every
cell population was detected: polymorphonuclear neutrophiles
attained the nadir at 4 weeks after the beginning of the therapy,
with a median of 1400/mm3 (990–2350), and a diminution of
45% (18–67%). The rest of parameters attained the nadir at
12 weeks after the beginning: haemoglobin concentration,
12.95 g/dL (12–13.58); platelet count, 121 000/mm3 (95 000–
151 250); lymphocyte count, 1230/mm3. The respective diminu-
tions of these values were 9% (5–16%), 31% (16–45%) and 50%
(16–63%). The decline was independent of response to the treat-
ment, but was higher in the PEG-interferon-a-2a group. There
were not haemorrhagic or infectious complications. Cell counts
and haemoglobin concentration returned at baseline levels after
the end of treatment.
Conclusions: A signiﬁcant decrease in all haematological series
must be expected in HIV–HCV coinfected patients treated with
interferon plus ribavirin, with a higher decrease in those treated
with PEG-interferon. This diminution occurs in the ﬁrst weeks of
treatment, and return at baseline levels after the end of it.
R2277 Prevalence of lichen Planus in HCV-infected
patients in Guilan Province (Iran), 2002
M. Rabii, Z. Mohtasham Amiri
Rasht, IR
Background: Hepatitis c virus account for over 90% transfusion –
associated hepatitis, >50% likelihood of chronicity, leading to cir-
rhosis or hepatocellular carcinoma in 25%. With regard to the
controversy in correlation between HCV infection and oral lichen
planus in various geographic areas, this investigation was done to
determine the prevalence of oral lichen planus in HCV positive
patients in Guilan (Iran).
Materials and methods: In this cross- sectional study, 63 HCV infec-
ted patients in Guilan were examined. The authors made use of
an enzyme-linked immunosorbent assay (ELISA I´I´) and positive
samples rechecked with Western blot.
Results: In this study, there were 33 female and 30 male. The
mean age was 43.8  17.4 SD years. Three cases had reticular
form of oral lichen planus (4.7%) that this prevalence rate is
higher than normal population rate in this area (0.5–2%).
Conclusion: This study showed that oral lichen planus is prevalent
in HCV-infected patients and diagnostic tests for HCV-antibodies
may be requested in conﬁrmed lichen planus cases.
R2278 Lamivudine treatment in renal transplant recipients
with chronic hepatitis B
L. Roznovsky, I. Orsagova, A. Sulakova, A. Kloudova, I. Lochman,
L. Pliskova
(Ostrava, Hradec Kralove, CZ)
Objectives: Lamivudine appears to be safe and effective in the
treatment of chronic hepatitis B virus infection in patients with
chronic renal failure, though experiences are still limited. We des-
cribed our experiences with lamivudine treatment in six renal
transplant recipients with chronic hepatitis B.
Methods: Six renal transplant recipients (three male, three female)
aged 40–70 years suffered by chronic hepatitis B. All patients were
HBsAg positive, three of them were HBeAg positive. All were
HBV-DNA-positive, precore mutant was proved in three of them.
654 Abstracts
All patients had serum alanine transferase (ALT) levels 3–10 times
the upper limit of normal prior to treatment. Four patients had
anti-HCV antibodies, HCV RNA was positive in two of them.
Blood samples were assessed monthly after initiation of lamivu-
dine treatment and later every 3 months. Samples were tested by
ELISA for HBsAg, HBeAg, anti-HBe and anti-HCV; by using PCR
for HBV DNA and HCV RNA.
Results: Lamivudine treatment was administered in six patients
for 15–55 months. Initial dose 100 mg/day was given in ﬁve
patients, initial dose 35 mg/day was given in one patient with
partial renal insufﬁciency. The lamivudine dose was reduced (10–
50 mg/day) in four patients according to creatinine clearance. The
graft of one patient was rejected and haemodialysis treatment was
reinstituted. HBV DNA became undetectable in all patients within
1–6 months of initiation of lamivudine therapy. Serum HBeAg
disappeared in three patients during 2–17 months, with the emer-
gence of anti-HBe in all of them. No patient lost HBsAg. Serum
ALT normalised in ﬁve patients within 1–9 months. Continuing
elevation of ALT was observed in one patient with chronic hepati-
tis C and positive result of HCV RNA. Recurrence of chronic
hepatitis B was observed in the oldest patient 7 months after initi-
ation of lamivudine treatment. Lamivudine treatment continued,
but the women died 8 months later for progression of liver cirrho-
sis. No side-effects of lamivudine treatment was observed during
therapy.
Conclusion: Lamivudine treatment induced initial virological
response in all 6 renal transplant recipients with chronic hepatitis
B. Recurrence of hepatitis B with progression of liver cirrhosis till
death was observed in one patient. No evidence of hepatitis B
recurrence was proved in the other ﬁve patients with lamivudine
therapy during 2–4 years monitoring.
R2279 Distribution of hepatitis B virus genotype in
patients with chronic HBV infection
M. Christoﬁdou, F. Kolonitsiou, G. Dimitracopoulos
Greece, GR
Objectives: To study the distribution of HBV genotype in a group
of chronic HBV infected patients.
Methods: HBV serological markers, HBsAg, antiHBc total or IgM,
HBeAg or anti HBe were detected in sera of 36 chronic HBV-
infected patients (28 men and eight women, range age 30–
60 years) by enzyme immunoassay (MEIA Axsym Abbott)
whereas HBV viral load was determined by a branched DNA
method (HBV DNA 3.0 bDNA assay, Versant). HBV genotypes
were determined by using the ampliﬁed HBV polymerase gene
(HBV-pol gene), domains B to C in a reverse hybridisation assay,
LiPA (INNO-LiPA HBV Genotype, Innogenetics). The ampliﬁca-
tion of HBV- pol gene, domain B to C was done in two steps (i)
DNA was isolated from 500l of patients sera (QE´A´a´mp Ultrasens
Virus Kit Qiagen) (ii) part of the extracted DNA was ampliﬁed by
a nested polymerase chain reaction procedure, using primers
derived from HBV DNA pol-gene. LiPA is a line probe assay cap-
able to identify HBV Genotypes A to G.
Results: Three distinct HBV serological proﬁles were found among
the 36 chronic HBV infected patients Twenty-eight of them had
HBsAg (+) antiHBcIgG (+), IgM () and anti HBe (+) whereas
another three patients had the same ﬁndings but anti HBc IgM
(+). Five of the 36 patients had HBsAg(+) anti HBc IgG (+), IgM
() and HBeAg (+). HBV DNA was positive in sera of all 36
patients and the viral load was ranged from 1120  103–
120 000  103 copies/mL. Only genotypes D (97%) and F (3%)
were found among the 36 chronic HBV infected patients.
Conclusions: HBV genotype D and F are prevalent among chronic
HBV liver disease patients in our area. Thirty patients have HBV
genotype D which is associated with the serological proﬁle HbsAg
(+), anti HBC IgG (+), anti HBe (+). This serological proﬁle usu-
ally was found in HBV chronic infected patients who had HBV
precore mutant infection in our area. Such mutants are thought to
be associated with faster progression of chronic disease and even
with fulminant hepatitis. Precore stop mutations seems to be asso-
ciated with HBV genotype D.
R2280 Early use and long-term follow-up of interferon
therapy in acute hepatitis C cases
N. Baykam, B. Dokuzoguz, S. Eren, A. Celikbas
Ankara, TR
Introduction: Acute hepatitis C infection has a wild course, and
patients rarely seek medical attention, therefore the diagnosis of
the acute illness is difﬁcult.
Case reports: Two patients attended to hospital with jaundice. Case
1 had been infected 6 weeks previously when he had a haircut.
Case 2 had an abdominal operation 4 weeks ago and both cases
were seronegative for HCV before the exposures. On admission to
hospital, the alanine aminotransferase levels of cases were 2730
and 1410, and the aspartate aminotransferase level of cases were
1120 and 910, respectively. Case 1 and 2 were positive for anti-
bodies to HCV, and HCV RNA was detected in serum of patients
by polymerase chain reaction. Other hepatitis markers and auto
antibodies were detected as negative. HCV was speciated as geno-
type 1b in both cases. In both of the patients, interferon a`-2b was
administered as induction treatment for the ﬁrst 5 days with daily
5 MU and then 3 MU thrice-a-week for 24 weeks. Viral clearence
occurred after 2 weeks for case 1 and 2. Viral clearence of cases
sustained after 3 and 5 years of the treatment, respectively.
Conclusion: Early treatment of acute hepatitis C with interferon
alone with induction in ﬁrst 5 days, may be chance for preventing
chronic infection whether the genotype of virus is 1b, which gives
poorer response during treatment of chronic infection.
R2281 Seroprevalence of hepatitis E in Nahavand, Iran: a
population-based study
M. Zali, M. Taremi, A. Mohammadalizadeh, S. Mahmoudarabi,
S. Ansari, A. Ardalan
Tehran, IR
Background and objective: Hepatitis E virus (HEV) infection has rec-
ognised as the most common form of acute viral hepatitis among
young adults in many developing countries. However, commu-
nity-based surveys on this infection are scarce. This study looks at
the seroepidemiology of HEV infection in the city of Nahavand
(with 72 000 inhabitants), in the western part of Iran.
Subjects and methods: This cross-sectional study was conducted in
February of 2003 among people of age 6 years and over in Nahav-
and. The six urban regions of Nahavand were considered as strata
and 1824 subjects were recruited through a random stratiﬁed
sampling (304 subjects from each stratum). Questionnaires were
completed by face-to-face interview (including socio-economic
and demographic variables) and blood samples were taken and
tested for anti-HEV IgG using ELISA. STATA 8 was used to ana-
lyse data considering complex sampling design.
Results: A total of 799 males (43.8%) and 1025 (56.2%) females
were included (34.7  19.5 and 32 years as mean  SD and med-
ian of age, respectively). The overall seroprevalence of hepatitis E
was 9.6% (95% CI: 8.2–10.9). Seropositive subjects had mean and
median age of 42.6  15.6 and 40.5 years, respectively. Fifty-nine
of seropositive subjects (34.7%) were male, 55 of them (32.4%)
were illiterate and median of their family size was 4.0 persons.
The prevalence of anti-HEV IgG antibody was not equally distri-
buted among age groups with highest rate observable in the 30–
39-year-old subjects (30%). Seropositivity for anti-HEV IgG was
positively associated with age (OR ¼ 1.02;%95CI: 1.01–1.03), sex
(F/M) (OR ¼ 1.52,%95 CI: 1.09–2.11) and educational level (illiter-
ate/literate) (OR ¼ 1.81,%95 CI: 1.28–2.55). No association
observed between family size and seropositivity [OR ¼ 0.82,%95
CI: 0.60–1.13]. Logistic multivariate regression indicated age and
sex as the only signiﬁcant risk factors of seropositivity. Adjusted
ORs for age and sex were 1.03 (%95 CI: 1.01–1.04) and 1.61 (%95
CI: 1.13–2.28), respectively.
Conclusions: The high prevalence of positive serology observed in
this study urges more researches in Nahavand and other regions
of the country considering related risk factors. It is also important
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to study the relative contribution of HEV infection to the burden
of acute viral hepatitis.
R2282 Seroprevalence of hepatitis A, B and C in hospital
personnel
V. Karabassi, M. Pouyiouka, C. Petrochilou, M. Dimopoulou,
A. Liapis, C. Kontou-Castellanou
Athens, GR
Objectives: Our study was conducted to estimate the seropreva-
lence of hepatitis A, B and C and to identify the risk factors deter-
mining occupational infection with the virus among the health
personnel of a Greek major hospital.
Methods: Samples of serum from 225 persons both male and
female, doctors and nurses who work in different wards of our
hospital, were tested for the detection of HAV (total antiHAV and
IgM antiHAV), HBV (HBsAg, HBeAg, antiHBs, antiHBc, antiHBe)
and HCV (antiHCV)-markers. All tests were performed by immu-
noenzymatic methodology (MEIA, AXSYM-ABBOTT).
Results: Of the 225 persons who were controlled were found to be
positive: for HBsAg 2 (0.89%), for total antiHBc alone 6 (2.6%),
for simultaneous presence of antiHBc and antiHBs 26 (11.5%), for
antiHBs due to vaccination 122 (54.2%). A total of 112 persons
(49.7%) had developed title antiHBs > 100 mIU/mL.A total of 74
persons (32.9%) received complete three doses while in 48 per-
sons (21.3%)the vaccination was incomplete. One person (0.44%)
was positive for antiHCV, 106 persons (47.1%) were positive for
total antiHAV and none was found to be positive for IgM anti-
HAV.
Conclusions: The direct contact with patients and handling of
blood and other body ﬂuids and secretions are risk factors rela-
ted to occupational infection with hepatitis virus. Therefore the
effort for the prevention must be continual and the control
measures with a HBV vaccination policy should be strictly
enforced for the elimination of hepatitis transmission among
health care workers.
R2283 The frequency of steatosis in chronic hepatitis B
and C by ultrasonography
K. O¨zden, A. Kadanali, M. Ertek, M.A. Tasyaran
Erzurum, TR
Objectives: Steatosis is commonly present in chronic hepatitis
C. Although liver biopsy is the gold standard in determining
presence of steatosis, its presence can be determined by ultrasono-
graphic examination with high sensitivity. Our aim in this study
was to evaluate whether steatosis present in hepatitis B and hepa-
titis C, to determine their frequency in both hepatitis type, and to
explore possible relationship between presence of steatosis and
the liver function tests.
Methods: The patients with chronic hepatitis, B and C or both,
were included in this study between January 2002 and September
2003. The patients having diabetes, cirrhosis or alcohol history
were excluded from the study. Firstly, liver steatosis in patients
with chronic hepatitis was investigated by ultrasonographic exam-
ination. The serum levels of alkaline phosphatase, c-glutamyl-
transferase, alanine aminotransferase, cholesterol and triglyceride
were obtained. Their serum levels were compared between
groups in patients having steatosis or not.
Results: A total of 115 adults patients with chronic hepatitis inclu-
ding hepatitis B (n ¼ 90), hepatitis C (n ¼ 22) and hepatitis B + C
(n ¼ 3), were included study. Of these patients, 67% (n ¼ 77)
were male and 33% (n ¼ 38) were female. Their mean age was
37  9 years (range, 21–53 years). Steatosis presences were 33.3,
54.5 and 100% in hepatitis B, C and B + C, respectively. The
serum levels of alkaline phosphatase, c-glutamyltransferase, alan-
ine aminotransferase, cholesterol and triglyceride were not statisti-
cally different between the groups with steatosis or not in all
patients. There was no signiﬁcant relationship between steatosis
and gender or age also.
Conclusions: Steatosis was lower in patients with chronic hepatitis
B than those with hepatitis C and hepatitis B + C. However, our
results suggest that not only presence of steatosis was high in
patients with hepatitis C, but also it was high in patients with
hepatitis B.
R2284 Efﬁcacy of lamivudine in treatment of HBeAg-
positive chronic hepatitis B
M.R. Hasanjani Roushan, S.A. Asgharzadeh Ahmadi, E. Shaﬁgh
Babol, IR
Objectives: Presence of HBeAg in serum of patients with chronic
hepatitis B indicates active disease. This study was conducted to
evaluate the efﬁcacy of 1-year of lamivudine therapy in these
patients.
Methods: A total of 25 cases of HbeAg-positive anti HBeAg negat-
ive chronic hepatitis B were treated with 100 mg lamivudine
orally, daily for 1 year in Babol, Iran from September 2000 to
March 2003. HBeAg, HBV-DNA, anti HBe and alanine amino-
transferase(ALT) in all cases were assessed every 3-months inter-
val during therapy. Proportions were compared with Fisher’s
exact test.
Results: A total of 15 men and 10 women with the mean age,
24.6  6 years and mean-ALT levels of 59.8  35 IU/L and mean
score of histological activity index (HAI) 6.5  3.5 were treated.
After treatment, nine (60%) men and ﬁve (50%) women became
HbeAg-negative (P ¼ 0.466). Anti HBe was observed in 11 (44%)
cases. HBV-DNA became negative in four (26.7%) men and one
(10%) women (P ¼ 0.313). Serum ALT levels returned to normal
values in 22 (88%) cases.
Conclusion: One year of lamivudine therapy has beneﬁcal effect in
these group of patients, however some patients need longer dur-
ation of therapy.
R2285 Tumour necrosis factor alpha, interleukins (IL)-
1beta, IL-2, IL-4 serum levels in patients with chronic hepatitis
C treated with interferon alpha
V. Mitsura, S. Zhavoronok, E. Krasavtsev
Gomel, BLR
Objectives: The aim of this study was to investigate the serum lev-
els of cytokines tumour necrosis factor (TNF) -alpha, interleukin
(IL)-1beta, IL-2, IL-4 in patients with chronic hepatitis C (CHC)
treated with interferon alpha.
Methods: The serum cytokine levels (TNF-alpha, IL-1beta, IL-2, IL-
4) in 10 healthy blood donors (I group), 35 patients with CHC
without antiviral treatment (II group) and in 20 of patients treated
with interferon alpha for 3–6 months (3 MU thrice a week, III
group) by means of ELISA test was performed. Mann–Whitney
test was used for statistical analysis.
Results: The serum level of TNF alpha was 24.0 pg/mL in I group,
128.3 pg/mL in II group and 190.9 pg/mL in III group (P I–
II ¼ 0.006, P I–III ¼ 0.005). The serum level of IL-1beta was
4.4 pg/mL in I group, 376.1 pg/mL in II group and 553.0 pg/mL
in III group (P I–II ¼ 0.0001, P I–III ¼ 0.0001). The serum levels of
IL-2 was 20.9 pg/mL in I group, 49.2 pg/mL in II group, 77.3 pg/
mL in III group (P I–III ¼ 0.031). The serum levels of cytokine IL-
4 was 21.9 pg/mL in I group, 79.8 pg/mL in II group and
147.0 pg/mL in III group (P I–III ¼ 0.047).
Conclusion: During the course of treatment with interferon alpha
the serum cytokines levels grow. The increasing amount of pro-
inﬂammatory cytokines (TNF alpha and IL-1beta) can damage
various organ including liver. The increase of cytokine IL-4
reﬂects activation of T-helper type 2, which promote sustained
viral persistence. Cytokines dysbalance aggravation during the
course of interferon alpha treatment probably may decrease ther-
apy effect.
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R2286 High prevalence of HIV, HBV, HCV infection in
Gypsy population residing in Chahar, Mahal and Bakhtiari
province
S. Hosseini Assl, M. Avijgan
Shahrekord, IR
Objective: Gypsies are groups of people who are not dependent
on any special area. Because of permanent immigration and their
life style that has been targeted to earn daily bread, they might be
exposed to multiple partner sexual contacts, addiction and various
kind of infections, like hepatitis B, C and AIDS. Purpose of this
study is to estimate prevalence of these infections in gypsies of
south west of IRAN (Shahr-e-kord).
Methods: This study was done in Sureshjan Pass near Shahr-e-
kord. 226 persons of gypsies were underwent tests for hepatitis B,
C and HIV. Collected serums were tested for serologic markers of
HBsAg, anti-HBc, anti-HCV, anti-HIV. The kits used were based
on third generation of enzyme immune assay (EIA) for HBV,
HIV, and second generation of EIA for HCV. All positive sera
were tested again. In fact positive sera in ﬁrst step were selected
and retested for HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc,
anti-HCV, anti-HIV antibodies. The kits used in this step had dif-
ferent mark of manufacturing.
Results: Serologic results indicated that 54 individuals (20.5%)
were positive for HBV markers and 22 of them (9.8% of overall)
had infectious hepatitis B, 13 of them (5.8% of overall) had only
HBsAg positive, 11 individuals (4.9% of overall) were at an
immune state for HBV and eight persons (3.5% of all ) had isola-
ted Anti-HBc. Also, seven persons (three women and four men)
(3.09%) had positive anti-HCV and four persons (two women and
two men) (1.7%) were HIV positive. The prevalence and relative
risk of HBV, HCV and HIV in this group has been faced much
higher rate than normal population. (relative risk is 2.6, 3.9, and
23, respectively)
Conclusion: The life style of gypsies as nomadic and margin dwell-
ing, absence of any moral and hygienic disciplines, and multiple
partner sexual contacts can transmit communicable diseases and
cause increase prevalence of them in different societies. We sug-
gest that, a good and effective health care system for gypsies
should be considered so that saves the society from the risk of
these diseases.
R2287 Detection of genotype and mutations of hepatitis B
virus during lamivudine therapy
C. Nogales, C. Serrano, L. Pe´rez, E. Sua´rez, R. Corpas, R. Claro,
R. Jarana, E. Martı´n-Mazuelos
Seville, E
Objective: The aim of this study was to compare two laboratory
methods used to determine HBV genotypes and mutations of
HBV during lamivudine therapy.
Material and Methods: A total of 14 serum samples from patients
affected by HBV chronic hepatitis receiving lamivudine therapy,
were included in the study. The serum samples tested contained
virus level between 103 and 108 copies DNA/mL (PCR Amplicor
Monitor Test, Roche). ALT and DNA-VHB levels (basal and sev-
eral during the therapy) were determined. Genotype and muta-
tions of HBV virus were studied by INNO-LiPA (LiPA HBV
Genotyping kit and LiPA HBV-DR, Innogenetics) and sequence
analysis (Trugene HBV Genotyping kit, Bayer).
Results: Among the 10 patients, eight were antiHBe+ and two
HBeAg+. Medium basal values: ALT 120.5 UI/L, DNA-VHB
1.20  107 copies/mL. Seven patients had detectable DNA levels
during the therapy. The three patients with negative DNA levels
in a moment during the therapy were the only ones with basal
DNA <106 copies/mL and were infected with genotype B or B/
D. Six patients had mutant virus, in one of them the mutation
appeared in the basal sample. Among the six patients, two were
infected with genotype A and had the mutation pattern
M204I + wt, two infected with genotype D had the
L180M + M204V + wt and two with genotype D had the M204I
or M204V  wt. The virus mutant appeared after 9–26 months of
therapy, the M204I appeared in the ﬁrst 12 months, the
L180M + M204V after 18 months and the M204V after 26 months.
The results obtained by sequencing were in agreement with LiPA
except in the detection of mixed populations (wild type and
mutant). In an 83% of the cases, the viral load increased >1 log10
prior to detection of mutations by LiPA. The medium DNA level
after the presence of mutations was lower for genotype B than
for genotype A and D. The ALT level was lower, similar or
higher than the basal value for genotype B, D and A, respect-
ively.
Conclusions: (i) LiPA and sequence analysis demonstrated a good
concordance in genotyping and in detecting lamivudine resistance
mutation, but LiPA had superior sensitivity for identiﬁcation of
mixed populations (wild type and mutant). (ii). An increase of
HBV DNA level was detected mainly before the detection of
mutants by LiPA, and before the increase of ALT. (iii). Only
patients infected with genotype B showed medium DNA level
and ALT values lower than the basal value after the presence of
mutations.
R2288 Genomic variability of pre-S/S region of hepatitis B
virus from patients in the Czech Republic
V. Nemecek, O. Struneck
Prague, CZ
Objectives: For global epidemiology of hepatitis B virus both
phenotype variability i.e. HBsAg subtypes and genotype variab-
ility are used. For determination of routes of transmission in
local outbreaks, comparison and analysis of nucleotide
sequences of HBV DNA from individual patients is needed.
The knowledge of heterogenity of HBV genome in patients
from given geographic region is useful. The aims of this study
was to determine heterogenity of pre-S/S region of HBV in the
Czech Republic and to use this knowledge for analysis of local
outbreak of HBV infection among patients of a haemodialysis
unit.
Methods: HBV pre-S/S region DNA ampliﬁed by PCR from sera
of 182 hepatitis B patients was sequenced. Consensus nucleotide
sequences were obtained using CLUSTAL W (European Bioinfor-
matics Institute, GB) followed by manual editing using Bioedit
5.09. Phylogenetic trees were constructed with MEGA 2.1 using
UPGMA Kimura two-parameter model.
Results: HBV-DNA was ampliﬁed by PCR from sera of 166
patients from different regions of the Czech Republic. Part of
pre-S/S region from PCR products were sequenced. Nucleo-
tide sequences were aligned and phylogenetic tree was con-
structed. In the tree were found 14 pairs of identical
sequences, one cluster with three identical sequences, one
cluster with four, one with ﬁve and one with 12 identical
sequences. These 18 clusters were analysed from geographic
point of view and retrospectively affordable data about epide-
miological relatedness of cases were considered. Fourteen clus-
ters were found in the group of patients with genotype A,
three clusters in patients with genotype D and one cluster in
the group with genotype B. The new phylogenetic tree was
constructed when nucleotide sequences from 16 patients infec-
ted with HBV during the outbreak in a haemodialysis unit
were added. The source of infection and route of transmis-
sion of HBV in this outbreak was identiﬁed with contribution
of phylogenetic analysis.
Conclusion: This study provided data about heterogenity of the
part of HBV genome-coding surface antigen among HBV infected
patients in the Czech Republic. Study conﬁrmed that sequence
analysis of pre-S/S region of HBV DNA is useful epidemiological
tool for identiﬁcation of routes of transmission of HBV infection,
mainly in medical facilities. Supported by grant IGA MZCR No.
NI 6796-3.
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R2289 Cytomegalovirus infection in a Portuguese hospital:
January 2000–September 2003
A. Azevedo, I. Manita, C. Gamelas, A. Dias, J. Pina
Lisbon, P
Objectives: The purpose of this study was to determine the preval-
ence of cytomegalovirus (CMV) infection and evaluate the chan-
ging pattern of seroprevalence of CMV antibodies by age and sex,
in patients followed at a central hospital in Lisbon, between Janu-
ary 2000 and September 2003.
Methods: Retrospective analysis of laboratory records. CMV anti-
bodies (IgM and IgG) were analysed in serum samples, using the
microparticle enzyme immunoassay (MEIA) technology (ABBOTT
- AXSYM System).
Results: During the study period 1305 samples were analysed, 198
of children under 15 years (102 female and 96 male) and 1107
adults (784 female and 323 male). In the overall study population,
68.4% of patients have been exposed to the disease (IgM/IgG+),
18.0% had active disease (IgM+/IgG or IgM+/IgG+) and 13.6%
were healthy (IgM/IgG) for the disease. The seropositivity for
CMV IgG antibodies (with IgM) was 66.2% among children
under 15 years, over than a half having <1 year, and was 68.7%
among adults with a predominancy of women. Women between
16 and 35 years are the most affected by the disease, correspond-
ing to almost 60.0% of the women with active disease and with
history of exposition to the virus. The number of cases with active
disease had a slightly increase in 2001, but now it tends to
decrease. However, the amount of patients that have been
exposed to the disease is high and tends to increase, while the
number of seronegative cases is stabilizing.
Conclusions: CMV is highly endemic in our population, with a
prevalence of 86.4%. Women between 16 and 35 years are the
most affected by the disease. It is important in this period, when
women can become pregnant, to do the test. Despite the amount
of CMV IgM/IgG+ in children of <1 year, there was no signiﬁ-
cant difference among the different age groups. It means that the
infection can occur at any time of our lives.
R2290 Cytomegalovirus (CMV) colitis in an
immunocompetent patient
M. Gali, P. Carfagna, F. Taglietti, D. Moscogiuri, C. Santini
Rome, I
Objectives: CMV infection in immunocompetent individuals is
rarely a cause of clinical illness. Gastrointestinal manifestation of
CMV infection occurring in such patients have been reported in
only few cases.
Methods: We report a case of CMV colitis in an immunocompetent
elderly patient.
Results: In August 2003, a 76-year-old woman was admitted to
hospital for abdominal pain, diarrhoea and fever of 10 days dur-
ation. She was treated with levodopa for Parkinson’s disease.
Physical examination revealed an ill-looking, pale woman, with
dehydrated skin and mucous membranes. Abdomen was mildly
distended with tenderness in the lower quadrants, with no guard-
ing or palpable masses. A stool specimen was positive for occult
blood, but negative for ova and parasites, performance of a C. diff-
icile stool toxin assay yielded normal results, and cultures were
negative for pathogenic bacteria. An abdominal radiograph
showed some dilated small bowel loops and few sings of air-ﬂuid
levels in the colon. Ciproﬂoxacin was administered for 7 days
without improvement. A colonoscopy was performed and showed
multiple, conﬂuent, aphtoid lesions and friable mucosa in the des-
cending and sigmoid colon. Microscopic examination showed
chronic inﬂammatory inﬁltrates. Numerous intranuclear inclu-
sions were detected in the endothelial cells. Immunohistochemical
staining with anti-CMV monoclonal antibody was positive in the
intranuclear inclusion bodies. CMV serology performed after the
histopathological diagnosis of CMV colitis was positive for IgG
antibodies (139 UI/mL) and negative for IgM. Tests for HIV were
negative. A 2-week therapy with intravenous ganciclovir was
completed. A second colonoscopy showed amelioration of the
lesions in the descending and sigmoid colon. Biopsies were negat-
ive for intranuclear inclusion bodies. The patient was discharged
and she is now healthy after a follow-up period of 3 months.
Conclusion: Clinically signiﬁcant CMV infections usually occur in
immunocompromised patients, such as patients with AIDS, trans-
plantation, or cancer; critically ill patients are also at risk.
Advanced age has been reported to play a role in the CMV reacti-
vation because of the decline of immunity. Our case had no evi-
dent causes of immunodepression, but the advanced age might
have played a role in the reactivation of CMV and in the severe
clinical manifestation of the infection. We conclude that CMV coli-
tis should be considered in differential diagnosis of diarrhoea in
elderly.
Emerging infectious diseases
R2291 The ﬁrst case of haemolytic-uraemic syndrome
caused by STEC O26 in Slovakia
A. Liptakova, L. Siegfried, D. Kotulova, A. Bencatova´,
M. Kosecka´, P. Ba´novcı´n
Kosice, Bratislava, Zilina, Martin, SK
Background: Shiga toxin-producing Escherichia coli (STEC) are asso-
ciated with life-threatening sequelae such as haemolytic-uraemic
syndrome (HUS). Particularly STEC O157 appears to be the most
frequent. However, it has been recognised for a number of years
that STEC belong to a broad range of O serogroups. We report a
case of HUS caused by Stx2-positive STEC O26.
Methods: Girl (4 years) was admitted to Hospital for Sick Children
with signs of HUS. Stool samples from patient and her family liv-
ing in the same house were collected. There were used selective
media (CT-SMAC, Enterohaemolysin agar, Oxoid, UK) for STEC
detection, immunomagnetic separation with anti-O157 beads (Dy-
nal, Norway), Vero cell assay and latex agglutination detecting
shiga toxin 1 and 2 (Stx1,2) (Oxoid, UK), multiplex PCR using
speciﬁc primers for genes encoding Stx1, Stx2, enterohaemolysin
and intimin. Epidemiological information was obtained by semi-
structured interviews undertaken by Epidemiology Unit staff with
all family members and contacts.
Results: On the basis of collected samples we have isolated sorbi-
tol-fermenting Escherichia coli O26 strain. Isolate originated from
patient with HUS. Isolate harboured the stx2 gene, the eae gene
encoding intimin and the ehxA gene encoding enterohaemolysin.
Stx2 activity was also demonstrated. Stool samples taken from
family members were negative for STEC O26.
Conclusions: Our data indicate the ﬁrst documented case of HUS
caused by shiga toxin 2-producing Escherichia coli O26 in our geo-
graphical area.
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R2292 Electrochemical release of metal ions for water
disinfection
R. Khaydarov, R Khaidarov, R. Olsen, S. Rogers
Tashkent, UZB; Denver, USA
At present day the creation of effective and affordable water-dis-
infecting methods is one of important tasks in arid and semi-arid
regions, where fresh water resources are limited and unevenly
distributed, and drinking water often contains extraordinary large
numbers of pathogenic bacteria. In remote regions of Uzbekistan
portable water is the main reason of infectious diseases. The
water disinfecting method presented in this work is based on the
destructive impact of low concentrations of metal ions on bacteria
in water. During the disinfection process, alloyed electrodes are
placed into the water body and a current applied to the electrode
causes the release of metal ions. The metal ions bind to the bacter-
ial cell wall, causing its disruption and lyses. The efﬁcacy of using
different metal ions (Ag+, Cu2+, Au) combinations (within the
limits of current drinking water regulations) for killing typhoid–
paratyphoid, Legionella pneumophila, Salmonella, V. cholera etc. was
examined. The cultivation, culture enrichment and the testing bac-
teria were performed following the Standard Methods for the
Examination of Water and Wastewater (American Public Health
Association, 1995) for the evaluation of disinfection. Tests which
were carried out by various independent labs and universities
during the period of 1999 through 2003 have shown the depend-
ence of bacteria killing time against metal ion concentration, dif-
ferent initial bacteria concentrations (from 103 to 1012 CFU/L),
and the inﬂuence of different ion (Cl, SO24 , S
2, Fe2þ, Fe3þ) con-
centrations on the disinfection process. The best disinfection is
obtained by using an alloy of silver/copper/gold composition
with concentrations of metals in the ratio 70–90%/10–30%/0.1–
0.2%, respectively. In the Aral Sea region (Uzbekistan) water dis-
infecting devices that were based on the developed method were
installed on several hundreds manual water pumps, that allowed
to decrease infectious diseases in this region.
R2293 Outbreak of cutaneous leishmaniasis in a
nonendemic area of central Iran
M.R. Yaghoobi-Ershadi
Tehran, IR
Objectives: To determine the epidemiological status of the cutane-
ous leishmaniasis outbreak, isolation and identiﬁcation of the
parasite in the study area.
Methods: This study was conducted from November 1999 to
March 2002 in Ghanavat rural district of Qom province. Studies
on human infection were carried out among students and the
population of three villages once a season. A special form was
completed to record necessary information for each households
and students. Parasites were isolated from patients and identiﬁed
by RAPD-PCR technique. Small mammals were caught in Sher-
man traps once a month and examined for the presence of amasti-
gotes. Household dogs were also physically examined for the
presence of any ulcer(s) or scar(s). Sandﬂies were collected and
identiﬁed biweekly from indoor and outdoor ﬁxed places in a vil-
lage using 30 sticky traps from the beginning to the end of active
season. Some female sandﬂies from rodents burrows were dissec-
ted and examined for the presence of promastigotes in September
2000 and 2001.
Results: A new outbreak of zoonotic cutaneous leishmaniasis
(ZCL) caused by Leishmania major was detected in the study area.
Among 1069 inhabitants examined in December 1999, 5.1% had
ulcers and 12.4% had scars. The most highly infected age group
was 5–9 years for ulcers with a rate of 6.6%. The incidence of the
disease was calculated 2.7 and 1.4% among the inhabitants and
2.8 and 2.3% among the students in 2000 and 2001, respectively.
Meriones libycus (66.7%), Nesokia indica (27.3%) and Hemiechinus
aurithis (6%) were present around the district. No leishmanial
infection was seen in the slides. Sixteen domestic dogs examined
and none of them appeared to be infected. A total of 7425 sand-
ﬂies representing four species were collected and identiﬁed dur-
ing April–October 2000. The common sandﬂies in indoors and
outdoors were Phlebotomus papatasi and Sergentomyia sintoni. The
active season of P. papatasi was from late April to early October in
indoors. Natural leptomonad infection was found only in S. sin-
toni in rodent borrows.
Conclusion: We are dealing with ZCL in this new focus with an
outbreak in 1999. Leishmania major is the agent, M. libycus and P.
papatasi are probable reservoir and vector, respectively. The occur-
rence of this outbreak seems to be the result of construction of
buildings near colonies of rodent burrows and also travelling of
inhabitants to other ZCL foci of Iran.
R2294 Post-ﬂood leptospirosis in the Czech Republic
K. Zitek, C. Benes
Prague, CZ
Objectives: Leptospirosis is a typical zoonosis with natural nidality
and its occurrence in the climatic conditions of the Czech Repub-
lic is sporadic and the incidence is normally about 0.3 cases per
100 000 inhabitans.
Methods and results: In 1997 and 2002, however, the incidence of le-
ptospirosis has been inﬂuenced by the actual natural phenomenon
– catastrophic ﬂoods, which increased the numbers of serologically
diagnosed and registered cases three times, i.c. to 0.9/100 000 in
comparison with previous years. In 1997 there have been examined
for leptospirosis a total of 7.156 subjects in the Czech Republic, and
the disease was diagnosed and registered in 94 of them (and in
2002 in 92 patients respectively). Two-third of these cases came
from inudate areas, half of them in direct relation with the ﬂoods.
Four of registered cases (1997) of Weil disease have died in the
Czech Republic. The difference between the actual and reported
morbidity is critically discussed. The poster contains graphs, maps
and tables, which described above mentioned.
R2295 Mycobacterium kansasii in Bilbao and Bizkaia
M.V. Leal, A. Gaafar, M.J. Unzaga, C. Ezpeleta, E. Urra,
R. Ayarza, F.E. Calvo, F. Garcı´a, G. Martı´n, R. Cisterna,
J.A. Crespo
Bilbao, E
Background: The aim of this study is to know clinical signiﬁcance
of isolates and the epidemiology of the infection.
Patients and methods: We reviewed 334 clinical records of patients
with M. kansasii isolated from 1994 to 2002 in Bilbao area and
from 2000 to 2002 in Bizkaia county. First, we used ATS diagnos-
tics criteria for nontuberculous mycobacterial disease to the cases
and then were further classiﬁed into according to modiﬁed cri-
teria into probable, possible, probable-deﬁnitive, and colonisation.
PCR-RFLP and AFLP analysis were also applied to clinical iso-
lates.
Results: A total of 199 patients met ATS criteria (59.6%), probable
disease 21 (6.3%), probable-deﬁnitive 37 (11.1%), possible 19
(5.7%) and colonisation 58 (17.4%). We considered ATS and prob-
able disease as M. kansasii disease: 220 patients. These were 184
(83.6%) HIV- and 36 (16.4%) HIV+ with male predominance (5/
1). 126 patients lived in Bilbao where the peripheral districts
showed higher incidence 6.94&. In Bizkaia county there were an
incidence of 5.07& in the period studied. The predisposing factors
were 25.9% COPD, 11.4% hepathopaty, 8.6% gastrectomy and
6.8% neoplasia. There was a higher frequency of COPD in HIV –
(P < 0.05) and greater proportion of hepathopathy between HIV+.
The respiratory symptoms were 70.9% cough, 24.1% dyspnoea,
18.2% haemoptysis and 20.5% chest pain. Fever, anorexia, weight
reduction, cough and expectoration were more frequent in HIV+
patients (P < 0.05). X-rays showed inﬁltrates (106) or cavity lesions
(106) and both (28). The predominant presentation was unilateral
and in the right upper lobe. HIV and + did not differ signiﬁ-
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cantly in X rays. Cavity lesions were associated with haemoptysis
(P < 0.05). Isoniazid, rifampicin and ethambutol was initiated or
previous theraphy was changed when M. kansasii was recovered
in 201 patients (34 HIV+ and 167 HIV). Subtype I was the only
subtype isolated and seven clones were obtained, one of them
with 42 strains of HIV and other one with 10 of HIV+. Conclu-
sions: ATS criteria, with their requirement for multiple positive
specimens may be excessively strict for clinical purposes. Only
subtype I was found although is heterogeneous.
R2296 Study of Escherichia coli DH5a lysogenisation with
verotoxin1-producing bacteriophage
M. Sattari, H. Hosain Zade
Tehran, IR
Verotoxigenic E. coli (VTEC) are of the most important world-
wide public health problems, causing outbreaks of haemorrhagic
colitis and haemolytic uraemic syndrome. This strains are gen-
etically and phenotypically highly heterogenous, and produce
verotoxin types 1 and 2, that are encoded within lambdoid
prophages (temperate bacteriophages).Expression of these toxins
is linked to bacteriophages induction and their genes are fre-
quently lost in clinical isolates of E. coli upon subcultivation. So
these genes are very instable, and act as a spreading factor of
related disease.
Methods: The possibility and time-dependent lysogenisation of E.
coli DH5a´ with the bacteriophage stock that prepared from vero-
toxin1 producing E. coli were studied. Lytic growth of the
phage-particles carrying the verotoxin1 gene, of the PA101 strain
was induced after treatment with mitomycin C. Production of
verotoxin1 was measured by VTEC-RPLA kit in infected bac-
teria.
Results: Our results indicated that verotoxin1 bacteriophage is a
mobile element, and could be easily transferred to other strains,
with transduction. So VTEC strains act as a phage-producing cen-
tres in nature and could spread them to other bacteria.
Discussion and conclusion: Based on the results of this study, using
phage-neutralising agents in health cares are necessary for pre-
venting such infections.
R2297 Crimean Congo haemorrhagic fever infection
simulating acute appendicitis
A. Celikbas, O. Ergonul, B. Dokuzoguz, S. Eren, N. Baykam
Ankara, TR
Objective: An unusual cause of acute abdominal pain simulating
acute appendicitis was presented.
Case: The patient was admitted with the complaints of fever,
malaise, headache, nausea, vomitting, diarrhoea, severe bleeding.
She was from Northeastern part of central Anatolia, where live-
stock husbandry was employed. On admission, she was
severely ill. In her laboratory investigation, the minimum level
of white blood cell count was 513/mm3, haemoglobin level was
5.3 g/L and platelet count was 8910/mm3. The maximum level
of AST was 3195 IU, ALT was 1443 IU and LDH was 8190. Rib-
avirin therapy was started with the possible diagnosis of CCHF.
While her clinical condition was improving, a sudden abdom-
inal pain became her major problem. She had an acute pain
with rebound at her right lower quadrant. She was consulted
with general surgery department. Explorative laparotomy was
performed with the possible diagnosis of acute appendicitis.
The haemorrhage within the muscles was observed. It was con-
cluded that, the haemorrhage was a complication of the infec-
tion with CCHF virus. Her CCHF serology was studied ELISA
in Pasteur Institute in Lyon. Acute serum was found to be
CCHF IgM-positive, and the convalescent serum was found to
be CCHF IgG positive.
Conclusion: Acute abdomen because of severe bleeding could be a
possible complication among the patients with CCHF infection.
Therefore, these patients should be investigated, and haemorrhage
should be ruled out before the decision of explorative laparotomy
in CCHF suspected cases.
R2298 Identiﬁcation of Borrelia burgdorferi from Ixodes
ricinus ticks from Southern Moravia, Czech Republic
K. Pejchalova´, E. Janousˇkovcova´, P. Nejedla´, A. Zˇa´kovska´,
J. Halouzka, M. Dendis
Brno, CZ
Objectives: The prevalence of Borrelia burgdorferi sensu lato in
Southern Moravia was investigated in suburban woods Pisa´rky
(city of Brno), Czech Republic from 1996 to 2003.
Methods and results: Using the method of dark ﬁeld microscopy
and following PCR was mean ticks positivity in 1997–2000 7.3%,
just examining with the PCR method in 2001–2002 positivity was
4.9% and using cultivation method and following DFM and PCR
methods in 2002–2003, the reached positivity was 11.8% under the
same condition of 14 days interval of collection. The last 2002–2003
collection resulted in 305 Ixodes ricinus ticks (21 larvae, 243
nymphs, 19 females and 22 males) collected from July to October
2002. Midgut tissue of each tick was dissected out and was trans-
ferred into BSK-H (Sigma) medium. After incubation each medium
was examined by dark-ﬁeld microscopy (DFM) for the presence of
borreliae. The mean infection rate was 14.8%. Among 22 male
adults 13.6% were positive, from 19 female adults 26.3% were
positive. 243 nymphs showed 14.4% positivity and among 21 lar-
vae 9.5% were positive. Isolation attempts resulted in 21 isolated
strains. The positive samples were identiﬁed by PCR and follow-
ing PCR-RFLP, conﬁrmed by gradient SDS-PAGE. 35 samples
were positive by PCR for the presence of B. burgdorferi sensu lato.
Species identiﬁcation by PCR-RFLP detection revealed strains of B.
afzelii, B. garinii and B. burgdorferi sensu stricto. Some isolates
showed a mixed population of these strains.
Conclusions: The results of all year collections refer to risk of human
and animal infection by borreliae in the area of city of Brno.
R2299 The presence of antibodies against Borrelia
burgdorferi sensu lato in rodents and occurence of this
spirochaete in the mites parasitizing on them
K. Vostal, J. Netusˇil, A. Zˇa´kovska´, M. Daniel, E. Janousˇkovcova´
Brno, CZ
Borrelia burgdorferi sensu lato, causing Lyme disease, is transmitted
by ticks (especially family Ixodidae), but is found also in some
other blood-sucking arthropods. Rodents are considered to be the
most frequent and important host group of these vectors. The pre-
valence of Borrelia burgdorferi sensu lato in wild rodents and in
their small mites was examined. A total of 174 wild-living rodents
belonging to two families (Muridae and Microtidae) was exam-
ined. Rodents were caught in a locality Bazantula in the north of
Moravia in two consecutive years (2001–2002). Yellow-necked
mouse (Apodemus ﬂavicollis) and wood mouse (Apodemus sylvati-
cus) predominated in obtained number of individuals. A presence
of antibodies against Borrelia afzelii in the blood of rodents was
found out by using indirect ELISA method. The mean positivity
was 43.7% and the majority of positive samples were representa-
tives of Apodemus sylvaticus. There were no signiﬁcant difference
in positivity between both rodent families as well as between gen-
ders. The wet ground character and often ﬂooding of this locality
results negligible number of ticks on vegetation and on single
rodents, on the contrary for the occurrence of gamasid mites this
area affords very favourable environment. 72 ectoparasites of
order Acarina were collected here from the hair of rodents in
1999. DFM method conﬁrmed the presence of spirochaetes in 14
specimens (19.4%). DNA of Borrelia burgdorferi sensu lato was
found out in six cases of these 14. Spirochetes from one sample
were successfully isolated and determined as Borrelia afzelii by
using gradient SDS-PAGE.
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R2300 Association of Chlamydia pneumoniae seropositivity
and lung cancer
S. Aksaray, S. Suzuk, E. Guvener, E. Unsal, B. Urunal, F. Aksaray,
S. Han, U. Sakinci
Ankara, TR
Objectives: We aimed to evaluate the relationship between Chlamy-
dia pneumoniae infection and lung cancer.
Methods: Seventy-nine, histopathologically diagnosed primary
lung cancer patients were evaluated; of 79, six were female, 73
were male. The age range was between 28 and 77 years. Of the
patients 13 were small cell carcinoma and 66 were nonsmall cell
carcinoma (42 epidermoid carcinoma, 17 adeno carcinoma and
seven large cell carcinoma). Also, 50 healthy people were evalu-
ated as the control group. The indirect immunoﬂuorescence test
(Euroimmun, Germany) was used to detect Chlamydia pneumoniae
speciﬁc IgG antibodies. The seropositivity was deﬁned as the titre
being greater than 1/100.
Results: Seropositivity was detected 69.6% of cancer patients and
43.2% of control group (P < 0.01). In the comparison of histologi-
cal types, seropositivity was mostly detected in epidermoid carci-
noma (30/42) and small cell carcinoma (11/12).
Conclusion: Our results revealed that there is a high seropositivity
in Chlamydia pneumoniae in lung cancer patients. But it is clearly
not sufﬁcient to claim that Chlamydia pneumoniae infection is a
cause of lung cancer. Much more prospective studies are needed
in the future.
R2301 Clinico-epidemiologic feature and outcome analysis
of haemorraghic form of Crimean Congo haemorraghic fever in
Iran
M. Mardani, B. Bijani
Tehran, IR
Crimean-Congo haemorrhagic fever is a zoonotic disease, which
has been reported from the most parts of Europe, Asia and
Africa. In this research the epidemiological features and the clin-
ical and laboratory manifestations of the disease in Iran has been
studied. From 51 probable cases from 1999 to 2002, in 13 cases
the diagnosis was conﬁrmed by positive IgM ELISA against the
Crimean-Congo haemorrhagic fever virus. The mean incubation
period was 4.2 days and the disease was more prevalent in men
and middle age and the maximum incidence was in August and
September. The clinical manifestations included extremely sud-
den, severe headache, myalgia, loss of appetite, nausea and
fever. Patients rapidly exhibited a haemorrhagic tendency. Epis-
taxis, bleeding from the gums, petechia, purpura, melena, haem-
atochesis, haematemesis, bleeding of venopuncture sites was
common. Large echimotic areas appeared on the trunck, arms
and legs and menmetrorrhagia was seen in female patients. Less
prevalent signs were relative bradycardia, hypotension, tachyp-
nea, abdominal pain, watery diarrhoea, icterus and leth-
argy. The most prevalent laboratory manifestations was
haematuria, proteinuria, prolonged partial thromboplastin time,
AST value >100 IU/dL, and less prevalent signs included anae-
mia, leucopenia, ALT value >100 IU/dL and prolonged pro-
thrombin time. In this study for eight patients oral Ribavirin (in
very ill patients by nasogasteric tube) was utilised in addition to
supportive measures including infusion of cristaloids, packed
cells, fresh frozen plasma and platelets and management of
shock and renal failure and intensive care. Among these patients
one patient died. In contrast in ﬁve patients who did not resieve
Ribavirin only two survived.the cause of death in all of the
patients were interactable haemorrhage and multiple organ fail-
ure. n the convalescent period except for the lassitude and as-
thenia (and development of erythema nodosum in one patient),
no signiﬁcant sequelae were seen in survivor. In the view of the
relatively high incidence of CCHF in Iran and neighbouring
countries, the education of the epidemiological features and the
clinical and laboratory manifestations and providing laboratory
facilities for rapid and accurate diagnosis of the disease has a
signiﬁcant priority.
R2302 Epidemiological monitoring of Astrakhan spotted
fever
I. Tarasevich, N. Fetisova, A. Kovtunov
Moscow, Astrakhan, RUS
ASF is emerging disease, appeared in the result of technogenic
transformation of environment. About 2000 cases of ASF have
been registered during 1983–2000 in Astrakhan region. The inci-
dence increased from six cases in 1983 to 216 cases in 2000. From
2000 to 2003 incidence increased in 37.3 times when compared
with 1983. The most of cases have been registered in the regions
closely located to gas-condensate complex – 114.5–100 000 of pop-
ulation. 80% of cases have been conﬁrmed serologically in IFT.
The incidence coincides with seasonal dynamics of the vector-ixo-
did tick Rhipicephalus pumilio mostly in July–August. Index of
abundance ticks on dog is 1.8–3.4.
Conclusion: ASF continues to be public health problem in endemic
region.
R2303 Evaluation of ocular lesions in hospitalised patients
with signiﬁcant bacteraemia
M. Cihangiroglu, I. Celik, T. Yilmaz, U. Kohle, A. Akbulut,
S. Felek, S.S. Kilic
Elazig, TR
Objectives: In this study, we investigated frequency, aetiology and
risk factors of retinal lesions in bacteraemic and septic patients.
Methods: A total of 150 adult bacteraemic, septic and control hos-
pitalised patients were included in the study. Demographic data,
area of admission, underlying diseases, Wilson’s severity index,
APACHE II scoring, Charlson’s comorbidity index, community or
nosocomial acquisition of bacteraemia, and responsible microor-
ganism were recorded on the previously prepared forms. Blood
cultures were obtained from all patients at least two times. All
patients were examined for ocular lesions with the same ophthal-
mologist in 48–72 h after the ﬁrst visit.
Results: Thirty-one (20.7%) patients were septic-bacteraemic, 43
(28.7%) were septic nonbacteraemic, 19 (12.7%) were severe
inﬂammatory response syndrome SIRS; 16 (10.7%) were nonseptic
nonbacteraemic infectious; and 23 (15.3%) were control. We found
bacteraemia related ocular lesions (BROLs) in 22 (14.7%) patients.
Winston scores were lower in the patients those have BROLs than
others. According to the underlying diseases; there were more
BROLs at the septic or bacteraemic patients with cancer (27.3%)
and central nervous system (CNS) diseases (31.8%) than the oth-
ers. The most detected agent at bacteraemia that has BROLs was
Pseudomonas spp (27.3%), the second agent was Staphylococcus spp
(22.7%).
Conclusion: As a result; BROLs were more frequent at bacterae-
mic-septic patients (12.7%) than the other groups. The most pre-
disposing underlying diseases for BROLS were cancer and CNS
diseases. Ocular examinations can give a clue for sepsis for this
type of patients.
Table. Ocular lesions according to the patient groups
Bacteremic
non-septic
Septic
non-
bacteremic
Septic
bacteremic SIRS
Non
septic. non-
bacteremic Control
No lesions 12 (8.0%) 30 (20.0%) 7 (4.7%) 14 (9.3%) 13 (8.7%) 15 (10.0%)
Non-related
lesions
6 (4.0%) 10 (6.7%) 5 (3.3%) 5 (3.3%) 3 (2.0%) 8 (5.3%)
Lesions related
with bacteremia
0 3 (2.0%) 19 (12.7%) 0 0 0
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R2304 West Nile virus meningoencephalitis in central
Tunisia: report of 13 cases
K. Naoufel, M. Khalifa, W. Hachﬁ, F. Bahri, L. Jemi, A. Letaief
Sousse, TN
Background: West Nile Virus (WNV) was ﬁrst isolated in 1937
from the blood of an infected women in the West Nile province
of what is known as Uganda. WNV infection is endemic in the
middle east, sub-saharian Africa and Asia. In Tunisia a ﬁrst out-
break was observed in 1997. Transmitted from birds to human
through the bite of culicine mousquitoes, most WNV infections
are mild or clinically unapparent. However, people older than
50 years are at highest risk of severe neurological disease.
Aim: This report describes clinical presentation, epidemiologic
data and outcome of patients with WNV meningoencephalitis.
Methods: Retrospective study of 18 cases of WNV meningoen-
cephalitis, recorded in a recent outbreak occurred in Central Tuni-
sia from July to October 2003. Diagnosis was conﬁrmed in 15
cases by detection of WNV antibodies with IgM capture and indi-
rect IgG ELISAs from sera or cerebro spinal ﬂuid (CSF).
Results: Data were obtained from 13 patients: 10 males and three
females, with mean age ¼ 58 years (22–80 years). All patients
were from rural origin. Nine patients had meningitis (isolated in
seven cases, associated to acute ﬂaccid paralysis in two cases) and
four patients had meningoencephalitis. CSF showed pleocytosis in
all cases with lymphocytic predominance in six cases and moder-
ate protein elevation in six cases. Hyponatraemia, lymphopenia
and cytolysis were noted in respectively four, two and three cases.
Only fatal case occurred in elderly patient, two had ﬂaccid paraly-
sis sequelae.
Conclusion: Since it’s the second outbreak of WNV in our country
and substantial morbidity in elderly persons, WNV surveillance
among patients, in vectors and birds is necessary.
R2305 Diabetes insipidus due to Streptococcus pneumoniae
meningitis
M. Ozden, A. Kalkan, Y. Ozkan, K. Demirdag, A. Denk
Elazig, TR
Diabetes insipidus (DI), which is characterised by polyuria and
polydipsia due to excessive urinary loss of solute-free water, can
be either central (CDI) or nephrogenic. The syndrome of inappro-
priate hormone secretion is a well-known complication of bacter-
ial meningitis, but, CDI is extremely rare in these patients. A 54-
year-old man with a central diabetes insipidus as a complication
to pneumococcal meningitis is presented. The patient was admit-
ted to our hospital with a 4-day history of severe headache and
vomiting. Two days before admission, he developed fever (39C)
and malaise. The initial examination showed slight confusion and
nuchal rigidity. Lumbar puncture revealed increased cerebrospi-
nal ﬂuid (CSF) pressure, purulent appearance and leukocytes
1200/mm3 (85% PNL and 15% lymphocytes), protein 450 mg/
dL, glucose 5 mg/dL. The Gram stain of CSF was positive for
Streptococcus pneumoniae. Culture of blood and CSF yielded S.
pneumoniae. According to the antimicrobial susceptibility test, cef-
triaxone 4 days and dexamethasone 32 mg/day were initiated.
Dexamethasone was stopped at fourth day of treatment diabetes
insipidus developed on day 6 after the admission. The diagnosis
of CDI was established by the response of the urine osmolarity
and serum sodium levels by water deprivation test and the
administration of 5 lg of arginine vasopressin. Desmopressin acet-
ate was added to treatment and ﬂuid adjustment was performed
in the patient. Ceftriaxone was stopped fourteenth day of treat-
ment. Urine density, serum osmolarity and urine output in 24 h
of the patient has become normal levels by treatment of desmo-
pressin. Despmopressin was stopped at tenth day of the treatment
since the urine output levels has become less than normal.
Although infection-precipitated CDI is a rare occurrence, its recog-
nition is important. Therefore, CDI should be kept in mind in
patients with bacterial meningitis.
R2306 Salmonella ﬁndings out and on a poultry farm
P. Marusic
Zajecar, CS
We formulated a hypothesis, that Salmonella is more frequent iso-
lated from poultry farm eggs than out of farm eggs.
Aim: (i) To research frequency of Salmonella ﬁndings in poultry
farm and out of farm eggs; (ii) To research Salmonella present in
food samples for chicken on and out of poultry farm; (iii) To
research frequency of Salmonella ﬁndings in faeces samples and
cloacal smears of chicken on and out of poultry farm.
Material and methods: We were taking samples from 880 chicken
eggs. From 10 farms we were taking samples from 597 eggs
(86%) 22 times. From small left farms we were taking samples
from 96 eggs. During the same period we were taking samples
from 187 (21%) out poultry farm eggs. We were taking 88 sam-
ples of chicken excrement. We homogenised each egg, and con-
tents planted on liquid nourishing bases which favoured
Salmonella multiplying.
Results: We isolated Salmonella from ﬁve (0.57%) of 880 inspected
chicken eggs. There is a signiﬁcant difference in Salmonella ﬁnd-
ings out and on poultry farm (P ¼ 0.008; Fisher’s correct test). Sal-
monella ﬁndings in chicken excrement: No. of samples – 79, and
no. of positive samples – 13 (14.8% ). 11 (12.5%) SE, and two
(2.3%) Salmonella typhimurium (STM) Salmonella ﬁndings in con-
centrate. We isolated STM in two (4.3%) of 47 inspected samples.
Both of samples are from Salas farm. We registered characteristic
plasmid proﬁle, presented with constitutive plasmid by 38 MDa,
in SE isolated from chicken excrement on farm.
Conclusion: (i) We reject active hypothesis, because we often ﬁnd
Salmonella in out of farm eggs then poultry farm eggs which in
opposite to our hypothesis. (ii) The results of this study shows
from 50 to 100 times often presence of Salmonella in eggs in regard
to existing estimates. Therefore, they are signiﬁcant ATI way of
transmission, provoked by this carrier (cause).
Vaccines
R2307 Evaluation of hepatitis B vaccine protection in
Iran’s routine immunisation programme
N. Pashapour, S. Golmahammadlou
Uromiyeh, IR
Objectives: More than 5% of the people are chronic carrier of
hepatitis B virus. Acute and chronic hepatitis and their complica-
tions are health problem around the world. Immunisation is the
best-known method of prophylaxis. Condition of vaccination has
direct impact on amount of antibody formation and prophylaxis.
To study the prophylactic effects of vaccination according to Iran
mass immunisation protocol, a prospective research was carried
out in Uromiyeh since 2002.
Materials and methods: Sixty neonates of HbsAg negative mothers
were admitted to this study. One month after the last vaccine,
Origin
of eggs
Isolated
Salmonella
Not isolated
Salmonella Total
Eggs from farm 1 (0.14%) 692 693
Eggs out of farm 4 (2.14%) 183 187
Total 5 (0.57%) 875 880
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according to Iran general program, all infants‘ sera were tested
for anti-HbsAg.
Results: The ﬁnal results of 39 patients who completed the study
include: (i) 21 males (53.85%). 18 females (46.15%) (ii) average
anti-HbsAg production in males and females were 546.86 and
639.781 IU/L. Mean of all samples was 589.74 IU/L. Lower limit
was 18 U and upper one was 1500.
Conclusion: The study shows 100% successes for routine pro-
gramme because for prophylaxis only 10 U is enough. Comparing
with other studies, the best results are extracted from this pro-
gramme so the study recommends the persuasion of the pro-
gramme.
R2308 Immunogenicity of an anti-Hav vaccine in infants
A. De Silvestri, G. Perricone, F. Zara, V. Terulla, R. Brerra,
S. Zucca, F. Polatti, L. Pagani, C. Belloni
Pavia, I
Background and objectives: Hepatitis A is a common viral infection
causing substantial morbidity and mortality. The anti-HAV vac-
cination in infants would guarantee the control of infection. How-
ever the immunogenicity of the HAV vaccine in infants could be
impaired by the presence of passively acquired maternal HAV
antibodies. Aim of this work was to evaluate safety and immuno-
genicity of anti-HAV inactivated vaccine administered during the
ﬁrst 4 months of life to anti-HAV seronegative babies.
Methods: Ninety-two babies born at IRCCS Policlinico San Matteo,
in northern Italy, during 8-months period (September 2002–April
2003) were vaccinated with a two dose schedule (4 and 10 months
of age), following obtained informed written consent from one
parent. All the babies were characterised seronegative at birth and
did not presented HAV-RNA positivity in a series of three stool
samples taken at 1, 2 and 3 months of age. The detection of anti-
HAV IgG was performed by MEIA method (AxSYM HAVAB 2.0,
Abbot Italy) quantitave dosage using a calibration curve with ﬁve
points: 0, 5, 10, 20, 50, 100 mIU/mL. The study was approved by
the Ethical Committee of IRCCS Policlinico San Matteo.
Results: Neither local side-effects (redness/swelling) nor general
(fever >38C) were observed. After the ﬁrst dose of vaccine 70/82
(85.4%) babies developed a protective titre (>10 mIU/mL): geo-
metric mean titre (GMT) was 17.5, median 18.65; 25 centile 12.4;
75 centile 26.4 mIU/mL. After the second dose of vaccine all
babies developed a protective titre: GMT 926.8; median 849.7;
interquartile range (that include 50% of the sample): 565.2–
1829 mIU/mL.
Conclusion: Anti-HAV vaccine resulted safe and highly immuno-
genic in seronegative babies, even if administered in ﬁrst year of
life. Our ﬁndings suggest that children born by anti-HAV negat-
ive mothers could be vaccinated early during the ﬁrst year of life
together with other routine vaccinations.
R2309 Rapid colorimetric assay for determination of
viability of BCG vaccine
W. Janaszek-Seydlitz
Warsaw, PL
Objective: The potency of BCG vaccine is evaluated as a content of
colony forming units (CFU). The current method recommended
by the EP and WHO for determination of potency of BCG vaccine
depends on counting the number of CFU produced after culture
on solid medium. Estimation of CFU count takes 3–4 weeks. Ten-
dency to clumping of mycobacteria and the type of medium used
may cause variable results. The aim of this study was developing
of a colorimetric assay of tetrazolium salts reduction as a rapid
method of BCG vaccine viability control.
Methods: Tetrazolium salts in presence of BCG were metabolically
reduced to highly coloured end products called formazans. The
quantity of formazan produced was directly proportional to CFU
count. Tested BCG vaccine prepared from Moreau substrain is
commercial preparation used for vaccination in Poland. Twenty
lots of BCG vaccine were controlled by tetrazolium salts test alter-
natively to culture method. For the preparing the calibration curve
the working reference BCG lot s. 4012002 was used. The different
variants of BCG and tetrazolium salts concentrations were tested.
BCG dilutions were transferred to microtitre plate and 25 ll of
XTT [2,3-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-
carboxanilide] (Sigma) were then added with intermediate elec-
tron carrier - menandione sodium bisulphate (MSB, Sigma) to
each well. Control wells had saline instead of either XTT or the
vaccine. The optical density of each well was measured at 450 nm
using a Labsystems Multiskan MS plate reader.
Results: The best calibration curve was obtained for range of BCG
concentration 5  104–20  106 CFU/mL and twofold dilutions.
The optimal concentration of XTT was 3 mg/mL. The viability of
tested BCG were read from optical calibration curve. The assay
using XTT showed great sensitivity in detection limits 4  105–
16  106 CFU/mL. In parallel, all lots of BCG vaccines were tes-
ted in cultures on Ogawa solid medium. The number of CFU was
counted after 3 weeks. In mentioned viability limits the correla-
tion of viable count of all test samples from one test method to
the second was never <0.82 using Pearson’s correlation.
Conclusions: Tetrazolium salt (XTT) assay is rapid method of eval-
uation of BCG vaccine potency that produces a result in 48 h. It is
signiﬁcant correlation (r  0.82) between results of conventional
viable count method and tetrazolium salts reduction method used
for control of potency of BCG vaccine.
R2310 Protection against leptospirosis with the peptide
PP(R) of 25 amino acid from Hap1 (haemolysin-associated
protein) in gerbils (Meriones unguiculatus)
C. Branger, B. Chatrenet, F. Aviat, A. Aubert, G. Andre´-Fontaine
Nantes, Nice, F
The leptospirosis is a widespread human and animal disease
caused by pathogenic leptospires. The medical and economic los-
ses caused by such forms of the zoonotic disease justify the use of
Leptospira vaccines in human or animal populations at risk. How-
ever, available vaccines enhance a lipopolysaccharide-directed
immune response, which is serogroup-speciﬁc.
Objectives: Our previous work determined that immunisation with
the haemolysis-associated protein Hap1 (as known LipL32)
expressed by adenovirus or plasmid induced in gerbils a signiﬁ-
cant protection against a virulent Leptospira challenge, while the
recombinant protein Hap1 did not provide any signiﬁcant protec-
tion. To avoid use of vector, we identiﬁed a peptide of 25 amino-
acid from the Hap1 protein and used it in experimental challenge
assay.
Methods: Gerbils were immunised three times with either PP
(30 lg) either PP coupled to the protein carrier KLH (30 lg), con-
trols received PBS at the same times. Two weeks after the last
immunisation, gerbils were challenged by intra-peritoneal route.
Each animal received 0.5 ml of fresh culture of the virulent L. in-
terrogans ss serovar canicola (107 leptospires). Gerbils were daily
observed, and mortality rate was recorded for 28 days after chal-
lenge. Serological response was followed by ELISA.
Results: ELISA against PP was realized on sera from gerbils pro-
tected against a leptospirosis challenge after immunization either
by adenovirus either by plasmid encoding for Hap1. The IgG
immuno response of gerbils immunised with PP-KLH or PP was
analysed by ELISA against the peptide PP. Statistical analyses of
mortality incidence and survival curves of gerbils showed that the
both groups of animals (vaccinated with the peptide PP-KLH or
PP alone) were signiﬁcantly protected against lethal onset of le-
ptospirosis.
Conclusion: Our results showed that the protective effect within
pathogenic strains of Leptospira sl is shared by the peptide PP
from the Hap1 protein. Peptide vaccination would efﬁciently pre-
vent leptospirosis. This ﬁnding should facilitate the design and
development of new generations of vaccines against pathogenic
leptospires.
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R2311 Seroprevalence of rubella antibodies among
university female students
A.E. Aktas, N. Yigit, A. Ayyildiz, M.H. Uyanik
Erzurum, TR
Objectives: Rubella is a relatively mild viral infection. It’s compli-
cations are arthritis, thrombopenic purpura, and encephalitis, but
its prognosis is generally favourable. The rubella virus can induce
problems in the next generation due to fetal infection. Seropreva-
lence of rubella in Turkey is still insufﬁcient and national immuni-
sation schedules do not include rubella vaccination. In this study
we aimed to investigate the seroprevalence of rubella at child
bearing age in an unvaccinated population in Erzurum, Turkey,
to discuss whether routine rubella vaccination is necessary, and if
so when it should be administered.
Methods: Serum specimens of 176 volunteers of healthy university
female students aged 18–22 years were randomly sampled for
screening rubella-speciﬁc IgG/IgM antibodies by an automated
enzyme immunoassay system (Clark Laboratories, Inc. Rubella
IgG ELISA).
Results: A total of 174 subjects were positive for rubella-speciﬁc
IgG antibody, giving a prevalence of 97.7%. Rubella-speciﬁc IgM
antibody was not detected in none of the students.
Conclusion: The present study indicate that majority of the females
in child-bearing age in our region have an immunity to rubella
due to natural infection. This may be interpreted that routine
rubella vaccination is not necessary. However, the incidence of
autism in the UK has increased markedly over the past decate.
Some have proposed that this may be related to introduction of
the MMR (measles–mumps–rubella) vaccine in 1988. But in some
recent studies it has been reported that there is not any relation
between MMR vaccination and the risk of autism. Nonetheless,
we think that with such a relative low proportion of susceptibility
(2.3%) among university students, a rubella vaccination pro-
gramme may be enforced to prevent possible outbreaks of con-
genital rubella infection in the future.
R2312 Signiﬁcance and interpretation of serological
investigation of antibodies after vaccination against tick-borne
encephalitis
E. Jı´lkova´, V. Kra´l, J. Januska, I. Stiborova´
stı´ Nad Labem, Ostrava, CZ
Objectives: Czech Republic is considered as an important endemic
tick-borne encephalitis (TBE) region in Europe. The morbidity
moves about 4–7/100 000 inhabitants per year for last decade. It
represents 415–750 TBE illnesses per year. The active vaccination
is very often practised in children and young people in our condi-
tions, rather less in adults and elderly persons. Protection after
basic immunisation is guaranteed for 3 years at least (vaccine
information sheet) or according to the speciﬁc antibody status
maybe longer.The aim of our study was to assess contribution of
detection postvaccination antiTBE IgG for rational decision in the
immunisation practice. Interpretation problems may occur from
cross-reactions with other ﬂaviviruses and neutralising capacity of
ELISA detected IgG antibodies is a question too. Testing of anti-
TBE antibodies avidity was done.
Methods: A total of 120 persons with basic vaccination schedule
were enrolled and antibodies persisting after basic vaccination in
time aplication of the ﬁrst, second and third booster were investi-
gated. Antibodies were assayed in ELISA IMMUNOZYM FSME-
IgG and were compared with neutralisation test (NT). Avidity
assay of anti-TBE antibodies: in-house system of protein denatu-
rating immunoassay (avidity-EIA).
Results: The investigation of antiTBE IgG antibodies after 3 years
since the last revaccination demonstrated their persistence longer
than the guaranteed 3 years. Geometric mean titres (GMT) ranged
514–690 VIEU/ml in ELISA and 18–32 (titres) in NT depending
on the number of applicated doses. The avidity index was higher
in group of vaccinated persons compared with patients in acute
disease state.
Conclusions: (i) The IgG ELISA results correlate well with the vir-
uses-neutralising antibody titres in check successful vaccination. It
was not found false positivity IgG in ELISA in investigated group
of vaccinated persons; (ii) the IgG antibodies elicited after vaccin-
ation are of high avidity; this characteristic correlate with greater
serum antiviral activity; (iii) we observed persistence of postvacc-
inal antibodies for period longer than 3 years in children and
young person particularly. In the immunisation practice there are
frequent cases, when is detection of antibodies advisable to use
(neurological illnes, allergic patient, pregnancy, etc). ELISA is
available method for this situation. Results interpretation is neces-
sary to do in connection with age, history of vaccination and
health status.
Infection in transplant recipients
R2313 Four cases of Mycobacterium tuberculosis infections
in liver transplant recipients in Korea
S. Kim, Y. Kim, J. Sohn, W. Shin, M. Kang
Seoul, KOR
Objectives: Korea has been one of endemic areas of M. tuberculosis,
but there has been no data in liver transplant recipients.
Methods: Four cases of M. tuberculosis infection were reviewed
among 98 liver transplant recipients between 1996 and 2002.
Results: Two patients were diagnosed tuberculosis before trans-
plantation, one probable case and one possible case. After trans-
plantation, one proven case and one probable case were
diagnosed. In 52-year-old male, screening test before transplanta-
tion revealed multiple right upper lung nodule. Biopsy ﬁndings
were compatible with M. tuberculosis and anti-tuberculosis medi-
cations (isoniazid, rifampicin, ethambutol and pyrazinamide) were
started 38 days before transplantation. No tuberculosis associated
illness was found during 12 months after transplantation. In 51-
year-old male, pleural effusion was found during preoperation
routine check. Anti-tuberculosis medication was started because
of high (123 IU/L) ADA level in pleural ﬂuid. The regimens were
isoniazid, ethambutol, rifampin and pyrazinamide that continued
for 12 months with no speciﬁc complication. Other 50-year-old
woman complained night sweating and back pain at 10 months
after transplant. ADA levels of pleural ﬂuid was elevated to
142 IU/L and acid-fast bacilli stain of spine was positive.
M. tuberculosis was cultured from the spine. During 12 months’
anti-tuberculosis therapy no recurrence was found. Thirty-eight
year old male complained haemoptysis 13 months after trans-
plant. He was diagnosed with sputum AFB smear test. Isoniazid,
rifampin and ethambutol were started but 1 month later rifampin
was held due to rash. Five months later he stopped medication by
himself. But no active lesion was found at follow up chest X-ray.
Forty-ﬁve months later, he expired because of liver failure.
Conclusion: In Korea, incidence of liver transplantation related
M. tuberculosis infection is low (1.0%) and INH prophylaxis seems
not needed. Most patients could be treated with the ﬁrst line anti-
tuberculosis medication and no relapse was observed during the
follow-up periods.
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Paediatric infections
R2314 Adenoviruses as causative agents of infections in
children
A. Agelatou, A. Galanopoulou, E. Christakou, S. Paratiras,
T. Kaza, A. Spiliopoulou
Patras, GR
Objectives: To deﬁne the frequency of positive anti-adenoviral IgG
and IgA antibodies in children hospitalised during the current
year (2003) in our children’s hospital.
Methods: A total of 355 children younger than 14 years of age
were examined, all of whom had been treated as inpatients for
symptoms of viral, febrile illness. Anti-adenoviral IgG and IgA
antibodies were assessed by conventional enzyme-linked immu-
nosorbent assay (ELISA). The major antigenic determinant that
was used, is common for all adenoviral subtypes that produce ill-
ness in humans. IgG quantiﬁcation was performed using the sin-
gle-cut-off method, which provides high accuracy and
reproducibility of results. High IgG and positive IgA antibody
titres were considered to be indicative of acute infection (early
phase). The ﬁnding of a low IgG antibody titre alone was inter-
preted as a normal immune response to recurrent, symptomatic
or clinically silent infection by various adenoviral subtypes.
Results: Of a total of 355 sera examined, 62 (17.4%) were found to
be positive for anti-adenoviral antibodies. The 62 patients with
positive antibody tests against adenoviruses had been mainly trea-
ted for upper (pharyngitis, tonsillitis) or lower (bronchiolitis,
pneumonia) respiratory-tract infections. 45% of all patients (355)
were found to be positive for IgG antibodies only, a ﬁnding sug-
gesting past infection, whether symptomatic or clinically silent.
Conclusion: Adenoviruses constitute a signiﬁcant causative agent
of respiratory infections in children, with a higher incidence dur-
ing spring time (54% of all cases examined).
R2315 The importance of EBNA1-IgG (nuclear antibody)
for the conﬁrmation of recent/acute infection from Epstein-Barr
virus in children’s hospital
A. Spiliopoulou, A. Agelatou, T. Kaza, G. Karioris, G. Krokidas
Patras, GR
Objectives: The early diagnosis of the recent/acute infection from
EBV is of great importance for the diagnosis of the disease and
the avoidance of the frequent, unnecessary use of antibiotics. The
determination of serological pattern of EBV in patients who prob-
ably suffer from infectious mononucleosis after the addition of the
EBNA1-IgG antibody in the serological screening by the microbio-
logical laboratory.
Methods: Our material was 233 serum samples of children aged
6 months–14 years admitted at out children’s hospital during the
last 8 months or visited our outpatients’ department with clinical
suspicion of infectious mononucleosis. The sera were tested for
VCA (viral capsid antibody) IgG and IgM of EBV using the
method of indirect immunoﬂuorescence (IFA) and for EBNA1-IgG
using the immunoenzymatic method ELISA.
Results: From the 233 serums tested, 34 were found positive for
recent/acute infection of EBV (14.6%). The proﬁle of the antibod-
ies of the positive samples is shown in the table below.
Conclusions: The measurement of VCA-IgM and VCA-IgG anti-
bodies only in the EBV serology results in the loss of 29.3% of the
cases of recent/acute infection, a problem which can be solved
with the help of EBNA1-IgG [proﬁle: EBNA1-IgG(), VCA-
IgG(++)]. Therefore the determination of EBNA1-IgG is consid-
ered necessary in order EBV infection to be diagnosed with high
ﬁdelity.
R2316 Evaluation of prenatal screening and intrapartum
antibiotic prophylaxis for the prevention of perinatal group B
streptococcal disease
I. Montesinos, M. Ramos, B. Castro, J. Martı´n, P. Fuster,
M. Miguel, A. Sierra
La Laguna. Tenerife, E
Objectives: The evaluation of prenatal screening for vaginal and
rectal colonisation and intrapartum antibiotic prophylaxis for the
prevention of perinatal group B streptococcal (GBS) disease in the
Hospital Universitario de Canarias (HUC) in the last 4 years.
Methods: The prenatal screening of the pregnant women was real-
ised at 39–40 week gestation with the swab collection both the
lower vagina and rectum and cultured 24–48 h in a tube of Gra-
nada Medium (Biomedics). The candidates to intrapartum antibi-
otic prophylaxis was the colonised pregnant women and the
pregnant women with risk factor (according with the last CDCs
recommendations). In 2003, we have changed the Granada Med-
ium for the Instant Granada Medium and we have also incre-
mented the nurses per delivery-rooms and a better
implementation of the intrapartum antibiotic prophylaxis. From
2000 to November 2003, we have evaluated the screening preg-
nant women percentage, the colonised pregnant women percent-
age, the incidence of the early-onset and the late-onset GBS
bacteraemia and Enterobacteriaceae bacteraemia.
Results: During 2000, 2001, 2002, until November 2003, the num-
ber of deliveries at HUC was 2418, 2543, 2448 and 2037, respect-
ively. 37.3, 38, 40, 40%, of the pregnant women was screened and
10, 11, 10 and 15% were colonised per year. In 2000 there were 4/
1000 early-onset GBS bacteraemia per live births; 4.4/1000 in 2001;
3.2/1000 in 2002 and 0.5/1000 in 2003. The late-onset GBS bacter-
aemia per live births were 0.4/1000, 0.4/1000, 1.6/1000 and 0/
1000, respectively. The evolution of Enterobacteriaceae bacterae-
mia projected an incidence of 11.1/1000 live births in 2000, 7.07/
1000 in 2001, 6.1/1000 in 2002 and 13.2/1000 in 2003. In 2003 we
have incremented by 5% the detection colonised pregnant women
and the incidence of early-onset bacteraemia has declined by
87.5% from 4/1000 live births in 2000 to 0.5/1000 live births in
2003.
Discussion: Declines in perinatal GBS diseases incidence in 2003
suggest that prevention strategies have been implemented succes-
fully, though it could be improved. Continued surveillance of
neonatal bacteraemia other than GBS is needed.
R2317 Pertussis is the main cause of prolonged cough
illness in children
I. Narkeviciute, E. Kavaliunaite, G. Bernatonien, R. Eidukevicius
Vilnius, LIT
Background: The morbidity of pertussis in Lithuania in fact is
higher than registered ofﬁcially. According to existing practice,
children in Lithuania are being vaccinated at 3, 4.5 and 6 months
of age using cellular pertussis vaccine and booster dose at
18 months of age. The aim of our study was to establish B. per-
tussis role of prolonged cough illness in children, by evaluating
pertussis epidemiological and clinical data.
Patients and methods: A total of 70 children with prolonged cough
illness hospitalised in Vilnius University Children’s Hospital,
were observed during 8 months of 2001 year. Individual and
Table 1. Positive Samples for EBV recent/acute infection
N % VCA-IGM VCA-IgG EBNAI-IgG
4 11.8 þ  
20 58.9 þ þ 
10 29.3  þ 
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epidemiological data, clinical manifestation and laboratory results
(B. pertussis IgM and IgA antibodies, ELISA, Labsystem, Finland)
have been evaluated.
Results: Pertussis was diagnosed in 53 children. To 49 children the
diagnosis of pertussis was conﬁrmed by serology tests and for
four children, only by clinical ﬁndings. Children age was
1 month–15 years (mean age 7.6  5.4 years). Nine of 16 infants
were not vaccinated at all, seven infants were not fully vaccinated
against pertussis. Fifty-eight per cent before they fell ill with per-
tussis, got in to contact with persons with prolonged cough illness
in the family, school or day-care centres. The duration of cough
before pertussis diagnosis was conﬁrmed was at average 47 days
(mean 4–270 days). Most of children (88.7%) had paroxysmal
cough, 41.2%, typical ‘whoop’ and 13.7%, apnea, 39.6% of the
patients had a cough leading to vomiting. Four children were
treated in ICU. All recovered.
Conclusions: Pertussis is the main cause of prolonged cough illness
in children. Most of the children had typical clinical symptoms of
pertussis.
R2318 Relationship between serum selenium levels, lipid
peroxidation and acute bronchiolitis in infancy
F. Gurkan, A. Ece, Y. Atamer, Y. Kocyigit, H. Tuzun, M. Mete
Diyarbakir, TR
Objectives: The possible interaction between serum malondialde-
hyde (MDA) and selenium (Se) levels and the occurrence and
severity of acute bronchiolitis in children was investigated in
order to discuss the possible role of Se for the disease manage-
ment.
Methods: Thirty-four infants with acute bronchiolitis were enrolled
into the study group at the paediatric emergency room in Dicle
University Hospital, Diyarbakir during September 2002 and May
2003, and were compared with 25 age-matched healthy controls.
Serum samples were taken for serum Se and MDA measurements,
and clinical score was assessed at admission. Blood was taken
again from the children with bronchiolitis at 2 months after dis-
charge from the hospital.
Results: MDA as a marker of free radical activity was signiﬁcantly
higher in patients with acute bronchiolitis than at postbronchioli-
tis stage and the controls 4.2  2.5, 1.4  0.8 and 0.7  0.2 nmol/
L, respectively (P < 0.001). Infants with bronchiolitis had lower
mean serum Se levels at the acute stage than after 2 months
(31.7  28.9lg/L vs. 68.4  26.4 lg/L, respectively); both of
which were signiﬁcantly lower than the control group measure-
ments (145.0  21.9 lg/L) (P < 0.001). There was a negative corre-
lation between serum MDA and Se levels in the patient group
(r ¼ 0.85, P < 0.001). There were no signiﬁcant correlations
between serum Se or MDA levels and patient’s clinical score at
admission, age of the patient, child’s immunisation status, paren-
tal smoking habit and family crowding index.
Conclusions: Increased MDA levels and impaired Se status demon-
strate the presence of possible relationship of these parameters
with pathogenesis of acute bronchiolitis, and antioxidant supple-
mentation with Se may be thought to supply therapeutic effect
against bronchiolitis.
R2319 Is there any relationship between Chlamydophilia
pneumoniae infection and juvenile idiopathic arthritis?
S. Altun, O¨. Kasapcopur, M. Aslan, S. Karaarslan, V. Ko¨ksal,
S. Saribas, N. Arisoy, B. Kocazeybek
Istanbul, TR
Objectives: The aim of the study is to investigate the role of Chla-
mydophilia pneumoniae in the development and exacerbation of
juvenile idiopathic arthritis (JIA).
Methods: Blood samples were taken from 60 JIA patients in active
period and 4 weeks after this period. Synovial ﬂuid samples were
taken from 20 of the 60 patients. Besides that, 22 familial Mediter-
ranean fever (FMF) patients in active period and also 35 healthy
children were taken into the study as the control group. Synovial
ﬂuid samples were taken from only three children with FMF. IgG,
IgM, IgA levels against C. pneumoniae were studied from the
serum samples with immunoﬂuorescence method and IgG anti-
body and PCR studies for C. pneumoniae DNA were studied from
the synovial ﬂuid samples.
Results: A total of 29 (48.3%), 18 (81.8%) and 11 (73.3%) of JIA,
FMF and healthy children cases were found preinfected with C.
pneumoniae, respectively. Preinfection with C. pneumoniae among
FMF patients was found signiﬁcantly higher than JIA cases. We
did not ﬁnd a signiﬁcant difference by comparing JIA cases with
healthy children. The markers of chronic C. pneumoniae infection
are IgG >1/512 and IgA >1/40 and this situation have been
observed only in six patients with JIA, one with FMF and in two
healthy children. Synovial ﬂuid antibodies were found higher
than 1/512 and four times higher than normal serum in one JIA
and three JIA patients, respectively. C. pneumoniae DNA was not
detected in any synovial ﬂuid sample from FMF or JIA patients
by PCR.
Conclusions: C. pneumoniae infection does not have a triggering
or a progressive effect on clinical situation in JIA aetiopathogen-
esis, resulting from multifactorial etiological factors. New, exten-
sive and serial studies (especially PCR studies for synovial
tissue) are needed in order to conﬁrm our indirect results in
case level.
R2320 Diagnostic value of virological, bacteriological and
cytological screening in children with chronic tonsillitis
S. Isajevs, A. Zilevica, J. Markovs, N. Zamiatina, V.I. Kalnina
Riga, LV
Objectives: Chronic tonsillitis (CT) is a common disease in clinical
practice. Specialised cell junctions (SCJ) of reticular epithelium of
the tonsillar crypt regulate paracellular movements of antigens.
The breakdown of SCJ during CT due to pathogens action may
facilitate the exfoliation of epitheliocytes into lumen of tonsillar
crypts. The aim of the study was to compare diagnostic value of
cytological, bacteriological and virological tests among patients
with chronic tonsillitis and determine the susceptibility of isolated
microorganisms to antimicrobial drugs.
Methods: Sixty chronic tonsillitis patients in disease exacerbation
stage (10–18 years old) were investigated for the presence of dif-
ferent bacteria, viruses and desquamated epithelial cells in the
crypts of palatine tonsil. The rapid diagnosis of adenovirus, para-
inﬂuenza, inﬂuenza A and B, and respiratory-syncytial virus
infection was made by viral antigen detection using immunoﬂuo-
rescence direct procedure from pharyngeal aspirates. The HHV1,
2 and CMV DNS was detected by polymerase chain reaction. Im-
munohistochemical staining was performed in Sweden Orebro
University on 30 tonsil specimens obtained from tonsillectomy.
Tissue sections were stained with CMV and EBV antibodies. A
bacterial throat culture was obtained from each patient by swab-
bing both tonsils with a cotton-tipped swab. Microorganisms’ bio-
chemical indentiﬁcation was performed using Crystal datorsystem
tests.
Results: We have shown that in CT the tonsils are reservoir of
streptococci, staphylococci, adenoviruses and Epstein-Barr virus.
The isolated microorganisms are resistant as a minimum to two
from eight used antimicrobial drugs. Obtained data showed an
increased desquamation of epithelial cells that correlates with
intense reproduction of viruses and microorganisms.
Conclusion: It is suggested that chronic inﬂammation is main-
tained by colonisation and multiplication of CT speciﬁc patho-
gens. In CT exacerbation pathogens proliferation lead to alteration
in SCJ morphology with consequent shedding of the epithelio-
cytes. The present study suggests the synergy between crypt
cytology, and bacteriological and virological ﬁndings.
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R2321 Haemophilus inﬂuenzae serotype e cross-infection
from a cystic ﬁbrosis patient in a paediatric hospital in Portugal
M. Bajanca, F. Teixeira, M. Canic¸a
Lisbon, Oporto, P
Background: Haemophilus inﬂuenzae (HI) has been responsible for a
number of human diseases, including chronic respiratory infec-
tions as cystic ﬁbrosis. Most of HI strains are noncapsulated,
being the capsulated strains classiﬁed in six serotypes, a–f. The
introduction of Hib vaccine in many countries contributed to a
decline of this serotype. Many studies have been done to ﬁnd out
the possible changes that may occur in the epidemiology of the
HI disease, namely changes related to capsule replacement and
virulence of non-b strains.
Objectives: Phenotype and molecular characterisation of three HI
strains isolated in a Children’s Hospital in OPorto, Portugal,
involved in a cross-infection. Two of the strains were isolated,
within 1 month from a boy, 11 years old, with cystic ﬁbrosis. The
other strain was collected from a nurse that was in contact with
this patient, 4 days after the ﬁrst isolate of the child.
Methods: Biotype, serotype (agglutination procedure and PCR), b-
lactamase production (nitroceﬁn) and antibiotic susceptibility
(microdilution assay) to 14 antibiotics (ampicillin, amoxicillin-cla-
vulanate, cefotaxime, cefaclor, cefuroxime, cefepime, meropenem,
tetracycline, chloramphenicol, trimethoprim–sulphamethoxazole,
rifampicin, ciproﬂoxacin, azithromycin and erythromycin) were
performed to characterise the phenotype of isolates. Breakpoints
used were according to NCCLS 2003. A molecular approach was
used to evaluate the clonality of isolates (pulsed-ﬁeld gel electro-
phoresis).
Results: All three strains were b-lactamase negative, belonged to
biotype IV and had the same capsular serotype, e. They had the
same antibiotic susceptibility pattern, being only resistant to trim-
ethoprim–sulphamethoxazole DNA typing permitted the identiﬁ-
cation of the same pattern in the three strains showing that all
had the same origin and were closely related.
Conclusion: These results are in agreement with a cross infection
of HI serotype e from a cystic ﬁbrosis child to the nurse that
was in contact with him. One month later the child was still
infected with the same strain. Serotype e strains are still rare in
Portugal, although they are emerging after the introduction of
the Hib vaccine. It is of most concern to continue monitoring
serotypes of HI responsible for different infections, to detect
possible changes that may occur after the introduction of the
vaccine in our country.
R2322 Coexistence of pseudomembranous enterocolitis
and Crohn’s disease: a rare occurrence
S. Oncel, N. Dalgic, A. Yagmurlu, D. Gumus, B. Ozturk,
F. Demirceken, E. C¸iftc¸i, E. Ince, A. Kansu, N. Girgin, U¨. Dogru
Ankara, TR
Introduction: The clinical picture of Clostridium difﬁcile infection
ranges from asymptomatic infection to severe diarrhoea, pseudo-
membranous enterocolitis, toxic megacolon and colonic perfor-
ation. Here we present a patient with pseudomembranous
enterocolitis, evolved in the setting of Crohn’s disease.
Case: A 9-year-old girl presented with a history of abdominal pain
that had started 10 days before. She had reportedly been given an
enema containing hydrogen peroxide in a medical facility; then
she started to pass watery, bloody stools. On admission to our cli-
nic, she had septic appearence and abdominal rigidity. Her clin-
ical status deteriorated gradually afterwards. There were no
pathological ﬁndings in laparoscopy except for some haemorrhag-
ic ﬂuid in the abdomen. She recovered with meropenem plus met-
ronidazole and was discharged. Two weeks later, she presented
with vomiting, diarrhoea, fever, dehydration with distention and
tenderness of the abdomen. Plain abdominal ﬁlms showed gas-
ﬂuid levels. Ultrasonography revealed ascites. ‘Accordion sign’,
noted in abdominal computed tomography and endoscopically-
detected yellow membranes on the rectosigmoid mucosa were
both suggestive of pseudomembranous enterocolitis. The presence
of C. difﬁcile toxin A conﬁrmed this diagnosis. Metronidazole in
combination with oral vancomycine was started and the patient’s
symptoms gradually subsided. A few days later, she began to
complain about abdominal pain again while still on antibiotics.
Rifampin and intravenous immune globulin were added to her
therapeutic regimen. Metronidazole was stopped and vancomy-
cine dosage was reduced. Repeat endoscopy was completely nor-
mal. Days later, her clinical status began to deteriorate once again.
She had diagnostic laparotomy and since the appearance of the
colon was very suggestive of inﬂammatory bowel disease, partial
colectomy was performed. The histopathological examination of
the surgical specimen showed characteristics of Crohn’s disease.
She was given prednisolone and sulfasalazine and is doing quite
well since then.
Discussion: This is the second case report of coexistence of pseu-
domembranous enterocolitis and Crohn’s disease in electronically
searchable medical literature. Crohn’s disease may be an underly-
ing pathology which facilitates pseudomembranous enterocolitis
and we propose that these coexistence be kept in mind when
dealing with patients showing the clinical manifestations of either
disease.
R2323 The outcome in children with congenital
cytomegalovirus infection
D. Bartosova, L. Klapacova
Brno, CZ
Objectives: In this report, the authors have presented clinical pic-
ture, course and therapy used in 18 infants with congenital CMV
infection hospitalised at the Department of Paediatric Infectious
Diseases in Brno within January 1998–August 2003.
Methods: The diagnosis of congenital CMV infection was estab-
lished partly clinically on the base of typical symptoms of congen-
itally acquired disease, in a part of infants even from personal
anamnesis (mother’s disease during pregnancy) and especially
veriﬁed by means of laboratory isolation of CMV virus in urine
and by means of serological examinations.
Results: In the set of 18 newborns with conﬁrmed congenital CMV
infection, 11 of them have permanent neurological consequences
involving motor of psychomotor problems. Five of them suffer
from sensoric affection (4 disturbance up to loss of hearing, 1
strabism).
Conclusions: (i) As most maternal infections are asypmtomatic,
repeated serological screening of all susceptible seronegative
women would be required throughout pregnancy. (ii) There is no
effective treatment for either mother or infant, and the only inter-
vention that could be offered to a woman with primary infection
is termination of the pregnancy. (iii) There is no established treat-
ment for congenital CMV infection, although ganciclovir or foscar-
net have been suggested for use to inhibit disease progression.
However, there are no approved antivirals for use in neonates to
prevent progression of CMV disease. (iv) The results have con-
ﬁrmed the well-known fact that more frequent and more serious
consequences are observed in neonates with symptomatic CMV
infection after the delivery.
R2324 Streptococcal toxic shock syndrome together with
multifocal osteomyelitis and myocarditis
E. Ince, E. C¸iftc¸i, M. Kologlu-Bingol, A. Comba, N. Dalgic,
S. Oncel, U¨. Dogru
Ankara, TR
Introduction: In addition to multisystem involvement streptococcal
toxic shock syndrome (STSS) results in soft tissue damage like
necrotising fasciitis, necrotising myositis, pyomyositis and gan-
grene. The association of osteomyelitis and STSS has not been pre-
viously reported in children.
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Case: A previously healthy 13-months-old male infant was
brought in for fever, rash, seizures and swelling and decreased
mobility of left forearm and right thigh. His initial complaints
were fever and swelling of left forearm which had started 3 days
before and other complaints had appeared during the last 24 h.
Physical exam revealed impaired consciousness, hypotension,
poor peripheral circulation, generalised erythematous rash, swell-
ing of left forearm and right thigh together with erythema,
increased warmth, decreased mobility, and necrosis over right
hand and foot. His laboratory tests revealed elevated renal and
liver function tests, elevated creatinine phosphokinase, thrombo-
cytopenia and prolonged PT and aPTT, together with increased
D-dimer levels. Intravenous ceftriaxone was started and clindamy-
cin was added after the blood culture grew Group A – b-haemo-
lytic Streptococcus. Shock and DIC were taken under control with
dopamine infusion and fresh frozen plasma and thrombocyte
transfusion. Liver and renal function tests returned to normal,
however heart failure developed during follow-up. Myocarditis
was diagnosed by low voltage EKG, and dilated heart and poor
ventricular functions shown by echocardiogram, which was trea-
ted successfully by dobutamine. Cardiac functions returned to
normal within 10 days. Computed tomography of the right
femoral region revealed intramuscular abscesses, which were
drained. Osteomyelitis of the left ulna and thrombosis of the left
axillary vein was also diagnosed and the thrombus resolved with
heparin treatment. During follow-up swelling of left foot devel-
oped and direct ﬁlms and bone scan showed osteomyelitis of left
and right foot ﬁrst metatarsal bone. Osteomyelitis resolved with-
out surgical drainage after 8 weeks of antibiotic treatment.
Discussion: Soft tissue involvement in STSS is due to focal inva-
sion during bacteraemia. The pyomyositis in our case shows
that in addition to the necrotic soft tissue involvement in STSS,
multifocal osteomyelitis can also develop. The other interesting
feature of this case is the development of myocarditis, which is
observed very rarely in STSS and is attributed to circulating
toxins.
R2325 The consequence of the aetiological agent in the
clinical course of paretic involvement in children
L. Krbkova, K. Holeckova, Z. Blechova, V. Maresova, K. Soltysova
Brno, CZ; Bratislava, SK; Prague, CZ
Objectives: To ﬁnd out the clinical course of paretic involvement
relevant to the aetiology in three major centres for infectious dis-
eases in Czech and Slovak Republic.
Methods: Five-year retrospective study between 1999 and 2003
evaluates all cases with peripheral and central pareses. Detailed
epidemiological, clinical and laboratory data were available from
273 children. Serological examinations for neurotropic viruses or
bacterial agents were performed according to epidemiological cir-
cumstances. CSF was analysed for cytology, proteins, glucose,
detection of bacterial antigens and antibodies against neurotropic
viruses, respectively antiborrelial antibodies or PCR.
Results: Isolated facial palsy was diagnosed in 53% of children
whereas facial palsy associated with aseptic meningitis was pro-
ven in 41% of children. Only 21% of them suffered from com-
plete unilateral paralysis. Both sides were affected equally (48%)
and bilateral facial palsy appeared in 4%. Other paretic involve-
ments occurred rarely: cranial neuritis of sixth nerve (two), hem-
iparesis (one), monoparesis (two), quadruplegia (one) or
paraplegia (one). Erythema migrans was conﬁrmed in 11% of
children. Febrile course was observed in 49% and the duration
of signs of pareses was median 14 days during admission, alto-
gether median 24 days. Abnormal CSF analysis appeared in
50%. Pleocytosis was detected in 47% and isolated abnormal
values of total protein in 3% of children. Borrelial aetiology was
proven in 43% of children, meningoneuritis (35%) was diag-
nosed by intrathecally produced antibodies in the ﬁrst CSF sam-
ple. 5% of children suffered from facial palsy of herpetic
aetiology. Enteroviruses caused only 1% of paretic involvement.
The part of other viral agents in the aetiology was <1%. The
aetiology remains unknown in 46% of children. Several statisti-
cally signiﬁcant distinctions (P < 0.05) were found in the clinical
course, and CSF ﬁndings between the group with bacterial and
viral or unknown aetiology.
Conclusion: The clinical manifestation of neuroborreliosis is unilat-
eral or bilateral facial palsy, respiratory meningoneuritis in chil-
dren, mostly diagnosed from paretic involvements. Viral aetiology
was proven in only 7% of cases. To reveal the full spectrum of
causative agents requires routinely using molecular biological
techniques. The most feared manifestations of CNS infections:
encephalomyelitis, meningomyeloradiculitis, Guillain-Barre´ syn-
drome tend to occur rarely in children.
R2326 Lyme carditis
L. Krbkova, P. Havlicek, J. Navratil, P. Vit, H. Stroblova
Brno, CZ
Objectives: To report two severe cases of Lyme carditis in children
and to point out the impact of early antibiotic therapy.
Patients: Two children were admitted to Children’s University
Hospital in Brno with complete heart block of unknown origin.
Basic laboratory tests, electrocardiogram (ECG), serology for car-
diotropic viruses and Lyme borreliosis were performed. Prior
heart disease was excluded.
Results: Previous tick bite was noticed in one child, stay in ende-
mic area in the second one. Onset of the ﬁrst cardiac symptoms:
weakness, palpitations, syncope and chest pain in July and Sep-
tember, suggested borrelial aetiology. Acute ECG changes show-
ing complete heart block allowed to initiate the antibiotic
therapy (ceftriaxone/cefotaxime). Four to seven days later, ﬁrst-
degree heart block was registered, I.PQ 0.36 s/II.0.39 s. In one
case an escape rhythm persisted (PQ 0.38–0.50 s) for 8 days. One
month later, no symptoms or signs of atrioventricular distur-
bance and normal PQ 0.16–0.17 s were present. High titres of
IgM antibodies against B. burgdorferi sensu stricto were conﬁrmed
in the ﬁrst samples, ﬁve speciﬁc antigens reacting in immuno-
blot. Seroconversion was detected in 18 days. In the second
child, signiﬁcant decline of speciﬁc IgM and IgG titres was
found 2 months later, only OspC and p41 were detectable in im-
munoblot. Cephalosporins of the third generation were given for
28 days intravenously. Neither child did require temporary car-
diac pacing.
Conclusion: Cardiac manifestation was seen for the ﬁrst time in
our children. Borrelial infection caused by B. burgdorferi sensu
stricto is rarely seen in Europe. Early diagnosed severe involve-
ment of the heart with appropriate antibiotic therapy had an
excellent prognosis for both children even associated with critical
atrioventricular conduction abnormality. Four-week course of
antibiotic treatment was sufﬁcient to prevent further sequelae and
effectively eradicated borrelial infection. The prognosis depended
on the management of the acute stage.
R2327 Pneumocystis carinii pneumonia in the neonatal
intensive care unit
L. Kolodziejczyk, B. Loniewska, B. Pawlus, W. Kuyna-Grygiel,
J. Rudnicki, R. Czajka
Szczecin, PL
Pneumocystis carinii (P. carinii) is a classical, opportunistic, patho-
genic factor, belonging to mycetes (Ascomycetes). It mostly affects
people with lowered immunity. It can be dangerous also in neo-
natal intensive care units (NICU) because of immature immune
system of newborn infants especially premature ones. There are
few other risk factors as parenteral nutrition, long antibiotics treat-
ment, possible hospital’s infection and adrenocortical hormonal
treatment.
Objective: The aim of the work was clinical analysis P. carinii
infection in the newborn infants.
Materials and methods: There have been analysed 57 newborns
with P. carinii pneumonia, hospitalised in NICU of the Depart-
ment of Obstetric and Perinatology Pomeranian Medical Univer-
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sity. In examination group there were 55 premature
(26.7  1.9 weeks of gestational age and birth weight 990  197 g)
and two full-term newborns with congenital abnormalities. There
was no patient infected HIV. All of them needed mechanical ven-
tilation. Suspection of P. carinii pneumonia was made on the basis
of characteristic clinical symptoms and also radiological changes
(interstitial pneumonia). Clinical diagnosis was proven by micro-
scope inspection of bronchoaspiration (BAL) with the usage of Gi-
emsa’s stain method. Control microscope inspection were taken
after 7–10 days of treatment. Biochemical tests were taken to local-
ise infection: C-reactive protein concentration, white blood cell
count, blood platelets count, the immature/total neutrophil ratio
was inspected.
Results: P. carinii pneumonia was diagnosed from sixth to 52nd
day of living (20  12 days). In the moment of diagnosis 48
infants were mechanically ventilated, none of them were brea-
thing without ventilation but after earlier extubation. First symp-
toms of P. carinii pneumonia were apnoeas and saturation
decreases without self-existing bradycardia. The most frequent
signs were: apnoea, grey or pale skin, excessive secretion in res-
piratory tract, convulsions and abdominal distension. Chest X-ray
showed interstitial pneumonia. Laboratory tests were nonspeciﬁc.
Diagnosis was conﬁrmed by presence of P. carinii cysts in micro-
scopic test of BAL. Associated cotrimoksazol and penthamidyne
treatment was performed for 14 days. In four newborns treatment
does not any clinical effect, three of them died.
Conclusion: Pneumocystis interstitial pneumonia is opportunistic
infection causing serious complications in severely ill, HIV-negat-
ive, mechanically ventilated newborns.
R2328 Community-aquired pneumonia in children
1997–2003
V. Maresova, Z. Blechova, S. La´sikova´, B. Horova´, M. Dohnanska
Prague, CZ
Objectives: Community-acquired pneumonia (CAP) has usually in
immunocompetent children a benign course. The aim of the study
was evaluation of primary diagnoses in children sent to hospital,
determination of aetiological agents and resistance and elabor-
ation of guidelines for primary-care settings.
Patients and methods: Children with suspicion of pneumonia
between 0 and 18 years of age admitted to the clinic of infectious
diseases were included in the study. The diagnosis of pneumonia
was established during the ﬁrst 48 h of hospitalisation and veri-
ﬁed by X-ray examination. Clinical symptoms, laboratory parame-
ters, complications, mortality and therapeutic approach were
monitored. Blood cultures were taken before antibiotic treatment
was started. In children with atypical symptoms were done also
serological examinations.
Results: During the studied period was CAP diagnosed in 192
children but only 39 (20.4%) children were sent to hospital
with this diagnosis. Other diagnoses were: bronchitis, suspicion
of neuroinfection, suspicion of GIT infection. In 55 children was
treatment with antibiotics started before admission. Blood cul-
tures were taken in 46 patients: 8 Streptococcus pneumoniae, 1
Neisseria meningitidis type C, 1 Streptococcus mitis, 5 Staphylo-
coccus epidermidis (presumably contamination). In one case was
S. pneumoniae found in aspirate and in one patient was positive
PCR in the serum. All strains were sensitive to penicillin and
erythromycin. Serological examinations were done in 47 chil-
dren: in 15 cases were detected respiratory viruses, in Mycoplas-
ma pneumoniae, in two cases was found mixed infection –
viruses and M. pneumoniae, 3 Chlamydia spp., 6 Varicella
pneumonia. Typical X-ray picture of lobar pneumonia was found
in ﬁve children; in three of them was conﬁrmed S. pneumoniae.
In 15 children was diagnosed pleuropneumonia, and in three of
them was detected S. pneumoniae. 36 children were admitted to
ICU.
Conclusions: (i) Identical diagnosis CAP before admission was in
20% only. (ii) Blood culture is a gold standard for diagnosis; the
other possibilities are detection of antigens or PCR. (iii) S. pneumo-
niae has good sensitivity to penicillins and macrolides. (iv) Viral
aetiology is more frequent than M. pneumoniae, and Chlamydia
spp. is rare in children. (v) Penicillins represent ﬁrst choice ther-
apy for lobar pneumonia or pleuropneumonia in children, macro-
lides for atypical pneumonia.
R2329 Varicella and its complications: a 5-year-long
retrospective analysis of hospitalised patients
V. Maresova, M. Maly, J. Kyncl, E. Bronska on behalf of the Study
Group Varicella
Objectives: The aim of the study was to analyse complications of
varicella both in healthy and immunocompromised individuals
and to elaborate guidelines for vaccination.
Methods: Retrospective analysis of patients hospitalised in selected
departments of infectious diseases in 1997–2001 years in the Czech
Republic (CR) and comparison of obtained ﬁgures with total num-
ber of cases reported in EPIDAT.
Results: During study period 1977 cases of varicella were hospi-
talised in CR. In 10 selected depts.infect.dis. were hospitalised
1317 (66.6%) patients. 79% of patients were children below
18 years of age, 21% were adults. The average duration of hos-
pitalisation was 8.1 day, median duration 7 days. In 147 (11.2%)
children were registered risk factors in anamnesis, 78 patients
were on immunosuppressive treatment. Complications were
observed in 851 (64.6%) patients: in 282 (21.4%) patients local
and in 569 systemic. Systemic complications were observed in
42.4% of children and in 46.4% of adults (RR ¼ 1.18; P ¼ 0.23).
There was no signiﬁcant difference in occurrence of complica-
tions between groups with or without risk factors: the occur-
rence of local complications in the group with risk factors was
29.3% compared with 29.6% in nonrisk group (RR ¼ 0.99;
P ¼ 0.98). Incidence of systemic complications in risk group was
33.3%. Signiﬁcantly higher incidence of systemic complications –
44.4% was among adult patients (RR ¼ 0.75; P ¼ 0.01). Alto-
gether 569 primary complications were observed – 104 cases of
encephalitis, 156 cases of liver involvement and in 21 patients
was diagnosed atypical pneumonia (average age 26.9 years). 141
patients were treated in intensive care units and three patients
required reanimation care. The average duration of stay in inten-
sive care unit was 6.0 days (median 5 days). Only 17 patients
had a history with risk factors. 527 patients were treated with
aciclovir.
Conclusions: (i) There was no signiﬁcant difference in occurrence
of complications between immunocompromised and immuno-
competent patients, higher incidence of complications was
observed in adults. (ii) Most frequent complications were liver
involvement and encephalitis and in adults atypical pneumonia.
(iii) The course of the disease was signiﬁcantly inﬂuenced by
administration of aciclovir. (iv) Vaccination against varicella is
recommendable for immunosuppressed children and adults and
immunocompetent nonimmune adults.
R2330 Break points in gut microﬂora formation
E. Sepp, T. Voor, K. Julge, K. Livukene, M. Mikelsaar
Tartu, EST
Formation of gut microﬂora is a gradual process in which several
stages can be distinguished. During the ﬁrst few days of life, the
intestinal tract is rapidly contaminated with different aerobic and
microaerophilic microorganisms. After 1 month the intestinal
microﬂora anaerobic microorganisms gradually exceed the colonic
aerobic ﬂora. However, little information is available about break
points of different microorganisms in gut microﬂora during the
ﬁrst 5 years of life. The aim of this study was to investigate the
formation of children gut microﬂora starting from birth up to the
5 years age.
Material and methods: We investigated 107 faecal samples from 36
children during 5 years of life. Weighed samples were serially
669Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
diluted, seeded on nine different media and incubated in certain
environment. After the identiﬁcation of bacteria the quantitative
composition was calculated: counts in log CFU/g and relative
share in total counts of microorganisms (%).
Results: During the ﬁrst 5 years of life the counts (r ¼ 0.565;
P < 0.0001) and the relative share (r ¼ 0.586; P < 0.0001) of aero-
bic bacteria showed negative correlation with age. The counts of
coagulase-negative staphylococci (r ¼ 0.484; P < 0.0001), Staphy-
lococcus aureus (r ¼ 0.542; P < 0.0001), enterococci (r ¼ 0.452;
P < 0.0001) and enterobacteria (r ¼ 0.470; P < 0.0001) decreased
with the increase of age. At the same time the total counts of
anaerobes did not change during 5 years, yet their relative share
(r ¼ 0.586; P < 0.0001) correlated positively with age. Differently,
the relative share of anaerobic biﬁdobacteria (r ¼ 0.586; P  0.05)
decreased from birth to 5 years, due to the decrease of their
counts after 1–2 years of life. During 5 years of life the break
points of bacterial counts were different high numbers of staphy-
lococci starting from ﬁrst month decreased to 3–6 month
(P < 0.01), enterococci and enterobacteria decreased from 1 to
2 years to 5 years of life (P < 0.0001), bacteroides (P < 0.05) and
clostridia (P < 0.0001) signiﬁcantly increased starting from 3 to
6 months to 1–2 years and decreased (P < 0.05; P < 0.0001) from
1–2 to 5 years of life.
Conclusion: The break points of different aerobic and anaerobic
bacteria counts in the gut microﬂora can be applied for estimation
of the age-balanced state during 5 years of life.
R2331 Quantitative culture of bronchoalveolar lavage ﬂuid
(BALF) in Greek children
H. Papavasileiou, A. Makri, D. Mermiri, L. Voyadzi, I. Andrianop-
oulou, K. Priftis
Athens, GR
Introduction: Culture of the secretion of the lower parts of lungs in
paediatric patients is difﬁcult and samples from certain pathologi-
cal parts of the lungs are impossible to obtain with conventional
methods. The ﬂexible ﬁbreoptic bronchoscopy (FFB) is a well
accepted technique to obtain bronchoalveolar secretions.
Objective: We registered the microbial growth in cultures and the
resistance to antibiotics after a FFB in certain paediatric respirat-
ory patients.
Materials and methods: A total of 198 BALF samples were obtained
and studied from children aged from 18 months to 12 years old.
Indications for the bronchoscopy were: persistent or recurrent
pneumonia or atelectasis, chronic cough and recurrent wheezing.
From the investigation excluded children with immunodeﬁciency
and cystic ﬁbrosis. BALF was obtained either from the abnormal
area of the lung, or from the right middle lobe in cases of nonfo-
cal pathology in a standardised manner. Quantitative cultures
were performed for common and anaerobic bacteria, fungi and
mycobacteria. Positive was considered the sample with growth of
104 and 103 CFU/mL of an isolated pathogen together with
presence of leucocytes.
Results: A total of 59 of 198 BALF (29.7%) cultures were positive
for common bacteria, whereas in two (simblings) grew M. tubercu-
losis. The frequency of the isolated bacteria was as follows: H. in-
ﬂuenzae 33/59 samples (55.9%), M. catarrhalis 19/59 (32.2%), S.
pneumoniae 13/59 (22.0%), S. aureus ﬁve of 59 (8.4%), Ps. aerugi-
nosa six of 59 (10.1%), Candida albicans three of 59 (5.0%) and
other bacteria three of 59 (5.0%). In 12/59 (20.3%) of the samples
two or more pathogens isolated in a growth of 104 CFU/mL. A
total of 42 of the bacteria positive samples obtained from children
with focal lesions. The rest had no evidence of alveolar involve-
ment (P < 0.01). Increasing resistance to antibiotics was found in
S. pneumoniae to penicillin (46.1%), H. inﬂuenzae to trim/sulpha
(24.5%), S. aureus to oxacillin (31.8%) and M. catarrhalis to ampi-
cillin (70.0%).
Conclusion: Haemophilus inﬂuenzae is the most common pathogen
isolated. BALF culture in children seems to give useful informa-
tion, which contributes to the clinical consideration of the problem
and the selection of the proper antibiotic.
R2332 Viral aetiology of acute lower respiratory infections
among hospitalised children in Greece
G. Antonaki, K. Kallergi, A. Zaﬁropoulou, I. Niniou, K. Brettos,
M. Foustoukou
Athens, GR
Objectives: The viral aetiology of acute lower respiratory infections
(ALRIs) in hospitalised children under 3 years of age was studied.
Methods: During the winter seasons from 1998 to 2003, 1847 chil-
dren with ALRIs were tested for the determination of the respon-
sible aetiologic viral agent. Nasopharyngeal aspirates (NPAs)
were analysed for the common respiratory viruses antigen detec-
tion (RSV, inﬂuenza A (IA) and B (IB), parainﬂuenza (PIV) 1 + 2
and 3 and adenoviruses), using indirect immunoﬂuorescence
assay (IFA).
Results: Viral agents were associated in 1032 of 1847 ALRIs cases
(56%). The annual occurrence of viral ALRIs with the respiratory
viruses detected is showed in Table 1: RSV was identiﬁed in 933
NPA samples (90,4% of all viral diagnoses). Inﬂuenza A virus
(5%), adenovirus (1.6%), inﬂuenza B (1.5%), PIV (1 + 2) (0.9%)
and PIV3 (0.7%) accounted for 9.6% of the viral diagnoses. RSV
was prevalent in children under 1 year of age (99%).
Conclusions: RSV is the main aetiologic agent of viral ALRIs in
young hospitalised children.
R2333 Prevalence and antimicrobial resistance of bacterial
isolates causing paediatric blood-stream infections in a tertiary
hospital in Tanzania
B. Blomberg, D.S.M. Mwakagile, K.P. Manji, S. Harthug,
N. Langeland on behalf of the joint study group on antimicrobial
resistance at Muhimbili National Hospital,
Dar es Salaam, Tanzania and the University of Bergen, Norway
Objectives: Blood-stream infections (BSI) are commonly associated
with case-fatality rates in excess of 25% and infections caused by
drug-resistant organisms represent an additional therapeutic chal-
lenge. The objective of this study was to assess the prevalence
and resistance patterns of bacterial isolates causing BSI in children
at Muhimbili National Hospital, Dar es Salaam, Tanzania.
Methods: Blood cultures were obtained from 1789 children (age 0–
7 years) with fever or signs of serious infection admitted to the
hospital during the period August 2001 to August 2002. Isolates
were identiﬁed by standard methods and susceptibility tested by
disc diffusion method. Since only one blood culture was obtained
from each patient, we did not consider coagulase-negative staphy-
lococci and other organisms of uncertain pathogenicity in this
study.
1998 1999 2000 2001 2002 2003
Total
(n)n % n % n % n % n % n %
RSV 88 46.3 93 46.5 164 49.5 214 56.5 220 62.3 154 39 933
Adeno 1 0.53 0 0 1 0.3 1 0.3 1 0.3 12 3 16
IA 7 3.7 2 1 12 3.6 3 0.8 7 2 2.1 5.3 52
IB 0 0 0 0 0 0 0 0 14 4 1 0.25 15
PIV (t+2) 0 0 0 0 0 0 0 0 1 0.3 8 2 9
PIV 3 0 0 1 0.5 1 0.3 1 0.3 2 0.6 2 0.5 7
Total
positive
96 96 178 219 245 198 1032
Total
samples
190 200 331 379 353 394 1847
Positive
samples
(%)
50.5 48 53.8 57.8 69.4 50.25 56
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Results: Among the 1789 children included in the study, 149
had Gram-negative rods, 61 had Gram-positive cocci, 19 had
Candida spp. and one had Mycobaterium tuberculosis recovered
from blood cultures. The most common Gram-negative isolates
were K. pneumoniae (n ¼ 48), E. coli (n ¼ 36) and various Sal-
monella enterica serotypes (n ¼ 37, two Salmonella Typhii, 15 S.
Typhimurium, 19 S. Enteritidis and one S. Newport). The most
common Gram-positive isolates were Staphylococcus aureus
(n ¼ 20), E. faecium (n ¼ 17) and E. fecalis (n ¼ 15). The Gram-
negative isolates displayed high rates of resistance to most com-
monly used antimicrobial drugs, and even extended-spectrum
b-lactamase phenotype was present in high proportions of the
isolates.
Conclusion: Gram-negative bacteria such as K. pneumoniae, E. coli
and Salmonella serotypes are the most prevalent organisms caus-
ing BSI in children at this Tanzanian hospital. High rates of resist-
ance against commonly used antimicrobials raise concerns as to
the efﬁciency of current treatment regimens, and there are no
obvious affordable and appropriate alternative drugs available.
R2334 Neonatal sepsis due to Klebsiella species:
prevalence, outcome and antibiotic sensitivity
E. Malakan Rad, N. Momtazmanesh
Kashan, IR
Introduction: Sepsis is a signiﬁcant cause of morbidity and mortal-
ity in neonates. The most common pathogens of bacterial sepsis
and antibiotic sensitivity patterns vary in different parts of the
world. The aim of this study was to determine the most common
pathogens of neonatal sepsis and antibiotic sensitivity and out-
come of neonatal sepsis due to Klebsiella species.
Materials and methods: A retrospective descriptive study was car-
ried out. The study was performed in a neonatal care unit in Ka-
shan between October 2000 and October 2003.Only those neonates
with positive blood culture were included. Patients with Klebsiella
septicemia were categorised into two groups of early-onset and
late-onset. Frequencies and Fisher’s exact test (to compare early-
onset outcome vs. late-onset) were calculated by SPSS. P-value
<0.05 was considered signiﬁcant.
Results: A total of 136 neonates had positive blood cultures out of
453 cases. The most common pathogens were Pseudomonas, Klebsi-
ella and coagulase-negative staphylococci, respectively. In 43 cases
(32%) Klebsiella species were isolated. These isolates were all
resistant to ampicillin. Seventy-three per cent were resistant to
gentamicin. Twenty-three per cent of Klebsiella isolates were multi-
resistant (resistant to ampicillin, amikacin, gentamicin and all
third generation cephalosporins). In patients with Klebsiella sepsis
mortality was higher in early-onset sepsis than late-onset sepsis
(Fisher’s exact test, P ¼ 0.043).
Conclusion: Considering our most common aetiologic pathogens of
neonatal sepsis and the signiﬁcant number of resistant Klebsiella,
to ampicillin and gentamicin it seems prudent to consider revising
the present choice of empirical antibiotic treatment.
R2335 The effect of bacterial septicaemia on the plasma
motilin concentration in neonates
G. Szirer, J. Behrendt, U. Godula-Stuglik, E. Czech, J. Karpe
Zabrze, PL
Background: Plasma motilin concentration increase in ﬁrst 2 weeks
of life both in full-term and preterm healthy neonates. In severe
infected neonates gastrointestinal symptoms such delayed gastric
emptying, vomiting and paralytic ileus are frequently observed
and their association with plasma gastrointestinal hormones activ-
ity remains unclear.
Objectives: To determine if bacterial septicaemia may inﬂuence
plasma motilin concentration in sick neonates.
Materials and method: A total of 45 septic and 24 severe infected
neonates mainly with pneumonia, without sepsis (32 full-term, 37
preterm) were included to the study. Control group consisted of
healthy, born with Apgar score >9, breast-fed neonates. Birth
asphyxia in 41% and clinical symptoms of gastrointestinal tract
disorders in 50% of all severe infected neonates were noted.
Plasma motilin concentration (pmol/L) in peripheral vein blood
detected by radioimmunoassay method (Euro-diagnostic AB Swe-
den Set) were measured twice: between the second and fourth
and between the 12th and 14th day of life in sick neonates. In con-
trol group the test was performed only once between the second
and fourth day of life (ethical reasons).
Results: Plasma motilin concentration (ﬁrst test) in septic full-
term neonates ranged from 30.38 to 257.38, mean
90.6  54.31 pmol/L was signiﬁcantly higher (P < 0.05) than the
mean value of plasma motilin in septic prematures (range from
30.35 to 133.54, mean 60.01  26.59 pmol/L). There was no defer-
ence in the ﬁrst test between mean motilin concentration in
healthy full-term (range 37.51–131.24, mean 76.6  27.4 pmol/L)
and preterm neonates (range 38.85–99.91, mean
64.51  14.43 pmol/L). Moreover no difference was noted
between mean values of motilin concentration in neonates with
other kind of infection both in ﬁrst and second determinations.
Signiﬁcant increase (P < 0.01) of the mean motilin value was
found during the ﬁrst 2 weeks of life as well in full-term septic
neonates and septic prematures.
Conclusions: Bacterial septicaemia in preterm neonates may cause
the decrease of plasma motilin concentration.
R2336 ESBL producing Enterobacteriaceae among
paediatric patients
B. Rybak, M. Neuman-Laniec, E. Czarniak, J. Wierzba, N. Irga,
A. Samet, A. Balcerska
Gdansk, PL
Objective: The aim of this study was to analyse occurrence of
ESBL-producing Enterobacteriaceae in patients without haemato-
logical malignancies who were hospitalised in the institute of Pe-
diatrics, Medical University of Gdansk.
Methods and materials: We analysed microbiologic records obtained
in 2003. Strains were identiﬁed by classical method and VITEK
cards (BioMerieux). Production of ESBL was detected by double
disc method. ESBL colonisation was determined by a positive
stool/rectal/throat culture without any sign of infection.
Results: In the studied period 249 patients were hospitalised.
ESBL + isolates were recovered from 35 patients. 11 patients
were infected and 16 colonised, eight patients were both colo-
nised and infected. Klebsiella pneumoniae was isolated from 10
patients (20 isolates) then E. coli (20 isolates from nine patients)
and K. oxytoca (six isolates from four patients), E. aerogenes (10
isolates from six patients). Isolates were recovered from stools
and rectal swabs (56.6%), urine (28.3%), respiratory tract (9.4%)
and intravenous catheter tips (5.7%). A total of 24 patients
were admitted to the units with established ESBL colonisation.
Eleven patients acquired ESBL during hospitalisation. 36.9%
patients received cephalosporins, 18.4% aminoglucosides, 15.8%
amoxyxylin/clavulanic acid and 28.9% were not given any anti-
biotic. 25% infecting ESBL strains were detected in patients
with urinary-tract infections, 12.5% with epilepsy, 12.5% with
suspected pneumonia and 10.4% with cholestatic jaundice. All
strains were susceptible to carbapenems, about 90% to ﬂuoro-
quinolones and about 80% urine isolates to nitrofurantoin, but
about 80% isolate were resistant to aminoglucosides and co-
trimoxazole. 70% patients who were ESBL negative on admis-
sion, were bottle-fed and 30% were breast-fed. 70% of those
breast-fed were earlier admitted to different hospitals in our
region.
Conclusions: High percentage of ESBL carriage among children
complicates infection control and treatment of common urinary
tract infection. Patients on admission and before discharged
should be screened for ESBL carriage.
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R2337 Occurrence of Gram-negative nonfermenters in
neonatal intensive care units
K. Kristof, V. Cser, D. Szabo, F. Rozgonyi
Budapest, HUN
Objectives: To determine the prevalence, the susceptibility to anti-
microbials and genotypic relationship of clinical isolates of Pseudo-
monas aeruginosa, Acinetobacter baumannii and Stenotrophomonas
maltophilia in neonatal intensive care units.
Methods: Gram-negative nonfermenter strains were isolated from
different samples (blood culture, respiratory tract and urine) of
neonates treated in the neonatal intensive care unit between Janu-
ary 2001 and November 2003. The strains were identiﬁed using
the ATB and Vitek systems (bioMe´rieux) and genotyped with AP-
PCR (ERIC-2). Susceptibility to antibiotics was evaluated by disc
diffusion method and by E-test strip.
Results: Of 6544 blood cultures from three NICUs of the univer-
sity hospitals 910 (14%) gave positive results. Among these cul-
tures, 27 P. aeruginosa (3%), two (0.2%) A. baumannii and four
(0.4%) S. maltophilia were isolated from colonised or infected neo-
nates. 212 P. aeruginosa strains (14%), 13 A. baumannii (0.9%) and
56 S. maltophilia (3.8%) were isolated. Amikacin, imipenem and
meropenem were the most effective antimicrobial agents against
P. aeruginosa and Acinetobacter baumannii strains with sensitivity
rates of 91/100%, 76.8/100% and 88.4/100%. The incidence of
resistance to aminoglycosides, ceftazidime, ciproﬂoxacin and
moxiﬂoxacin among strains of S. maltophilia was 100, 34, 76 and
0%. No cotrimoxasole resistant strain was found. Based on the
results of AP-PCR the strains could be divided many different
clones.
Conclusion: Nowadays Gram-negative nonfermenter strains seem
to be one of the leading causes of nosocomial infections, especially
in intensive care units. These strains could have been isolated
from respiratory tract samples more frequently, than other type of
samples. Management of these infections may be difﬁcult due to
the inherent multidrug resistance of strains. The high genetic
diversity among the isolates probably means that the multiple
independent environmental sources are more relevant than the
cross-transmission in nosocomial infections, therefore the inde-
pendent infections are more probable.
R2338 Neonatal brucellosis: probable transmission from
breast milk
A. Enrı´quez, M. Garcı´a-Hortelano, A. Amor, M. Martı´nez-Padial,
M. Baquero
Madrid, E
Brucellosis is primarily a zoonotic infection which can be trans-
mitted to humans through direct contact with infected animals,
their carcasses or ingestion of unpasteurised milk or milk prod-
ucts. Human-to-human transmission is rare. Neonatal infection
can be acquired transplacentally or during delivery. However,
some cases of breast-feeding transmission have been described.
The diagnosis of brucellosis is difﬁcult in infancy because the
symptoms are nonspeciﬁc and the disease may be mild and self-
limited.
Case: A 3-month-old child with acute brucellosis is reported. Fif-
teen days after delivery, the mother became acutely ill with fever
and progressive malaise. Based on a positive seroaglutinattion
test. The patient was treated with doxycycline and gentamicin.
Brucella melitensis grew in blood cultures and agglutination titre in
serum was signiﬁcant. At the same time, the child was submitted
to the Pediatrics department. He was healthy, without fever and,
except for splenomegaly, the physical examination was normal. B.
melitensis was also isolated in blood cultures. The infant had been
exclusively breast-fed when his mother developed brucellosis. In
order to avoid complications due to the use of tetracyclines, the
patient was treated with rifampicin and cotrimoxazole with good
evolution and tolerance.
Conclusions: B. melitensis transmission can occur through breast-
milk and should be considered in children who were breast-feed-
ing in mother recently infected
R2339 Fatal acute infectious purpura fulminans in a child
caused by Haemophilus inﬂuenzae – a case report
E. Arlukowicz, A. Samet, T. Goss
Gdansk, PL
Objective: The aim of the study was to present a case report of
child who suffered from acute infectious purpura fulminans. The
progression of the disease was so rapid that we could not take
specimens for culture. Postmortem cultures were obtained.
Case report: A mother of an 8-month-old child noticed high tem-
perature and haemorrhagic rash on skin. Additionaly, bronchial
infection was suspected. The child died within 10 h from the
onset of symptoms. In the postmortem examination, the following
day, no signs of respiratory tract infection nor infectious organ
inﬁltration were found. There was only a haemorrhagic effusion
of suprarenal glands. In postmortem cultures we isolated Haemo-
philus inﬂuenzae (HI) from cerebrospinal ﬂuid and bronchial aspir-
ate and Streptococcus pneumoniae (SP) from bronchial aspirate.
Blood cultures were negative.
Conclusions: Acute HI infection could be very rapid and fatal. The
recognised symptoms, which were nonspeciﬁc, included fever
and haemorrhagic rush all over the body.
R2340 Study of the epidemiology of Shigella spp. in
Tehran, Iran during 2002–2003
R. Ranjbar, M.M. Soltan Dallal, M.R. Pourshaﬁe
Tehran, IR
Objective: Shigellosis is an infectious disease caused by a group
of bacteria called Shigella. The illness is also known as ‘bacillary
dysentery’ and is more severe than other forms of gastroenter-
itis. Shigellosis in children remains an important problem in
developing countries. The purpose of this study was to investi-
gate epidemiology of shigellosis in Tehran, Iran during a 1-year
period.
Methods: Between January 2002 and December 2003, faecal sam-
ples of individual patients referring to the Children’s Hospital
Medial Center, Moﬁd Children’s Hospital, Baqiatallah (a.s), Mil-
lad, and Firozabadi Hospitals were cultured for Shigella spp. using
standard microbiological techniques. Isolates were identiﬁed by
biochemical and serotyping methods.
Results: From a total 302 Shigella isolates, 178 were identiﬁed as S.
sonnei (58.940%), 110 as S. ﬂexneri (36.424%), 10 as S. boydii
(3.311%), and four as S. dysenteriae (1.324%). In this study Shigella
sonnei was the predominant species, followed by S. ﬂexnery. Over-
all, 167 patients (55.3%) were males and 135 (44.7%) were
females. Shigella was isolated frequently from children under
5 years of age, who accounted for 66% of all isolates. About
29.2% of all isolates came from persons aged 5–10 years, and
4.8% from persons aged over 10 years of age. The peak of infec-
tion occurred during summer. In Children’s Hospital Medial Cen-
ter Mortality rates of shigellosis was 2.14%.
Conclusion: Bacillary dysentery still constitutes a signiﬁcant pro-
portion of acute intestinal disease in the children of Iran. Unlike
previous years, in this study S. sonnei was reported as the pre-
dominant serotype.
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R2341 Serotypes and subtypes of N. meningitidis
serogroup B from Argentinian children with invasive disease
S. Gonza´lez Ayala, C. Vescina, M. Agosti, B. Gatti, E. Cecchini,
M. Regueira
La Plata, AR
Introduction: N. meningitidis (Nm) is the leading causative agent of
bacterial meningitis in children in Argentina.
Objective: To study the frequency of isolation for NmB serotypes
and subtypes through a 3-year period, 2000–2002.
Material and method: Blood an CSF cultures and typiﬁcation were
made by standard methods, and identiﬁcation with DIFCO serum
at Microbiology Laboratory, Sor Marı´a Ludovica Children Hospi-
tal, La Plata, Argentina. Sero and subtyping with speciﬁc mono-
clonal antibodies by ELISA were made at National Institute for
Infectious Diseases Dr Carlos G. Malbra´n (Buenos Aires).
Results: A total of 102 strains were isolated. The number of isola-
ted strains were 40, 29, and 33 for the year 2000, 2001 and 2002,
respectively. The most frequent sero and subtypes were: (i) for
the year 2000, B15.P1.7.16 (27.5%), B4.P1.NT (23.2%), B4.P1.15
(10%), B15.P1.NT (7.5%) and B1.P1.NT (7.5%); (ii) for the year
2001, B4.P1.NT (24.1%), B15.P1.NT (13.8%), B15.P1.7 (13.8%),
B1.P1.NT (6.9%) and B4.P1.14 (6.9%); (iii) for the year 2002,
B4.P1.NT (18.2%), B4 P1.15, B15.P1.NT, B15.P1.7 and B4.P1.14
(6.7% for each one).
Comment: Clinical laboratory data is useful for surveillance and to
identify common antigens in order to obtain an eﬁcacious vaccine.
R2342 Study of mortality rates of shigellosis and a report
of three shigellosis cases resulted in death in the Children’s
Hospital Medical Center, Tehran, Iran during 2002–2003
R. Ranjbar, M.M. Soltan Dallal, N. Parvaneh
Tehran, IR
Objectives: More than 1 million deaths occur yearly due to infec-
tions with Shigella and the victims are mostly children of the
developing world. Small children and the elderly are at greatest
risk to experience mortality from a Shigella infection. In this
research, we studied mortality rate of shigellosis during 1-year
period in the Children’s Hospital Medical Center, Tehran, Iran.
Moreover clinical and microbiological features of three cases of
shigellosis that resulted in death was studied.
Methods: Between January 2002 and December 2003, all of patients
with gastrointestinal disease referring to the Children’s Hospital
Medical Center were studied for shigellosis. Of all patients that
were identiﬁed as shigellosis cases, three patients died. Before
death, these three patients were admitted with a history of watery
diarrhoea, vomiting, and generalised tonic clonic seizures. They
were transferred to intensive care unit (ICU) and were intubated.
Intravenous antibiotic therapy with ceftriaxone was administrated
immediately after admission. Faecal specimens were cultured for
Shigella spp.using standard microbiological methods. Antibiotic
susceptibility of bacterial isolates to the 20 antibiotic was per-
formed.
Results: Of 140 causative bacterial isolates, 68 were identiﬁed as
S. sonnei (48.6%), 65 as S. ﬂexnery (46.4%), ﬁve as S. boydii
(3.6%), and two as S. dysenteriae (1.4%). From of total cases,
three patients died (mortality rates 2.1%). These three patients
have been admitted with a history of watery diarrhoea, vomit-
ing, and generalised tonic clonic seizures. No signs of severe
dehydration were observed. The symptoms of patients were not
improved with treatment, and all three patients were expired
within 24 h of hospitalisation. Two patients were female and one
other was male. The ages of these three patients ranged from
13 months to 8 years. In two patients, stool cultures were posit-
ive for S. sonnei and in one other patients, were positive for S.
ﬂexnery. Of three isolates, two had similar antimicrobial resist-
ance patterns.
Discussion: Dysentery accounts for 20% of the 4.6 million diar-
rhoea-associated deaths among children in developing countries
and Shigellosis accounts for the majority of dysenteric episodes.
Many studies have shown that fatality may be as high as 10–15%
with some strains. In this study mortality rates was 2.1%.
Whereas mortality caused by other species than S. dysenteriae is
rare but in this study S. sonnei and S. ﬂexnery were causative
agents of three deaths.
Mycobacterial infections (incl. diagnosis)
R2343 Comparison of the MB/BacT ALERT 3D system, the
Lowenstein-Jensen medium and the Middlebrook 7H10/7H11
plate for recovery of mycobacteria
H. Adler, C. Straub, R. Frei
Basle, CH
Objective: A retrospective study was carried out in order to com-
pare the MB/BacT ALERT 3D system, the Lowenstein–Jensen (LJ)
medium and the Middlebrook 7H10/7H11 plate for the recovery
of mycobacteria from clinical specimens.
Material and methods: During a period of 25 months 6250 clinical
samples were tested for mycobacteria. All isolates where data of
all three media were available were included in the evaluation.
Isolates from urine and blood were excluded because a different
panel of media had been used.
Results: A total of 343 isolates of mycobacteria, namely 285 iso-
lates of M. tuberculosis (MTBC) and 58 isolates of nontuberculous
mycobacteria (NTM), were included in the evaluation. BacT/
ALERT detected 308 isolates (90%), LJ medium 277 isolates (81%)
and 7H10/7H11 detected 273 isolates (80%). The combination of
BacT/ALERT and LJ medium detected 334 isolates (97%), the
combination BacT/ALERT and 7H10/7H11 detected 327 isolates
(95%) and the combination of LJ medium and 7H10/7H11 detec-
ted 315 isolates (92%).
Conclusions: The combination of BacT/ALERT and LJ medium
performed only marginally worse than the combination of all
three media. Although it missed four isolates of MTBC, it detected
MTBC in other specimens of the same patients, thus not missing
any case of tuberculosis. Accordingly, although it missed ﬁve iso-
lates of NTM, it missed only one case (M. marinum) that was con-
sidered clinically relevant. The combination of Bact/ALERT and
LJ medium is sufﬁcient and costeffective for the isolation of myco-
bacteria in the clinical laboratory. It poses less problems with con-
tamination than a panel of media that contains Middlebrook agar.
R2344 Comparison of two different therapeutic regimens
of DOT strategy in patients with pulmonary tuberculosis
B. Ataei, A. Omoumi, A. Javadi
Isfahan, IR
Objectives: To compare the effect, complication, and treatment cost
of two different therapeutic regimens of DOT’s strategy in treating
patients with pulmonary tuberculosis (TB) and positive sputum
smear test.
Methods: A clinical trial was done on 200 patients aged 15–
50 years with pulmonary tuberculosis and no history of previous
treatment for TB, Immunocompromise, liver, and kidney diseases.
(pregnant women excluded from this study) Selected patients
divided into two groups randomly and one group was treated by
using the Denver method (62 doses), and the other group treated
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with routine standard method (180 doses), Sputum smear test
was performed for each patient at the end of 2, 4, and 6 months
of treatment, and ﬁnally collected data were analysed by SPSS
software and Fisher method (P < 0.05).
Results: Cure occurred in 94% of patients treated by Denver
method and in 93% with routine standard method, this result
was not signiﬁcant, also we could not ﬁnd signiﬁcant difference
in complications occurred during using these two methods. (9%
in Denver method vs. 6% in standard method)
Conclusion: With regard to using drugs just twice a week in Den-
ver method and its lower cost treatment, Denver method will be
better than standard method and patients compliance will be
more in this method.
R2345 Comparison of the VersaTREK to the ESP Culture
System II for mycobacterial detection and susceptibility testing
V. LaBombardi, D. Fett, A. Kamel, N. Sullivan
New York, Madison, USA
Objective: Studies were conducted at two sites, Trek Diagnostic
Systems Laboratory (TS) Sun Prairie WI, USA, and at Vincent’s
Hospital (SVH) New York, New York, USA, to validate the per-
formance of the VersaTREK (VT) instrument for the detection and
susceptibility testing of mycobacteria.
Methods: In a study conducted at TS, standardised suspensions of
nine isolates of mycobacteria were tested in the VT and the ESP
Culture System II (ESP). The time to detection (TTD) of a positive
culture and typical curve response was evaluated. Reproducibility
studies using ﬁve isolates of M. tuberculosis (M. tb) tested on three
different days were conducted at TS. A seeded study comparing
TTD in the VT and in the ESP using seven strains of M. tb was
conducted at SVH. Susceptibility studies using strains of M. tb
with known resistance proﬁles were conducted at TS, while a
comparative study using clinical isolates was conducted at SVH.
A clinical trial using split patient specimens for the ability to
detect growth of mycobacteria is ongoing at SVH.
Results: The nine isolates representing seven species of mycobacte-
ria were shown to exhibit comparable TTD and typical curve
response when tested in both systems. The reproducibility studies
with M. tb demonstrated that the average TTD for the VT was
5.53 days compared with 5.37 days for the ESP. Studies on seeded
clinical isolates showed that the isolates incubated in the VT had
comparable TTD to those incubated in the ESP. Susceptibility
studies using isolates of M. tb correctly identiﬁed three isolates
that were susceptible to the four ﬁrst line agents, one that was
resistant to INH and one resistant to ethambutol. Comparative
susceptibility studies between the VT and ESP were in complete
agreement with the four ﬁrst line agents and PZA. An ongoing
split sample clinical trial at SVH has not demonstrated any signiﬁ-
cant difference between the two systems.
Conclusions: The VT was demonstrated to be comparable to the
ESP for the detection of mycobacteria and for susceptibility testing
of M. tb.
R2346 Application of nested PCR and reverse
hybridisation for diagnosis of central nervous system
tuberculosis
J. Paluch-Oles, A. Kolodziejek, M. Koziol-Montewka
Lublin, PL
Tuberculosis of central nervous system (CNS) is regarded to be
the less common form of extrapulmonary tuberculosis, but at the
same time, the most severe with the highest mortality rate among
all forms of the disease. Low rate of Mycobacterium tuberculosis
detection in cerebrospinal ﬂuid (CSF) when culture methods are
used is the main diagnostic problem. In consequence, it results in
low gauges of CNS tuberculosis in epidemiological data. Increas-
ing frequency of the drug-resistant strains and their long-lasting
identiﬁcation with classical methods are other major contributing
factors to the difﬁculties in rapid selection of the most appropriate
treatment course.
Objectives: Evaluation with nested PCR of M. tuberculosis complex
presence in CSF of patients with suspicion of CNS tuberculosis
and identiﬁcation of rifampin-resistant strains with application of
reverse hybridisation. Improvement of the diagnosis by detecting
the bacteria in blood samples, which is to our knowledge the ﬁrst
to be used.
Methods: A total of 52 CSF and 11 blood samples derived from 39
patients with suspicion of CNS tuberculosis (mean age: 40.7 years)
and hospitalised at neurology departments of Lublin clinics
between June 2000 and December 2003 was studied. The commer-
cial kit of A&A Biotechnology (Poland) was used for DNA extrac-
tion from the samples. Protocols and reagents of Inno-Lipa Rif.TB
(Innogenetics, Belgium) for nested PCR were used to detect M.
tuberculosis. The target gene was RNA-polymerase b-subunit gene
(rpoB) for M. tuberculosis complex. Reverse hybridisation was
applied after ampliﬁcation reaction to conﬁrm positive result of
nested PCR and to identify rifampin-resistant strains.
Results: During the study period 15 of 37 patients (40.5%) were
detected Mycobacterium tuberculosis complex in the CSF and four
of 11 patients (26.7%) in blood samples. Application of the
hybridisation allowed to exclude three false-positive results of the
nested PCR reaction and to identify four strains of 16 evaluated
as rifampin-resistant.
Conclusions: We conclude that application of genetic tools increa-
ses the identiﬁcation of CNS tuberculosis and a detection of rifam-
pin-resistance strains allows quick selection of the accurate
treatment. Blood samples may be useful in the disease diagnos-
tics. Diagnosis with use of PCR indicates on more frequent inci-
dence of CNS tuberculosis in epidemiological data then it has
been previously regarded.
R2347 Evaluation of the MB/BacT system for antimicrobial
drug susceptibility testing of Mycobacterium tuberculosis
J. Lago, A. Reme´dios, A. Silva Grac¸a
Lisbon, P
Objective: Evaluate the ability of the MB/BacT culture system to
perform antimicrobial susceptibility testing of Mycobacterium tuber-
culosis to isoniazid, rifampin, streptomycin and ethambutol by
comparing the results to those obtained by the agar proportion
method on Lowenstein-Jensen (LJ) medium.
Methods: We performed paired antimicrobial susceptibility test
(AST) on 34 Mycobacterium tuberculosis complex (Mt) clinical
strains with the MB/BacT system (Biome´rieux) using the BacT/
ALERT SIRE kit and the agar proportion method on LJ using the
Mycobacterial susceptibility testing (Biome´rieux). The control
strain H37Rv (ATCC 27294) was tested by both methods as a
quality control. All strains were identiﬁed by the Accuprobe cul-
ture identiﬁcation test (Gen Probe). Four antimicrobial drugs were
evaluated: streptomycin (1.0 lg/mL in MB/BacT and 4.0 and
10.0 lg/mL in LJ), isoniazid (0.1 lg/mL in MB/BacT and 0.2 and
1.0 lg/mL in LJ), ethambutol (5.0 lg/mL in MB/BacT and 2.0
and 3.0 lg/mL in LJ) and rifampin (1.0 lg/mL in MB/BacT and
20 and 40 lg/mL in LJ). The tests were conducted according to
the instructions given by the manufacturer.
Results: The control strain H37Rv performed as expected: sus-
ceptible to four drugs by the two methods. Of the 34 Mt strains
tested with the MB/BacT system, we detected seven strains
resistant to one or more drugs (three were multiresistants) and
27 strains susceptible to all four drugs. Full agreement of rifam-
pin and isoniazid results was found for all isolates. The two
methods showed concordance for the four drugs tested in 30
strains (88.2%). There was disagreement in one case (2.9%) for
Ethambutol (resistant by LJ and susceptible by MB/BacT) and
three cases (8.8%) for streptomycin (one susceptible by LJ and
resistant by MB/BacT and two resistants by LJ and susceptibles
by MB/BacT). Turnaround times for AST ranged from 5.5 to
13.0 days for MB/BacT.
Conclusions: These results indicate that the MB/BacT system is
shown to be a reliable, rapid, fully automated, nonradiometric
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system for the susceptibility test of Mycobacterium tuberculosis com-
plex.
R2348 Second-line antituberculosis drug susceptibility in
multiresistant Mycobacterium tuberculosis strains
R. Kayali, N. Coplu, I. Ceyhan, M.B. Saygan, B. Esen
Ankara, TR
Objectives: MDR-TB is a worldwide problem and second-line
drugs should be added to the therapy. In Turkey in spite of
some regional studies, there is no national data about second-
line drugs. In this study, the objective was to evaluate the drug
resistance pattern of the second-line drugs in MDR-TB strains in
Turkey.
Methods: This study was performed in Tuberculosis Referance
Laboratory, RSNHC. The tests were done in 51 MDR-TB strains,
which were from nine provinces among ﬁve of the seven regions
in Turkey between August 2002 and August 2003. The number
and the incidence (per 100 000) of the strains in the provinces
Trabzon, Ankara, Van, Elazig, Kayseri, Duzce, Samsun, Izmir,
Antalya were 17/18.05, 10/14.22, 8/14.36, 5/27.04, 4/13.96, 4/
44.87, 1/34.07, 1/33.52 and 1/17.33, respectively. Indirect propor-
tion method with Loewenstein-Jensen medium was applied for
the susceptibility tests of the second-line antituberculosis drugs.
The antibiotics used, and the concentration critics in microgram
per millilitre were: ethionamide (ETH 20–30), thioacetazone (TIA
2), cycloserin (CYC 30–40), kanamycin (K 20–30), p-aminosalicylic
acid (PAS 0.25–0.5), oﬂoxacine (OFL 2) and capreomycin (CAP
20–40). M. tuberculosis H37Rv strain was used for quality control.
Results: The number and the ratio of the resistant strains for ETH,
CYC, K, PAS, OFL, TIA and CAP were 24 (47%), four (8%), three
(6%), three (6%), two (4%), one (2%), 0. (0%) respectively. The
41% of the strains showed resistance to one drug, 8% to two
drugs, 2% to three drugs, and 2% to four drugs.
Conclusion: In this study, second-line drugs which are important
in MDR-TB therapy seem to be effective with >8% resistance ratio
other than ETH. It is also realised that polydrug resistance is not
high so that these drugs are promising for treatment.
R2349 Mycobacterium tuberculosis sigma factor genes
expression after exposure to rifampicin
J. Pendzich, W. Mazur, U. Mazurek, S. Dworniczak, J. Kozielski,
K. Oklek
Katowice, PL
Objectives: The aim of this work was to determine Mycobacterium
tuberculosis sigA, sigE, sigF, sigH and sigI genes, and the reference
85B gene expression under stress conditions due to rifampicin
exposure.
Methods: The sputum sample was processed, seeded on L-J med-
ium, and incubated for 4 weeks in standard conditions. Than, M.
tuberculosis culture was transferred to the Middlebrook 7H 9 med-
ium, standardised to McFarland 0.5 and grown for further 48 h.
The cells were exposed to rifampicin concentrations of 10, 20, 25,
35 and 40 lg/mL. Cell suspensions were collected after 1, 12 and
48 h of exposure. The obtained mycobacterial strain was suscept-
ible to rifampicin. Total RNA was extracted from 100 lL of each
broth culture by a modiﬁed guanidine–phenol–chloroform
method. A one-step RT-QPCR reaction was done with ABI-PRISM
7700 sequence detection system (TaqMan). Sequence speciﬁc PCR
primers and oligonucleotide detector probes labelled with FAM
and TAMRA were used.
Results: Changes in 85B, sigA, sigE, sigH and sigI mRNA levels
were noted in comparison with the control M. tuberculosis cul-
tures. In the exposed cultures a decrease of 85B, sigE, sigH mRNA
levels was seen. SigA and sigI mRNA were not detected in the
control cultures. Exposure to rifampicin induced expression of
these genes. SigF transcript was not detected neither in the
exposed cultures, nor in the controls.
Conclusion: The results of our studies suggests that M. tuberculosis
genes encoding sigma factors A, E, H and I, and 85B mRNA parti-
cipate in cellular response/reaction to rifampicin exposure.
R2350 Beijing genotype in Bilbao
J.L. Barrios, M.J. Unzaga, C. Aspichueta, C. Ezpeleta, F. Calvo,
A.B. Lope´z, P. Velasco, B. Amezua, R. Cisterna
Bilbao, E
Introduction: Due to the notiﬁcations of an increment in the num-
ber of multirresistant Mycobacterium tuberculosis around the world,
the objective of our work was to know the situation of this trouble
in our hospital. This centre is Basurto’s Hospital, a tertiary Hospi-
tal with 800 beds that give cover to the area of Bilbao.
Material and methods: We have realised a retrospective study of
the sensibility of M. tuberculosis in our hospital since 1998–2002.
The used method to know the sensibility was Susceptibility Test
Kit of BIO RAD based in Cannetti’s proportions method, and
since 1999 we started use the liquid system BD BACTECMGIT
960, both of them following the maker instructions. MGIT 960 uti-
lises these concentrations of antibiotics: isoniazid (I) (0.1 lg/mL),
rifampin (R) (1.00 lg/mL), ethambutol (E) (5.00 lg/mL), strepto-
mycin (S) (1.00 lg/mL) and pyrazinamide (P) (100 lg/mL). We
have considered multirresistance if appear resistance for two ﬁrst
line tuberculostatics.
Results: For the 365 studied isolates, we only have found one
multirresistant isolate. This resistant was for all ﬁrst line tubercul-
ostatics (I, R, E, S and P). The case was a male of 55 years old,
VIH-, smoker and moderate drinker, worked as host. His anteced-
ents were: Pleuritis 35 years ago and some residual pulmonary
images in chest radiography. Before the patients got admitted in
the hospital suffered a subacute syndrome based in: chest pain,
cough with mucous expectoration ocassionally green and without
fever. In the day of his ingress had sputums with blood. In the
chest radiography were observed calciﬁed nodular images in left
lung and cavitated inﬁltrate in upper right lobule. They instaurat-
ed treatment with I, R and P but was changed due to Microbio-
logy Service informs and reiterated positive baciloscopes. The
resistant was primary for all of them and the genotypic study
conﬁrmed that was Beijing genotype.
Conclusions: In our medium is still very small the number of
multi-resistant stems (1/365) being more frequent the resistant for
one tuberculostatic as I (7%) or R (1.1%). Our case was a 55 years
smoker male, host and without interest antecedents who presen-
ted a subacute pulmonary syndrome. We do not know any trans-
mission from the patient to his contact group. Presented primary
resistant for all ﬁrst line tuberculostatics and the genotypic study
showed that it was Beijing type.
R2351 Mycobacterium tuberculosis drug resistance in
Adana, Turkey
F. Kibar, A. Yaman, I.H. Du¨ndar
Adana, TR
Objective: To evaluate the drug resistance pattern to ﬁrst-line anti-
tuberculosis drugs for Mycobacterium tuberculosis strains isolated in
our University Hospital.
Methods: In this retrospective study, isolation and susceptibility
testing of Mycobacterium tuberculosis was carried out using the
BACTEC 460TB system and/or the mycobacterial growth indica-
tor tube (MGIT). From January 1, 1998 to December 31, 2002, a
total of 774 strains of M. tuberculosis were analysed. The annual
number of isolates was 107, 162, 172, 164 and 169, in the 5-years
period between 1998 and 2002, respectively.
Results: Total resistance to any drug was 24.3% (26 strains) in
1998, 27.8% (45 strains) in 1999, 20.9% (36 strains) in 2000, 34.8%
(57 strains) in 2001 and 29.6% (50 strains) in 2002. Of 774 isolates,
214 (27.6%) had resistance to at least one ﬁrst-line antituberculosis
drug, of which 115 (14.9%) had mono-resistance, 69 (8.9%) had
multidrug-resistance (MDR-TB; resistance to at least isoniazid and
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rifampicin). The overall proportion of isolates resistant to each
drug were as follows: isoniazid, 23.8%; rifampicin, 10.2%; etham-
butol, 6.3%; and streptomycin, 5.4%. Monodrug resistance was
observed most often to isoniazid (11.4%, 88 strains). Resistance to
rifampicin, ethambutol and streptomycin alone was rarely seen
(0.9%, seven strains; 1.2%, nine strains and 1.4%, 11 strains,
respectively).
Conclusion: These data have demonstrated that resistance of M.
tuberculosis to ﬁrst-line antituberculosis (TB) drugs, particularly to
isoniazid and rifampicin, is a growing problem in our region. For
this reason, the application of the effective treatment and TB con-
trol programmes are of a great importance.
R2352 Pneumoniae caused by Mycoplasma pneumoniae
J. Videnovic-Ivanov
Belgrade, CS
In the previous period of 6 years we analysed patients with
improved clinical, radiographs and laboratories, pneumonias. The
leading symptom and indication for hospitalisations in 29 (5.3%)
patients were haemoptysis. Patients were in ages from 15 to
45 years, and mainly males: 18 (62.1%) and 11 (37.9%) females.
Besides haemoptysis in 14 (48.2%) patients dominated high tem-
peratures, cough, headache, chest pain and myalgia. 20 (41.3%)
patients had subfebrile states. In three (10.3%) patients haemopty-
sis were the only symptom of illness. Radiographic manifestations
on admission to the hospital, showed hilar lymphadenopathies
accompanied with nonhomogenous shadows in the upper right
lung in ﬁve (17.2%) patients and almost the same lesions on the
right were ﬁnd in four (13.5%) on the left side. 10 (34.4%)
patients had in homogenous shadows in lower lobe. Prominent
reticular ﬁndings were localised in the middle lobe in 2 (6.8%)
patients. Basal spot shadows on the left with ipsilateral pleural
effusion were found out in three (10.3%) patients. Round shaped
shadowings in the left upper lobe were reported in ﬁve (17.2%)
patients. In all 29 patients serologic reactions of complement bind-
ing conﬁrmed Mycoplasma pneumoniae with antibody IgG and IgM
titres. The effects of macrolides therapies were good in all patients
after average period of 19.4 days.
R2353 Tuberculous otitis media in a renal transplant
recipient
K.-O. Memikoglu, A. Altunsoy, S. O¨zkan, K. Go¨kcan, F. Cokca
Ankara, TR
Introduction: Tuberculosis was a serious public health problem.
Tuberculous (TB) otitis media can be difﬁcult to diagnose because
it can easily be confused with other acute or chronic middle ear
conditions. As TB oitis media in a rare disease, the diagnosis is
usually delayed.
Case report: We present the case of a 25-year-old female, devel-
oped persistent oititis media at 5 years, which failed to respond to
multiple courses of antibiotics and surgery. A patient underwent
renal transplantasion in 1997 and she is still on corticosteroid and
cyclosporine-A therapy. She had a chronic tympanic membrane
perforation, abundant pale granulation tissue in the middle ear
and ear drainage associated with progressive and profound hear-
ing loss. Postmastoidectomy recurrence of granulation tissue, slow
wound healing, persistent otorrhoea. ARB was detected by EZN
that conﬁrmed the diagnosis of Mycobacterium infection. She was
given ethambutol 1500 mg/day, isoniazid 300 mg/day, rifampin
600 mg/day and morphozinamide 2500 mg/day.
Conclusion: Finally, the ﬁnal diagnosis can be difﬁcult because it
requires special culture and pathologic studies. Early treatment is
essential in order to avoid propagation of the disease and lasting
loss of function.
R2354 Pott’s disease: a case report
O. Baylan, E. Oguz, O. Kisa, A. Albay, L. Doganci
Ankara, TR
Pott’s disease, the most dangerous form of tuberculosis, still con-
stitutes a public health problem in developing and underdevel-
oped countries. We reported a patient with loss of weight, a 7-
month history of severe back pain, weakness, lack of appetite,
progressive disability to walk, kyphotic deformity. Deﬁnitive
diagnosis was performed by microbiological diagnostic proce-
dures (acid-fast stain, conventional and radiometric cultures, po-
lymerase chain reaction) and the patient was treated with the
combination of surgery and antituberculosis chemotherapy. The
combined application of culture methods with molecular identiﬁ-
cation of mycobacteria is an effective strategy to prevent a delay
in deﬁnitive diagnosis and completely treatment of Pott’s disease.
This combination of surgery and antituberculosis chemotherapy
produced good results in our patient. Physicians must not omit
tuberculosis in the differential diagnosis of any spine inﬂamma-
tory process so that speciﬁc treatment may be initiated as soon as
possible.
R2355 Antimycobacterial activity of oﬂoxacin, ciproﬂoxacin
and amikacin against Mycobacterium tuberculosis
A. Raﬁ, R Moaddab, S. Amini
Tabriz, IR
Objectives: Despite recent advances in chemotherapy and a steady
improvement in health conditions, tuberculosis still represents a
common disease in the world. The incidence of resistant Mycobac-
terium tuberculosis to single or multiple drug therapies employing
standard drugs is increasing in almost all countries. The aim of
this study was to investigate the in vitro susceptibility of resistant
Mycobacterium tuberculosis isolates to some anti-mycobacterial
agents.
Methods: In the present study, in vitro activities of oﬂoxacin, ci-
proﬂoxacin and amikacin against 45 drug resistant and 15 sus-
ceptible Mycobacterium tuberculosis isolates were studied by
proportion method. Susceptible strains were used as a control
group.
Results: All of the 60 isolates were found to be susceptible to oﬂ-
oxacin and ciproﬂoxacin. From 24 isolates that were resistant to
streptomycin, only six were resistant to amikacin. Fifteen suscept-
ible strains as a control group were sensitive to alternative drugs.
Conclusions: The ﬁndings of this study suggest the usefulness of
oﬂoxacin, ciproﬂoxacin and amikacin as alternative drugs in the
treatment of resistant tuberculosis.
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